NCT ID,Acronym,Overall Status,Start Date,Conditions,Interventions,Locations,Primary Completion Date,Study First Post Date,Last Update Post Date,Study Type,Phases,Sponsor,Sponsor Type,Disease
NCT00742326,Unknown,TERMINATED,2008-08,"HIV, Hepatitis C, Liver Disease, Fatty Liver, Steatosis","Pioglitazone, Placebo","Washington - United States, Bethesda - United States",2013-01,2008-08-27,2016-12-09,INTERVENTIONAL,PHASE4,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01717326,C-WORTHy,COMPLETED,2013-02-07,Hepatitis C,"Grazoprevir, Elbasvir, Placebo to Elbasvir, Ribavirin",No locations listed,2015-02-23,2012-10-30,2021-02-05,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01641926,Unknown,TERMINATED,2012-11-26,"Hepatitis B, Chronic","PEG-Intron™, PEGASYS™",No locations listed,2016-01-21,2012-07-17,2018-08-27,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00240526,Unknown,COMPLETED,2003-10,Hepatitis B,"Engerix™ -B, Hepatitis B immunoglobulin (HBIg)",Bangkok - Thailand,2010-03,2005-10-18,2016-12-07,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05177926,Unknown,UNKNOWN,2021-04-04,"Hepatitis B, Chronic, Mother to Child Transmission",antiviral prophylaxis with Tenofovir Alafenamide Fumarate,"Chang chun - China, Foshan - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Hangzhou - China, Nanjing - China, Shanghai - China, Shenzhen - China, Xi'an - China",2023-12-31,2022-01-05,2022-01-05,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT01492426,COMMAND-3,COMPLETED,2012-01,Hepatitis C,"Daclatasvir, Telaprevir, Peginterferon alfa-2a, Ribavirin","Birmingham - United States, Phoenix - United States, Long Beach - United States, San Diego - United States, New Haven - United States, Orlando - United States, Atlanta - United States, Marietta - United States, Chicago - United States, Chicago - United States, Baltimore - United States, Lutherville - United States, Saint Paul - United States, St. Louis - United States, New York - United States, Chapel Hill - United States, Charlotte - United States, Durham - United States, Philadelphia - United States, Providence - United States, Providence - United States, Ft. Sam Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Prov. Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Camperdown - Australia, Penrith - Australia, Westmead Nsw - Australia, Greenslopes Qld - Australia, Adelaide - Australia, Fitzroy - Australia, Prahran - Australia, Linz - Austria, Wien - Austria, Wien - Austria, Sao Paulo - Brazil, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Ottawa - Canada, Toronto - Canada, Hvidovre - Denmark, Odense - Denmark, Besancon - France, Bondy Cedex - France, Grenoble Cedex 09 - France, Lille Cedex - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Pessac - France, Strasbourg - France, Berlin - Germany, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Koeln - Germany, Haifa - Israel, Nazareth - Israel, Tel Aviv - Israel, Zefat - Israel, Bergamo - Italy, Cisanello (pisa) - Italy, Firenze - Italy, Napoli - Italy, Torino - Italy, Bialystok - Poland, Chorzow - Poland, Kielce - Poland, Myslowice - Poland, Raciborz - Poland, Wroclaw - Poland, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Alcorcon - Spain, Barcelona - Spain, Barcelona - Spain, Valencia - Spain, Zurich - Switzerland, London - United Kingdom, Edinburgh - United Kingdom, Glasgow - United Kingdom, Birmingham - United Kingdom",2013-12,2011-12-15,2016-06-03,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00860626,Unknown,UNKNOWN,2008-01,"Hepatitis B, Chronic","interferon α plus nucleoside analogue, interferon α, interferon α",Guang zhou - China,2009-12,2009-03-12,2009-03-12,INTERVENTIONAL,NA,Sun Yat-sen University,OTHER,hepatitis
NCT04620226,Unknown,RECRUITING,2024-02-01,"Hepatitis C, Hepatitis B",Quality Improvement,"Toronto - Canada, Toronto - Canada",2025-07,2020-11-06,2024-02-08,INTERVENTIONAL,PHASE4,Jordan Feld,OTHER,hepatitis
NCT01548326,Unknown,UNKNOWN,2011-09,"Hepatitis B, Vaccination Failure","Atorvastatin, placebo","Tehran - Iran, Islamic Republic of",2012-07,2012-03-08,2012-03-08,INTERVENTIONAL,PHASE4,Nematollah Jonaidi Jafari,OTHER,hepatitis
NCT00056862,Unknown,COMPLETED,2003-03,Hepatitis C,"Peginterferon alfa-2a, Peginterferon alfa-2a, Ribavirin",Bethesda - United States,2010-01,2003-03-25,2013-12-06,INTERVENTIONAL,PHASE4,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02340962,Unknown,COMPLETED,2015-05,"Hepatitis C, Chronic","TG-2349, Ribavirin, Interferon Alfa-2a",Kaohsiung - Taiwan,2016-08-12,2015-01-19,2023-07-14,INTERVENTIONAL,PHASE2,"TaiGen Biotechnology Co., Ltd.",INDUSTRY,hepatitis
NCT01825980,CBZF961X2201,COMPLETED,2013-03,Hepatitis C,"BZF961, Ritonavir, Placebo","San Diego - United States, Orlando - United States, San Antonio - United States",2014-12,2013-04-08,2021-02-21,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01225380,Unknown,COMPLETED,2010-10,Chronic Hepatitis C Infection,"GS-9190, GS-9256, Pegasys®, Copegus®, GS-9190 placebo, GS-9256, Pegasys®, Copegus®, GS-9190 placebo, GS-9256 placebo, Pegasys®, Copegus®","Phoenix - United States, Anaheim - United States, La Jolla - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Englewood - United States, Gainesville - United States, Miami - United States, Orlando - United States, Sarasota - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Indianapolis - United States, Baton Rouge - United States, Lutherville - United States, Boston - United States, Detroit - United States, Santa Fe - United States, Great Neck - United States, New York - United States, New York - United States, New York - United States, Durham - United States, Cleveland - United States, Providence - United States, Germantown - United States, Arlington - United States, Dallas - United States, San Antonio - United States, Fairfax - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Graz - Austria, Innsbruck - Austria, Linz - Austria, Vienna - Austria, Vienna - Austria, Antwerpen - Belgium, Brussels - Belgium, Brussels - Belgium, Edegem - Belgium, Liege - Belgium, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Brno - Czech Republic, Melnik - Czech Republic, Plzen - Czech Republic, Prague - Czech Republic, Prague - Czech Republic, Usti Nad labem - Czech Republic, Clichy - France, Créteil - France, Lille - France, Lyon - France, Marseille - France, Vandoeuvre - France, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt/M - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Leipzig - Germany, Mainz - Germany, München - Germany, Brescia - Italy, Milano - Italy, Padova - Italy, Palermo - Italy, Parma - Italy, Torino - Italy, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Lodz - Poland, Lublin - Poland, Radom - Poland, Szczecin - Poland, Warszawa - Poland, Warszawa - Poland, Warszawa - Poland, Wroclaw - Poland, Barcelona - Spain, Granada - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain, Birmingham - United Kingdom, Greater Manchester - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Plymouth - United Kingdom",2013-01,2010-10-21,2014-01-28,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01932762,Unknown,COMPLETED,2013-10-01,Hepatitis C,"Grazoprevir, Elbasvir, Ribavirin",No locations listed,2014-12-04,2013-08-30,2021-02-04,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03833362,PIONEER,COMPLETED,2014-05-07,Hepatitis C,"Narlaprevir, Ritonavir, Placebo Narlaprevir, Placebo Ritonavir, Pegylated interferon alfa-2a/ Pegylated interferon alfa-2b, Ribavirin","Chelyabinsk - Russian Federation, Kazan - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Samara - Russian Federation, Samara - Russian Federation, Saratow - Russian Federation, Stavropol' - Russian Federation, Stavropol' - Russian Federation",2016-03-23,2019-02-07,2019-02-07,INTERVENTIONAL,PHASE3,R-Pharm,INDUSTRY,hepatitis
NCT02485262,Unknown,UNKNOWN,2013-11,Hepatitis C,Sofosbuvir and simeprevir,Colton - United States,2016-11,2015-06-30,2015-06-30,OBSERVATIONAL,Not Available,Arrowhead Regional Medical Center,OTHER,hepatitis
NCT00277862,Unknown,COMPLETED,2002-04,Hepatitis C,"Pegylated IFN- alpha 2b, Ribavirin","Cairo; - Egypt, Cairo - Egypt, Cairo - Egypt, Mynia and Cairo - Egypt",2007-03,2006-01-18,2008-02-26,INTERVENTIONAL,PHASE4,Ain Shams University,OTHER,hepatitis
NCT00734162,Unknown,COMPLETED,2008-12,Hepatitis B Virus (HBV),"Tenofovir disoproxil fumarate (TDF), Placebo","Oakland - United States, Indianapolis - United States, Seattle - United States, Plovdiv - Bulgaria, Sofia - Bulgaria, Bron Cedex - France, Lille Cedex - France, Białystok - Poland, Bydgoszcz - Poland, Bydgoszcz - Poland, Kraków - Poland, Poznan - Poland, Poznań - Poland, Warszawa - Poland, Wrocław - Poland, Bucharest - Romania, Bucharest - Romania, Napaco - Romania, Madrid - Spain, Madrid - Spain, Izmir - Turkey",2011-03,2008-08-14,2016-09-01,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00781274,Unknown,COMPLETED,2008-12,Hepatitis C,"MP-424, Ribavirin, Peginterferon Alfa-2b",Kawasaki City - Japan,2010-07,2008-10-28,2014-05-02,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT02214420,Unknown,COMPLETED,2014-10,Hepatitis C,"Simeprevir, Sofosbuvir, Ribavirin","La Jolla - United States, New York - United States, Murray - United States",2016-06,2014-08-12,2018-06-19,INTERVENTIONAL,PHASE4,"SC Liver Research Consortium, LLC",OTHER,hepatitis
NCT03537274,Unknown,COMPLETED,1997-08-05,Hepatitis C,"PEG-Intron, Interferon Alfa-2B",No locations listed,1999-07-23,2018-05-25,2019-04-09,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05067374,Mammo'C,RECRUITING,2022-03-23,"Hepatitis C, Breast Cancer",No interventions listed,"Montpellier - France, Montpellier - France, Montpellier - France, Montpellier - France",2024-03-23,2021-10-05,2022-04-08,OBSERVATIONAL,Not Available,"University Hospital, Montpellier",OTHER,hepatitis
NCT05466565,Unknown,RECRUITING,2021-12-01,Hepatocellular Carcinoma,No interventions listed,Changsha - China,2027-10-31,2022-07-20,2022-07-20,OBSERVATIONAL,Not Available,Xiangya Hospital of Central South University,OTHER,hepatitis
NCT04543565,Unknown,UNKNOWN,2020-09,Chronic Hepatitis b,"Pradefovir Mesylate;Placebo of Tenofovir disoproxil fumarate tablet, Tenofovir disoproxil fumarate tablet;Placebo of Pradefovir Mesylate",Changchun - China,2022-10,2020-09-10,2020-09-10,INTERVENTIONAL,PHASE3,"Xi'an Xintong Pharmaceutical Research Co.,Ltd.",OTHER,hepatitis
NCT02331589,Unknown,COMPLETED,2011-08,Fatigue,"KRG (Korea Red ginseng), Placebo (for KRG)",No locations listed,2012-04,2015-01-06,2015-02-10,INTERVENTIONAL,PHASE4,Chuncheon Sacred Heart Hospital,OTHER,hepatitis
NCT04585789,INSIGHT,COMPLETED,2021-03-11,Hepatitis B,"JNJ-73763989, JNJ-56136379, Entecavir (ETV), Tenofovir disoproxil, Tenofovir alafenamide (TAF), PegIFN-alpha-2a (Optional)","Baltimore - United States, Edegem - Belgium, Toronto - Canada, Clichy - France, Hamburg - Germany, Milano - Italy, Auckland - New Zealand, Myslowice - Poland, London - United Kingdom, London - United Kingdom",2023-02-08,2020-10-14,2025-01-13,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT00744289,HAVIT,COMPLETED,2008-09,Hepatitis B,Incentive condition,Sydney - Australia,2011-05,2008-08-29,2011-06-16,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT02726789,Unknown,COMPLETED,2012-10,"Hepatitis B, Chronic","REP 2139-Ca, pegylated interferon, entecavir",No locations listed,2016-09,2016-04-04,2019-05-08,INTERVENTIONAL,PHASE2,Replicor Inc.,INDUSTRY,hepatitis
NCT00211692,Unknown,COMPLETED,2005-07,Chronic Hepatitis C,"consensus interferon (Interferon Alfacon-1) and ribavirin, Consensus Interferon alfa (CIFN) and ribavirin",No locations listed,2008-07,2005-09-21,2014-11-21,INTERVENTIONAL,PHASE3,Minneapolis Veterans Affairs Medical Center,FED,hepatitis
NCT05406089,Unknown,COMPLETED,2016-01-01,"Hepatocellular Carcinoma, Hepatitis B Virus, Survival",Medication history,No locations listed,2019-06-30,2022-06-06,2022-06-21,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT01172392,PEGAN,UNKNOWN,2011-01,"Chronic Hepatitis B, AgHbs Negativation","Pegylated interferon-alpha-2a, Nucleotidic or Nucleosidic Treatment",Marseille - France,2015-06,2010-07-29,2013-03-29,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03488589,Unknown,UNKNOWN,2018-10-01,Hepatitis E,serum samples for HEV RNA PCR,No locations listed,2019-10-01,2018-04-05,2018-07-24,OBSERVATIONAL,Not Available,Mahmoud Abdel Rahman,OTHER,hepatitis
NCT02673489,Unknown,COMPLETED,2016-03-15,Hepatitis C,"DCV, SOF, RBV","Los Angeles - United States, San Francisco - United States, Marietta - United States, Chicago - United States, Catonsville - United States, Bethlehem - United States, Providence - United States, Arlington - United States, Dallas - United States, San Antonio - United States, Falls Church - United States, Richmond - United States, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Montreal - Canada, Regina - Canada",2017-03-02,2016-02-04,2018-05-08,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00004848,Unknown,COMPLETED,1981-07,Hepatitis,No interventions listed,Bethesda - United States,Unknown Date,2002-12-10,2008-03-04,OBSERVATIONAL,Not Available,National Institutes of Health Clinical Center (CC),NIH,hepatitis
NCT02056548,Unknown,UNKNOWN,2014-03,"Lymphoma, Chronic Hepatitis B",No interventions listed,No locations listed,2017-12,2014-02-06,2014-02-06,OBSERVATIONAL,Not Available,Seoul St. Mary's Hospital,OTHER,hepatitis
NCT01760148,sIFN-pred2,UNKNOWN,2012-07,"Hepatitis C, Chronic, Liver Diseases, Interferon Deficiency",interferon alpha 2b,Changchun - China,2014-02,2013-01-04,2013-01-04,OBSERVATIONAL,Not Available,Junqi Niu,OTHER,hepatitis
NCT00538265,BEFIRTH,COMPLETED,2005-05,Liver Transplantation,"tacrolimus, tacrolimus, ATG, ATG+mycophénolate mofétil+tacrolimus","Bordeaux - France, Marseille - France, Montpellier - France, Nice - France, Paris - France, Rennes - France, Toulouse - France, Villejuif - France",2010-01,2007-10-02,2011-02-03,INTERVENTIONAL,PHASE4,"University Hospital, Toulouse",OTHER,hepatitis
NCT02563665,Unknown,WITHDRAWN,2015-09,CKD With Hepatitis C,No interventions listed,New Delhi - India,2017-09,2015-09-30,2019-11-05,OBSERVATIONAL,Not Available,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT01027065,CONVERT,UNKNOWN,2009-12,Chronic Hepatitis B,"CYT107+GenHevac+entecavir or tenofovir, CYT107+ entecavir or tenofovir","Creteil - France, Grenoble - France, Lyon - France, Marseille - France, Nice - France, Paris - France, Strasbourg - France, Bologna - Italy",2012-11,2009-12-07,2012-10-18,INTERVENTIONAL,PHASE2,Cytheris SA,INDUSTRY,hepatitis
NCT01537965,FIBRECHO,COMPLETED,2012-01,Liver Fibrosis,"Fibroscan® of Echosens, Aixplorer® of Supersonic Imagine, Aplio XG of Toshiba, QRS software developed by Pr I.Bricault, Acuson S2000 of Siemens",Grenoble - France,2014-01,2012-02-23,2014-02-24,INTERVENTIONAL,NA,"University Hospital, Grenoble",OTHER,hepatitis
NCT01947465,Unknown,COMPLETED,2013-10,"Arthritis, Rheumatoid, Spondylarthritis, Vasculitis",Hepatitis A vaccine and tetanus vaccine,"Aarau - Switzerland, Basel - Switzerland, Basel - Switzerland, Bern - Switzerland, Bern - Switzerland, Geneva - Switzerland, Geneva - Switzerland, St. Gallen - Switzerland, Zürich - Switzerland, Zürich - Switzerland",2015-12,2013-09-20,2016-02-25,OBSERVATIONAL,Not Available,University of Zurich,OTHER,hepatitis
NCT01878565,Unknown,UNKNOWN,2013-06,Chronic Hepatitis B,"Drug, GM-CSF control",Beijing - China,2014-12,2013-06-17,2013-07-24,INTERVENTIONAL,PHASE2,Beijing 302 Hospital,OTHER,hepatitis
NCT02068365,Unknown,COMPLETED,2013-06,Chronic Hepaititis B,Pegyinterferon-alfa-2a,Sha Tin - Hong Kong,2019-06,2014-02-21,2019-07-31,INTERVENTIONAL,PHASE4,Chinese University of Hong Kong,OTHER,hepatitis
NCT01371162,Unknown,COMPLETED,2011-06,"Hepatitis C, Chronic, Healthy Volunteer","RO5428029, placebo","Montpellier - France, Strasbourg - France, Leiden - Netherlands, Chorzow - Poland, Warsaw - Poland, Wrocław - Poland",2011-12,2011-06-10,2016-11-02,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02356562,Unknown,COMPLETED,2015-02-03,Chronic Hepatitis C Infection,"ombitasvir/paritaprevir/ritonavir and dasabuvir, Sofosbuvir, Ribavirin",No locations listed,2016-10-28,2015-02-05,2017-12-20,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT00798460,Unknown,TERMINATED,2008-12,Chronic Hepatitis B,"adefovir, clevudine, lamivudine","Goyang - Korea, Republic of",2010-06,2008-11-26,2011-06-23,INTERVENTIONAL,PHASE4,Inje University,OTHER,hepatitis
NCT02940691,DARLO-C,TERMINATED,2017-05-01,Hepatitis C,Grazoprevir/elbasvir,"Darlinghurst - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Kingswood - Australia, Newcastle - Australia",2018-11-01,2016-10-21,2020-03-09,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT01766960,Unknown,COMPLETED,2012-11,Fatty Liver,"High fat meal, Morphine",Chapel Hill - United States,2014-03,2013-01-11,2016-03-03,INTERVENTIONAL,PHASE1,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT03776760,SCALE-C,UNKNOWN,2019-05-28,"Hepatitis C, Hepatitis, Liver Diseases, Hepatitis, Viral, Human, RNA Virus Infections, Digestive System Diseases","Fingerstick GeneXpert HCV RNA quantitative assay, sofosbuvir/velpatesvir, glecaprevir/pibrentasvir","Lismore - Australia, Quirindi - Australia, Mount Gambier - Australia, Port Lincoln - Australia",2022-08,2018-12-17,2022-04-14,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT04036760,Unknown,COMPLETED,2015-05,Hepatitis C,Research transitional care coordination,New York - United States,2017-04,2019-07-30,2019-07-31,OBSERVATIONAL,Not Available,NYU Langone Health,OTHER,hepatitis
NCT05265026,FitLiver,COMPLETED,2022-03-14,"Hepatitis B, Chronic, Hepatic Steatosis",High Intensity Interval Training,Copenhagen - Denmark,2023-09-30,2022-03-03,2023-10-27,INTERVENTIONAL,NA,"Rigshospitalet, Denmark",OTHER,hepatitis
NCT00751426,Unknown,COMPLETED,1999-08,"Mental Disorders, Drug Addiction",No interventions listed,Munich - Germany,2002-02,2008-09-12,2008-09-12,OBSERVATIONAL,Not Available,"Charite University, Berlin, Germany",OTHER,hepatitis
NCT06325826,Unknown,ACTIVE_NOT_RECRUITING,2022-02-01,Hepatocellular Carcinoma,General Evaluation Score (GES),Talkha - Egypt,2023-06-30,2024-03-22,2024-03-26,OBSERVATIONAL,Not Available,Egyptian Liver Hospital,OTHER,hepatitis
NCT03781726,MYTHIC,COMPLETED,2019-04-10,"Renal Failure Chronic, Hepatitis C",glecaprevir/pibrentasvir treatment,"Chicago - United States, Baltimore - United States, Boston - United States, Ann Arbor - United States, New York - United States, Cincinnati - United States, Philadelphia - United States",2020-03-20,2018-12-20,2022-01-26,INTERVENTIONAL,PHASE4,Raymond Chung,OTHER,hepatitis
NCT00881582,Unknown,COMPLETED,2009-01,"Chronic Hepatitis C, Renal Transplant",Pegylated interferon alfa-2a plus ribavarin,"Riyadh - Saudi Arabia, Riyadh - Saudi Arabia",2011-12,2009-04-15,2012-09-14,INTERVENTIONAL,PHASE4,King Abdulaziz Medical City,OTHER_GOV,hepatitis
NCT05678582,Unknown,COMPLETED,2023-01-01,Chronic Hepatitis,Liver biopsy,Sohag - Egypt,2023-06-30,2023-01-10,2023-07-21,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT00641082,Unknown,COMPLETED,2008-02,HBeAg(-) Chronic Hepatitis B With Compensated Liver Function,"Clevudine, Adefovir dipivoxil","Bundang - Korea, Republic of, Seoul - Korea, Republic of",2012-03,2008-03-21,2012-04-25,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00956982,Unknown,UNKNOWN,2004-12,Hepatitis C Virus,Pegylated interferon alpha-2b plus ribavirin,Fukuoka - Japan,2008-07,2009-08-11,2009-08-11,INTERVENTIONAL,NA,Kyushu University,OTHER,hepatitis
NCT00998426,Unknown,COMPLETED,2009-10,Hepatitis B,"glucose monitoring before and after HepaGam B administration, HepaGam B (Hepatitis B Immune Globulin (HBIG))",Washington - United States,2011-09,2009-10-20,2015-09-28,INTERVENTIONAL,PHASE4,Georgetown University,OTHER,hepatitis
NCT06290726,Unknown,COMPLETED,2002-02,Living Donor Liver Transplantations With Anti-HBc (+) Grafts,No interventions listed,No locations listed,2016-02,2024-03-04,2024-03-05,OBSERVATIONAL,Not Available,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT05861674,Unknown,ENROLLING_BY_INVITATION,2023-06-16,Chronic Hepatitis Delta Virus Infection,"HH-003(20mg/kg), HH-003(10mg/kg), TAF",Beijing - China,2024-07-18,2023-05-17,2024-10-10,INTERVENTIONAL,PHASE2,Huahui Health,INDUSTRY,hepatitis
NCT00057265,Unknown,COMPLETED,2003-02,Chronic Hepatitis B,telbivudine or lamivudine,"Los Angeles - United States, Orange - United States, San Diego - United States, Hackensack - United States, Houston - United States, Seoul - Korea, Republic of, Barcelona - Spain, Valencia - Spain, Bangkok - Thailand, Istanbul - Turkey, London - United Kingdom",2006-04,2003-03-31,2015-03-20,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT01214226,CorpentoxHAA,COMPLETED,2007-12,"Alcoholic Hepatitis, Alcoholic Liver Disease","Pentoxifylline, placebo","Brussel - Belgium, Angers - France, Bondy - France, Bordeaux - France, Béthune - France, Caen - France, Clamart - France, Clichy - France, Creil - France, Créteil - France, Dunkerque - France, Lens - France, Lille - France, Maubeuge - France, Montpellier - France, Nantes - France, Nice - France, Paris - France, Paris - France, Paris - France, Poitiers - France, Rennes - France, Roubaix - France, Strasbourg - France, Tourcoing - France, Valenciennes - France, Vandoeuvre les nancy - France, Villejuif - France",2010-12,2010-10-04,2011-06-01,INTERVENTIONAL,PHASE3,"University Hospital, Lille",OTHER,hepatitis
NCT06745973,Unknown,NOT_YET_RECRUITING,2024-12-20,Chronic Hepatitis B,EPI-003,Shanghai - China,2026-12-31,2024-12-24,2024-12-24,INTERVENTIONAL,PHASE1,"Epigenic Therapeutics, Inc",INDUSTRY,hepatitis
NCT00226382,Unknown,COMPLETED,2005-01,Chronic Hepatitis B,Pegylated Interferon-alfa-2a,Hong Kong SAR - China,2008-04,2005-09-27,2010-06-11,INTERVENTIONAL,PHASE4,Chinese University of Hong Kong,OTHER,hepatitis
NCT03567382,AVERT-HBV,COMPLETED,2018-09-24,"Hepatitis B, Vertical Transmission of Infectious Disease","Tenofovir Disoproxil Fumarate, Monovalent HBV vaccine","Kinshasa - Congo, The Democratic Republic of the",2020-03-06,2018-06-25,2021-02-24,INTERVENTIONAL,PHASE4,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT04195282,Unknown,UNKNOWN,2019-12,"Hepatitis B, Acute-On-Chronic Liver Failure","Plasma exchange, RL-1 Novel Human-derived Bio-artificial Liver Treatment",Guangzhou - China,2021-12,2019-12-11,2019-12-11,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02319031,Unknown,COMPLETED,2015-02,Hepatitis C,"Daclatasvir, Sofosbuvir, Ribavirin","Darlinghurst - Australia, Greenslopes - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Heidelberg - Australia, Creteil Cedex - France, Grenoble Cedex 09 - France, Paris Cedex 14 - France, Vandoeuvre Les Nancy - France",2015-10,2014-12-18,2017-01-27,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01121731,Unknown,COMPLETED,2010-05,"Chronic Hepatitis C Virus Infection, Genotype 1, Treatment-Experienced Patients, Relapses","Interferon α-5, Interferon-α5 plus Interferon-α 2b, Interferon α-2b (INTRON® A)","A Coruña - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Granada - Spain, León - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Pamplona - Spain, Santander - Spain, Sevilla - Spain",2012-10,2010-05-12,2013-02-05,INTERVENTIONAL,PHASE2,Digna Biotech S.L.,INDUSTRY,hepatitis
NCT00440531,Unknown,COMPLETED,2006-11,Hepatitis B,"Comparator: RECOMBIVAX HB™ Hepatitis B Vaccine (Recombinant), Comparator: Modified Process Hepatitis B Vaccine (Experimental), Comparator: ENGERIX-B™ (currently licensed product)",No locations listed,2007-11,2007-02-27,2017-04-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02071082,Unknown,COMPLETED,2014-02-25,"HIV, HBV",E/C/F/TAF,"Phoenix - United States, Beverly Hills - United States, Los Angeles - United States, Los Angeles - United States, Washington - United States, Clearwater - United States, Fort Lauderdale - United States, Fort Pierce - United States, Miami Beach - United States, Vero Beach - United States, West Palm Beach - United States, Berkley - United States, Kansas City - United States, Saint Louis - United States, Santa Fe - United States, Austin - United States, Bellaire - United States, Dallas - United States, Houston - United States, Houston - United States, Seattle - United States, Toronto - Canada, Toronto - Canada, Shinjuku-ku - Japan",2015-01-23,2014-02-25,2018-11-16,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT04366973,NeoVie,COMPLETED,2020-05-26,Hepatitis C Virus (HCV),No interventions listed,"Nice - France, Valence - France, Bagnols Sur Ceze - France, Nimes - France, Bordeaux - France, Montpellier - France, Montpellier - France, Bagneux - France, Ploermel - France, Metz - France, Lille - France, Saintes - France, Montauban - France, Bron - France, Antibes - France, Bayonne - France, Clermont Ferrand - France, Cognac - France, Colmar - France, Fontaine-lès-Dijon - France, Le Coudray - France, Limoges - France, Marseille - France, Mulhouse - France, Nantes - France, Nice - France, Paris - France, Paris - France, Pau - France, Strasbourg - France",2023-12-31,2020-04-29,2024-02-01,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02601573,Unknown,COMPLETED,2016-01-05,Hepatitis C,"Grazoprevir, Elbasvir, Ribavirin, Sofosbuvir",No locations listed,2016-10-18,2015-11-10,2019-08-13,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04496882,CHANGE,UNKNOWN,2020-09-09,"Chronic Hepatitis b, Hepatitis B Reactivation",Vemlidy,"Chiayi City - Taiwan, Chiayi City - Taiwan, Douliu - Taiwan, Kaohsiung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2022-12-31,2020-08-03,2021-08-05,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT00895882,Unknown,WITHDRAWN,2010-11,Chronic Genotype 1 Hepatitis C Virus Infection,"vaniprevir (MK7009), Comparator: vaniprevir (MK7009), Comparator: Pegylated Interferon (peg-IFN) alfa-2a, Comparator: Ribavirin, Comparator: Placebo to vaniprevir",No locations listed,2013-01,2009-05-08,2015-10-22,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02267473,BONIKA,UNKNOWN,2014-10,"Hepatitis B, Chronic",No interventions listed,"Mainz - Germany, Frankfurt - Germany",2020-10,2014-10-17,2018-04-02,OBSERVATIONAL,Not Available,Johann Wolfgang Goethe University Hospital,OTHER,hepatitis
NCT05905731,Unknown,ACTIVE_NOT_RECRUITING,2023-06-01,Chronic Hepatitis B,TCR-T,Beijing - China,2025-06,2023-06-15,2023-06-15,INTERVENTIONAL,PHASE1,Beijing 302 Hospital,OTHER,hepatitis
NCT01913431,Unknown,COMPLETED,2013-09-12,HBeAg-Positive Chronic Hepatitis B,"Baracle Tab.®, Baraclude Tab.®","Seoul - Korea, Republic of",2015-11-06,2013-08-01,2017-08-31,INTERVENTIONAL,PHASE4,"Dong-A ST Co., Ltd.",INDUSTRY,hepatitis
NCT03020082,Unknown,COMPLETED,2016-06,Chronic Hepatitis C,"Danoprevir, Ritonavir, peginterferon alfa-2a, RBV",No locations listed,2017-05,2017-01-13,2021-03-23,INTERVENTIONAL,PHASE3,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT04980482,Unknown,ACTIVE_NOT_RECRUITING,2021-10-29,Chronic Hepatitis B,"AB-729, Peg-IFNα-2a","Chandler - United States, Tucson - United States, San Diego - United States, Miami - United States, Detroit - United States, Hillsborough - United States, Kingswood - Australia, Melbourne - Australia, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Chisinau - Moldova, Republic of, Chiayi City - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Kyiv - Ukraine",2024-05-30,2021-07-28,2025-02-14,INTERVENTIONAL,PHASE2,Arbutus Biopharma Corporation,INDUSTRY,hepatitis
NCT05451082,Unknown,NOT_YET_RECRUITING,2022-07,Hepatitis D,No interventions listed,Beijing - China,2028-06,2022-07-11,2022-07-11,OBSERVATIONAL,Not Available,Lai Wei,OTHER,hepatitis
NCT00726882,Unknown,COMPLETED,2008-08,HCV Infection,"Blood sample collection only, ABT-333","Anaheim - United States, Los Angeles - United States, Los Angeles - United States, Orlando - United States, Baton Rouge - United States, San Antonio - United States, Santurce - Puerto Rico",2010-05,2008-08-01,2015-01-08,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT05991531,Unknown,NOT_YET_RECRUITING,2023-08-15,Chronic Hepatitis B Patients,No interventions listed,Beijing - China,2024-08-15,2023-08-14,2023-08-16,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT02854631,Unknown,COMPLETED,2016-09-01,Alcoholic Hepatitis (AH),"Selonsertib, Prednisolone, Placebo","Little Rock - United States, Coronado - United States, Los Angeles - United States, Weston - United States, New Orleans - United States, Boston - United States, Ann Arbor - United States, Philadelphia - United States, Dallas - United States, Newport News - United States, Seattle - United States, Graz - Austria, Innsbruck - Austria, Vienna - Austria, Brussels - Belgium, Brussels - Belgium, Ghent - Belgium, Leuven - Belgium, Liège - Belgium, Calgary - Canada, Winnipeg - Canada, Toronto - Canada, Amiens - France, Angers - France, Besançon - France, Caen - France, Créteil - France, La Tronche - France, Lille - France, Lyon - France, Paris - France, Villejuif - France, Zurich - Switzerland, Brighton - United Kingdom, Hull - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom, Portsmouth - United Kingdom",2018-02-16,2016-08-03,2019-02-06,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01289782,QUEST-1,COMPLETED,2011-02,Hepatitis C,"Placebo, TMC435, Peginterferon alpha-2a (PegIFN alpha-2a), Ribavirin (RBV)","Dothan - United States, Hoover - United States, Phoenix - United States, Bakersfield - United States, Coronado - United States, Long Beach - United States, San Diego - United States, Aurora - United States, Englewood - United States, Miami - United States, Chicago - United States, Jackson - United States, Tupelo - United States, Saint Louis - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Philadelphia - United States, Nashville - United States, Dallas - United States, Houston - United States, San Antonio - United States, Darlinghurst - Australia, Fitzroy - Australia, Kingswood - Australia, Melbourne - Australia, Sydney - Australia, Wolloongabba - Australia, Calgary - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Berlin - Germany, Heidelberg - Germany, Kiel - Germany, Tübingen - Germany, Guadalajara - Mexico, Mex Ctity - Mexico, Monterrey - Mexico, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, San Juan - Puerto Rico, Bucuresti - Romania, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain, Donetsk - Ukraine, Kiev - Ukraine, Kyiv - Ukraine, Vinnytsia - Ukraine, Derby - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom",2013-01,2011-02-04,2014-06-04,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT02945982,Unknown,UNKNOWN,2018-04-05,Portal Hypertension,"Entecavir+Carvedilol, Entecavir+Carvedilol+ Fuzheng Huayu","Shanghai - China, Shanghai - China, Shanghai - China",2020-06,2016-10-26,2020-02-13,INTERVENTIONAL,PHASE4,ShuGuang Hospital,OTHER,hepatitis
NCT04577482,CHOICE,COMPLETED,2020-10-07,Hepatitis C Virus (HCV),No interventions listed,"Chelyabinsk - Russian Federation, Domodedovo - Russian Federation, Irkutsk - Russian Federation, Krasnodar - Russian Federation, Moscow - Russian Federation, Nizhniy Novgorod - Russian Federation, Oryol - Russian Federation, Samara - Russian Federation, St. Petersburg - Russian Federation, Stavropol - Russian Federation",2022-09-03,2020-10-08,2023-08-14,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02886182,Unknown,UNKNOWN,2016-08,Chronic Hepatitis B,No interventions listed,Beijing - China,2019-01,2016-09-01,2016-09-01,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00495131,Unknown,COMPLETED,2006-06,"Hepatitis C, Chronic","Pegylated interferon alfa-2a plus ribavirin, Pegylated interferon alfa-2a plus ribavirin","Douliou - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2008-06,2007-07-02,2009-09-10,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT01678131,Unknown,COMPLETED,2012-10-30,Chronic Hepatitis C,"Vaniprevir 600 mg, Peg-IFN alfa-2b, Ribavirin, Liver samples from FNA, Vaniprevir 300 mg, Liver samples from CNB",No locations listed,2013-08-27,2012-09-03,2022-08-26,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02788682,Unknown,COMPLETED,2013-09,Chronic Hepatitis C,WT+ Diplotype,No locations listed,2015-07,2016-06-02,2016-07-26,OBSERVATIONAL,Not Available,Cairo University,OTHER,hepatitis
NCT05392673,Unknown,COMPLETED,2020-06-01,Chronic-on-acute Liver Failure,"KM-8800 plasma exchange device (Kuraray, Tokyo, Japan)",Changsha - China,2021-10-31,2022-05-26,2022-05-26,INTERVENTIONAL,NA,Xiangya Hospital of Central South University,OTHER,hepatitis
NCT06277882,Unknown,RECRUITING,2024-02-29,"Cirrhosis, Hep A, Vaccination",HAVRIX,Bangkok Noi - Thailand,2025-03-01,2024-02-26,2024-03-19,INTERVENTIONAL,PHASE4,Mahidol University,OTHER,hepatitis
NCT00377182,Unknown,COMPLETED,2006-09,"Hepatitis C, Chronic","Copegus, PEGASYS, RO5024048 1500mg, RO5024048 3000mg","La Jolla - United States, Long Beach - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Bradenton - United States, Gainesville - United States, Chicago - United States, Novi - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Dallas - United States, Fort Sam Houston - United States, Richmond - United States, Santurce - Puerto Rico",2008-08,2006-09-18,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01529073,Unknown,UNKNOWN,2012-02,"HCV Coinfection, HIV Infection",Nitazoxanide,Seville - Spain,2015-02,2012-02-08,2015-01-14,INTERVENTIONAL,PHASE2,Juan Macías,OTHER_GOV,hepatitis
NCT00680173,PBMC,COMPLETED,2006-08,Chronic Hepatitis C,pegylated interferon alpha 2a and plus ribavirin,Kaohsiung - Taiwan,2016-03,2008-05-19,2016-03-14,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT01290731,Unknown,COMPLETED,2011-01,"Hepatitis C, Chronic","TMC435, Pegylated interferon (pegIFN alpha-2a), Ribavirin (RBV)","Hiroshima - Japan, Ichikawa - Japan, Kagoshima - Japan, Matsumoto - Japan, Musashino - Japan, Ohmura - Japan, Osaka - Japan, Sapporo - Japan, Suita - Japan, Touon - Japan",2012-08,2011-02-07,2014-02-04,INTERVENTIONAL,PHASE3,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT01667731,Unknown,COMPLETED,2012-07,"Hepatitis C, Human Immunodeficiency Virus","SOF, RBV","Birmingham - United States, Coronado - United States, Los Angeles - United States, Lutherville - United States, Oakland - United States, Sacramento - United States, San Francisco - United States, Torrance - United States, Washington DC - United States, Miami - United States, Orlando - United States, Tampa - United States, Chicago - United States, Springfield - United States, Kansas City - United States, Hillsborough - United States, Santa Fe - United States, New York - United States, Chapel Hill - United States, Durham - United States, Allentown - United States, Philadelphia - United States, Providence - United States, Dallas - United States, Houston - United States, Seattle - United States, San Juan - Puerto Rico",2013-11,2012-08-17,2014-11-21,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00697931,Unknown,COMPLETED,1997-05,Hepatitis B,"Recombinant MPL- adjuvanted hepatitis B vaccine, Engerix™-B",Leuven - Belgium,1998-06,2008-06-16,2008-06-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01340573,Unknown,TERMINATED,2007-03-23,Chronic Hepatitis C,"PegIntron Pen, Ribavirin",No locations listed,2007-10-29,2011-04-22,2024-06-12,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02731131,Unknown,COMPLETED,2004-09,"Hepatitis D, Chronic","Peginterferon alfa-2a, Ribavirin",Cagliari - Italy,2009-05,2016-04-07,2016-07-15,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01765231,Unknown,UNKNOWN,2013-01,Hepatitis B,"Entecavir prophylaxis, Observation arm","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China",2017-12,2013-01-10,2017-01-10,INTERVENTIONAL,PHASE4,Peking University,OTHER,hepatitis
NCT04718831,Unknown,COMPLETED,2019-10-29,Chronic Hepatitis b,Spirulina,Taipei - Taiwan,2020-08-30,2021-01-22,2021-01-22,INTERVENTIONAL,NA,Taipei Medical University WanFang Hospital,OTHER,hepatitis
NCT01918631,Unknown,COMPLETED,2013-08,Chronic Heptitis B,"tenofovir disoproxil fumarate, Entecavir",Hong Kong - Hong Kong,2017-01,2013-08-08,2017-07-19,INTERVENTIONAL,NA,Chinese University of Hong Kong,OTHER,hepatitis
NCT03767231,Unknown,NOT_YET_RECRUITING,2025-11,Hepatitis C,Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid),Baltimore - United States,2027-11,2018-12-06,2024-11-13,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT02113631,Unknown,COMPLETED,2011-09,"Hepatitis C, Chronic, Cirrhosis","Telaprevir, Boceprevir, Peg-IFN, Ribavirin",Cleveland - United States,2013-04,2014-04-14,2017-03-15,INTERVENTIONAL,NA,Louis Stokes VA Medical Center,FED,hepatitis
NCT03329820,Unknown,COMPLETED,2006-11,Chronic Hepatitis B Infection,No interventions listed,Hong Kong - Hong Kong,2009-06,2017-11-06,2017-11-06,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT03149874,Unknown,COMPLETED,2014-12-01,"Hepatitis B, Hemodialysis Complication","Hepatitis B recombinant DNA vaccine, Combined hepatitis A and B vaccine",No locations listed,2017-04-30,2017-05-11,2023-02-08,INTERVENTIONAL,NA,Benha University,OTHER,hepatitis
NCT00560274,Unknown,COMPLETED,2008-03,Anemia,"Pegasys, Ribavirin, epoetin beta [NeoRecormon]","Angers - France, Besancon - France, Caen - France, Chambray Les Tours - France, Clichy - France, Creteil - France, Creteil - France, Limoges - France, Lyon - France, Marseille - France, Marseille - France, Montpellier - France, Nice - France, Paris - France, Paris - France, Pessac - France, Rennes - France, Rouen - France, Saint Laurent Du Var - France, Strasbourg - France, Toulouse - France, Tourcoing - France, Vandoeuvre-les-nancy - France, Villejuif - France",2011-11,2007-11-19,2016-02-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00362674,Unknown,COMPLETED,2005-06,Hepatitis B,No interventions listed,"Jung-gu, - Korea, Republic of, Seoul - Korea, Republic of, Bupyoung-dong, Bupyoung-gu - Korea, Republic of, Sinhung-dong, Jung-gu - Korea, Republic of, Iksan-City - Korea, Republic of, Jeonju-city - Korea, Republic of, Seoul - Korea, Republic of, Ilsan-gu - Korea, Republic of, Pucheon - Korea, Republic of, Seongnam-gu - Korea, Republic of, Incheon - Korea, Republic of, Hagye 1-dong - Korea, Republic of, Ami-dong, Seo-gu - Korea, Republic of, Amnam-dong, Seo-gu - Korea, Republic of, Anam-dong, Sungbuk-ku - Korea, Republic of, Daelim-dong, Yongdeungpo-gu - Korea, Republic of, Dogok-dong, Kangnam-gu - Korea, Republic of, Gongneung-dong, Nowon-gu - Korea, Republic of, Ilwon-dong, Songpa-gu - Korea, Republic of, Jeo-dong - Korea, Republic of, Mok-dong, Yangcheon-gu - Korea, Republic of, Pungnap-dong, Kangnam-gu - Korea, Republic of, Pyoung-dong, Chongro-gu, - Korea, Republic of, Shinchon- dong, Seodaemun-gu - Korea, Republic of, Ji-dong,, Paldal-gu - Korea, Republic of, Daemyoung-dong, Nam-gu - Korea, Republic of, Seoul - Korea, Republic of",Unknown Date,2006-08-10,2017-02-01,OBSERVATIONAL,Not Available,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00388674,Unknown,COMPLETED,2006-12-18,Chronic Hepatitis B,"entecavir, Other anti-HBV medication","Coronado - United States, Los Angeles - United States, San Francisco - United States, Farmington - United States, Miami - United States, Orlando - United States, Atlanta - United States, Chicago - United States, Indianapolis - United States, New Orleans - United States, Flushing - United States, Flushing - United States, New York - United States, New York - United States, Charlotte - United States, Oklahoma City - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Dallas - United States, Ciudad De Buenos Aires - Argentina, El Palomar - Argentina, San Salvador De Jujuy - Argentina, Guaymallen - Argentina, Salta - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Neuquen - Argentina, Rio Branco - Brazil, Manaus - Brazil, Salvador - Brazil, Salvador - Brazil, Goiania - Brazil, Cuiaba - Brazil, Belo Horizonte - Brazil, Belo Horizonte - Brazil, Belo Horizonte - Brazil, Ipatinga - Brazil, Juiz De Fora - Brazil, Curitiba - Brazil, Belem - Brazil, Recife - Brazil, Rio De Janeiro / Rj - Brazil, Porto Alegres/rs - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Sao Jose - Brazil, Campinas - Brazil, Campinas - Brazil, Marilia - Brazil, Santo Andre - Sp - Brazil, Sao Jose Do Rio Preto - Brazil, Sorocaba - Brazil, Sao Paulo - Brazil, Ribeirao Preto - Brazil, Rio De Janeiro - Brazil, Rio De Janeiro - Brazil, Sao Paulo - Brazil, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Toronto - Canada, Montreal - Canada, Hefei - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Guiyang - China, Haikou - China, Zhengzhou - China, Zhengzhou - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Suzhou - China, Changchun - China, Dalian - China, Shenyang - China, Shenyang - China, Taiyuan - China, Xi'an - China, Xi'an - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Chengdu - China, Tianjin - China, Tianjin - China, Kunming - China, Hangzhou - China, Hangzhou - China, Linhai - China, Ningbo - China, Guangzhou - China, ShangHai - China, Bogota - Colombia, Bogota - Colombia, Brno - Czechia, Hradec Kralove - Czechia, Ostrava - Czechia, Prague 8 - Czechia, Usti Nad Labem - Czechia, Creteil - France, Grenoble Cedex 9 - France, Lille - France, Limoges Cedex - France, Lyon - France, Paris Cedex 14 - France, Paris Cedex - France, Paris - France, Vandoeuvre Cedex - France, Berlin - Germany, Bonn - Germany, Dusseldorf - Germany, Hamburg - Germany, Leipzig - Germany, Tuebingen - Germany, Wurzburg - Germany, Athens - Greece, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Hyderabad - India, Hyderabad - India, Hyderabad - India, Hyderabad - India, Visakhapatnam - India, Secunderabad - India, Ahemedabad - India, Ahmedabad - India, Gurgaon - India, Bangalore - India, Bangalore - India, Mangalore - India, Kochi - India, Bhopal - India, Nagpur - India, Nasik - India, Ludhiana - India, Jaipur - India, Madurai - India, Chennai - India, Madurai - India, Lucknow - India, Coimbatore - India, Hyderabad - India, Indore - India, Kolkata - India, Ludhiana - India, Mumbai - India, New Delhi - India, Bologna - Italy, Napoli - Italy, Rome - Italy, Ansan-si - Korea, Republic of, Uijeongbu-Si - Korea, Republic of, Bucheon - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Chuncheon - Korea, Republic of, Chung-ju - Korea, Republic of, Dae-jeon - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon City - Korea, Republic of, Gangneung-si - Korea, Republic of, Goyang - Korea, Republic of, Gwangju - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeongju - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jinju - Korea, Republic of, Koyang City - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Sungnam-si - Korea, Republic of, Sungnam - Korea, Republic of, Suwon-si - Korea, Republic of, Suwon - Korea, Republic of, Ulsan - Korea, Republic of, Wonju - Korea, Republic of, Saltillo - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Zapopan - Mexico, Zapopan - Mexico, Cuernavaca - Mexico, Monterrey, N.l. - Mexico, Monterrey - Mexico, Culiacan, Sin. - Mexico, Boca Del Rio - Mexico, Distrito Federal - Mexico, Durango - Mexico, Cebu City - Philippines, Davao City - Philippines, Ermita Manila - Philippines, Manila - Philippines, Manila - Philippines, Metro Manila - Philippines, Quezon City - Philippines, Krakow - Poland, Krakow - Poland, Lodz - Poland, Poznan - Poland, Raciborz - Poland, Szczecin - Poland, Zawiercie - Poland, Braga - Portugal, Coimbra - Portugal, Lisbon - Portugal, Porto - Portugal, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Constanta - Romania, Iasi - Romania, Timisoara - Romania, Kazan - Russian Federation, Arkhangelsk - Russian Federation, Irkutsk - Russian Federation, Kirov - Russian Federation, Krasnoyarsk - Russian Federation, Lipetsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizhniy Novgord - Russian Federation, Nizhniy Novgorod - Russian Federation, Ryazan - Russian Federation, Samara - Russian Federation, Yakutsk - Russian Federation, Singapore - Singapore, Granada - Spain, Madrid - Spain, Madrid - Spain, Oviedo - Spain, San Sebastian Guipuzcuoa - Spain, Sevilla - Spain, Valencia - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Young Kang City - Taiwan, Hatyai - Thailand, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Khon Kaen - Thailand, Pathumthani - Thailand, Adana - Turkey, Ankara - Turkey, Eskisehir - Turkey, Izmir - Turkey, Izmir - Turkey, Kayseri - Turkey, Trabzon - Turkey",2016-10-26,2006-10-17,2018-07-30,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01500265,HBVSECURE,COMPLETED,2011-12,"Hepatitis B, Renal Failure With Tubular Necrosis","plasma and urine samples, sample with ADN","Amiens - France, Angers - France, Besancon - France, Bordeaux - France, Brest - France, Caen - France, Clermont Ferrand - France, Clichy - France, Creil - France, Hyères - France, La Roche sur Yon - France, Le Kremlin Bicêtre - France, Lille - France, Limoges - France, Lyon - France, Montpellier - France, Nice - France, Paris - France, Paris - France, Pessac - France, Point à Pitre - France, Poitiers - France, Strasbourg - France, Tours - France, Vandoeuvre les Nancy - France",2013-12,2011-12-28,2016-02-24,OBSERVATIONAL,Not Available,"University Hospital, Limoges",OTHER,hepatitis
NCT03736265,Carvedilol,UNKNOWN,2017-10-09,"Cirrhosis, Liver, Portal Hypertension",Carvedilol,"Beijing - China, Beijing - China, Beijing - China, Beijing - China, Shanghai - China, Shanghai - China",2022-11-30,2018-11-09,2022-12-01,INTERVENTIONAL,NA,Beijing Friendship Hospital,OTHER,hepatitis
NCT01311674,Unknown,TERMINATED,2009-09,Healthy Volunteers,"hepatitis B vaccine, hepatitis B vaccine","Altamonte Springs - United States, Frederick - United States",2011-03-11,2011-03-09,2024-03-18,INTERVENTIONAL,PHASE3,Emergent BioSolutions,INDUSTRY,hepatitis
NCT03753074,ATTENTION,ACTIVE_NOT_RECRUITING,2019-02-18,Chronic Hepatitis b,Tenofovir Alafenamide,"Daegu - Korea, Republic of, Seongnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of",2031-12-31,2018-11-26,2024-12-17,INTERVENTIONAL,PHASE4,Young-Suk Lim,OTHER,hepatitis
NCT01020565,Unknown,COMPLETED,2003-02,Chronic Hepatitis B,Entecavir,No locations listed,2005-02,2009-11-25,2010-08-06,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT04038320,Unknown,COMPLETED,2018-03-26,Hepatitis C Virus,Sofosbuvir/ledipasvir (SOF/LDV),"Kiev - Ukraine, Kyiv - Ukraine",2019-03-30,2019-07-30,2019-07-30,OBSERVATIONAL,Not Available,Right to Care,OTHER,hepatitis
NCT01579474,Unknown,COMPLETED,2012-04,Hepatitis C,"BI 201335 high dose, BI 201335 low dose, BI 201335 high dose, BI 201335 high dose","Chuo-ku, Chiba - Japan, Chuo-ku, Kobe, Hyogo - Japan, Fukui, Fukui - Japan, Gifu, Gifu - Japan, Itabashi-ku, Tokyo - Japan, Izunokuni, Shizuoka - Japan, Kanazawa, Ishikawa - Japan, Kita-gun, Kagawa - Japan, Kofu, Yamanashi - Japan, Kurume, Fukuoka - Japan, Mtsuyama, Ehime - Japan, Nagoya, Aichi - Japan, Nishinomiya, Hyogo - Japan, Ogaki, Gifu - Japan, Oo mura, Nagasaki, - Japan, Osaka, Osaka - Japan, Osakasayama, Osaka - Japan, Sapporo, Hokkaido - Japan, Sendai, Miyagi - Japan, Tanabe, Wakayama - Japan, Toyama,Toyama - Japan, Tsu, Mie - Japan, Yahatanishi-ku, Kitakyusyu, Fukuoka - Japan, Yamagata, Yamagata - Japan",2013-12,2012-04-18,2015-08-03,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT03524365,BRAVES,COMPLETED,2018-12-06,Non Alcoholic Steatohepatitis,"RYGB, SG, Intensive Lifestyle Modification","Roma - Italy, Roma - Italy, Rome - Italy",2022-07-20,2018-05-14,2023-02-21,INTERVENTIONAL,NA,Catholic University of the Sacred Heart,OTHER,hepatitis
NCT01925820,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,Pegasys&Entecavir,Taipei - Taiwan,2018-12,2013-08-20,2014-12-04,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT01777074,PRALINE,COMPLETED,2009-11,Hepatitis B,Data collection,"Agde cedex - France, Agen cedex - France, Agen - France, Aire sur la lys - France, Aizenay - France, Albi - France, Ales - France, Alleins - France, Amiens - France, Ancenis - France, Andresy - France, Angers - France, Anglet - France, Annecy le vieux - France, Annecy - France, Antony - France, Argenteuil - France, Arles - France, Arnas - France, Arsac - France, Asnieres sur seine - France, Aubagne - France, Aubergenville - France, Aubervilliers - France, Aucamville - France, Auchy les mines - France, Auriol - France, Avignon - France, Bagneux - France, Bagnols sur ceze - France, Bar le duc - France, Barr - France, Beaulieu les loches - France, Beaumont - France, Beaupreau - France, Beausoleil - France, Beauvais - France, Belfort - France, Bellegarde - France, Berre l etang - France, Besancon - France, Bethune - France, Betton - France, Beziers - France, Biarritz - France, Bievres - France, Biganos - France, Biscarrosse - France, Bischheim - France, Bois guillaume cedex - France, Bollene - France, Boos - France, Bordeaux - France, Bordeaux - France, Bosmie l aiguille - France, Boulogne billancourt - France, Bourg en bresse - France, Bousse - France, Brest - France, Bron - France, Bron - France, Bruges cedex - France, Buchy - France, Caen - France, Cambrai - France, Camphin en carembault - France, Cannes - France, Carresse Cassaber - France, Caveirac - France, Cergy st christophe - France, Cergy - France, Cestas - France, Chalamont - France, Challans - France, Chalon sur saone - France, Chambly - France, Champigny sur marne - France, Chanteloup les vignes - France, Chantilly - France, Chartres - France, Chassieu - France, Chateauneuf les martigues - France, Chatenois les forges - France, Chatou - France, Cherbourg - octeville - France, Clamart - France, Clapiers - France, Clermont Ferrand - France, Clermont ferrand - France, Clichy - France, Colmar - France, Colomars - France, Colombelles - France, Combs la ville - France, Compiegne - France, Conde sur noireau - France, Corbeil essonnes - France, Courpiere - France, Creutzwald - France, Crolles - France, Cugnaux - France, Cusset - France, Darnetal - France, Deluz - France, Dessenheim - France, Digne les bains - France, Divonne les bains - France, Domene - France, Domont - France, Draguignan - France, Einvaux - France, Epinal cedex 9 - France, Equeurdreville hainneville - France, Esquerdes - France, Essey les Nancy - France, Estrees st denis - France, Evreux - France, Evry - France, Fecamp - France, Fenioux - France, Feurs - France, Figeac - France, Fontaine les dijon - France, Fontaine - France, Fontains - France, Fontenay sous bois - France, Forges les eaux - France, Fouesnant - France, Foussais payre - France, Francheville - France, Fumel - France, Gamarde les bains - France, Gemozac - France, Gondecourt - France, Gonneville la mallet - France, Gouvieux - France, Gouy sous bellonne - France, Gouzeaucourt - France, Grenoble - France, Greoux les bains - France, Grigny - France, Guenange - France, Haguenau - France, Hatten - France, Hesdin - France, Hoenheim - France, Houilles - France, Houplin ancoisne - France, Hyeres - France, Illkirch graffenstaden - France, Istres - France, Jarny - France, Joue les tours - France, L aigle - France, L huisserie - France, La chapelle sur erdre - France, La couronne - France, La creche - France, La garenne colombes - France, La madeleine - France, La meziere - France, La motte servolex - France, La source orleans - France, La talaudiere - France, La voulte sur rhone - France, Lamarche sur saone - France, Lambersart - France, Landivisiau - France, Lanester - France, Langon - France, Laval - France, Le barp - France, Le Bouscat - France, Le cannet - France, Le chesnay - France, Le creusot - France, Le havre - France, Le kremlin bicetre - France, Le lavandou - France, Le palais sur vienne - France, Le passage d' agen - France, Le rheu - France, Les sables d olonne - France, Les Sables D'olonne - France, Les ulis - France, Lesquin - France, Lille Cedex - France, Limas - France, Limoges - France, Lingolsheim - France, Lisieux - France, Lognes - France, Lomme - France, Loos en gohelle - France, Lorient - France, Luzinay - France, Lyon - France, Lyon - France, Lyon - France, Lyon - France, Malakoff - France, Mantes la ville - France, Marchenoir - France, Marcq en baroeul - France, Marguerittes - France, Marmande - France, Marnay - France, Marseille - France, Marseille - France, Marseille - France, Marseille - France, Marseille - France, Marseille - France, Martigues - France, Martin eglise - France, Martinsart - France, Mauze sur mignon - France, Meaux - France, Merignac - France, Merkwiller pechelbronn - France, Mery sur oise - France, Metz - France, Meudon - France, Meylan - France, Meyssac - France, Mirecourt - France, Moivrons - France, Molsheim - France, Mondeville - France, Mons en baroeul - France, Montauban - France, Montelimar - France, Monteux - France, Montfermeil - France, Montgeron - France, Montigny le bretonneux - France, Montigny les metz - France, Montoire sur le loir - France, Montpellier - France, Montpellier - France, Montreuil - France, Morlaas - France, Morlaix - France, Mornas - France, Mouans sartoux - France, Moutiers tarentaise - France, Moyeuvre grande - France, Mur de sologne - France, Nanterre - France, Nantes - France, Nemours - France, Neuville sur saone - France, Niort - France, Nogent sur marne - France, Noisy le roi - France, Noyon - France, Obernai - France, Oloron ste marie - France, Orleans - France, Orleans - France, Orthez - France, Oucques - France, Ouistreham - France, Oust - France, Ozoir la ferriere - France, Palaiseau - France, Pamiers - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Pau cedex - France, Pau - France, Pertuis - France, Pierrefitte sur sauldre - France, Plouguernevel - France, Pont a mousson - France, Pont l abbe d arnoult - France, Pont ste maxence - France, Pontarlier - France, Pornic - France, Port sur saone - France, Provins - France, Publier - France, Puteaux - France, Quevreville la poterie - France, Raches - France, Rennes - France, Rennes - France, Rennes - France, Reze - France, Rillieux la pape - France, Riom - France, Rivery - France, Roanne - France, Roche la moliere - France, Rodez - France, Romainville - France, Romans sur isere - France, Romille - France, Ronchin - France, Rosieres en santerre - France, Rouen - France, Royan - France, Ruy - France, Sahurs - France, Saint-Aubin - France, Saintes - France, Sanary sur mer - France, Segonzac - France, Segré - France, Selestat - France, Sens - France, Septemes les vallons - France, Serres - France, Sillery - France, Soissons - France, Sorgues - France, St astier - France, St aubin sur scie - France, St brevin les pins - France, St brieuc - France, St chamond - France, St cheron - France, St cloud - France, St cyr au mont d'or - France, St denis - France, St etienne de montluc - France, St etienne - France, St flour - France, St genis laval - France, St germain les arpajon - France, St herblain - France, St ismier - France, St jean de la ruelle - France, St jean - France, St leu la foret - France, St louis - France, St loup sur semouse - France, St malo - France, St nazaire - France, St pierre d irube - France, St pol sur mer - France, St priest - France, St remy de provence - France, St tropez - France, Ste foy la grande - France, Ste maxime - France, Strasbourg cedex - France, Strasbourg - France, Strasbourg - France, Sucy en brie - France, Suresnes - France, Talence - France, Tarascon - France, Thiais - France, Thonon les bains - France, Thun st amand - France, Toulon - France, Toulon - France, Toulouse - France, Toul - France, Tours - France, Trie chateau - France, Troyes - France, Vabres l abbaye - France, Val de vesle - France, Valence - France, Vallauris - France, Vandoeuvre les nancy - France, Vannes cedex - France, Vannes - France, Vaugneray - France, Vaulx en velin - France, Vaureal - France, Vaux le penil - France, Vendargues - France, Vernouillet - France, Versailles - France, Vertou - France, Villars les Dombes - France, Villeblevin - France, Villeneuve d ascq cedex - France, Villeurbanne cedex - France, Villiers sur marne - France, Vincennes - France, Viry chatillon - France, Vitrolles - France, Vitry sur Seine - France, Voreppe - France, Wattignies - France, Yerres - France, Zillisheim - France",2012-04,2013-01-28,2013-02-04,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01754974,BASIS,COMPLETED,2013-03,Hepatitis C Virus (HCV),"Peginterferon Lambda-1a, Ribavirin, Peginterferon alfa-2a","Hradec Kralove - Czech Republic, Praha 4 - Czech Republic, Usti Nad Labem - Czech Republic, Chungcheongnam-do - Korea, Republic of, Daegu - Korea, Republic of, Gangwon-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeongsangnam-do - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Mexico - Mexico, Mexico City - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Distrito Federal - Mexico",2014-09,2012-12-21,2015-01-28,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00038974,Unknown,COMPLETED,2002-08,Hepatitis C,"peginterferon alfa-2a, Ribavirin","San Francisco - United States, Miami - United States, Chicago - United States, Baltimore - United States, Boston - United States, Ann Arbor - United States, New York - United States, Chapel Hill - United States",2004-12,2002-06-10,2017-08-03,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01447420,Unknown,COMPLETED,2011-02,"Hepatitis C, Chronic","peginterferon alfa-2a, ribavirin [Copegus]","Salvador - Brazil, Vitoria - Brazil, Juiz de Fora - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Joinville - Brazil, Sao Jose Do Rio Preto - Brazil, Botucatu - Brazil, Campinas - Brazil, Campinas - Brazil, Santos - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil",2012-11,2011-10-06,2016-07-25,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02713620,Unknown,COMPLETED,2015-01,Hepatitis B,"recombinant HBV vaccine (Hepavax-Gene® Berna, Korea)",Muang - Thailand,2016-01,2016-03-21,2017-04-19,INTERVENTIONAL,PHASE4,Chiang Mai University,OTHER,hepatitis
NCT01283074,Unknown,COMPLETED,2009-05,"Hepatitis B, Chronic",No interventions listed,"Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Larissa - Greece, Patra - Greece, Piraeus - Greece, Piraeus - Greece, Rhodes - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Thessaloniki - Greece",2012-11,2011-01-25,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04195074,Unknown,UNKNOWN,2019-01-01,Chronic Hepatitis b,"Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide",Guangzhou - China,2023-12-31,2019-12-11,2019-12-17,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00876174,Unknown,WITHDRAWN,2009-04-15,Chronic Hepatitis C,"Blood sampling of peripheral blood mononuclear cells, Blood draw, 20ml peripheral blood mononuclear cells",No locations listed,2010-01-08,2009-04-06,2023-08-16,OBSERVATIONAL,Not Available,University of Nebraska,OTHER,hepatitis
NCT02002065,Unknown,COMPLETED,2008-10,Hepatitis A,"Inactivated HAV vaccine, Attenuated alive HAV vaccine",Tianjin - China,2013-11,2013-12-05,2016-07-14,OBSERVATIONAL,Not Available,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00249574,Unknown,COMPLETED,2003-06,"Hepatitis C, Heroin Dependence","Buprenorphine/naloxone, pegInterferon",Oakland - United States,2004-03,2005-11-07,2017-01-16,INTERVENTIONAL,NA,National Institute on Drug Abuse (NIDA),NIH,hepatitis
NCT05350865,Unknown,RECRUITING,2023-01-30,HDV,No interventions listed,"Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand",2025-05,2022-04-28,2024-10-02,OBSERVATIONAL,Not Available,The HIV Netherlands Australia Thailand Research Collaboration,OTHER,hepatitis
NCT01205165,Unknown,COMPLETED,2004-12-17,"Hepatitis B, Chronic",Adefor dipivoxil,No locations listed,2006-04-28,2010-09-20,2018-07-02,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05526820,Unknown,COMPLETED,2021-04-08,Varicella,The live attenuated varicella vaccine and the inactivated hepatitis A vaccine,Tai'an - China,2021-04-08,2022-09-02,2022-09-02,INTERVENTIONAL,PHASE4,"Sinovac (Dalian) Vaccine Technology Co., Ltd.",INDUSTRY,hepatitis
NCT03703674,Unknown,UNKNOWN,2017-11-19,Alcoholic Hepatitis,GCSF,Chandigarh - India,2020-11-18,2018-10-12,2018-10-12,INTERVENTIONAL,PHASE4,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT02902120,Unknown,COMPLETED,2017-05-01,"Hepatitis C, Renal Insufficiency, Chronic, Disorder of Transplanted Kidney",Post-transplant Grazoprevir and Elbasvir,Baltimore - United States,2021-09-01,2016-09-15,2024-04-22,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,hepatitis
NCT03181074,Unknown,COMPLETED,2015-10-21,Hepatitis C,Non-Interventional,"Benito Juarez - Mexico, Mexico, D.f. - Mexico",2019-08-19,2017-06-08,2020-03-18,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03620474,Unknown,COMPLETED,2018-07-24,"Hepatitis C, Hepatitis B, Liver Cirrhoses",PRI-724,"Ichikawa - Japan, Bunkyō-Ku - Japan, Fukuoka - Japan",2021-07-13,2018-08-08,2024-10-10,INTERVENTIONAL,PHASE2,"Kiminori Kimura, MD",OTHER,hepatitis
NCT03118674,Unknown,COMPLETED,2017-09-06,"Porphyria Cutanea Tarda, Hepatitis C",Harvoni,"San Francisco - United States, Winston-Salem - United States, Galveston - United States",2022-03-04,2017-04-18,2023-07-03,INTERVENTIONAL,PHASE2,Wake Forest University Health Sciences,OTHER,hepatitis
NCT00662220,VIRID,TERMINATED,2008-04,Chronic Hepatitis C,"ribavirin, ribavirin","Arnhem - Netherlands, Nijmegen - Netherlands, Nijmegen - Netherlands, Winschoten - Netherlands, Heerlen - Netherlands, Breda - Netherlands, Eindhoven - Netherlands, Tilburg - Netherlands, Tilburg - Netherlands, Alkmaar - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Hoofddorp - Netherlands, Deventer - Netherlands, Terneuzen - Netherlands, Vlissingen - Netherlands, Capelle aan de IJssel - Netherlands, Delft - Netherlands, Den Haag - Netherlands, Dordrecht - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Rotterdam - Netherlands, Rotterdam - Netherlands, Groningen - Netherlands, Utrecht - Netherlands",2013-06,2008-04-21,2014-07-14,INTERVENTIONAL,PHASE3,Foundation for Liver Research,OTHER,hepatitis
NCT00940420,Unknown,COMPLETED,2002-10,"Hepatitis C, Chronic","Copegus (ribavirin), Copegus (ribavirin), peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Afula - Israel, Ashkelon - Israel, Bat Yam - Israel, Beer Sheva - Israel, Hadera - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Holon - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Nazareth - Israel, Petach Tikva - Israel, Petach Tikva - Israel, Ramat Gan - Israel, Rehovot - Israel, Safed - Israel, Tel Aviv - Israel, Zerifin - Israel",2009-11,2009-07-16,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00527774,Unknown,COMPLETED,2007-09,"Hepatitis C, Hemodialysis, Quality of Life, Mortality, Hospitalization",No interventions listed,Chiayi City - Taiwan,2008-02,2007-09-11,2016-05-05,OBSERVATIONAL,Not Available,St. Martin De Porress Hospital,OTHER,hepatitis
NCT02169674,Unknown,COMPLETED,2014-09,Hepatitis B,"EngerixB, GlaxoSmithKline Vaccines",Vancouver - Canada,2015-08,2014-06-23,2019-03-21,INTERVENTIONAL,PHASE4,University of British Columbia,OTHER,hepatitis
NCT03350074,Unknown,COMPLETED,2013-11-05,"Hepatitis B, Chronic",No interventions listed,No locations listed,2016-05-01,2017-11-22,2017-11-22,OBSERVATIONAL,Not Available,"Central Hospital, Nancy, France",OTHER,hepatitis
NCT05372874,Unknown,UNKNOWN,2022-05-06,Hepatitis C,Direct Acting Antivirals,No locations listed,2022-07-12,2022-05-13,2022-05-13,OBSERVATIONAL,Not Available,Tanta University,OTHER,hepatitis
NCT05808374,Unknown,RECRUITING,2023-04-30,Chronic Hepatitis B,"HRS-5635, HRS-5635, HRS-5635, Placebo",Hefei - China,2024-05-31,2023-04-11,2023-06-18,INTERVENTIONAL,PHASE1,"Fujian Shengdi Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT00948220,Unknown,COMPLETED,2003-07,"Hepatitis C, Chronic, Liver Diseases, Virus Diseases",peginterferon alfa-2a and ribavirin,Ulm - Germany,2007-01,2009-07-29,2011-06-07,INTERVENTIONAL,PHASE4,University of Ulm,OTHER,hepatitis
NCT03042520,LONGHEAD,UNKNOWN,2016-08,"Liver Fibroses, HepatoCellular Carcinoma, Cryoglobulinemia, Metabolic Disease, Diabetes Mellitus",Observation only,"Ansan - Korea, Republic of, Asan - Korea, Republic of, Bucheon - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Changhua - Taiwan, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Keelung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2022-09,2017-02-03,2021-10-12,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03025074,Unknown,RECRUITING,2013-07,"Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate",No interventions listed,Buffalo - United States,2099-12,2017-01-19,2024-06-18,OBSERVATIONAL,Not Available,State University of New York at Buffalo,OTHER,hepatitis
NCT00724620,Unknown,COMPLETED,2005-06,"Hepatitis C, Chronic","Peginterferon alfa-2b (SCH 054031), Ribavirin (SCH 018908)",No locations listed,2008-02,2008-07-29,2008-07-29,INTERVENTIONAL,PHASE4,Schering-Plough,INDUSTRY,hepatitis
NCT01998620,Unknown,UNKNOWN,2013-11,"Hepatitis B, Cholestasis","Ademetionine 2, Ademetionine 1, Ademetionine 3",Shanghai - China,2015-05,2013-12-02,2014-05-29,INTERVENTIONAL,PHASE4,Zhejiang Hisun Pharmaceutical Co. Ltd.,INDUSTRY,hepatitis
NCT01439373,Unknown,COMPLETED,2011-07-07,"Hepatitis C, Chronic","GSK2336805, Pegylated interferon alfa-2a, Ribavirin, GSK2336805 Matching Placebo","Anaheim - United States, Chula Vista - United States, Coronado - United States, La Mesa - United States, Oceanside - United States, Miramar - United States, Las Vegas - United States, Tulsa - United States, Houston - United States, San Juan - Puerto Rico",2011-12-05,2011-09-23,2017-12-11,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00037076,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C",No interventions listed,"Birmingham - United States, Phoenix - United States, Los Angeles - United States, Oakland - United States, San Diego - United States, San Francisco - United States, Denver - United States, Farmington - United States, New Haven - United States, Washington - United States, Miami - United States, Augusta - United States, Columbus - United States, Chicago - United States, Chicago - United States, Chicago - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Springfield - United States, Worcester - United States, Detroit - United States, Newark - United States, Brooklyn - United States, New York - United States, New York - United States, Rochester - United States, Stony Brook - United States, Syracuse - United States, Chapel Hill - United States, Durham - United States, Philadelphia - United States, Philadelphia - United States, Memphis - United States, Nashville - United States, Dallas - United States, Houston - United States, San Juan - Puerto Rico, San Juan - Puerto Rico",Unknown Date,2002-05-15,2012-10-31,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00843076,Viro-steatosis,TERMINATED,2009-01,Chronic Hepatitis C,No interventions listed,"Blois - France, Bourges - France, Chateauroux - France, Dreux - France, Orleans - France, Tours - France",2011-04,2009-02-13,2013-11-11,OBSERVATIONAL,Not Available,"University Hospital, Tours",OTHER,hepatitis
NCT01181427,Unknown,COMPLETED,2010-08,HCV Infection,"ABT-267, Placebo, Blood Sample Collection, Cytochrome P450 inhibitor","Orlando - United States, Waukegan - United States, San Antonio - United States",2011-03,2010-08-13,2012-01-24,INTERVENTIONAL,PHASE1,Abbott,INDUSTRY,hepatitis
NCT01464827,Unknown,COMPLETED,2011-10,"Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1","ABT-450, ABT-333, ABT-267, Ribavirin, Ritonavir","Birmingham - United States, Birmingham - United States, Dothan - United States, Phoenix - United States, Tucson - United States, Bakersfield - United States, Coronado - United States, Costa Mesa - United States, Los Angeles - United States, San Diego - United States, Aurora - United States, Bradenton - United States, Fort Pierce - United States, Gainesville - United States, Jacksonville - United States, Wellington - United States, Wellington - United States, Zephyrhills - United States, Macon - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Bowling Green - United States, Shreveport - United States, Annapolis - United States, Baltimore - United States, Lutherville - United States, Boston - United States, Springfield - United States, Ann Arbor - United States, Detroit - United States, St. Paul - United States, Jackson - United States, Kansas City - United States, St. Louis - United States, Egg Harbor Township - United States, Manhasset - United States, Monticello - United States, New York - United States, New York - United States, Poughkeepsie - United States, Rochester - United States, Charlotte - United States, Fayetteville - United States, Statesville - United States, Cincinnati - United States, Cincinnati - United States, Medford - United States, Portland - United States, Philadelphia - United States, Germantown - United States, Germantown - United States, Nashville - United States, Houston - United States, San Antonio - United States, Annandale - United States, Newport News - United States, Seattle - United States, Madison - United States, Milwaukee - United States, Adelaide - Australia, Herston - Australia, Kogarah - Australia, Calgary - Canada, Vancouver - Canada, Clichy - France, Creteil - France, Lyon - France, Marseilles - France, Montpellier - Cedex 5 - France, Paris - France, Pessac - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Berlin - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Wuerzburg - Germany, Auckland - New Zealand, San Juan - Puerto Rico, San Juan - Puerto Rico, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, Seville - Spain, Valencia - Spain, Dundee - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Southampton - United Kingdom",2013-03,2011-11-04,2015-04-22,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT03721627,Unknown,UNKNOWN,2018-04-03,"Gaucher Disease, HCV",Ledipasvir/Sofosbuvir,Mansoura - Egypt,2019-04,2018-10-26,2018-10-30,INTERVENTIONAL,PHASE4,Mansoura University Children Hospital,OTHER,hepatitis
NCT01641276,THBC-HSL2,COMPLETED,2012-04,"Hepatitis, Hepatocellular Carcinomas",Low intensity amplitude-moduled electromagnetic fields,São Paulo - Brazil,2015-06,2012-07-16,2015-09-14,INTERVENTIONAL,NA,Hospital Sirio-Libanes,OTHER,hepatitis
NCT06777173,Unknown,ENROLLING_BY_INVITATION,2023-12-01,"Chronic Hepatitis b, Immunotherapy",Peg interferon alfa-2b,Beijing - China,2026-11-01,2025-01-15,2025-01-15,INTERVENTIONAL,NA,Beijing Ditan Hospital,OTHER,hepatitis
NCT04189627,DETI-2,COMPLETED,2020-02-17,Hepatitis C Virus (HCV),No interventions listed,"Makhachkala - Russian Federation, Kazan - Russian Federation, Chelyabinsk - Russian Federation, Ekaterinburg - Russian Federation, Irkutsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation",2021-06-24,2019-12-06,2022-06-27,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01094873,Unknown,COMPLETED,2009-11,Hepatitis C,"AdCh3NSmut, Ad6NSmut","Birmingham - United Kingdom, Headington, Oxford - United Kingdom",2013-04,2010-03-29,2015-04-23,INTERVENTIONAL,PHASE1,ReiThera Srl,INDUSTRY,hepatitis
NCT00148031,Unknown,COMPLETED,2003-09,"Hepatitis C, Liver Diseases, Drug Abuse, Alcoholism","Pegylated Interferon and Ribavirin, Psychosocial, On-site (MMT Clinic) HCV evaluation and treatment, Off-site HCV evaluation and treatment","Syracuse - United States, Syracuse - United States",2007-03,2005-09-07,2013-04-24,INTERVENTIONAL,PHASE4,State University of New York - Upstate Medical University,OTHER,hepatitis
NCT03245931,Unknown,COMPLETED,2017-07-20,Hepatitis C,Qualitative Interview,Cincinnati - United States,2019-08-26,2017-08-10,2019-08-28,OBSERVATIONAL,Not Available,TriHealth Inc.,OTHER,hepatitis
NCT04915573,Unknown,UNKNOWN,2021-06-07,Cirrhosis,Specimen,Tanta - Egypt,2021-09,2021-06-07,2021-06-10,OBSERVATIONAL,Not Available,Mansoura University,OTHER,hepatitis
NCT03468673,SexLife,COMPLETED,2015-02-20,"Sexual Dysfunction, HIV, Hepatitis C",No interventions listed,"Sydney - Australia, são Paulo - Brazil, Montréal - Canada, Bordeaux - France, Dijon - France, Le Kremlin-Bicêtre - France, Marseille - France, Nantes - France, Paris - France, Paris - France, Paris - France, Paris - France, Saint Germain en Laye - France, Saint-Nazaire - France, Suresnes - France, Toulouse - France, Villejuif - France",2018-12-31,2018-03-16,2021-04-27,OBSERVATIONAL,Not Available,University Paris 7 - Denis Diderot,OTHER,hepatitis
NCT05551273,Unknown,RECRUITING,2023-05-05,"Hepatitis B, HIV Infections","Selgantolimod, Placebo","Birmingham - United States, San Diego - United States, San Francisco - United States, Torrance - United States, Aurora - United States, Washington - United States, Atlanta - United States, Chicago - United States, Baltimore - United States, Boston - United States, Saint Louis - United States, Newark - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Chapel Hill - United States, Greensboro - United States, Cincinnati - United States, Cleveland - United States, Columbus - United States, Philadelphia - United States, Pittsburgh - United States, Nashville - United States, Houston - United States, Seattle - United States, Gaborone - Botswana, Porto Alegre - Brazil, Rio De Janeiro - Brazil, Rio de Janeiro - Brazil, Port-au-Prince - Haiti, Lima - Peru, Cavite - Philippines, Johannesburg - South Africa, Durban - South Africa, Pathum Wan - Thailand, Chiang Mai - Thailand, Kampala - Uganda, Milton Park - Zimbabwe",2026-11-19,2022-09-22,2025-02-11,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT03343431,Unknown,ACTIVE_NOT_RECRUITING,2018-08-02,"Hepatitis B, Pregnancy",Anti-HBV antiviral prophylaxis,"Champasak - Lao People's Democratic Republic, Luang Prabang - Lao People's Democratic Republic, Savannakhet - Lao People's Democratic Republic, Sayaboury - Lao People's Democratic Republic, Vientiane - Lao People's Democratic Republic, Vientiane - Lao People's Democratic Republic, Vientiane - Lao People's Democratic Republic, Vientiane - Lao People's Democratic Republic, Chiang Kham - Thailand, Bangkok - Thailand, Chanthaburi - Thailand, Chiang Mai - Thailand, Chiang Mai - Thailand, Chiang Rai - Thailand, Chon Buri - Thailand, Chon Buri - Thailand, Lampang - Thailand, Lamphun - Thailand, Samut Prakan - Thailand, Samut Sakhon - Thailand",2023-01-13,2017-11-17,2024-06-06,INTERVENTIONAL,PHASE3,Institut de Recherche pour le Developpement,OTHER_GOV,hepatitis
NCT03074331,Unknown,COMPLETED,2017-03-23,Hepatitis C Virus Infection,SOF/VEL,"New Delhi - India, Mumbai - India, Nagpur - India, Delhi - India, Mumbai - India, Chandigarh - India, Chennai - India, Coimbatore - India, Secunderabad - India, Lucknow - India, Kolkata - India, Guwahati - India, Hyderabad - India, Kochi - India, Ludhiana - India, Surat - India",2018-02-07,2017-03-08,2019-03-19,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT02511431,Unknown,COMPLETED,2015-07-29,Hepatitis D,"Lonafarnib, Ritonavir, Placebo",Bethesda - United States,2017-02-23,2015-07-30,2018-09-25,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03476031,Unknown,UNKNOWN,2018-11,Cryoglobulinaemia Due to Chronic Hepatitis C,renal biopsy,Assuit - Egypt,2019-10,2018-03-23,2018-03-23,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01090531,Unknown,UNKNOWN,2009-08,"Hepatitis B, Chronic",No interventions listed,"Berlin - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Kiel - Germany",2021-08,2010-03-22,2020-04-22,OBSERVATIONAL,Not Available,Johann Wolfgang Goethe University Hospital,OTHER,hepatitis
NCT06802731,Unknown,RECRUITING,2024-01-01,"Liver Inflammation, Fatty Liver Disease",No interventions listed,Beijing - China,2025-03-31,2025-01-31,2025-01-31,OBSERVATIONAL,Not Available,Wuxi Hisky Medical Technology Co Ltd,INDUSTRY,hepatitis
NCT00524173,Unknown,TERMINATED,2007-08-29,Hepatitis B,"Tenofovir & Emtricitabine, Tenofovir",Bethesda - United States,2017-02-16,2007-09-03,2019-06-05,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02718573,Unknown,COMPLETED,2015-01,"Hepatitis C, HCV, Liver Transplant",No interventions listed,New York - United States,2017-12-11,2016-03-24,2018-01-18,OBSERVATIONAL,Not Available,Icahn School of Medicine at Mount Sinai,OTHER,hepatitis
NCT00289731,Unknown,COMPLETED,2003-11-24,"Hepatitis B, Hepatitis A","TWINRIX™, Engerix™-B, HAVRIX™, HB VAX PRO™, Vaqta™","Wilrijk - Belgium, Hradec Kralove - Czechia, Finsterwalde - Germany, Dresden - Germany, Geringswalde - Germany, Pirna - Germany, Bad Bramstedt - Germany, Bad Segeberg - Germany, Elmshorn - Germany",2004-12-21,2006-02-10,2019-11-15,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00699231,Unknown,COMPLETED,1992-02,Hepatitis B,"HBV-MPL vaccine 208129, Engerix™-B",Brussels - Belgium,1992-12,2008-06-17,2008-06-17,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00018031,HEPCPR,COMPLETED,2001-06,"Hepatitis C, HIV Infections","Peginterferon alfa-2b, Ribavirin",Bethesda - United States,2009-04,2001-06-28,2014-10-01,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT02133131,Unknown,COMPLETED,2014-06-13,Hepatitis C,"Grazoprevir/Elbasvir FDC, Sofosbuvir",No locations listed,2015-11-02,2014-05-07,2021-02-05,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02463331,Unknown,COMPLETED,2003-05,Autoimmune Hepatitis,"Chloroquine diphosphate, prednisone, azathioprine",No locations listed,2015-06,2015-06-04,2017-02-15,INTERVENTIONAL,PHASE4,University of Sao Paulo General Hospital,OTHER,hepatitis
NCT02202473,Unknown,COMPLETED,Unknown Date,Chronic Hepatitis B,"Lamivudine, Lamivudine+Oxymatrine Capsules",Nanjing - China,2014-02,2014-07-29,2014-07-29,INTERVENTIONAL,PHASE4,"Southeast University, China",OTHER,hepatitis
NCT00994773,Unknown,COMPLETED,2009-12,Hepatitis B,"Simvastatin, Tenofovir, Entecavir",Oklahoma City - United States,2011-10,2009-10-14,2012-08-16,INTERVENTIONAL,PHASE1,"Bader, Ted, M.D.",INDIV,hepatitis
NCT01200420,Unknown,COMPLETED,2010-09,Hepatitis C,"miravirsen, saline","San Antonio - United States, Frankfurt - Germany, Amsterdam - Netherlands, Rotterdam - Netherlands, Warszawa - Poland, San Juan - Puerto Rico, Bratislava, - Slovakia",2011-12,2010-09-13,2012-01-31,INTERVENTIONAL,PHASE2,Santaris Pharma A/S,INDUSTRY,hepatitis
NCT05710120,Unknown,COMPLETED,2023-01-16,Hepatitis C,"Hepatitis C Screening Alerts in CHORUS™, Standard of Care",Los Angeles - United States,2023-10-17,2023-02-02,2024-02-16,OBSERVATIONAL,Not Available,Epividian,INDUSTRY,hepatitis
NCT01471574,Unknown,COMPLETED,2011-12,"Hepatitis C, Genotype 1","Daclatasvir, Ribavirin, PEG-Interferon alfa 2a","Birmingham - United States, La Jolla - United States, Los Angeles - United States, Palm Springs - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, West Haven - United States, Washington - United States, Miami - United States, Orlando - United States, Lutherville - United States, Newark - United States, Bronx - United States, Monticello - United States, New York - United States, New York - United States, Chapel Hill - United States, Charlotte - United States, Dallas - United States, Houston - United States, San Antonio - United States, Richmond - United States, Ciudad De Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Cordoba - Argentina, Darlinghurst Nsw - Australia, Darlinghurst - Australia, Clayton - Australia, Parkville - Australia, Antwerpen - Belgium, Brussels - Belgium, Brussels - Belgium, Porto Alegre - Brazil, Rio De Janeiro - Brazil, Rio De Janeiro - Brazil, Sao Paulo - Brazil, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Ottawa - Canada, Torono - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Marseille Cedex 09 - France, Montpellier Cedex 5 - France, Paris Cedex 10 - France, Paris - France, Paris - France, Paris - France, Paris - France, Pessac Cedex - France, Berlin - Germany, Bonn - Germany, Frankfurt Am Main - Germany, Frankfurt - Germany, Hamburg - Germany, Brescia - Italy, Milano - Italy, Milano - Italy, Modena - Italy, Torino - Italy, San Juan - Puerto Rico, San Juan - Puerto Rico, Kaluga - Russian Federation, Lipetsk - Russian Federation, Moscow - Russian Federation, Nizhniy Novgorod - Russian Federation, Saratov - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, St.petersburg - Russian Federation, Volgograd - Russian Federation, Badalona - Spain, Barcelona - Spain, Cordoba - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, London - United Kingdom",2014-06,2011-11-15,2016-01-29,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02338674,Unknown,COMPLETED,2014-10,"Hepatitis B, Chronic","Tenofovir and telbivudine, Tenofovir",Fuzhou - China,2016-10,2015-01-14,2018-09-24,INTERVENTIONAL,PHASE2,Fuzhou General Hospital,OTHER,hepatitis
NCT01438320,Q,COMPLETED,2011-07,Chronic Hepatitis C,Quercetin,los Angeles - United States,2014-06,2011-09-22,2015-03-20,INTERVENTIONAL,PHASE1,"University of California, Los Angeles",OTHER,hepatitis
NCT04544020,CREED,COMPLETED,2019-09-01,Alcoholic Hepatitis,NG feeding,Aberdeen - United Kingdom,2023-04-21,2020-09-10,2023-05-22,OBSERVATIONAL,Not Available,University of Aberdeen,OTHER,hepatitis
NCT03650920,Unknown,COMPLETED,2018-09-02,Liver Failure,Liver Transplantation,Loma Linda - United States,2021-02-19,2018-08-29,2022-03-18,INTERVENTIONAL,NA,Loma Linda University,OTHER,hepatitis
NCT05092074,Unknown,UNKNOWN,2021-10-01,"Hepatitis C Virus Infection, Treatment Side Effects, Adherence, Treatment, Effect of Drug",Vosevi 400/100/100 Oral Tablet,"Beigang - Taiwan, Changhua - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Dalin - Taiwan, Douliu - Taiwan, Liuying - Taiwan, New Taipei City - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2022-12-31,2021-10-25,2021-11-01,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT05451420,Unknown,COMPLETED,2017-12-01,Chronic Hepatitis B,PegIFN α- 2b,Zhengzhou - China,2020-06-30,2022-07-11,2022-07-13,INTERVENTIONAL,NA,Henan Provincial People's Hospital,OTHER,hepatitis
NCT01544920,Unknown,COMPLETED,2012-05-30,"Hepatitis C, Chronic","peg-Interferon alfa-2a, Ribavirin, Boceprevir",No locations listed,2015-05-19,2012-03-06,2018-09-11,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05482282,Unknown,NOT_YET_RECRUITING,2025-01,"Diphtheria Vaccine Adverse Reaction, Tetanus Vaccine Adverse Reaction, Pertussis Vaccine Adverse Reaction, Haemophilus Influenzae Type B Vaccine Adverse Reaction, Hepatitis B Vaccine Adverse Reaction","Recombinant Hepatitis B new Bulk vaccine, DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine, Recombinant Hepatitis B vaccine (Registered BioFarma), Pentabio","Bandung - Indonesia, Bandung - Indonesia, Bandung - Indonesia",2025-04,2022-08-01,2024-04-08,INTERVENTIONAL,PHASE3,PT Bio Farma,INDUSTRY,hepatitis
NCT03759782,Unknown,UNKNOWN,2019-01-10,"Hepatitis B, Chronic","Ribavirin, Tenofovir","Calgary - Canada, Ottawa - Canada",2022-01-31,2018-11-30,2021-09-14,INTERVENTIONAL,PHASE3,Ottawa Hospital Research Institute,OTHER,hepatitis
NCT01973582,Unknown,UNKNOWN,2011-07,Hepatitis B,No interventions listed,Taipei - Taiwan,2014-07,2013-10-31,2013-10-31,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT06368882,Unknown,RECRUITING,2024-01-01,"Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b",Peg-Interferon α,"Ningbo - China, Rui'an - China, Wenzhou - China, Wenzhou - China, Yueqing - China",2028-12-31,2024-04-16,2024-04-16,INTERVENTIONAL,PHASE4,First Affiliated Hospital of Wenzhou Medical University,OTHER,hepatitis
NCT00318682,FIBROSTIC,TERMINATED,2006-05,"Hepatitis, Viral, Human",FIBROSCAN,"Clichy - France, Paris - France",2008-08,2006-04-27,2009-02-12,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT02579382,Unknown,COMPLETED,2015-11-10,Chronic Hepatitis B,"TDF, Vesatolimod, Placebo","Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, Honolulu - United States, Catonsville - United States, Boston - United States, Flushing - United States, Philadelphia - United States, Toronto - Canada, Kowloon - Hong Kong, Bologna - Italy, Milano - Italy, Pisa - Italy, San Giovanni Rotondo - Italy, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Grafton - New Zealand, Dalin - Taiwan, Kaohsiung - Taiwan, London - United Kingdom",2017-01-16,2015-10-19,2020-05-18,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01968382,TREAT,COMPLETED,2014-12,"Hepatitis, Alcoholic","IMM 124-E (Hyperimmune Bovine Colostrum), Placebo (High protein milk powder)","Indianapolis - United States, Rochester - United States, Richmond - United States",2018-12-22,2013-10-24,2020-01-27,INTERVENTIONAL,PHASE2,Virginia Commonwealth University,OTHER,hepatitis
NCT05948982,Unknown,NOT_YET_RECRUITING,2023-07-30,Decompensated Liver Cirrhosis,Human Umbilical Cord Mesenchymal Stem Cells,No locations listed,2026-12-31,2023-07-17,2023-07-17,INTERVENTIONAL,PHASE2,"Asia Cell Therapeutics (Shanghai) Co., Ltd.",INDUSTRY,hepatitis
NCT02640482,ENDURANCE-2,COMPLETED,2015-11,Chronic Hepatitis C Virus (HCV) Infection,"ABT-493/ABT-530, Placebo for ABT-493/ABT-530",No locations listed,2016-09,2015-12-29,2021-07-16,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT05368974,TiP-HepC,RECRUITING,2022-02-11,Hepatitis C,Direct Acting Antivirals,Atlanta - United States,2026-06-30,2022-05-10,2024-12-18,OBSERVATIONAL,Not Available,The Task Force for Global Health,OTHER,hepatitis
NCT00441974,Unknown,COMPLETED,2006-12,Chronic Hepatitis B,adefovir dipivoxil,"Guangzhou - China, Guangzhou - China, Wuhan - China, Nanjing - China, Nanjing - China, Nanjing - China, Changchun - China, Chengdu - China, Hangzhou - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Changsha - China, Chongqing - China, Chongquin - China, Fuzhou - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Tianjin - China",2008-09,2007-03-01,2009-10-20,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01290965,Unknown,COMPLETED,2007-04,Chronic Hepatitis C,"Placebo, SCY-635","San Francisco - United States, Richmond - United States",2008-12,2011-02-07,2014-11-06,INTERVENTIONAL,PHASE1,"Scynexis, Inc.",INDUSTRY,hepatitis
NCT01270165,Unknown,UNKNOWN,2010-06,Chronic Hepatitis B,telbivudine,"Seoul - Korea, Republic of",2012-05,2011-01-05,2012-02-02,INTERVENTIONAL,PHASE3,Yonsei University,OTHER,hepatitis
NCT04568265,Unknown,RECRUITING,2020-06-03,"Hepatitis B, Chronic Hep B, HBV","APG-1387, Entecavir 0.5 mg","Guangzhou - China, Guangzhou - China, Shanghai - China, Chengdu - China",2022-10-31,2020-09-29,2021-08-26,INTERVENTIONAL,PHASE2,Ascentage Pharma Group Inc.,INDUSTRY,hepatitis
NCT03919565,HBV,UNKNOWN,2019-02-01,"Hepatitis B, Liver Fibrosis","Tenofovir Disoproxil Fumarate, Peginterferon Alfa-2a, Peginterferon Alfa-2b",Guangzhou - China,2021-10-31,2019-04-18,2019-04-19,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00279565,Unknown,TERMINATED,2005-08,"Hepatitis C, Chronic","buprenorphine, methadone, pegylated interferon alfa-2b plus ribavirin",No locations listed,2007-02,2006-01-19,2012-11-22,INTERVENTIONAL,PHASE4,Indivior Inc.,INDUSTRY,hepatitis
NCT02779465,VDHCC,NOT_YET_RECRUITING,2016-06,"Hepatitis B, Carcinoma, Hepatocellular",Vitamin D3,No locations listed,2016-06,2016-05-20,2016-05-20,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01131065,Unknown,COMPLETED,2010-07,"Hepatitis B, Liver Transplantation",Hepatitis B immune globulin,"Modena - Italy, Padova - Italy, Pisa - Italy, Torino - Italy",2014-06,2010-05-26,2016-02-25,INTERVENTIONAL,PHASE3,"Instituto Grifols, S.A.",INDUSTRY,hepatitis
NCT00215865,Unknown,COMPLETED,Unknown Date,Chronic Hepatitis C Virus Infection,PEGIntron plus ribavirin,Baltimore - United States,Unknown Date,2005-09-22,2005-09-22,INTERVENTIONAL,PHASE3,Hepatitis Resource Network,OTHER,hepatitis
NCT02393365,Unknown,COMPLETED,2015-03-10,Hepatitis C,"Questionnaire, HCV serology","Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium",2018-12-17,2015-03-19,2019-04-17,INTERVENTIONAL,NA,Brugmann University Hospital,OTHER,hepatitis
NCT01025765,Unknown,UNKNOWN,2009-11,Chronic Hepatitis C,"Pioglitazone, Acarbose, Metformin",Taipei - Taiwan,2012-12,2009-12-04,2012-11-27,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT02300792,Unknown,COMPLETED,2013-11,Hepatitis A,"honey, molasses",No locations listed,2014-05,2014-11-25,2014-11-26,INTERVENTIONAL,PHASE2,Ain Shams University,OTHER,hepatitis
NCT00480792,VIHVAC-B,COMPLETED,2007-06,HIV Infections,"GenHevac B Pasteur, GenHevac B Pasteur, GenHevac B Pasteur",Paris - France,2008-12,2007-05-31,2013-07-23,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT01429792,Unknown,COMPLETED,2008-09-25,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin [Copegus]","Afula - Israel, Ashdod - Israel, Ashkelon - Israel, Bat Yam - Israel, Beer Sheva - Israel, Beer Sheva - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Holon - Israel, Jerusalem - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Nazareth - Israel, Petach Tikva - Israel, Petach Tikva - Israel, Ramat Gan - Israel, Rehovot - Israel, Rishon Lezion - Israel, Safed - Israel, Tel Aviv - Israel, Tel Aviv - Israel, Tel Aviv - Israel, Tiberias - Israel, Zerifin - Israel",2013-06-10,2011-09-07,2018-10-23,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02333292,FPSMON201401,COMPLETED,2014-12,Chronic Hepatitis C Infection,"Telaprevir, Boceprevir, Sofosbuvir, Simeprevir, Daclatasvir, Ledipasvir, ritonavir-boosted Paritaprevir/ Ombitasvir, Dasabuvir, Velpatasvir, Elbasvir, Grazoprevir",Seville - Spain,2016-12-31,2015-01-07,2022-06-29,OBSERVATIONAL,Not Available,Valme University Hospital,OTHER,hepatitis
NCT03551444,CAUTIOUS,UNKNOWN,2017-10-01,"Hepatocellular Carcinoma, Hepatitis C, Chronic",Administration of DAA-based treatment,Cairo - Egypt,2019-04-01,2018-06-11,2018-06-11,INTERVENTIONAL,PHASE3,Ain Shams University,OTHER,hepatitis
NCT01899092,Unknown,COMPLETED,2014-01,Hepatitis C,TT-034,"San Diego - United States, Durham - United States, Dallas - United States, San Antonio - United States",2016-09,2013-07-15,2016-11-30,INTERVENTIONAL,PHASE2,"Tacere Therapeutics, Inc.",INDUSTRY,hepatitis
NCT00218192,Unknown,COMPLETED,2000-09,"HCV Negative Status, HCV Risk Behavior",Behavior Therapy,Providence - United States,2006-11,2005-09-22,2015-05-22,INTERVENTIONAL,PHASE3,Butler Hospital,OTHER,hepatitis
NCT01344889,Unknown,COMPLETED,2009-10,"Hepatitis C, Chronic",No interventions listed,"Elbasan - Albania, Tirana - Albania, Algiers - Algeria, Bahrain - Bahrain, Manama - Bahrain, Antwerpen - Belgium, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Brussel - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Charleroi - Belgium, Edegem - Belgium, Genk - Belgium, Gent - Belgium, Gerrardsbergen - Belgium, Haine-Saint-Paul - Belgium, Hasselt - Belgium, Kortrijk - Belgium, Leuven - Belgium, Liège - Belgium, Mont-godinne - Belgium, Namur - Belgium, Oostende - Belgium, Roeselare - Belgium, Seraing - Belgium, Sijsele - Belgium, Verviers - Belgium, Banja Luka - Bosnia and Herzegovina, Bihac - Bosnia and Herzegovina, Mostar - Bosnia and Herzegovina, Sarajevo - Bosnia and Herzegovina, Tuzla - Bosnia and Herzegovina, Zenica - Bosnia and Herzegovina, Salvador - Brazil, Belo Horizonte - Brazil, Uberaba - Brazil, Nova Iguacu - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Botucatu - Brazil, Campinas - Brazil, Santo Andre - Brazil, Santos - Brazil, Sao Jose do Rio Preto - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil, Alexandria - Egypt, Cairo - Egypt, Tanta - Egypt, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Ioannina - Greece, Patra - Greece, Piraeus - Greece, Piraeus - Greece, Rhodes - Greece, Thessaloniki - Greece, Ajka - Hungary, Balassagyarmat - Hungary, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Debrecen - Hungary, Gyor - Hungary, Gyula - Hungary, Kaposvár - Hungary, Kecskemet - Hungary, Miskolc - Hungary, Miskolc - Hungary, Mosonmagyaróvár - Hungary, Nyíregyháza - Hungary, Pecs - Hungary, Sopron - Hungary, Szeged - Hungary, Szolnok - Hungary, Szombathely - Hungary, Székesfehérvár - Hungary, Tatabánya - Hungary, Zalaegerszeg - Hungary, Zalaegerszeg - Hungary, Pune - India, Cochin - India, Hyderabad - India, Lucknow - India, Ludhiana - India, Mizoram - India, Mumbai - India, Mumbai - India, Noida - India, Tehran - Iran, Islamic Republic of, Tehran - Iran, Islamic Republic of, Pescara - Italy, Pescara - Italy, Catanzaro - Italy, Reggio Calabria - Italy, Avellino - Italy, Benevento - Italy, Gragnano - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Salerno - Italy, Bologna - Italy, Carpi - Italy, Modena - Italy, Parma - Italy, Ravenna - Italy, Udine - Italy, Frosinone - Italy, Gaeta - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Genova - Italy, Brescia - Italy, Brescia - Italy, Busto Arsizio - Italy, Como - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Treviglio - Italy, Torrette Di Ancona - Italy, Campobasso - Italy, Asti - Italy, Biella - Italy, Novara - Italy, Omegna (VB) - Italy, Orbassano - Italy, Torino - Italy, Torino - Italy, Brindisi - Italy, Foggia - Italy, Galatina - Italy, San Giovanni Rotondo - Italy, Cagliari - Italy, Cagliari - Italy, Sassari - Italy, Catania - Italy, Comiso - Italy, Messina - Italy, Palermo - Italy, Firenze - Italy, Pisa - Italy, Perugia - Italy, Padova - Italy, Rovigo - Italy, Buchun - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of, Hawali - Kuwait, Safat - Kuwait, Safat - Kuwait, Baabda - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Saida - Lebanon, Tripoli - Lebanon, Skopje - Macedonia, The Former Yugoslav Republic of, Casablanca - Morocco, Casablanca - Morocco, Rabat - Morocco, Rabat - Morocco, Faisalabad - Pakistan, Hyderabad - Pakistan, Karachi - Pakistan, Lahore - Pakistan, Rawalpindi - Pakistan, Bialystok - Poland, Bydgoszcz - Poland, Bytom - Poland, Chorzow - Poland, Cieszyn - Poland, Gdansk - Poland, Katowice - Poland, Krakow - Poland, Krakow - Poland, Lancut - Poland, Lodz - Poland, Pulawy - Poland, Raciborz - Poland, Tychy - Poland, Walbrzych - Poland, Warszawa - Poland, Warszawa - Poland, Wroclaw - Poland, Łodz - Poland, Almada - Portugal, Amadora - Portugal, Aveiro - Portugal, Beja - Portugal, Beja - Portugal, Coimbra - Portugal, Faro - Portugal, Lisboa - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Santarém - Portugal, Vila Real - Portugal, Doha - Qatar, Brasov - Romania, Brasov - Romania, Brasov - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Cluj Napoca - Romania, Cluj-napoca - Romania, Constanta - Romania, Craiova - Romania, Iasi - Romania, Iasi - Romania, Timisoara - Romania, Belgrade - Serbia, Kragujevac - Serbia, NIS - Serbia, Novi Sad - Serbia, Banska Bystrica - Slovakia, Bratislava - Slovakia, Bratislava - Slovakia, Bratislava - Slovakia, Kosice - Slovakia, Kosice - Slovakia, Martin - Slovakia, Presov - Slovakia, Trencin - Slovakia, Abu Dhabi - United Arab Emirates, Dubai - United Arab Emirates",2013-06,2011-04-29,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01125189,HEPCAT,COMPLETED,2010-07,Hepatitis C Virus,"Daclatasvir, Daclatasvir, Placebo, peg-interferon alfa-2a, ribavirin","Montgomery - United States, La Jolla - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, New Haven - United States, Gainesville - United States, Miami - United States, South Miami - United States, Indianapolis - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Lutherville - United States, Springfield - United States, Bronx - United States, Great Neck - United States, Monticello - United States, Chapel Hill - United States, Statesville - United States, Tulsa - United States, Tulsa - United States, Philadelphia - United States, Providence - United States, Nashville - United States, Arlington - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Madison - United States, Darlinghurst - Australia, Westmead Nsw - Australia, Woolloongabba - Australia, Adelaide - Australia, Clayton Vic - Australia, Camperdown - Australia, Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Toronto - Canada, Aarhus - Denmark, Hvidovre - Denmark, Odense - Denmark, Shebin Elkom - Egypt, Cairo - Egypt, Creteil - France, Marseille Cedex 08 - France, Montpellier Cedex 5 - France, Paris Cedex 12 - France, Paris Cedex 14 - France, Duesseldorf - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Cisanello (pisa) - Italy, Pavia - Italy, Guadalajara - Mexico, San Juan - Puerto Rico, Gothenburg - Sweden, Stockholm - Sweden",2012-04,2010-05-18,2015-10-23,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01463592,Unknown,UNKNOWN,2010-06,"Hepatitis C, Chronic","RENESSANS , INTERFERON ALPHA 2b, Ribavirin, Interferon Alfa-2b AND RIBAVIRIN, RENESSANS",Lahore - Pakistan,2013-06,2011-11-02,2011-11-22,INTERVENTIONAL,PHASE3,"MTI Medical Private Limited, Pakistan",OTHER,hepatitis
NCT01353989,Unknown,COMPLETED,2010-07,Hepatitis A,No interventions listed,Arnhem - Netherlands,2015-07,2011-05-16,2016-06-28,OBSERVATIONAL,Not Available,Rijnstate Hospital,OTHER,hepatitis
NCT00188240,Unknown,UNKNOWN,2003-08,"Hepatitis C, Hepatitis B",Pegasys; Copegus.,Toronto - Canada,Unknown Date,2005-09-16,2005-11-29,INTERVENTIONAL,NA,"University Health Network, Toronto",OTHER,hepatitis
NCT00915057,Unknown,COMPLETED,2009-03,"Hepatitis, Viral, Human",NRL972,"Sofia - Bulgaria, Bucharest - Romania, Cluj - Romania, Timisoara - Romania",2009-03,2009-06-05,2009-12-23,INTERVENTIONAL,PHASE2,Norgine,INDUSTRY,hepatitis
NCT04083157,Unknown,COMPLETED,2019-08-12,"Inflammatory Bowel Diseases, Hepatitis B","Intradermal hepatitis B vaccine with imiquimod, Intramuscular hepatitis B vaccine with aqueous cream",Hong Kong - China,2020-12-30,2019-09-10,2022-05-18,INTERVENTIONAL,PHASE3,The University of Hong Kong,OTHER,hepatitis
NCT03246048,Unknown,COMPLETED,2016-01,"Chronic Hepatitis C, Chronic Liver Disease, Cirrhosis",No interventions listed,No locations listed,2021-01,2017-08-11,2022-09-21,OBSERVATIONAL,Not Available,Hospital Universitari Vall d'Hebron Research Institute,OTHER,hepatitis
NCT00657657,Unknown,COMPLETED,2008-04,Hepatitis B,Engerix™-B,Bangkok - Thailand,2008-08,2008-04-14,2016-12-21,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01350648,Unknown,COMPLETED,2011-08-23,"Hepatitis B, Hepatitis C, HIV-HCV Co-Infection",No interventions listed,"Washington - United States, Bethesda - United States",2022-03-04,2011-05-10,2024-10-01,OBSERVATIONAL,Not Available,National Institutes of Health Clinical Center (CC),NIH,hepatitis
NCT05099757,Unknown,UNKNOWN,2022-02-20,Hepatitis B Vaccine,20 µg dose hepatitis B vaccine,No locations listed,2022-11-25,2021-10-29,2021-12-06,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT00894257,EPIALHICE B,COMPLETED,2009-05-25,"Hepatitis C Virus, HIV Infections, Pregnancy",No interventions listed,"Montpellier - France, Nice - France, Toulouse - France",2014-04-15,2009-05-06,2023-11-13,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de Nice,OTHER,hepatitis
NCT00968357,Unknown,COMPLETED,2009-09,Chronic Hepatitis C,SCV-07,"Anaheim - United States, Los Angeles - United States, Palm Springs - United States, Littleton - United States, Washington - United States, Washington - United States, Miami - United States, Atlanta - United States, Louisville - United States, Madisonville - United States, Baltimore - United States, Durham - United States, Cincinnati - United States, Nashville - United States, Houston - United States, Falls Church - United States",2011-01,2009-08-31,2012-06-08,INTERVENTIONAL,PHASE2,SciClone Pharmaceuticals,INDUSTRY,hepatitis
NCT05041348,Unknown,COMPLETED,2021-08-17,Sarcopenia,CT at the level of the third lumbar vertebra (L3),Qingdao - China,2022-07-15,2021-09-13,2022-09-15,OBSERVATIONAL,Not Available,The Affiliated Hospital of Qingdao University,OTHER,hepatitis
NCT03169348,Unknown,UNKNOWN,2017-11-01,Hepatitis C,"sofosbuvir daclatasvir, Ledipasvir/sofosbuvir",Assiut - Egypt,2019-06,2017-05-30,2017-12-07,INTERVENTIONAL,NA,Assiut University,OTHER,hepatitis
NCT01453348,Unknown,COMPLETED,2011-10,"Meningococcal Disease, Meningococcal Meningitis, Hepatitis A, Hepatitis B","MenACWY-CRM, Combined inactivated hepatitis A & recombinant hepatitis B, Recombinant hepatitis B vaccine, Inactivated hepatitis A vaccine","Berlin - Germany, Hamburg - Germany, München - Germany, Rostock - Germany",2012-01,2011-10-17,2017-06-08,INTERVENTIONAL,PHASE3,Novartis Vaccines,INDUSTRY,hepatitis
NCT02592057,Unknown,COMPLETED,2015-11-30,Hepatitis C Virus,SOF,"Hyderabad - India, New Delhi - India, Surat - India, Gurgaon - India, Bengaluru - India, Bengaluru - India, Kochi - India, Nagpur - India, Jaipur - India, Jaipur - India, Jaipur - India, Chennai - India, Coimbatore - India, Lucknow - India, Chandigarh - India, Kolkata - India, Ahmedabad - India, Ahmedabad - India, Chennai - India, Hyderabad - India, Lucknow - India, Lucknow - India, Ludhiana - India, Mumbai - India, New Delhi - India, Varanasi - India",2017-11-30,2015-10-30,2018-05-15,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT06403657,DETECT-B,NOT_YET_RECRUITING,2024-05,Viral Hepatitis B,An enhanced model of hepatitis B testing and linkage to care,No locations listed,2025-07,2024-05-08,2024-05-08,INTERVENTIONAL,NA,Vietnam Viral Hepatitis Alliance,OTHER,hepatitis
NCT01245257,Unknown,COMPLETED,2010-11,Alcoholic Hepatitis,No interventions listed,Aarhus - Denmark,2015-06,2010-11-22,2016-09-12,OBSERVATIONAL,Not Available,University of Aarhus,OTHER,hepatitis
NCT00614757,IR,SUSPENDED,2005-05,"Insulin Resistance, Metabolic Syndrome x","N-acetylcysteine 20% 4ml, N-acetylcysteine 20% in 4 ml",Kansas City - United States,2013-12,2008-02-13,2012-10-26,INTERVENTIONAL,NA,Midwest Biomedical Research Foundation,OTHER,hepatitis
NCT03158857,Unknown,WITHDRAWN,2022-01,Hepatitis C,Sofosbuvir 400 mg,Yangon - Myanmar,2024-01,2017-05-18,2021-12-17,OBSERVATIONAL,Not Available,Myanmar Oxford Clinical Research Unit,OTHER,hepatitis
NCT02203357,Unknown,COMPLETED,2014-03,Hepatitis B,Hepatitis B vaccine,Beijing - China,2016-06,2014-07-29,2019-10-18,INTERVENTIONAL,PHASE4,Peking University,OTHER,hepatitis
NCT02823457,VBMI SUD/HCV,COMPLETED,2017-04-05,"Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders",VBMI,Jackson - United States,2020-01-30,2016-07-06,2022-01-18,INTERVENTIONAL,NA,G.V. (Sonny) Montgomery VA Medical Center,FED,hepatitis
NCT06000657,Unknown,RECRUITING,2023-08-28,"Hepatitis B, Chronic","Vemliver tablet, Baracross Tablet","Seoul - Korea, Republic of",2025-02-04,2023-08-21,2025-01-23,INTERVENTIONAL,PHASE4,Daewoong Pharmaceutical Co. LTD.,INDUSTRY,hepatitis
NCT00194857,Unknown,TERMINATED,2002-02,"Anemia, Neutropenia, Hepatitis C Virus, HIV Infections","erythropoietin, GCSF",New York - United States,2005-12,2005-09-19,2012-12-17,INTERVENTIONAL,PHASE4,Weill Medical College of Cornell University,OTHER,hepatitis
NCT06377748,Unknown,COMPLETED,2024-06-15,"Procedural Pain, Pain, Acute, Nursing Caries","Facilitated tucking position, ShotBlocker, Combined facilitated tucking and ShotBlocker",Istanbul - Turkey,2024-09-30,2024-04-22,2024-10-16,INTERVENTIONAL,NA,Istanbul Medeniyet University,OTHER,hepatitis
NCT02862548,Unknown,COMPLETED,2016-09-16,Chronic Hepatitis B,"TAF, TDF, Other approved antivirals",Auckland - New Zealand,2018-02-08,2016-08-11,2022-06-08,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT05614466,Unknown,NOT_YET_RECRUITING,2023-04,Hepatitis B Virus Related Hepatocellular Carcinoma,The Simply B Study,No locations listed,2025-06,2022-11-14,2022-11-14,INTERVENTIONAL,NA,Nadine Barnes,OTHER,hepatitis
NCT00313274,Unknown,TERMINATED,2003-07,Hepatitis B,Clevudine,"Bupyoung-dong - Korea, Republic of, Pyoung-dong - Korea, Republic of, Jung-gu - Korea, Republic of, Hak-1-dong - Korea, Republic of, Seoul City - Korea, Republic of, Iksan-City - Korea, Republic of, Jeonju-city - Korea, Republic of, Seoul - Korea, Republic of, Sinhung-dong - Korea, Republic of, Dogok-dong - Korea, Republic of, Pungnap-dong - Korea, Republic of, Ilsan-gu - Korea, Republic of, Puch'onae - Korea, Republic of, Seongnam-gu - Korea, Republic of, Dae myoung-dong - Korea, Republic of, Incheon - Korea, Republic of, Hagye 1-dong - Korea, Republic of, Ji-dong - Korea, Republic of, Gaegeum-dong - Korea, Republic of, Ami-dong - Korea, Republic of, Amnam-dong - Korea, Republic of, Banpo-dong - Korea, Republic of, Shinchon- dong - Korea, Republic of, Jeo-dong - Korea, Republic of, Ilwon-dong - Korea, Republic of, Anam-dong - Korea, Republic of, Mokdong - Korea, Republic of, Daelim-dong - Korea, Republic of, Hannam-dong - Korea, Republic of, Seoul - Korea, Republic of",Unknown Date,2006-04-12,2017-02-01,INTERVENTIONAL,PHASE3,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT02281266,Unknown,UNKNOWN,2015-01,Curable Hepatitis B Virus-Related Hepatocellular Carcinoma,"curative resection, thymalfasin, nucleoside analog (suggest to use entecavir)",Shanghai - China,2018-06,2014-11-02,2014-11-21,INTERVENTIONAL,PHASE4,Jia Fan,OTHER,hepatitis
NCT00964665,Unknown,TERMINATED,2009-07,Chronic Hepatitis B,"albinterferon alfa-2b, albinterferon alfa-2b, albinterferon alfa-2b, albinterferon alfa-2b, Pegasys®","Beijing - China, Sha Tin - Hong Kong, Taipo - Hong Kong, Bialystok - Poland, Lodz - Poland, Warsaw - Poland, Kaohsiung - Taiwan, Taipei - Taiwan, Tau-Yuan County - Taiwan, Bangkok - Thailand, Chiangmai - Thailand, Songkla - Thailand",2010-11,2009-08-25,2011-01-06,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT03186365,Unknown,COMPLETED,2017-06-12,"Hepatitis C, Chronic",Zepatier Oral Product,Kaohsiung - Taiwan,2018-09-19,2017-06-14,2019-01-09,INTERVENTIONAL,PHASE3,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT01639066,IN-US-0205,COMPLETED,2012-09-25,Chronic Viral Hepatitis B Without Delta-agent,"Tenofovir, Entecavir, Tenofovir","Seoul - Korea, Republic of",2017-09-22,2012-07-12,2018-02-20,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT01146626,Unknown,UNKNOWN,2011-08,Hepatitis C,"Peg+ Vitamin D+ Ribavirine, Peg+ Ribavirine","Hedera - Israel, Safed, Israel - Israel",2012-02,2010-06-17,2011-04-28,INTERVENTIONAL,NA,Ziv Hospital,OTHER_GOV,hepatitis
NCT03654365,Unknown,COMPLETED,2016-11-17,Hepatitis C,"Bulk ordering and bulk messaging, Routine alerting",No locations listed,2017-03-25,2018-08-31,2018-08-31,INTERVENTIONAL,NA,MetroHealth Medical Center,OTHER,hepatitis
NCT01641666,Unknown,WITHDRAWN,2014-05,Chronic Hepatitis C,"Boceprevir, Peginterferon Alfa-2b 1.5 mcg/kg/week, Ribavirin",No locations listed,2016-09,2012-07-17,2015-09-09,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03797066,ATTIC,TERMINATED,2019-03-23,"Hepatitis C, Chronic",ZEPATIER 50Mg-100Mg Tablet,London - United Kingdom,2020-07-28,2019-01-08,2023-05-06,INTERVENTIONAL,PHASE4,King's College Hospital NHS Trust,OTHER,hepatitis
NCT03665766,Unknown,COMPLETED,2014-05-15,Liver Transplantation,"Cycloserine,Tacrolimus",No locations listed,2018-04-02,2018-09-11,2018-09-11,OBSERVATIONAL,Not Available,Ain Shams University,OTHER,hepatitis
NCT04157257,Unknown,UNKNOWN,2019-07-26,Chronic Hepatitis b,"TDF tablet, Entecavir Tablet, QL-007","Guangzhou - China, Changchun - China",2020-12,2019-11-08,2019-11-08,INTERVENTIONAL,PHASE2,"Qilu Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT00819026,Unknown,COMPLETED,2008-10,Hepatitis C Virus,No interventions listed,Madison - United States,2013-08,2009-01-08,2014-12-10,OBSERVATIONAL,Not Available,"University of Wisconsin, Madison",OTHER,hepatitis
NCT03977857,Unknown,COMPLETED,2019-03-01,"Acute-on-Chronic Liver Failure, Hepatitis B, Chronic",No interventions listed,Xi'an - China,2019-12-31,2019-06-06,2021-02-25,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT04980157,Unknown,COMPLETED,2021-11-01,"Hepatitis C Virus Infection, Colorectal Cancer",CARES-HCV,Tampa - United States,2022-12-01,2021-07-28,2023-01-23,OBSERVATIONAL,Not Available,H. Lee Moffitt Cancer Center and Research Institute,OTHER,hepatitis
NCT00627926,Unknown,COMPLETED,2008-03,Hepatitis C,"Pegylated Interferon Alfa 2a, Telaprevir, Ribavirin, Placebo","Birmingham - United States, Birmingham - United States, Phoenix - United States, Fresno - United States, LaJolla - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Sarasota - United States, South Miami - United States, Atlanta - United States, Savannah - United States, Honolulu - United States, Chicago - United States, Carmel - United States, Indianapolis - United States, Portland - United States, Baltimore - United States, Laurel - United States, Boston - United States, Boston - United States, Worcester - United States, Detroit - United States, Kansas City - United States, St Louis - United States, Omaha - United States, Albuquerque - United States, Manhasset - United States, New York City - United States, New York City - United States, New York City - United States, New York City - United States, Valhalla - United States, Chapel Hill - United States, Charlotte - United States, Durham - United States, Fayetteville - United States, Cincinatti - United States, Cincinnati - United States, Cleveland - United States, Hershey - United States, Philadelphia - United States, Pittsburgh - United States, Columbia - United States, Germantown - United States, Dallas - United States, Dallas - United States, Dallas - United States, Houston - United States, San Antonio - United States, Annandale - United States, Charlottesville - United States, Richmond - United States, Buenos Aires - Argentina, Darlinghurst - Australia, Fitzroy - Australia, Greenslopes - Australia, Melbourne - Australia, Perth - Australia, Westmead - Australia, Woolloongabba - Australia, Linz - Austria, Vienna - Austria, Calgary - Canada, Toronto - Canada, Vancouver - Canada, Winnipeg - Canada, Clichy - France, Creteil - France, Grenoble - France, Lyon - France, Nice - France, Paris - France, Pessac - France, Toulouse - France, Berlin - Germany, Bochum - Germany, Dusseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Koln - Germany, Muenchen - Germany, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petah Tikva - Israel, Tel Hashomer - Israel, Bologna - Italy, Milano - Italy, Torino - Italy, Bialystok - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Lodz - Poland, Wroclaw - Poland, Santurce - Puerto Rico, Barcelona - Spain, Valencia - Spain, Glasgow - United Kingdom, Hampstead - United Kingdom, London - United Kingdom",2010-05,2008-03-04,2014-08-08,INTERVENTIONAL,PHASE3,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01436357,Unknown,COMPLETED,2012-03-06,Hepatitis C,"AdCh3NSmut1, MVA-NSmut, Placebo","San Francisco - United States, San Francisco - United States, San Francisco - United States, Baltimore - United States, Albuquerque - United States",2018-05-25,2011-09-19,2019-11-19,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT02863757,Unknown,RECRUITING,2016-08,"Chronic Hepatitis B, Nonalcoholic Fatty Liver Disease",No interventions listed,Hong Kong - China,2026-12,2016-08-11,2022-12-21,OBSERVATIONAL,Not Available,Humanity and Health Research Centre,OTHER,hepatitis
NCT02434848,Unknown,COMPLETED,2015-07-23,"HIV, Communicable Diseases, Hepatitis B, HBV, Infectious Diseases","Engerix B, Fendrix",Sheffield - United Kingdom,2022-06-10,2015-05-05,2022-09-29,INTERVENTIONAL,PHASE3,Sheffield Teaching Hospitals NHS Foundation Trust,OTHER,hepatitis
NCT04317248,Unknown,UNKNOWN,2020-04-01,Hepatocellular Carcinoma,"Cyclophosphamide, Multiple Signals loaded Dendritic Cells Vaccine","Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China",2022-04-30,2020-03-23,2020-10-29,INTERVENTIONAL,PHASE2,Yuehua Huang,OTHER,hepatitis
NCT01435226,Unknown,COMPLETED,2011-09,"Hepatitis C, Chronic","GS-5885, GS-9451, tegobuvir, placebo to match tegobuvir, placebo to match RBV, Ribavirin","Tucson - United States, Anaheim - United States, Beverly Hills - United States, Coronado - United States, La Jolla - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Washington - United States, DeLand - United States, Miami - United States, Decatur - United States, Kansas City - United States, Baltimore - United States, Lutherville - United States, Boston - United States, Boston - United States, Novi - United States, Bronx - United States, New York - United States, New York - United States, Chapel Hill - United States, Philadelphia - United States, Providence - United States, Germantown - United States, Dallas - United States, Galveston - United States, Houston - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Madison - United States, Berlin - Germany, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, Muenchen - Germany, Würzburg - Germany",2013-01,2011-09-16,2013-12-17,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01349465,Unknown,COMPLETED,2011-07-04,Hepatitis C,No treatment,"Bakersfield - United States, La Jolla - United States, Los Angeles - United States, Jacksonville - United States, Orlando - United States, Chicago - United States, New Orleans - United States, Saint Paul - United States, Tupelo - United States, Chapel Hill - United States, Cincinnati - United States, San Antonio - United States, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Gent - Belgium, Leuven - Belgium, Calgary - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Creteil - France, Grenoble - France, Lyon - France, Nice N/A - France, Paris - France, Vandoeuvre-Les-Nancy - France, Berlin - Germany, Düsseldorf - Germany, Frankfurt A. M. - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Köln - Germany, Würzburg - Germany, Bialystok - Poland, Bydgoszcz - Poland, Czeladz - Poland, Myslowice - Poland, Warszawa - Poland, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation",2016-01-05,2011-05-06,2017-04-10,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT03402165,Unknown,UNKNOWN,2017-01-01,Hepatitis C,Sofosbuvir and Ledipasvir or sofosbuvir and daklatasuvir,Tanta - Egypt,2022-12-01,2018-01-18,2018-08-27,INTERVENTIONAL,PHASE4,Sherief Abd-Elsalam,OTHER,hepatitis
NCT01211626,Unknown,COMPLETED,2008-06,HCV Infection,"ANA773, Placebo","Amsterdam - Netherlands, Groningen - Netherlands, Rotterdam - Netherlands",2009-08,2010-09-29,2012-11-14,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02287857,Unknown,UNKNOWN,2014-09,Chronic Hepatitis B,"Domestic Tenofovir Disoproxil Fumarate Tablets, Tenofovir Disoproxil Fumarate Tablets of Gilead","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Zhengzhou - China, Zhengzhou - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Chengdou - China, Hangzhou - China",2019-10,2014-11-11,2019-03-19,INTERVENTIONAL,NA,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT02640157,ENDURANCE-3,COMPLETED,2015-12,"Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus","ABT-493/ABT-530, Sofosbuvir, Daclatasvir",No locations listed,2016-10,2015-12-28,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT03109457,Unknown,COMPLETED,2017-09-06,Hepatitis C,oral squamous cell carcinoma,Giza - Egypt,2018-02-07,2017-04-12,2020-02-05,OBSERVATIONAL,Not Available,Cairo University,OTHER,hepatitis
NCT04620148,Unknown,UNKNOWN,2021-12,Acute-On-Chronic Liver Failure,"TAK-242, Placebo",No locations listed,2022-12,2020-11-06,2021-08-02,INTERVENTIONAL,PHASE2,Akaza Bioscience Ltd,INDUSTRY,hepatitis
NCT00163657,Unknown,COMPLETED,2002-07,"End Stage Liver Disease, Hepatitis C","Daclizumub, Tacrolimus, Cyclosporine, MMF",Dallas - United States,2006-04,2005-09-14,2017-01-12,INTERVENTIONAL,PHASE4,Baylor Research Institute,OTHER,hepatitis
NCT00768157,Unknown,UNKNOWN,2007-04,"Hepatocellular Carcinoma, Hepatitis B Virus, Recurrence","antiviral treatment (lamivudine or entecavir), radical resection of HBV-related HCC",Guangzhou - China,2009-08,2008-10-07,2009-02-09,INTERVENTIONAL,PHASE4,Sun Yat-sen University,OTHER,hepatitis
NCT00926757,HBVNHL,COMPLETED,2009-04,"Non Hodgkin's Lymphoma, Hepatitis B","Entecavir prophylaxis, Therapeutic entecavir",Taipei - Taiwan,2012-11,2009-06-24,2013-05-29,INTERVENTIONAL,PHASE4,"Taipei Veterans General Hospital, Taiwan",OTHER_GOV,hepatitis
NCT00167557,Unknown,WITHDRAWN,2005-01,Hepatitis C,"Pegylated Interferon, Ribavirin, Liver Biopsy",Houston - United States,2008-03,2005-09-14,2013-11-19,INTERVENTIONAL,PHASE4,"The University of Texas Health Science Center, Houston",OTHER,hepatitis
NCT00005657,Unknown,COMPLETED,2000-05-04,"Hepatitis C, Liver Disease",No interventions listed,Bethesda - United States,Unknown Date,2000-05-08,2017-07-02,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00876148,Unknown,COMPLETED,Unknown Date,"Hepatitis B Virus, Allograft, Hematological Malignancies",No interventions listed,Torino - Italy,Unknown Date,2009-04-06,2009-04-06,OBSERVATIONAL,Not Available,Azienda Ospedaliera San Giovanni Battista,OTHER,hepatitis
NCT01797848,COMMAND-Asia,WITHDRAWN,2014-06,Hepatitis C,"Peginterferon alfa 2a, Ribavirin, Placebo matching Daclatasvir, Daclatasvir",No locations listed,2016-11,2013-02-25,2013-11-25,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01273948,Unknown,COMPLETED,2011-01,Hepatitis C,"Bavituximab, Pegylated interferon (PEG-IFN)",Tbilisi - Georgia,2012-01,2011-01-11,2012-02-06,INTERVENTIONAL,PHASE2,Peregrine Pharmaceuticals,INDUSTRY,hepatitis
NCT00289757,Unknown,COMPLETED,2004-01-01,Hepatitis A,Havrix™,Wilrijk - Belgium,2013-03-01,2006-02-10,2018-07-23,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05244057,Unknown,COMPLETED,2022-08-23,Chronic Hepatitis B,"Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets, Pegylated Interferon alfa 2a",Shanghai - China,2024-06-24,2022-02-17,2024-07-15,INTERVENTIONAL,PHASE2,"Shanghai HEP Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT04387526,Unknown,COMPLETED,2016-04-01,Chronic Hepatitis C Virus Infection,"(SOF and DCV), (SOF, DCV, and RBV)",No locations listed,2017-05-31,2020-05-14,2020-05-15,INTERVENTIONAL,PHASE3,Beni-Suef University,OTHER,hepatitis
NCT02041325,Unknown,COMPLETED,2005-04,Plasma Cell Disorder,"Lenalidomide, Placebo","Boston - United States, Boston - United States",2011-01,2014-01-22,2016-05-17,INTERVENTIONAL,PHASE2,"Boston VA Research Institute, Inc.",OTHER,hepatitis
NCT00343525,Unknown,COMPLETED,2006-05,Hepatitis C,bavituximab,"Sarasota - United States, San Antonio - United States",2007-01,2006-06-23,2008-05-07,INTERVENTIONAL,PHASE1,Peregrine Pharmaceuticals,INDUSTRY,hepatitis
NCT00697125,Unknown,COMPLETED,1993-06,Hepatitis B,"Engerix™-B, HBV-MPL vaccine (208129), Hepatitis B vaccine, experimental formulation",Gent - Belgium,1994-07,2008-06-13,2008-06-13,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02176525,Unknown,COMPLETED,2007-12,"Hepatitis C, Chronic","BI 207127 NA, Placebo",No locations listed,2009-12,2014-06-27,2016-06-06,INTERVENTIONAL,PHASE1,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00704522,Unknown,COMPLETED,2005-03,"Hepatitis C, Chronic, Hepacivirus","Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908), Patient assistance program",No locations listed,2009-04,2008-06-25,2015-10-06,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02419625,Unknown,UNKNOWN,2015-06,Chronic Hepatitis E,questionnaires,No locations listed,2017-04,2015-04-17,2016-07-21,INTERVENTIONAL,NA,Carmel Medical Center,OTHER,hepatitis
NCT00140725,Unknown,COMPLETED,2000-04,Chronic Hepatitis B,"Lamivudine plus Polyethylene glyco-interferon alfa-2b, Lamivudine",Shatin - Hong Kong,Unknown Date,2005-09-01,2008-10-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06203925,Unknown,NOT_YET_RECRUITING,2024-01-08,Hepatitis C,"Hepatitis C virus self-test (oral fluid HCVST), Hepatitis C virus self-test (blood-based HCVST)",Rio de Janeiro - Brazil,2025-12-31,2024-01-12,2024-01-12,OBSERVATIONAL,Not Available,Oswaldo Cruz Foundation,OTHER,hepatitis
NCT03674125,Unknown,COMPLETED,2018-09-04,HCV Infection,GLS-6150,"Busan - Korea, Republic of, Seoul - Korea, Republic of",2020-04-07,2018-09-17,2020-05-27,INTERVENTIONAL,PHASE1,"GeneOne Life Science, Inc.",INDUSTRY,hepatitis
NCT02600325,DAHHS-2,COMPLETED,2016-02,"Acute Hepatitis C, Human Immunodeficiency Virus, Hepatitis C",Grazoprevir/Elbasvir 100mg/50mg,"Antwerpen - Belgium, Rotterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Arnhem - Netherlands, Groningen - Netherlands, Maastricht - Netherlands, Nijmegen - Netherlands, Utrecht - Netherlands",2018-04-01,2015-11-09,2019-07-08,INTERVENTIONAL,PHASE3,Erasmus Medical Center,OTHER,hepatitis
NCT03706222,Unknown,COMPLETED,2018-10-22,Drug Interaction Potentiation,elbasvir/grazoprevir,Tainan - Taiwan,2019-02-25,2018-10-15,2019-03-13,OBSERVATIONAL,Not Available,National Cheng-Kung University Hospital,OTHER,hepatitis
NCT01159925,Unknown,COMPLETED,2009-07,"Acute Hepatitis A, Hepatitis",Serum sample,Clayton - Panama,2011-12,2010-07-12,2012-11-22,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT04072822,AlcHepNet,COMPLETED,2020-07-10,Alcoholic Hepatitis,"Anakinra and Zinc, Prednisone, Placebos","Phoenix - United States, Jacksonville - United States, Indianapolis - United States, Louisville - United States, Boston - United States, Rochester - United States, Cleveland - United States, Pittsburgh - United States, Dallas - United States, Richmond - United States",2022-05-24,2019-08-28,2025-02-10,INTERVENTIONAL,PHASE2,Indiana University,OTHER,hepatitis
NCT05839522,AusHep,RECRUITING,2022-04-27,"Hepatitis C, Hepatitis B, HIV Infections","Point-of-care hepatitis C antibody test, Point-of-care hepatitis C RNA test, Point-of-care hepatitis B surface antibody test, Point-of-care hepatitis B surface antigen test, Point-of-care HIV antibody test, Interview-style survey","Hume - Australia, Bathurst - Australia, Berkshire Park - Australia, Cessnock - Australia, Kempsey - Australia, Nowra - Australia, Silverwater - Australia, Wuuluman - Australia, Alice Springs - Australia, Howard Springs - Australia, Ironbark - Australia, Ironbark - Australia, Ironbark - Australia, Townsville - Australia, Murray Bridge - Australia, Northfield - Australia, Northfield - Australia, Risdon Vale - Australia, Risdon Vale - Australia, Risdon Vale - Australia, Bunbury - Australia, Casuarina - Australia, Roebourne - Australia, West Swan - Australia",2023-05-01,2023-05-03,2023-05-03,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT02898922,Unknown,COMPLETED,2013-06,Hepatitis B Vaccines,hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae,No locations listed,2015-01,2016-09-13,2016-09-15,INTERVENTIONAL,PHASE4,Shandong Province Centers for Disease Control and Prevention,OTHER,hepatitis
NCT03357822,COST,UNKNOWN,2018-01-25,Chronic Hepatitis B,"Pegylated interferon, Entecavir, Tenofovir disoproxil fumarate","Beijing - China, Beijing - China, Chongqing - China, Fuzhou - China, Nanning - China, Zhejiang - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Shantou - China, Wenzhou - China",2022-01-25,2017-11-30,2018-04-25,INTERVENTIONAL,PHASE4,Tongji Hospital,OTHER,hepatitis
NCT01318525,Unknown,UNKNOWN,2010-10,"Liver Failure, Acute","ALF-5755, Saline solution (0.9% NaCl)","Besançon Cedex - France, Clermont-Ferrand Cedex 1 - France, Clichy - France, Grenoble Cedex 9 - France, Lille cedex - France, Lyon - France, Marseille Cedex 5 - France, Montpellier Cedex 5 - France, Nice - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Villejuif Cedex - France",2012-05,2011-03-18,2011-04-05,INTERVENTIONAL,PHASE2,Alfact Innovation,INDUSTRY,hepatitis
NCT00804622,Unknown,COMPLETED,2008-12,Chronic Hepatitis B,"telbivudine, tenofovir disproxil fumarate, telbivudine plus tenofovir disproxil fumarate",Hong Kong - China,2009-06,2008-12-09,2012-07-11,INTERVENTIONAL,PHASE2,The University of Hong Kong,OTHER,hepatitis
NCT03248622,Unknown,COMPLETED,2017-06-03,Hepatitis B,No interventions listed,Bethesda - United States,2019-05-28,2017-08-14,2023-11-30,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03343925,SHARP-C,COMPLETED,2018-08-17,"Hepatitis C, Chronic",No interventions listed,"Darlinghurst - Australia, Kingswood - Australia, Newcastle - Australia, Adelaide - Australia",2021-07-01,2017-11-17,2022-04-14,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT02548325,Unknown,COMPLETED,2014-06-01,Hepatitis B,Not apply,Terrassa - Spain,2015-05-31,2015-09-14,2019-02-01,OBSERVATIONAL,Not Available,Corporacion Parc Tauli,OTHER,hepatitis
NCT00180674,Unknown,COMPLETED,2005-08,Liver Fibrosis,Warfarin,London - United Kingdom,2006-09,2005-09-16,2020-12-01,INTERVENTIONAL,PHASE2,Imperial College London,OTHER,hepatitis
NCT02120274,Unknown,TERMINATED,2014-03,"RNA Virus Infections, Flaviviridae Infections, Hepatitis C, Hepatitis C, Chronic","Vitamin D, Vitamin B 12",São Paulo - Brazil,2016-05,2014-04-22,2016-08-24,INTERVENTIONAL,PHASE4,Federal University of São Paulo,OTHER,hepatitis
NCT03282474,Unknown,COMPLETED,2017-12-07,"Hepatitis E, Hepatitis Chronic Viral",Sofosbuvir,"Hanover - Germany, Berlin - Germany, Hamburg - Germany",2018-11-26,2017-09-14,2019-03-08,INTERVENTIONAL,PHASE2,Hannover Medical School,OTHER,hepatitis
NCT02186574,Unknown,UNKNOWN,2015-05,"Hepatitis B, Lymphoma, Non-Hodgkin","Tenofovir disoproxil, Placebo Oral Tablet","Toronto - Canada, Toronto - Canada",2021-02,2014-07-10,2019-12-12,INTERVENTIONAL,PHASE3,"University Health Network, Toronto",OTHER,hepatitis
NCT06649266,Unknown,RECRUITING,2024-08-21,Chronic Hepatitis D,"RBD1016, Placebo","Stockholm - Sweden, Stockholm - Sweden",2026-06,2024-10-18,2025-01-23,INTERVENTIONAL,PHASE2,Ribocure Pharmaceuticals AB,INDUSTRY,hepatitis
NCT03576066,Unknown,COMPLETED,2018-06-11,Chronic Hepatitis B,"ABI-H0731, SOC NUC, Placebo Oral Tablet","Beverly Hills - United States, Coronado - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Stanford - United States, Miami - United States, Baltimore - United States, Catonsville - United States, Hillsborough - United States, Flushing - United States, New York - United States, New York - United States, Philadelphia - United States, Philadelphia - United States, Toronto - Canada, Toronto - Canada, Vancouver - Canada, Auckland - New Zealand",2019-07-05,2018-07-03,2021-02-17,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT02725866,Unknown,COMPLETED,2016-04-05,Chronic Hepatitis C,"Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin",No locations listed,2017-10-31,2016-04-01,2019-03-15,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02874066,PIVOTAL,COMPLETED,2017-03-13,Hepatitis Viruses,PTV/r/OBV/DSV,"Chiayi City - Taiwan, Douliu - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2018-10-30,2016-08-22,2019-07-19,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT03865966,Unknown,RECRUITING,2019-07-05,Hepatitis B Infection,No intervention name listed,Chongqing - China,2023-12-31,2019-03-07,2019-07-08,OBSERVATIONAL,Not Available,Qiu Li,OTHER,hepatitis
NCT04248426,Unknown,COMPLETED,2020-02-05,"Hepatitis B, Chronic","ATI-2173, ATI-2173 Placebo","Montréal - Canada, Chisinau - Moldova, Republic of, Kyiv - Ukraine",2021-05-18,2020-01-30,2021-08-19,INTERVENTIONAL,PHASE1,"Antios Therapeutics, Inc",INDUSTRY,hepatitis
NCT01813266,TPEGHCVS,WITHDRAWN,2013-05,Chronic Hepatitis C Virus Infection,No interventions listed,Murray - United States,2014-04,2013-03-18,2018-03-22,OBSERVATIONAL,Not Available,"Intermountain Health Care, Inc.",OTHER,hepatitis
NCT00959166,Unknown,COMPLETED,2009-06,"Acute Hepatitis C, HIV, HIV Infections",PET scan,London - United Kingdom,2011-06,2009-08-14,2019-10-22,INTERVENTIONAL,NA,Imperial College London,OTHER,hepatitis
NCT03362866,HEPEPID,UNKNOWN,2019-01,"Hepatitis B, Hepatitis C, Hepatitis D",No interventions listed,No locations listed,2023-04,2017-12-05,2018-09-05,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de la Réunion,OTHER,hepatitis
NCT03032666,Unknown,COMPLETED,2017-05-01,"Thalassemia, Hepatitis C",sofosbuvir/velpatasvir,Beirut - Lebanon,2018-08-06,2017-01-26,2018-10-11,INTERVENTIONAL,PHASE4,Ala'a Sharara,OTHER,hepatitis
NCT02785666,HCVree,COMPLETED,2016-06,"Hepatitis C, HIV","grazoprevir/elbasvir, ribavirin, Behavioural Intervention",Zurich - Switzerland,2018-04,2016-05-30,2018-08-31,INTERVENTIONAL,PHASE3,University of Zurich,OTHER,hepatitis
NCT02135666,Unknown,WITHDRAWN,2015-05,"Hepatitis B, Hepatitis A",Blood sampling,Hradec Kralove - Czech Republic,2019-10,2014-05-12,2015-11-18,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01698866,EVACC-B,UNKNOWN,2012-07,Indolent Lymphoproliferative Disorders,Vaccin GenHevac B Pasteur,Vandoeuvre Les Nancy - France,2017-07,2012-10-03,2016-06-16,INTERVENTIONAL,PHASE4,"Central Hospital, Nancy, France",OTHER,hepatitis
NCT06380166,Unknown,TERMINATED,2024-07-24,Hepatitis C,Hepatitis C core antigen,Bloomington - United States,2024-08-20,2024-04-23,2025-01-06,OBSERVATIONAL,Not Available,HealthPartners Institute,OTHER,hepatitis
NCT03566966,BIOEPA,COMPLETED,2015-07-01,"Viral Hepatitis C, Therapy Adverse Effect","Non-organ-specific Ab positive, Non-organ-specific Ab negative",Bari - Italy,2016-08-31,2018-06-25,2023-12-05,OBSERVATIONAL,Not Available,University of Bari,OTHER,hepatitis
NCT05484466,Unknown,UNKNOWN,2022-11-11,"Hepatitis B, Chronic","ZM-H1505R, ZM-H1505R placebo, Baraclude",Changchun - China,2022-12-20,2022-08-02,2023-05-08,INTERVENTIONAL,PHASE2,"Shanghai Zhimeng Biopharma, Inc.",INDUSTRY,hepatitis
NCT00957866,Praire,COMPLETED,2009-05,Chronic Hepatitis C,Pegylated Interferons (Peg-IFN) and Ribavirin,"Winnipeg - Canada, Regina - Canada, Saskatoon - Canada",2012-10,2009-08-13,2014-05-16,INTERVENTIONAL,PHASE4,University of Manitoba,OTHER,hepatitis
NCT02480166,Unknown,COMPLETED,2015-06,PT-NANBH,"8 weeks SOF/LED, 12 weeks SOF/LED","Palo Alto - United States, San Jose - United States, Houston - United States, Plano - United States",2016-10,2015-06-24,2017-09-19,INTERVENTIONAL,PHASE4,Stanford University,OTHER,hepatitis
NCT04166266,HEPDELTA,RECRUITING,2020-02-19,"Hepatitis D, Chronic, Hepatitis B, Chronic",Blood draw for the laboratory assessment,"Angers - France, Annecy - France, Bobigny - France, Bobigny - France, Bordeaux - France, Clermont-Ferrand - France, Clichy - France, Créteil - France, Créteil - France, Dijon - France, Grenoble - France, Lille - France, Limoges - France, Lyon - France, Lyon - France, Lyon - France, Marseille - France, Montpellier - France, Nantes - France, Nantes - France, Nice - France, Orléans - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Rennes - France, Rouen - France, Strasbourg - France, Toulouse - France, Toulouse - France, Tours - France, Villejuif - France",2027-12-31,2019-11-18,2025-02-05,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03615066,Unknown,COMPLETED,2018-08-28,Chronic Hepatitis B,"Placebo, Selgantolimod, TAF","Calgary - Canada, Toronto - Canada, Toronto - Canada, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taipei City - Taiwan",2019-12-12,2018-08-03,2022-05-10,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00705666,ADEQUATION,COMPLETED,2006-02,"Hepatitis C, Chronic, Hepacivirus","Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908)",No locations listed,2008-07,2008-06-26,2015-10-02,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01531166,Unknown,COMPLETED,2011-09,Chronic Hepatitis B,pegylated Interferon-alpha 2a,"Seoul - Korea, Republic of",2014-08,2012-02-10,2016-08-17,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT01655966,Unknown,UNKNOWN,2012-05,Chronic Hepatitis c,"vitamin D +pegylated interferon + ribavirin, pegylated interferon + ribavirin",Cairo - Egypt,2014-02,2012-08-02,2014-01-29,INTERVENTIONAL,PHASE3,Cairo University,OTHER,hepatitis
NCT00845065,Unknown,COMPLETED,2009-02,"Hepatitis C, Chronic","Boceprevir, Placebo, Peginterferon alfa-2a, Ribavirin",No locations listed,2010-10,2009-02-16,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01011166,Unknown,COMPLETED,2009-11,Chronic Hepatitis C Infection,"IDX184, Placebo, Peginterferon alfa-2a (Peg-IFN), Ribavirin (RBV)",No locations listed,2010-07,2009-11-11,2015-04-23,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02097966,Unknown,NO_LONGER_AVAILABLE,Unknown Date,Chronic Hepatitis C,"Daclatasvir, Sofosbuvir, Ribavirin","Amstetten - Austria, Braunua/Inn - Austria, Graz - Austria, Innsbruck - Austria, Linz - Austria, Oberndorf - Austria, Oberpullendorf - Austria, Salzburg - Austria, Vienna - Austria, Wien - Austria, Aachen - Germany, Augsburg - Germany, Berlin - Germany, Bonn - Germany, Cologne - Germany, Essen - Germany, Frankfurt Am Main - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Jena - Germany, Kiel - Germany, Leipzig - Germany, Muenchen - Germany, Muenster - Germany, Munchen - Germany, Stuttgart - Germany, Tuebingen - Germany, Ulm - Germany, Wuerzburg - Germany, Amsterdam - Netherlands, Rotterdam - Netherlands, Urecht - Netherlands, Falun - Sweden, Gothenburg - Sweden, Helsingborg - Sweden, Kalmar - Sweden, Lulea - Sweden, Lund - Sweden, Stockholm - Sweden, Sundsvall - Sweden, Plymouth - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Liverpool - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Newcastle Upon Tyne - United Kingdom, Birmingham - United Kingdom, Leeds - United Kingdom, Brighton - United Kingdom, Cardiff - United Kingdom, Frimley - United Kingdom, Guildford - United Kingdom, London - United Kingdom, Wrexham - United Kingdom",Unknown Date,2014-03-27,2016-01-27,EXPANDED_ACCESS,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03069365,EXPEDITION-5,COMPLETED,2017-03-28,Hepatitis C Virus (HCV),Glecaprevir/pibrentasvir,"La Jolla - United States, Pasadena - United States, Tampa - United States, Shreveport - United States, Boston - United States, New Hyde Park - United States, New York - United States, Charlotte - United States, Philadelphia - United States, Philadelphia - United States, San Antonio - United States, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Mannheim - Germany, Frankfurt am Main - Germany, Hannover - Germany, Mainz - Germany, Athens - Greece, Alexandroupolis - Greece, Athens - Greece, Thessaloniki - Greece, Bologna - Italy, Roma - Italy, Palermo - Italy, Salerno - Italy, Seongdong - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Lublin - Poland, Bialystok - Poland, San Juan - Puerto Rico, San Juan - Puerto Rico, Málaga - Spain, Barcelona - Spain, Madrid - Spain, Stockholm - Sweden",2018-02-20,2017-03-03,2019-03-04,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT04271865,Unknown,COMPLETED,2017-02-26,"Anemia, Iron Deficiency","Nutritional Education, model nutrition kitchen, recipe book, Provision of Dates",Giza - Egypt,2019-07-15,2020-02-17,2020-02-17,INTERVENTIONAL,NA,"National Research Centre, Egypt",OTHER,hepatitis
NCT02566148,PARCOURS,COMPLETED,2012-02,"HIV Infection, Chronic Hepatitis B",No interventions listed,No locations listed,2012-02,2015-10-02,2017-05-15,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT00633230,Unknown,WITHDRAWN,Unknown Date,Hepatitis C Virus,"standardized herbal formula, Sho-saiko-to (SST), placebo capsule identical to the active herbal formula",No locations listed,Unknown Date,2008-03-11,2015-06-25,INTERVENTIONAL,PHASE1,University of Virginia,OTHER,hepatitis
NCT00624325,SCIN-C,COMPLETED,2007-07,Chronic Hepatitis C,"interferon alfa-2b, interferon alfa-2b, interferon alfa-2b",Rotterdam - Netherlands,2010-06,2008-02-27,2011-03-11,INTERVENTIONAL,PHASE3,Foundation for Liver Research,OTHER,hepatitis
NCT02468648,Unknown,COMPLETED,2015-06-09,Chronic Hepatitis C,"Sofosbuvir, GS-5816",Bethesda - United States,2018-09-14,2015-06-11,2020-03-19,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT06289725,Unknown,RECRUITING,2024-01-01,Chronic Hepatitis b,antiviral treatment,"Ho Chi Minh City - Vietnam, Ho Chi Minh City - Vietnam",2026-01-01,2024-03-04,2024-03-18,OBSERVATIONAL,Not Available,Ly Hoa Anh Minh,OTHER,hepatitis
NCT02368522,Unknown,COMPLETED,2014-12,Hepatitis,No interventions listed,Hamburg - Germany,2017-02,2015-02-23,2017-03-07,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01200225,Unknown,COMPLETED,2010-02,"Hepatitis C, Chronic",No interventions listed,Neuilly-sur-seine - France,2013-06,2010-09-13,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00435825,Unknown,COMPLETED,2007-03,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Atlanta - United States, Flushing - United States, Portland - United States, Philadelphia - United States, Richmond - United States, Fitzroy - Australia, Greenslopes - Australia, Woolloongabba - Australia, Campinas - Brazil, Ribeirão Preto - Brazil, Salvador - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Beijing - China, Beijing - China, Guangzhou - China, Hunan - China, Shanghai - China, Shanghai - China, Clichy - France, Montpellier - France, Nice - France, Strasbourg - France, Toulouse - France, Villejuif - France, Berlin - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Hannover - Germany, Köln - Germany, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Hamilton - New Zealand, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Singapore - Singapore, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Songkhla - Thailand",2010-12,2007-02-16,2013-06-25,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01202825,Unknown,COMPLETED,2010-04,Hepatitis C,"TMC647055, Placebo, TMC647055, TMC647055, Placebo, TMC435, Placebo, TMC647055, Placebo, TMC647055",Antwerp - Belgium,2011-11,2010-09-16,2013-03-04,INTERVENTIONAL,PHASE1,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT03364725,ELIMINATEC,UNKNOWN,2018-01-15,"Hepatitis C, Addict Heroin",Glecaprevir-pibrentasvir,Hillsborough - United States,2018-09-01,2017-12-07,2017-12-07,INTERVENTIONAL,PHASE4,Id Care,OTHER,hepatitis
NCT05131230,HepOnFire,WITHDRAWN,2022-03-15,"Acute on Chronic Liver Failure, Alcoholic Hepatitis",CytoSorb® treatment,"Bochum - Germany, Rostock - Germany",2023-03,2021-11-23,2022-11-29,OBSERVATIONAL,Not Available,CytoSorbents Europe GmbH,INDUSTRY,hepatitis
NCT03109730,Unknown,COMPLETED,2017-06-15,Chronic Hepatitis B,"ABI-H0731, Placebo for ABI-H0731, Entecavir, Tenofovir Disoproxil Fumarate, Pegasys","Clayton - Australia, Fitzroy - Australia, Melbourne - Australia, Nedlands - Australia, Hong Kong - Hong Kong, Chuncheon - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Keelung - Taiwan, Taipei - Taiwan, London - United Kingdom, London - United Kingdom, London - United Kingdom",2018-03-31,2017-04-12,2018-07-06,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT04563026,AHFIRM,COMPLETED,2021-01-22,Alcoholic Hepatitis,"DUR-928 30 mg, DUR-928 90 mg, Placebo+ Standard of Care (SOC)","Birmingham - United States, Phoenix - United States, Coronado - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Francisco - United States, Stanford - United States, New Haven - United States, Washington - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Chicago - United States, Maywood - United States, Indianapolis - United States, Louisville - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Boston - United States, Detroit - United States, Minneapolis - United States, Kansas City - United States, Saint Louis - United States, Omaha - United States, Newark - United States, Albuquerque - United States, Manhasset - United States, New York - United States, New York - United States, Charlotte - United States, Cleveland - United States, Charleston - United States, Dallas - United States, Dallas - United States, Dallas - United States, Dallas - United States, Dallas - United States, Edinburg - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Charlottesville - United States, Richmond - United States, Richmond - United States, Seattle - United States, Camperdown - Australia, Kingswood - Australia, South Brisbane - Australia, Adelaide - Australia, Bedford Park - Australia, Box Hill - Australia, Nedlands - Australia, Perth - Australia, Graz - Austria, Brussels - Belgium, Edegem - Belgium, Besançon - France, Lille - France, Lyon - France, Marseille - France, London - United Kingdom, London - United Kingdom, London - United Kingdom, Plymouth - United Kingdom, London - United Kingdom",2023-09-06,2020-09-24,2024-09-05,INTERVENTIONAL,PHASE2,Durect,INDUSTRY,hepatitis
NCT02349126,Unknown,WITHDRAWN,2015-02,Chronic Hepatitis B,ARC-520 Injection,Melbourne - Australia,2015-12,2015-01-28,2015-08-14,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT01037166,Unknown,COMPLETED,2002-12,Chronic Hepatitis B,Entecavir,"Aichi-Gun - Japan, Nagoya-Shi - Japan, Nagoya - Japan, Chiba-Shi - Japan, Kurume - Japan, Ogaki-Shi - Japan, Asahikawa-Shi - Japan, Sapporo-Shi - Japan, Akashi-Shi - Japan, Morioka-Shi - Japan, Sendai - Japan, Okayama-Shi - Japan, Minato-Ku - Japan, Musashino-Shi - Japan, Shinjuku-Ku - Japan, Kyoto - Japan",2005-02,2009-12-21,2011-01-31,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02175966,FOURward,COMPLETED,2014-07-28,Hepatitis C,"DCV/ASV/BMS-791325, Ribavirin, Sofosbuvir, Peginterferon α-2a","Rialto - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Lutherville - United States, San Antonio - United States",2015-01-28,2014-06-26,2020-08-11,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT04231565,ALTHBV,RECRUITING,2020-06-04,Hepatitis B Virus,Tenofovir alafenamide Fumarate,Guangzhou - China,2024-06-01,2020-01-18,2024-03-01,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01995266,Unknown,COMPLETED,2014-02-28,Hepatitis C,"Asunaprevir, Daclatasvir","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Changchun - China, Shenyang - China, Xi'an - China, Xi'an - China, Shanghai - China, Shanghai - China, Beijing - China, Shanghai - China, Tianjin - China, Beijing - China, Chongqing - China, Seoul - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Daegu - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kaohsiung - Taiwan, Tainan - Taiwan, Kaohsiung - Taiwan, Tainan - Taiwan",2015-07-31,2013-11-26,2020-08-11,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02597166,Unknown,COMPLETED,2016-01,"Hepatitis C, Chronic, Cirrhosis, Decompensated",Ledipasvir/Sofosbuvir,Toronto - Canada,2018-06,2015-11-05,2018-10-25,INTERVENTIONAL,PHASE3,"University Health Network, Toronto",OTHER,hepatitis
NCT01856426,Unknown,COMPLETED,2013-06,Hepatitis C,"EDP239, Placebo","Miami - United States, San Antonio - United States, Murray - United States, Frankfurt - Germany, Hamburg - Germany",2014-11,2013-05-17,2016-01-29,INTERVENTIONAL,PHASE1,"Enanta Pharmaceuticals, Inc",INDUSTRY,hepatitis
NCT01488526,Unknown,COMPLETED,2012-03-01,"Hepatitis B Infection, Chronic Infection, Viremia",TDF treatment,"Chongqing - China, Shijiazhuang - China, Nanyang - China, Nanjing - China, Chang Chun - China",2014-04-28,2011-12-08,2019-12-09,INTERVENTIONAL,PHASE4,New Discovery LLC,INDUSTRY,hepatitis
NCT04903626,Unknown,COMPLETED,2021-08-24,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir (GLE/PIB),"Chandler - United States, Peoria - United States, Little Rock - United States, Beverly Hills - United States, Chula Vista - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, Doral - United States, Fort Lauderdale - United States, Fort Pierce - United States, Oakland Park - United States, Orlando - United States, Tampa - United States, West Palm Beach - United States, Zephyrhills - United States, Atlanta - United States, Iowa City - United States, Lexington - United States, Louisville - United States, Baltimore - United States, Baltimore - United States, Detroit - United States, Jackson - United States, Las Vegas - United States, Newark - United States, New York - United States, Fayetteville - United States, Cincinnati - United States, Cincinnati - United States, Tahlequah - United States, Philadelphia - United States, Providence - United States, Nashville - United States, Houston - United States, Norfolk - United States, Milwaukee - United States, Adelaide - Australia, Melbourne - Australia, Sankt Poelten - Austria, Linz - Austria, Vienna - Austria, Vancouver - Canada, Victoria - Canada, Hamilton - Canada, Montreal - Canada, Montpellier Cedex 5 - France, Clichy - France, TOURCOING Cedex - France, Creteil - France, Lyon - France, Lyon - France, Paris - France, Frankfurt am Main - Germany, Bonn - Germany, Dortmund - Germany, Berlin - Germany, Hamburg - Germany, Munich - Germany, Bologna - Italy, Milan - Italy, Naples - Italy, Rome - Italy, Foggia - Italy, Badalona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Valencia - Spain",2024-09-17,2021-05-26,2024-12-04,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT06355726,Unknown,RECRUITING,2024-04-09,Alcoholic Hepatitis,"Plasma Exchange, Standard Medical Treatment",New Delhi - India,2025-02-28,2024-04-09,2024-06-24,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT03993925,Unknown,ACTIVE_NOT_RECRUITING,2019-09-20,"Chronic Hepatitis C, Intravenous Drug Usage",No interventions listed,Hong Kong - Hong Kong,2025-12-31,2019-06-21,2022-11-04,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT04109625,DiVHeB,COMPLETED,2019-10-21,"Hepatitis B, Healthy, Diagnoses Disease",Demonstrator MAGIA,Grenoble - France,2022-05-13,2019-09-30,2022-05-24,INTERVENTIONAL,NA,"University Hospital, Grenoble",OTHER,hepatitis
NCT06550622,Unknown,RECRUITING,2024-08-10,"Hepatitis B, Chronic",No interventions listed,Shanghai - China,2027-08-10,2024-08-13,2024-08-13,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT03217422,AMBER,ACTIVE_NOT_RECRUITING,2018-02-15,Autoimmune Hepatitis,"VAY736, Placebo","Coronado - United States, Rialto - United States, Sacramento - United States, Houston - United States, Caba - Argentina, Caba - Argentina, Gent - Belgium, Edmonton - Canada, Toronto - Canada, Montreal - Canada, Vinohrady - Czechia, Aachen - Germany, Hamburg - Germany, Hannover - Germany, Mainz - Germany, Wuerzburg - Germany, Sapporo-city - Japan, Takamatsu city - Japan, Itabashi ku - Japan, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Bern - Switzerland, Birmingham - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom",2023-12-28,2017-07-14,2025-01-27,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01590225,Unknown,WITHDRAWN,2013-01-28,Chronic Hepatitis C,"Boceprevir, Peginterferon alpha-2b, Ribavirin, Boceprevir, Peginterferon alfa-2b, Ribavirin",No locations listed,2021-08-18,2012-05-02,2021-01-29,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02216422,Turquoise-IV,COMPLETED,2014-09,Chronic Hepatitis C Virus (HCV) Infection,"Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir, Ribavirin (RBV)",No locations listed,2015-12,2014-08-15,2016-06-29,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00664625,Unknown,COMPLETED,2008-05,Chronic Hepatitis C,"BMS-791325, Placebo","Anaheim - United States, Cypress - United States, St. Louis - United States, Philadelphia - United States, San Antonio - United States, Buenos Aires - Argentina",2009-06,2008-04-23,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06041022,Unknown,NOT_YET_RECRUITING,2023-10-01,"Hepatitis B, Chronic",Exposure factors,No locations listed,2023-11-01,2023-09-18,2023-09-18,OBSERVATIONAL,Not Available,Qilu Hospital of Shandong University,OTHER,hepatitis
NCT02726022,Unknown,COMPLETED,2007-02,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Aigaleo - Attiki - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Heraklion - Greece, Piraeus - Greece, Piraeus - Greece, Thessaloniki - Greece",2011-07,2016-04-01,2016-08-15,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05300425,Unknown,COMPLETED,2022-03-03,"Leptospirosis, Hepatitis E Virus Infection, Tularemia","Blood sample collection, Data collection","Basel - Switzerland, Val Müstair - Switzerland",2024-11-15,2022-03-29,2024-12-13,OBSERVATIONAL,Not Available,"University Hospital, Basel, Switzerland",OTHER,hepatitis
NCT02784925,Unknown,COMPLETED,2016-06,Fatty Liver,Ultrasound (US) B mode image,No locations listed,2016-07,2016-05-27,2017-06-22,INTERVENTIONAL,NA,Taipei Medical University WanFang Hospital,OTHER,hepatitis
NCT05028322,IDMODVHB,UNKNOWN,2021-11-01,"Cirrhosis, Liver, Vaccination Failure, HBV, Vaccine Reaction","IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN",No locations listed,2024-12-01,2021-08-31,2021-08-31,INTERVENTIONAL,PHASE2,"Central Hospital, Nancy, France",OTHER,hepatitis
NCT06184230,Unknown,NOT_YET_RECRUITING,2024-01,Hepatitis A,Hepatitis A Vaccine,No locations listed,2025-03,2023-12-28,2023-12-28,INTERVENTIONAL,PHASE4,Best Healthcare Inc.,OTHER,hepatitis
NCT01522625,Unknown,COMPLETED,2012-01,Chronic Hepatitis B,"tenofovir disoproxil fumarate 300mg per day, Placebo","Chiayi City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Yunlin - Taiwan",2018-11,2012-01-31,2019-02-12,INTERVENTIONAL,PHASE4,E-DA Hospital,OTHER,hepatitis
NCT02836925,Unknown,COMPLETED,2016-03,"Indolent B-cell Lymphoma, Hepatitis C","Ledipasvir+Sofosbuvir, Sofosbuvir+Velpatasvir","Brescia - Italy, Aviano - Italy, Vicenza - Italy, Milano - Italy, Milano - Italy, Padova - Italy, Parma - Italy, Pavia - Italy, Piacenza - Italy, Roma - Italy, Rozzano - Italy, Torino - Italy, Varese - Italy",2020-02,2016-07-19,2023-03-31,INTERVENTIONAL,PHASE2,Fondazione Italiana Linfomi - ETS,OTHER,hepatitis
NCT01674725,PEARL-II,COMPLETED,2012-08,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin",No locations listed,2014-01,2012-08-29,2021-07-12,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT03208322,Unknown,WITHDRAWN,2018-11-30,Hepatitis C,Non-Interventional,"Df - Mexico, Magdalena De Las Salinas - Mexico",2019-02-27,2017-07-05,2022-05-27,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT04084522,SFAH,COMPLETED,2019-10-01,Alcoholic Hepatitis,"Saturated Fat- Desi Ghee (Clarified Butter), Soyabean Oil",New Delhi - India,2022-01-31,2019-09-10,2022-03-31,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT02068222,Unknown,COMPLETED,2014-04,"Chronic Hepatitis C, Hepatitis C Virus","ABT-450/ritonavir (r), ABT-530, Ribavirin (RBV)",No locations listed,2015-03,2014-02-21,2018-02-22,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT00518622,Unknown,COMPLETED,2007-07,Hepatitis C,"Comparator: MK7009, Comparator: Placebo",No locations listed,2008-09,2007-08-21,2015-08-25,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02472925,WTC,COMPLETED,2015-06,Hepatitis C,MedSignals Pill Box,"Philadelphia - United States, Philadelphia - United States",2017-12,2015-06-16,2022-02-08,INTERVENTIONAL,NA,University of Pennsylvania,OTHER,hepatitis
NCT02139722,Unknown,COMPLETED,2014-01-02,"Hepatitis B, Hepatitis C, Liver Disease","Video Doctor, PA + PPN","San Francisco - United States, San Francisco - United States",2017-05-28,2014-05-15,2020-07-21,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,hepatitis
NCT00456625,Unknown,COMPLETED,2007-04,Hepatitis B,Engerix™-B,Bangkok - Thailand,2008-01,2007-04-05,2016-12-16,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT04443725,Unknown,UNKNOWN,2020-07,COVID-19,"Hydroxychloroquine , Sofosbuvir, daclatasvir, Standard of care treatment",No locations listed,2020-10,2020-06-23,2020-06-25,INTERVENTIONAL,PHASE3,Cairo University,OTHER,hepatitis
NCT01817725,Unknown,COMPLETED,2013-03,Chronic Hepatitis B,HBV vaccine (Engerix B),Taoyuan Xian - Taiwan,2016-02,2013-03-25,2017-05-02,INTERVENTIONAL,PHASE1,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT01938625,Unknown,COMPLETED,2013-12-12,"Hepatitis C, Chronic","Simeprevir, Daclatasvir, Ribavirin, Cyclosporine, Tacrolimus","Essen - Germany, Hamburg - Germany, Warszawa - Poland, Barcelona - Spain, Madrid - Spain, Valencia - Spain",2015-04-27,2013-09-10,2018-11-21,INTERVENTIONAL,PHASE2,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT02648022,Unknown,COMPLETED,2012-01,"Hepatitis C, Depression, PTSD, Substance Use Disorder, Fibrosis",Brief mental health interventions and case management,San Diego - United States,2013-01,2016-01-06,2016-05-20,INTERVENTIONAL,NA,VA Office of Research and Development,FED,hepatitis
NCT00037622,Unknown,TERMINATED,Unknown Date,Chronic Hepatitis B,"ACH-126, 443 (beta-L-Fd4C)",No locations listed,Unknown Date,2002-05-20,2009-08-19,INTERVENTIONAL,NA,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT06786429,Unknown,NOT_YET_RECRUITING,2026-01,"Hepatitis B, Human Papilloma Virus, Gall Stones (& [Calculus - Gall Bladder]), Mental Health Issue, Cancer Liver, Cancer of Cervix, Depression, Anxiety","Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy",No locations listed,2030-09-30,2025-01-22,2025-01-31,INTERVENTIONAL,PHASE4,Eunice Dube,OTHER,hepatitis
NCT06582329,EARTH,NOT_YET_RECRUITING,2025-04,Alcohol-Associated Hepatitis,Alfa1 Antitrypsin,Innsbruck - Austria,2025-07,2024-09-03,2025-03-06,INTERVENTIONAL,PHASE2,Medical University Innsbruck,OTHER,hepatitis
NCT02956629,Unknown,TERMINATED,2016-11-16,Hepatitis C,"Uprifosbuvir, Ruzasvir, Ribavirin",No locations listed,2017-12-22,2016-11-06,2021-02-02,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00805389,Unknown,COMPLETED,2008-12-15,Hepatitis B,"Engerix-B™, Fendrix™, GSK Biologicals' Hepatitis B vaccines (GSK223192A), HBsAg (Booster injection)","Bruxelles - Belgium, Gent - Belgium, La Louvière - Belgium, Wilrijk - Belgium, Tuebingen - Germany, Haag - Germany, Muenchen - Germany, Muenchen - Germany, Regensburg - Germany, Wuerzburg - Germany, Mainz - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany",2010-09-29,2008-12-09,2018-08-20,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT04317729,Unknown,COMPLETED,2020-01-30,Hepatitis C Virus Infection,Fujirebio INNOTEST® HCV Ab IV assay,"Lviv - Ukraine, Lviv - Ukraine",2020-04-30,2020-03-23,2020-07-07,INTERVENTIONAL,NA,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT01447680,Unknown,COMPLETED,2011-08,"Human Immunodeficiency Virus Infection, Hepatitis C",No interventions listed,"Fort Lauderdale - United States, Douglasville - United States, Baltimore - United States, Baltimore - United States, Baltimore - United States, Baltimore - United States, New York - United States",2012-12,2011-10-06,2015-09-07,OBSERVATIONAL,Not Available,G & W Laboratories Inc.,INDUSTRY,hepatitis
NCT00291980,Unknown,COMPLETED,2006-03,Hepatitis B,"HB-AS02V vaccine, HBVAXPRO vaccine","Aalst - Belgium, ATH - Belgium, Baudour - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Gent - Belgium, La Louvière - Belgium, Leuven - Belgium, Montigny le tilleul - Belgium, Tournai - Belgium, Hradec Kralove - Czech Republic, Jihlava - Czech Republic, Liberec - Czech Republic, Olomouc - Czech Republic, Ostrava - Poruba - Czech Republic, Pardubice - Czech Republic, Prague - Czech Republic, Prague - Czech Republic, Sokolov - Czech Republic, Debrecen - Hungary, Eger - Hungary, Esztergom - Hungary, Győr - Hungary, Hatvan - Hungary, Szombathely - Hungary",2007-10,2006-02-15,2008-08-28,INTERVENTIONAL,PHASE3,Henogen,INDUSTRY,hepatitis
NCT01441180,Unknown,COMPLETED,2011-09,Hepatitis C,"GS7977, RBV",Bethesda - United States,2013-03,2011-09-27,2014-09-26,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT02442180,GraCiAH,TERMINATED,2015-07,Alcoholic Hepatitis,"G-CSF (Filgrastim injection), steroid, placebo","Chuncheon - Korea, Republic of",2022-07,2015-05-13,2022-08-08,INTERVENTIONAL,PHASE3,Chuncheon Sacred Heart Hospital,OTHER,hepatitis
NCT02761629,Unknown,COMPLETED,2005-04,"Hepatitis C, Chronic","Peg-Interferon Alpha-2A, Ribavirin","Campinas - Brazil, Florianopolis - Brazil, Itajaí - Brazil, Juiz de Fora - Brazil, Porto Alegre - Brazil, Recife - Brazil, Ribeirão Preto - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Rio Grande - Brazil, Santo Andre - Brazil, Santos - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil",2008-05,2016-05-04,2016-08-16,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02858180,Unknown,COMPLETED,2016-12,"Hepatitis C, Chronic, Heart Failure, Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial",Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC),"Detroit - United States, New York - United States, Durham - United States, Seattle - United States",2019-04-11,2016-08-08,2020-04-21,INTERVENTIONAL,PHASE4,Duke University,OTHER,hepatitis
NCT01252680,Unknown,COMPLETED,2010-04,Hepatitis A,"Healive+Healive, Healive+Havrix, Havrix+Havrix, Havrix+Healive",Tianjin - China,2011-02,2010-12-03,2013-03-15,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00324389,Unknown,COMPLETED,2006-05,Hepatitis C,Interferon alpha,Galveston - United States,Unknown Date,2006-05-11,2010-08-27,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT03888729,SHARED3,UNKNOWN,2019-08-26,"Hepatitis C, Chronic","sofosbubir/velpatasvir, sofosbubir/velpatasvir/voxilaprevir",Kigali - Rwanda,2020-03,2019-03-25,2019-09-11,INTERVENTIONAL,PHASE4,Partners in Health,OTHER,hepatitis
NCT03166280,hepatitisc,UNKNOWN,2017-06,Hepatitis C,"Sofosbuvir 400 mg, Daclatasvir 60 mg/day",No locations listed,2017-11,2017-05-25,2017-05-25,OBSERVATIONAL,Not Available,Eman Sayed Hassan Abd Allah,OTHER,hepatitis
NCT02281929,AntibioCor,COMPLETED,2015-06-13,"Alcoholic Hepatitis, Alcoholic Liver Disease","Amoxicillin, Placebo, Prednisolone","Amiens - France, Angers - France, Besançon - France, Bondy - France, Caen - France, Clichy - France, Dunkerque - France, Grenoble - France, Lille - France, Montpellier - France, Nantes - France, Nice - France, Paris - France, Paris - France, Poitiers - France, Rennes - France, Rouen - France, Toulouse - France, Valenciennes - France, Villejuif - France",2019-11-19,2014-11-04,2021-03-25,INTERVENTIONAL,PHASE3,"University Hospital, Lille",OTHER,hepatitis
NCT04129489,Unknown,TERMINATED,2019-02-07,Autoimmune Hepatitis,Cannabidiol,Petach Tikva - Israel,2020-03-01,2019-10-16,2020-06-16,INTERVENTIONAL,PHASE2,Stero Biotechs Ltd.,INDUSTRY,hepatitis
NCT00909129,DICO,COMPLETED,Unknown Date,"Human Immunodeficiency Virus, Chronic Hepatitis C","pegylated interferon-alpha (Pegasys), ribavirin (COPEGUS)",Stockholm - Sweden,Unknown Date,2009-05-27,2009-05-27,INTERVENTIONAL,NA,Karolinska Institutet,OTHER,hepatitis
NCT01804829,Unknown,COMPLETED,2013-06,"Hepatitis C Infection, Viruses, Hepatocellular Carcinoma, Hepatitis, Viral, Human, Liver Cirrhosis",Civacir® 10%,"Los Angeles - United States, San Francisco - United States, Miami - United States, Orlando - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Lexington - United States, New Orleans - United States, Boston - United States, Burlington - United States, New York - United States, New York - United States, New York - United States, Portland - United States, Memphis - United States, Nashville - United States, Dallas - United States, Houston - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Charlottesville - United States",2016-02,2013-03-05,2017-03-15,INTERVENTIONAL,PHASE3,Biotest Pharmaceuticals Corporation,INDUSTRY,hepatitis
NCT03164889,Unknown,TERMINATED,2017-01,"Hepatitis B, Chronic","Granulocyte Macrophage-colony Stimulating Factor, Entecavir",Beijing - China,2018-01-01,2017-05-24,2022-03-24,INTERVENTIONAL,NA,Beijing 302 Hospital,OTHER,hepatitis
NCT01337791,Unknown,COMPLETED,2008-08,"Chronic Hepatitis B, Pregnancy Complications, High Viral Load, Elevated Alanine Aminotransferase Levels",Telbivudine treatment,Nan Jing - China,2009-12,2011-04-19,2011-04-19,INTERVENTIONAL,PHASE4,"Southeast University, China",OTHER,hepatitis
NCT02744560,Unknown,COMPLETED,2015-03,Beta Thalassemia Major,spirulina,Tanta - Egypt,2017-12,2016-04-20,2018-09-11,INTERVENTIONAL,NA,Tanta University,OTHER,hepatitis
NCT02428491,Unknown,COMPLETED,2015-04-20,"Diphtheria, Tetanus, Pertussis, Poliomyelitis, Hepatitis B, Haemophilus Influenzae Type b",Hexaxim®,Thai Binh - Vietnam,2017-01-11,2015-04-28,2022-04-05,INTERVENTIONAL,PHASE3,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT00682591,Unknown,WITHDRAWN,2008-07,Chronic Hepatitis C Infection,No interventions listed,Wuerzburg - Germany,2011-12,2008-05-22,2009-02-04,OBSERVATIONAL,Not Available,University of Wuerzburg,OTHER,hepatitis
NCT00237991,Unknown,COMPLETED,2005-06,Hepatitis A,Hepatitis A,No locations listed,Unknown Date,2005-10-13,2008-10-16,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01846494,CARE-Hep C,COMPLETED,2013-05-10,Hepatitis C,No interventions listed,"Anaheim - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Minneapolis - United States, Kansas City - United States, New York - United States, Asheville - United States, Tulsa - United States, Lancaster - United States, Austin - United States, San Antonio - United States, San Juan - Puerto Rico",2018-03-19,2013-05-03,2019-03-22,OBSERVATIONAL,Not Available,Duke University,OTHER,hepatitis
NCT06631560,HepE-Onko-BB,COMPLETED,2020-09-01,"Hepatitis E Infection, Hepatitis; Epidemic, Oncologic Disorders",ELISA testing,Brandenburg An Der Havel - Germany,2021-10-29,2024-10-08,2024-10-08,INTERVENTIONAL,NA,Medizinische Hochschule Brandenburg Theodor Fontane,OTHER,hepatitis
NCT02964091,SHARED,COMPLETED,2016-10,Chronic Hepatitis C,sofosbuvir/ledipasvir,Kanombe - Rwanda,2020-08-28,2016-11-15,2021-09-21,INTERVENTIONAL,PHASE4,Partners in Health,OTHER,hepatitis
NCT05813691,ERADIcATE,NOT_YET_RECRUITING,2023-04-10,"Hepatitis C, Chronic, Hepatitis C, Hepatitis",Meridan Bioscience Point of Care test against HCV antibodies,No locations listed,2025-01-31,2023-04-14,2023-04-14,OBSERVATIONAL,Not Available,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,OTHER,hepatitis
NCT02822794,Unknown,COMPLETED,2016-07-25,Hepatitis C Virus Infection,"SOF/VEL, RBV","Ehime - Japan, Hiroshima - Japan, Ichikawa-shi - Japan, Iruma-gun - Japan, Kashihara - Japan, Kurume-shi - Japan, Kyoto - Japan, Maebashi - Japan, Musashino-shi - Japan, Nagoya - Japan, Nishinomiya - Japan, Ogaki City - Japan, Okayama - Japan, Omura - Japan, Sapporo - Japan, Suita - Japan, Takamatsu-shi - Japan, Yamagata - Japan",2017-06-02,2016-07-04,2018-11-14,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT02889094,COVViB,UNKNOWN,2016-10,"Hepatitis B, HIV, Liver Cirrhosis, End Stage Liver Disease",Routine care,"Lyon - France, Paris - France, Paris - France, Paris - France",2018-03-31,2016-09-05,2018-04-26,OBSERVATIONAL,Not Available,Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba,OTHER,hepatitis
NCT01264094,Unknown,TERMINATED,2009-11,Chronic Hepatitis B,Clevudine,"Seoul - Korea, Republic of",2014-11,2010-12-21,2015-07-22,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00645294,Unknown,COMPLETED,2003-02,Hepatitis B,"Adefovir dipivoxil, Adefovir Dipivoxil, Adefovir Dipivoxil","Bruxelles - Belgium, Frankfurt - Germany, Hannover - Germany, Mainz - Germany, Munchen - Germany, Wuppertal - Germany, Krakow - Poland, Warszawa - Poland, London - United Kingdom, Birmingham - United Kingdom",2003-08,2008-03-27,2008-03-27,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01254994,Unknown,COMPLETED,2007-08,Liver Failure,"entecavir, Traditional comprehensive medical treatment",Guangzhou - China,2009-07,2010-12-07,2010-12-07,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT00249860,Unknown,COMPLETED,2002-09,Hepatitis C,"Interferon-beta-1a, Placebo, Ribavirin plus Interferon-beta-1a",No locations listed,2005-08,2005-11-07,2013-08-06,INTERVENTIONAL,PHASE3,EMD Serono,INDUSTRY,hepatitis
NCT01647191,Unknown,COMPLETED,2011-07-01,Hepatitis C,"intervention group, control group","Shanghai - China, Shanghai - China",2015-05-01,2012-07-23,2020-01-13,INTERVENTIONAL,NA,Shanghai Mental Health Center,OTHER,hepatitis
NCT00907894,Unknown,COMPLETED,2009-02,Chronic Hepatitis B,LDT600 (Telbivudine),"Brussels - Belgium, Frankfurt - Germany, Starnberg - Germany, Wuppertal - Germany, Manila - Philippines, Quezon City - Philippines, Birmingham - United Kingdom",2012-03,2009-05-25,2020-12-19,INTERVENTIONAL,PHASE1,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02957994,Unknown,UNKNOWN,2016-12-22,Hepatitis B,Tenofovir alafenamide fumarate,No locations listed,2017-06-21,2016-11-08,2017-06-29,INTERVENTIONAL,PHASE4,Asian Pacific Liver Center at Coalition of Inclusive Medicine,OTHER,hepatitis
NCT03108794,Unknown,RECRUITING,2012-06-30,Chronic Hepatitis B,No interventions listed,"Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Lanzhou - China, Lanzhou - China, Guangzhou - China, Guiyang - China, Guiyang - China, Haikou - China, Shijiazhuang - China, Shijiazhuang - China, Shijiazhuang - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Wuhai - China, Xuzhou - China, Changchun - China, Yanbian - China, Shenyang - China, Yinchuan - China, Jinan - China, Weifang - China, Shanghai - China, Shanghai - China, Taiyuan - China, Taiyuan - China, Xi'an - China, Yanan - China, Chengdu - China, Luzhou - China, Tianjin - China, Tianjin - China, Changji - China, Urumqi - China, Urumqi - China, Kunming - China, Hangzhou - China",2022-12-31,2017-04-11,2017-11-06,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT02817594,3DUTCH,COMPLETED,2016-01-20,Chronic Hepatitis C,No interventions listed,"Dordrecht - Netherlands, Alkmaar - Netherlands, Amsterdam - Netherlands, Groningen - Netherlands, Leiden - Netherlands, Nijmegen - Netherlands, Rotterdam - Netherlands, Rotterdam - Netherlands, Utrecht - Netherlands",2018-03-07,2016-06-29,2019-05-17,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00168194,Unknown,COMPLETED,2004-12,"Hepatitis B, HIV Infections",No interventions listed,Melbourne - Australia,Unknown Date,2005-09-15,2012-01-20,OBSERVATIONAL,Not Available,The Alfred,OTHER,hepatitis
NCT01179594,Unknown,WITHDRAWN,2010-09-18,"Hepatitis B, Chronic","entecavir, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], placebo",No locations listed,2014-11,2010-08-11,2017-02-17,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03529760,Unknown,UNKNOWN,2018-05-08,Reactivation of Hepatitis B Virus,No interventions listed,Chongqing - China,2019-07-15,2018-05-18,2019-07-16,OBSERVATIONAL,Not Available,Children's Hospital of Chongqing Medical University,OTHER,hepatitis
NCT00703560,VK,COMPLETED,2005-09,Hepatitis C,No interventions listed,No locations listed,2011-09,2008-06-23,2013-01-21,OBSERVATIONAL,Not Available,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT00983060,Unknown,COMPLETED,2009-09,Chronic Hepatitis C Genotype-1 Relapse,"NIM811, Placebo BID + SOC","San Diego - United States, Orlando - United States, Sarasota - United States, Tampa - United States, San Antonio - United States, Clayton - Australia, Westmead - Australia, Wentworthville - Australia, Brussels - Belgium, Leuven - Belgium, Frankfurt - Germany, San Juan - Puerto Rico, Barcelona - Spain, Sevilla - Spain, Taipei - Taiwan, Kaohsiung - Taiwan",2011-04,2009-09-23,2020-12-19,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT05708560,MAFLD-HBV 1,UNKNOWN,2022-03-01,"Hepatitis B, Chronic",No interventions listed,"Amsterdam - Netherlands, Dordrecht - Netherlands, Maastricht - Netherlands",2023-01-31,2023-02-01,2023-02-01,OBSERVATIONAL,Not Available,Erasmus Medical Center,OTHER,hepatitis
NCT06155760,Unknown,NOT_YET_RECRUITING,2023-11-25,Severe Alcoholic Hepatitis,"Prednisolone, Standard Medical therapy, Placebo",New Delhi - India,2025-02-27,2023-12-04,2023-12-04,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT02570191,Unknown,COMPLETED,2004-11,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Pleven - Bulgaria, Plovdiv - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria",2007-02,2015-10-07,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00087594,Unknown,COMPLETED,2003-11,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin","San Francisco - United States, Farmington - United States, Honolulu - United States, Downers Grove - United States, Baltimore - United States, New York - United States, Richmond - United States",2006-10,2004-07-14,2016-03-04,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01318694,Unknown,COMPLETED,2011-03,Hepatitis C,"Alisporivir, Peginterferon alfa-2a, Ribavirin, ALV Placebo","Beverly Hills - United States, Oakland - United States, San Diego - United States, San Diego - United States, San Diego - United States, Ventura - United States, Bradenton - United States, Maitland - United States, Tampa - United States, Springfield - United States, Indianapolis - United States, Shreveport - United States, Baltimore - United States, Baltimore - United States, Minneapolis - United States, St. Louis - United States, St. Louis - United States, Omaha - United States, Newark - United States, Brooklyn - United States, New York - United States, New York - United States, Charlotte - United States, Fayetteville - United States, Arlington - United States, Dallas - United States, Dallas - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Fairfax - United States, Newport News - United States, Rosario - Argentina, Rosario - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Cordoba - Argentina, Darlinghurst - Australia, Kingswood - Australia, Kogarah - Australia, Westmead - Australia, Greenslopes - Australia, Fitzroy - Australia, Brussel - Belgium, Bruxelles - Belgium, Gent - Belgium, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Downsview - Canada, London - Canada, Toronto - Canada, Toronto - Canada, Clichy - France, Grenoble - France, Lyon Cedex 04 - France, Toulouse cedex 9 - France, Villejuif - France, Berlin - Germany, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Köln - Germany, Leipzig - Germany, Mainz - Germany, Hong Kong - Hong Kong, Hongkong - Hong Kong, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Kaposvár - Hungary, Pecs - Hungary, Szekesfehervar - Hungary, Bologna - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Rozzano - Italy, Palermo - Italy, Padova - Italy, Pavia - Italy, Roma - Italy, Torino - Italy, Bologna - Italy, Napoli - Italy, Yangsan-si - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kyunggi - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, México - Mexico, Monterrey - Mexico, Bialystok - Poland, Bydgoszcz - Poland, Chorzów - Poland, Kielce - Poland, Lódz - Poland, San Juan - Puerto Rico, Bucharest - Romania, Bucharest - Romania, Iasi - Romania, Bucharest - Romania, Cluj Napoca - Romania, Craiova - Romania, Iasi - Romania, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, St.- Petersburg - Russian Federation, Sevilla - Spain, Barcelona - Spain, Barcelona - Spain, Valencia - Spain, Majadahonda - Spain, Madrid - Spain, Chia-Yi - Taiwan, Kaohsiung - Taiwan, Niaosong Township - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Yun-Lin - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Songkla - Thailand, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Nottingham - United Kingdom, Hanoi - Vietnam, Ho Chi Minh - Vietnam",2013-08,2011-03-18,2016-09-30,INTERVENTIONAL,PHASE3,Debiopharm International SA,INDUSTRY,hepatitis
NCT02327676,Unknown,UNKNOWN,2015-01,"Hepatitis B, Chronic",Emtricitabine,No locations listed,2015-07,2014-12-30,2014-12-30,INTERVENTIONAL,PHASE4,"Asian-Pacific Alliance of Liver Disease, Beijing",OTHER,hepatitis
NCT04636827,Unknown,UNKNOWN,2020-11-11,Vaccination,"sIPV+DTaP+HepA, sIPV, DTaP, HepA","Shijia Zhuang - China, Xi'an - China, Taiyuan - China",2021-08,2020-11-19,2020-11-19,INTERVENTIONAL,PHASE4,China National Biotec Group Company Limited,INDUSTRY,hepatitis
NCT06668727,SAMBA,RECRUITING,2024-08-26,Hepatitis B,HepB mAb19,Aarhus N - Denmark,2027-08-26,2024-10-31,2024-10-31,INTERVENTIONAL,PHASE1,Aarhus University Hospital,OTHER,hepatitis
NCT05568576,Unknown,COMPLETED,2015-01-01,Survival,No interventions listed,Assiut - Egypt,2022-12-30,2022-10-05,2023-05-06,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT03638076,Unknown,COMPLETED,2017-07-26,Chronic Hepatitis B,"GLS4, RTV",Changchun - China,2018-11-22,2018-08-20,2020-07-23,INTERVENTIONAL,PHASE2,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,hepatitis
NCT02053727,RA,WITHDRAWN,2014-07,"Rheumatoid Arthritis, Chronic Hepatitis B","Abatacept, Placebo",Los Angeles - United States,2018-06-12,2014-02-04,2020-11-16,INTERVENTIONAL,NA,"University of California, Los Angeles",OTHER,hepatitis
NCT00362427,Unknown,COMPLETED,2006-08,"Diphtheria, Pertussis, Polio, Hepatitis B, Tetanus","Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC, Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC, Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC","Coquitlam - Canada, Surrey - Canada, Winnipeg - Canada, Halifax - Canada, Ottawa - Canada, Beauport - Canada, Montréal - Canada, Montréal - Canada",2009-02,2006-08-10,2014-01-14,INTERVENTIONAL,PHASE2,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT01487876,Unknown,UNKNOWN,2011-09,Chronic Hepatitis B,"HBV DNA vaccine, Placebo",Beijing - China,2012-08,2011-12-08,2011-12-08,INTERVENTIONAL,PHASE2,Fuqiang Yang,OTHER,hepatitis
NCT03369327,HIV200,COMPLETED,2017-01-01,"Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus",sofosbuvir and daclatasvir,"Tehran - Iran, Islamic Republic of, Tehran - Iran, Islamic Republic of",2018-09-01,2017-12-12,2019-02-20,INTERVENTIONAL,PHASE3,Tehran University of Medical Sciences,OTHER,hepatitis
NCT03743727,Unknown,UNKNOWN,2018-08-01,Hepatitis C Genotype 4,Combined therapy LDV and SOF,Nasr City - Egypt,2019-03-30,2018-11-16,2018-11-16,INTERVENTIONAL,PHASE4,Yassin Abdelghaffar Charity Center for Liver Disease and Research,OTHER,hepatitis
NCT00257127,Unknown,COMPLETED,2006-02,HIV Infections,"Pneumococcal 7-valent conjugate vaccine, Pneumococcal polysaccharide vaccine, Hepatitis B vaccine, Measles, mumps, and rubella virus vaccine, live","Birmingham - United States, Alhambra - United States, Long Beach - United States, San Diego - United States, Aurora - United States, New Haven - United States, Fort Lauderdale - United States, Gainesville - United States, Jacksonville - United States, Chicago - United States, Chicago - United States, New Orleans - United States, Boston - United States, Boston - United States, Worcester - United States, Newark - United States, Bronx - United States, Brooklyn - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Stony Brook - United States, Philadelphia - United States, San Juan - Puerto Rico, San Juan - Puerto Rico",2006-08,2005-11-22,2021-11-01,INTERVENTIONAL,NA,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00040027,Unknown,COMPLETED,2002-04,"Hepatitis C, Hepatitis C, Chronic","thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a, placebo + PEGinterferon alfa-2a","Mobile - United States, Scottsdale - United States, Berkeley - United States, La Jolla - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Washington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Atlanta - United States, Savannah - United States, Meridian - United States, Chicago - United States, Louisville - United States, Louisville - United States, New Orleans - United States, Baltimore - United States, Chevy Chase - United States, Boston - United States, Worcester - United States, Royal Oak - United States, Jackson - United States, Kansas City - United States, SainT Louis - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Charlotte - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Portland - United States, Philadelphia - United States, Providence - United States, Memphis - United States, Memphis - United States, Dallas - United States, Dallas - United States, Houston - United States, Fairfax - United States, Richmond - United States, Milwaukee - United States, Ponce - Puerto Rico, Santurce - Puerto Rico",Unknown Date,2002-07-04,2008-01-15,INTERVENTIONAL,PHASE3,SciClone Pharmaceuticals,INDUSTRY,hepatitis
NCT04102176,HALT-NUCS,UNKNOWN,2019-01-29,Chronic Hepatitis B,"stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue",Singapore - Singapore,2021-03,2019-09-25,2019-09-26,INTERVENTIONAL,NA,Seng Gee Lim,OTHER,hepatitis
NCT00524576,Unknown,COMPLETED,2007-11-28,Hepatitis B,Engerix™-B,"Westmead - Australia, Bruxelles - Belgium, Wilrijk - Belgium",2008-05-14,2007-09-03,2018-09-07,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00437476,Unknown,UNKNOWN,2007-02,"HIV Infections, Hepatitis C","LPV/r, Nucleoside Reverse Transcriptase Inhibitors, PEG-IFNa 2a, Ribavirin",Milan - Italy,2010-07,2007-02-21,2009-02-06,INTERVENTIONAL,PHASE3,IRCCS San Raffaele,OTHER,hepatitis
NCT00291876,Unknown,COMPLETED,2004-01-01,Hepatitis A,Havrix™,Wilrijk - Belgium,2013-03-01,2006-02-15,2017-11-29,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00781976,Unknown,COMPLETED,2008-11,Hepatitis C,"AZD7295, Placebo",Auckland - New Zealand,2010-03,2008-10-29,2010-03-31,INTERVENTIONAL,PHASE1,Arrow Therapeutics,INDUSTRY,hepatitis
NCT01798576,Unknown,TERMINATED,2012-11,"Hepatitis C, Chronic","Pegylated Interferon alfa-2a, Ribavirin",Brasov - Romania,2015-06,2013-02-26,2016-09-15,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05144776,HBVPOCT,COMPLETED,2022-11-17,Hepatitis B,"GeneXpert HBV DNA Viral Load Assay, Dried Blood Spot HBV DNA test","Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Melbourne - Australia",2024-06-01,2021-12-03,2025-03-06,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT01830127,Unknown,COMPLETED,2013-04,"Hepatitis C, Chronic","Ribavirin, BI 207127 high dose, Faldaprevir, Ribavirin, BI 207127 low dose, Faldaprevir","La Mesa - United States, San Diego - United States, Deland - United States, West Palm Beach - United States, Arlington - United States, Norfolk - United States, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Frankfurt am Main - Germany, Hannover - Germany, Leipzig - Germany, Mainz - Germany, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, London - United Kingdom",2014-10,2013-04-12,2015-11-20,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00575627,Unknown,UNKNOWN,2007-09,Chronic Hepatitis C,Peg-Interferon alpha2a plus Ribavirin,Torino - Italy,2009-09,2007-12-18,2008-06-04,INTERVENTIONAL,PHASE4,"University of Turin, Italy",OTHER,hepatitis
NCT03794791,CHARSET,COMPLETED,2019-02-20,Hepatitis B and Hepatitis C (Disorder),"education, no education",Chongqing - China,2020-12-31,2019-01-07,2021-01-20,OBSERVATIONAL,Not Available,Hong Ren,OTHER,hepatitis
NCT03249194,Unknown,COMPLETED,2017-08-17,"Kidney Transplant, Hepatitis C",Direct acting Anti-Viral Therapy using Epclusa or Zepatier,Richmond - United States,2020-03-15,2017-08-15,2020-03-27,INTERVENTIONAL,PHASE1,Virginia Commonwealth University,OTHER,hepatitis
NCT01405560,Unknown,COMPLETED,2011-09-02,"Hepatitis C, Chronic","Vaniprevir, peg-IFN, ribavirin",No locations listed,2013-03-29,2011-07-29,2018-10-18,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01740791,Unknown,COMPLETED,2012-11-06,Chronic Hepatitis C Virus,"Velpatasvir, Placebo","Costa Mesa - United States, DeLand - United States, Orlando - United States, Kansas City - United States, Marlton - United States, Philadelphia - United States, Knoxville - United States, San Antonio - United States, Tacoma - United States, San Juan - Puerto Rico",2013-03-15,2012-12-04,2020-12-16,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT01447394,Unknown,WITHDRAWN,2012-03,Hepatitis C Virus (HCV),"Pegylated Interferon Lambda, Pegylated Interferon Alfa-2a, Ribavirin","San Diego - United States, Rochester - United States, Houston - United States, Vancouver - Canada, Vaughan - Canada, Hong Kong - China, Bogota - Colombia, Cali - Colombia, Medellin - Colombia, Hradec Kralove - Czech Republic, Praha 4 - Czech Republic, Usti Nad Labem - Czech Republic, Shebin Elkom - Egypt, Cairo - Egypt, Lai Chi Kok - Hong Kong, Tai Po - Hong Kong, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Miskolc - Hungary, Hyderabad - India, Coimbatore - India, Gurgaon - India, Ludhiana - India, Nagpur - India, New Delhi - India, Dublin 8 - Ireland, Dublin - Ireland, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of, Amsterdam - Netherlands, Leiden - Netherlands, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Lodz - Poland, Lublin - Poland, Olsztyn - Poland, Pulawy - Poland, Raciborz - Poland, Sosnowiec - Poland, Warszawa - Poland, Wroclaw - Poland, Zielona Gora - Poland, Bucharest - Romania, Iasi - Romania, Timisoara - Romania, Ioshkar-Ola - Russian Federation, Kaluga - Russian Federation, Lipetsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizhniy Novgorod - Russian Federation, Poselok Noviy - Russian Federation, Samara - Russian Federation, Saratov - Russian Federation, Smolensk - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, St.Petersburg - Russian Federation, St.Petersburg - Russian Federation, Toliatti - Russian Federation, Volgograd - Russian Federation, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, A Coruna - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Ankara - Turkey, Bornova Izmir - Turkey, Diyarbakir - Turkey, Istanbul - Turkey, Trabzon - Turkey, London - United Kingdom, Edinburgh - United Kingdom, Birmingham - United Kingdom",2014-03,2011-10-06,2012-02-03,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02759991,Unknown,COMPLETED,2017-10-02,Hepatitis E Infection,"Hecolin, Hepa-B",Dhaka - Bangladesh,2019-09-30,2016-05-03,2024-08-15,INTERVENTIONAL,PHASE4,Norwegian Institute of Public Health,OTHER_GOV,hepatitis
NCT00495391,STEALTHC-2,COMPLETED,2007-07,Chronic Hepatitis C,"Nitazoxanide, Placebo, Peginterferon alfa-2a, Ribavirin","Palo Alto - United States, Stanford - United States, New Haven - United States, Gainesville - United States, Largo - United States, Atlanta - United States, New York - United States, Nashville - United States, Fort Sam Houston - United States, Richmond - United States",2010-02,2007-07-03,2014-05-08,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT02392494,Unknown,COMPLETED,2015-04-28,Hepatitis C,MK-1075,No locations listed,2015-08-10,2015-03-19,2019-01-22,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01782794,PopCorn,COMPLETED,2009-05,Hepatitis B,Data collection,No locations listed,2012-06,2013-02-04,2013-02-04,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05229991,LOWR6,ACTIVE_NOT_RECRUITING,2021-05-15,"Hepatitis D, Chronic","Lonafarnib, Ritonavir","Be'er Sheva - Israel, Auckland - New Zealand, Istanbul - Turkey",2024-12-31,2022-02-08,2023-05-06,INTERVENTIONAL,PHASE3,Soroka University Medical Center,OTHER,hepatitis
NCT00956891,Unknown,COMPLETED,2005-05,"Liver Failure, Mesenchymal Stem Cells",No interventions listed,Guangzhou - China,2009-06,2009-08-11,2010-12-07,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT03416491,KW-136_II,COMPLETED,2017-02-15,"Hepatitis C, Chronic","KW-136, Sofosbuvir","Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guanzhou - China, Zhengzhou - China, Nanjing - China, Changchun - China, Dalian - China, Shenyang - China, Ji'nan - China, Qingdao - China",2017-09-17,2018-01-31,2018-01-31,INTERVENTIONAL,PHASE2,"Kawin Technology Share-holding Co., Ltd.",INDUSTRY,hepatitis
NCT00608894,Unknown,TERMINATED,2007-12,Autoimmune Hepatitis,"LCP-Tacro (tacrolimus), Azathioprine","Phoenix - United States, Jacksonville - United States, Chicago - United States, Minneapolis - United States, Rochester - United States, New York - United States, Houston - United States, Richmond - United States, Calgary - Canada, Edmonton - Canada, Winnipeg - Canada, Halifax - Canada",2009-04,2008-02-06,2020-03-17,INTERVENTIONAL,PHASE2,Veloxis Pharmaceuticals,INDUSTRY,hepatitis
NCT03895294,HEPCSTRATEGY,UNKNOWN,2019-04-01,Hepatitis C,"Health care under the strategic purchase-Clinical pathway, Usual care process prior strategic purchase-clinical pathway",Medellín - Colombia,2020-07-31,2019-03-29,2019-06-07,INTERVENTIONAL,NA,Universidad de Antioquia,OTHER,hepatitis
NCT03908294,Unknown,COMPLETED,2018-08-13,"Glucose Metabolism Disorders, Liver Fibrosis, Hepatitis C","Lab tests, non-invasive fibrosis (Fibroscan/ARFI)",Frankfurt am Main - Germany,2020-04-01,2019-04-09,2020-07-21,OBSERVATIONAL,Not Available,Johann Wolfgang Goethe University Hospital,OTHER,hepatitis
NCT02651194,EXPEDITION-4,COMPLETED,2015-12,Chronic Hepatitis C Virus (HCV) Infection,ABT-493/ABT-530,No locations listed,2016-10,2016-01-08,2017-10-16,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT03579576,Unknown,COMPLETED,2017-12-20,"Hepatitis C, Hepatitis B, HIV Infections",sofosbuvir 400 mg/velpatasvir 100 mg (SOF/VEL) orally once daily for 12 weeks with or without weight-based ribavirin.,"Kāchen - Myanmar, Mandalay - Myanmar, Yangon - Myanmar",2019-03-30,2018-07-06,2019-07-29,OBSERVATIONAL,Not Available,Right to Care,OTHER,hepatitis
NCT03855176,Unknown,COMPLETED,2017-09-12,"Hepatitis A, Human Immunodeficiency Virus, Vaccine Response Impaired",Vaqta Injectable Product,Taipei - Taiwan,2022-12-30,2019-02-26,2023-01-26,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT01439776,Addwin,COMPLETED,2011-09,Chronic Hepatitis C,Vit D,"Cheonan - Korea, Republic of, Bucheon - Korea, Republic of, Guri - Korea, Republic of, Seongnam - Korea, Republic of, Chuncheon - Korea, Republic of, Wonju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2017-12-15,2011-09-23,2023-03-06,INTERVENTIONAL,PHASE4,Hanyang University,OTHER,hepatitis
NCT01204827,Unknown,WITHDRAWN,Unknown Date,Chronic Hepatitis B,13C Methacetin Breath Test (BreathID),Jerusalem - Israel,Unknown Date,2010-09-17,2012-08-28,INTERVENTIONAL,PHASE3,Hadassah Medical Organization,OTHER,hepatitis
NCT06020976,Unknown,NOT_YET_RECRUITING,2023-09-10,Autoimmune Hepatitis,liver biobsy,Sohag - Egypt,2024-09-10,2023-09-01,2023-09-01,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT02170727,UNITY 4,COMPLETED,2014-06-26,Hepatitis C Virus,DCV/ASV/BMS-791325,"Busan - Korea, Republic of, Busan - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-Do - Korea, Republic of, Gyeongsangnam-do - Korea, Republic of, Inchoen - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kazan - Russian Federation, Moscow - Russian Federation, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2015-06-12,2014-06-23,2020-10-29,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05705427,COMBAT-HBV,RECRUITING,2023-08-17,"Hepatitis B, Vertical Transmission of Infectious Disease","Tenofovir Disoproxil Fumarate 300 MG, Hepatitis B monovalent vaccine, Placebo","Kinshasa - Congo, The Democratic Republic of the",2025-08,2023-01-30,2024-08-16,INTERVENTIONAL,PHASE4,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT02174276,Unknown,COMPLETED,2014-07-24,Chronic Hepatitis B,"Tenofovir disoproxil fumarate, GS-4774","Palo Alto - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Honolulu - United States, Baltimore - United States, Boston - United States, New York - United States, Philadelphia - United States, Richmond - United States, Springfield - United States, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Bologna - Italy, Parma - Italy, Pisa - Italy, San Giovanni Rotondo - Italy, Daegu - Korea, Republic of, Seocho - Korea, Republic of, Seongnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Yangsan - Korea, Republic of, Auckland - New Zealand, Bucharest - Romania, Bucharest - Romania",2016-02-17,2014-06-25,2019-06-04,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00845676,Unknown,COMPLETED,2008-03,"Hepatitis C, Human Immunodeficiency Virus, HIV Infections",Pegylated interferon alfa-2a + Ribavirin,San Francisco - United States,2010-12,2009-02-18,2020-05-18,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,hepatitis
NCT00661076,Unknown,COMPLETED,2008-08,"Hepatitis B, Chronic","adefovir dipivoxil, peginterferon alfa-2a [Pegasys]","Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Gaziantep - Turkey",2011-05,2008-04-18,2016-11-02,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00724776,Unknown,COMPLETED,2008-07,Chronic Hepatitis C,Albinterferon alfa 2b,Tokyo - Japan,2009-07,2008-07-30,2020-12-08,INTERVENTIONAL,PHASE1,Novartis,INDUSTRY,hepatitis
NCT03293576,ADAPT,COMPLETED,2018-02-22,Hepatitis C,Volitional Help Sheet,Dundee - United Kingdom,2020-01-03,2017-09-26,2020-08-14,INTERVENTIONAL,NA,University of Dundee,OTHER,hepatitis
NCT00389376,SyNCH,COMPLETED,2006-11,"Hepatitis C, Non-Alcoholic Fatty Liver Disease","Placebo, Silymarin, Silymarin, Silymarin, Silymarin, Silymarin, Silymarin, Silymarin","Boston - United States, Chapel Hill - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States",2008-01,2006-10-18,2008-02-20,INTERVENTIONAL,PHASE1,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT05755776,POWER,UNKNOWN,2023-03-01,Chronic Hepatitis B,TMF,"Chongqing - China, Chongqing - China, Guangxi - China, Jilin - China, Kunming - China, Kunming - China, Nanjing - China, Ningbo - China, Shanghai - China, Shanghai - China, Shenyang - China, Taicang - China, Zibo - China",2024-12,2023-03-06,2023-09-21,OBSERVATIONAL,Not Available,The Second Affiliated Hospital of Chongqing Medical University,OTHER,hepatitis
NCT05328427,STOP-B,NOT_YET_RECRUITING,2022-05-15,"Hepatitis B, Chronic",Stopping,Gothenburg - Sweden,2023-12-31,2022-04-14,2022-04-14,INTERVENTIONAL,NA,Göteborg University,OTHER,hepatitis
NCT01944527,ANRSCO23CUPILT,UNKNOWN,2013-10,"HCV Recurrence, Liver Transplantation, Direct-acting Antiviral Agents",No interventions listed,Rennes - France,2015-12,2013-09-17,2016-02-02,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT00475176,Unknown,COMPLETED,2007-05,Chronic Hepatitis C,"Peginterferon alfa-2a, Ribavirin, S-adenosyl methionine for Chronic Liver Disease",Bethesda - United States,2011-05,2007-05-21,2013-07-05,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT06121427,Unknown,RECRUITING,2023-09-01,Chronic Hepatitis D,No interventions listed,Moscow - Russian Federation,2025-02-28,2023-11-08,2023-12-06,OBSERVATIONAL,Not Available,Center of target therapy,OTHER,hepatitis
NCT01251276,Unknown,COMPLETED,2010-11-30,Hepatitis B,Modified Process Hepatitis B Vaccine,No locations listed,2011-04-12,2010-12-01,2022-09-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05763576,Unknown,TERMINATED,2023-04-28,Chronic Hepatitis B,"RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment","San Francisco - United States, Paris - France, Hong Kong - Hong Kong, Shatin, New Territories - Hong Kong, Chuncheon - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Vigo - Spain, Taoyuan City - Taiwan, Xitun Dist. - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand",2024-12-23,2023-03-10,2025-01-07,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06874127,Unknown,RECRUITING,2024-02-01,"Chronic Hepatitis B Virus (HBV) Infection, Liver Fibrosis",Nucleos(t)ide Analogs (NA),Beijing - China,2026-02-01,2025-03-13,2025-03-13,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT02430194,LOWR-2,COMPLETED,2014-12,Chronic Hepatitis D Infection,"lonafarnib, ritonavir, Pegylated interferon-alfa-2a",Ankara - Turkey,2017-04-18,2015-04-30,2023-03-03,INTERVENTIONAL,PHASE2,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT05483894,STAPH,UNKNOWN,2022-08-01,"Hepatitis B, Portal Hypertension","Atorvastatin 10mg, Placebo",No locations listed,2024-07-31,2022-08-02,2022-08-02,INTERVENTIONAL,PHASE2,Samsung Medical Center,OTHER,hepatitis
NCT00662194,Unknown,UNKNOWN,2008-04,"HIV-hepatitis Co-infection, HIV Infections",No interventions listed,Melbourne - Australia,2014-04,2008-04-21,2014-03-10,OBSERVATIONAL,Not Available,Bayside Health,OTHER_GOV,hepatitis
NCT03425994,Unknown,UNKNOWN,2018-02-06,"Chronic Hepatitis B in HIV Patient, Kidney Injury, Bone Diseases",Elvitegravir/Cobicistat/Emtricitabine,Taipei - Taiwan,2019-02-22,2018-02-08,2019-08-28,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT00164060,Unknown,TERMINATED,2004-02,"Hepatitis C, HIV Infections",No interventions listed,Melbourne - Australia,2007-05,2005-09-14,2013-12-05,OBSERVATIONAL,Not Available,Bayside Health,OTHER_GOV,hepatitis
NCT01519960,Unknown,COMPLETED,2012-07-11,"Hepatitis B, Chronic","peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","San Francisco - United States, Baltimore - United States, Boston - United States, Saint Louis - United States, Houston - United States, Seattle - United States, North Adelaide - Australia, Melbourne - Australia, Bruxelles - Belgium, Gent - Belgium, Sofia - Bulgaria, Varna - Bulgaria, Beijing City - China, Beijing - China, Changchun - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Kunming - China, Urumqi (乌鲁木齐) - China, Wuhan - China, Xi'an - China, Wuppertal - Germany, Haifa - Israel, Jerusalem - Israel, Nahariya - Israel, Bologna - Italy, Bydgoszcz - Poland, Krakow - Poland, Łodz - Poland, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Samara - Russian Federation, Kyiv - Ukraine, Kyiv - Ukraine, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom",2015-07-09,2012-01-27,2022-11-18,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01826760,Unknown,COMPLETED,2010-04,Acute-on-chronic Hepatitis B Liver Failure,Using training and testing groups to construct ANN based on laboratory tests,Wenzhou - China,2010-05,2013-04-08,2013-04-08,OBSERVATIONAL,Not Available,Wenzhou Medical University,OTHER,hepatitis
NCT00938860,SUSTAIN,COMPLETED,2009-09,"Hepatitis C, Liver Transplantation","cyclosporin (Neoral), tacrolimus (Prograf)","Phoenix - United States, Palo Alto - United States, San Francisco - United States, Gainesville - United States, Chapel Hill - United States, Oklahoma City - United States, Houston - United States, Houston - United States, Madison - United States, Bruxelles - Belgium, Fortaleza - Brazil, São Paulo - Brazil, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Toronto - Canada, Bogotá - Colombia, Bogotá - Colombia, Creteil - France, Lyon Cedex 04 - France, Montpellier - France, Paris - France, Toulouse Cedex 4 - France, Villejuif - France, Frankfurt - Germany, Hamburg - Germany, Mainz - Germany, Muenchen - Germany, Bologna - Italy, Padova - Italy, Udine - Italy, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Moscow - Russian Federation, Moscow - Russian Federation, Oviedo - Spain, Valladolid - Spain, Barcelona - Spain, Barcelona - Spain, Santiago de Compostela - Spain, Zurich - Switzerland, Birmingham - United Kingdom",2013-05,2009-07-14,2015-05-22,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT04189276,Unknown,UNKNOWN,2019-12-10,Hepatitis B Virus (HBV),"ETV/TDF+T101 No.1, ETV/TDF+T101 No.2, ETV or TDF, ETV/TDF+Peg-IFNα-2b","Beijing - China, Beijing - China, Tianjin - China",2021-06-30,2019-12-06,2021-02-08,INTERVENTIONAL,PHASE2,"Tasly Tianjin Biopharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT00834860,Unknown,UNKNOWN,2007-01,"Chronic Hepatitis C, Hepatocellular Carcinoma",peginterferon alpha-2a and ribavirin,Kaohsiung - Taiwan,2009-12,2009-02-03,2010-02-15,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT00332176,Unknown,UNKNOWN,2006-06,Chronic Hepatitis C,"Celgosivir, Celgosivir, Peginterferon alfa 2b + ribavirin","Vancouver - Canada, Vancouver - Canada, Toronto - Canada",2008-12,2006-06-01,2008-04-08,INTERVENTIONAL,PHASE2,BioWest Therapeutics Inc,INDUSTRY,hepatitis
NCT03511794,Unknown,COMPLETED,2018-04-13,Hepatitis B,No interventions listed,Bethesda - United States,2021-06-01,2018-04-30,2022-02-07,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT02773394,PICTURE,COMPLETED,2016-04-12,Hepatitis C Virus,No interventions listed,"Goiania - Brazil, Porto Alegre - Brazil, Porto Velho - Brazil, Recife - Brazil, Rio Branco - Brazil, Rio de Janeiro - Brazil, Salvador - Brazil, Sao Paulo - Brazil",2016-11-30,2016-05-16,2025-02-03,OBSERVATIONAL,Not Available,Janssen-Cilag Ltd.,INDUSTRY,hepatitis
NCT01198860,HBV,APPROVED_FOR_MARKETING,Unknown Date,CHRONIC HEPATITIS B,CTH Chronic Hepatitis B,Hồ Chí Minh - Vietnam,Unknown Date,2010-09-10,2021-10-14,EXPANDED_ACCESS,Not Available,"Nguyen Thi Trieu, MD",INDIV,hepatitis
NCT02588560,Unknown,UNKNOWN,2015-09,"Lymphoma, Hepatitis C Antibodies, Drug Therapy",No interventions listed,No locations listed,2019-08,2015-10-28,2015-10-28,OBSERVATIONAL,Not Available,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT05391360,Unknown,COMPLETED,2021-10-11,"Hepatitis B, Chronic","Freethiadine tablets(part I), Freethiadine tablets (part II), Freethiadine placebo tablets, entecavir tablets","Guangzhou - China, Changchun - China",2023-01-17,2022-05-25,2023-04-12,INTERVENTIONAL,PHASE1,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,hepatitis
NCT01413360,Unknown,COMPLETED,2011-08,"Chronic Hepatitis, Chronic Hepatitis C, Chronic Alcoholic Hepatitis",High dose vitamin C,"Seoul - Korea, Republic of",2013-12,2011-08-10,2016-07-15,INTERVENTIONAL,PHASE4,Seoul National University Hospital,OTHER,hepatitis
NCT05317260,Unknown,COMPLETED,2002-01-01,"Fatty Liver, Chronic Hepatitis b",Antiviral Agents,Bangkoknoi - Thailand,2020-12-31,2022-04-07,2022-04-07,OBSERVATIONAL,Not Available,Mahidol University,OTHER,hepatitis
NCT05976594,Unknown,RECRUITING,2023-08-12,Hepatitis E,serology and virology detection of hepatitis E virus,Dongtai - China,2025-07-01,2023-08-04,2023-08-15,OBSERVATIONAL,Not Available,Xiamen University,OTHER,hepatitis
NCT01356160,Unknown,COMPLETED,2011-07,"Hepatitis C, Chronic","GS-5885, GS-9451, peginterferon alfa-2a, ribavirin tablet, GS-9451 Placebo","Tucson - United States, Beverly Hills - United States, Coronado - United States, Costa Mesa - United States, San Diego - United States, Aurora - United States, Englewood - United States, Bradenton - United States, Baltimore - United States, Baltimore - United States, Burlington - United States, Kansas City - United States, Forest Hills - United States, Manhasset - United States, Durham - United States, Cincinnati - United States, Nashville - United States, Arlington - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Herston - Australia, San Juan - Puerto Rico",2013-06,2011-05-19,2014-02-03,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00536627,VAC-ADN,COMPLETED,2008-01,Chronic Hepatitis B,DNA vaccine pCMVS2.S,Paris - France,2010-11,2007-09-28,2011-12-19,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT03149627,HEP-ZED,COMPLETED,2017-06-07,"HBV, Alcoholic Hepatitis, Liver Fibroses",Estimates - prevalence of lifetime/chronic HBV infection,Lusaka - Zambia,2018-12-19,2017-05-11,2019-01-15,OBSERVATIONAL,Not Available,University of Alabama at Birmingham,OTHER,hepatitis
NCT04629976,Unknown,COMPLETED,2021-01-12,Chronic Hepatitis B,"NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg",Monterey Park - United States,2022-09-30,2020-11-16,2023-01-04,INTERVENTIONAL,PHASE1,"Nucorion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT00383227,Unknown,COMPLETED,1999-12,Hepatitis B,Hepatitis B adjuvanted vaccine,No locations listed,2000-11,2006-10-03,2016-09-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00996476,DRAGON,COMPLETED,2009-07,"Hepatitis C, Chronic","TMC435, PegIFNα-2a, RBV","Amagasaki - Japan, Hiroshima N/A - Japan, Kagoshima - Japan, Kawasaki - Japan, Kitakyushu - Japan, Kurume - Japan, Kyoto - Japan, Matsumoto - Japan, Musashino - Japan, Nishinomiya - Japan, Ohmura - Japan, Osaka-Sayama - Japan, Osaka - Japan, Sakai - Japan, Sapporo - Japan, Suita - Japan, Tokyo - Japan, Touon - Japan, Yokohama - Japan",2011-01,2009-10-16,2014-04-17,INTERVENTIONAL,PHASE2,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT02337127,Unknown,UNKNOWN,2011-06,Chronic Hepatitis B,Lamivudine,Kaohsiung - Taiwan,2015-05,2015-01-13,2015-01-13,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT01208376,Unknown,UNKNOWN,2010-10,HIV Infection and Chronic Alanine Aminotransferase Elevation,Fibroscan,Zurich - Switzerland,2018-08,2010-09-23,2016-12-20,OBSERVATIONAL,Not Available,Helen Kovari-Kramer,OTHER,hepatitis
NCT03170076,Unknown,UNKNOWN,2017-07,"Hepatitis C, Chronic",No interventions listed,No locations listed,2018-07,2017-05-30,2017-05-30,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01148576,Unknown,UNKNOWN,2010-06,"Chronic Hepatitis B, Hepatic Steatosis","entecavir, entecavir, essentiale + entecavir, Vitamin E + entecavir",Hangzhou - China,2011-12,2010-06-22,2010-06-22,INTERVENTIONAL,PHASE4,Zhejiang University,OTHER,hepatitis
NCT02601976,EUROP,COMPLETED,2010-08,Hepatitis C,"Peginterferon alfa-2a, Ribavirin",No locations listed,2012-09,2015-11-11,2018-09-27,INTERVENTIONAL,PHASE4,Getz Pharma,INDUSTRY,hepatitis
NCT02783976,Unknown,COMPLETED,2016-10-28,HCV Infection,Sovaldi,"Cuernavaca - Mexico, Durango - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Mexico City - Mexico, Monterrey - Mexico",2018-06-20,2016-05-26,2018-10-02,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03437876,Unknown,UNKNOWN,2016-10-31,"Cirrhosis, Liver",intestinal microbiota transplant,Xiamen - China,2020-11,2018-02-19,2018-02-19,INTERVENTIONAL,NA,Zhongshan Hospital Xiamen University,OTHER,hepatitis
NCT03188276,Unknown,COMPLETED,2016-02-01,Chronic Hepatitis C,"Ledipasvir-Sofosbuvir, Daclatasvir-Sofosbuvir",No locations listed,2017-05-01,2017-06-15,2017-06-15,INTERVENTIONAL,PHASE1,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04371276,Unknown,COMPLETED,2018-09-01,Viral Hepatitis,No intervention,Hong Kong - China,2021-12-31,2020-05-01,2023-02-08,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT00277576,Unknown,COMPLETED,2006-01,Chronic Hepatitis B,ppdpSC18 administered by PMED,"Hong Kong - Hong Kong, Shatin - Hong Kong, Tai Po, N. T. - Hong Kong, Singapore - Singapore, Singapore - Singapore, Taipei - Taiwan, Taoyan - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand",Unknown Date,2006-01-16,2008-11-21,INTERVENTIONAL,PHASE1,PowderMed,INDUSTRY,hepatitis
NCT00117676,Unknown,COMPLETED,2005-02,Chronic Hepatitis B,"TDF, ADV, TDF placebo, ADV placebo, FTC/TDF","La Jolla - United States, Pasadena - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Atlanta - United States, Honolulu - United States, Boston - United States, Ann Arbor - United States, Detroit - United States, St. Louis - United States, Flushing - United States, New York - United States, New York - United States, Falls Church - United States, Richmond - United States, Camperdown - Australia, Concord - Australia, Westmead - Australia, Woolloongabba - Australia, Clayton - Australia, Fitzroy - Australia, Heidelberg - Australia, Prahan - Australia, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Calgary - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Brno - Czech Republic, Hradec Kralove - Czech Republic, Praha 4 - Czech Republic, Praha 6 - Stresovice - Czech Republic, Clichy - France, Creteil - France, Lille - France, Lyon - France, Nancy - France, Paris - France, Strasbourg - France, Toulouse - France, Duesseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Homburg/Saar - Germany, Mainz - Germany, Munchen - Germany, Tubingen - Germany, Athens - Greece, Larissa - Greece, Leipzig - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Bologna - Italy, Torino - Italy, Rotterdam - Netherlands, Auckland - New Zealand, Hamilton - New Zealand, Whakatane - New Zealand, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Krakow - Poland, Warszawa - Poland, Wroclaw - Poland, Majadahonda - Spain, Barcelona - Spain, Valencia - Spain, Bursa - Turkey, Istanbul - Turkey, Istanbul - Turkey, Izmir - Turkey, London - United Kingdom, London - United Kingdom",2007-04,2005-07-08,2017-03-07,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01185860,Unknown,COMPLETED,2009-08,"Hepatitis C, Chronic","danoprevir, peginterferon alfa-2a [Pegasys], placebo, ribavirin, ritonavir","Montpellier - France, Christchurch - New Zealand, Grafton - New Zealand, Warszawa - Poland",2012-01,2010-08-20,2016-11-02,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00877760,ARES,COMPLETED,2009-08,Chronic Hepatitis B,"pegylated interferon a-2a, Entecavir","Shanghai - China, Shanghai - China, Shanghai - China, Amsterdam - Netherlands, Rotterdam - Netherlands, Bydgoszcz - Poland, Wroclaw - Poland, Zawiercie - Poland, Bucharest - Romania, Bucharest - Romania, Ankara - Turkey, Ankara - Turkey, Istanbul - Turkey",2013-07,2009-04-08,2014-03-28,INTERVENTIONAL,PHASE4,Foundation for Liver Research,OTHER,hepatitis
NCT06454760,Unknown,NOT_YET_RECRUITING,2024-09,Risk Factors and Frequency of Acute Idiopathic Hepatitis in Children at Assiut Children Hospital,No interventions listed,No locations listed,2025-09,2024-06-12,2024-06-12,OBSERVATIONAL,Not Available,Youssef Khalifa Fakher Botros,OTHER,hepatitis
NCT05479760,479/65,COMPLETED,2023-08-17,"HCV, HIV",KP-Led HCV test and treat service,"Bangkok - Thailand, Pathum wan - Thailand, Bangkok - Thailand, Chiang Mai - Thailand",2025-02-15,2022-07-29,2025-03-05,INTERVENTIONAL,NA,"Institute of HIV Research and Innovation Foundation, Thailand",OTHER,hepatitis
NCT03106194,CM-HCV,COMPLETED,2016-07,"Drug Abuse, Intravenous",case management,Genk - Belgium,2018-11-30,2017-04-10,2020-01-27,INTERVENTIONAL,NA,Hasselt University,OTHER,hepatitis
NCT02075294,Unknown,COMPLETED,2010-01,"Hepatitis B, Chronic",Adefovir dipivoxil or Entecavir,Beijing - China,2012-10,2014-03-03,2014-10-28,OBSERVATIONAL,Not Available,Ying-Jie Ji,OTHER,hepatitis
NCT02032160,Unknown,COMPLETED,2014-05,Hepatitis B,"Engerix B IM injection - 20ug, Fendrix IM injection - 20ug",Guildford - United Kingdom,2016-02,2014-01-09,2016-02-08,INTERVENTIONAL,NA,University of Surrey,OTHER,hepatitis
NCT00348660,Unknown,COMPLETED,2005-08,"Hepatitis C, Pregnancy",No interventions listed,Toronto - Canada,2010-10,2006-07-04,2019-02-22,OBSERVATIONAL,Not Available,Unity Health Toronto,OTHER,hepatitis
NCT04032860,Unknown,ACTIVE_NOT_RECRUITING,2017-07-01,"HCC, HBV Coinfection","Tenofovir Disoproxil, Entecavir",Chengdu - China,2022-07-01,2019-07-25,2022-05-25,INTERVENTIONAL,PHASE4,West China Hospital,OTHER,hepatitis
NCT03593460,Unknown,WITHDRAWN,2019-01-01,"Hepatitis, Autoimmune",Synthetic PreImplantation Factor,No locations listed,2019-11-01,2018-07-20,2019-01-03,INTERVENTIONAL,PHASE2,"Christopher O'Brien, MD",OTHER,hepatitis
NCT00625560,Unknown,COMPLETED,2008-02,"Hepatitis B, Chronic","Entecavir, Lamivudine","Busan - Korea, Republic of, Seoul - Korea, Republic of",2009-11,2008-02-28,2012-05-08,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT00608192,Unknown,COMPLETED,2008-01,"Hepatitis, Viral, Human, HIV Infections","Testing, Education, & Counseling (TEC), Hepatitis Care Coordination (HCC)","San Francisco - United States, New York - United States",2011-06,2008-02-06,2013-01-16,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,hepatitis
NCT00840489,RIBACIR,TERMINATED,2009-01,Chronic Hepatitis C,"Ribavirin, Colchicine","Madrid - Spain, Madrid - Spain, Madrid - Spain",2012-12,2009-02-10,2013-01-31,INTERVENTIONAL,PHASE2,Hospital Universitario Ramon y Cajal,OTHER,hepatitis
NCT02360592,Unknown,COMPLETED,2013-06,"Hepatitis B, Chronic","Entecavir, Interferon alfa-2b, Interleukin 2, Hepatitis B Vaccine","Hefei - China, Beijing - China, Beijing - China, Beijing - China, Fuzhou - China, Guangzhou - China, Wuhan - China, Changsha - China, Shenyang - China, Shanghai - China, Hangzhou - China, Wenzhou - China",2016-12,2015-02-10,2018-05-09,INTERVENTIONAL,PHASE4,Tongji Hospital,OTHER,hepatitis
NCT01565889,Unknown,COMPLETED,2012-03,"Hepatitis C, HIV","SOF, EFV/FTC/TDF, EFV, ZDV/3TC, ATV, Ritonavir, FTC/TDF, DRV, RAL, PEG, RBV",San Juan - Puerto Rico,2013-08,2012-03-29,2014-10-01,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02877589,HepScreen,COMPLETED,2012-05,Solid Tumor,hepatitis B virus (HBV) and hepatitis C virus (HCV) serologies and a screening questionnaire to detect risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV),Reims - France,2013-07,2016-08-24,2016-08-24,OBSERVATIONAL,Not Available,CHU de Reims,OTHER,hepatitis
NCT00688389,Unknown,UNKNOWN,2007-07,Dengue Fever,case/control,Kaohsiung - Taiwan,2020-12-31,2008-06-02,2019-02-28,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT01628692,Unknown,COMPLETED,2012-07,Hepatitis C Virus,"Daclatasvir, Simeprevir, Ribavirin","San Francisco - United States, San Francisco - United States, Indianapolis - United States, Lutherville - United States, Nashville - United States, Arlington - United States, Fairfax - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Creteil Cedex - France, Limoges - France, Marseille Cedex 08 - France, Paris Cedex 13 - France, Paris Cedex 14 - France, Pessac - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Frankfurt - Germany, Hamburg - Germany, Koeln - Germany, Budapest - Hungary, Budapest - Hungary, Gyula - Hungary, Barcelona - Spain, Madrid - Spain, Valencia - Spain",2013-08,2012-06-27,2017-02-23,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01639092,IN-US-0202,COMPLETED,2012-09-28,Chronic Viral Hepatitis B Without Delta-agent,"Tenofovir, Tenofovir, Entecavir","Seoul - Korea, Republic of",2018-03-29,2012-07-12,2018-05-09,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT01355289,Unknown,COMPLETED,2011-11,Thrombocytopenia,"Avatrombopag, Placebo, Pegylated interferon (PEG-IFN), Telaprevir, Ribavirin","Los Angeles - United States, Fairfax - United States",2014-02,2011-05-18,2018-02-22,INTERVENTIONAL,PHASE2,Eisai Inc.,INDUSTRY,hepatitis
NCT01740089,Unknown,COMPLETED,2011-11,"Hepatitis, Hepatitis C","Algeron, PegIntron, Ribavirin",Moscow - Russian Federation,2012-07,2012-12-04,2015-08-18,INTERVENTIONAL,PHASE3,Biocad,INDUSTRY,hepatitis
NCT03320889,Unknown,COMPLETED,2017-10-30,Hepatitis C,Educational Intervention,Cincinnati - United States,2019-08-26,2017-10-25,2019-08-28,INTERVENTIONAL,NA,TriHealth Inc.,OTHER,hepatitis
NCT00076427,Unknown,COMPLETED,2004-01-14,"Hepatitis C, HIV Infections",No interventions listed,"Washington, D.C. - United States, Washington, D.C. - United States, Washington, D.C. - United States, Bethesda - United States",Unknown Date,2004-01-22,2017-10-06,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01675427,Unknown,COMPLETED,2011-08,"Hepatitis C, Chronic",Interleukin 28B testing,"Alexandria - United States, Buenos Aires - Argentina, Mar del Plata - Argentina, Antwerpen - Belgium, Brugge - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Genk - Belgium, Gent - Belgium, Hasselt - Belgium, Heusy - Belgium, Kortrijk - Belgium, Leuven - Belgium, Liege - Belgium, Oostende - Belgium, Roeselare - Belgium, Santiago - Chile, Santiago - Chile, Cairo - Egypt, Cairo - Egypt, Giza - Egypt, Menoufiya - Egypt, Tanta - Egypt, Kohtla-Järve - Estonia, Pärnu - Estonia, Tallinn - Estonia, Tallinn - Estonia, Tartu - Estonia, Avignon - France, Chateauroux - France, Creteil - France, Lille - France, Lyon - France, Marseille - France, Nice - France, Paris - France, Paris - France, Pessac - France, Rennes - France, Rouen - France, Strasbourg - France, Toulouse - France, Vandoeuvre-les-nancy - France, Aachen - Germany, Berlin - Germany, Berlin - Germany, Burghausen - Germany, Düsseldorf - Germany, Erlangen - Germany, Essen - Germany, Frankfurt an der Oder - Germany, Kassel - Germany, Köln - Germany, Lübeck - Germany, Magdeburg - Germany, Mannheim - Germany, Rostock - Germany, Rottenburg - Germany, Tübingen - Germany, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Ioannina - Greece, Larissa - Greece, Nea Kifissia - Greece, Patra - Greece, Thessaloniki - Greece, Chieti - Italy, Reggio Calabria - Italy, Avellino - Italy, Gragnano - Italy, Marcianise - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Nocera Inferiore - Italy, Nola - Italy, Bologna - Italy, Modena - Italy, Parma - Italy, Piacenza - Italy, Udine - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Genova - Italy, Savona - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Torrette Di Ancona - Italy, Biella - Italy, Cuorgnè (TO) - Italy, Omegna (VB) - Italy, Bari - Italy, Bisceglie - Italy, Castellana Grotte - Italy, San Giovanni Rotondo - Italy, Cagliari - Italy, Cagliari - Italy, Sassari - Italy, Catania - Italy, Catania - Italy, Messina - Italy, Palermo - Italy, Arezzo - Italy, Firenze - Italy, Livorno - Italy, Padova - Italy, Safat - Kuwait, Riga - Latvia, Baabda - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Nabatieh - Lebanon, Tripoli - Lebanon, Kaunas - Lithuania, Kaunas - Lithuania, Klaipeda - Lithuania, Panevezys - Lithuania, Siauliai - Lithuania, Vilnius - Lithuania, Vilnius - Lithuania, Skopje - Macedonia, The Former Yugoslav Republic of, Culiacan - Mexico, Mexico City - Mexico, Mexico City - Mexico, Tijuana - Mexico, Muscat - Oman, Faisalabad - Pakistan, Gujranwala - Pakistan, Karachi - Pakistan, Lahore - Pakistan, Lahore - Pakistan, Rawalpindi - Pakistan, La Victoria, Lima - Peru, Lima - Peru, Almada - Portugal, Amadora - Portugal, Aveiro - Portugal, Faro - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Doha - Qatar, Bucharest - Romania, Bucharest - Romania, Cluj-napoca - Romania, Constanta - Romania, Iasi - Romania, Iasi - Romania, Timisoara - Romania, Timisoara - Romania, Belgrade - Serbia, Novi Sad - Serbia, Banska Bystrica - Slovakia, Bratislava - Slovakia, Bratislava - Slovakia, Bratislava - Slovakia, Martin - Slovakia, Presov - Slovakia, Gävle - Sweden, Karlstad - Sweden, Uppsala - Sweden, Lugano - Switzerland, St. Gallen - Switzerland, Aleppo - Syrian Arab Republic, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Adana - Turkey, Adapazari - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Eskisehir - Turkey, Hatay - Turkey, ISTANBULt - Turkey, Istanbul - Turkey, Izmir - Turkey, Kayseri - Turkey, Mersin - Turkey, Samsun - Turkey, Tokat - Turkey, Trabzon - Turkey, Zonguldak - Turkey, Dubai - United Arab Emirates, Sharjah - United Arab Emirates, Caracas - Venezuela, Caracas - Venezuela, Caracas - Venezuela, Caracas - Venezuela, Maracaibo - Venezuela",2013-10,2012-08-30,2015-08-26,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05613127,Unknown,UNKNOWN,2022-12,"Hepatitis A, Hep A","Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL","Suwon - Korea, Republic of, Chiang Mai - Thailand",2024-07,2022-11-14,2022-11-14,INTERVENTIONAL,PHASE3,"Boryung Biopharma Co., Ltd.",INDUSTRY,hepatitis
NCT01155427,Unknown,COMPLETED,2009-05,"Hepatitis B, Chronic",No interventions listed,No locations listed,2010-04,2010-07-01,2010-07-01,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02581020,Unknown,COMPLETED,2016-01-14,Hepatitis C Virus,No interventions listed,"Nagoya-shi - Japan, Matsuyama-shi - Japan, Fukuoka-shi - Japan, Fukuoka-shi - Japan, Kurume-shi - Japan, Ogaki-shi - Japan, Maebashi-shi - Japan, Takasaki-shi - Japan, Hiroshima-shi - Japan, Hiroshima-shi - Japan, Obihiro-shi - Japan, Sapporo-shi - Japan, Hitachi-shi - Japan, Kanazawa-shi - Japan, Kita-gun - Japan, Yokohama-shi - Japan, Yokohama-shi - Japan, Kumamoto-shi - Japan, Okayama-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Saga-shi - Japan, Iruma-gun - Japan, Hamamatsu-shi - Japan, Shimotsuga-gun - Japan, Shimotsuke-shi - Japan, Bunkyo-ku - Japan, Bunkyo-ku - Japan, Minato-ku - Japan, Minato-ku - Japan, Toyama-shi - Japan, Ube-shi - Japan, Chuo-shi - Japan, Asakura - Japan, Fukui - Japan, Gifu - Japan, Gifu - Japan, Ikeda - Japan, Inashiki - Japan, Inzai - Japan, Kagoshima - Japan, Kawasaki - Japan, Kawasaki - Japan, Matsuyama - Japan, Okayama - Japan, Osaka - Japan, Saitama - Japan, Suita - Japan, Takamatsu - Japan, Tanabe - Japan, Tokyo - Japan, Tokyo - Japan, Yufu-shi - Japan",2020-12-08,2015-10-20,2021-12-08,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT05624086,Unknown,UNKNOWN,2022-10-15,"Hepatitis C, Erectile Dysfunction",exercise,Giza - Egypt,2023-04-15,2022-11-21,2022-11-21,INTERVENTIONAL,NA,Cairo University,OTHER,hepatitis
NCT06491563,Unknown,ACTIVE_NOT_RECRUITING,2024-08-06,For Treatment of Chronic Hepatitis B Virus Infection,"BRII-179, BRII-835 (VIR-2218), PEG-IFNα","Beijing - China, Beijing - China, Xiamen - China, Foshan - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Shanghai - China, Shanghai - China, Chengdu - China, Chengdu - China, Hangzhou - China",2026-12,2024-07-09,2024-12-30,INTERVENTIONAL,PHASE2,Brii Biosciences Limited,INDUSTRY,hepatitis
NCT00286663,Unknown,TERMINATED,2006-01,"Hepatitis, Autoimmune",No interventions listed,No locations listed,Unknown Date,2006-02-03,2008-07-09,OBSERVATIONAL,Not Available,University of Rochester,OTHER,hepatitis
NCT02598063,Unknown,COMPLETED,2005-10,"Hepatitis B, Chronic","Adefovir dipivoxil, Lamivudine, Peginterferon alfa-2a","Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Hangzhou - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Hong Kong - Hong Kong, Hong Kong - Hong Kong",2009-04,2015-11-05,2016-02-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02992457,Unknown,COMPLETED,2015-01,Hepatitis C,"Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a, Simeprevir, Daclatasvir, Ritaprevir, paritaprevir, ombetasvir, Sofosbuvir and Ledipasvir, Salvage therapy","Tanta - Egypt, Tanta - Egypt",2018-12,2016-12-14,2023-08-25,INTERVENTIONAL,PHASE4,Tanta University,OTHER,hepatitis
NCT02349048,ACCORDION-1,COMPLETED,2015-01,Hepatitis C Virus,"Simeprevir 150 mg, Daclatasvir 60 mg, Sofosbuvir 400 mg","Bakersfield - United States, Jacksonville - United States, Lutherville - United States, Winston Salem - United States, Knoxville - United States, Arlington - United States, San Antonio - United States, Toronto - Canada",2016-02,2015-01-28,2017-03-01,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT03931239,Unknown,COMPLETED,2018-03-01,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus Influenzae Type B",Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval,Hung Yen - Vietnam,2018-06-30,2019-04-30,2019-05-03,INTERVENTIONAL,NA,Vabiotech,INDUSTRY,hepatitis
NCT01726439,EVOLVE,COMPLETED,2012-12,Chronic Hepatitis B,No interventions listed,"Beijing - China, Chongqing - China, Chongqing - China, Fuzhou - China, Quanzhou - China, Xiamen - China, Foshan - China, Shenzhen - China, Nanning - China, Guiyang - China, Guiyang - China, Haikou - China, Baoding - China, Shijiazhuang - China, Daqing - China, Haerbin - China, Zhengzhou - China, Zhengzhou - China, Shiyan - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Changsha - China, Erdos - China, Changshu - China, Changzhou - China, Nanjing - China, Suzhou - China, Nangchang - China, Changchun - China, Yanji - China, Dalian - China, Fushun - China, Shengyang - China, Shenyang - China, Yinchuan - China, Jinan - China, Qingdao - China, Yantai - China, Taiyuan - China, Taiyuan - China, Xi'an - China, Xi'an - China, Chengdu - China, Chengdu - China, Tianjin - China, Urumqi - China, Wulumuqi - China, Wulumuqi - China, Hangzhou - China, Hangzhou - China, Hangzhou - China, Jinghua - China, Ningbo - China",2018-12-31,2012-11-15,2020-07-15,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05661786,PILOT,RECRUITING,2022-12,Chronic Hepatitis b,"Observation, Antiviral treatment","Changzhou - China, Huai'an - China, Nanjing - China, Suqian - China, Suzhou - China",2028-02,2022-12-22,2022-12-22,OBSERVATIONAL,Not Available,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,OTHER,hepatitis
NCT00502086,Unknown,COMPLETED,2005-05,"Cirrhosis, Chronic Hepatitis C","Viusid (nutritional supplement), Placebo",Plaza de la Revolución - Cuba,2009-07,2007-07-17,2011-02-11,INTERVENTIONAL,PHASE3,Catalysis SL,INDUSTRY,hepatitis
NCT01587586,Unknown,COMPLETED,2011-10-18,"Hepatitis C, Chronic","PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses, P1101 450µg Q2W, 24 doses","Changhua - Taiwan, Douliu - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Keelung - Taiwan, Linkou - Taiwan, New Taipei City - Taiwan, Sindian City - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2016-11-22,2012-04-30,2021-10-15,INTERVENTIONAL,PHASE2,PharmaEssentia,INDUSTRY,hepatitis
NCT02387463,Unknown,COMPLETED,2012-03,Chronic Hepatitis B,No interventions listed,Beijing - China,2017-05-21,2015-03-13,2017-07-06,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT02878863,Unknown,WITHDRAWN,2016-08,"Hepatitis, Autoimmune","Paeoniflorin + phosphatidylcholine or silymarin, Phosphatidylcholine or silymarin",Chengdu - China,2017-03,2016-08-25,2017-07-13,INTERVENTIONAL,PHASE3,Xiaoli Fan,OTHER,hepatitis
NCT02327663,Unknown,UNKNOWN,2014-12,"Hepatitis B, Chronic",Emtricitabine,No locations listed,2017-06,2014-12-30,2014-12-30,INTERVENTIONAL,PHASE4,"Asian-Pacific Alliance of Liver Disease, Beijing",OTHER,hepatitis
NCT00189163,Unknown,COMPLETED,2005-01,Chronic Hepatitis C,"Pioglitazone, Placebo Oral Tablet",Ann Arbor - United States,2007-12,2005-09-16,2016-12-16,INTERVENTIONAL,PHASE4,University of Michigan,OTHER,hepatitis
NCT02797522,Unknown,TERMINATED,2016-06,Hepatitis B,"ARC-521 Injection, Placebo, antihistamine, acetaminophen, entecavir, tenofovir",Grafton - New Zealand,2016-11,2016-06-13,2018-09-25,INTERVENTIONAL,PHASE1,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT00984139,Unknown,COMPLETED,2009-10-12,Hepatitis B,Engerix™-B Kinder,"Ettenheim - Germany, Kehl - Germany, Mannheim - Germany, Pforzheim - Germany, Schwaebisch-Hall - Germany, Stuttgart - Germany, Tuttlingen - Germany, Bindlach - Germany, Cham - Germany, Gilching - Germany, Kempten - Germany, Kirchheim - Germany, Muenchen - Germany, Muenchen - Germany, Noerdlingen - Germany, Braunatal - Germany, Duisburg - Germany, Muenster - Germany, Frankenthal - Germany, Worms - Germany, Weimar - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany",2010-04-07,2009-09-25,2018-08-20,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05717686,Unknown,COMPLETED,2023-02-28,Chronic Hepatitis B,"AHB-137 injection, Placebo","Redwood City - United States, Baltimore - United States, New York - United States, Houston - United States, Hong Kong - Hong Kong, Grafton - New Zealand, Chiayi City - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan",2025-01-07,2023-02-08,2025-02-14,INTERVENTIONAL,PHASE1,AusperBio Therapeutics Inc.,INDUSTRY,hepatitis
NCT02336139,SIMPLIFY,COMPLETED,2016-03-16,Hepatitis C,Sofosbuvir (SOF)/GS-5816,Sydney - Australia,2017-04-17,2015-01-12,2019-02-27,INTERVENTIONAL,PHASE2,Kirby Institute,OTHER_GOV,hepatitis
NCT00215839,Unknown,UNKNOWN,Unknown Date,"Chronic Hepatitis C Infection in HIV Infected Persons, HIV Infections",Peginterferon a-2a plus Ribavirin,New York - United States,Unknown Date,2005-09-22,2005-10-25,INTERVENTIONAL,PHASE3,Hepatitis Resource Network,OTHER,hepatitis
NCT04234139,Unknown,ENROLLING_BY_INVITATION,2020-04-01,"Liver Diseases, Alcoholic, Alcohol-Related Disorders, Transplant; Failure, Liver, Transplant; Complication, Rejection, Liver Diseases, Hepatitis, Alcoholic, Alcohol-Induced Disorders",liver transplant,Baltimore - United States,2025-12-31,2020-01-21,2024-04-11,OBSERVATIONAL,Not Available,Johns Hopkins University,OTHER,hepatitis
NCT00248339,Unknown,COMPLETED,2002-05,Hepatitis C,"Peginterferon-alpha-2b (PEG-Intron), Ribavirin, Epoetin-alpha (Procrit)",Richmond - United States,2005-07,2005-11-03,2017-03-20,INTERVENTIONAL,PHASE3,Virginia Commonwealth University,OTHER,hepatitis
NCT00625339,Unknown,COMPLETED,2008-02,"Hepatitis B, Chronic","Entecavir, Lamivudine","Busan - Korea, Republic of, Seoul - Korea, Republic of",2010-11,2008-02-28,2012-05-08,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT01436539,Unknown,UNKNOWN,2011-09,Chronic Hepatitis B,"Adefovir Dipivoxil and polyene phosphatidylcholine, Adefovir Dipivoxil",Beijing - China,2013-03,2011-09-19,2011-09-19,INTERVENTIONAL,PHASE4,Jun Cheng,OTHER,hepatitis
NCT01896739,Unknown,COMPLETED,2009-08,Healthy Infants,Eutravac,"Suwon - Korea, Republic of, Daejeon - Korea, Republic of, Incheon - Korea, Republic of, Jeju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2011-11,2013-07-11,2013-07-11,INTERVENTIONAL,PHASE3,LG Life Sciences,INDUSTRY,hepatitis
NCT02615639,CTHBVACADCHB,UNKNOWN,2015-11,Chronic Hepatitis B,"HPDC-T cells & Entecavir, Entecavir, HPDC-T cells & IFN-a-2a, IFN-a-2a, HPDC-T cells & Telbivudine, Telbivudine",No locations listed,2018-11,2015-11-26,2015-11-26,INTERVENTIONAL,PHASE2,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01508286,Unknown,NO_LONGER_AVAILABLE,Unknown Date,Hepatitis C,"Telaprevir + peginterferon alfa + ribavirin, peginterferon alfa + ribavirin, peginterferon alfa + ribavirin","Adelaide - Australia, Bedford - Australia, Box Hill - Australia, Camperdown N/A - Australia, Camperdown - Australia, Central Queensland M C - Australia, Concord - Australia, Darlinghurst - Australia, Fitzroy - Australia, Fremantle - Australia, Greenslopes - Australia, Heidelberg - Australia, Herston - Australia, Kingswood - Australia, Kogarah - Australia, Liverpool - Australia, Melbourne - Australia, New Lambton Heights - Australia, Parkville - Vic - Australia, Parkville - Australia, Perth - Australia, Sydney - Australia, Woolloongabba - Australia, Graz - Austria, Innsbruck - Austria, Linz - Austria, Wels N/A - Austria, Wien - Austria, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Edegem - Belgium, Genk - Belgium, Gent - Belgium, Laken (Brussel) - Belgium, Leuven - Belgium, Liège - Belgium, Pinheiros - Brazil, Porto Alegre - Brazil, Recife - Brazil, Rio De Janeiro - Brazil, Sao Paulo - Brazil, São Paulo - Brazil, Hradec Kralove - Czech Republic, Opava - Czech Republic, Praha 2 - Czech Republic, Praha 4 N/A - Czech Republic, Usti Nad Labem - Czech Republic, Berlin - Germany, Düsseldorf - Germany, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Koln - Germany, Leipzig - Germany, München - Germany, Münster - Germany, Würzburg - Germany, Alexandroupolis - Greece, Athens - Greece, Heraklion Crete - Greece, Ioannina - Greece, Larisa - Greece, Patra - Greece, Thessalonikis - Greece, Thessaloniki - Greece, Budapest - Hungary, Debrecen - Hungary, Gyula - Hungary, Kaposvár - Hungary, Pecs - Hungary, Szeged N/A - Hungary, Székesfehérvár - Hungary, Luxembourg - Luxembourg, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Bucharest - Romania, Bucuresti - Romania, Constanta - Romania, Iasi - Romania, Ploiesti - Romania, Timisoara - Romania, Ekaterinbourg - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Stavropol - Russian Federation, Tyumen - Russian Federation, Belgrade Serbia - Serbia, Belgrade - Serbia, Nis - Serbia, Novi Sad - Serbia, A Coruña - Spain, Alcorcon - Spain, Alicante - Spain, Almeria - Spain, Avila - Spain, Baracaldo - Spain, Barcelona - Spain, Cordoba - Spain, Girona - Spain, Granada - Spain, La Coruÿa N/A - Spain, Leon - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, Malaga - Spain, Málaga - Spain, Oviedo - Spain, Palma De Mallorca - Spain, Pamplona - Spain, Pontevedra - Spain, Sabadell - Spain, San Sebastian, - Spain, Santa Cruz De Tenerife - Spain, Santander - Spain, Sevilla - Spain, Toledo - Spain, Valencia - Spain, Zaragoza - Spain, Basel Bs - Switzerland, Basel - Switzerland, Bern - Switzerland, Geneve 14 - Switzerland, Lausanne - Switzerland, Lugano - Switzerland, St Gallen - Switzerland, Zürich - Switzerland",Unknown Date,2012-01-11,2015-07-24,EXPANDED_ACCESS,Not Available,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT04063839,Prindsen,UNKNOWN,2015-01,"Hepatitis C, Substance Use Disorders",Elbasvir / Grazoprevir Oral Tablet,Lørenskog - Norway,2019-10-31,2019-08-21,2019-08-21,OBSERVATIONAL,Not Available,"University Hospital, Akershus",OTHER,hepatitis
NCT02732639,Unknown,COMPLETED,2005-10,"Hepatitis D, Chronic",Pegylated Interferon (PEG-IFN) alfa-2a,"Bucharest - Romania, Bucharest - Romania, Cluj-napoca - Romania, Constanta - Romania, Craiova - Romania, Iasi - Romania, Timisoara - Romania",2008-12,2016-04-08,2016-08-26,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01994486,STEADFAST,COMPLETED,2013-12,"Hepatitis C, Chronic",Telaprevir and Sofosbuvir,Gainesville - United States,2014-04,2013-11-25,2018-04-23,INTERVENTIONAL,PHASE2,University of Florida,OTHER,hepatitis
NCT01281839,PROMISE,COMPLETED,2011-02,Hepatitis C,"TMC435, Placebo, Peginterferon alpha-2a (PegIFN alpha-2a), Ribavirin (RBV)","Bakersfield - United States, Aurora - United States, Jacksonville - United States, Orlando - United States, Atlanta - United States, Crestview Hills - United States, Saint Paul - United States, Jackson - United States, Germantown - United States, Houston - United States, San Antonio - United States, Adelaide - Australia, Kingswood - Australia, Melbourne - Australia, Sydney - Australia, Woolloongabba N/A - Australia, Wien - Austria, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Brussel - Belgium, Gent - Belgium, Leuven - Belgium, Vancouver - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Creteil N/A - France, Grenoble - France, Lyon - France, Nice N/A - France, Paris Cedex 12 - France, Paris - France, Rennes Cedex - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Halle (Saale) - Germany, Hamburg - Germany, Kiel - Germany, Leipzig - Germany, Munchen - Germany, Würzburg - Germany, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Bialystok - Poland, Bydgoszcz - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Warszawa - Poland, Ponce Pr - Puerto Rico, San Juan - Puerto Rico, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain, Birmingham - United Kingdom, Derby - United Kingdom, Glasgow - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2013-02,2011-01-24,2014-04-23,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT03564639,Unknown,COMPLETED,2019-10-01,Hepatitis C,No interventions listed,Nairobi - Kenya,2021-02-01,2018-06-21,2021-04-20,OBSERVATIONAL,Not Available,Yale University,OTHER,hepatitis
NCT03429439,CHB,UNKNOWN,2017-12-29,Chronic Hepatitis b,"intestinal microbiota transplant, Antiviral Agents",Xiamen - China,2020-10,2018-02-12,2018-02-12,INTERVENTIONAL,NA,Zhongshan Hospital Xiamen University,OTHER,hepatitis
NCT02161939,Unknown,NO_LONGER_AVAILABLE,Unknown Date,Chronic Hepatitis C,"Daclatasvir (BMS-790052), Sofosbuvir","Phoenix - United States, Los Angeles - United States, New Haven - United States, Gainesville - United States, Atlanta - United States, Indianapolis - United States, New Orleans - United States, Baltimore - United States, Boston - United States, Worchester - United States, Detroit - United States, Bronx - United States, New York - United States, New York - United States, Chapel Hill - United States, Charlotte - United States, Philadephia - United States, Houston - United States, Richmond - United States, Seattle - United States",Unknown Date,2014-06-12,2016-01-29,EXPANDED_ACCESS,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03036839,ESRD,COMPLETED,2017-06-27,Hepatitis C Virus Infection,LDV/SOF,"Boston - United States, Detroit - United States, Bronx - United States, Dallas - United States, San Antonio - United States, Seattle - United States, Brussels - Belgium, Brussels - Belgium, Frankfurt - Germany, Hamburg - Germany, Hamburg - Germany, Leipzig - Germany, San Giovanni Rotondo - Italy, Antella - Italy, Milan - Italy, Torino - Italy, Changhua - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan",2018-11-22,2017-01-30,2020-03-02,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00517439,Unknown,COMPLETED,2007-12,"Hepatitis C, Chronic","Copegus, Pegasys, Pegasys, RO4588161, RO4588161, RO4588161","Phoenix - United States, La Jolla - United States, Long Beach - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Englewood - United States, Bradenton - United States, Gainesville - United States, Miami - United States, Chicago - United States, Baltimore - United States, Plymouth - United States, Bronx - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Portland - United States, Hershey - United States, Providence - United States, Nashville - United States, Dallas - United States, Fort Sam Houston - United States, San Antonio - United States, Salt Lake City - United States, Fairfax - United States, Richmond - United States, Adelaide - Australia, Greenslopes - Australia, Melbourne - Australia, Sydney - Australia, Sydney - Australia, Wien - Austria, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Ottawa - Canada, Toronto - Canada, Clichy - France, Creteil - France, Marseille - France, Paris - France, Paris - France, Pessac - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Köln - Germany, Bologna - Italy, Napoli - Italy, Torino - Italy, Santurce - Puerto Rico, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain",2010-01,2007-08-17,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01758939,Unknown,UNKNOWN,2011-01,"Hepatitis C, Chronic",No interventions listed,Cairo - Egypt,2016-01,2013-01-01,2013-04-17,OBSERVATIONAL,Not Available,Cairo University,OTHER,hepatitis
NCT02226939,Unknown,COMPLETED,2002-09,"Liver Cirrhosis, Hepatitis C, Chronic","BILN 2061 ZW, Placebo",No locations listed,2002-11,2014-08-27,2014-08-27,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00436163,Unknown,COMPLETED,2007-03,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Tallinn - Estonia, Tallinn - Estonia, Tartu - Estonia, Riga - Latvia, Kaunas - Lithuania, Kaunas - Lithuania, Klaipeda - Lithuania, Vilnius - Lithuania, Vilnius - Lithuania",2010-05,2007-02-16,2016-10-24,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05929963,Unknown,ENROLLING_BY_INVITATION,2023-05-09,"Hepacivirus, Pregnancy",HCV infection status,Beijing - China,2024-02-20,2023-07-05,2023-07-05,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT04820686,Unknown,TERMINATED,2021-05-07,Chronic Hepatitis B,"VBR, AB-729, SOC NrtI","Darlinghurst - Australia, Kogarah - Australia, Liverpool - Australia, Westmead - Australia, Footscray - Australia, Melbourne - Australia, Parkville - Australia, Nedlands - Australia, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Vancouver - Canada, Vancouver - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Québec - Canada, Auckland - New Zealand, Wellington - New Zealand",2023-03-30,2021-03-29,2023-11-14,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT02791386,NAs resistance,COMPLETED,2016-11-22,Hepatitis B,No interventions listed,Changsha - China,2017-10-30,2016-06-06,2017-11-14,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00412763,Unknown,COMPLETED,2003-07,Hepatitis,Silymarin (Silybum marianum),No locations listed,Unknown Date,2006-12-18,2021-04-23,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,hepatitis
NCT01821963,Unknown,TERMINATED,2013-04,Infection,"Pegylated Interferon Alfa 2a, Ribavirin, Telaprevir",Houston - United States,2014-02,2013-04-01,2020-09-24,INTERVENTIONAL,PHASE3,M.D. Anderson Cancer Center,OTHER,hepatitis
NCT00097435,Unknown,COMPLETED,2004-10,Hepatitis C,"Albuferon, Ribavirin","Phoenix - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Baltimore - United States, Rochester - United States, Durham - United States, Fairfax - United States",2007-08,2004-11-24,2013-08-02,INTERVENTIONAL,PHASE2,Human Genome Sciences Inc.,INDUSTRY,hepatitis
NCT02309086,Unknown,TERMINATED,2011-05,"Hepatitis C, Chronic",Autologous dendritic cells transduced with Ad encoding NS3,No locations listed,2013-05,2014-12-05,2017-10-24,INTERVENTIONAL,PHASE2,"Clinica Universidad de Navarra, Universidad de Navarra",OTHER,hepatitis
NCT04353986,Unknown,UNKNOWN,2018-06-11,"HCV Infection, Beta Thalassemia Major",Sofosbuvir and Ledipasvir,Cairo - Egypt,2023-04,2020-04-21,2023-03-06,INTERVENTIONAL,PHASE3,Ain Shams University,OTHER,hepatitis
NCT01065363,Unknown,UNKNOWN,2009-08,Chronic Hepatitis B,standardized exercise program and dietary counseling,Taipei - Taiwan,2010-07,2010-02-09,2010-02-09,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT02908763,Unknown,UNKNOWN,2016-08,Chronic Hepatitis B,peginterferon alfa,Guangzhou - China,2019-09,2016-09-21,2018-05-22,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00952263,MBL-HCV1,COMPLETED,2009-07,Healthy,MBL-HCV1,Minneapolis - United States,2009-12,2009-08-06,2016-09-15,INTERVENTIONAL,PHASE1,MassBiologics,OTHER,hepatitis
NCT04485663,Unknown,TERMINATED,2020-08-17,Chronic Hepatitis B,"ALG-010133, Placebo","Guangzhou - China, Changchun - China, Hong Kong - Hong Kong, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Chisinau - Moldova, Republic of, Auckland - New Zealand, London - United Kingdom",2022-03-08,2020-07-24,2022-03-15,INTERVENTIONAL,PHASE1,Aligos Therapeutics,INDUSTRY,hepatitis
NCT00148863,Unknown,COMPLETED,2004-06,"Hepatitis C, Chronic","Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug)","Pessac - France, Pessac - France",Unknown Date,2005-09-08,2007-08-30,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00033163,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis B","Adefovir dipivoxil, Tenofovir disoproxil fumarate","Sacramento - United States, Sacramento - United States, San Francisco - United States, Aurora - United States, Chicago - United States, Chicago - United States, Baltimore - United States, New York - United States, New York - United States, New York - United States, New York - United States, Cincinnati - United States, Cleveland - United States, Nashville - United States, Seattle - United States",Unknown Date,2002-04-09,2021-11-01,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00108563,Unknown,COMPLETED,2003-10,"Hepatitis C, Depression",Citalopram or Placebo,Portland - United States,Unknown Date,2005-04-18,2009-01-21,INTERVENTIONAL,PHASE4,US Department of Veterans Affairs,FED,hepatitis
NCT00246363,Unknown,COMPLETED,2005-01,"HIV Infections, Hepatitis C","Silymarin, Placebo",New York - United States,2007-12,2005-10-30,2011-09-15,INTERVENTIONAL,PHASE2,Henry Sacks,OTHER,hepatitis
NCT05182463,Unknown,RECRUITING,2022-01-08,"Hepatitis B, Chronic","Peginterferon Alfa-2B, Nucleoside Analogs",Guangzhou - China,2026-12-13,2022-01-10,2022-04-05,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02068963,Unknown,COMPLETED,2014-02,Hepatitis C,No interventions listed,"North Little Rock - United States, Bakersfield - United States, Rialto - United States, San Francisco - United States, Upland - United States, Ventura - United States, Englewood - United States, New Haven - United States, Miami - United States, Atlanta - United States, Marietta - United States, Indianapolis - United States, Annapolis - United States, Baltimore - United States, Brockton - United States, Springfield - United States, Kansas City - United States, Asheville - United States, Durham - United States, Fayetteville - United States, Tulsa - United States, Charleston - United States, Nashville - United States, Nashville - United States, Austin - United States, Austin - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, Lynchburg - United States, Norfolk - United States, Seattle - United States, San Juan - Puerto Rico",2015-04,2014-02-21,2016-02-04,OBSERVATIONAL,Not Available,"Hologic, Inc.",INDUSTRY,hepatitis
NCT06058286,MENJAGA,NOT_YET_RECRUITING,2023-10-01,"Hiv, Syphilis, Hepatitis B",Continuous quality improvement,Bandung City And Bogor District - Indonesia,2024-10-31,2023-09-28,2023-09-28,INTERVENTIONAL,NA,"Yanri Wijayanti Subronto, MD, PhD,",OTHER,hepatitis
NCT00606086,Unknown,COMPLETED,2007-12,Genotype 1 Chronic Hepatitis C,"GI-5005, Pegylated Interferon and Ribavirin","Birmingham - United States, Tucson - United States, La Jolla - United States, San Diego - United States, Aurora - United States, Englewood - United States, Farmingtom - United States, New Haven - United States, Marietta - United States, Honolulu - United States, Valparaiso - United States, New Orleans - United States, Laurel - United States, Detroit - United States, Rochester - United States, Jackson - United States, St. Louis - United States, New York - United States, New York - United States, Durham - United States, Dallas - United States, Houston - United States, San Antonio - United States, Newport News - United States, Richmond - United States",2012-11,2008-02-01,2014-06-27,INTERVENTIONAL,PHASE2,GlobeImmune,INDUSTRY,hepatitis
NCT00693186,Unknown,COMPLETED,2008-10,Hepatitis B,"HBVaxPRO® 5 µg / 0.5 mL, Engerix B® 10 µg / 0.5 mL","Quarto - Italy, Latisana - Italy, Modica - Italy, Ragusa - Italy, Sassari - Italy",2009-12,2008-06-06,2017-09-11,INTERVENTIONAL,PHASE3,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT03276039,Unknown,COMPLETED,2014-04-15,Non Alcoholic Fatty Liver Disease,plasma pentraxin-3,No locations listed,2016-04-15,2017-09-08,2017-09-08,OBSERVATIONAL,Not Available,Ain Shams University,OTHER,hepatitis
NCT01292239,Unknown,COMPLETED,2011-02,"Hepatitis C, Chronic","Placebo, TMC435, Peginterferon alfa-2a (pegIFN alfa-2a), Ribavirin (RBV)","Amagasaki - Japan, Chiba - Japan, Chuo - Japan, Hiroshima - Japan, Ichikawa - Japan, Ikeda - Japan, Inashiki - Japan, Iruma - Japan, Kagoshima - Japan, Kanazawa - Japan, Kitakyushu - Japan, Kumamoto - Japan, Kurume - Japan, Kyoto - Japan, Matsumoto - Japan, Musashino - Japan, Nagoya - Japan, Niigata - Japan, Nishinomiya - Japan, Ohmura - Japan, Osaka-Sayama - Japan, Osaka - Japan, Sakai - Japan, Sapporo - Japan, Sendai - Japan, Tokyo - Japan, Touon - Japan, Yokohama - Japan",2012-10,2011-02-09,2014-01-17,INTERVENTIONAL,PHASE3,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT04439539,Unknown,COMPLETED,2020-09-14,"Hepatitis B, Chronic","JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil, Tenofovir alafenamide, JNJ-56136379","Los Angeles - United States, Pittsburgh - United States, Seattle - United States, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Clichy - France, Grenoble - France, Lyon - France, Nantes - France, Paris - France, Rennes - France, Vandoeuvre les Nancy - France, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hannover - Germany, Hiroshima shi - Japan, Kashihara - Japan, Musashino - Japan, Nagoya - Japan, Yokohama - Japan, Irkutsk - Russian Federation, Kazan - Russian Federation, Saint Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Barcelona - Spain, Valencia - Spain, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Ankara - Turkey, Istanbul - Turkey, Istanbul - Turkey, Izmir - Turkey, Kucukcekmece - Turkey, Trabzon - Turkey, Glasgow - United Kingdom, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom",2023-08-29,2020-06-19,2025-03-03,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT03209986,Unknown,UNKNOWN,2017-11-08,Liver Cirrhosis,"mesenchymal stem cell transplantation via peripheral vein, mesenchymal stem cell",Xi'an - China,2019-06-30,2017-07-06,2018-09-11,INTERVENTIONAL,NA,Xijing Hospital of Digestive Diseases,OTHER,hepatitis
NCT00217139,Unknown,COMPLETED,2005-09,"Hepatitis C, Chronic",Celgosivir,"Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Halifax - Canada, London - Canada",Unknown Date,2005-09-22,2006-09-29,INTERVENTIONAL,PHASE2,BioWest Therapeutics Inc,INDUSTRY,hepatitis
NCT02804386,HEATS,COMPLETED,2016-06,"Hepatitis C, Chronic",Sofosbuvir,Karachi - Pakistan,2017-12-31,2016-06-17,2018-09-17,INTERVENTIONAL,PHASE4,PharmEvo Pvt Ltd,INDUSTRY,hepatitis
NCT02082639,Unknown,WITHDRAWN,2015-02,"Infections, Papillomavirus","Cervarix™, Havrix",No locations listed,2015-08,2014-03-10,2015-07-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06744686,Unknown,COMPLETED,2023-06-12,Chronic Hepatitis B,"HT-102, HT-102, Placebo","Fuzhou - China, Qingyuan - China, Luoyang - China, Zhengzhou - China, Jinan - China, Shanghai - China, Hangzhou - China",2024-03-12,2024-12-20,2024-12-20,INTERVENTIONAL,PHASE1,"Suzhou HepaThera Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT00418639,Unknown,COMPLETED,2005-02,Chronic Hepatitis C,Nitazoxanide,"Alexandria - Egypt, Cairo - Egypt, Tanta - Egypt",Unknown Date,2007-01-05,2007-01-05,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT00240539,Unknown,COMPLETED,2003-10,Hepatitis B,Blood sampling,Bangkok - Thailand,2008-07,2005-10-18,2016-12-08,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03982186,REEF-1,COMPLETED,2019-08-01,"Hepatitis B, Chronic","JNJ-73763989, Placebo for JNJ-73763989, JNJ-56136379, Placebo for JNJ-56136379, Nucleos(t)ide Analog (NA)","Bakersfield - United States, Los Angeles - United States, San Clemente - United States, Washington - United States, Baltimore - United States, Saint Louis - United States, Hillsborough - United States, New York - United States, Bruxelles - Belgium, Edegem - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Manaus - Brazil, Salvador - Brazil, Sao Paulo - Brazil, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Guangzhou - China, Hradec Kralove - Czechia, Plzen - Czechia, Praha 2 - Czechia, Praha - Czechia, Clichy - France, Grenoble - France, Lyon - France, Marseille - France, Nantes - France, Paris - France, Rennes - France, Villejuif - France, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, Mainz - Germany, Hong Kong - Hong Kong, Shatin - Hong Kong, Messina - Italy, Milano - Italy, Modena - Italy, Pisa - Italy, Rome - Italy, Bunkyo Ku - Japan, Chiba - Japan, Fukui City - Japan, Fukuyama - Japan, Hiroshima shi - Japan, Kagawa - Japan, Kashihara - Japan, Musashino - Japan, Nagasaki - Japan, Nagoya - Japan, Nishinomiya - Japan, Sapporo-shi - Japan, Suita-shi - Japan, Tokyo - Japan, Toyoake - Japan, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Alor Setar - Malaysia, Batu Caves - Malaysia, Kota Bharu - Malaysia, Kuala Lumpur - Malaysia, Bydgoszcz - Poland, Gdansk - Poland, Myslowice - Poland, Warszawa - Poland, Wroclaw - Poland, Chelyabinsk - Russian Federation, Ekaterinburg - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Santander - Spain, Valencia - Spain, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Songkla - Thailand, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Istanbul - Turkey, Izmir - Turkey, Trabzon - Turkey, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2021-03-29,2019-06-11,2025-02-04,INTERVENTIONAL,PHASE2,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT00565539,Unknown,COMPLETED,2007-12,"Hepatitis C, Chronic",PEGylated recombinant interleukin 29 (PEG-rIL-29),"Chicago - United States, Detroit - United States, Rochester - United States, Newark - United States, Durham - United States, Portland - United States, Houston - United States, Houston - United States, San Antonio - United States, Richmond - United States, London - Canada",2009-10,2007-11-30,2009-10-07,INTERVENTIONAL,PHASE1,ZymoGenetics,INDUSTRY,hepatitis
NCT02556086,Unknown,WITHDRAWN,2015-12,Hepatitis C,"Daclatasvir, Sofosbuvir","Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Regina - Canada, Quebec - Canada, Marseille - France, Nantes - France, Nice Cedex - France, Paris Cedex 14 - France, Paris Cedex 18 - France, Paris - France, Paris - France, Paris - France, Pessac - France",2016-06,2015-09-22,2016-01-20,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05839639,Unknown,COMPLETED,2021-10-09,Chronic Hepatitis B,"NrtIs, HH-003, HH-003+NrtIs",Guangzhou - China,2022-12-05,2023-05-03,2023-09-28,INTERVENTIONAL,PHASE2,Huahui Health,INDUSTRY,hepatitis
NCT02658786,Unknown,WITHDRAWN,2016-01,"HBV, NAFLD, HCV",No interventions listed,New Delhi - India,2020-12,2016-01-20,2019-10-09,OBSERVATIONAL,Not Available,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT01900886,Perseo,UNKNOWN,2010-12,"Hepatitis C, Chronic, Personality Disorders in Prison","Peginterferon alfa-2a, Ribavirin","Jerez de la Frontera - Spain, Albolote - Spain, Las Palmas de Gran Canaria - Spain, Santa Cruz de Tenerife - Spain, Ocaña - Spain, Almeria - Spain, Badajoz - Spain, Cordoba - Spain, Jaen - Spain, Salamanca - Spain, Sevilla - Spain",2013-06,2013-07-17,2013-07-17,OBSERVATIONAL,Not Available,Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria,OTHER,hepatitis
NCT02874586,Unknown,UNKNOWN,2016-12,"Hepatitis, Autoimmune",Plasma exchange combination of immunosuppressive regimens,Chengdu - China,2021-04,2016-08-22,2020-11-10,INTERVENTIONAL,NA,Xiaoli Fan,OTHER,hepatitis
NCT01979939,Unknown,COMPLETED,2013-12,Hepatitis C,DCV/ASV/BMS-791325,"La Jolla - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Jacksonville - United States, Orlando - United States, South Miami - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Catonsville - United States, Lutherville - United States, Novi - United States, Kansas City - United States, Kansas City - United States, Saint Louis - United States, Vineland - United States, Binghamton - United States, Bronx - United States, New York - United States, Poughkeepsie - United States, Asheville - United States, Durham - United States, Statesville - United States, Wilmington - United States, Winston-salem - United States, Cleveland - United States, Tulsa - United States, Tulsa - United States, Allentown - United States, Philadelphia - United States, Pittsburg - United States, Providence - United States, Nashville - United States, Fort Sam Houston - United States, Houston - United States, San Antonio - United States, Alexandria - United States, Falls Church - United States, Newport News - United States, Norfolk - United States, Madison - United States, Darlinghurst - Australia, Greenslopes - Australia, Adelaide - Australia, Fitzroy - Australia, Heidelberg - Australia, Fremantle - Australia, Clayton - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Hamilton - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Clichy - France, Limoges Cedex - France, Montpellier - France, Paris Cedex 14 - France, Pessac - France, Vandoeuvre Les Nancy - France, San Juan - Puerto Rico",2014-08,2013-11-08,2015-11-03,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00670839,B-BOOST,COMPLETED,2008-05,"Hepatitis B, HIV Infection","GenHevac-B, GenHevac-B",Strasbourg - France,2011-12,2008-05-02,2013-08-12,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT04638439,Unknown,RECRUITING,2022-08-17,"Chronic Hepatitis B Infection, Chronic Hepatitis D Infection",P1101 + Nivolumab + Entecavir,"Chia-Yi City - Taiwan, Taipei City - Taiwan, Taipei city - Taiwan, Taipei city - Taiwan, Taoyuan city - Taiwan",2025-12,2020-11-20,2025-01-13,INTERVENTIONAL,PHASE1,PharmaEssentia,INDUSTRY,hepatitis
NCT00993122,RBV,COMPLETED,2009-10,Hepatitis C,ribavirin pre-treatment,Rome - Italy,2010-04,2009-10-12,2015-06-22,INTERVENTIONAL,PHASE4,University of Roma La Sapienza,OTHER,hepatitis
NCT00023322,Unknown,COMPLETED,2001-08,Hepatitis D,Peginterferon Alpha-2a,Bethesda - United States,2012-05,2001-09-03,2013-07-10,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00139139,Unknown,COMPLETED,2003-09,Hepatitis A,Hepatitis A vaccine,Almaty - Kazakhstan,Unknown Date,2005-08-31,2022-01-13,INTERVENTIONAL,NA,Centers for Disease Control and Prevention,FED,hepatitis
NCT02103439,Unknown,COMPLETED,2013-06-06,"Hepatitis, Hepatitis C, Hepatitis C/ Human Immunodeficiency Virus Coinfection","Algeron, PegIntron","Kazan - Russian Federation, Nizhny Novgorod - Russian Federation, Sankt-Petersburg - Russian Federation, Saratov - Russian Federation, Vladivostok - Russian Federation, Volgograd - Russian Federation",2015-08-26,2014-04-03,2018-08-09,INTERVENTIONAL,PHASE3,Biocad,INDUSTRY,hepatitis
NCT00005339,Unknown,COMPLETED,1992-02,"Hepatitis, Viral, Human, Blood Transfusion, Blood Donors",No interventions listed,No locations listed,Unknown Date,2000-05-26,2016-02-18,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT04382339,HCV,COMPLETED,2015-03,Hepatitis C Virus Infection,SOF/RBV/PegINFα-2,No locations listed,2015-11,2020-05-11,2020-05-11,INTERVENTIONAL,PHASE2,Beni-Suef University,OTHER,hepatitis
NCT02967939,Unknown,COMPLETED,2017-03-28,Hepatitis B， Chronic,"DA-2802, Viread®","Seoul - Korea, Republic of",2019-01-23,2016-11-18,2021-04-14,INTERVENTIONAL,PHASE3,"Dong-A ST Co., Ltd.",INDUSTRY,hepatitis
NCT03489239,Unknown,ACTIVE_NOT_RECRUITING,2017-11-16,Hepatitis B,Tenofovir Alafenamide,Philadelphia - United States,2020-08-15,2018-04-05,2020-06-25,INTERVENTIONAL,PHASE3,Thomas Jefferson University,OTHER,hepatitis
NCT03819322,Unknown,ACTIVE_NOT_RECRUITING,2019-08-15,"Liver Transplant, Hepatitis C",sofosbuvir/velpatasvir,Pittsburgh - United States,2025-03-17,2019-01-28,2024-10-18,INTERVENTIONAL,PHASE2,Naudia Jonassaint. MD,OTHER,hepatitis
NCT01745822,iTAP,COMPLETED,2013-01,"Hepatitis B Chronic Infection, Pregnancy","tenofovir disoproxil fumarate, placebo","Mae Chan - Thailand, Bang Lamung - Thailand, Nakhon Ratchasima - Thailand, Chiang Kham - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chanthaburi - Thailand, Chiang Mai - Thailand, Chiang Mai - Thailand, Chiang Rai - Thailand, Chon Buri - Thailand, Khon Kaen - Thailand, Lampang - Thailand, Lamphun - Thailand, Phayao - Thailand, Samut Prakan - Thailand, Samut Sakhon - Thailand",2016-12,2012-12-10,2021-03-05,INTERVENTIONAL,PHASE3,Institut de Recherche pour le Developpement,OTHER_GOV,hepatitis
NCT06707922,Unknown,ENROLLING_BY_INVITATION,2022-03-18,Chronic Hepatitis B,Peginterferon α-2b Injection; Tenofovir Alafenamide Fumarate,"Beijing - China, Beijing - China, Beijing - China, Changsha - China, Changsha - China, Chengdu - China, Chengdu - China, Fuzhou - China, Fuzhou - China, Guangzhou - China, Guanzhou - China, Harbin - China, Hefei - China, Shanghai - China, Shanghai - China, Shenyang - China, Shenzhen - China, Shenzhen - China, Taiyuan - China, Tianjin - China, Tianjin - China, Urumqi - China, Urumqi - China, Wuhan - China, Xi'an - China, Xi'an - China, Xiamen - China, Xiamen - China, Yanji - China, Zhengzhou - China",2029-05-31,2024-11-27,2024-12-04,INTERVENTIONAL,NA,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT00553930,SAEI_IFN_1,COMPLETED,2007-11,"Hepatitis C, Chronic, HIV Infections","Pegylated interferon alfa-2a and Ribavirin, Pegylated interferon alfa 2a and Ribavirin",Sevilla - Spain,2010-05,2007-11-06,2010-05-18,INTERVENTIONAL,PHASE4,Sociedad Andaluza de Enfermedades Infecciosas,NETWORK,hepatitis
NCT00724230,Unknown,COMPLETED,2006-02,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2008-12,2008-07-29,2015-02-03,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01033448,Unknown,COMPLETED,2009-12,"Hepatitis C, Chronic","COPEGUS, peginterferon alfa-2a [Pegasys]","Afula - Israel, Ashdod - Israel, Bat Yam - Israel, Beer Sheva - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Holon - Israel, Jerusalem - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Nazareth - Israel, Petach Tikva - Israel, Rehovot - Israel, Rishon Lezion - Israel, Safed - Israel, Tel Aviv - Israel, Tiberias - Israel, Zerifin - Israel",2013-06,2009-12-16,2017-10-03,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00275548,Unknown,COMPLETED,2004-07,"Liver Transplant, Hepatitis C","Pegasys, Copegus",Rochester - United States,2007-06,2006-01-12,2011-11-11,INTERVENTIONAL,PHASE4,Mayo Clinic,OTHER,hepatitis
NCT02936648,HCVCBOC,COMPLETED,2015-10,Hepatitis C,quality improvement intervention,Bedford - United States,2016-09,2016-10-18,2018-11-20,INTERVENTIONAL,NA,VA Office of Research and Development,FED,hepatitis
NCT02510248,Unknown,TERMINATED,2015-07-31,Chronic Hepatitits C,"AL-704, Placebo","Rennes - France, Tbilisi - Georgia, Chisinau - Moldova, Republic of",2015-11-24,2015-07-29,2017-11-08,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT06364930,Unknown,RECRUITING,2024-03-26,Chronic Hepatitis B,"Dapagliflozin 10mg Tab, Placebo 10mg Tab",Hong Kong - Hong Kong,2030-10-31,2024-04-15,2024-08-28,INTERVENTIONAL,PHASE4,Chinese University of Hong Kong,OTHER,hepatitis
NCT01508130,Unknown,COMPLETED,2012-01-31,"Hepatitis C, Chronic",No interventions listed,"Birmingham - United States, Birmingham - United States, Little Rock - United States, Loma Linda - United States, Pasadena - United States, San Diego - United States, San Diego - United States, Torrance - United States, Aurora - United States, Torrington - United States, Daytona Beach - United States, Largo - United States, Maitland - United States, Orlando - United States, Orlando - United States, Tampa - United States, Decatur - United States, Decatur - United States, Macon - United States, Chicago - United States, Indianapolis - United States, Crestview Hills - United States, Baton Rouge - United States, Metairie - United States, New Orleans - United States, Baltimore - United States, Brockton - United States, Springfield - United States, Worcester - United States, Detroit - United States, Wyoming - United States, Rochester - United States, Kansas City - United States, Kansas City - United States, St. Louis - United States, Lebanon - United States, Haddon Heights - United States, Morristown - United States, Twp - United States, Bronx - United States, Brooklyn - United States, Catskill - United States, Flushing - United States, Manhasset - United States, New York - United States, Rochester - United States, Asheville - United States, Durham - United States, Rocky Mount - United States, Oklahoma City - United States, Bend - United States, DuBois - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Memphis - United States, Austin - United States, Dallas - United States, Galveston - United States, Houston - United States, Houston - United States, Houston - United States, Burlington - United States, Charlottesville - United States, Fairfax - United States, San Juan - Puerto Rico",2014-03-31,2012-01-11,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03854630,Unknown,UNKNOWN,2017-09-06,"Viral Hepatitis B, Immunization; Infection, HIV Infections",Engerix-B,Taipei - Taiwan,2023-06-01,2019-02-26,2020-05-22,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT06871930,Unknown,NOT_YET_RECRUITING,2025-04-01,Hepatocellular Carcinoma (HCC),No interventions listed,No locations listed,2026-04-01,2025-03-12,2025-03-12,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT04065230,Unknown,UNKNOWN,2019-08,"Hepatitis B Virus, Mother to Child Transmission",Tenofovir Alafenamide Fumarate tablets,Nanjing - China,2021-08,2019-08-22,2019-08-22,OBSERVATIONAL,Not Available,"Southeast University, China",OTHER,hepatitis
NCT01707030,Unknown,COMPLETED,2015-03-01,"Hepatitis C, Alcohol Abuse","Web-Based Brief Alcohol Intervention, Usual Care","Palo Alto - United States, San Francisco - United States",2018-06-29,2012-10-15,2020-06-09,INTERVENTIONAL,NA,VA Office of Research and Development,FED,hepatitis
NCT01907230,Unknown,UNKNOWN,2013-09-10,"Rheumatoid Arthritis, Hepatitis B Reactivation, Exposure to Hepatitis B Virus",Entecavir,Taipei - Taiwan,2018-12-31,2013-07-24,2019-03-13,INTERVENTIONAL,PHASE4,"Taipei Veterans General Hospital, Taiwan",OTHER_GOV,hepatitis
NCT05006430,Unknown,RECRUITING,2023-01-21,Alcoholic Hepatitis,"Fecal Microbiota Transplantation, Placebo",Houston - United States,2025-06-30,2021-08-16,2025-01-23,INTERVENTIONAL,PHASE2,Prasun Kumar Jalal,OTHER,hepatitis
NCT03231930,Unknown,COMPLETED,2017-06-29,Hepatitis C,"OraQuick HCV Ab test, Xpert HCV viral load test","Collingwood - Australia, Footscray - Australia, Richmond - Australia",2017-11-01,2017-07-27,2019-07-15,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT01847430,Unknown,COMPLETED,2013-07-19,Hepatitis B,Engerix™-B Kinder,"Kehl - Germany, Tuttlingen - Germany, Bindlach - Germany, Kirchheim - Germany, Goch - Germany, Frankenthal - Germany, Leipzig - Germany, Flensburg - Germany, Berlin - Germany, Neumuenster - Germany",2014-02-21,2013-05-06,2018-08-20,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01821625,SQUELCH-C,TERMINATED,2013-04,"Thrombocytopenia, Hepatitis C",Eltrombopag,Dallas - United States,2015-04,2013-04-01,2019-11-13,INTERVENTIONAL,PHASE3,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT00980330,ASPIRE,COMPLETED,2009-10,Hepatitis C,"TMC435, Placebo, Peg-IFN-alfa-2a (P), Ribavirin (R)","La Jolla - United States, Los Angeles - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Palm Harbor - United States, Chicago - United States, New Orleans - United States, Laurel - United States, Jackson - United States, Tupelo - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Germantown - United States, Nashville - United States, San Antonio - United States, Concord - Australia, Darlinghurst - Australia, Fitzroy - Australia, Melbourne - Australia, New Lambton Heights - Australia, Parkville - Australia, Sydney - Australia, Woolloongabba N/A - Australia, Wien - Austria, Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Roeselare - Belgium, Calgary - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Creteil N/A - France, Grenoble - France, Lyon - France, Nice - France, Paris Cedex 12 - France, Paris - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Frankfurt A. M. - Germany, Freiburg - Germany, Hannover - Germany, Köln - Germany, Stuttgart - Germany, Würzburg - Germany, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petah Tiqva - Israel, Ramat-Gan - Israel, Tel-Aviv - Israel, Zefat - Israel, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Nordbyhagen - Norway, Oslo - Norway, Tromsø - Norway, Bialystok - Poland, Bydgoszcz - Poland, Czeladz - Poland, Kielce - Poland, Warszawa - Poland, Coimbra - Portugal, Lisboa - Portugal, Porto - Portugal, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, London - United Kingdom, Plymouth - United Kingdom",2011-08,2009-09-21,2014-06-09,INTERVENTIONAL,PHASE2,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT06484530,Unknown,RECRUITING,2024-03-12,"Tuberculosis (TB), Isoniazid Toxicity, Rifampicin Toxicity, Pyrazinamide Adverse Reaction, Ethambutol Toxicity, NAT2 Slow Acetylator Status, NAT2 Rapid Acetylator Status, NAT2 Polymorphism, N-Acetylcysteine",N acetyl cysteine,Bangkok Noi - Thailand,2024-09-18,2024-07-03,2024-07-03,INTERVENTIONAL,PHASE4,Mahidol University,OTHER,hepatitis
NCT03546530,Unknown,COMPLETED,2016-06-01,"Hepatitis B, Interferon","Interferon, Interferon+resveratrol",No locations listed,2017-01,2018-06-06,2020-10-14,INTERVENTIONAL,NA,The First Hospital of Jilin University,OTHER,hepatitis
NCT00030030,Unknown,COMPLETED,2000-07,"Hepatitis C, Chronic",Silymarin (milk thistle),No locations listed,Unknown Date,2002-01-31,2006-08-18,INTERVENTIONAL,PHASE2,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT00368225,Unknown,COMPLETED,2006-06-22,"Hepatitis C, Cirrhosis",No interventions listed,"Washington, D.C. - United States, Bethesda - United States, Falls Church - United States",Unknown Date,2006-08-24,2017-07-02,OBSERVATIONAL,Not Available,National Institutes of Health Clinical Center (CC),NIH,hepatitis
NCT03566030,Unknown,UNKNOWN,2018-09-01,"Hepatitis B, Antiviral Drug Adverse Reaction","Tenofovir disoproxil fumarate 300mg, Tenofovir Alafenamide 25 mg",No locations listed,2019-08-31,2018-06-21,2018-06-21,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT02899130,Unknown,UNKNOWN,2016-10,Chronic Hepatitis B,"Polyherbal, Placebo",Bangalore - India,2018-06,2016-09-14,2017-12-06,INTERVENTIONAL,NA,Composite Interceptive Med Science,INDUSTRY,hepatitis
NCT00769730,Unknown,COMPLETED,2008-01,"Hepatocellular Carcinoma, Hepatitis B Virus",No interventions listed,Kaohsiung - Taiwan,2009-02,2008-10-09,2009-08-04,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03740230,Maviret PMS,COMPLETED,2018-09-26,Hepatitis C,No interventions listed,"Cheonan-si - Korea, Republic of, Anyang - Korea, Republic of, Bucheon - Korea, Republic of, Buncheon - Korea, Republic of, Goyang - Korea, Republic of, Goyang - Korea, Republic of, Seongnam - Korea, Republic of, Suwon - Korea, Republic of, Suwon - Korea, Republic of, Uijeongbu - Korea, Republic of, Yangsan-si - Korea, Republic of, Iksan - Korea, Republic of, Gwangju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Changwon - Korea, Republic of, Cheonan - Korea, Republic of, Chuncheon - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Daejeon - Korea, Republic of, Goyang - Korea, Republic of, Gumi-si - Korea, Republic of, Gwangju - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jeju - Korea, Republic of, Jeonnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suncheon - Korea, Republic of, Ulsan - Korea, Republic of, Wonju - Korea, Republic of",2023-07-21,2018-11-14,2024-07-19,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01599130,Unknown,UNKNOWN,2012-07,Hepatitis B,"Entecavir, Peginterferon alfa-2a",Guangzhou - China,2014-04,2012-05-15,2012-05-15,INTERVENTIONAL,NA,Sun Yat-sen University,OTHER,hepatitis
NCT00158535,Unknown,TERMINATED,2002-06,"HIV Infections, Hepatitis C",liver transplantation,Villejuif - France,Unknown Date,2005-09-12,2005-09-12,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00722358,Unknown,COMPLETED,2008-12,Chronic Hepatitis C,"BMS-650032, Placebo","Anaheim - United States, Orlando - United States, Baltimore - United States, Austin - United States, Santurce - Puerto Rico",2009-12,2008-07-25,2011-06-27,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00317122,Unknown,COMPLETED,2004-10,Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis,DTPw-HBV/Hib-MenAC conjugate vaccine,"Brits - South Africa, Brits - South Africa, Centurion - South Africa, Ga-Rankuwa - South Africa",2005-07,2006-04-24,2016-09-21,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00197158,Unknown,COMPLETED,2005-03,Hepatitis B,Hepatitis B vaccine,Wilrijk - Belgium,2005-12,2005-09-20,2016-09-21,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05001022,Unknown,TERMINATED,2021-09-25,Chronic Hepatitis B,"ALG-020572, Placebo","Auckland - New Zealand, London - United Kingdom, London - United Kingdom",2022-07-18,2021-08-11,2023-04-25,INTERVENTIONAL,PHASE1,Aligos Therapeutics,INDUSTRY,hepatitis
NCT00956722,Unknown,WITHDRAWN,2012-01,Asymptomatic Chronic HCV Carriers,Bovine Colostrum Powder,Jerusalem - Israel,2014-01,2009-08-11,2012-08-28,INTERVENTIONAL,PHASE1,Hadassah Medical Organization,OTHER,hepatitis
NCT01080222,Unknown,TERMINATED,2010-08,Chronic Hepatitis C Virus Infection,"telaprevir, VX-222, ribavirin, peginterferon-alfa-2a, VX-222","La Jolla - United States, San Francisco - United States, Aurora - United States, Gainesville - United States, Atlanta - United States, Marietta - United States, Lutherville - United States, Rochester - United States, Saint Louis - United States, Egg Harbor Township - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Providence - United States, Germantown - United States, Arlington - United States, San Antonio - United States, Falls Church - United States, Auckland - New Zealand, Christchurch - New Zealand",2013-10,2010-03-04,2020-09-30,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT06307522,Unknown,NOT_YET_RECRUITING,2024-09-01,"Alcoholic Hepatitis, Acute Alcoholic Hepatitis",MRG-001,No locations listed,2026-09-01,2024-03-13,2024-03-13,INTERVENTIONAL,PHASE2,MedRegen LLC,INDUSTRY,hepatitis
NCT03585322,Unknown,COMPLETED,2018-07-04,Chronic Hepatitis B,APG-1387 for Injection,"Guangzhou - China, Guangzhou - China",2021-10-15,2018-07-13,2021-11-08,INTERVENTIONAL,PHASE1,Ascentage Pharma Group Inc.,INDUSTRY,hepatitis
NCT00158522,Unknown,COMPLETED,2003-02,Hepatitis C,pegylated interferon alpha2a,Cairo - Egypt,2007-12,2005-09-12,2008-02-08,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT01760122,Unknown,COMPLETED,2013-03,Chronic Hepatitis B,"Ypeginterferon alfa-2b, Pegasys","Xiamen - China, Shenzhen - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changsha - China, Changsha - China, Chengdu - China, Chongqing - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Guangzhou - China, Guilin - China, Hangzhou - China, Harbin - China, Jinan - China, Lanzhou - China, Nanchang - China, Nanchang - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenyang - China, Shenyang - China, Shijiazhuang - China, Taiyuan - China, Tianjin - China, Wenzhou - China, Wuhan - China, Wuhan - China, Wulumuqi - China, Xi'an - China, Xi'an - China, Xiamen - China, Zhengzhou - China",2015-07,2013-01-03,2015-08-31,INTERVENTIONAL,PHASE3,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT01725529,Unknown,COMPLETED,2012-11,"Hepatitis C, Chronic","TMC435, Peginterferon-alpha (PegIFNα-2a), Ribavirin (RBV), Placebo","Beijing - China, Changchun - China, Changsha - China, Chengdu - China, Chongqing - China, Guangzhou - China, Hangzhou - China, Harbin - China, Jinan - China, Lanzhou - China, Nanjing - China, Shanghai - China, Shenyang - China, Tianjin - China, Wuhan - China, Zhengzhou - China, Busan - Korea, Republic of, Chuncheon, Gangwon-Do - Korea, Republic of, Gyeongsangnam-Do - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of",2014-08,2012-11-14,2015-08-13,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT00637429,Unknown,UNKNOWN,2007-11,"HIV Infections, HIV-HBV Co-Infection",No interventions listed,Melbourne - Australia,Unknown Date,2008-03-18,2008-04-02,OBSERVATIONAL,Not Available,Bayside Health,OTHER_GOV,hepatitis
NCT01296529,Unknown,COMPLETED,2011-07,"HIV Infection, Hepatitis C Infection, Fibrosis, Inflammation",No interventions listed,"Chicago - United States, Chicago - United States",2011-12,2011-02-15,2012-12-12,OBSERVATIONAL,Not Available,Rush University Medical Center,OTHER,hepatitis
NCT03332329,NPGV,UNKNOWN,2015-12-01,Chronic Hepatitis b,"Entecavir, Granulocyte Macrophage Colony Stimulating Factor, Y peginterferon alfa-2b, HBV vaccine",No locations listed,2018-12-31,2017-11-06,2017-11-06,INTERVENTIONAL,PHASE4,Qin Ning,OTHER,hepatitis
NCT03067129,DORA,COMPLETED,2017-03-20,Hepatitis C Virus (HCV),"Glecaprevir/Pibrentasvir Adult Formulation, Glecaprevir + Pibrentasvir Pediatric Formulation","San Francisco - United States, Aurora - United States, Hartford - United States, Gainesville - United States, Orlando - United States, Indianapolis - United States, Boston - United States, Boston - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Philadelphia - United States, Pittsburgh - United States, Nashville - United States, Houston - United States, Woluwe-Saint-Lambert - Belgium, Leuven - Belgium, Calgary - Canada, Edmonton - Canada, Toronto - Canada, Freiburg im Breisgau - Germany, Berlin - Germany, Wuppertal - Germany, Kurume-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Bunkyo-ku - Japan, San Juan - Puerto Rico, Moscow - Russian Federation, Moscow - Russian Federation, Saint-petersburg - Russian Federation, Esplugues de Llobregat - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Birmingham - United Kingdom, Glasgow - United Kingdom, London - United Kingdom",2020-05-21,2017-03-01,2023-05-09,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01958229,Unknown,COMPLETED,2009-12,"Chronic Hepatitis B, Roadmap Concept in Chronic Hepatitis B Treatment, 24-week PCR Negativity of Telbivudine, PCR Negativity at 52 and 104 Week, HBeAg Seroconversion Rate at 52 and 104 Week",No interventions listed,Taipei City - Taiwan,2012-03,2013-10-09,2013-10-09,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02577029,MONARCH,TERMINATED,2015-12,"Hepatitis B, Hepatitis D","ARC-520, entecavir, pegylated interferon alpha 2a, tenofovir disoproxil, antihistamine","Camperdown - Australia, Concord - Australia, Darlinghurst - Australia, Westmead - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Parkville - Australia, Nedlands - Australia, Pleven - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Hong Kong - China, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Chisinau - Moldova, Republic of, Papatoetoe - New Zealand, Dunedin - New Zealand, Auckland - New Zealand, Douliou - Taiwan, Changhua - Taiwan, Kaohsiung - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Pathumthani - Thailand",2016-12,2015-10-15,2019-04-12,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT03053180,CITRIN,COMPLETED,2017-03-20,Chronic Hepatitis C,No interventions listed,"Chelyabinsk - Russian Federation, Kirov - Russian Federation, Krasnodar - Russian Federation, Orenburg - Russian Federation, Samara - Russian Federation, Saratov - Russian Federation, Ulyanovsk - Russian Federation",2017-12-18,2017-02-15,2019-03-14,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01349829,Unknown,COMPLETED,2010-03,Hepatitis A,"HAVpur Junior, Havrix 720 Junior","Indore - India, Thane - India, Ludhiana - India",2011-04,2011-05-09,2013-12-17,INTERVENTIONAL,PHASE4,Crucell Holland BV,INDUSTRY,hepatitis
NCT00216229,Unknown,UNKNOWN,2004-09,Antibody Response After Vaccination,Combined vaccine against hepatitis A and B (Twinrix),Leuven - Belgium,Unknown Date,2005-09-22,2005-12-14,INTERVENTIONAL,PHASE4,IDEWE Occupational Health Services,OTHER,hepatitis
NCT00122629,Unknown,TERMINATED,2000-10,"Hepatitis C, Chronic","peg-interferon alfa-2b, ribavirin, amantadine",Lyon Cedex - France,Unknown Date,2005-07-22,2005-07-29,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00945880,CLEAN-1,COMPLETED,2009-07,Hepatitis C,clemizole hydrochloride,No locations listed,2010-08,2009-07-24,2021-04-15,INTERVENTIONAL,PHASE1,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT00412529,Unknown,COMPLETED,2006-12,"Hepatitis B, Chronic Hepatitis B","Entecavir, Telbivudine","Bucheon,Kyunggi - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2008-02,2006-12-18,2015-03-13,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT04449029,B-Clear,COMPLETED,2020-07-27,Hepatitis B,"GSK3228836, Placebo, Nucleos(t)ide therapy","Los Angeles - United States, Miami - United States, Miami - United States, Decatur - United States, Boston - United States, New York - United States, Pittsburgh - United States, Richmond - United States, Ciudad Autonoma de Buenos Aires - Argentina, Buenos Aires - Argentina, Sliven - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Calgary - Canada, Victoria - Canada, London - Canada, Toronto - Canada, Montreal - Canada, Regina - Canada, Québec - Canada, Wuhan - China, Shenyang - China, Chongqing - China, Beijing - China, Beijing - China, Beijing - China, Guangzhou - China, Shanghai - China, Clichy Cedex - France, Créteil cedex - France, Limoges cedex - France, Lyon cedex 04 - France, Nice cedex 3 - France, Strasbourg - France, Erlangen - Germany, Frankfurt - Germany, Frankfurt - Germany, Berlin - Germany, Hamburg - Germany, Pokfulam - Hong Kong, Modena - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Ehime - Japan, Hiroshima - Japan, Hiroshima - Japan, Hokkaido - Japan, Ishikawa - Japan, Ishikawa - Japan, Kagawa - Japan, Kumamoto - Japan, Kumamoto - Japan, Miyagi - Japan, Nagasaki - Japan, Osaka - Japan, Tokyo - Japan, Tokyo - Japan, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Kuala Lumpur - Malaysia, Makati City - Philippines, Quezon City - Philippines, Lancut - Poland, Lublin - Poland, Myslowice - Poland, Warszawa - Poland, Brasov - Romania, Bucharest - Romania, Cluj Napoca - Romania, Cluj-Napoca - Romania, Craiova - Romania, Galati - Romania, Iasi - Romania, Timisoara - Romania, Chelyabinsk - Russian Federation, Kaliningrad - Russian Federation, Krasnodar - Russian Federation, Krasnojarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Novosibirsk - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, St. Petersburg - Russian Federation, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Port Elizabeth - South Africa, Ennerdale - South Africa, Lenasia Johannesburg - South Africa, Durban - South Africa, Kwaguqa Emalahleni - South Africa, Vosloorus Ext 2 - South Africa, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, Málaga - Spain, Santander - Spain, Sevilla - Spain, Changhua - Taiwan, Taichung - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiangmai - Thailand, Phitsanulok - Thailand, Songkla - Thailand, London - United Kingdom, Newcastle-upon-Tyne - United Kingdom, Plymouth - United Kingdom",2022-03-18,2020-06-26,2023-05-16,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03566940,Unknown,COMPLETED,2018-07-31,Healthy,"sIPV, cIPV","Dasmarinas - Philippines, Dasmarinas - Philippines, Manila - Philippines",2019-08-07,2018-06-25,2025-02-03,INTERVENTIONAL,PHASE2,Janssen Vaccines & Prevention B.V.,INDUSTRY,hepatitis
NCT03145844,HEPCTURKEY,COMPLETED,2017-04-09,"Hepatitis C, Hepatitis C Relapse, Hepatitis C Recurrent",No interventions listed,Istanbul - Turkey,2018-12-31,2017-05-09,2019-10-01,OBSERVATIONAL,Not Available,Fehmi Tabak,OTHER,hepatitis
NCT02772744,Unknown,UNKNOWN,2017-11-01,Hepatitis C,"Daclatasvir 60 MG Oral Tablet [Daklinza], Sofosbuvir 400 MG Oral Tablet [Sovaldi], Ribavirin Oral Product",No locations listed,2018-12-31,2016-05-13,2017-10-10,OBSERVATIONAL,Not Available,Zagazig University,OTHER_GOV,hepatitis
NCT00687544,Unknown,TERMINATED,2005-12,"Hepatitis C, Chronic, Hepacivirus, HIV Infections","Peginterferon alfa-2b (SCH 054031), Ribavirin (SCH 018908)",No locations listed,2008-09,2008-05-30,2017-04-06,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01323244,Unknown,COMPLETED,2011-12,Hepatitis C,TMC435,"Bakersfield - United States, Los Angeles - United States, San Diego - United States, Englewood - United States, Jacksonville - United States, Orlando - United States, New Orleans - United States, Jackson - United States, Tupelo - United States, Chapel Hill - United States, Cincinnati - United States, Philadelphia - United States, Dallas - United States, Houston - United States, San Antonio - United States, Buenos Aires - Argentina, Rosario, Santa Fe - Argentina, Adelaide - Australia, Concord - Australia, Melbourne - Australia, Wentworthville - Australia, Woolloongabba N/A - Australia, Wien - Austria, Antwerpen - Belgium, Brussels - Belgium, Gent - Belgium, Sao Paulo - Brazil, Sofia - Bulgaria, Toronto - Canada, Montreal - Canada, Grenoble - France, Lyon - France, Nice Cedex 03 N/A - France, Paris Cedex 12 - France, Berlin - Germany, Frankfurt A. M. - Germany, Hamburg - Germany, Kiel - Germany, Münster - Germany, Ulm - Germany, Würzburg - Germany, Haifa - Israel, Zefat - Israel, Monterrey - Mexico, Amsterdam - Netherlands, Rotterdam - Netherlands, Auckland - New Zealand, Christchurch - New Zealand, Bydgoszcz - Poland, Chorzów - Poland, Czeladz - Poland, Kielce - Poland, Myslowice - Poland, Warschau - Poland, Coimbra - Portugal, Lisboa - Portugal, San Juan - Puerto Rico, Bucuresti - Romania, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain, Donetsk - Ukraine, Kyiv - Ukraine, Vinnitsa - Ukraine, Birmingham - United Kingdom, London - United Kingdom",2015-03,2011-03-25,2016-04-04,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT06316492,rural_remote,NOT_YET_RECRUITING,2024-08-01,"Hepatitis B, Hepatitis C",No interventions listed,No locations listed,2024-12-01,2024-03-18,2024-03-18,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00674492,Unknown,COMPLETED,2008-05,Hepatitis C,No interventions listed,Bedford - United States,2008-08,2008-05-08,2015-05-15,OBSERVATIONAL,Not Available,US Department of Veterans Affairs,FED,hepatitis
NCT00228592,Unknown,TERMINATED,Unknown Date,"Hepatitis B, Liver Transplantation","HepeX-B, Hepatitis B Immune Globulin (HBIg)","Los Angeles - United States, San Francisco - United States, San Francisco - United States, Rochester - United States, Omaha - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Philadelphia - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Paris - France, Berlin - Germany, Jerusalem - Israel, Petach Tikva - Israel, Tel Aviv - Israel, Auckland - New Zealand, Valencia - Spain, London - United Kingdom",Unknown Date,2005-09-29,2007-02-13,INTERVENTIONAL,PHASE2,"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",INDUSTRY,hepatitis
NCT00638144,Unknown,UNKNOWN,2008-02,Hepatitis C,No interventions listed,"Strasbourg - France, Strasbourg - France, Strasbourg - France",2015-12,2008-03-18,2015-09-30,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,hepatitis
NCT00289744,Unknown,COMPLETED,2004-02-16,"Hepatitis B, Hepatitis A","TWINRIX™ ADULT, Engerix TM",Wilrijk - Belgium,2009-04-15,2006-02-10,2018-08-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00397540,Unknown,COMPLETED,2004-10,"Carcinoma, Hepatocellular, Chronic Hepatitis B","PEIT, RFTA","Seoul - Korea, Republic of",2011-05,2006-11-09,2019-03-18,INTERVENTIONAL,NA,Seoul National University Hospital,OTHER,hepatitis
NCT01914744,Unknown,UNKNOWN,2013-02,"Non-Hodgkin Lymphoma, Hepatitis B Reactivation","Entecavir, Lamivudine",Shanghai - China,2015-12,2013-08-02,2013-08-02,INTERVENTIONAL,PHASE2,Fudan University,OTHER,hepatitis
NCT04933292,Unknown,UNKNOWN,2021-06-16,"Autoimmune Hepatitis, Primary Biliary Cirrhosis","Methylprednisolone and Mycophenolate mofetil, Methylprednisolone and azathioprine",Chengdu - China,2022-05,2021-06-21,2021-06-21,INTERVENTIONAL,PHASE4,Xiaoli Fan,OTHER,hepatitis
NCT04032392,Unknown,UNKNOWN,2019-07-23,Hepatocellular Carcinoma,autologous γδT cells,"Beijing - China, Beijing - China",2021-07-30,2019-07-25,2019-07-25,INTERVENTIONAL,PHASE1,Beijing 302 Hospital,OTHER,hepatitis
NCT03112044,Unknown,ACTIVE_NOT_RECRUITING,2017-09-19,"Lung Transplant Infection, Hepatitis C","Sofosbuvir-velpatasvir (400 mg/100 mg), Ex Vivo Lung Perfusion (EVLP)",Toronto - Canada,2020-01-02,2017-04-13,2023-12-06,INTERVENTIONAL,PHASE1,"University Health Network, Toronto",OTHER,hepatitis
NCT03343444,Unknown,UNKNOWN,2017-04-15,"Hepatitis C Virus Infection, Response to Therapy of","12 weeks (Sofosbuvir 400mg/Ledipasvir 90mg), 8 weeks (Sofosbuvir 400mg/Ledipasvir 90mg)",Mansourah - Egypt,2018-11-01,2017-11-17,2018-05-24,INTERVENTIONAL,PHASE3,Egyptian Liver Hospital,OTHER,hepatitis
NCT00697840,Unknown,COMPLETED,1995-06,Hepatitis B,"Engerix™-B, HBV-MPL 208129, Vaccine containing HBsAg absorbed on aluminium salts - experimental formulation",Vienna - Austria,1996-01,2008-06-16,2008-06-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01345240,Unknown,COMPLETED,2011-11-17,"Malaria, Malaria Vaccines","GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049, Engerix-B™ vaccine, Infanrix/Hib™ vaccine, Polio Sabin™ vaccine, Rotarix™ vaccine, Synflorix™ vaccine, Measles vaccine, Yellow fever vaccine","Ouagadougou 01 - Burkina Faso, Kumasi - Ghana",2013-01-09,2011-05-02,2019-07-18,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05294744,Unknown,UNKNOWN,2022-04,Alcoholic Hepatitis,N-acetylcysteine,Vitoria-Gasteiz - Spain,2023-07,2022-03-24,2022-03-24,INTERVENTIONAL,NA,Bioaraba Health Research Institute,NETWORK,hepatitis
NCT05238844,Unknown,TERMINATED,2022-04-11,Chronic Hepatitis b,"ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet","Chisinau - Moldova, Republic of, Kyiv - Ukraine",2022-05-25,2022-02-14,2022-05-31,INTERVENTIONAL,PHASE2,"Antios Therapeutics, Inc",INDUSTRY,hepatitis
NCT01087944,Unknown,COMPLETED,2010-03,"Hepatitis C, Chronic","Autoinjector, Pre-filled syringe","Los Angeles - United States, Bradenton - United States, Orlando - United States, Marietta - United States, Framingham - United States, Newark - United States, Vineland - United States, New York - United States, Poughkeepsie - United States, Asheville - United States, Columbia - United States, San Antonio - United States",2010-06,2010-03-16,2016-02-09,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00883844,PADD,COMPLETED,2009-04,Chronic Hepatitis B,"Nucleos(t)ide analogue treatment with a peginterferon add-on strategy, Nucleos(t)ide analogue treatment","Amsterdam - Netherlands, Rotterdam - Netherlands",2012-06,2009-04-20,2013-04-19,INTERVENTIONAL,PHASE4,Foundation for Liver Research,OTHER,hepatitis
NCT01545544,Lympho C,UNKNOWN,2006-11,Chronic Hepatitis C,No interventions listed,Paris - France,2014-11,2012-03-06,2014-02-07,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT00491244,Unknown,COMPLETED,2007-06,Chronic Hepatitis C,"Peginterferon alfa-2a and ribavirin, Peginterferon alfa-2a",Taipei - Taiwan,2013-09,2007-06-26,2014-02-10,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT03086044,Unknown,UNKNOWN,2017-03-01,"Hepatitis C, Awaiting Organ Transplant","Sofosbuvir/velpatasvir, Monitoring",Boston - United States,2023-12,2017-03-22,2022-10-12,INTERVENTIONAL,PHASE4,Brigham and Women's Hospital,OTHER,hepatitis
NCT04535544,REEF-D,ACTIVE_NOT_RECRUITING,2020-09-17,"Hepatitis D, Chronic","JNJ-73763989, Placebo, Entecavir (ETV) monohydrate, Tenofovir disoproxil, Tenofovir alafenamide (TAF)","Redwood City - United States, Boston - United States, Camperdown - Australia, Footscray - Australia, Westmead - Australia, Boa Vista - Brazil, Manaus - Brazil, Porto Velho - Brazil, Beijing - China, Beijing - China, Changchun - China, Chengdu - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Shanghai - China, Clichy - France, Lyon - France, Nantes - France, Paris - France, Rennes - France, Essen - Germany, Frankfurt - Germany, Hannover - Germany, Milano - Italy, Pisa - Italy, Rome - Italy, Torino - Italy, Bunkyo Ku - Japan, Hiroshima - Japan, Iizuka-shi - Japan, Ikeda - Japan, Kumamoto - Japan, Kumamoto - Japan, Nagasaki - Japan, Nagasaki - Japan, Nakagami gun - Japan, Okinawa - Japan, Suita-shi - Japan, Suita - Japan, Sumida ku - Japan, Auckland - New Zealand, Krasnoyarsk - Russian Federation, Saint Petersburg - Russian Federation, Samara - Russian Federation, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Santander - Spain, Danderyd - Sweden, Malmö - Sweden, Stockholm - Sweden, Kaohsiung - Taiwan, Taipei - Taiwan, Tiachung - Taiwan, Istanbul - Turkey, Izmir - Turkey, Kocaeli - Turkey, Trabzon - Turkey, London - United Kingdom",2023-10-19,2020-09-02,2025-03-04,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT00543244,Unknown,UNKNOWN,2006-01,Chronic Hepatitis C,Pegylated interferon alfa and ribavirin,"Ramat-Gan - Israel, Douliou - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2008-10,2007-10-12,2008-11-21,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02412592,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,No interventions listed,Beijing - China,2018-12,2015-04-09,2016-08-18,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT03452540,Unknown,TERMINATED,2018-11-28,Severe Acute Decompensated Alcoholic Hepatitis,1000mg DS102 (BID),"Miami - United States, Miami - United States, Kansas City - United States, Boston - United States, Charleston - United States, Newport News - United States, Batumi - Georgia, Kutaisi - Georgia",2019-06-19,2018-03-02,2022-07-29,INTERVENTIONAL,PHASE2,Afimmune,INDUSTRY,hepatitis
NCT04211844,HCV DAAS,UNKNOWN,2019-10-01,Chronic Hepatitis C,"sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir",Cairo - Egypt,2020-04,2019-12-26,2020-01-02,OBSERVATIONAL,Not Available,Ain Shams University,OTHER,hepatitis
NCT05422092,Unknown,UNKNOWN,2022-09-20,Type 2 Diabetes Mellitus With Complication,"Canagliflozin, Pioglitazone",No locations listed,2023-01,2022-06-16,2022-09-21,INTERVENTIONAL,NA,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT02601040,Unknown,COMPLETED,2011-11,Hepatitis A,"Attenuated Hepatitis A Vaccine, H2 Strain, Inactivated Hepatitis A Vaccine, Lu8 Strain, Group A Meningococcal Polysaccharide vaccine","Nanjing - China, Kunming - China",2014-06,2015-11-10,2015-11-10,INTERVENTIONAL,PHASE4,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT03089944,EXPEDITION-8,COMPLETED,2017-04-28,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir,"Phoenix - United States, Phoenix - United States, Little Rock - United States, Bakersfield - United States, Long Beach - United States, Los Angeles - United States, San Diego - United States, Stanford - United States, West Hollywood - United States, Miami - United States, West Palm Beach - United States, Atlanta - United States, Chicago - United States, Des Moines - United States, Iowa City - United States, Louisville - United States, Shreveport - United States, Baltimore - United States, Rochester - United States, Jackson - United States, Omaha - United States, Omaha - United States, Newark - United States, Bronx - United States, Bronx - United States, New York - United States, New York - United States, Durham - United States, Fayetteville - United States, Statesville - United States, Cleveland - United States, Cleveland - United States, Tulsa - United States, Allentown - United States, Pittsburgh - United States, Nashville - United States, Dallas - United States, Houston - United States, Richmond - United States, Madison - United States, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Calgary - Canada, Victoria - Canada, Halifax - Canada, Ottawa - Canada, Toronto - Canada, Plzen - Czechia, Prague - Czechia, Prague - Czechia, Orleans CEDEX 2 - France, TOULOUSE Cedex 9 - France, Amiens CEDEX 1 - France, Clermont Ferrand - France, Creteil - France, Lyon - France, Athens - Greece, Kifissia - Greece, Larisa - Greece, Thessaloniki - Greece, Budapest - Hungary, Budapest - Hungary, Dublin 8 - Ireland, Dublin 4 - Ireland, Dublin - Ireland, Tel Aviv-Yafo - Israel, Haifa - Israel, Haifa - Israel, Ramat Gan - Israel, Napoli - Italy, Bologna - Italy, Milano - Italy, Rozzano - Italy, Milan - Italy, Wrocław - Poland, Lublin - Poland, Bialystok - Poland, Myslowice - Poland, Lisbon - Portugal, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Ponce - Puerto Rico, Ponce - Puerto Rico, San Juan - Puerto Rico, Sector 2 - Romania, Sector 2 - Romania, Sector 2 - Romania, Sector 2 - Romania, Bucuresti - Romania, Samara - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Stavropol - Russian Federation, Tyumen - Russian Federation, Barcelona - Spain, Barcelona - Spain, Cordoba - Spain, Donostia - Spain, Oviedo - Spain, Taichung City - Taiwan, Kaohsiung - Taiwan, Taipei City - Taiwan, Basildon - United Kingdom, London - United Kingdom, Crumpsall - United Kingdom, Edinburgh - United Kingdom, Nottinghamshire - United Kingdom, Hanoi - Vietnam, Ho Chi Minh - Vietnam, Ho Chi Minh - Vietnam",2019-07-31,2017-03-24,2020-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00128544,Unknown,COMPLETED,2005-05,Hepatitis B,"telbivudine, valtorcitabine","Pokfulam - Hong Kong, Auckland - New Zealand, Singapore - Singapore",2007-05,2005-08-10,2017-06-16,INTERVENTIONAL,PHASE2,Novartis,INDUSTRY,hepatitis
NCT01448044,Unknown,COMPLETED,2011-12,Hepatitis C,"BMS-790052 (NS5A Replication Complex Inhibitor), Placebo matching BMS-790052, Pegylated-interferon alfa 2a, Ribavirin","San Clemente - United States, Worcester - United States, Providence - United States, Annandale - United States, Bondy Cedex - France, Creteil - France, La Roche-Sur-Yon Cedex 9 - France, Marseille Cedex 08 - France, Nice Cedex 03 - France, Orleans Cedex 2 - France, Paris - France, Paris - France, Strasbourg Cedex - France, Toulouse Cedex 09 - France, Villejuif - France, Thesaloniki - Greece, Roma - Italy, Torino - Italy, San Juan - Puerto Rico, A Coruna - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, London - United Kingdom, London - United Kingdom, London - United Kingdom",2013-10,2011-10-07,2015-10-12,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00723892,Unknown,COMPLETED,2005-07,"Hepatitis C, Chronic, Hepacivirus","Peginterferon alfa-2b (PegIntron), Rebetol (Ribavirin), Psychotherapy support program",No locations listed,2009-05,2008-07-29,2015-10-30,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05874440,Unknown,RECRUITING,2023-04-15,Chronic Hepatitis b Patients,Tenofovir Disoproxil Fumarate and Entcavir,Sohag - Egypt,2024-04-30,2023-05-24,2023-05-24,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT01559844,Unknown,COMPLETED,2012-03,"Hepatitis C, Hepatocellular Carcinoma","Sofosbuvir, Ribavirin","Los Angeles - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Miami Beach - United States, Miami - United States, Boston - United States, Burlington - United States, Detroit - United States, St. Louis - United States, New York - United States, Philadelphia - United States, Dallas - United States, Auckland - New Zealand, Pamplona - Spain",2014-05,2012-03-21,2016-07-27,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01360892,PICTURE,UNKNOWN,2010-09,"Chronic Hepatitis B, Chronic Hepatitis C",No interventions listed,Osaka-sayama - Japan,2013-08,2011-05-26,2011-05-26,OBSERVATIONAL,Not Available,Kindai University,OTHER,hepatitis
NCT04025944,Unknown,RECRUITING,2019-07-20,"Hepatitis, Chronic",No interventions listed,Shanghai - China,2024-08-01,2019-07-19,2019-07-19,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT05042544,Unknown,RECRUITING,2022-02-22,Hepatitis C,Point-of-Care Testing,"Canberra - Australia, Bathurst - Australia, Broken Hill - Australia, Broken Hill - Australia, Coffs Harbour - Australia, Gosford - Australia, Inverell - Australia, Lismore - Australia, Penrith - Australia, Port Macquarie - Australia, Quirindi - Australia, South Grafton - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Wagga Wagga - Australia, Waratah - Australia, Wollongong - Australia, Alice Springs - Australia, Brisbane - Australia, Brisbane - Australia, Cairns - Australia, Coorparoo - Australia, Inala - Australia, Inala - Australia, Ipswich - Australia, Ipswich - Australia, Maroochydore - Australia, Adelaide - Australia, Adelaide - Australia, Adelaide - Australia, Adelaide - Australia, Hackney - Australia, Mount Gambier - Australia, Hobart - Australia, New Town - Australia, Footscray - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Morwell - Australia, Bunbury - Australia, Fremantle - Australia, Perth - Australia, Perth - Australia, Perth - Australia, Perth - Australia, Perth - Australia",2024-12,2021-09-13,2024-06-13,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT04042740,PURGE-C,COMPLETED,2019-11-20,"Hepatitis C Infection, HIV Infection",Glecaprevir/Pibrentasvir (G/P),"San Diego - United States, San Francisco - United States, Aurora - United States, Washington - United States, Baltimore - United States, Boston - United States, New York - United States, New York - United States, New York - United States, Chapel Hill - United States, Seattle - United States, Rio de Janeiro - Brazil",2023-05-18,2019-08-02,2024-07-11,INTERVENTIONAL,PHASE2,Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,NETWORK,hepatitis
NCT06685692,Unknown,RECRUITING,2024-11-04,Alcohol Hepatitis,"ADX-629, ADX-629","Bradenton - United States, Tampa - United States, Dallas - United States, Houston - United States, San Antonio - United States, Richmond - United States",2025-12-31,2024-11-12,2025-01-29,INTERVENTIONAL,PHASE2,"Aldeyra Therapeutics, Inc.",INDUSTRY,hepatitis
NCT01390844,Unknown,COMPLETED,2011-10-21,"Hepatitis C, Chronic","Boceprevir (BOC), Placebo to boceprevir, Peginterferon alfa-2b (PEG), Ribavirin (RBV), Cross-Over Boceprevir Treatment",No locations listed,2015-06-19,2011-07-11,2018-09-11,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01467492,Unknown,TERMINATED,2012-01,Hepatitis C,"Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a","Birmingham - United States, San Francisco - United States, New Haven - United States, Washington - United States, Miami - United States, Orlando - United States, Tampa - United States, West Palm Beach - United States, Atlanta - United States, Chicago - United States, Baton Rouge - United States, New Orleans - United States, Shreveport - United States, Baltimore - United States, Boston - United States, Detroit - United States, Vineland - United States, Bronx - United States, New York - United States, Charlotte - United States, Durham - United States, Philadelphia - United States, Dallas - United States, Houston - United States, San Antoinio - United States, Norfolk - United States, Seattle - United States",2014-05,2011-11-08,2015-08-03,INTERVENTIONAL,PHASE4,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT05470829,Unknown,COMPLETED,2021-05-27,"Healthy Volunteers, Hepatitis B, Chronic","ZM-H1505R, ZM-H1505R Placebo",Changchun - China,2021-11-17,2022-07-22,2022-07-22,INTERVENTIONAL,PHASE1,"Shanghai Zhimeng Biopharma, Inc.",INDUSTRY,hepatitis
NCT01906580,Unknown,UNKNOWN,2011-07,Chronic Hepatitis B,"Peg-IFNα-2a, Entecavir",Beijing - China,2016-07,2013-07-24,2015-08-17,INTERVENTIONAL,PHASE4,Beijing 302 Hospital,OTHER,hepatitis
NCT04035980,Unknown,RECRUITING,2019-07-05,Hepatitis C Virus Infection,Telemedicine based healthcare programme,La Laguna - Spain,2023-12-31,2019-07-29,2023-05-18,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT04047680,Unknown,COMPLETED,2015-02,"Hepatitis C, Renal Disease, Viral Hepatitis C","Sofosbuvir / Velpatasvir Oral Tablet, Sofosbuvir and Ledipasvir, Sofosbuvir Tablets, Ombitasvir/paritaprevir/ritonavir, Elbasvir / Grazoprevir Oral Tablet, Glecaprevir and Pibrentasvir","Douliu - Taiwan, Taipei - Taiwan",2018-12,2019-08-07,2019-08-08,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT01528280,Unknown,COMPLETED,2013-01,Other Condition That May be a Focus of Clinical Attention,"Vaccination against hepatitis A, No Intervention","Sao Paulo - Brazil, Sao Paulo - Brazil",2014-09,2012-02-08,2018-01-11,INTERVENTIONAL,NA,Federal University of São Paulo,OTHER,hepatitis
NCT00823862,Unknown,COMPLETED,2008-10,Chronic Hepatitis C,"SD-101, ribavirin","Bydgoszcz - Poland, Lublin - Poland, Warszawa - Poland, Warszawa - Poland, Wrocław - Poland",2009-12,2009-01-16,2019-04-16,INTERVENTIONAL,PHASE1,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT05957380,Unknown,COMPLETED,2023-03-20,Hepatitis B,"DA-2803, DA-2803-R, Placebo of DA-2803, Placebo of DA-2803-R","Seoul - Korea, Republic of",2024-09-30,2023-07-24,2024-10-23,INTERVENTIONAL,PHASE4,"Dong-A ST Co., Ltd.",INDUSTRY,hepatitis
NCT01170962,HEPCAT,COMPLETED,2010-08,Hepatitis C Virus,"BMS-790052, BMS-790052, Placebo, peginterferon alfa-2a, ribavirin","Montgomery - United States, La Jolla - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, New Haven - United States, Gainesville - United States, South Miami - United States, Indianapolis - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Lutherville - United States, Springfield - United States, St. Louis - United States, Albany - United States, Bronx - United States, Great Neck - United States, Monticello - United States, Rochester - United States, Chapel Hill - United States, Statesville - United States, Tulsa - United States, Philadelphia - United States, Providence - United States, Nashville - United States, Arlington - United States, Houston - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Randwick - Australia, Clayton - Australia, Heidelberg - Australia, Prahan - Australia, Fremantle - Australia, Perth - Australia, Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Toronto - Canada, Aarhus - Denmark, Hvidovre - Denmark, Odense - Denmark, Clichy Cedex - France, Creteil Cedex - France, Lyon Cedex 04 - France, Nice Cedex 03 - France, Paris Cedex 14 - France, Paris Cedex - France, Vandoeuvre Les Nancy - France, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Cisanello (pisa) - Italy, Pavia - Italy, Guadalajara - Mexico, Cuernavaca - Mexico, Monterrey - Mexico, Ponce - Puerto Rico, San Juan - Puerto Rico, Gothenburg - Sweden, Stockholm - Sweden",2012-06,2010-07-28,2015-10-12,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01327729,Unknown,UNKNOWN,2010-11,"Self Efficacy, Hepatitis C",pegylated interferon alpha 2a YPEG-IFN α-2a 180mcg,Cairo - Egypt,2011-04,2011-04-04,2011-04-04,INTERVENTIONAL,PHASE3,BioGeneric Pharma,INDUSTRY,hepatitis
NCT02143180,Unknown,UNKNOWN,2014-05,Chronic Hepatitis,No interventions listed,Guangzhou - China,2015-12,2014-05-20,2014-05-20,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00229580,Unknown,COMPLETED,2003-12,"Alcoholism, Alcohol Abuse, Hepatitis C, Liver Disease","3 session brief intervention with health behavior feedback, treatment as usual",Seattle - United States,Unknown Date,2005-09-29,2007-11-30,INTERVENTIONAL,PHASE1,University of Washington,OTHER,hepatitis
NCT03951662,Unknown,WITHDRAWN,2020-07-01,"HIV/AIDS, Alcoholic Hepatitis","Alcoholic Hepatitis Group, Heavy Drinking Controls without Hepatitis",Indianapolis - United States,2020-09-30,2019-05-15,2021-01-22,OBSERVATIONAL,Not Available,Indiana University,OTHER,hepatitis
NCT00152880,Unknown,UNKNOWN,2005-07,Hepatitis B,No interventions listed,Toronto - Canada,Unknown Date,2005-09-09,2005-12-01,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT02499562,HBV,COMPLETED,2015-06-25,"Hepatitis B, Chronic","Hydronidone, Placebo, Entecavir","Shanghai - China, Beijing - China",2020-11-20,2015-07-16,2022-06-23,INTERVENTIONAL,PHASE2,"Shanghai Genomics, Inc.",INDUSTRY,hepatitis
NCT04674462,Unknown,RECRUITING,2022-07-07,Vaccine Reaction,"CpG-adjuvanted HBV Vaccine, Traditional HBV Vaccine",New York - United States,2026-07,2020-12-19,2025-01-29,INTERVENTIONAL,PHASE4,NYU Langone Health,OTHER,hepatitis
NCT03500562,Unknown,TERMINATED,2018-05-08,Chronic Hepatitis C,No interventions listed,"Beijing - China, Guangzhou - China",2019-03-29,2018-04-18,2021-09-01,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00151580,TRANSPEG,COMPLETED,2002-02,"Liver Transplantation, Hepatitis C","Ribavirin, Placebo","Besancon - France, Bordeaux - France, Clichy - France, Créteil - France, Lille - France, Lyon - France, Lyon - France, Marseille - France, Montpellier - France, Nice - France, Paris - France, Paris - France, Rennes - France, Strasbourg - France, Toulouse - France, Villejuif - France",Unknown Date,2005-09-09,2012-05-21,INTERVENTIONAL,PHASE3,Rennes University Hospital,OTHER,hepatitis
NCT02479880,Unknown,TERMINATED,2015-07-03,Hepatitis B,"Tenofovir DF, DEXA Scan","Brussels - Belgium, Bron - France, Chaidari - Greece, Bologna - Italy, Bucharest - Romania, Constanta - Romania, Iaşi - Romania, Badalona - Spain, Barcelona - Spain, Vigo - Spain, Birmingham - United Kingdom",2018-02-28,2015-06-24,2019-05-20,INTERVENTIONAL,PHASE4,Gilead Sciences,INDUSTRY,hepatitis
NCT01282762,Unknown,COMPLETED,2010-12,Chronic Kidney Disease,"HEPLISAV, Engerix-B",Norfolk - United States,2013-08,2011-01-25,2019-03-20,OBSERVATIONAL,Not Available,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT01037062,Unknown,COMPLETED,2003-12,Chronic Hepatitis B,Entecavir,"Aichi-Gun - Japan, Nagoya-Shi - Japan, Nagoya-Shi - Japan, Nagoya - Japan, Chiba-Shi - Japan, Onsen-Gun - Japan, Fukuoka-Shi - Japan, Kurume - Japan, Gifu-Shi - Japan, Ogaki-Shi - Japan, Fukuyama-Shi - Japan, Hiroshima City - Japan, Hiroshima-Shi - Japan, Asahikawa-Shi - Japan, Sapporo-Shi - Japan, Sapporo-Shi - Japan, Akashi-Shi - Japan, Morioka-Shi - Japan, Mitoyo-Gun - Japan, Takamatsu-City - Japan, Kumamoto-Shi - Japan, Sendai - Japan, Miyazaki-Gun - Japan, Matsumoto City - Japan, Nagasaki City - Japan, Omura-Shi - Japan, Oita-Gun - Japan, Kurashiki-Shi - Japan, Okayama-Shi - Japan, Okayama-Shi - Japan, Okayama-Shi - Japan, Tsuyama-Shi - Japan, Kawachinagano-Shi - Japan, Osaka-Shi - Japan, Sakai-Shi - Japan, Suita-Shi - Japan, Iruma-Gun - Japan, Minato-Ku - Japan, Musashino-Shi - Japan, Shinjuku-Ku - Japan, Shinjuku-Ku - Japan, Shinjuku-Ku - Japan, Ube-Shi - Japan, Nakakoma-Gun - Japan, Kyoto - Japan, Niigata - Japan, Osaka - Japan, Tokyo - Japan",2006-12,2009-12-21,2011-01-31,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02596880,SD100,COMPLETED,2015-09,"Hepatitis C, Cirrhosis","Sofosbuvir, Daclatasvir, Ribavirin","Tehran - Iran, Islamic Republic of",2016-04,2015-11-04,2023-04-20,INTERVENTIONAL,PHASE3,Tehran University of Medical Sciences,OTHER,hepatitis
NCT00687180,Unknown,COMPLETED,Unknown Date,Autoimmune Hepatitis,"Treatment with mycophenolat mofetil, Treatment with azathioprin",Copenhagen - Denmark,Unknown Date,2008-05-30,2008-05-30,INTERVENTIONAL,PHASE4,"Rigshospitalet, Denmark",OTHER,hepatitis
NCT02593162,Unknown,COMPLETED,2015-10,"Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 4","Faldaprevir, TD-6450, Ribavirin",Coronado - United States,2016-12,2015-10-30,2017-01-30,INTERVENTIONAL,PHASE2,"Trek Therapeutics, PBC",INDUSTRY,hepatitis
NCT00194480,Unknown,COMPLETED,2003-04,"Substance-Related Disorders, Hepatitis",Pegylated Interferon,Seattle - United States,2006-12,2005-09-19,2017-01-12,INTERVENTIONAL,PHASE4,National Institute on Drug Abuse (NIDA),NIH,hepatitis
NCT02485080,Unknown,WITHDRAWN,2015-09,PT-NANBH,"Simeprevir, Sofosbuvir","Palo Alto - United States, New Haven - United States",2016-01,2015-06-30,2016-10-13,INTERVENTIONAL,PHASE4,Stanford University,OTHER,hepatitis
NCT00921180,Unknown,UNKNOWN,2007-02,"Hepatitis B, Chronic","Entecavir and peginterferon alfa-2a, Placebo and peginterferon","Douliou - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2013-12,2009-06-16,2012-12-20,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT02105662,Unknown,COMPLETED,2014-06-03,Chronic Hepatitis C,Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets,No locations listed,2015-02-20,2014-04-07,2021-02-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04565262,Unknown,UNKNOWN,2020-09,HBeAg Positive Chronic Hepatitis B,NAs+IFN-α,Beijing - China,2023-07,2020-09-25,2020-09-30,INTERVENTIONAL,PHASE4,Beijing 302 Hospital,OTHER,hepatitis
NCT02806362,GIFT-R,WITHDRAWN,2016-09,Chronic Hepatitis C Virus,Ombitasvir/paritaprevir/ritonavir,No locations listed,2018-06,2016-06-20,2016-12-05,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00316680,Unknown,TERMINATED,2006-03,"Haemophilus Influenzae Type b, Diphtheria, Tetanus, Hepatitis B, Whole Cell Pertussis","Diphtheria, tetanus, pertussis, hepatitis B, Hib vaccine",Santo Domingo - Dominican Republic,Unknown Date,2006-04-21,2016-10-07,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01991262,Help-B,WITHDRAWN,2015-04,HBV Treatment Adherence by Support Program,No interventions listed,No locations listed,2016-05,2013-11-25,2018-07-24,OBSERVATIONAL,Not Available,Carmel Medical Center,OTHER,hepatitis
NCT01918462,AHIL,COMPLETED,2013-04,Alcoholic Hepatitis,No interventions listed,Aarhus - Denmark,2018-04-20,2013-08-07,2021-04-29,OBSERVATIONAL,Not Available,University of Aarhus,OTHER,hepatitis
NCT01859962,Unknown,COMPLETED,2013-05,Chronic Hepatitis C,"PPI-668, BI 207127 Dose 1, BI 207127 Dose 2, Faldaprevir, Ribavirin, BI 207127 Placebo",San Francisco - United States,2014-05,2013-05-22,2015-11-25,INTERVENTIONAL,PHASE2,"Presidio Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT04610762,Unknown,COMPLETED,2020-11-17,"Hepatitis C, Chronic",GeneXpert HCV VL Fingerstick test,Bruxelles - Belgium,2021-11-17,2020-10-30,2023-05-06,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire Saint Pierre,OTHER,hepatitis
NCT00835380,Unknown,COMPLETED,2008-03,Hepatitis A Virus Infection,"Hepatitis A Vaccine, Purified Inactivated (VAQTA™)",No locations listed,2008-10,2009-02-03,2017-04-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05507762,Unknown,UNKNOWN,2021-07-20,Cirrhosis Due to Hepatitis B,"UC-MSCs, Saline solution",Wuhan - China,2023-07-20,2022-08-19,2022-08-19,INTERVENTIONAL,PHASE2,Renmin Hospital of Wuhan University,OTHER,hepatitis
NCT01143662,Unknown,COMPLETED,2010-07,Chronic Hepatitis B,"Ypeginterferon alfa-2b, Peginterferon alfa-2a","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changsha - China, Changsha - China, Chengdu - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guilin - China, Hangzhou - China, Harbin - China, Hefei - China, Jinan - China, Lanzhou - China, Nanchang - China, Nanjing - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenzhen - China, Shijiazhuang - China, Taiyuan - China, Tianjin - China, Wenzhou - China, Wuhan - China, Xian - China, Zhengzhou - China, Zhengzhou - China",2011-04,2010-06-14,2013-02-04,INTERVENTIONAL,PHASE2,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT02176980,HepART-RCT,COMPLETED,2014-10,"Hepatitis C, Chronic; AUD","Brief alcohol counseling, Group and Individual Therapy Sessions",Durham - United States,2018-09-30,2014-06-27,2018-10-18,INTERVENTIONAL,NA,Duke University,OTHER,hepatitis
NCT01871662,HEPASIL,WITHDRAWN,2013-08,"Hepatitis C, Chronic","Legalon® SIL (Silibinin), Pegylated interferon alfa2b, Ribavirin",Cairo - Egypt,2016-02,2013-06-07,2015-03-05,INTERVENTIONAL,PHASE3,Rottapharm,INDUSTRY,hepatitis
NCT00125762,Unknown,COMPLETED,2005-03,"Cirrhosis, Hepatitis B, Hepatitis C",FibroScan,"Boston - United States, Saint Louis - United States, Durham - United States",2008-05-01,2005-08-02,2017-10-27,INTERVENTIONAL,NA,"Afdhal, Nezam, M.D.",INDIV,hepatitis
NCT02243280,Unknown,COMPLETED,2014-08,"Chronic Hepatitis C, Hepatitis C Virus, HCV","ABT-493, ABT-530",No locations listed,2016-02,2014-09-17,2021-07-13,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT04101162,NAFLD,UNKNOWN,2019-09-15,Non-Alcoholic Fatty Liver Disease,shear waves elastography; liver biopsy,Latina - Italy,2020-10-15,2019-09-24,2020-04-01,INTERVENTIONAL,NA,University of Roma La Sapienza,OTHER,hepatitis
NCT00039962,Unknown,COMPLETED,2002-05,"Hepatitis C, Hepatitis C, Chronic","thymalfasin (thymosin alpha 1), PEGinterferon alfa-2a","Mobile - United States, Scottsdale - United States, Anaheim - United States, Berkeley - United States, La Jolla - United States, Loma Linda - United States, Pasadena - United States, Sacramento - United States, Sacramento - United States, San Francisco - United States, San Mateo - United States, Santa Clara - United States, Littleton - United States, Washington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Atlanta - United States, Savannah - United States, Meridian - United States, Chicago - United States, Louisville - United States, New Orleans - United States, Baltimore - United States, Chevy Chase - United States, Towson - United States, Boston - United States, Royal Oak - United States, Jackson - United States, Kansas City - United States, Kansas City - United States, Manhasset - United States, New York - United States, New York - United States, Charlotte - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Cleveland - United States, Portland - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Providence - United States, Charleston - United States, Memphis - United States, Austin - United States, Dallas - United States, Houston - United States, Houston - United States, Fairfax - United States, Richmond - United States, Milwaukee - United States, Ponce - Puerto Rico, Santurce - Puerto Rico",Unknown Date,2002-06-19,2008-01-15,INTERVENTIONAL,PHASE3,SciClone Pharmaceuticals,INDUSTRY,hepatitis
NCT00000580,Unknown,COMPLETED,1975-11,"Hepatitis B, Hepatitis, Viral, Human, Liver Diseases","immunoglobulins, intravenous",No locations listed,Unknown Date,1999-10-28,2013-11-26,INTERVENTIONAL,PHASE3,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT01310062,Unknown,UNKNOWN,2010-08,"Hepatitis B,Chronic, Carcinoma,Hepatocellular",No interventions listed,"Alor Star - Malaysia, Kota Kinabalu - Malaysia, Kuching - Malaysia, Selayang - Malaysia, Kuala Lumpur - Malaysia, Pulau Pinang - Malaysia, Pulau Pinang - Malaysia, Pulau Pinang - Malaysia",Unknown Date,2011-03-07,2011-03-07,OBSERVATIONAL,Not Available,"Ministry of Health, Malaysia",OTHER_GOV,hepatitis
NCT05883891,AH2023,COMPLETED,2017-06-01,Alcoholic Hepatitis,prothrombin time,Rome - Italy,2022-09-30,2023-06-01,2023-06-01,OBSERVATIONAL,Not Available,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,OTHER,hepatitis
NCT04480294,Unknown,UNKNOWN,2020-07-28,Chronic Hepatitis B,HRS5091,Shanghai - China,2021-11-23,2020-07-21,2021-10-22,INTERVENTIONAL,PHASE1,"Jiangsu HengRui Medicine Co., Ltd.",INDUSTRY,hepatitis
NCT01756794,QuickTrans,COMPLETED,2012-12-05,"Alcoholic Hepatitis, Alcoholic Cirrhosis",Liver transplantation,"Anvers - Belgium, Bruxelles - Belgium, Gent - Belgium, Liege - Belgium, Amiens - France, Angers - France, Besançon - France, Bondy - France, Brest - France, Caen - France, Chambray les tours - France, Clamart - France, Clichy - France, Créteil - France, Dijon - France, Grenoble - France, Lille - France, Lyon - France, Montpellier - France, Nancy - France, Nantes - France, Nice - France, Paris - France, Paris - France, Paris - France, Pessac - France, Poitiers - France, Reims - France, Rennes - France, Strasbourg - France, Toulouse - France, Villejuif - France",2018-06-07,2012-12-27,2020-04-02,INTERVENTIONAL,NA,"University Hospital, Lille",OTHER,hepatitis
NCT01628094,Unknown,COMPLETED,2012-06,"Hepatitis C, Chronic","RO5024048, RO5190591, RO5466731, ribavirin [Copegus], ritonavir","LaJolla - United States, Englewood - United States, South Miami - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Kansas City - United States, Detroit - United States, Saint Louise - United States, Asheville - United States, Dallas - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Vancouver - United States, Kingswood - Australia, Sydney - Australia, Westmead - Australia, Herston - Australia, Parkville - Australia, Berlin - Germany, Frankfurt Am Main - Germany, Hamburg - Germany, Hannover - Germany, Dunedin - New Zealand, Grafton - New Zealand, Hamilton - New Zealand, Bialystok - Poland, Chorzow - Poland, Lodz - Poland, Myslowice - Poland",2013-11,2012-06-26,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01509391,IM1,COMPLETED,2012-01,"Chronic Hepatitis C, Liver Cirrhosis",keyhole-limpet hemocyanin,Graz - Austria,2012-10,2012-01-13,2012-10-17,INTERVENTIONAL,NA,Medical University of Graz,OTHER,hepatitis
NCT02185794,Unknown,COMPLETED,2014-06-13,Hepatitis C Virus Infection,"Voxilaprevir, Placebo to match voxilaprevir, SOF/VEL","Costa Mesa - United States, DeLand - United States, Orlando - United States, Kansas City - United States, Saint Louis - United States, Berlin - United States, Marlton - United States, Philadelphia - United States, Knoxville - United States, San Antonio - United States, San Juan - Puerto Rico",2014-12-22,2014-07-10,2020-09-17,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT00423891,Unknown,COMPLETED,2007-06-30,"Hepatitis B, Chronic",Entecavir,"San Francisco - United States, Hartford - United States, Gainesville - United States, Baltimore - United States, Boston - United States, New York - United States, Philadelphia - United States, Providence - United States, Dallas - United States, Buenos Aires - Argentina, Bruxelles - Belgium, Porto Alegre - Brazil, Sco Paulo - Brazil, Toronto - Canada, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Taipei - Taiwan, London - United Kingdom, Birmingham - United Kingdom",2013-08-31,2007-01-18,2018-05-02,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01604291,Unknown,COMPLETED,2012-05-28,"Hepatitis C, Chronic",No interventions listed,"Afula - Israel, Ashkelon - Israel, Beer Sheva - Israel, Hadera - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Holon - Israel, Jerusalem - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Nazareth - Israel, Petach Tikva - Israel, Petah Tiqwa - Israel, Ramat Gan - Israel, Rehovot - Israel, Safed - Israel, Tel Aviv - Israel, Tiberias - Israel, Zerifin - Israel",2016-02-10,2012-05-23,2019-03-14,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02908191,Unknown,COMPLETED,2016-11,Chronic Hepatitis B,"ABI-H0731, Placebo for ABI-H0731, Entecavir, Tenofovir disoproxil fumarate, Pegasys, Nucleos(t)ide","Auckland - New Zealand, Hamilton - New Zealand",2018-03-31,2016-09-20,2019-04-04,INTERVENTIONAL,PHASE1,Assembly Biosciences,INDUSTRY,hepatitis
NCT00975091,Unknown,COMPLETED,2004-05,Chronic Hepatitis B Virus,"Entecavir, Entecavir",No locations listed,2007-08,2009-09-11,2010-02-02,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01987791,Unknown,UNKNOWN,2005-01,"Thrombocytopenia, Hepatitis B, Cirrhosis",No interventions listed,No locations listed,2013-11,2013-11-19,2013-11-19,OBSERVATIONAL,Not Available,Peking University People's Hospital,OTHER,hepatitis
NCT01485991,ATTAIN,COMPLETED,2012-02,Hepatitis C,"TMC435, TVR","Bakersfield - United States, San Diego - United States, Aurora - United States, Washington - United States, Jacksonville - United States, Orlando - United States, West Palm Beach - United States, Atlanta - United States, Honolulu - United States, Chicago - United States, Crestview Hills - United States, New Orleans - United States, Chevy Chase - United States, Jackson - United States, Tupelo - United States, Kansas City - United States, Missoula - United States, Newark - United States, New York - United States, Rochester - United States, Cincinnati - United States, Cleveland - United States, Allentown - United States, Philadelphia - United States, Pittsburgh - United States, Arlington - United States, Houston - United States, Odessa - United States, San Antonio - United States, Falls Church - United States, Bellevue - United States, Seattle - United States, Buenos Aires N/A - Argentina, Buenos Aires - Argentina, Rosario, Santa Fe - Argentina, Darlinghurst - Australia, Greenslopes - Australia, Kingswood - Australia, Melbourne - Australia, Parkville - Vic - Australia, Perth - Australia, Sydney - Australia, Woolloongabba N/A - Australia, Linz - Austria, Wien - Austria, Brussels - Belgium, Brussel - Belgium, Haine-Saint-Paul, La Louviere - Belgium, Leuven - Belgium, Liège - Belgium, Campinas - Brazil, Ribeirão Preto - Brazil, Salvador - Brazil, Sao Paulo - Brazil, Sofia - Bulgaria, Varna - Bulgaria, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Toronto - Canada, Montreal - Canada, Brno - Czech Republic, Karlovy Vary - Czech Republic, Plzen - Czech Republic, Praha 2 - Czech Republic, Praha 4 - Czech Republic, Copenhagen - Denmark, Hvidovre N/A - Denmark, Odense N/A - Denmark, Grenoble - France, Lyon - France, Marseille - France, Nice - France, Paris Cedex 12 - France, Paris - France, Pessac - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Frankfurt N/A - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Kiel - Germany, Mainz - Germany, München - Germany, Stuttgart - Germany, Ulm - Germany, Würzburg - Germany, Alexandroupolis - Greece, Athens - Greece, Larissa - Greece, Budapest - Hungary, Debrecen - Hungary, Kaposvár - Hungary, Pecs - Hungary, Szeged N/A - Hungary, Haifa - Israel, Jerusalem - Israel, Petah Tiqva - Israel, Ramat-Gan - Israel, Tel-Aviv - Israel, Zefat - Israel, Fredrikstad - Norway, Nordbyhagen - Norway, Stavanger - Norway, Tromsø - Norway, Bydgoszcz - Poland, Chorzow - Poland, Kielce - Poland, Lodz - Poland, Lublin - Poland, Myslowice - Poland, Raciborz - Poland, Warszawa - Poland, Lisboa - Portugal, Lisbon - Portugal, Porto - Portugal, Santurce - Puerto Rico, Bucuresti - Romania, Constanta - Romania, Iasi - Romania, Timisoara - Romania, Barcelona - Spain, Madrid - Spain, Santander N/A - Spain, Sevilla N/A - Spain, Valencia - Spain, Göteborg - Sweden, Lund - Sweden, Malmö - Sweden, Stockholm - Sweden, Örebro - Sweden, Lugano - Switzerland, St Gallen - Switzerland, Zurich N/A - Switzerland, Glasgow - United Kingdom, Leeds - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Plymouth - United Kingdom, Southampton - United Kingdom",2014-04,2011-12-06,2016-04-26,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT00215891,Unknown,COMPLETED,Unknown Date,"Chronic Hepatitis C Infection in HIV-Infected Persons, HIV Infections",PEG-Interferon a-2b + Ribavirin,Baltimore - United States,Unknown Date,2005-09-22,2005-10-25,INTERVENTIONAL,PHASE3,Hepatitis Resource Network,OTHER,hepatitis
NCT02707991,Care2Cure,COMPLETED,2016-07,"HIV, Hepatitis C, Chronic",Nurse Case Management,Baltimore - United States,2018-04,2016-03-15,2019-05-02,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT00861744,Unknown,COMPLETED,2009-06-03,"Rubella, Mumps, Measles, Measles-Mumps-Rubella Vaccine","GSK Biological's investigational vaccine 209762, M-M-R® II (Merck and Co), Varivax®, Havrix®, Prevnar®","Tuscaloosa - United States, Conway - United States, Jonesboro - United States, Little Rock - United States, Anaheim - United States, Downey - United States, Fresno - United States, Huntington Beach - United States, Paramount - United States, Santa Ana - United States, West Covina - United States, Altamonte Springs - United States, Dalton - United States, Marietta - United States, Nampa - United States, DeKalb - United States, Arkansas City - United States, Bardstown - United States, Bossier City - United States, Metairie - United States, Baltimore - United States, Fall River - United States, Kansas City - United States, Great Falls - United States, Henderson - United States, Utica - United States, Cary - United States, Raleigh - United States, Cincinnati - United States, Dayton - United States, Tulsa - United States, Gresham - United States, East Norriton - United States, Rydal - United States, Charleston - United States, Bristol - United States, Kingsport - United States, Corpus Christi - United States, Layton - United States, Provo - United States, Saint George - United States, Springville - United States, West Jordan - United States, Virginia Beach - United States, Huntington - United States, Bayamon - Puerto Rico, San Germán - Puerto Rico, San Juan - Puerto Rico",2010-07-21,2009-03-13,2020-01-03,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00040144,Unknown,TERMINATED,2002-07,Chronic Hepatitis B,"ACH126, 433","Los Angeles - United States, Orange - United States, Pasadena - United States, San Francisco - United States, Miami - United States, Chicago - United States, Chicago - United States, Boston - United States, New York - United States, Dallas - United States, Dallas - United States, Fairfax - United States, Seattle - United States, Vancouver - Canada, Toronto - Canada, Toronto - Canada, Montréal - Canada, Hong Kong - China",Unknown Date,2002-06-25,2021-02-18,INTERVENTIONAL,PHASE2,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT01861444,Unknown,TERMINATED,2011-03,"Hepatitis D, Chronic",No interventions listed,Bucharest - Romania,2015-03,2013-05-23,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01435044,QUANTUM,COMPLETED,2011-09,"Hepatitis C, Chronic","Sofosbuvir, GS-0938, RBV, Placebo to match sofosbuvir, Placebo to match GS-0938","Montgomery - United States, Bakersfield - United States, Coronado - United States, La Mesa - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Denver - United States, Engelwood - United States, Englewood - United States, Washington - United States, Deland - United States, Gainesville - United States, Miami - United States, Orlando - United States, Orlando - United States, South Miami - United States, Trinity - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Marietta - United States, Downers Grove - United States, Annapolis - United States, Baltimore - United States, Hillsborough - United States, New York - United States, New York - United States, Ashville - United States, Statesville - United States, Winston-Salem - United States, Cincinnati - United States, Germantown - United States, Nashville - United States, Arlington - United States, Austin - United States, San Antonio - United States, Norfolk - United States, Seattle - United States, San Juan - Puerto Rico, San Juan - Puerto Rico",2013-04,2011-09-15,2014-02-06,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00850044,Unknown,COMPLETED,2009-02,HCV Infection,"ABT-450, ritonavir, placebo for ABT-450, Placebo for ritonavir",Waukegan - United States,2009-07,2009-02-24,2017-11-20,INTERVENTIONAL,PHASE1,AbbVie,INDUSTRY,hepatitis
NCT02316444,Unknown,COMPLETED,2015-11,HIV/AIDS and Infections,Hepatitis B vaccine,Kampala - Uganda,2017-04-28,2014-12-12,2019-01-25,INTERVENTIONAL,PHASE4,Fred Hutchinson Cancer Center,OTHER,hepatitis
NCT01453244,Unknown,COMPLETED,2011-07,Chronic Hepatitis C,No interventions listed,"Busan - Korea, Republic of",2013-03,2011-10-17,2013-06-03,OBSERVATIONAL,Not Available,Inje University,OTHER,hepatitis
NCT01359644,Unknown,COMPLETED,2011-06,Chronic Hepatitis C,"PSI-7977, Daclatasvir, Ribavirin","Coronado - United States, San Diego - United States, Aurora - United States, Gainesville - United States, Orlando - United States, South Miami - United States, Baltimore - United States, Lutherville - United States, Ann Arbor - United States, Bronx - United States, New York - United States, Tulsa - United States, Tulsa - United States, Philadelphia - United States, San Antonio - United States, Annandale - United States, Madison - United States, San Juan - Puerto Rico",2013-01,2011-05-25,2015-10-23,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02533544,Unknown,COMPLETED,2015-10,Chronic Hepatitis B,tenofovir disoproxil fumarate,"Junggu - Korea, Republic of",2018-10,2015-08-27,2019-01-30,OBSERVATIONAL,Not Available,Myeong Jun Song,OTHER,hepatitis
NCT05840640,Unknown,COMPLETED,2017-10-01,Alcoholic Hepatitis,"Standard Medical Therapy, G-CSF, G-CSF and NAC",Chandigarh - India,2021-02-28,2023-05-03,2023-05-03,INTERVENTIONAL,PHASE4,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT02358044,Unknown,COMPLETED,2015-02-27,Hepatitis C,"Sofosbuvir, PegIntron, Ribavirin, Grazoprevir/Elbasvir (100 mg/50 mg) FDC",No locations listed,2015-11-26,2015-02-06,2018-10-03,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00088140,Unknown,COMPLETED,2004-07,"Hepatitis C, Chronic","IDN-6556, Placebo","Phoenix - United States, La Jolla - United States, San Francisco - United States, San Francisco - United States, Miami - United States, Indianapolis - United States, Boston - United States, Detroit - United States, Rochester - United States, New York City - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Richmond - United States",2005-10,2004-07-21,2012-08-13,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT01997944,Unknown,COMPLETED,2013-11,Chronic Hepatitis B,"Human Serum ALbumin/interferon alpha2a, Pegasys",Changchun - China,2014-09,2013-11-28,2014-11-17,INTERVENTIONAL,PHASE2,Beijing Bio-Fortune Ltd.,INDUSTRY,hepatitis
NCT00519792,Unknown,COMPLETED,2007-08,Chronic Hepatitis C,Omega DUROS device,"Los Angeles - United States, San Francisco - United States, St Louis - United States, New York - United States, Durham - United States, Dallas - United States, San Antonio - United States, San Juan - Puerto Rico",2010-03,2007-08-23,2011-06-08,INTERVENTIONAL,PHASE1,Intarcia Therapeutics,INDUSTRY,hepatitis
NCT01686789,Unknown,COMPLETED,2011-01,Chronic Hepatitis C Virus,Pegylated interferon alpha-2a,"Riyadh - Saudi Arabia, Riyadh - Saudi Arabia, Riyadh - Saudi Arabia",2015-08,2012-09-18,2016-02-24,INTERVENTIONAL,PHASE4,King Abdulaziz Medical City,OTHER_GOV,hepatitis
NCT00035789,Unknown,COMPLETED,2001-11,Chronic Hepatitis B,Entecavir,"Birmingham - United States, Tucson - United States, La Jolla - United States, Los Angeles - United States, Orange - United States, San Francisco - United States, Farmington - United States, Miami Beach - United States, Atlanta - United States, Honolulu - United States, Chicago - United States, Iowa City - United States, Kansas City - United States, Dundalk - United States, Worcester - United States, Ann Arbor - United States, Royal Oak - United States, St. Paul - United States, Manhasset - United States, New York - United States, Rochester - United States, Charlotte - United States, Cleveland - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Nashville - United States, Dallas - United States, Fairfax - United States, Richmond - United States, Seattle - United States",2005-05,2002-05-06,2011-04-14,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02850289,Unknown,COMPLETED,2006-04,"Hepatitis C, Chronic","Pegylated interferon (PEG-INF) alfa-2a, Ribavirin","Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Edmonton - Canada, Abbotsford - Canada, Surrey - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vernon - Canada, West Vancouver - Canada, Winnipeg - Canada, Barrie - Canada, Brampton - Canada, Downsview - Canada, Hamilton - Canada, Kingston - Canada, London - Canada, London - Canada, London - Canada, Mississauga - Canada, Newmarket - Canada, Oshawa - Canada, Oshawa - Canada, Ottawa - Canada, Ottawa - Canada, Richmond Hill - Canada, Richmond Hill - Canada, Sudbury - Canada, Thunder Bay - Canada, Toronto - Canada, Toronto - Canada, Windsor - Canada, Windsor - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Quebec City - Canada, Quebec City - Canada, Quebec City - Canada, Quebec City - Canada, St-charles Borromee - Canada, Regina - Canada, Saskatoon - Canada",2008-10,2016-07-29,2017-10-03,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05751889,Unknown,RECRUITING,2023-03-01,Viral Hepatitis C,"Serious Game, Traditional Health Education",Taipei - Taiwan,2025-12-31,2023-03-02,2024-04-25,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT02165189,GALAXY,COMPLETED,2014-08,Hepatitits C,"Simeprevir, Sofosbuvir, Ribavirin, Simeprevir, Sofosbuvir","Aurora - United States, Gainesville - United States, Miami - United States, Boston - United States, Ann Arbor - United States, Detroit - United States, New York - United States, Durham - United States, Philadelphia - United States, Pittsburgh - United States, Dallas - United States",2015-11,2014-06-17,2016-11-11,INTERVENTIONAL,PHASE2,"Janssen Scientific Affairs, LLC",INDUSTRY,hepatitis
NCT00931229,Unknown,UNKNOWN,2009-06,Non-Hodgkin's Lymphoma,entecavir,Taipei - Taiwan,2017-12,2009-07-02,2016-11-09,INTERVENTIONAL,NA,"National Health Research Institutes, Taiwan",OTHER,hepatitis
NCT02129829,WATCH,COMPLETED,2011-10,"Hepatitis B, Chronic, Hepatocellular Carcinoma",Tenofovir disoproxil,"Fajara - Gambia, Thies - Senegal",2018-07-31,2014-05-02,2020-09-28,OBSERVATIONAL,Not Available,Imperial College London,OTHER,hepatitis
NCT05513729,Unknown,UNKNOWN,2022-08-18,Type 2 Diabetes Mellitus With Complication,"Canagliflozin, Pioglitazone",Xi'an - China,2023-12-31,2022-08-24,2022-08-24,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT00697229,Unknown,COMPLETED,1992-09,Hepatitis B,"Engerix™-B, HBV-MPL vaccine",Wilrijk - Belgium,1996-05,2008-06-13,2008-06-13,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00001729,Unknown,COMPLETED,1997-10,"Chronic Hepatitis C, Fibrosis, Hemolytic Anemia",Ribavirin,Bethesda - United States,Unknown Date,1999-11-04,2008-03-04,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02939989,MAGELLAN-3,COMPLETED,2016-11-21,Hepatitis C Virus Infection,"Sofosbuvir, Glecaprevir/Pibrentasvir, Ribavirin","Dothan - United States, Los Angeles - United States, Baltimore - United States, Detroit - United States, Buffalo - United States, Statesville - United States, Germantown - United States, San Antonio - United States, Herston - Australia, Parkville - Australia, Calgary - Canada, Beijing - China, Chengdu - China, Chongqing - China, Fuzhou - China, Düsseldorf - Germany, Hamburg - Germany, Seoul - Korea, Republic of, Grafton - New Zealand, Hamilton - New Zealand, Otago - New Zealand, Samara - Russian Federation, Majadahonda - Spain, Solna - Sweden, Bern - Switzerland, London - United Kingdom",2021-05-07,2016-10-20,2022-05-04,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00307489,Unknown,COMPLETED,2006-03,Chronic Hepatitis B,"tenofovir DF, emtricitabine /tenofovir DF","San Francisco - United States, San Jose - United States, Flushing - United States, New York - United States, New York - United States, New York - United States, Philadelphia - United States, Fairfax - United States, Norfolk - United States, Richmond - United States, Angers - France, Clichy - France, Lille - France, Lyon - France, Marseille - France, Rouen - France, Strasbourg - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Erlangen - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Munchen - Germany, Sevilla - Spain",2008-01,2006-03-28,2011-11-01,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02581189,AMBER,COMPLETED,2015-10-13,Chronic Hepatitis C,"Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin",No locations listed,2017-12-20,2015-10-20,2019-03-27,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01378104,Unknown,COMPLETED,2008-10,"Sustained Virologic Response, IL28B Polymorphism","peginterferon alfa 2a (pegasys), peginterferon alfa-2a (pegasys)","Bucheon - Korea, Republic of, Chunchun - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejun - Korea, Republic of, Daejun - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Koyang-si - Korea, Republic of, Koyang-si - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Wonju-si - Korea, Republic of",2011-09,2011-06-22,2013-03-08,INTERVENTIONAL,PHASE4,The Catholic University of Korea,OTHER,hepatitis
NCT02247401,Unknown,COMPLETED,2014-11-04,"HCV, Hepatitis C Infection, Genotype 4","2 DAA, RBV",No locations listed,2016-08-01,2014-09-25,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT06746701,Unknown,RECRUITING,2023-05-25,HBV,"Peg-IFNα-2b combined with NA, Nucleotide Analogues","Guangzhou - China, Chenzhou - China, Hengyang - China, Hengyang - China",2027-05-25,2024-12-24,2024-12-24,OBSERVATIONAL,Not Available,Xiangya Hospital of Central South University,OTHER,hepatitis
NCT00188201,Unknown,UNKNOWN,2002-01,"Hepatitis C, Hepatitis B",No interventions listed,Toronto - Canada,Unknown Date,2005-09-16,2005-11-29,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT04667104,PENGUIN,COMPLETED,2021-02-01,"Hepatitis B, Chronic","JNJ-73763989, Tenofovir disoproxil, Tenofovir alafenamide (TAF), Entecavir (ETV) monohydrate, PegIFN-alpha2a","Bunkyo Ku - Japan, Suita-shi - Japan, Auckland - New Zealand, Papatoetoe - New Zealand, Gdansk - Poland, Myslowice - Poland, Warszawa - Poland, Wroclaw - Poland, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan",2022-05-16,2020-12-14,2024-07-03,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT01912404,AH,TERMINATED,2013-07,Alcoholic Hepatitis,"IDN-6556, Placebo","Indianapolis - United States, Rochester - United States, Richmond - United States",2015-08,2013-07-31,2016-11-04,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT02845401,BeNEG-DO,ACTIVE_NOT_RECRUITING,2016-11-17,Chronic Hepatitis B Virus,Stop NA therapy,"San Francisco - United States, San Francisco - United States",2026-05-25,2016-07-27,2023-07-07,INTERVENTIONAL,NA,California Pacific Medical Center Research Institute,OTHER,hepatitis
NCT04456504,Unknown,COMPLETED,2020-09-15,"Healthcare Worker, Hepatitis B Vaccine, Nonresponder",Recombinant hepatitis B vaccine with CpG adjuvant,Madison - United States,2023-12-06,2020-07-02,2024-07-16,INTERVENTIONAL,PHASE4,"University of Wisconsin, Madison",OTHER,hepatitis
NCT04780204,ATTACH,ACTIVE_NOT_RECRUITING,2021-08-23,"Hepatitis B, Chronic",Treatment,"Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of",2027-01,2021-03-03,2024-10-09,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT00323804,Unknown,COMPLETED,2006-05,"Hepatitis C, Chronic, Liver Fibrosis","Peginterferon alfa-2b, Ribavirin, Ribavirin-Placebo","Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, La Louvière - Belgium, Liège - Belgium, Aix en Provence - France, Amiens - France, Amiens - France, Angers - France, Argenteuil - France, Bobigny - France, Bondy - France, Bordeaux Pessac - France, Bourgoin-Jallieu - France, Brest - France, Caen - France, Châteauroux - France, Clermont-Ferrand - France, Clichy - France, Corbeil-Essonnes - France, Dijon - France, Grenoble - France, La Roche sur Yon - France, Le Kremlin-Bicêtre - France, Le Mans - France, Lille - France, Lyon - France, Marseille - France, Montauban - France, Montelimar - France, Montpellier - France, Nantes - France, Nice - France, Orléans - France, Paris - France, Paris - France, Rennes - France, Rouen - France, Saint Quentin - France, Strasbourg - France, Toulouse - France, Toulouse - France, Tours - France, Vandoeuvre les Nancy - France, Villejuif - France",2013-02,2006-05-10,2014-09-04,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT04652804,STOP-C,ACTIVE_NOT_RECRUITING,2021-01-21,"Hepatitis C, HIV Coinfection","Low intensity HCV treatment adherence support, Medium intensity HCV treatment adherence support, High intensity HCV treatment adherence support",Chennai - India,2023-12-30,2020-12-03,2024-05-20,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT01052701,Unknown,COMPLETED,2009-12,"Hepatitis C, HIV","Ribavirin, Ribavirin plus Abacavir (ABC)",Baltimore - United States,2012-09,2010-01-20,2017-05-01,INTERVENTIONAL,PHASE1,Johns Hopkins University,OTHER,hepatitis
NCT01852604,Unknown,COMPLETED,2013-03,Chronic Hepatitis C Virus,"Samatasvir, Simeprevir, Ribavirin (RBV), TMC647055, Ritonavir (RTV), Pegylated interferon (Peg-IFN), Samatasvir matching placebo",No locations listed,2015-04,2013-05-14,2015-04-23,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT06159504,CUTTS HepC,NOT_YET_RECRUITING,2024-03,"Hepatitis C, RDT","sofosbuvir/velpatasvir (SOF/VEL), Shortened read time of rapid diagnostic test for hepatitis C virus.",No locations listed,2026-12,2023-12-06,2023-12-06,INTERVENTIONAL,PHASE1,Médecins du Monde,OTHER,hepatitis
NCT00953589,480S,COMPLETED,2009-07,"Hepatitis C, Chronic",ribavirin,"Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Haifa - Israel, Nazareth - Israel, Petah-Tiqwa - Israel, Tel Aviv - Israel, Zefat - Israel, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Iasi - Romania",2010-05,2009-08-06,2012-02-02,INTERVENTIONAL,PHASE2,"Biolex Therapeutics, Inc.",INDUSTRY,hepatitis
NCT00507689,Unknown,COMPLETED,2007-09,Chronic Hepatitis B,"FTC/TDF, Hepatitis B Immunoglobulin (HBIg)","Los Angeles - United States, San Francisco - United States, San Francisco - United States, Atlanta - United States, Chicago - United States, New York - United States, New York - United States",2011-05,2007-07-26,2014-03-14,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT03149289,Unknown,COMPLETED,2015-03-01,"Hepatitis C, Chronic, Hemoglobinopathies",Antiviral drugs,No locations listed,2016-03-01,2017-05-11,2017-05-11,OBSERVATIONAL,Not Available,Società Italiana Talassemie ed Emoglobinopatie,OTHER,hepatitis
NCT06159244,HepatAlc-IM,RECRUITING,2023-11-15,"Severe Acute Alcoholic Hepatitis, Alcohol, Intestinal Microbiota, Corticosteroids",stool withdrawal,Amiens - France,2028-11,2023-12-06,2023-12-06,INTERVENTIONAL,NA,"Centre Hospitalier Universitaire, Amiens",OTHER,hepatitis
NCT02108444,Unknown,COMPLETED,2007-01,"Hepatitis, Hepatitis B, Lymphoma, Hematologic Diseases",No interventions listed,Beijing - China,2013-12,2014-04-09,2014-07-24,OBSERVATIONAL,Not Available,Peking University,OTHER,hepatitis
NCT00551629,Unknown,COMPLETED,2001-05,Bacterial Infections; Virus Diseases,"AR51 (12, 10), PR51 (3, 10), PR51 (6, 10), PR51 (6, 15)",No locations listed,2003-03,2007-10-31,2015-10-30,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03695029,Unknown,UNKNOWN,2010-12-29,Hepatitis B Virus Infection,Tenofovir Alafenamide,Taipei - Taiwan,2020-12-31,2018-10-03,2020-11-27,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT06829329,Unknown,RECRUITING,2024-12-05,Chronic Hepatitis B,"AHB-137, Placebo","Chongqing - China, Fuzhou - China, Zhenjiang - China, Hangzhou - China",2025-10-21,2025-02-17,2025-02-17,INTERVENTIONAL,PHASE2,"Ausper Biopharma Co., Ltd.",INDUSTRY,hepatitis
NCT00991289,Unknown,COMPLETED,2010-01,"HIV Infection, Hepatitis C Infection","Nitazoxanide (NTZ), Pegylated interferon alfa-2a (PEG), Ribavirin (RBV)","Birmingham - United States, Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, Boston - United States, Newark - United States, New York - United States, New York - United States, Rochester - United States, Rochester - United States, Chapel Hill - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Providence - United States, Richmond - United States, San Juan - Puerto Rico",2010-11,2009-10-08,2021-11-04,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01554189,Unknown,TERMINATED,2012-04,"Hepatitis C, Chronic","MK-8325, Placebo",No locations listed,2013-04,2012-03-14,2015-07-21,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04698629,HepPSI,COMPLETED,2020-11-05,Hepatitis C,No interventions listed,Seattle - United States,2023-06-30,2021-01-07,2024-06-07,OBSERVATIONAL,Not Available,University of Washington,OTHER,hepatitis
NCT05285592,Unknown,UNKNOWN,2022-04-01,Alcoholic Hepatitis,"Fecal Transplantation, Standard Medical Treatment",New Delhi - India,2024-03-31,2022-03-17,2022-04-20,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT05970289,Unknown,ACTIVE_NOT_RECRUITING,2023-08-22,Chronic Hepatitis B Virus Infection,"PEG-IFNα, BRII-835","Kingswood - Australia, Birtinya - Australia, Melbourne - Australia, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Hong Kong - China, Hong Kong - China, Changchun - China, Shanghai - China, Kaohsiung - China, Taipei - China, Taipei - China, Hangzhou - China, Busan - Korea, Republic of, Chuncheon-si - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Soeul - Korea, Republic of, Singapore - Singapore, Singapore - Singapore, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Nonthaburi - Thailand, Songkhla - Thailand",2025-08,2023-08-01,2024-03-21,INTERVENTIONAL,PHASE2,Brii Biosciences Limited,INDUSTRY,hepatitis
NCT01466192,Unknown,COMPLETED,2012-05,Chronic Hepatitis C,"MP-424 (generic name:Telaprevir), Ribavirin, Peginterferon alfa-2b",Minato-ku - Japan,2013-08,2011-11-06,2014-11-02,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00895596,Unknown,COMPLETED,2004-03,Chronic Hepatitis B,LB80380,"Hong Kong - China, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2006-08,2009-05-08,2009-05-08,INTERVENTIONAL,PHASE2,LG Life Sciences,INDUSTRY,hepatitis
NCT05286216,Unknown,UNKNOWN,2022-04-15,"Hepatitis B, Chronic, Adherence, Medication, Quality of Life",effectiveness of education,No locations listed,2022-04-15,2022-03-18,2022-03-18,INTERVENTIONAL,NA,Istanbul University - Cerrahpasa,OTHER,hepatitis
NCT02940496,Unknown,COMPLETED,2016-12-09,"BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Hepatitis C Infection, Refractory Liver Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7, Stage IIIA Hepatocellular Carcinoma AJCC v7, Stage IIIB Hepatocellular Carcinoma AJCC v7, Stage IIIC Hepatocellular Carcinoma AJCC v7, Stage IV Hepatocellular Carcinoma AJCC v7, Stage IVA Hepatocellular Carcinoma AJCC v7, Stage IVB Hepatocellular Carcinoma AJCC v7","Elbasvir/Grazoprevir, Laboratory Biomarker Analysis, Pembrolizumab, Ribavirin",Houston - United States,2023-08-09,2016-10-21,2023-09-15,INTERVENTIONAL,PHASE2,M.D. Anderson Cancer Center,OTHER,hepatitis
NCT03320616,Unknown,COMPLETED,2017-02-10,"Hepatitis B, Chronic",EYP001a,Groningen - Netherlands,2017-10-12,2017-10-25,2018-03-05,INTERVENTIONAL,PHASE1,Enyo Pharma,INDUSTRY,hepatitis
NCT00480116,Unknown,COMPLETED,2008-01,Hepatitis B,"Adjuvanted Hepatitis B vaccine Lot 1, Adjuvanted Hepatitis B vaccine Lot 2, Adjuvanted Hep B vaccine Lot 3",Hradec Kralove - Czech Republic,2008-04,2007-05-30,2008-08-25,INTERVENTIONAL,PHASE3,Henogen,INDUSTRY,hepatitis
NCT00926016,Unknown,COMPLETED,2006-06,Chronic Hepatitis C,Pioglitazone (Actos),San Antonio - United States,2010-03,2009-06-23,2012-02-14,INTERVENTIONAL,NA,Brooke Army Medical Center,FED,hepatitis
NCT05395416,Unknown,UNKNOWN,2021-06-21,Chronic HCV Infection,"HEC74647PA+HEC110114, Placebo","Bengbu - China, Hefei - China, Hefei - China, Beijing - China, Beijing - China, Fuzhou - China, Foshan - China, Guangzhou - China, Guangzhou - China, Haikou - China, Shijiazhuang - China, Wuhan - China, Haerbin - China, Luoyang - China, Xinxiang - China, Zhengzhou - China, Zhengzhou - China, Zhengzhou - China, Changsha - China, Changsha - China, Hengyang - China, Lianyungang - China, Nanjing - China, Nanjing - China, Wuxi - China, Xuzhou - China, Zhenjiang - China, Nanyang - China, Changchun - China, Tonghua - China, Yanbian - China, Shenyang - China, Qingdao - China, Shanghai - China, Tianjin - China, Beijing - China",2023-04-22,2022-05-27,2023-04-12,INTERVENTIONAL,PHASE3,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,hepatitis
NCT03219216,Unknown,COMPLETED,2018-06-06,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir,"Vitoria - Brazil, São Luís - Brazil, Maringá - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Botucatu - Brazil, Campinas - Brazil, Ribeirão Preto - Brazil, São Paulo - Brazil, São Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil",2019-03-11,2017-07-17,2020-03-17,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT03903796,Unknown,COMPLETED,2018-08-16,Chronic HBV Infection,"HS-10234, TDF",Changchun - China,2020-05-31,2019-04-04,2024-12-17,INTERVENTIONAL,PHASE3,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT02897596,EARLY-HEP-C,UNKNOWN,2017-04-28,"Hepatitis C, HIV","Grazoprevir 100 mg/d 8 weeks, Elbasvir 50 mg/d 8 weeks, Grazoprevir 100 mg/d 12 weeks, Elbasvir 50 mg/d 12 weeks",Barcelona - Spain,2019-04-28,2016-09-13,2019-02-15,INTERVENTIONAL,PHASE3,Fundacion Clinic per a la Recerca Biomédica,OTHER,hepatitis
NCT03373396,HEPATOCHLORD,COMPLETED,2011-11-08,"Fibrosis, Liver",Blood samples,Pointe-à-Pitre - Guadeloupe,2015-12-21,2017-12-14,2017-12-14,INTERVENTIONAL,NA,Centre Hospitalier Universitaire de la Guadeloupe,OTHER,hepatitis
NCT03932396,HONEST,UNKNOWN,2019-05-10,"Hepatotropic Virus Infection, Addictive Behaviours o Conducts, Mental Disease, People Sentenced to Non-custodial Sentences",Observational study,Santander - Spain,2021-03-01,2019-04-30,2019-04-30,OBSERVATIONAL,Not Available,Instituto de Investigación Marqués de Valdecilla,OTHER,hepatitis
NCT03539016,Unknown,UNKNOWN,2015-07,"Hepatitis B, Chronic",No interventions listed,"Guangzhou - China, Beijing - China, Beijing - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Jiujiang - China, Jiujiang - China, Nanjing - China",2018-02,2018-05-29,2018-05-29,OBSERVATIONAL,Not Available,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT01946516,Unknown,COMPLETED,2013-08-29,Cancer,No interventions listed,"Fontana - United States, Harbor City - United States, Martinez - United States, Oakland - United States, Oakland - United States, Palm Springs - United States, Panorama City - United States, Roseville - United States, San Francisco - United States, Vacaville - United States, Lone Tree - United States, Honolulu - United States, Honolulu - United States, Meridian - United States, Berwyn - United States, Chicago - United States, Hines - United States, River Forest - United States, Leavenworth - United States, Topeka - United States, Baton Rouge - United States, Baton Rouge - United States, Baton Rouge - United States, Baton Rouge - United States, Covington - United States, Covington - United States, Houma - United States, Houma - United States, Metairie - United States, Monroe - United States, New Orleans - United States, Shreveport - United States, Slidell - United States, Boston - United States, Kansas City - United States, Billings - United States, Butte - United States, New York - United States, Chillicothe - United States, Columbus - United States, Columbus - United States, Marion - United States, Mount Vernon - United States, Newark - United States, Portsmouth - United States, Portland - United States, Greenville - United States, Greenville - United States, Greenville - United States, Greenville - United States, Greenville - United States, Greer - United States, Seneca - United States, Spartanburg - United States, Amarillo - United States, Houston - United States, San Antonio - United States, San Antonio - United States",2018-01-01,2013-09-19,2023-07-03,OBSERVATIONAL,Not Available,SWOG Cancer Research Network,NETWORK,hepatitis
NCT00547716,Unknown,WITHDRAWN,2009-06,Hepatitis C,"Omega-3 Fatty Acids, Placebo comparator","Kansas City - United States, Kansas City - United States",2012-08,2007-10-23,2017-01-09,INTERVENTIONAL,NA,"University of Missouri, Kansas City",OTHER,hepatitis
NCT03604016,Unknown,UNKNOWN,2018-09-23,Hepatitis B,"Besifovir dipivoxil, L-carnitine, Tenofovir Alafenamide",No locations listed,2020-07-30,2018-07-27,2018-08-23,INTERVENTIONAL,PHASE4,IlDong Pharmaceutical Co Ltd,INDUSTRY,hepatitis
NCT00598416,Unknown,COMPLETED,2006-09,"Hepatitis C, Substance Abuse",Family-Responsive Psychoeducation Program (PERF),St. Louis - United States,2013-08,2008-01-21,2014-11-04,INTERVENTIONAL,NA,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,hepatitis
NCT00062816,Unknown,COMPLETED,2003-06,"Hepatitis C, Chronic","ISIS 14803, peginterferon alfa, ribavirin","Birmingham - United States, Phoenix - United States, Orange - United States, Colorado Springs - United States, Wheat Ridge - United States, Jacksonville - United States, Miami - United States, Boise - United States, New Orleans - United States, Boston - United States, Springfield - United States, Royal Oak - United States, Saint Louis - United States, New York - United States, Rochester - United States, Durham - United States, Cincinnati - United States, Altoona - United States, Germantown - United States, Memphis - United States, Nashville - United States, Houston - United States, Richmond - United States, Bellevue - United States, Spokane - United States",2004-01,2003-06-18,2022-12-05,INTERVENTIONAL,PHASE2,"Ionis Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02563158,OHx-NOHx,UNKNOWN,2016-01,"Liver Cancer, Surgery",non-occlusion technique,Beijing - China,2019-01,2015-09-30,2016-05-12,INTERVENTIONAL,NA,Chinese PLA General Hospital,OTHER,hepatitis
NCT05293158,HBIG,NOT_YET_RECRUITING,2024-11,"Hepatocellular Carcinoma, HBV",Hepatect CP 50 I.E./ml infusion solution,No locations listed,2026-06,2022-03-24,2024-01-18,INTERVENTIONAL,NA,Medical University of Graz,OTHER,hepatitis
NCT00120796,Unknown,TERMINATED,2005-08,Hepatitis B,"Lamivudine, Recombinant hepatitis B surface antigen",Dakar - Senegal,2008-07,2005-07-19,2016-07-21,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00358696,Unknown,COMPLETED,2006-07,"HIV, HIV Infections",tenofovir,Vancouver - Canada,2009-10,2006-08-01,2009-10-20,INTERVENTIONAL,PHASE4,University of British Columbia,OTHER,hepatitis
NCT00970216,Unknown,COMPLETED,2009-02,Chronic Hepatitis B,Telbivudine,"LinKou, Taoyuan County - Taiwan",2016-01,2009-09-02,2016-02-29,OBSERVATIONAL,Not Available,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT02799316,Unknown,UNKNOWN,2016-06,Hepatitis B,HBV core antibodies testing. • Real time PCR testing.,Cairo - Egypt,2017-12,2016-06-14,2017-06-20,INTERVENTIONAL,NA,Sherief Abd-Elsalam,OTHER,hepatitis
NCT02936596,Unknown,UNKNOWN,2016-12,"Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary, Cholestasis","Ursodeoxycholic acid combination of immunosuppressive agents, Ursodeoxycholic Acid",Chengdu - China,2022-06-01,2016-10-18,2021-10-27,INTERVENTIONAL,NA,Xiaoli Fan,OTHER,hepatitis
NCT01178996,Unknown,COMPLETED,2004-12,Chronic Hepatitis C,"Thymosin alpha 1, Ribavirin, PEGinterferon alfa2a, Placebo","Paris - France, Tübingen - Germany, Ioannina - Greece, San Giovanni Rotondo - Italy, Bologna - Italy, Napoli - Italy, Rome - Italy, Turin - Italy, Barcelona - Spain",2008-05,2010-08-10,2010-08-10,INTERVENTIONAL,PHASE3,sigma-tau i.f.r. S.p.A.,INDUSTRY,hepatitis
NCT01143896,HEPTIDES,COMPLETED,2012-02,"Hepatitis C, Depression",Depression collaborative care model,"Little Rock - United States, West Los Angeles - United States, St Louis - United States, Houston - United States",2014-09,2010-06-14,2016-05-16,INTERVENTIONAL,NA,VA Office of Research and Development,FED,hepatitis
NCT01896596,Infanrix,COMPLETED,2013-07,"Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease, Diphtheria, Tetanus and Pertussis, Hepatitis b","Menjugate, Menitorix, NeisVac-C",London - United Kingdom,2017-04,2013-07-11,2020-10-01,INTERVENTIONAL,PHASE4,Public Health England,OTHER_GOV,hepatitis
NCT02511496,Unknown,UNKNOWN,2015-09,"Chronic Hepatitis C, Human Immunodeficiency Virus (HIV)",No interventions listed,No locations listed,2020-11,2015-07-30,2015-07-31,OBSERVATIONAL,Not Available,Maimónides Biomedical Research Institute of Córdoba,OTHER,hepatitis
NCT01500616,Unknown,COMPLETED,2012-06,"Hepatitis C, Chronic","Telaprevir, Telaprevir","Antwerpen - Belgium, Brussel - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Gent - Belgium, Leuven - Belgium, Liège - Belgium, Berlin - Germany, Bonn - Germany, Dortmund - Germany, Frankfurt - Germany, Hannover - Germany, Köln - Germany, Stuttgart - Germany, Tübingen - Germany, Budapest - Hungary, Dublin - Ireland, Luxembourg - Luxembourg, Amadora - Portugal, Lisboa - Portugal, Lisbon - Portugal, Porto - Portugal, Perm - Russian Federation, Saint-Petersburg - Russian Federation, St Petersburg - Russian Federation, Toliatti - Russian Federation, Volgograd - Russian Federation, Yoshkar - Ola - Russian Federation, Glasgow - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2014-08,2011-12-28,2016-08-18,INTERVENTIONAL,PHASE3,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT00187473,Unknown,COMPLETED,2000-06,Chronic Hepatitis C,liver biopsy,No locations listed,2021-12-31,2005-09-16,2024-01-12,OBSERVATIONAL,Not Available,"University of California, San Francisco",OTHER,hepatitis
NCT03612973,Unknown,COMPLETED,2019-06-01,Chronic Hepatitis c,"lipid profile, fasting insulin, fibro scan",Assiut - Egypt,2022-05-31,2018-08-02,2023-06-15,INTERVENTIONAL,NA,Assiut University,OTHER,hepatitis
NCT01405027,OPTIMAL,COMPLETED,2011-12,"Chronic Hepatitis C, Genotype 1","Educational Intervention, Patient education and management skills training","Beverly Hills - United States, Calabasas - United States, Santa Monica - United States, Torrance - United States, Torrance - United States, Colorado Springs - United States, Englewood - United States, Clearwater - United States, Hialeah - United States, Lakeland - United States, Largo - United States, North Miami Beach - United States, Pinellas Park - United States, Sarasota - United States, Tampa - United States, Bourbonnais - United States, Indianapolis - United States, Munster - United States, Munster - United States, Terre Haute - United States, Iowa City - United States, Metairie - United States, Detroit - United States, Farmington Hills - United States, Madison Heights - United States, St Clair Shores - United States, Kansas City - United States, Kansas City - United States, Kansas City - United States, St. Louis - United States, St. Louis - United States, Bronx - United States, Great Neck - United States, Manhasset - United States, New York - United States, Philadelphia - United States, Philadelphia - United States, Pottsville - United States, Wynnewood - United States, Live Oak - United States, San Antonio - United States, Fairfax - United States, Lynchburg - United States",2014-07,2011-07-29,2015-01-06,INTERVENTIONAL,PHASE4,Chronic Liver Disease Foundation,OTHER,hepatitis
NCT01591460,Unknown,COMPLETED,2012-08,"Hepatitis C, Chronic","boceprevir, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], ribavirin (Copegus], ribavirin (Copegus]","Graz - Austria, Innsbruck - Austria, Linz - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Dortmund - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hannover - Germany, Oberhausen - Germany, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Kaposvar - Hungary, Pecs - Hungary, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Lublin - Poland, Wrocław - Poland, Łodz - Poland, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Constanta - Romania, Timisoara - Romania, Vigo - Spain, Baracaldo - Spain, Granada - Spain, Zaragoza - Spain",2014-06,2012-05-04,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03432260,AH,COMPLETED,2018-04-18,Alcoholic Hepatitis,"DUR-928 30 mg, DUR-928 90 mg, DUR-928 150 mg","San Diego - United States, Miami - United States, Atlanta - United States, Chicago - United States, Indianapolis - United States, Louisville - United States, San Antonio - United States",2019-09-09,2018-02-14,2024-09-24,INTERVENTIONAL,PHASE2,Durect,INDUSTRY,hepatitis
NCT01926860,PCV13+HepA,COMPLETED,2013-08-24,"Measurement of Immune Response to Prevenar13, Measurement of Immune Response to Hepatitis a","Prevenar13, Hepatitis A vaccine","Helsinki - Finland, Eskilstuna - Sweden",2019-10-28,2013-08-21,2024-12-05,INTERVENTIONAL,PHASE4,Helsinki University Central Hospital,OTHER,hepatitis
NCT00596960,Unknown,COMPLETED,2008-11,"Alcohol Dependence, Chronic Hepatitis C","Motivational Enhancement Therapy (MET), Health education","Minneapolis - United States, Portland - United States",2012-06,2008-01-17,2014-11-28,INTERVENTIONAL,NA,US Department of Veterans Affairs,FED,hepatitis
NCT05561673,Unknown,ACTIVE_NOT_RECRUITING,2022-10-04,Hepatitis B,"GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2","Leuven - Belgium, Koeln - Germany, Hamburg - Germany, Magdeburg - Germany, Cambridge - United Kingdom",2024-12-26,2022-09-30,2024-07-03,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03420573,Unknown,UNKNOWN,2018-03,Parkinson Disease,No interventions listed,No locations listed,2019-10,2018-02-05,2018-02-05,OBSERVATIONAL,Not Available,Kasr El Aini Hospital,OTHER,hepatitis
NCT02332720,Unknown,COMPLETED,2015-01-28,Hepatitis C,"Grazoprevir, Uprifosbuvir, Elbasvir, Ruzasvir, MK-3682B, Ribavirin (RBV)",No locations listed,2016-09-19,2015-01-07,2019-07-30,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT06638320,Unknown,NOT_YET_RECRUITING,2024-10-01,"Hepatitis Delta With Hepatitis B Carrier State, Chronic Hepatitis b",No interventions listed,No locations listed,2025-06-30,2024-10-15,2024-10-15,OBSERVATIONAL,Not Available,Tam Anh Research Institute,OTHER,hepatitis
NCT00926120,PureLo,COMPLETED,2008-12,Hepatitis C,Mogroside sweetener (PureLo),San Antonio - United States,2009-04,2009-06-23,2012-02-14,INTERVENTIONAL,PHASE2,Brooke Army Medical Center,FED,hepatitis
NCT00164073,Unknown,UNKNOWN,2004-02,Hepatitis C,Liver biopsy,Melbourne - Australia,Unknown Date,2005-09-14,2007-08-01,OBSERVATIONAL,Not Available,Bayside Health,OTHER_GOV,hepatitis
NCT00790673,Unknown,COMPLETED,2009-07,Chronic Hepatitis C,"CF 102, Placebo",Tel Aviv - Israel,2011-06,2008-11-13,2015-04-15,INTERVENTIONAL,PHASE2,Can-Fite BioPharma,INDUSTRY,hepatitis
NCT04550273,Unknown,UNKNOWN,2020-02-09,Hepatitis C,aerobic treadmill exercise,Giza - Egypt,2021-01,2020-09-16,2020-09-16,INTERVENTIONAL,NA,Cairo University,OTHER,hepatitis
NCT01717560,Unknown,UNKNOWN,2005-02,"Chronic Hepatitis C, Illicit Drug Use","Collaborative, multidisciplinary, integrated care",New York - United States,2012-12,2012-10-30,2012-10-30,INTERVENTIONAL,NA,Brian Edlin,OTHER,hepatitis
NCT01241760,Unknown,COMPLETED,2010-12,"Genotype 1 Chronic Hepatitis C, Treatment Naive","Ribavirin, Telaprevir, Pegylated interferon alfa-2a, Telaprevir","La Jolla - United States, Los Angeles - United States, San Diego - United States, Aurora - United States, New Haven - United States, Bradenton - United States, Jacksonville - United States, Atlanta - United States, Marietta - United States, Chicago - United States, Downers Grove - United States, New Orleans - United States, Lutherville - United States, Kansas City - United States, Lebanon - United States, Egg Harbor Twp - United States, Santa Fe - United States, New York - United States, Charlotte - United States, Durham - United States, Statesville - United States, Winston Salem - United States, Cincinnati - United States, Allentown - United States, Hershey - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Charleston - United States, Columbia - United States, Arlington - United States, Dallas - United States, Houston - United States, San Antonio - United States, Falls Church - United States, Norfolk - United States, Seattle - United States, Adelaide - Australia, Camperdown - Australia, Clayton - Australia, Darlinghurst - Australia, Fitzroy - Australia, Greenslopes - Australia, Melbourne - Australia, Perth - Australia, Graz N/A - Austria, Linz - Austria, Wien - Austria, Antwerpen - Belgium, Brussels - Belgium, Genk - Belgium, Gent - Belgium, Leuven - Belgium, Liege - Belgium, Campinas - Brazil, Salvador - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, São Paulo - Brazil, Clichy - France, Creteil - France, Grenoble - France, Lille - France, Lyon - France, Paris - France, Pessac - France, Vandoeuvre Les Nancy - France, Villejuif Cedex - France, Berlin - Germany, Bochum - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Kiel - Germany, Mainz - Germany, Regensburg - Germany, Dublin 9 - Ireland, Dublin - Ireland, Mex Ctity - Mexico, Mexico - Mexico, Monterrey - Mexico, Bialystok - Poland, Bydgoszcz - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Warszawa - Poland, Barcelona N/A - Spain, Barcelona - Spain, Madrid - Spain, Malaga N/A - Spain, Santander N/A - Spain, Sevilla N/A - Spain, Valencia - Spain, Göteborg - Sweden, Malmö - Sweden, Stockholm - Sweden, Birmingham - United Kingdom, Edinburgh - United Kingdom, Glasgow - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2012-08,2010-11-16,2014-06-04,INTERVENTIONAL,PHASE3,Janssen Infectious Diseases BVBA,INDUSTRY,hepatitis
NCT01908660,Unknown,COMPLETED,2007-01,"Human Immunodeficiency Virus, Hepatitis B, Chronic, Hepatitis C, Chronic",antiretroviral drugs,Seville - Spain,2015-09,2013-07-26,2015-11-11,OBSERVATIONAL,Not Available,Valme University Hospital,OTHER,hepatitis
NCT01532973,Unknown,COMPLETED,2012-02-16,"Hepatitis, Viral, Human","Elbasvir, Placebo",No locations listed,2013-05-17,2012-02-15,2018-07-17,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02332473,Unknown,COMPLETED,2014-06,Chronic Hepatitis B,"Ypeginterferon alfa-2b, Granulocyte-macrophage colony stimulating factor","Beijing - China, Beijing - China, Fuzhou - China, Xiamen - China, Guangzhou - China, Zhengzhou - China, Wuhan - China, Changsha - China, Shenyang - China, Shanghai - China, Xi'an - China, Wenzhou - China",2016-02,2015-01-06,2017-01-25,INTERVENTIONAL,PHASE2,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT06800131,Unknown,NOT_YET_RECRUITING,2025-02-05,Hepatitis B Vaccine,"Hepatitis B Vaccine administered trans-dermally via Microneedle Array Patch (MAP), Active comparator vaccine via intramuscular injection",No locations listed,2026-08-05,2025-01-29,2025-01-29,INTERVENTIONAL,PHASE1,International Vaccine Institute,OTHER,hepatitis
NCT06384131,Unknown,RECRUITING,2024-05-08,Chronic Hepatitis B,"ABI-4334, Placebo","Sofia - Bulgaria, Chisinau - Moldova, Republic of, Auckland - New Zealand, Bucharest - Romania, Cluj-Napoca - Romania",2025-02-28,2024-04-25,2025-01-07,INTERVENTIONAL,PHASE1,Assembly Biosciences,INDUSTRY,hepatitis
NCT00001982,Unknown,COMPLETED,1993-06,Hepatitis C,No interventions listed,Bethesda - United States,Unknown Date,2002-12-10,2008-03-04,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03880682,Unknown,COMPLETED,2018-11-01,"Kidney Transplant; Complications, Hepatitis C, Chronic",No interventions listed,Istanbul - Turkey,2019-06-15,2019-03-19,2019-11-12,OBSERVATIONAL,Not Available,Istanbul University,OTHER,hepatitis
NCT03221582,HCV,TERMINATED,2017-08-28,"Human Immunodeficiency Virus, Hepatitis C",EBR/GZR,Dallas - United States,2018-11-26,2017-07-18,2019-08-19,INTERVENTIONAL,PHASE4,Dallas VA Medical Center,FED,hepatitis
NCT05630820,B-Well 2,ACTIVE_NOT_RECRUITING,2022-12-06,"Chronic Hepatitis B, Hepatitis B, Chronic","Bepirovirsen, Placebo","Centreville - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Colorado Springs - United States, Fort Pierce - United States, Miami - United States, Glen Burnie - United States, Minneapolis - United States, Philadelphia - United States, Denison - United States, Seattle - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Ciudad Autonoma De Bueno - Argentina, Santa Fe - Argentina, Box Hill - Australia, Fitzroy - Australia, Herston - Australia, Westmead - Australia, Botucatu - Brazil, Fortaleza - Brazil, Nova IguaCu - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Rio de Janeiro - Brazil, Salvador - Brazil, Vitoria - Brazil, Plovdiv - Bulgaria, Sliven - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Halifax - Canada, Montreal - Canada, Montreal - Canada, Regina - Canada, Toronto - Canada, Beijing - China, Beijing - China, Changchun - China, Chengdu - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Hangzhou - China, Hefei - China, Kunming - China, Liuzhou - China, Nanjing - China, Shanghai - China, Shanghai - China, Shenzhen - China, Taiyuan - China, Tianjin - China, Urumchi - China, Wuhan - China, Xiamen - China, Xian - China, Zhengzhou - China, Zunyi - China, CrEteil Cedex - France, Grenoble cedex 9 - France, Limoges cedex - France, Lyon - France, Paris - France, Paris - France, Rouen cedex - France, Toulouse cedex 9 - France, Frankfurt - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Athens - Greece, Heraklion Crete - Greece, Thessaloniki - Greece, Szeged - Hungary, SzEkesfehErvAr - Hungary, Zalaegerszeg - Hungary, Ahmedabad - India, Chennai - India, Kanpur - India, Kochi - India, Kolkata - India, Kolkata - India, Mumbai - India, Mumbai - India, Nagpur - India, New Delhi - India, New Delhi - India, New Delhi - India, Pune - India, Raipur - India, Secunderabad - India, Milano - Italy, Napoli - Italy, Padova - Italy, Palermo - Italy, Pisa - Italy, Roma - Italy, Sassari - Italy, Torino - Italy, Fukui - Japan, Hiroshima - Japan, Hokkaido - Japan, Hokkaido - Japan, Hokkaido - Japan, Ishikawa - Japan, Kagawa - Japan, Kumamoto - Japan, Nagasaki - Japan, Nara - Japan, Niigata - Japan, Osaka - Japan, Tokyo - Japan, Yamaguchi - Japan, Yamanashi - Japan, Ansan - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Johor Bahru - Malaysia, Kota Bharu Kelantan - Malaysia, Kota Kinabalu - Malaysia, Kuala Lumpur - Malaysia, Kuala Terengganu - Malaysia, Kuantan - Malaysia, Aguascalientes - Mexico, Auckland - New Zealand, Papatoetoe Auckland - New Zealand, Panama - Panama, Cebu City - Philippines, Makati City - Philippines, Pasig City - Philippines, Silang - Philippines, Gdansk - Poland, Myslowice - Poland, Zychlin - Poland, Bucharest - Romania, Bucuresti - Romania, Cluj Napoca - Romania, Constanta - Romania, Galati - Romania, Oradea - Romania, Alcorcon Madrid - Spain, Badajoz - Spain, Granada - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sabadell Barcelona - Spain, Sevilla - Spain, Valencia - Spain, Valladolid - Spain, Zaragoza - Spain, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Chiangmai - Thailand, Ankara - Turkey, Istanbul - Turkey, Izmir - Turkey, Liverpool - United Kingdom, London - United Kingdom, Middlesbrough - United Kingdom, Newcastle upon Tyne - United Kingdom, Plymouth - United Kingdom",2025-11-13,2022-11-30,2024-09-23,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00984620,Unknown,COMPLETED,2009-09,Hepatitis C,"BI 201335, BI 201335, Pegylated Interferon-alpha (IFN), Ribavirin (RBV)","Tulepo - United States, New York - United States, Germantown - United States, Jackson - United States, Nashville - United States, Austin - United States, Linz - Austria, Wien - Austria, Calgary - Canada, Vancouver - Canada, Ottawa - Canada, Montreal - Canada, Montreal - Canada, Clichy - France, Lille - France, Marseille - France, Montpellier - France, Paris - France, Rennes Cedex 09 - France, Berlin - Germany, Berlin - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Hamburg - Germany, Mainz - Germany, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania",2011-04,2009-09-25,2015-09-07,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT05457920,Unknown,UNKNOWN,2021-10-01,Chronic Hepatitis B,"continuous treatment, pulse therapy",Zhengzhou - China,2023-10-31,2022-07-14,2022-07-14,INTERVENTIONAL,NA,Henan Provincial People's Hospital,OTHER,hepatitis
NCT03222531,Unknown,ACTIVE_NOT_RECRUITING,2017-08-01,"Hepatitis C, Heart Transplant, Cardiac Transplant",sofosbuvir/velpatasvir,Pittsburgh - United States,2025-05-31,2017-07-19,2025-02-04,INTERVENTIONAL,PHASE2,"Mary E. Keebler, MD",OTHER,hepatitis
NCT04301882,Unknown,UNKNOWN,2019-09-01,Chronic Hepatitis C,"interferon combined with ribavirin (PR) antiviral therapy, direct antiviral drugs (DAAs)",Beijing - China,2020-09-01,2020-03-10,2020-03-10,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT01805882,Unknown,COMPLETED,2013-01,"Hepatitis C, Chronic","Sofosbuvir, Ledipasvir, GS-9669, GS-9451","Washington, D.C. - United States, Washington, D.C. - United States, Bethesda - United States",2015-08,2013-03-06,2017-06-08,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00927082,Unknown,COMPLETED,2009-04,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Fitzroy - Australia, Salvador - Brazil, Campinas - Brazil, Ribeirao Preto - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Beijing - China, Beijing - China, Changsha - China, Guangzhou - China, Shanghai - China, Shanghai - China, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Hamilton - New Zealand, Samara - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Singapore - Singapore, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Songkhla - Thailand",2014-11,2009-06-24,2016-03-09,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00812331,Unknown,COMPLETED,2009-03,Hepatitis C,TMC435,"Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Berlin - Germany, Frankfurt N/A - Germany, Freiburg - Germany, Hannover - Germany, Bangkok - Thailand, Chiang Mai - Thailand",2009-11,2008-12-22,2014-07-28,INTERVENTIONAL,PHASE2,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT01544582,Unknown,COMPLETED,2012-05,Hepatitis C Chronic,No interventions listed,No locations listed,2015-07,2012-03-06,2016-09-16,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02797782,Unknown,UNKNOWN,2016-06,Hepatitis B Vaccines,Detection of anti HBs antibody titer,Cairo - Egypt,2018-12,2016-06-13,2017-06-20,OBSERVATIONAL,Not Available,Sherief Abd-Elsalam,OTHER,hepatitis
NCT00663182,Unknown,UNKNOWN,2008-01,"Hepatitis B Virus, Decompensated Cirrhosis",Entecavir,Shanghai - China,2010-12,2008-04-22,2008-04-23,INTERVENTIONAL,PHASE4,Shanghai Changzheng Hospital,OTHER,hepatitis
NCT02760758,Unknown,COMPLETED,2016-04,Hepatitis C,"CDI-31244, Placebo",Montreal - Canada,2017-03,2016-05-04,2021-04-20,INTERVENTIONAL,PHASE1,"Cocrystal Pharma, Inc.",INDUSTRY,hepatitis
NCT04575896,Unknown,COMPLETED,2020-11-20,"End Stage Renal Disease, Hepatitis C",Glecaprevir/pibrentasvir,Baltimore - United States,2023-11-28,2020-10-05,2024-01-10,INTERVENTIONAL,PHASE4,Johns Hopkins University,OTHER,hepatitis
NCT00291616,Unknown,COMPLETED,2005-12,Chronic Hepatitis B,"Pegylated Interferon-alpha2a, Thymosin alpha1 & Pegylated Interferon-alpha2a","Seoul - Korea, Republic of",2008-08,2006-02-14,2011-07-21,INTERVENTIONAL,PHASE4,Seoul National University Hospital,OTHER,hepatitis
NCT05410496,Unknown,ACTIVE_NOT_RECRUITING,2021-06-22,"Safety Issues, Chronic Hepatitis B, Transplant Recipient",Tenofovir Alafenamide 25 MG,"Taichung - Taiwan, Taichung - Taiwan",2024-07-30,2022-06-08,2025-01-09,INTERVENTIONAL,PHASE4,Taichung Veterans General Hospital,OTHER,hepatitis
NCT00166296,Unknown,COMPLETED,2005-03,"Major Depressive Disorder, Hepatitis C, Chronic","Escitalopram, Placebo","Alcorcon - Spain, Avila - Spain, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sabadell - Spain, Salamanca - Spain, Tarrasa - Spain, Valencia - Spain, Valencia - Spain, Valencia - Spain, Zaragoza - Spain",2007-10,2005-09-14,2020-08-17,INTERVENTIONAL,PHASE2,Germans Trias i Pujol Hospital,OTHER,hepatitis
NCT00996216,ENABLE-ALL,COMPLETED,2009-09,Hepatitis C,"Eltrombopag, Antiviral therapy","San Diego - United States, New Haven - United States, Honolulu - United States, Manhasset - United States, Nashville - United States, Seattle - United States, Camperdown - Australia, Randwick - Australia, Herston - Australia, Toronto - Canada, Montreal - Canada, Marseille Cedex 08 - France, Nice cedex 3 - France, Pessac Cedex - France, Freiburg - Germany, Ulm - Germany, Muenchen - Germany, Duesseldorf - Germany, Berlin - Germany, Athens - Greece, Bologna - Italy, Genova - Italy, Milano - Italy, Lahore - Pakistan, La Coruña - Spain, Madrid - Spain, Pontevedra - Spain, Valencia - Spain",2013-02,2009-10-16,2013-12-06,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00122616,Unknown,COMPLETED,2003-11,"HIV Infections, Hepatitis C, Chronic","Peginterferon alpha-2a (Pegasys®), Ribavirin, HIV antiretroviral therapy, HIV antiretroviral therapy",Rennes - France,2009-03,2005-07-22,2012-02-22,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT06564116,Unknown,COMPLETED,2023-03-22,Hepatitis E,"Thiomersal-free Recombinant Hepatitis E Vaccine (Escherichia Coli), Recombinant Hepatitis E Vaccine (Escherichia Coli)",Sanming - China,2024-03-28,2024-08-21,2024-08-21,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00230958,Unknown,COMPLETED,2003-12,Chronic Hepatitis C,"Viramidine, Ribavirin, pegylated interferon alfa-2b",No locations listed,2006-01,2005-10-03,2012-06-22,INTERVENTIONAL,PHASE3,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT00158496,Unknown,COMPLETED,2002-08,Chronic Hepatitis C,"pegylated interferon alpha2a, ribavirin","Zawiat Razin - Egypt, Cairo - Egypt",Unknown Date,2005-09-12,2007-04-24,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT06649396,SACADE,NOT_YET_RECRUITING,2024-11-30,Delta Hepatitis,"Dried Blood Spot, Analysis on plasma",Bobigny - France,2025-12-01,2024-10-18,2024-10-18,INTERVENTIONAL,NA,Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba,OTHER,hepatitis
NCT03537196,DRIVE-C,COMPLETED,2018-11-13,"Hepatitis C, Drug Use, Viral Hepatitis C","Sofosbuvir 400 mg and Daclatasvir 60 mg, Sofosbuvir 400 mg and Daclatasvir 90 mg, Ribavirin, Sofosbuvir and Daclatasvir for 24 weeks","Hai Phong - Vietnam, Hải Phòng - Vietnam",2020-11-30,2018-05-25,2023-10-26,INTERVENTIONAL,PHASE4,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT06369116,Unknown,COMPLETED,2023-10-12,Hepatitis C,INSTI HCV Self Test,Parktown - South Africa,2024-04-25,2024-04-16,2025-02-21,INTERVENTIONAL,NA,bioLytical Laboratories,INDUSTRY,hepatitis
NCT01977196,Unknown,COMPLETED,2011-04,Healthy,DPT/HepatitisB/Hib vaccine,Bandung - Indonesia,2011-07,2013-11-06,2013-11-06,INTERVENTIONAL,PHASE1,PT Bio Farma,INDUSTRY,hepatitis
NCT01102296,Unknown,COMPLETED,2009-06,Hepatitis,Hepatitis A vaccine,Taipei - Taiwan,2012-03,2010-04-13,2012-12-27,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT02098616,RHACE 1,COMPLETED,2014-07,Hepatitis C,"DCV/ASV/BMS-791325, DCV/ASV/BMS-791325 + RBV",Long Beach - United States,2016-02,2014-03-28,2016-04-19,INTERVENTIONAL,NA,"Timothy Morgan, MD",OTHER,hepatitis
NCT01237496,Unknown,COMPLETED,2005-07,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Bologna - Italy, Brescia - Italy, Milano - Italy, Parma - Italy, Reggio Emilia - Italy",2009-09,2010-11-09,2016-11-02,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02252016,Unknown,COMPLETED,2014-10-22,Hepatitis C,"Grazoprevir + Elbasvir, Placebo",No locations listed,2015-12-07,2014-09-29,2018-10-03,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01750216,Unknown,COMPLETED,2012-07,"Hepatitis C, Chronic",No interventions listed,"Bydgoszcz - Poland, Bytom - Poland, Chorzow - Poland, Ciechanow - Poland, Debica - Poland, Katowice - Poland, Koszalin - Poland, Lancut - Poland, Lodz - Poland, Mielec - Poland, Pulawy - Poland, Radom - Poland, Walbrzych - Poland, Warszawa - Poland",2015-01,2012-12-17,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00780416,Unknown,COMPLETED,2008-11,Hepatitis C,"MP-424, Ribavirin, Peginterferon Alfa-2b, Ribavirin, Peginterferon Alfa-2b",Kawasaki City - Japan,2010-08,2008-10-27,2014-05-02,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT04075916,THINKER-NEXT,ACTIVE_NOT_RECRUITING,2021-06-22,End Stage Renal Disease,Epclusa,"Birmingham - United States, Gainesville - United States, Miami - United States, Baltimore - United States, Boston - United States, New York - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Charleston - United States, Nashville - United States",2025-06-22,2019-09-03,2025-01-10,INTERVENTIONAL,PHASE2,University of Pennsylvania,OTHER,hepatitis
NCT02952924,Unknown,COMPLETED,2016-12-14,"Hepatitis B, Chronic","Midazolam, Placebo, RO7049389","Herston - Australia, Parkville - Australia, Sofia - Bulgaria, Guangzhou - China, Shanghai City - China, Shanghai - China, Hong Kong - Hong Kong, Shatin, New Territories - Hong Kong, Auckland - New Zealand, Grafton - New Zealand, Singapore - Singapore, Singapore - Singapore, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei City - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand",2022-03-16,2016-11-02,2024-10-31,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06358196,CESAH,NOT_YET_RECRUITING,2024-05-01,Alcoholic Hepatitis,No interventions listed,Kosice - Slovakia,2025-04-30,2024-04-10,2024-04-10,OBSERVATIONAL,Not Available,Pavol Jozef Safarik University,OTHER,hepatitis
NCT01220596,POTENT,UNKNOWN,2010-06,"Hepatitis B, Chronic","Entecavir and Pegylated interferon α-2a Sequential Treatment Group, Pegylated interferon α-2a Monotreatment Group","Cheonan - Korea, Republic of, Chuncheon - Korea, Republic of, Wonju - Korea, Republic of, Bucheon - Korea, Republic of, Guri - Korea, Republic of, Sungnam - Korea, Republic of, Yangsan - Korea, Republic of, Jeju - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2013-06,2010-10-14,2011-07-04,INTERVENTIONAL,PHASE3,Hanyang University,OTHER,hepatitis
NCT05017116,Unknown,COMPLETED,2021-08-09,Chronic Hepatitis B,"RBD1016, Placebo, Entecavir",Hong Kong - China,2023-10-25,2021-08-23,2024-12-06,INTERVENTIONAL,PHASE1,Suzhou Ribo Life Science Co. Ltd.,INDUSTRY,hepatitis
NCT00010816,Unknown,COMPLETED,1998-09,Hepatitis C,Herbal remedies,Minneapolis - United States,Unknown Date,2001-02-05,2006-08-18,INTERVENTIONAL,PHASE2,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT04790916,Unknown,TERMINATED,2021-04-19,"Autoimmune Hepatitis, Autoimmune Chronic Hepatitis","RO7049665, Placebo","Melbourne - Australia, Toronto - Canada, Montreal - Canada, Hamburg - Germany, Monza - Italy, Castellana Grotte - Italy, Busan - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Amstermdam - Netherlands, Nijmegen - Netherlands, Vila Real - Portugal, London - United Kingdom, Nottingham - United Kingdom",2021-11-18,2021-03-10,2023-09-18,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06058416,Unknown,ACTIVE_NOT_RECRUITING,2023-10-24,Hepatitis A,"Healive (hepatitis A vacine(human diploid cell), inactivated)",Shenyang - China,2028-03-17,2023-09-28,2024-08-21,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00778596,Unknown,UNKNOWN,2009-02,Chronic Hepatitis B,"Prednisolone, Placebo priming","Chiayi County - Taiwan, Kaohsiung City - Taiwan, Keelung City - Taiwan, Linkou, Taoyuan County - Taiwan",2012-12,2008-10-23,2012-05-25,INTERVENTIONAL,PHASE4,Yun-Fan Liaw,OTHER,hepatitis
NCT03413696,Unknown,COMPLETED,2017-09-08,"Hepatitis C, Hepatitis C, Chronic, HIV/AIDS",No interventions listed,San Diego - United States,2019-12-31,2018-01-29,2021-09-05,OBSERVATIONAL,Not Available,"University of California, San Diego",OTHER,hepatitis
NCT00874796,Unknown,TERMINATED,2009-05,HCV Infection,"GS-9450, Placebo","Phoenix - United States, Tucson - United States, Anaheim - United States, Beverly Hills - United States, Cypress - United States, La Jolla - United States, Mission Hills - United States, Palm Springs - United States, Pasadena - United States, San Clemente - United States, San Diego - United States, Washington - United States, Hialeah - United States, Miami - United States, North Miami Beach - United States, Orlando - United States, Sarasota - United States, Tampa - United States, Decatur - United States, Chicago - United States, Indianapolis - United States, Louisville - United States, Baton Rouge - United States, New Orleans - United States, Annapolis - United States, Baltimore - United States, Boston - United States, Novi - United States, St. Louis - United States, Plymouth - United States, Omaha - United States, Las Vegas - United States, Hillsborough - United States, Morristown - United States, Santa Fe - United States, Johnson City - United States, New York - United States, Plainview - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Providence - United States, Chattanooga - United States, Germantown - United States, Dallas - United States, San Antonio - United States, Fairfax - United States, Falls Church - United States, Norfolk - United States, Seattle - United States, Madison - United States, Vancouver - Canada, Winnipeg - Canada, London - Canada, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hannover - Germany, Köln - Germany, Mainz - Germany, Bialystok - Poland, Bydgoszcz - Poland, Chorzów - Poland, Kielce - Poland, Wroclaw - Poland, San Juan - Puerto Rico, Santurce - Puerto Rico, Brighton - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Sheffield - United Kingdom",2010-04,2009-04-03,2014-02-04,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00342186,Unknown,COMPLETED,2002-09-27,"Hepatitis, Viral, Human",No interventions listed,Peking - China,2018-02-22,2006-06-21,2020-06-16,OBSERVATIONAL,Not Available,National Cancer Institute (NCI),NIH,hepatitis
NCT01935635,Unknown,COMPLETED,2015-01,Chronic Hepatitis B,HPDCs-T immune therapy,"Guangzhou - China, Kunming - China, Shanghai - China",2019-12,2013-09-05,2020-10-30,INTERVENTIONAL,PHASE2,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00800735,Unknown,COMPLETED,2009-04,"Hepatitis C, Chronic","Pegylated-interferon alfa-2a, Ribavirin","Sacramento - United States, San Francisco - United States, Lutherville - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Portland - United States, Providence - United States, Nashville - United States, San Antonio - United States, Salt Lake City - United States, Wien - Austria, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Clichy - France, Berlin - Germany, Frankfurt Am Main - Germany, Koeln - Germany, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain",2012-03,2008-12-02,2013-10-30,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00496158,QUASH2,TERMINATED,2007-08,"Chronic Hepatitis, Hepatitis B","Clevudine, Adefovir","Birmingham - United States, Anaheim - United States, Anaheim - United States, Fresno - United States, Fresno - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, San Clemente - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Mateo - United States, Norwich - United States, North Miami Beach - United States, Tampa - United States, Tampa - United States, Tampa - United States, Honolulu - United States, Des Moines - United States, New Orleans - United States, New Orleans - United States, College Park - United States, Boston - United States, Tupelo - United States, St. Louis - United States, Hillsborough - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Asheville - United States, Durham - United States, Cincinnati - United States, Cincinnati - United States, Portland - United States, Portland - United States, Portland - United States, Germantown - United States, Nashville - United States, Austin - United States, Austin - United States, Dallas - United States, Dallas - United States, Galveston - United States, Houston - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Salt Lake City - United States, Charlottesville - United States, Fairfax - United States, Fairfax - United States, Richmond - United States, Seattle - United States, Tacoma - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Cordoba - Argentina, Mar del Plata - Argentina, Concord - Australia, Sydney - Australia, Brisbane - Australia, Brisbane - Australia, Adelaide - Australia, Fitzroy - Australia, Footscray - Australia, Melbourne - Australia, Fremantle - Australia, Perth - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Halifax - Canada, Hamilton - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Hong Kong - China, Hong Kong - China, Hong Kong - China, Athens - Greece, Athens - Greece, Athens - Greece, Santurce - Puerto Rico, Alicante - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Hat Yai - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Phitsanulok - Thailand, Glasgow - United Kingdom, London - United Kingdom",Unknown Date,2007-07-04,2009-04-27,INTERVENTIONAL,PHASE3,Pharmasset,INDUSTRY,hepatitis
NCT02461563,Unknown,COMPLETED,2015-06-23,Hepatitis C Virus Infection,"200 mg MK-1075, 400 mg MK-1075, 800 mg MK-1075",No locations listed,2015-12-23,2015-06-03,2018-11-13,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01458535,Navigator,COMPLETED,2011-09,Hepatitis C Virus,"ABT-450, ABT-267, ribavirin, ritonavir",No locations listed,2013-05,2011-10-25,2016-07-11,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT04135235,Unknown,UNKNOWN,2019-08-01,"Chronic Hepatitis B Infection, High Viral Load","TAF, TDF",Beijing - China,2021-08-01,2019-10-22,2019-10-22,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT04439435,Unknown,UNKNOWN,2020-07,Vaccine Reaction,No interventions listed,Chongqing - China,2020-12,2020-06-19,2020-06-19,OBSERVATIONAL,Not Available,Children's Hospital of Chongqing Medical University,OTHER,hepatitis
NCT00221286,Unknown,TERMINATED,2004-09,"Chronic Hepatitis B, HIV Infections","pegylated interferon alfa-2a, tenofovir DF / emtricitabine combination therapy, pegIFN / TDF / FTC combination therapy","Hannover - Germany, Bonn - Germany, Berlin - Germany, Hamburg - Germany, Hamburg - Germany",2007-01,2005-09-22,2009-02-18,INTERVENTIONAL,PHASE3,"University Hospital, Bonn",OTHER,hepatitis
NCT00705263,Unknown,COMPLETED,2005-10,"Hepatitis C, Chronic, Hepacivirus","Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908)",No locations listed,2008-05,2008-06-26,2009-08-25,OBSERVATIONAL,Not Available,Schering-Plough,INDUSTRY,hepatitis
NCT05786963,Unknown,UNKNOWN,2022-12-29,"Chronic Hepatitis b, Non-Alcoholic Fatty Liver Disease",No interventions listed,Beijing - China,2023-12,2023-03-28,2023-03-28,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT01528735,Unknown,COMPLETED,2012-02,"Hepatitis C, Chronic","BI 207127 NA, peginterferon, Ribavirin, Ribavirin, BI 207127 NA, BI 201335 NA, BI 201335 NA, peginterferon","Kofu, Yamanashi - Japan, Kurashiki, Okayama - Japan, Nagoya, Aichi - Japan, Nishinomiya, Hyogo - Japan, Omura, Nagasaki - Japan",2013-08,2012-02-08,2016-04-13,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT05108935,PARTNERUP,COMPLETED,2022-02-17,"Opioid Use, Opioid Use Disorder, Risk Reduction, Hiv, Hepatitis C","Suboxone, Truvada, Mavyret","Durham - United States, Greensboro - United States",2023-03-30,2021-11-05,2023-04-27,INTERVENTIONAL,NA,Duke University,OTHER,hepatitis
NCT00120835,Unknown,COMPLETED,2004-07,Chronic Hepatitis C,"valopicitabine, pegylated interferon","Bradenton - United States, San Antonio - United States, Santurce - Puerto Rico",Unknown Date,2005-07-19,2010-06-10,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02808663,CALPRO-HAA,COMPLETED,2015-05-06,Severe Alcoholic Hepatitis,"fecal calprotectin concentration, blood collection",France - France,2017-02-01,2016-06-22,2018-01-08,INTERVENTIONAL,NA,CHU de Reims,OTHER,hepatitis
NCT02581163,Unknown,COMPLETED,2015-10-07,"Chronic Hepatitis C, Genotype 1 or 4","Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin",No locations listed,2018-02-12,2015-10-20,2019-05-06,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00362635,Unknown,COMPLETED,2006-08,Hepatitis B,Clevudine,"Tai Po - Hong Kong, Road - Hong Kong",2011-12,2006-08-10,2012-07-26,INTERVENTIONAL,PHASE3,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00008463,Unknown,COMPLETED,2000-11,"HIV Infections, Hepatitis C","Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a","San Diego - United States, San Francisco - United States, Aurora - United States, Miami - United States, Atlanta - United States, Honolulu - United States, Indianapolis - United States, Indianapolis - United States, Indianapolis - United States, Iowa City - United States, Boston - United States, Boston - United States, Boston - United States, Boston - United States, Minneapolis - United States, New York - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Rochester - United States, Cincinnati - United States, Philadelphia - United States, Dallas - United States",Unknown Date,2001-08-31,2021-11-01,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01102335,TACEHBV,UNKNOWN,2010-04,Hepatocellular Carcinoma,"Transcatheter arterial chemoembolization (TACE), Telbivudine",Shanghai - China,2011-12,2010-04-13,2010-04-13,INTERVENTIONAL,PHASE4,Fudan University,OTHER,hepatitis
NCT04208035,CELINE,UNKNOWN,2018-09-17,Chronic Hepatitis c,No interventions listed,Nijmegen - Netherlands,2021-01-01,2019-12-23,2019-12-23,OBSERVATIONAL,Not Available,Radboud University Medical Center,OTHER,hepatitis
NCT03697135,Unknown,COMPLETED,2018-09-01,Hepatitis C,Respondent Driven Sampling,Dundee - United Kingdom,2019-12-30,2018-10-05,2020-08-04,OBSERVATIONAL,Not Available,NHS Tayside,OTHER_GOV,hepatitis
NCT03868163,EVEREST,COMPLETED,2019-02-28,Chronic Hepatitis C (CHC),No interventions listed,"Samara - Russian Federation, Stavropol - Russian Federation, Kazan - Russian Federation, Chelyabinsk - Russian Federation, Novosibirsk - Russian Federation, Oryol - Russian Federation, Perm - Russian Federation, Samara - Russian Federation, St. Petersburg - Russian Federation",2020-09-04,2019-03-08,2021-08-30,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00630058,Unknown,COMPLETED,2008-04,Hepatitis C,"MP-424(H), PEG-IFN-a-2b, RBV, MP-424 (L), PEG-IFN-a-2b, RBV",Kawasaki City - Japan,2009-03,2008-03-06,2014-05-02,INTERVENTIONAL,PHASE1,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT03864263,Unknown,UNKNOWN,2019-07-04,Hepatitis b Virus Infection,No intervention name listed,Chongqing - China,2020-12-31,2019-03-06,2019-07-08,OBSERVATIONAL,Not Available,Qiu Li,OTHER,hepatitis
NCT00536263,Unknown,COMPLETED,2007-09,"Hepatitis B, Chronic","pegylated interferon alpha-2b, pegylated interferon alpha-2b, pegylated interferon alpha-2b",No locations listed,2009-11,2007-09-27,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04904835,Unknown,RECRUITING,2019-10-15,HBV,Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays,"Amiens - France, Bois Guillaume - France, Ivry-sur-Seine - France, Rouen - France, St Ouen l'Aumone - France",2025-12,2021-05-27,2024-12-04,OBSERVATIONAL,Not Available,"Beckman Coulter, Inc.",INDUSTRY,hepatitis
NCT01691235,SIMpill HCV,WITHDRAWN,2012-09,Chronic Hepatitis C Virus,SIMpill device,Chicago - United States,2013-01,2012-09-24,2014-10-08,OBSERVATIONAL,Not Available,University of Chicago,OTHER,hepatitis
NCT00227435,Unknown,COMPLETED,2003-02,Chronic Hepatitis C,val-mCyd,"Pasadena - United States, Boston - United States, Worcester - United States, Fairfax - United States",2004-07,2005-09-28,2016-04-27,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01810835,Unknown,COMPLETED,2011-11,Hepatitis B,No interventions listed,"Paris - France, Paris - France",2013-11,2013-03-14,2013-12-06,OBSERVATIONAL,Not Available,Hopital Lariboisière,OTHER,hepatitis
NCT00637663,Unknown,COMPLETED,2008-02,"Hepatitis B, Chronic","Entecavir, Lamivudine","Busan - Korea, Republic of, Seoul - Korea, Republic of",2010-11,2008-03-18,2015-03-05,INTERVENTIONAL,PHASE4,Pusan National University Hospital,OTHER,hepatitis
NCT01908335,Unknown,COMPLETED,2012-10,Chronic Hepatitis C,"PEG-IFN-SA /RBV low dose, PEG-IFN-SA /RBV middle dose, PEG-IFN-SA /RBV high dose, Pegasys /RBV","Fuzhou - China, Lanzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Nanning - China, Shijiazhuang - China, Harbin - China, Harbin - China, Xinxiang - China, Zhengzhou - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Suzhou - China, Nanchang - China, Changchun - China, Yanji - China, Shenyang - China, Xi'an - China, Xi'an - China, Xi'an - China, Jinan - China, Jinan - China, Jinan - China, Qingdao - China, Taiyuan - China, Chengdu - China, Chengdu - China, Urumqi - China, Hangzhou - China, Wenzhou - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Chongqing - China, Shanghai - China, Shanghai - China, Tianjin - China",2013-08,2013-07-25,2014-10-20,INTERVENTIONAL,PHASE2,"Beijing Kawin Technology Share-Holding Co., Ltd.",INDUSTRY,hepatitis
NCT03090035,Unknown,COMPLETED,2014-01-01,"Hepatitis C, Hepatitis C Relapse","Pegylated Interferon α2, Ribavirin",Sadiqabad - Pakistan,2014-07-01,2017-03-24,2017-04-25,INTERVENTIONAL,PHASE3,Sheikh Zayed Medical College,OTHER_GOV,hepatitis
NCT05808335,Unknown,RECRUITING,2022-01-11,Chronic Hepatitis B,Standard of care,"Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2024-03-27,2023-04-11,2023-06-15,INTERVENTIONAL,PHASE2,"ImmuneMed, Inc.",INDUSTRY,hepatitis
NCT01949857,HAV,COMPLETED,2013-09,Hepatitis A,"Attenuated HAV Vaccine, H2 Strain, Attenuated HAV Vaccine, L-A-1 Strain, Inactivated HAV Vaccine, Lu8 Strain, Inactivated HAV Vaccine, TZ84 Strain",Kunming - China,2015-12,2013-09-25,2023-10-10,INTERVENTIONAL,PHASE4,"Institute of Medical Biology, Chinese Academy of Medical Sciences",OTHER,hepatitis
NCT05561530,Unknown,TERMINATED,2022-10-07,Chronic Hepatitis B,"ALG-125755, Placebo","Sofia - Bulgaria, Chisinau - Moldova, Republic of, Auckland - New Zealand, Bucharest - Romania",2023-06-15,2022-09-30,2024-03-15,INTERVENTIONAL,PHASE1,Aligos Therapeutics,INDUSTRY,hepatitis
NCT00800748,Unknown,COMPLETED,2006-02-01,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Beroun - Czechia, Brno - Czechia, Ceska Lipa - Czechia, Ceské Budejovice - Czechia, Chomutov - Czechia, Decin - Czechia, Havirov - Czechia, Havlickuv Brod - Czechia, Hradec Kralove - Czechia, Hradec Kralove - Czechia, Jablonec/nisou - Czechia, Jihlava - Czechia, Karlovy Vary - Czechia, Kolin - Czechia, Liberec - Czechia, Melnik - Czechia, Most - Czechia, Olomouc - Czechia, Opava - Czechia, Ostrava - Czechia, Pardubice - Czechia, Praha 2 - Czechia, Praha - Czechia, Praha - Czechia, Praha - Czechia, Praha - Czechia, Prostejov - Czechia, Usti Nad Labem - Czechia, Banska Bystrica - Slovakia, Bratislava - Slovakia, Bratislava - Slovakia, Kosice - Slovakia, Kosice - Slovakia, Martin - Slovakia, Trencin - Slovakia",2009-01-09,2008-12-02,2017-05-22,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01753557,Unknown,COMPLETED,2012-12,Chronic Hepatitis C (CHC),"MP-424, RBV, PEG-IFN alfa-2a",Kawasaki City - Japan,2014-11,2012-12-20,2016-10-03,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00456248,ENHANCE,TERMINATED,2007-02,Hepatitis C,Infergen and ribavirin,"Atlanta - United States, New Orleans - United States, Harrisburg - United States, Dallas - United States",2007-10,2007-04-04,2012-10-15,INTERVENTIONAL,PHASE4,"Kadmon Corporation, LLC",INDUSTRY,hepatitis
NCT06566248,Unknown,RECRUITING,2024-03-20,Chronic Hepatitis B,"TQA3810 tablets+NUC, Placebo+NUC","Wuwei - China, Zunyi - China, Nanjing - China, Suzhou - China, Shenyang - China, Xi'an - China",2024-09,2024-08-22,2024-08-22,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT06221657,Unknown,NOT_YET_RECRUITING,2024-02-01,Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication,"Vemlidy, Virreal",No locations listed,2026-12-01,2024-01-24,2024-01-24,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT01796457,Unknown,ACTIVE_NOT_RECRUITING,2013-03,Hepatitis B,No interventions listed,"San Francisco - United States, San Francisco - United States, Boston - United States, Plymouth - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2025-12-01,2013-02-21,2025-01-14,OBSERVATIONAL,Not Available,University of Pennsylvania,OTHER,hepatitis
NCT01197157,Unknown,COMPLETED,2010-09,Hepatitis C,"Placebo, Nitazoxanide",Shebin El-Kom - Egypt,2014-04,2010-09-09,2014-09-30,INTERVENTIONAL,PHASE3,"National Liver Institute, Egypt",OTHER,hepatitis
NCT06535048,AV-FLCHB,ACTIVE_NOT_RECRUITING,2015-01-01,"Fatty Liver Disease, Chronic Hepatitis B, Antiviral Treatment",Entecavir；Tenofovir Disoproxil Fumarate (TDF)； Tenofovir alafenamide fumarate (TAF)；Interferons,No locations listed,2019-06-30,2024-08-02,2024-08-02,OBSERVATIONAL,Not Available,Tianjin Second People's Hospital,OTHER,hepatitis
NCT01023230,Unknown,COMPLETED,2009-09,"Hepatitis B, Chronic","DV-601, Entecavir","Bydgoszcz - Poland, Szczecin - Poland, Warsaw - Poland, Wrocław - Poland",2011-05,2009-12-02,2019-04-16,INTERVENTIONAL,PHASE1,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT03296930,Unknown,UNKNOWN,2017-10-01,Antiviral Drug Adverse Reaction,"Sofosbuvir 400 MG Oral Tablet,, Ombitasvir/paritaprevir/ritonavir",No locations listed,2018-09-30,2017-09-29,2017-09-29,INTERVENTIONAL,PHASE4,Assiut University,OTHER,hepatitis
NCT00001457,Unknown,COMPLETED,1995-09,"Chronic Hepatitis B, Chronic Hepatitis D, Glomerulonephritis, Polyarteritis Nodosa",Lamivudine,Bethesda - United States,Unknown Date,1999-11-04,2008-03-04,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01159457,Unknown,UNKNOWN,2011-04,Celiac Disease,"Hepatitis B vaccination (Sci-B-Vac), Hepatitis B vaccination (EngerixB)",Jerusalem - Israel,2012-06,2010-07-09,2011-04-15,INTERVENTIONAL,NA,Shaare Zedek Medical Center,OTHER,hepatitis
NCT03487848,Unknown,TERMINATED,2018-06-25,"Hepatitis C, Chronic Hepatitis","Daclatasvir, Sofosbuvir","Melbourne - Australia, Barcelona - Spain",2018-10-18,2018-04-04,2021-04-20,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06661148,Unknown,NOT_YET_RECRUITING,2024-12-01,"Chronic Hepatitis B, HBV (Hepatitis B Virus)",EPI-003,"Westmead - Australia, Hong Kong - China, Grafton - New Zealand, Christchurch - New Zealand",2027-06-30,2024-10-28,2024-10-28,INTERVENTIONAL,PHASE1,"Epigenic Therapeutics, Inc",INDUSTRY,hepatitis
NCT01353248,Unknown,COMPLETED,2011-05,"Hepatitis C, Chronic","GS-5885, Tegobuvir, GS-9451, ribavirin tablet, GS-5885","Birmingham - United States, Dothan - United States, Anaheim - United States, Coronado - United States, Fresno - United States, Palo Alto - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Washington - United States, Bradenton - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Orlando - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Opelousas - United States, Lutherville - United States, Boston - United States, Boston - United States, Detroit - United States, Jackson - United States, Albuquerque - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cleveland - United States, Tulsa - United States, Philadelphia - United States, Germantown - United States, Germantown - United States, Nashville - United States, Nashville - United States, Dallas - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Falls Church - United States, Newport News - United States, San Juan - Puerto Rico",2012-10,2011-05-13,2013-12-20,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00726557,SUPPORT,COMPLETED,2005-10,"Hepatitis C, Chronic, Substance Abuse, Intravenous","PegIntron (pegylated interferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2009-01,2008-08-01,2015-10-09,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05674448,Unknown,TERMINATED,2021-08-11,Chronic Hepatitis B and Hepatitis D Co-infection,"HH-003 20mg/kg, HH-003 3mg/kg",Changchun - China,2022-07-25,2023-01-06,2023-10-10,INTERVENTIONAL,PHASE2,Huahui Health,INDUSTRY,hepatitis
NCT00298363,Unknown,COMPLETED,2006-04,Chronic Hepatitis B,"Tenofovir disoproxil fumarate (tenofovir DF; TDF), Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), Entecavir (ETV), TDF placebo, FTC/TDF placebo, ETV placebo","Los Angeles - United States, San Francisco - United States, Miami - United States, Chicago - United States, Detroit - United States, New York - United States, New York - United States, Fairfax - United States, Seattle - United States, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Marseille - France, Berlin - Germany, Heidelberg - Germany, Mainz - Germany, Athens - Greece, Padova - Italy, Udine - Italy, Bialystok - Poland, Bydgoszcz - Poland, Warsaw - Poland, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Kaoshiung Hsien - Taiwan, Tainan - Taiwan, Taipei City - Taiwan, Taipei - Taiwan, Istanbul - Turkey, Izmir - Turkey",2011-04,2006-03-02,2013-04-25,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02624063,Unknown,COMPLETED,2015-12,"Hepatitis C, Chronic","Daclatasvir + Sofosbuvir, Simeprevir + Sofosbuvir",São Paulo - Brazil,2017-03,2015-12-08,2017-08-01,INTERVENTIONAL,PHASE4,Federal University of São Paulo,OTHER,hepatitis
NCT03186235,Unknown,COMPLETED,2018-07-01,Hepatitis C,Flow cytometry,Assiut - Egypt,2019-08-01,2017-06-14,2019-12-18,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00352235,Unknown,COMPLETED,2003-08,Chronic Hepatitis C,KRN7000,Rotterdam - Netherlands,Unknown Date,2006-07-14,2006-07-14,INTERVENTIONAL,PHASE2,Foundation for Liver Research,OTHER,hepatitis
NCT00175435,Unknown,COMPLETED,2005-08,Hepatitis B,"Resiquimod gel, Resiquimod gel, Resiquimod gel",Vancouver - Canada,2007-04,2005-09-15,2010-11-02,INTERVENTIONAL,PHASE2,University of British Columbia,OTHER,hepatitis
NCT03566563,EPIC,COMPLETED,2017-02-21,Hepatitis C,Screening,Singapore - Singapore,2020-02-07,2018-06-25,2020-10-08,OBSERVATIONAL,Not Available,Changi General Hospital,OTHER,hepatitis
NCT00196586,Unknown,COMPLETED,2003-04,"HIV Infections, Chronic Hepatitis C","Interleukin 2, pegylated interferon alpha 2a, ribavirin",Paris - France,Unknown Date,2005-09-20,2007-11-16,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00713986,Unknown,COMPLETED,2006-03,"Pain, Analgesia","Water 2mL PO 2 minutes prior to intra-muscular injection, skin-to-skin contact, Glucose 25% 2 mL PO 2 minutes prior to injection, neonates will receive skin-to-skin contact beginning 2 minutes after the intra-muscular injection and stopping 2 minutes afterwards.",No locations listed,2007-10,2008-07-14,2008-07-14,INTERVENTIONAL,PHASE3,Federal University of São Paulo,OTHER,hepatitis
NCT02510963,Unknown,UNKNOWN,2015-11,"Hepatitis B, Chronic","Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate",Xi'an - China,2017-06,2015-07-29,2016-08-10,INTERVENTIONAL,NA,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT02057263,Unknown,COMPLETED,2014-04,Hepatitis B,"Alendronate, Hepatitis B Vaccine, Placebo",Boston - United States,2016-02,2014-02-07,2016-10-21,INTERVENTIONAL,PHASE1,Massachusetts General Hospital,OTHER,hepatitis
NCT00958763,NIAAA,COMPLETED,2006-03,Hepatitis C,"Motivational Interviewing, Single - MIS, Motivational Interviewing Group, Usual Care Group - UCG","Los Angeles - United States, Los Angeles - United States, Los Angeles - United States",2008-12,2009-08-13,2009-08-13,INTERVENTIONAL,PHASE2,"University of California, Los Angeles",OTHER,hepatitis
NCT00207363,Unknown,COMPLETED,2002-02,Hepatitis C,"Ribavirin, Peg interferon alfa 2b, induction therapy",Ft. Sam Houston - United States,2010-01,2005-09-21,2012-02-14,INTERVENTIONAL,PHASE4,Brooke Army Medical Center,FED,hepatitis
NCT00001035,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C","Interferon alfa-2b, Zidovudine, Zalcitabine, Didanosine","Los Angeles - United States, Indianapolis - United States, New York - United States",Unknown Date,2001-08-31,2012-04-30,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01023035,Unknown,COMPLETED,2009-12-07,"Hepatitis C, Chronic","Boceprevir, Peginterferon alfa-2b (PEG2b), Ribavirin (RBV), Erythropoietin",No locations listed,2011-10-26,2009-12-01,2021-02-08,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05207163,Unknown,UNKNOWN,2022-02-10,Viral Hepatitis,Continuing medical education,Tháng 07 - Vietnam,2023-02-10,2022-01-26,2022-09-30,INTERVENTIONAL,NA,Pham Ngoc Thach University of Medicine,OTHER,hepatitis
NCT00911963,Unknown,COMPLETED,2009-04,Hepatitis C,"VCH-222 or matching placebo, VCH-222 or matching placebo, peginterferon alfa-2a, ribavirin","Marietta - United States, Detroit - United States, Dallas - United States, San Antonio - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Vancouver - Canada, Winnipeg - Canada, Ottawa - Canada, Santurce - Puerto Rico",2012-09,2009-06-03,2014-03-10,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT00044135,Unknown,UNKNOWN,2002-08,Hepatitis B,clevudine (drug),"Chicago - United States, Philadelphia - United States, Vancouver - Canada, Vancouver - Canada, Hong Kong - China, Hong Kong - China, Clichy - France, Lyon - France, Paris - France, Vandoeuvre - France, Singapore - Singapore",Unknown Date,2002-08-21,2005-06-24,INTERVENTIONAL,PHASE2,Triangle Pharmaceuticals,INDUSTRY,hepatitis
NCT01258686,Unknown,COMPLETED,2010-11,Hepatitis C,"Silymarin, Placebo","Seoul - Korea, Republic of",2012-11,2010-12-13,2013-11-25,INTERVENTIONAL,PHASE3,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT01428063,Unknown,COMPLETED,2011-09,Hepatitis C Virus Infection,"Daclatasvir, Asunaprevir, Pegylated interferon alfa-2a, Ribavirin","Montgomery - United States, La Jolla - United States, Los Angeles - United States, Aurora - United States, New Haven - United States, Gainesville - United States, Miami - United States, Baltimore - United States, Catonsville - United States, Detroit - United States, St. Louis - United States, Manhasset - United States, Durham - United States, Tulsa - United States, Philadelphia - United States, Nashville - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Prov. Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Darlinghurst - Australia, Kogarah - Australia, Westmead Nsw - Australia, Adelaide - Australia, Clayton Vic - Australia, Fitzroy - Australia, Heidelberg - Australia, Melbourne - Australia, Fremantle - Australia, Perth - Australia, Graz - Austria, Wien - Austria, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Vaughan - Canada, Montreal - Canada, Montreal - Canada, Quebec - Canada, Hvidovre - Denmark, Bondy Cedex - France, Clichy Cedex - France, Creteil - France, Creteil - France, Lille - France, Lyon Cedex 02 - France, Marseille Cedex 08 - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Paris Cedex 14 - France, Toulouse Cedex 09 - France, Toulouse - France, Vandoeuvre Cedex - France, Villejuif Cedex - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Thesaloniki - Greece, Dublin 8 - Ireland, Dublin - Ireland, Brescia - Italy, Cisanello (pisa) - Italy, Messina - Italy, Milano - Italy, Pavia - Italy, Roma - Italy, Roma - Italy, Torino - Italy, Viale Del Policlinico, 155 - Italy, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Guadalajara - Mexico, Auckland - New Zealand, Bialystok - Poland, Wroclaw - Poland, Barcelona - Spain, Gothenburg - Sweden, Stockholm - Sweden, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Glasgow - United Kingdom",2014-09,2011-09-02,2016-05-27,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01728935,Unknown,COMPLETED,2008-04,Chronic Hepatitis B,Tenofovir disoproxil,Hong Kong - Hong Kong,2012-11,2012-11-20,2014-12-30,INTERVENTIONAL,NA,The University of Hong Kong,OTHER,hepatitis
NCT03038763,Unknown,COMPLETED,2017-05-11,"Hepatitis C, Hepatitis C, Chronic","Eligibility Screening, HCV test",Philadelphia - United States,2019-06-30,2017-02-01,2019-07-17,OBSERVATIONAL,Not Available,University of Pennsylvania,OTHER,hepatitis
NCT02000063,ATAHC Recall,COMPLETED,2012-08,Acute Hepatitis C,No interventions listed,"Sydney - Australia, Adelaide - Australia, Melbourne - Australia",2014-03,2013-12-03,2014-10-01,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT02011763,Unknown,COMPLETED,2013-12,"Hepatitis A, Hepatitis A Virus",Avaxim 80U Pediatric: Inactivated Hepatitis A Virus,Beijing - China,2014-09,2013-12-13,2015-10-01,INTERVENTIONAL,PHASE4,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT00702663,Unknown,UNKNOWN,2007-10,Hepatitis B,No interventions listed,Taipei - Taiwan,Unknown Date,2008-06-20,2008-06-20,OBSERVATIONAL,Not Available,Far Eastern Memorial Hospital,OTHER,hepatitis
NCT00880763,Unknown,COMPLETED,2009-04-20,Hepatitis C,"Vaniprevir, Pegylated Interferon (peg-IFN), Ribavirin, Comparator: Placebo",No locations listed,2010-06-03,2009-04-14,2018-10-09,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04267458,Unknown,UNKNOWN,2019-07-01,Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment,evaluation of sofuspovir containing DAA regien expected insult on kidney,Cairo - Egypt,2020-04-30,2020-02-12,2020-02-12,INTERVENTIONAL,PHASE4,Cairo University,OTHER,hepatitis
NCT03113058,Unknown,UNKNOWN,2017-05-02,Adoptive Treatment for Hepatitis B With γδT Cells,Adoptive transfer of γδT cells,Guangzhou - China,2018-10-05,2017-04-13,2017-04-21,INTERVENTIONAL,PHASE1,Jinan University Guangzhou,OTHER,hepatitis
NCT04412863,Unknown,COMPLETED,2020-07-03,Chronic Hepatitis B,"VIR-2218, pegylated interferon-alfa 2a","Birtinya - Australia, Fitzroy - Australia, Hong Kong - Hong Kong, Busan - Korea, Republic of, Chuncheon - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Batu Caves - Malaysia, Kajang - Malaysia, Kuala Lumpur - Malaysia, Kuantan - Malaysia, Auckland - New Zealand, Auckland - New Zealand, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Hat Yai - Thailand, Khlong Luang - Thailand, Khon Kaen - Thailand",2024-03-25,2020-06-02,2024-09-19,INTERVENTIONAL,PHASE2,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT05453435,REHEB,RECRUITING,2022-07-15,"Resolved Hepatitis B, CD20 Positive B-cell Lymphoma",Entecavir,Guangzhou - China,2025-07,2022-07-12,2024-05-07,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT03669835,Unknown,COMPLETED,2018-03-28,Hepatitis C,"Mare milk supplement, Standard therapy",Almaty - Kazakhstan,2019-09-20,2018-09-13,2021-02-08,INTERVENTIONAL,NA,Asfendiyarov Kazakh National Medical University,OTHER,hepatitis
NCT00917358,Unknown,COMPLETED,2005-07,Hepatitis C,Pegylated interferon alfa-2a,"Chiayi - Taiwan, Chiayi - Taiwan, Douliou - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2008-06,2009-06-10,2012-12-20,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT02327416,Unknown,UNKNOWN,2014-10,"Hepatitis B, Chronic","Y peginterferon alfa-2b, Granulocyte-macrophage colony stimulating factor, Entecavir and or adefovir dipivoxil","Beijing - China, Wuhan - China, Changsha - China, Wenzhou - China",2018-12,2014-12-30,2016-08-15,INTERVENTIONAL,PHASE3,Tongji Hospital,OTHER,hepatitis
NCT01718158,STRUCTURE,COMPLETED,2013-01,Hepatitis C,"Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin, Daclatasvir, Telaprevir","Long Beach - United States, Marietta - United States, New York - United States, Poughkeepsie - United States, Allentown - United States, Nashville - United States, Arlington - United States, Houston - United States, Capital Federal - Argentina, Mar Del Plata - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Clichy Cedex - France, Grenoble Cedex 9 - France, Villejuif Cedex - France, Berlin - Germany, Essen - Germany, Hamburg - Germany, Mannheim - Germany, Muenchen - Germany, Haifa - Israel, Tel Aviv - Israel, Tel-Hashomer - Israel, Zafed - Israel, Foggia - Italy, Messina - Italy, Modena - Italy, Pavia - Italy, Pisa - Italy, Nagoya-shi - Japan, Kitakyushu-shi - Japan, Kitakyushu - Japan, Hiroshima-shi - Japan, Sapporo-shi - Japan, Kobe-shi - Japan, Higashiibaraki-gun - Japan, Kawasaki-shi - Japan, Yokohama-shi - Japan, Yokohama - Japan, Kyoto-shi - Japan, Kyoto-shi - Japan, Minato-ku - Japan, Musashino-shi - Japan, Sumida-ku - Japan, Tanabe-shi - Japan, Gifu - Japan, Kumamoto - Japan, Saga - Japan, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bialystok - Poland, Lodz - Poland, Myslowice - Poland, Wroclaw - Poland, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Madrid - Spain, Santander - Spain, Zaragoza - Spain, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, London - United Kingdom",2014-10,2012-10-31,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02751996,ACHIEVE,COMPLETED,2016-05,"Hepatitis B, Hepatitis, Viral","SB 9200, Placebo, Tenofovir","Calgary - Canada, Vancouver - Canada, London - Canada, Toronto - Canada, Vaughan - Canada, Hong Kong - Hong Kong, Shatin - Hong Kong, Chuncheon-si - Korea, Republic of, Yangsan-si - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Goyang-si - Korea, Republic of, Seoul - Korea, Republic of, Chia-Yi City - Taiwan, New Taipei City - Taiwan, Taipei - Taiwan, Taoyuan County - Taiwan",2020-02-10,2016-04-26,2020-02-11,INTERVENTIONAL,PHASE2,"F-star Therapeutics, Inc.",INDUSTRY,hepatitis
NCT02582658,REAL,COMPLETED,2015-10-06,Chronic Hepatitis C,No interventions listed,No locations listed,2017-01-12,2015-10-21,2019-06-05,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02786758,co-EC,COMPLETED,2016-04,"Hepatitis C, HIV",No interventions listed,"Carlton - Australia, Melbourne - Australia, North Fitzroy - Australia, Parkville - Australia, Prahran - Australia, St Kilda - Australia",2019-07,2016-06-01,2020-02-28,OBSERVATIONAL,Not Available,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT01767116,PEARL-III,COMPLETED,2012-12,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin",No locations listed,2013-12,2013-01-14,2021-07-12,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT00710216,EVD,WITHDRAWN,Unknown Date,"Hepatitis B, Chronic","Lamivudine, Telbivudine",Ulm - Germany,Unknown Date,2008-07-04,2009-04-20,INTERVENTIONAL,PHASE4,University of Ulm,OTHER,hepatitis
NCT06508996,Unknown,COMPLETED,2024-02-06,HCV,Xpert HCV,Lexington - United States,2024-05-10,2024-07-19,2024-07-19,OBSERVATIONAL,Not Available,Cepheid,INDUSTRY,hepatitis
NCT01289496,Unknown,COMPLETED,2011-02,Chronic Hepatitis C,"Peg-interferon alpha-2a, Ribavirin",Montréal - Canada,2013-08,2011-02-03,2014-02-26,INTERVENTIONAL,PHASE2,Centre hospitalier de l'Université de Montréal (CHUM),OTHER,hepatitis
NCT00761735,Unknown,COMPLETED,2007-07,"Hepatitis C, Chronic","Peginterferon alfa-2b, Ribavirin",No locations listed,2013-01,2008-09-29,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01701063,Unknown,TERMINATED,2013-01,Hepatitis C,"Telaprevir, Peginterferon alfa-2b, Ribavirin","Phoenix - United States, San Francisco - United States, Denver - United States, Washington - United States, Gainesville - United States, Miami - United States, Indianapolis - United States, Baltimore - United States, Bronx - United States, New York - United States, Philadelphia - United States, Houston - United States, Seattle - United States, Brussel - Belgium, Bruxelles - Belgium, Wuppertal - Germany, Milano - Italy, Padova - Italy, Pisa - Italy, Esplugues de Llobregat - Spain, Madrid - Spain, Birmingham - United Kingdom, Leeds - United Kingdom, London - United Kingdom",2015-04,2012-10-04,2016-07-20,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02545335,Unknown,COMPLETED,2014-11-01,Chronic Hepatitis C,No interventions listed,Graz - Austria,2020-12-31,2015-09-09,2023-01-12,OBSERVATIONAL,Not Available,Medical University of Graz,OTHER,hepatitis
NCT02503735,Unknown,TERMINATED,2015-07-15,"Hepatitis C, Chronic Kidney Disease",Sofosbuvir/Ledipasvir FDC,Boston - United States,2017-09,2015-07-21,2020-01-13,INTERVENTIONAL,NA,Massachusetts General Hospital,OTHER,hepatitis
NCT00834158,TACEPVE,COMPLETED,2009-01,Hepatocellular Carcinoma,"TACE, PVE",Shanghai - China,2009-12,2009-02-03,2016-04-01,INTERVENTIONAL,NA,Eastern Hepatobiliary Surgery Hospital,OTHER,hepatitis
NCT00317135,Unknown,COMPLETED,2003-12-11,"Diphtheria, Hepatitis B, Whole Cell Pertussis, Haemophilus Influenzae Type b, Tetanus","Tritanrix-HepB/Meningitec conjugate vaccine, Tritanrix/Hiberix vaccine",Muntinlupa - Philippines,2004-10-23,2006-04-24,2018-08-15,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03829735,NeoVac2S,WITHDRAWN,2020-11-01,Hepatitis B,Human biological samples,No locations listed,2021-06-30,2019-02-04,2022-03-23,INTERVENTIONAL,NA,Institut Pasteur,INDUSTRY,hepatitis
NCT01471535,Unknown,COMPLETED,2008-05,Chronic Hepatitis B,Pegylated interferon alfa-2a,Beijing - China,2012-12,2011-11-15,2015-03-10,INTERVENTIONAL,NA,Beijing Ditan Hospital,OTHER,hepatitis
NCT04070235,Unknown,UNKNOWN,2019-03-29,"Hepatitis C, Chronic","SH229 tablets, Daclatasvir dihydrochloride",Jilin - China,2019-12,2019-08-28,2019-08-28,INTERVENTIONAL,PHASE3,"Nanjing Sanhome Pharmaceutical, Co., Ltd.",INDUSTRY,hepatitis
NCT01593735,Unknown,COMPLETED,2012-05,Hepatitis C,"MK-2748, Placebo",No locations listed,2013-02,2012-05-08,2015-01-22,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03825458,CirB-RNA,RECRUITING,2019-02-25,Hepatitis B,Blood sampling,"Lyon - France, Lyon - France, Lyon - France, Milan - Italy, Palermo - Italy, Parma - Italy",2029-06-25,2019-01-31,2023-11-18,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT01387958,Unknown,TERMINATED,2011-07,Hepatitis C,"LCQ908, Placebo","Auckland - New Zealand, Christchurch - New Zealand",2012-02,2011-07-06,2012-05-08,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT03099135,Unknown,TERMINATED,2017-04-10,Hepatitis C,No Treatment,"Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Auckland - New Zealand, Christchurch - New Zealand, Lodz - Poland, Lublin - Poland, Myslowice - Poland, Singapore - Singapore",2018-02-01,2017-04-04,2025-02-03,INTERVENTIONAL,PHASE3,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT01095835,Unknown,COMPLETED,2005-02,"Hepatitis B, Chronic","Pegylated interferon (PEG-IFN) alfa-2a, 180 mcg, Pegylated interferon (PEG-IFN) alfa-2a, 135 mcg, Lamivudine (LAM)","Caserta - Italy, Napoli - Italy, Napoli - Italy, Bologna - Italy, Parma - Italy, Reggio Emilia - Italy, Trieste - Italy, Udine - Italy, Brescia - Italy, Milano - Italy, Milano - Italy, Torino - Italy, Torino - Italy, Bari - Italy, Castellana Grotte - Italy, San Giovanni Rotondo - Italy, Cagliari - Italy, Messina - Italy, Palermo - Italy, Pisa - Italy, Padova - Italy, Verona - Italy",2010-01,2010-03-30,2016-11-03,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00782158,Unknown,COMPLETED,2008-10-27,"Hepatitis B, HIV Infections",No interventions listed,"Kampala - Uganda, Rakai - Uganda",Unknown Date,2008-10-31,2019-12-05,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT03083158,HVP01,COMPLETED,2017-03-06,"Hepatitis B, Immunization; Infection",Hepatitis B vaccine,Vancouver - Canada,2018-02-01,2017-03-17,2020-11-25,INTERVENTIONAL,PHASE4,University of British Columbia,OTHER,hepatitis
NCT03365635,HD,COMPLETED,2019-09-22,"Hepatitis C, Hemodialysis, Nosocomial Infection",Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier],Philadelphia - United States,2020-05-01,2017-12-07,2021-12-15,INTERVENTIONAL,PHASE4,University of Pennsylvania,OTHER,hepatitis
NCT01794234,Unknown,TERMINATED,2012-08,"Hepatitis B, Chronic",No interventions listed,"Bytom - Poland, Debica - Poland, Gdansk - Poland, Krakow - Poland, Krakow - Poland, Lancut - Poland, Myslowice - Poland, Raciborz - Poland, Wroclaw - Poland",2013-09,2013-02-18,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04398134,Unknown,TERMINATED,2020-08-28,Chronic Hepatitis B,"ABI-H2158, Placebo, Entecavir (ETV)","Los Angeles - United States, Pasadena - United States, Redwood City - United States, San Diego - United States, San Francisco - United States, Miami - United States, Baltimore - United States, Flushing - United States, Manhasset - United States, New York - United States, Philadelphia - United States, San Antonio - United States, Seattle - United States, Camperdown - Australia, Darlinghurst - Australia, New Lambton - Australia, Greenslopes - Australia, Fitzroy - Australia, Melbourne - Australia, Parkville - Australia, Vancouver - Canada, Toronto - Canada, Changchun - China, Chongqing - China, Changsha - China, Guangzhou - China, Guangzhou - China, Sha Tin - Hong Kong, Hong Kong - Hong Kong, Chuncheon - Korea, Republic of, Yangsan - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Hamilton - New Zealand, Kaohsiung City - Taiwan, Taichung - Taiwan, Taipei City - Taiwan, Taipei City - Taiwan, Taoyuan - Taiwan, London - United Kingdom",2021-10-14,2020-05-21,2022-09-15,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT00545558,ART and HCV,COMPLETED,2006-04,"Hepatitis C, HIV Infections","Efavirenz, Emtricitabine/Tenofovir disoproxil fumarate","Cincinnati - United States, Richmond - United States",2012-03,2007-10-17,2014-08-12,INTERVENTIONAL,PHASE1,University of Cincinnati,OTHER,hepatitis
NCT04069858,Unknown,UNKNOWN,2016-12-01,Chronic Hepatitis B,Switching to Generic Entecavir (Baracle®),"Ansan - Korea, Republic of",2019-03-01,2019-08-28,2020-02-17,INTERVENTIONAL,PHASE4,Korea University,OTHER,hepatitis
NCT03894696,Unknown,UNKNOWN,2019-08-01,Chronic Hepatitis c,Direct Acting Antivirals,No locations listed,2020-04-01,2019-03-28,2019-07-08,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01585324,Unknown,COMPLETED,2012-01,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin [Copegus]",Most - Czech Republic,2014-01,2012-04-25,2015-07-24,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01292824,ITX5061,COMPLETED,2011-02,"Hepatitis C, Evidence of Liver Transplantation",ITX 5061,Birmingham - United Kingdom,2013-01,2011-02-10,2015-12-03,INTERVENTIONAL,PHASE1,University of Birmingham,OTHER,hepatitis
NCT00162734,Unknown,COMPLETED,2005-02,Chronic Hepatitis C,"Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks",No locations listed,2007-06,2005-09-13,2012-06-22,INTERVENTIONAL,PHASE3,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT00910624,PROVIDE,COMPLETED,2009-06-22,"Hepatitis C, Chronic","Boceprevir, Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908)",No locations listed,2012-12-07,2009-06-01,2021-02-08,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01616524,PRINCIPAL,COMPLETED,2012-07,Hepatitis C Virus (HCV),"Pegylated interferon lambda (pegIFNλ), Pegylated interferon lambda (pegIFNλ), Pegylated interferon alfa-2a (pegIFNα-2a), Ribavirin, Ribavirin, Daclatasvir, Placebo matching Daclatasvir","Phoenix - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, New Haven - United States, Orlando - United States, Orlando - United States, Marietta - United States, Honolulu - United States, Detroit - United States, Charlotte - United States, Cincinnati - United States, Tulsa - United States, Pittsburgh - United States, Arlington - United States, Houston - United States, Murray - United States, Autonoma - Argentina, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Mar Del Plata - Argentina, Quilmes - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Cordoba - Argentina, Camperdown - Australia, Concord - Australia, Darlinghurst - Australia, Randwick - Australia, Westmead Nsw - Australia, Brisbane - Australia, Greenslopes - Australia, Herston - Australia, Adelaide - Australia, Clayton Vic - Australia, Fitzroy - Australia, Melbourne - Australia, Parville - Australia, Fremantle - Australia, Brussels - Belgium, Leuven - Belgium, Liege - Belgium, Santiago - Chile, Hus - Finland, Clichy Cedex - France, Creteil Cedex - France, Montpellier Cedex 5 - France, Nice Cedex 3 - France, Athens - Greece, Thessaloniki - Greece, Hong Kong - Hong Kong, Tai Po - Hong Kong, Firenze - Italy, Milano - Italy, Milano - Italy, Napoli - Italy, Novara - Italy, Fukuoka-shi - Japan, Kitakyushu - Japan, Hiroshima-Shi - Japan, Sapporo-shi - Japan, Kobe-shi - Japan, Tsuchiura-shi - Japan, Takamatsu-shi - Japan, Kagoshima-shi - Japan, Kawasaki-shi - Japan, Okayama-shi - Japan, Iruma-gun - Japan, Bunkyo-ku - Japan, Minato-ku - Japan, Musashino-shi - Japan, Wakayama-shi - Japan, Fukuoka - Japan, Miyazaki - Japan, Saga - Japan, Saitama - Japan, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeongsangnam-do - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Mexico City - Mexico, Mexico - Mexico, Tlalpan - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Distrito Federal - Mexico, Guadalajara - Mexico, Mexico City - Mexico, Amsterdam - Netherlands, Leiden - Netherlands, Auckland - New Zealand, Chelyabinsk - Russian Federation, Irkutsk - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Yunlin - Taiwan, Hull - United Kingdom, Nottingham - United Kingdom, Birmingham - United Kingdom, London - United Kingdom",2014-06,2012-06-11,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00499434,Unknown,UNKNOWN,2007-08,"Acquired Immune Deficiency Syndrome, Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted, HIV Infections",No interventions listed,Botucatu - Brazil,2009-01,2007-07-11,2009-12-04,OBSERVATIONAL,Not Available,UPECLIN HC FM Botucatu Unesp,OTHER,hepatitis
NCT06576024,Unknown,RECRUITING,2023-12-19,"Hepatitis A, Immunodeficiency, HIV Infections","2 doses of HAV, At least one dose of HAV",Liuzhou - China,2024-10-19,2024-08-28,2024-08-28,INTERVENTIONAL,PHASE4,LiuZhou People's Hospital,OTHER,hepatitis
NCT01465516,Unknown,TERMINATED,2011-11,Hepatitis C Infection,Boceprevir,Riverside - United States,2013-12,2011-11-04,2015-06-30,OBSERVATIONAL,Not Available,Arrowhead Regional Medical Center,OTHER,hepatitis
NCT04783116,Unknown,UNKNOWN,2021-03-15,"Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Childhood Obesity, Childhood Overweight, Pediatric Obesity","Plant stanols (3g/day), Placebo",Maastricht - Netherlands,2022-12-31,2021-03-05,2021-03-05,INTERVENTIONAL,NA,Maastricht University Medical Center,OTHER,hepatitis
NCT01953458,HEPATHER,UNKNOWN,2012-08-06,"Viral Hepatitis B, Viral Hepatitis C",No interventions listed,Multiple Locations - France,2024-12,2013-10-01,2023-01-31,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT02907996,Unknown,COMPLETED,2016-09-09,Hepatitis C Virus,Sofosbuvir,"Wonju - Korea, Republic of, Sungnam - Korea, Republic of, Anyang - Korea, Republic of, Bucheon-si - Korea, Republic of, Bucheon-Si - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Cheonan - Korea, Republic of, Cheonan - Korea, Republic of, Chuncheon-si - Korea, Republic of, Chungju - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Daejeon - Korea, Republic of, Daejeon - Korea, Republic of, Gangneung - Korea, Republic of, Goyang-si - Korea, Republic of, Goyang - Korea, Republic of, Goyang - Korea, Republic of, Gumi - Korea, Republic of, Guri - Korea, Republic of, Gwangjin-gu - Korea, Republic of, Gwangju - Korea, Republic of, Gwangju - Korea, Republic of, Gyeongju - Korea, Republic of, Hwaseong-si - Korea, Republic of, Hwasun - Korea, Republic of, Iksan - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jeju-Si - Korea, Republic of, Jeonju-si - Korea, Republic of, Jeonju - Korea, Republic of, Jinju - Korea, Republic of, Seongnam-si - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon-si - Korea, Republic of, Suwon - Korea, Republic of, Uijeongbu - Korea, Republic of, Ulsan - Korea, Republic of, Yangsan - Korea, Republic of, Yongin - Korea, Republic of",2021-12-09,2016-09-20,2021-12-27,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03820258,Unknown,TERMINATED,2019-01-28,Hepatitis C Virus Infection,SOF/VEL/VOX,"Firenze - Italy, Milano - Italy, Milan - Italy, Napoli - Italy, San Giovanni Rotondo - Italy, Bydgoszcz - Poland, Poznan - Poland, Wroclaw - Poland, Birmingham - United Kingdom, London - United Kingdom",2019-12-04,2019-01-29,2020-10-23,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00621296,Unknown,COMPLETED,2008-01,Hepatitis C,MP-424 (Telaprevir),Kawasaki City - Japan,2009-02,2008-02-22,2014-05-02,INTERVENTIONAL,PHASE2,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00289796,Unknown,COMPLETED,2004-07,Hepatitis B,DTPa-HBV-IPV/Hib,Mainz - Germany,2006-04,2006-02-10,2017-02-08,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01930058,Unknown,COMPLETED,2013-10-02,Hepatitis C,MK-8876,No locations listed,2014-05-05,2013-08-28,2018-10-25,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00700401,Unknown,COMPLETED,2008-11,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin [Copegus]","Brasilia - Brazil, Vitoria - Brazil, Sao Luis - Brazil, Rio de Janeiro - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Campinas - Brazil, Campinas - Brazil, Ribeirao Preto - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil",2010-11,2008-06-18,2016-06-21,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01258101,Unknown,COMPLETED,2003-05,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], ribavirin, ribavirin","Gratwein - Austria, Graz - Austria, Innsbruck - Austria, Linz - Austria, Linz - Austria, Oberndorf - Austria, Ried-innkreis - Austria, Salzburg - Austria, Villach - Austria, Wels - Austria, Wiener Neustadt - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria",2008-07,2010-12-10,2016-07-11,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03506867,Unknown,RECRUITING,2019-01-03,"Nicotine Dependence, Substance Use Disorders","Life skills, training, education and work/volunteer opportunities, Standard Care",Ottawa - Canada,2027-03-31,2018-04-24,2023-03-31,INTERVENTIONAL,NA,Ottawa Hospital Research Institute,OTHER,hepatitis
NCT00988767,RBM99026,COMPLETED,2001-02,Chronic Hepatitis B,DNA vaccine,Paris - France,2003-11,2009-10-02,2009-10-05,INTERVENTIONAL,PHASE1,"Institut National de la Santé Et de la Recherche Médicale, France",OTHER_GOV,hepatitis
NCT01909401,Unknown,COMPLETED,2013-06,Liver Transplantation,boceprevir,Indianapolis - United States,2014-07,2013-07-26,2014-07-24,INTERVENTIONAL,PHASE1,Indiana University,OTHER,hepatitis
NCT04382404,Unknown,COMPLETED,2020-10-22,"Hepatitis C, Chronic",Sofosbuvir-Velpatasvir Drug Combination,Pittsburgh - United States,2023-10-16,2020-05-11,2025-01-01,INTERVENTIONAL,PHASE1,Catherine Anne Chappell,OTHER,hepatitis
NCT01371604,Unknown,COMPLETED,2011-07,"Hepatitis C, Chronic","IDX184, Peginterferon alfa-2a (Peg-IFN), Ribavirin (RBV), Placebo",No locations listed,2013-03,2011-06-13,2015-02-06,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03198104,Kids4LIFe,COMPLETED,2016-04-01,"Non-alcoholic Steatohepatitis, Liver Diseases, Liver Fibroses, Autoimmune Hepatitis, Liver Cirrhoses",MRI,Warsaw - Poland,2019-03-01,2017-06-23,2019-08-30,OBSERVATIONAL,Not Available,Perspectum,INDUSTRY,hepatitis
NCT00635804,Unknown,COMPLETED,2008-02-19,Hepatitis C,"MK-3281, Placebo to MK-3281",No locations listed,2009-12-22,2008-03-14,2018-09-05,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04075201,Unknown,COMPLETED,2019-07-07,Hepatitis B,"One dose of investigational vaccine, One dose of control vaccine, Three doses of investigational vaccine, Three doses of control vaccine",Zhumadian - China,2021-05-30,2019-08-30,2021-07-29,INTERVENTIONAL,PHASE1,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT02097004,E+VIP,COMPLETED,2014-04,"Hepatitis B, Chronic","Peginterferon alfa-2a, HBV vaccination, Entecavir","Seoul - Korea, Republic of",2018-01,2014-03-26,2018-05-09,INTERVENTIONAL,PHASE4,Seoul National University Hospital,OTHER,hepatitis
NCT02745704,Unknown,UNKNOWN,2016-04,Chronic Hepatitis B,Peginterferon alfa,Guangzhou - China,2019-04,2016-04-20,2019-01-15,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00710801,Unknown,COMPLETED,2005-05,Hepatitis C Virus,No interventions listed,Edmonton - Canada,Unknown Date,2008-07-04,2011-09-15,OBSERVATIONAL,Not Available,University of Alberta,OTHER,hepatitis
NCT02777801,Unknown,UNKNOWN,2015-06,Stomach Neoplasms,Entecavir,Guangzhou - China,2017-12,2016-05-19,2017-10-13,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT00811967,Unknown,TERMINATED,2003-02,"Hepatitis C, Chronic, Liver Cirrhosis","PegIntron (peginterferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2006-05,2008-12-19,2017-03-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01264367,Unknown,COMPLETED,2008-12,HBeAg(+) Chronic Hepatitis B,"Clevudine, Clevudine + Peg-interferon","Uijeongbu - Korea, Republic of",2013-08,2010-12-21,2014-12-18,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT04415567,Unknown,COMPLETED,2018-06-01,Hepatocellular Carcinoma,Lenvatinib,Shanghai - China,2020-03-31,2020-06-04,2020-06-04,OBSERVATIONAL,Not Available,Jinyang Gu,OTHER,hepatitis
NCT01970904,Unknown,COMPLETED,2013-10,"Hepatitis C, Liver Disease","Alisporivir, Ribavirin, Peg-IFNα2a","Berlin - Germany, Berlin - Germany, Duesseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Köln - Germany, Muenchen - Germany, Würzburg - Germany, Bialystok - Poland, Lublin - Poland, Warszawa - Poland, Göteborg - Sweden, Luleå - Sweden, Lund - Sweden, Malmo - Sweden, Stockholm - Sweden, Umea - Sweden, Frimley - United Kingdom, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom",2015-03,2013-10-28,2016-04-20,INTERVENTIONAL,NA,Debiopharm International SA,INDUSTRY,hepatitis
NCT01277601,Unknown,COMPLETED,2011-04,Chronic Hepatitis B,"TDF, Peg-IFN","Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Jose - United States, Deland - United States, Maitland - United States, Miami - United States, Chicago - United States, New Orleans - United States, New Orleans - United States, Baltimore - United States, Boston - United States, Detroit - United States, Hillsborough - United States, Flushing - United States, Great Neck - United States, New York - United States, New York - United States, New York - United States, Philadelphia - United States, Houston - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Richmond - United States, Richmond - United States, Camperdown - Australia, Concord - Australia, Kogarah - Australia, Liverpool - Australia, Westmead - Australia, Herston - Australia, Woolloongabba - Australia, Adelaide SA - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Melbourne - Australia, Parkville - Australia, Fremantle - Australia, Nedlands - Australia, Perth - Australia, Calgary - Canada, Zeidler Ledcore Centre - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Clichy - France, Lyon - France, Paris - France, Rennes Cedex 9 - France, Rouen - France, Strasbourg - France, Toulouse - France, Villejuif Cedex - France, Mainz - Germany, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Köln - Germany, Leipzig - Germany, Thessaloniki - Greece, Attica - Greece, Patra - Greece, Thessaloniki - Greece, Hong Kong - Hong Kong, Kowloon - Hong Kong, Shatin - Hong Kong, Tai Po - Hong Kong, Hyderabad - India, Guwahati - India, Ahmedabad - India, Surat - India, Bangalore - India, Mumbai - India, Mumbai - India, Nagpur - India, Sangli - India, Delhi - India, Coimbatore - India, Kolkata - India, New Delhi - India, Monserrato - Italy, Milano - Italy, Milano - Italy, Napoli - Italy, Parma - Italy, Roma - Italy, Rome - Italy, Torino - Italy, Cheonan - Korea, Republic of, Wonju - Korea, Republic of, Ansan-si - Korea, Republic of, Bucheon - Korea, Republic of, Seoul - Korea, Republic of, Sungnam - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Yangsan - Korea, Republic of, Busan - Korea, Republic of, Goyang, Gyeonggi-Do - Korea, Republic of, Kwangjin-gu, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Amsterdam - Netherlands, Amsterdam - Netherlands, Rotterdam - Netherlands, Lodz - Poland, Lublin - Poland, Chorzów - Poland, Bialystok - Poland, Bydgoszcz - Poland, Krakow - Poland, Lodz - Poland, Warszawa - Poland, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Brasov - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucuresti - Romania, Sibiu - Romania, Timisoara - Romania, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Malaga - Spain, Sevilla - Spain, Vigo, Pontevedra - Spain, New Taipei City - Taiwan, Tao-Yuan - Taiwan, Changhua - Taiwan, Chia-Yi - Taiwan, Hualien - Taiwan, Kaohsiung - Taiwan, Kaosiung - Taiwan, Keelung Town/KEELUNG CITY - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Ankara - Turkey, Ankara - Turkey, Gaziantep - Turkey, Istanbul - Turkey, Mersin - Turkey, Birmingham, WSTMID - United Kingdom, Hampstead,London - United Kingdom, London - United Kingdom, London - United Kingdom",2014-08,2011-01-17,2016-08-26,INTERVENTIONAL,PHASE4,Gilead Sciences,INDUSTRY,hepatitis
NCT04454567,Unknown,TERMINATED,2020-11-11,Chronic Hepatitis B,"ABI-H0731, Placebo, NrtI","Los Angeles - United States, Pasadena - United States, San Diego - United States, San Francisco - United States, Miami - United States, Baltimore - United States, Hillsborough - United States, Manhasset - United States, Philadelphia - United States, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Grafton - New Zealand",2021-04-08,2020-07-01,2022-10-20,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT01406704,Unknown,TERMINATED,2004-01,NASH (Non-alcoholic Steato-hepatitis),"Rosiglitazone, alpha-lipoic acid, Rosiglitazone/alpha-lipoic acid",No locations listed,2010-12,2011-08-01,2011-08-19,INTERVENTIONAL,PHASE4,Seoul St. Mary's Hospital,OTHER,hepatitis
NCT01711567,STEEP,COMPLETED,2013-04,Chronic Hepatitis B,"tenofovir, entecavir","Ansan - Korea, Republic of",2015-12,2012-10-22,2016-11-09,INTERVENTIONAL,PHASE4,Korea University,OTHER,hepatitis
NCT00238901,Unknown,COMPLETED,2002-12,Liver Transplant,Basiliximab,No locations listed,2005-07,2005-10-14,2010-09-01,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT01057667,Unknown,COMPLETED,2010-02,"Hepatitis C, Chronic","RO5024048, Ribavirin [Copegus], peginterferon alfa-2a [Pegasys]","La Jolla - United States, Bradenton - United States, Atlanta - United States, Honolulu - United States, Honolulu - United States, Chicago - United States, Indianapolis - United States, Kansas City - United States, Kansas City - United States, Lebanon - United States, Albuquerque - United States, Bronx - United States, New York - United States, New York - United States, Philadelphia - United States, Columbia - United States, Nashville - United States, Houston - United States, San Antonio - United States, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Ottawa - Canada",2012-04,2010-01-27,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04643990,Unknown,UNKNOWN,2020-12-01,Chronic Hepatitis B,No interventions listed,Guangzhou - China,2021-11-30,2020-11-25,2020-12-22,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02765490,Unknown,COMPLETED,2016-11-09,"Hepatitis C, Chronic","AL-335, Odalasvir, Simeprevir","Antwerpen - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Kortrijik - Belgium, Leuven - Belgium, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Vaughan - Canada, Monteral - Canada, Montreal - Canada, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Leipzig - Germany, Lodz - Poland, Lublin - Poland, Mysłowice - Poland, Warszawa - Poland, Wroclaw - Poland, Singapore - Singapore, Barcelona - Spain, Madrid - Spain, Málaga - Spain, Seville - Spain, Valencia - Spain",2017-08-09,2016-05-06,2019-11-20,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT04745403,SAFE-T-HBV,RECRUITING,2022-05-20,Hepatocellular Carcinoma,mRNA HBV/TCR T-cells,Singapore - Singapore,2026-07-01,2021-02-09,2023-11-18,INTERVENTIONAL,PHASE1,Lion TCR Pte. Ltd.,INDUSTRY,hepatitis
NCT01572103,Unknown,COMPLETED,2010-01,Chronic HCV-related Hepatitis,"Coffee, coffee abstinence",No locations listed,2010-12,2012-04-06,2012-04-06,INTERVENTIONAL,PHASE3,Azienda Ospedaliera di Padova,OTHER,hepatitis
NCT04114890,PK-TDF,COMPLETED,2021-01-08,"Hepatitis B, Tenofovir, Pregnancy",Tenofovir Disoproxil Fumarate,Mae sot - Thailand,2023-09-29,2019-10-03,2024-03-27,INTERVENTIONAL,PHASE2,University of Oxford,OTHER,hepatitis
NCT05760703,Unknown,TERMINATED,2023-04-25,Chronic Hepatitis b,STSG-0002 Injection,"Beijing - China, Beijing - China, Beijing - China, Chongqing - China",2023-12-11,2023-03-08,2023-12-19,INTERVENTIONAL,PHASE2,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",INDUSTRY,hepatitis
NCT02690103,Unknown,COMPLETED,2012-07,"Hepatitis C, Chronic","pegylated IFN, Biobran, Ribavirin",No locations listed,2015-06,2016-02-24,2016-02-24,INTERVENTIONAL,PHASE2,Cairo University,OTHER,hepatitis
NCT00707603,Unknown,COMPLETED,2006-05,"Hepatitis C, Insulin Resistance",No interventions listed,"Sydney - Australia, Sydney - Australia",2008-12,2008-07-01,2015-07-14,OBSERVATIONAL,Not Available,Garvan Institute of Medical Research,OTHER,hepatitis
NCT02189603,Unknown,COMPLETED,2014-06,Hepatitis E,Recombinant (E. Coli) Hepatitis E Vaccine,Xiamen - China,2015-12-07,2014-07-14,2018-08-17,INTERVENTIONAL,PHASE4,Jun Zhang,OTHER,hepatitis
NCT00689390,Unknown,TERMINATED,2007-02-20,"Hepatitis C, Chronic, Hepacivirus","Boceprevir, Narlaprevir, Peginterferon alfa-2b, Ribavirin, Blood/Plasma Collection",No locations listed,2014-10-13,2008-06-03,2018-09-11,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01466790,COSMOS,COMPLETED,2012-01,Hepatitis C,"TMC435, PSI-7977 (GS7977), Ribavirin","Hoover - United States, Bakersfield - United States, La Jolla - United States, San Diego - United States, New Haven - United States, Brandenton - United States, Jacksonville - United States, Orlando - United States, Tampa - United States, Wellington - United States, Atlanta - United States, Chicago - United States, Lutherville - United States, Lebanon - United States, New York - United States, Pittsburgh - United States, Arlington - United States, Dallas - United States, San Antonio - United States, Falls Church - United States, Norfolk - United States, Seatle - United States, Santurce - Puerto Rico",2013-11,2011-11-08,2015-02-09,INTERVENTIONAL,PHASE2,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT04320290,Unknown,WITHDRAWN,2020-05-21,"Kidney Failure, Hepatitis C",Direct Acting Antivirals,No locations listed,2020-06-16,2020-03-24,2022-08-31,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT02219503,TURQUOISE-III,COMPLETED,2014-09,"Chronic Hepatitis C Infection, Compensated Cirrhosis","Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir",No locations listed,2015-06,2014-08-19,2021-07-12,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00867243,Unknown,TERMINATED,2005-10,"Complication of Transplanted Liver, Hepatitis C, Chronic",No interventions listed,Chicago - United States,2010-05,2009-03-23,2013-06-11,OBSERVATIONAL,Not Available,Northwestern University,OTHER,hepatitis
NCT01581203,Hallmark DUAL,COMPLETED,2012-05,Hepatitis C Virus,"Asunaprevir (ASV), Daclatasvir (DCV), Pegylated-interferon alfa 2a (PegIFN), Ribavirin (RBV)","Montgomery - United States, La Jolla - United States, Los Angeles - United States, Aurora - United States, Gainesville - United States, Lutherville - United States, Boston - United States, Detroit - United States, Saint Louis - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Charlotte - United States, Durham - United States, Houston - United States, Houston - United States, San Antonio - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Darlinghurst - Australia, Kogarah - Australia, Randwick - Australia, Fitzroy - Australia, Adelaide - Australia, Bedford Park, Sa - Australia, Clayton - Australia, Heidelberg - Australia, Melbourne - Australia, Fremantle - Australia, Nedlands - Australia, Perth - Australia, Graz - Austria, Linz - Austria, Salzburg - Austria, Wien - Austria, Wien - Austria, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Toronto - Canada, Vaughan - Canada, Montreal - Canada, Montreal - Canada, Quebec - Canada, Clichy Cedex - France, Creteil - France, Lyon Cedex 04 - France, Marseille Cedex 08 - France, Paris Cedex 13 - France, Paris - France, Toulouse - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Muenchen - Germany, Dublin - Ireland, Dublin - Ireland, Haifa - Israel, Jerusalem - Israel, Jerusalem - Israel, Tel Aviv - Israel, Tel Hashomer - Israel, Zafed - Israel, Messina - Italy, Milano - Italy, Roma - Italy, Torino - Italy, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeongsangnam-do - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Auckland - New Zealand, Hamilton - New Zealand, Wellington - New Zealand, Bialystok - Poland, Wroclaw - Poland, Chelyabinsk - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, Tyumen - Russian Federation, Alicante - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Glasgow - United Kingdom",2013-10,2012-04-20,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01250743,Unknown,TERMINATED,2009-01,Hepatitis C,ascorbic acid (vitamin C),Kansas City - United States,2011-12,2010-12-01,2011-02-18,INTERVENTIONAL,NA,"Health Innovations, Frontier Research Institute",OTHER,hepatitis
NCT00736190,Unknown,COMPLETED,2008-08,Chronic Hepatitis B,Tenofovir disoproxil fumarate,"Fountain Valley - United States, Hacienda Heights - United States, Los Angeles - United States, Monterey Park - United States, Mountain View - United States, Oakland - United States, Palo Alto - United States, San Jose - United States, Hamden - United States, Baltimore - United States, Laurel - United States, Silver Spring - United States, Englewood - United States, Brooklyn - United States, Flushing - United States, New York - United States, New York - United States, Philadelphia - United States, Fairfax - United States, Falls Church - United States, Bellevue - United States",2010-07,2008-08-15,2011-12-05,INTERVENTIONAL,PHASE4,Gilead Sciences,INDUSTRY,hepatitis
NCT01523990,Unknown,COMPLETED,2011-10,"Healthy, Hepatitis C, Chronic","TG-2349, placebo",Cypress - United States,2012-04,2012-02-01,2014-12-19,INTERVENTIONAL,PHASE1,"TaiGen Biotechnology Co., Ltd.",INDUSTRY,hepatitis
NCT01685203,PEARL-I,COMPLETED,2012-08,"Hepatitis C, Chronic","ABT-450/r, ABT-267, Ribavirin (RBV)",No locations listed,2014-06,2012-09-14,2021-07-30,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT02057003,Unknown,UNKNOWN,2012-01,"Hepatitis C, Chronic, Human Immunodeficiency Virus",DAA against HCV,Seville - Spain,2020-12,2014-02-06,2016-10-17,OBSERVATIONAL,Not Available,Valme University Hospital,OTHER,hepatitis
NCT06562803,Unknown,RECRUITING,2024-09-27,"Acute-On-Chronic Liver Failure, Sepsis","double plasma cytokine adsorption system with sequential low-dose plasma exchange, plasma exchange",Guangzhou - China,2026-09-01,2024-08-20,2024-11-29,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02508090,Unknown,COMPLETED,2013-08-02,Chronic Hepatitis C,No interventions listed,San Juan - Puerto Rico,2017-01-13,2015-07-24,2017-11-01,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00845403,Unknown,UNKNOWN,2008-09,Hepatitis B,No interventions listed,Singapore - Singapore,2016-12,2009-02-18,2014-01-13,OBSERVATIONAL,Not Available,"National University Hospital, Singapore",OTHER,hepatitis
NCT01482403,Unknown,COMPLETED,2011-11,"Hepatitis C, Chronic","Copegus, Copegus, Pegasys, Pegasys, boceprevir, boceprevir, mericitabine, mericitabine placebo, boceprevir placebo, boceprevir","Littleton - United States, Chicago - United States, Shreveport - United States, Detroit - United States, Kansas City - United States, San Antonio - United States, Chesapeake - United States, Calgary - Canada, Vancouver - Canada, London - Canada, Creteil - France, Nice - France, Rennes - France, Berlin - Germany, Hamburg - Germany, Hannover - Germany, Napoli - Italy, Milano - Italy, Firenze - Italy, Ponce - Puerto Rico, Santander - Spain, Palma de Mallorca - Spain, Pontevedra - Spain, Valencia - Spain",2014-01,2011-11-30,2016-08-05,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02241590,Unknown,UNKNOWN,2014-09,Liver Cirrhosis Due to Hepatitis B Virus,"Entecavir + Placebo, Entecavir + Fuzheng Huayu Tablet","Nanning - China, Shijiazhuang - China, Anyang - China, Jingmen - China, Wuhan - China, Wuhan - China, Changsha - China, Huai'an - China, Suzhou - China, Nanchang - China, Yinchuan - China, Jinan - China, Wenzhou - China, Beijing - China, Beijing - China, Beijing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenzhen - China",2019-06,2014-09-16,2018-10-15,INTERVENTIONAL,PHASE4,ShuGuang Hospital,OTHER,hepatitis
NCT01598090,PEDESTAL,COMPLETED,2012-06-14,Hepatitis C Virus,"Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin, Telaprevir","Birmingham - United States, Birmingham - United States, Birmingham - United States, Anaheim - United States, Garden Grove - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, San Francisco - United States, Torrance - United States, Orlando - United States, Orlando - United States, Tampa - United States, Marietta - United States, Baltimore - United States, Kansas City - United States, Saint Louis - United States, Charlotte - United States, Tulsa - United States, Tulsa - United States, Germantown - United States, Arlington - United States, Fort Sam Houston - United States, San Antonio - United States, Murray - United States, Annandale - United States, Newport News - United States, Norfolk - United States, Graz - Austria, Linz - Austria, Bruxelles - Belgium, Edegem - Belgium, Leuven - Belgium, Liege - Belgium, Salvador - Brazil, Salvador - Brazil, Curitiba - Brazil, Curitiba - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Botucatu - Brazil, Botucatu - Brazil, Rio De Janeiro - Brazil, Rio De Janeiro - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Montreal - Canada, Hradec Kralove - Czechia, Praha 2 - Czechia, Praha 4 - Czechia, Orleans Cedex 2 - France, Poitiers - France, Rennes Cedex 9 - France, Rouen Cedex - France, Toulouse Cedex - France, Villejuif - France, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Muenster - Germany, Ulm - Germany, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Ramat Gan - Israel, Bergamo - Italy, Cisanello (pisa) - Italy, Milano - Italy, Roma - Italy, Torino - Italy, Bialystok - Poland, Kielce - Poland, Lancut - Poland, Myslowice - Poland, Raciborz - Poland, Wroclaw - Poland, Kazan - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, St-petersburg - Russian Federation, Stavropol - Russian Federation, A Coruna - Spain, Alicante - Spain, San Sebastian - Spain, Santiago De Compostela - Spain, Sevilla - Spain, Sevilla - Spain, Basel - Switzerland, Zurich - Switzerland, Birmingham - United Kingdom",2015-02-04,2012-05-15,2019-07-31,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03559790,Unknown,UNKNOWN,2018-07-18,Chronic Hepatitis b,tenofovir alafenamide,"Junggu - Korea, Republic of",2020-08,2018-06-18,2019-01-30,OBSERVATIONAL,Not Available,The Catholic University of Korea,OTHER,hepatitis
NCT02597790,CTSI-PLACE,COMPLETED,2013-10,"HIV, Hepatitis C",No interventions listed,Los Angeles - United States,2019-01,2015-11-05,2022-01-20,OBSERVATIONAL,Not Available,"University of California, Los Angeles",OTHER,hepatitis
NCT02219490,TOPAZ-I,COMPLETED,2014-10-30,Chronic Hepatitis C Virus (HCV) Infection Genotype 1,"ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV)","Algiers - Algeria, Algiers - Algeria, Algiers - Algeria, Darlinghurst - Australia, Kingswood - Australia, Westmead - Australia, Greenslopes - Australia, Herston - Australia, Adelaide - Australia, Fitzroy Melbourne - Australia, Parkville - Australia, Linz - Austria, Graz - Austria, Vienna - Austria, Brussels - Belgium, Woluwe-Saint-Lambert - Belgium, Leuven - Belgium, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Saint John - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Vaughan - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Québec - Canada, Hvidovre - Denmark, Odense C - Denmark, Aarhus - Denmark, Helsinki - Finland, Turku - Finland, Marseille - France, Limoges CEDEX 1 - France, Pessac CEDEX - France, Montpellier CEDEX 5 - France, Nantes - France, Bondy - France, La Tronche - France, Lyon - France, Nice - France, Rennes - France, Strasbourg cedex - France, Toulouse - France, Freiburg - Germany, Heidelberg - Germany, Tubingen - Germany, Munich - Germany, Frankfurt am Main - Germany, Düsseldorf - Germany, Herne - Germany, Berlin - Germany, Essen - Germany, Hamburg - Germany, Hannover - Germany, Muenster - Germany, Athens - Greece, Athens - Greece, Alexandroupolis - Greece, Beaumont - Ireland, Dublin 8 - Ireland, Elm Park - Ireland, Ramat Gan - Israel, Tel Aviv-Yafo - Israel, Haifa - Israel, Haifa - Israel, Bologna - Italy, Cona - Italy, San Giovanni Rotondo - Italy, Rome - Italy, Milan - Italy, Rome - Italy, Bergamo - Italy, Florence - Italy, Foggia - Italy, Messina - Italy, Milano - Italy, Milano - Italy, Milan - Italy, Milan - Italy, Milan - Italy, Napoli - Italy, Napoli - Italy, Palermo - Italy, Parma - Italy, Salerno - Italy, Turin - Italy, Udine - Italy, Tijuana - Mexico, Guadalajara - Mexico, Ciudad de Mexico - Mexico, Delegacion Tlalpan - Mexico, Distrito Federal - Mexico, Mexico City - Mexico, Rotterdam - Netherlands, Amsterdam - Netherlands, Leiden - Netherlands, Lorenskog - Norway, Trondheim - Norway, Stavanger - Norway, Bydgoszcz - Poland, Lodz - Poland, Lublin - Poland, Warsaw - Poland, Bialystok - Poland, Myslowice - Poland, Coimbra - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Sector 2 - Romania, Sector 2 - Romania, Timisoara - Romania, Bucuresti - Romania, Iasi - Romania, Samara - Russian Federation, Kazan - Russian Federation, Chelyabinsk - Russian Federation, Kemerovo - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Samara - Russian Federation, Stavropol - Russian Federation, Tolyatti - Russian Federation, Tyumen - Russian Federation, Yekaterinburg - Russian Federation, Jeddah - Saudi Arabia, Riyadh - Saudi Arabia, Riyadh - Saudi Arabia, Oviedo - Spain, Badalona - Spain, Santander - Spain, Donostia - Spain, Palma de Mallorca - Spain, Cartagena - Spain, Barakaldo - Spain, A Coruna - Spain, Cordoba - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Malaga - Spain, Sevilla - Spain, Zaragoza - Spain, Malmo - Sweden, Solna - Sweden, Gothenburg - Sweden, St. Gallen - Switzerland, Zürich - Switzerland, Bern - Switzerland, Konak - Turkey, Ankara - Turkey, Ankara - Turkey, Bursa - Turkey, Istanbul - Turkey, Izmir - Turkey, Trabzon - Turkey, Poole - United Kingdom, Southampton - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Glasgow - United Kingdom, Birmingham - United Kingdom, Dundee - United Kingdom, Edinburgh - United Kingdom, Leeds - United Kingdom, London - United Kingdom, Plymouth - United Kingdom, Portsmouth - United Kingdom, Salford - United Kingdom, Tooting - United Kingdom",2021-05-13,2014-08-19,2023-04-07,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT04822090,Unknown,UNKNOWN,2018-02-10,Parvovirus B19 Infection,Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG),Sohag - Egypt,2021-02-10,2021-03-30,2021-03-30,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT00290303,Unknown,COMPLETED,2004-05,"Haemophilus Influenzae Type b, Diphtheria, Whole Cell Pertussis, Hepatitis B, Tetanus",DTPw-HBV/Hib-MenAC conjugate vaccine,"Manila - Philippines, Quezon CIty - Philippines, Sampaloc, Manila - Philippines",2005-03,2006-02-13,2016-09-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05170490,Unknown,UNKNOWN,2018-06-01,Chronic Hepatitis c,No interventions listed,Sohag - Egypt,2023-01-01,2021-12-28,2022-06-30,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT00927290,PEGLIST C,TERMINATED,2009-12-03,"Chronic Hepatitis C, Insulin Resistance","Pioglitazone, Placebo",Paris - France,2012-07-06,2009-06-24,2017-01-24,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT02326103,Unknown,COMPLETED,2015-04,"Alcoholic Hepatitis, Alcoholic Cirrhosis","Ciprofloxacin, Placebo",Helsinki - Finland,2017-01,2014-12-25,2017-01-19,INTERVENTIONAL,PHASE1,University of Helsinki,OTHER,hepatitis
NCT02128503,Unknown,TERMINATED,2013-02,"Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis, Rheumatic Diseases, Hepatitis B, Chronic",HBV DNA level monitoring,Hong Kong - Hong Kong,2015-10-16,2014-05-01,2017-04-25,INTERVENTIONAL,NA,Chinese University of Hong Kong,OTHER,hepatitis
NCT03105310,Unknown,UNKNOWN,2016-01,"Hepatitis D, Chronic","Pegylated interferon alfa, Ezetimibe",No locations listed,2016-12,2017-04-07,2017-04-07,INTERVENTIONAL,PHASE2,Aga Khan University,OTHER,hepatitis
NCT00435812,Unknown,COMPLETED,2006-12,Hepatitis B,"HEPLISAV and/or Placebo, Engerix-B","Edmonton - Canada, Surrey - Canada, Winnipeg - Canada, Mount Pearl - Canada, St. John's - Canada, Halifax - Canada, Ottawa - Canada, Sarnia - Canada, Toronto - Canada, Charlottetown - Canada, Montréal - Canada, Québec - Canada, Berlin - Germany, Hamburg - Germany, Leipzig - Germany, Magdeburg - Germany, Munich - Germany, Ulm - Germany",2008-02,2007-02-15,2019-03-20,INTERVENTIONAL,PHASE3,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT00426712,Unknown,COMPLETED,2006-01,Hepatitis B,"1018 ISS immunostimulatory oligonucleotide with HBV surface antigen, Hepatitis B Vaccine (Recombinant)","Costa Mesa - United States, Brooklyn Center - United States, Austin - United States, Charlottesville - United States",2008-03,2007-01-25,2019-03-20,INTERVENTIONAL,PHASE1,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT03570112,Unknown,COMPLETED,2018-06-08,"Hepatitis C, Pregnancy Complications, Vertical Disease Transmission",SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg,Cincinnati - United States,2022-11-22,2018-06-26,2024-02-08,OBSERVATIONAL,Not Available,The Christ Hospital,OTHER,hepatitis
NCT05286346,Unknown,COMPLETED,2018-10-12,Chronic Hepatitis b,"Tenofovir disoproxil 245mg, Tenofovir disoproxil fumarate 300mg","Busan - Korea, Republic of",2020-08-10,2022-03-18,2022-03-18,INTERVENTIONAL,PHASE4,"Samjin Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01645969,Unknown,COMPLETED,2011-04,"Hepatitis B, Chronic",No interventions listed,"Changsha - China, Fu Zhou - China, Guangzhou - China, Wuhan - China, Xi'an - China",2012-10,2012-07-20,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00684268,NRSily,COMPLETED,2007-10,Hepatitis C,"Silibinin, Silibinin",Wien - Austria,2011-02,2008-05-26,2017-03-27,INTERVENTIONAL,PHASE2,Medical University of Vienna,OTHER,hepatitis
NCT00087568,Unknown,COMPLETED,2003-01,"Hepatitis C, Chronic","Ribavirin, peginterferon alfa-2a [Pegasys]","Bakersfield - United States, Pasadena - United States, San Diego - United States, San Mateo - United States, Bradenton - United States, Miami - United States, Orlando - United States, Austell - United States, Annapolis - United States, Baltimore - United States, Boston - United States, Kansas City - United States, Bayside - United States, Brooklyn - United States, Manhasset - United States, New York - United States, Valhalla - United States, Statesville - United States, Cincinnati - United States, Knoxville - United States, Memphis - United States, Houston - United States, Fairfax - United States, Richmond - United States, Tacoma - United States",2006-03,2004-07-14,2016-06-08,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04749368,Unknown,COMPLETED,2021-04-12,"Hepatitis B, Chronic","BRII-835 (VIR-2218), BRII-179 (VBI-2601) with IFN-α, BRII-179 (VBI-2601)","Kingswood - Australia, Westmead - Australia, Herston - Australia, Changhua, Taiwan - China, Hongkong - China, Hongkong - China, Hongkong - China, Kaohsiung, Taiwan - China, Kaohsiung, Taiwan - China, NEW Territories, Hong Kong - China, Taichung, Taiwan - China, Taipei CITY - China, Busan - Korea, Republic of, Seongnam-si, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Dunedin Central - New Zealand, Auckland - New Zealand, Singapore - Singapore, Singapore - Singapore, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Nonthaburi - Thailand, Nonthaburi - Thailand, Pathumthani - Thailand, Songkhla - Thailand",2023-07-04,2021-02-11,2024-06-18,INTERVENTIONAL,PHASE2,Brii Biosciences Limited,INDUSTRY,hepatitis
NCT03258710,Unknown,COMPLETED,2017-10-02,"Hepatitis B, Chronic",Tenofovir Disoproxil Fumarate,"Aichi - Japan, Chiba - Japan, Ehime - Japan, Ehime - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Hiroshima - Japan, Hokkaido - Japan, Hokkaido - Japan, Kanagawa - Japan, Kanagawa - Japan, Kumamoto - Japan, Nagasaki - Japan, Osaka - Japan, Tokyo - Japan, Tokyo - Japan, Tottori - Japan",2018-12-28,2017-08-23,2020-08-04,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01525212,Unknown,WITHDRAWN,2012-04,Chronic Hepatitis C,"BMS-929075, BMS-929075, BMS-929075, BMS-929075, Placebo matching BMS-929075, Placebo matching BMS-929075","Herston - Australia, Adelaide - Australia, Melbourne - Australia",2013-02,2012-02-02,2013-06-21,INTERVENTIONAL,PHASE1,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01226446,ANRS VITAVIC,COMPLETED,2010-11,Chronic Hepatitis C,vitamin D,Paris - France,2012-02,2010-10-22,2014-08-11,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT01457768,Unknown,COMPLETED,2011-12-19,"Hepatitis C, Chronic",No interventions listed,"Birmingham - United States, Birmingham - United States, Dothan - United States, Phoenix - United States, Tucson - United States, Anaheim - United States, Bakersfield - United States, Coronado - United States, Costa Mesa - United States, Davis - United States, La Jolla - United States, La Jolla - United States, La Jolla - United States, La Mesa - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Oceanside - United States, Palo Alto - United States, Pasadena - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Jose - United States, San Jose - United States, Torrance - United States, Torrance - United States, Aurora - United States, Englewood - United States, New Haven - United States, Washington - United States, Washington - United States, Bradenton - United States, Gainesville - United States, Miami - United States, New Port Richey - United States, Orlando - United States, Orlando - United States, Orlando - United States, Tampa - United States, Tampa - United States, Tampa - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Decatur - United States, Marietta - United States, Chicago - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Kansas City - United States, Kansas City - United States, Bowling Green - United States, Baton Rouge - United States, Baton Rouge - United States, Baltimore - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Boston - United States, Boston - United States, Burlington - United States, Springfield - United States, Worcester - United States, Detroit - United States, Plymouth - United States, Rochester - United States, Rochester - United States, Saint Paul - United States, Tupelo - United States, Kansas City - United States, Saint Louis - United States, Saint Louis - United States, Las Vegas - United States, Hillsborough - United States, Morristown - United States, Newark - United States, Newark - United States, Vineland - United States, Albuquerque - United States, Santa Fe - United States, Johnson City - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Yonkers - United States, Asheville - United States, Chapel Hill - United States, Durham - United States, Fayetteville - United States, Winston-Salem - United States, Tulsa - United States, Medford - United States, Portland - United States, Allentown - United States, Allentown - United States, Lancaster - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Pittsburgh - United States, Providence - United States, Providence - United States, Germantown - United States, Germantown - United States, Germantown - United States, Nashville - United States, Nashville - United States, Nashville - United States, Arlington - United States, Arlington - United States, Austin - United States, Austin - United States, Dallas - United States, Dallas - United States, Dallas - United States, Dallas - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Salt Lake City - United States, Salt Lake City - United States, Salt Lake City - United States, Fairfax - United States, Falls Church - United States, Newport News - United States, Norfolk - United States, Richmond - United States, Richmond - United States, Seattle - United States, Madison - United States, Canberra - Australia, Camperdown - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Liverpool - Australia, Westmead - Australia, Woolloongabba - Australia, Bedford Park - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Murdoch - Australia, Perth - Australia, Fitzroy - Australia, QLD - Australia, Woolloongabba - Australia, Graz - Austria, Wien - Austria, Vancouver - Canada, Toronto - Canada, Calgary - Canada, Edmonton - Canada, Montreal - Canada, Toronto - Canada, Toronto - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Praha 4 - Czechia, Praha 6 - Czechia, Talinn - Estonia, Tartu - Estonia, Pessac Cedex - France, Clermont-Ferrand - France, CRETEIL Cedex - France, Paris Cedex 12 - France, Paris cedex 12 - France, Paris cedex 18 - France, Paris - France, Lille - France, Lille - France, Marseille cedex 08 - France, Nice - France, Cedex 9 - France, clichy Cedex - France, Montpellier - France, Nice cedex 3 - France, Paris - France, Paris - France, Rennes Cedex 9 - France, Strasbourg - France, Vandoeuvre - France, Freiburg im Breisgau - Germany, Freiburg - Germany, Heidelberg - Germany, Frankfurt am Main - Germany, Frankfurt am Main - Germany, Hannover - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Essen - Germany, Herne - Germany, Köln - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Dusseldorf - Germany, Frankfurt - Germany, Frankfurt - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, Mainz - Germany, Muenchen - Germany, Wurzburg - Germany, Wüerzburg - Germany, San Giovanni Rotondo - Italy, Bergamo - Italy, Bologna - Italy, Bologna - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Padova - Italy, Palermo - Italy, Parma - Italy, Roma - Italy, Roma - Italy, Torino - Italy, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Nijmegen - Netherlands, Grafton - New Zealand, Grafton - New Zealand, Grafton - New Zealand, Tauranga - New Zealand, Newton - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Hamilton - New Zealand, Wellington - New Zealand, Wroclaw - Poland, Wroclaw - Poland, Warszawa - Poland, Warszawa - Poland, Bialystok - Poland, Chorzów - Poland, Myslowice - Poland, Chorzow - Poland, Lodz - Poland, Myslowice - Poland, San Juan - Puerto Rico, San Juan - Puerto Rico, San Juan - Puerto Rico, Majadahonda - Spain, Majadahonda - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Sevilla - Spain, Valencia - Spain, Valencia - Spain, Göteborg - Sweden, Göteborg - Sweden, Lund - Sweden, Lund - Sweden, Malmö - Sweden, Solna - Sweden, Birmingham - United Kingdom, Hampshire - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Bristol - United Kingdom, Plymouth - United Kingdom",2018-04-09,2011-10-24,2018-05-04,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT00939068,Unknown,UNKNOWN,2008-02,"Chronic Hepatitis B, Gestation","Telbivudine, engineered HB vaccine",No locations listed,2010-07,2009-07-14,2009-10-14,INTERVENTIONAL,PHASE4,"Southeast University, China",OTHER,hepatitis
NCT02531269,Unknown,COMPLETED,2015-03,Hepatitis C,No interventions listed,Basel - Switzerland,2016-02,2015-08-24,2016-05-09,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01838772,Unknown,COMPLETED,2013-12,"Hepatitis C, HIV",Pegylated-Interferon and Ribavirin,"Jakarta - Indonesia, Kuala Lumpur - Malaysia, Bangkok - Thailand, Hanoi - Vietnam",2016-06,2013-04-24,2016-10-27,INTERVENTIONAL,PHASE4,"amfAR, The Foundation for AIDS Research",OTHER,hepatitis
NCT01890772,Unknown,WITHDRAWN,2013-08,Hepatitis C,"Telaprevir, Peginterferon alfa-2a, Ribavirin, Vitamin D","Long Beach - United States, Minneapolis - United States, Kansas City - United States, Philadelphia - United States",2015-10,2013-07-02,2014-05-14,INTERVENTIONAL,PHASE3,"Timothy Morgan, MD",OTHER,hepatitis
NCT04123769,Unknown,COMPLETED,2019-09-03,Hepatitis b & Liver Dysfunction,Hydronidone,Wuhan - China,2020-10-09,2019-10-11,2021-03-24,INTERVENTIONAL,PHASE1,"Beijing Continent Pharmaceutical Co, Ltd.",INDUSTRY,hepatitis
NCT01560468,Unknown,TERMINATED,2012-03,Hepatitis C Infection,ITX 5061,New York - United States,2018-04,2012-03-22,2018-04-18,INTERVENTIONAL,PHASE1,"Schiano, Thomas D., MD",OTHER,hepatitis
NCT00668369,Unknown,COMPLETED,2008-04,"Hepatitis C Virus Infection, Liver Transplantation",Gradual immunosuppression drug withdrawal.,Barcelona - Spain,2011-09,2008-04-29,2013-12-20,INTERVENTIONAL,PHASE2,Hospital Clinic of Barcelona,OTHER,hepatitis
NCT04507269,Unknown,COMPLETED,2020-08-18,"Hepatitis B, Chronic","VIR-2218, Placebo","Beijing - China, Changchun - China",2021-09-30,2020-08-11,2024-08-26,INTERVENTIONAL,PHASE2,Brii Biosciences Limited,INDUSTRY,hepatitis
NCT00707772,Unknown,COMPLETED,2007-03,"Hepatitis C, Hemophilia","PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin), PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)","Tehran - Iran, Islamic Republic of",2009-09,2008-07-01,2009-09-17,INTERVENTIONAL,PHASE4,Baqiyatallah Medical Sciences University,OTHER,hepatitis
NCT02865369,RELIF-C,UNKNOWN,2016-09,Chronic Hepatitis C,Daclatasvir and Asunaprevir,"Cheonan - Korea, Republic of, Bucheon - Korea, Republic of, Ansan - Korea, Republic of, Jung-gu - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Wonju - Korea, Republic of",2018-12,2016-08-12,2017-03-07,OBSERVATIONAL,Not Available,Sang Gyune Kim,OTHER,hepatitis
NCT03777969,Unknown,ACTIVE_NOT_RECRUITING,2018-06-29,Chronic Hepatitis b,No interventions listed,"Beijing - China, Beijing - China, Guangzhou - China, Wuxi - China, Shanghai - China, Shanghai - China, Hangzhou - China",2028-12-31,2018-12-19,2022-09-06,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT01498068,Unknown,COMPLETED,2012-01,Genotype 1 Chronic Hepatitis C,"Telaprevir, Pegylated-interferon-alfa-2a, Ribavirin","Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, Stavropol - Russian Federation",2012-04,2011-12-23,2015-01-30,INTERVENTIONAL,PHASE3,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT01479868,Unknown,COMPLETED,2011-10,Hepatitis C Virus Genotype-1,"TMC435, Pegylated interferon alpha-2a, Ribavirin","Los Angeles - United States, Washington - United States, Orlando - United States, Atlanta - United States, Chicago - United States, Newark - United States, Albany - United States, New York - United States, Dallas - United States, Houston - United States, Toronto - Canada, Montreal - Canada, Lyon - France, Montpellier Cedex 5 - France, Nantes - France, Paris - France, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Köln - Germany, Amadora - Portugal, Lisboa - Portugal, Porto - Portugal, San Juan - Puerto Rico, Badalona - Spain, Elche - Spain, Madrid - Spain, Brighton - United Kingdom, London - United Kingdom",2013-08,2011-11-28,2014-10-29,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT00718172,Unknown,COMPLETED,2008-07-11,"Hepatitis C, Chronic","Liver Biopsy, Peginterferon &amp; Ribavirin for Hepatitis C, Pre-treatment Ribavirin",Bethesda - United States,Unknown Date,2008-07-18,2019-12-17,INTERVENTIONAL,PHASE1,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01056172,Unknown,UNKNOWN,2010-01,Chronic Hepatitis C,"Peginterferon alfa-2a and Ribavirin, Peginterferon alfa-2a and Ribavirin","Yangsan - Korea, Republic of, Bucheon - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Goyang - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of",2012-06,2010-01-26,2012-04-20,INTERVENTIONAL,PHASE4,Pusan National University Yangsan Hospital,OTHER,hepatitis
NCT01198769,Unknown,COMPLETED,2010-11-11,"Infections, Rotavirus",Rotarix TM,Taipei - Taiwan,2011-04-18,2010-09-10,2018-08-20,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01577069,GENUPI,COMPLETED,2011-02,Chronic Hepatitis C,No interventions listed,Pessac - France,2013-01,2012-04-13,2016-06-22,OBSERVATIONAL,Not Available,Association HGE CHU Bordeaux Sud,OTHER,hepatitis
NCT00513968,Unknown,COMPLETED,2007-07,Chronic Hepatitis B,"a mixed plasmid DNA (HB-110), Adefovir","Seoul - Korea, Republic of",2010-04,2007-08-09,2012-08-06,INTERVENTIONAL,PHASE1,"Genexine, Inc.",INDUSTRY,hepatitis
NCT00442572,Unknown,COMPLETED,2006-07-03,"Hepatitis B, Chronic",PEGASYS [peginterferon alfa-2a],Sofia - Bulgaria,2012-04-23,2007-03-02,2017-04-06,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00735969,Unknown,COMPLETED,2008-08,Chronic Hepatitis C,"Peginterferon, Ribavirin",Bethesda - United States,2013-06,2008-08-15,2014-10-20,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03026569,Unknown,COMPLETED,2012-05,Chronic Infection,Orange juice (500 mL/d),Araraquara - Brazil,2012-07,2017-01-20,2017-01-23,INTERVENTIONAL,NA,São Paulo State University,OTHER,hepatitis
NCT00763568,Unknown,COMPLETED,2006-08,Chronic Hepatitis C,"Nitazoxanide, Peginterferon alfa-2a",Tanta - Egypt,2008-09,2008-10-01,2008-10-01,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT00336479,Unknown,COMPLETED,2006-06,Chronic Hepatitis C,"Telaprevir, Ribavirin, Pegylated Interferon Alfa 2a, Placebo","Phoenix - United States, Los Angeles - United States, Palo Alto - United States, San Francisco - United States, Denver - United States, Englewood - United States, Gainesville - United States, Miami - United States, Chicago - United States, Indianapolis - United States, Baton Rouge - United States, Baltimore - United States, Boston - United States, Boston - United States, Worcester - United States, Detroit - United States, Rochester - United States, St. Louis - United States, Albuquerque - United States, Manhasset - United States, New York - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Philadelphia - United States, Philadelphia - United States, Dallas - United States, Dallas - United States, Dallas - United States, San Antonio - United States, Annandale - United States, Charlotteville - United States, Fairfax - United States, Richmond - United States, Milwaukee - United States, Santurce - Puerto Rico",2008-02,2006-06-13,2014-07-23,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02859584,CORT-HEPAT,COMPLETED,2011-08,Acute Hepatitis,"Measure OF SERUM TOTAL CORTISOL, SERUM FREE AND SALIVARY CORTISOL",No locations listed,2014-02,2016-08-09,2016-08-19,INTERVENTIONAL,NA,Centre Hospitalier Universitaire de Besancon,OTHER,hepatitis
NCT01580202,Unknown,COMPLETED,2012-04,"Malignancy, Hepatitis B","Entecavir, Lamivudine","Goyang - Korea, Republic of, Seongnam - Korea, Republic of, Bucheon-si - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2017-06,2012-04-18,2017-06-29,INTERVENTIONAL,PHASE3,Seoul National University Hospital,OTHER,hepatitis
NCT04886102,Unknown,UNKNOWN,2021-02-11,"Hepatitis B, Chronic, Adults",An additional 5 mL venous blood tube taken from patients during their routine medical check-up at the hospital,Cayenne - French Guiana,2022-02-01,2021-05-13,2021-05-13,OBSERVATIONAL,Not Available,Centre Hospitalier de Cayenne,OTHER,hepatitis
NCT05503979,EHCUS,UNKNOWN,2022-11-15,Hepatitis C in Substance Users,Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa],No locations listed,2023-08-15,2022-08-17,2022-09-29,OBSERVATIONAL,Not Available,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,OTHER,hepatitis
NCT01700179,Unknown,COMPLETED,2012-09,Chronic Hepatitis C Infection,"ACH-0143102, Ribavirin",No locations listed,2013-09,2012-10-04,2023-08-29,INTERVENTIONAL,PHASE1,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT04070079,Unknown,UNKNOWN,2019-01-29,"Hepatitis B, Chronic",Tenofovir Alafenamide,Toronto - Canada,2022-08-30,2019-08-28,2019-08-28,INTERVENTIONAL,PHASE4,"University Health Network, Toronto",OTHER,hepatitis
NCT03063879,SD-CRF,COMPLETED,2017-04-01,"Hepatitis C, Chronic, Chronic Renal Failure",Sofosbuvir 400 mg and daclatasvir 60 mg,"Tehran - Iran, Islamic Republic of",2018-09-01,2017-02-24,2019-09-30,INTERVENTIONAL,PHASE4,Tehran University of Medical Sciences,OTHER,hepatitis
NCT03839979,Unknown,COMPLETED,2018-10-01,"Hepatitis C, Acute, Diabetes, Hypertension","BIOLINE HCV kits, ACCU-CHEK kits, ErKameter 3000 mercury manometer",Asyut - Egypt,2018-12-31,2019-02-15,2021-03-18,OBSERVATIONAL,Not Available,Cairo University,OTHER,hepatitis
NCT02263079,Unknown,COMPLETED,2014-06-16,Pediatric Immuno-Tolerant Chronic Hepatitis B,"Entecavir, Lamivudine, Pegylated Interferon Alfa-2A","Kansas City - United States, New York - United States, Philadelphia - United States, North Adelaide - Australia, Bruxelles - Belgium, Gent - Belgium, Essen - Germany, Mainz - Germany, München - Germany, Wuppertal - Germany, Bologna - Italy, Kuala Lumpur - Malaysia, Bucharest - Romania, Saint Petersburg - Russian Federation, Samara - Russian Federation, Taoyuan County - Taiwan, Adana - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Kyiv - Ukraine, Birmingham - United Kingdom, Leeds - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2020-01-29,2014-10-13,2020-08-24,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00262379,Unknown,COMPLETED,2005-12,Chronic Hepatitis C,epoetin beta (NeoRecormon®),"Aix en Provence - France, Angers - France, Avignon - France, Bourgoin-Jallieu - France, Brest - France, Caen - France, Châteauroux - France, Clermont Ferrand - France, Corbeil-Essonnes - France, Creil - France, Créteil - France, Dijon - France, Dreux - France, Freyming-Merlebach - France, Grasse - France, Grenoble - France, La Roche sur Yon - France, Le Mans - France, Limoges - France, Lyon - France, Marseille - France, Montauban - France, Montpellier - France, Montélimar - France, Nantes - France, Orléans - France, Paris - France, Paris - France, Pau - France, Poitiers - France, Rennes - France, Rouen - France, Saint Laurent du Var - France, Saint-Dizier - France, Toulouse - France, Tourcoing - France, Tours - France",2009-06,2005-12-06,2014-12-12,INTERVENTIONAL,PHASE3,"University Hospital, Angers",OTHER_GOV,hepatitis
NCT00630084,Unknown,COMPLETED,2006-08,"Chronic Hepatitis C, Neoplasms","pegylated interferon alpha 2a and plus ribavirin, pegylated interferon alpha 2a and plus ribavirin",Kaohsiung - Taiwan,2008-10,2008-03-06,2015-09-04,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT02442284,Unknown,COMPLETED,2015-05-13,"Chronic Hepatitis C, Cirrhosis, Hepatitis C Virus","ombitasvir/paritaprevir/ritonavir and dasabuvir, Ribavirin",No locations listed,2016-08-22,2015-05-13,2017-10-16,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02723084,CERTAIN-2,COMPLETED,2016-04-08,"Chronic Hepatitis C Virus, Hepatitis C Virus","ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV)",No locations listed,2017-01-19,2016-03-30,2021-07-16,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT06360484,Unknown,COMPLETED,2022-06-01,"Hepatitis B, Hepatitis D, Viral Hepatitis",investigations for Hepatitis D virus,Khartoum - Sudan,2022-09-01,2024-04-11,2024-04-11,OBSERVATIONAL,Not Available,National Center for Gastroentestinal and Liver Disease,OTHER,hepatitis
NCT04600479,SaPHIR,COMPLETED,2020-11-26,Hepatitis C,"Evaluation of the prevalence of HCV, HBV and HIV viral infections","Blain - France, Bouguenais - France, Nantes - France",2023-03-24,2020-10-23,2023-04-06,INTERVENTIONAL,NA,Nantes University Hospital,OTHER,hepatitis
NCT02458079,Unknown,COMPLETED,2014-12-01,Alcoholic Hepatitis,"Pentoxiphylline, Stool microbiota transplantation",New Delhi - India,2016-07-27,2015-05-29,2019-08-15,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT03146884,Unknown,UNKNOWN,2017-02-16,"Hepatitis, Autoimmune",No interventions listed,"Lugano - Switzerland, Basel - Switzerland, Basel - Switzerland, Bern - Switzerland, Bern - Switzerland, Chur - Switzerland, Geneve - Switzerland, Geneve - Switzerland, Lausanne - Switzerland, Liestal - Switzerland, Lugano - Switzerland, Luzern - Switzerland, Sankt Gallen - Switzerland, Sankt Gallen - Switzerland, Winterthur - Switzerland, Winterthur - Switzerland, Zurich - Switzerland, Zurich - Switzerland",2022-12-31,2017-05-10,2022-04-20,OBSERVATIONAL,Not Available,Fondazione Epatocentro Ticino,OTHER,hepatitis
NCT00979979,Unknown,COMPLETED,2009-07,Hepatitis C,No interventions listed,"Douliou - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2013-10,2009-09-18,2014-10-21,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT01133184,Unknown,UNKNOWN,2010-09,Liver Fibrosis,Sci B vac,Jerusalem - Israel,2011-03,2010-05-28,2010-06-17,INTERVENTIONAL,PHASE4,Hadassah Medical Organization,OTHER,hepatitis
NCT00704184,Unknown,COMPLETED,2008-07-25,Hepatitis C,"Comparator: Vaniprevir, Comparator: Pegylated-Interferon (Peg-IFN), Comparator: Ribavirin, Comparator: placebo",No locations listed,2008-12-12,2008-06-24,2018-10-09,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00420784,Unknown,COMPLETED,2007-02,Hepatitis C,"Telaprevir, Ribavirin, Pegylated Interferon Alfa 2a, Matching Placebo","Birmingham - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Denver - United States, Englewood - United States, Bardenton - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Miami - United States, Sarasota - United States, Atlanta - United States, Chicago - United States, Indianapolis - United States, Baton Rouge - United States, Portland - United States, Baltimore - United States, Boston - United States, Detroit - United States, St Louis - United States, Omaha - United States, Albuquerque - United States, Manhasset - United States, New York - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Hershey - United States, Pittsburgh - United States, Columbia - United States, Germantown - United States, Dallas - United States, Houston - United States, San Antonio - United States, Annandale - United States, Fairfax - United States, Richmond - United States, Seattle - United States, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Berlin - Germany, Frankfurt - Germany, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Santurce - Puerto Rico",2008-12,2007-01-11,2014-08-05,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT03214302,Unknown,UNKNOWN,2017-01-01,Chronic Hepatitis B,Tenofovir Disoproxil Fumarate,Beijing - China,2019-12-30,2017-07-11,2017-07-13,INTERVENTIONAL,NA,Beijing Ditan Hospital,OTHER,hepatitis
NCT03155984,Unknown,COMPLETED,2013-10-01,"Liver Dysfunction, Immune Suppression, Hepatitis B",Anti-CD20 antibody,Hong Kong - Hong Kong,2017-06-01,2017-05-16,2018-05-04,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT01469884,CONCERVIC,COMPLETED,2011-11,"Renal Allograft, Hepatitis C","Everolimus, Cyclosporine, Tacrolimus",Porto Alegre - Brazil,2015-04,2011-11-10,2015-04-03,INTERVENTIONAL,PHASE4,Irmandade Santa Casa de Misericórdia de Porto Alegre,OTHER,hepatitis
NCT02807402,Unknown,COMPLETED,2016-07-14,Chronic Hepatitis C,No interventions listed,No locations listed,2017-08-04,2016-06-21,2019-01-25,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00141284,Unknown,COMPLETED,2005-10,"HIV Infection, Hepatitis C","nelfinavir 1,250 mg twice daily, Zidovudine 300 mg twice daily, Lamivudine 150 mg twice daily","Bakersfield - United States, Miami - United States, Shreveport - United States, Dallas - United States, Toronto - Canada",2006-12,2005-09-01,2011-05-16,INTERVENTIONAL,PHASE4,Pfizer,INDUSTRY,hepatitis
NCT00393484,Unknown,COMPLETED,2007-02,Chronic Hepatitis B,"Entecavir, Lamivudine Placebo, Lamivudine, Entecavir Placebo","Bucheon - Korea, Republic of, Busan - Korea, Republic of, Chuncheon - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Guri - Korea, Republic of, Jeonju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2009-01,2006-10-27,2014-11-26,INTERVENTIONAL,PHASE4,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00437684,Unknown,UNKNOWN,2007-02,"HIV Infections, Hepatitis C","LPV/r, PEG-IFNa 2a, Ribavirin, NUCS",Milan - Italy,2010-07,2007-02-21,2009-02-06,INTERVENTIONAL,PHASE3,IRCCS San Raffaele,OTHER,hepatitis
NCT06591468,Unknown,ENROLLING_BY_INVITATION,2024-10-30,Primary Biliary Cholangitis (PBC),"Prednisone, UDCA (Ursodeoxycholic acid)",Xi'an - China,2027-12-31,2024-09-19,2024-12-27,INTERVENTIONAL,PHASE3,Han Ying,OTHER,hepatitis
NCT01181804,Unknown,COMPLETED,2010-06,Hepatitis C,"boceprevir, boceprevir, boceprevir, boceprevir",No locations listed,2010-12,2010-08-13,2017-04-07,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00556504,TCM-700C,COMPLETED,2007-07,Chronic Hepatitis C,"TCM-700C, Peginterferon alfa-2a, Ribavirin, Placebo",Taoyuan - Taiwan,2011-01,2007-11-12,2014-08-07,INTERVENTIONAL,PHASE2,TCM Biotech International Corp.,INDUSTRY,hepatitis
NCT02605304,Unknown,TERMINATED,2016-02-17,"HIV-1 Infection, Hepatitis C","Ledipasvir/sofosbuvir, Ribavirin","San Francisco - United States, New York - United States",2017-01-20,2015-11-16,2018-05-02,INTERVENTIONAL,PHASE2,Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,NETWORK,hepatitis
NCT02099604,ViZIR,WITHDRAWN,2014-04,Chronic Hepatitis C,Vitamin D + Pegylated Interferon Alpha 2b + Ribavirin,Cairo - Egypt,2014-04,2014-03-31,2017-07-12,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT04008004,Unknown,COMPLETED,2019-06-26,Chronic HBV Infection,"EDP-514, Placebo","Coronado - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, Miami - United States, Lenexa - United States, Catonsville - United States, New York - United States, Houston - United States, San Antonio - United States, Seattle - United States, Calgary - Canada, Vancouver - Canada, Toronto - Canada, Montréal - Canada",2021-07-14,2019-07-05,2022-01-11,INTERVENTIONAL,PHASE1,"Enanta Pharmaceuticals, Inc",INDUSTRY,hepatitis
NCT04778904,Unknown,COMPLETED,2020-12-22,Hepatitis B,"ChAdOx1-HBV, MVA-HBV, Nivolumab","Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Dalin - Taiwan, Kaohsiung City - Taiwan, Chiayi City - Taiwan, Kaohsiung - Taiwan, Nottingham - United Kingdom, London - United Kingdom",2023-02-24,2021-03-03,2024-08-13,INTERVENTIONAL,PHASE2,Barinthus Biotherapeutics,INDUSTRY,hepatitis
NCT00807001,Unknown,COMPLETED,2008-12,Chronic Hepatitis C (HCV),IDX184,No locations listed,2009-07,2008-12-11,2016-08-19,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04057001,HERCULES,TERMINATED,2019-07-01,"Liver Transplant; Complications, Hepatitis C",No interventions listed,New Haven - United States,2023-03-06,2019-08-14,2023-08-25,OBSERVATIONAL,Not Available,Yale University,OTHER,hepatitis
NCT02105701,Unknown,COMPLETED,2014-06-05,Hepatitis C Infection,"Grazoprevir + Elbasvir, Ribavirin",No locations listed,2015-03-24,2014-04-07,2021-02-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT06497504,B-Focus,RECRUITING,2024-09-17,Hepatitis B,"Bepirovirsen, Placebo","Bakersfield - United States, Fort Pierce - United States, Orlando - United States, Baltimore - United States, Minneapolis - United States, Hillsborough - United States, Almagro - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, La Plata - Argentina, Rosario - Argentina, Aracaju - Brazil, Campinas - Brazil, Curitiba - Brazil, Manaus - Brazil, Salvador - Brazil, SAo Paulo - Brazil, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Quebec City - Canada, Marseille - France, Melun - France, Montpellier Cedex 5 - France, Nantes cedex 1 - France, Paris - France, Paris - France, Firenze - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Napoli - Italy, Roma - Italy, Sassari - Italy, Cape Town - South Africa, Durban - South Africa, Johannesburg - South Africa, Reiger Park - South Africa, Barcelona - Spain, Cordoba - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Banchiau Taipei - Taiwan, Kaohsiung - Taiwan, Bristol Avon - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2027-01-27,2024-07-11,2024-10-15,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01731301,Unknown,UNKNOWN,2013-01,"Chronic Hepatitis C, End Stage Renal Disease","Ribavirin, Peginterferon, Boceprevir",Richmond - United States,2014-01,2012-11-21,2012-11-22,INTERVENTIONAL,PHASE4,Liver Institute of Virginia,OTHER,hepatitis
NCT01705704,Unknown,COMPLETED,2012-06,"Hepatitis B, Chronic",No interventions listed,"Herston - Australia, Fitzroy - Australia, Clichy - France, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Brescia - Italy, Bari - Italy, Cagliari - Italy, Pisa - Italy, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Hamilton - New Zealand, Samara - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Singapore - Singapore, Singapore - Singapore, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Songkhla - Thailand",2013-02,2012-10-12,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00004804,Unknown,COMPLETED,1993-08,Hepatitis C,interferon alfa,No locations listed,Unknown Date,2000-02-25,2005-06-24,INTERVENTIONAL,PHASE3,National Center for Research Resources (NCRR),NIH,hepatitis
NCT01718301,BOC-HIV,COMPLETED,2013-03,"Hepatitis C, HIV Infections, COINFECTION","boceprevir, Ribavirin, Peginterferon alfa-2a, Peginterferon alfa-2b",Barcelona - Spain,2015-03,2012-10-31,2015-07-09,INTERVENTIONAL,PHASE3,Anna Cruceta,OTHER,hepatitis
NCT03254901,Unknown,UNKNOWN,2018-01-01,Hepatitis C,Screening test by Oraquick test,Assiut - Egypt,2018-06-01,2017-08-21,2017-08-21,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT02032901,ALLY 3,COMPLETED,2014-01,Hepatitis C,"Daclatasvir, Sofosbuvir","La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Pasadena - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Deland - United States, Gainesville - United States, Atlanta - United States, Marietta - United States, Downers Grove - United States, Baltimore - United States, Baltimore - United States, Kansas City - United States, Santa Fe - United States, Manhasset - United States, Poughkeepsie - United States, Asheville - United States, Winston-salem - United States, Perkasie - United States, Pittsburgh - United States, Germantown - United States, Arlington - United States, San Antonio - United States, Murray - United States, Salt Lake City - United States, Falls Church - United States, Seattle - United States, San Juan - Puerto Rico",2014-09,2014-01-10,2015-10-01,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01022801,Unknown,COMPLETED,2003-08,Chronic Hepatitis B,Entecavir,No locations listed,2005-03,2009-12-01,2010-02-02,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00150904,Unknown,COMPLETED,2005-08,"Hepatitis C, HIV Infections",venous blood puncture,Utrecht - Netherlands,2008-09,2005-09-08,2009-02-16,OBSERVATIONAL,Not Available,UMC Utrecht,OTHER,hepatitis
NCT01441804,Unknown,UNKNOWN,2011-05,Chronic Hepatitis C,"Peginterferon alfa2a, Ribavirin, Peginterferon alfa2a, Ribavirin","Guangzhou - China, Guangzhou - China, Guangzhou - China, Zhongshan - China",2014-05,2011-09-28,2013-10-01,INTERVENTIONAL,PHASE3,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01451801,Unknown,UNKNOWN,2011-10,Hepatitis B,Twinrix,Aarhus N - Denmark,2013-07,2011-10-14,2012-10-26,INTERVENTIONAL,PHASE4,University of Aarhus,OTHER,hepatitis
NCT00532701,Unknown,COMPLETED,2007-11,Chronic Hepatitis C,"Peg-IFN + WB RBV for 16 weeks, Peg-IFN + LD RBV for 16 weeks, Peg-IFN + WB RBV for 24 weeks, Peg-IFN + WB RBV for 48 weeks, Peg-IFN + LD RBV for 24 weeks","Douliou - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Pingtung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2014-03,2007-09-20,2014-06-04,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT00088504,Unknown,COMPLETED,2004-07,"Hepatitis C, Hepatitis","Merimepodib, PEG-Interferon-alpha 2a (Pegasys®), Ribavirin (Copegus®)","Birmingham - United States, Huntsville - United States, Phoenix - United States, Anaheim - United States, Fresno - United States, Los Angeles - United States, Palo Alto - United States, Pasadena - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Englewood - United States, Farmington - United States, Miami - United States, Palm Harbor - United States, Marietta - United States, Boise - United States, Chicago - United States, Chicago - United States, Oak Forest - United States, Springfield - United States, Lexington - United States, Baton Rouge - United States, Baton Rouge - United States, Monroe - United States, New Orleans - United States, New Orleans - United States, Annapolis - United States, Baltimore - United States, Baltimore - United States, Silver Spring - United States, Attleboro - United States, Boston - United States, Worcester - United States, Detroit - United States, Rochester - United States, Saint Paul - United States, Saint Louis - United States, Florham Park - United States, Trenton - United States, Manhasset - United States, New York - United States, New York - United States, Charlotte - United States, Durham - United States, Fayetteville - United States, Cincinnati - United States, Tulsa - United States, Portland - United States, Hershey - United States, Philadelphia - United States, Pittsburgh - United States, Columbia - United States, Memphis - United States, Nashville - United States, Dallas - United States, Dallas - United States, Houston - United States, Houston - United States, San Antonio - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Bellevue - United States, Seattle - United States, Tacoma - United States, Tacoma - United States",Unknown Date,2004-07-28,2007-12-21,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02250001,Unknown,COMPLETED,2014-09-30,Chronic Hepatitis C,No interventions listed,Chuo-ku - Japan,2017-01-20,2014-09-26,2017-05-03,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01356901,Unknown,COMPLETED,2011-01,"Hepatitis B, Chronic",No interventions listed,Herne - Germany,2015-01,2011-05-20,2015-07-07,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03980301,Unknown,COMPLETED,2018-10-11,Hepatitis C,ultrasound,Giza - Egypt,2020-06-15,2019-06-10,2020-11-03,OBSERVATIONAL,Not Available,Aljazeera Hospital,OTHER,hepatitis
NCT00071201,Unknown,COMPLETED,2003-06,Chronic Hepatitis B,"Adefovir Dipivoxil for oral suspension, 2 mg/mL",Foster City - United States,2006-03,2003-10-17,2013-10-16,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01710501,Unknown,COMPLETED,2012-12-07,Chronic Hepatitis C (CHC),"Grazoprevir, pegylated interferon alfa-2b, Ribavirin, Placebo",No locations listed,2013-11-25,2012-10-19,2021-02-04,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02108301,Unknown,UNKNOWN,2011-12,"Chronic Hepatitis C-virus Infection, Renal Transplantation",tacrolimus-cyclosporine A,Vienna - Austria,2013-06,2014-04-09,2014-04-11,INTERVENTIONAL,PHASE4,Prof. Dr. Alice Schmidt,OTHER,hepatitis
NCT00753467,Unknown,UNKNOWN,2008-09,Hepatitis B,"IFN-γ 1b (Actimmune), Adefovir dipivoxil, IFN-γ 1b and Adefovir dipivoxil combination",Pasadena - United States,2009-08,2008-09-16,2010-10-21,INTERVENTIONAL,PHASE2,Huntington Medical Research Institutes,OTHER,hepatitis
NCT01697501,Unknown,COMPLETED,2012-11-08,"Hepatitis B, Chronic",Interleukin 28B testing,"Caserta - Italy, Napoli - Italy, Bologna - Italy, Parma - Italy, Milano - Italy, Milano - Italy, Bari - Italy, Castellana Grotte - Italy, Cagliari - Italy, Palermo - Italy, Pisa - Italy, Padova - Italy",2013-06-21,2012-10-02,2017-04-10,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03587467,HBV,UNKNOWN,2017-12-01,"Chronic Hepatitis B Infection, Healthy",collect fecal specimens,Xiamen - China,2020-12-01,2018-07-16,2018-07-16,OBSERVATIONAL,Not Available,Zhongshan Hospital Xiamen University,OTHER,hepatitis
NCT02105467,Unknown,COMPLETED,2014-06-05,Chronic Hepatitis C Virus,"Grazoprevir 100mg / Elbasvir 50 mg FDC, Placebo to Grazoprevir / Elbasvir 50 mg FDC",No locations listed,2015-02-26,2014-04-07,2018-10-02,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01732367,Unknown,COMPLETED,2012-11,Chronic Hepatitis B,"Lamivudine plus adefovir, Tenofovir","Daegu - Korea, Republic of",2016-03,2012-11-22,2016-10-28,INTERVENTIONAL,PHASE4,Keimyung University Dongsan Medical Center,OTHER,hepatitis
NCT05397067,Unknown,COMPLETED,2022-07-12,"Hepatitis C, Chronic, Substance Use Disorders",Peer specialist (PS) and vouchers,Roanoke - United States,2025-02-04,2022-05-31,2025-03-04,INTERVENTIONAL,NA,Carilion Clinic,OTHER,hepatitis
NCT05727267,Unknown,RECRUITING,2024-01-23,Chronic Hepatitis B,"HEPLISAV B; TherVacB, TherVacB","Hamburg - Germany, Munich - Germany",2025-02,2023-02-14,2024-02-09,INTERVENTIONAL,PHASE1,Universitätsklinikum Hamburg-Eppendorf,OTHER,hepatitis
NCT04233840,Unknown,UNKNOWN,2019-02-12,Hepatocellular Carcinoma,"P1101 (Ropeginterferon alfa-2b), Nivolumab",Taipei city - Taiwan,2022-12-31,2020-01-18,2022-01-27,INTERVENTIONAL,PHASE2,National Taiwan University Hospital,OTHER,hepatitis
NCT03778567,Unknown,COMPLETED,2013-08-01,"Hepatitis B, Chronic, Chronic Kidney Diseases",Telbivudine,Hong Kong - Hong Kong,2016-06-16,2018-12-19,2018-12-19,INTERVENTIONAL,PHASE4,The University of Hong Kong,OTHER,hepatitis
NCT00531167,Unknown,COMPLETED,2007-04,Chronic Hepatitis B,combination of lamivudine+adefovir vs entecavir,"Ansan - Korea, Republic of, Seoul - Korea, Republic of",2011-04,2007-09-18,2012-10-22,INTERVENTIONAL,PHASE4,Korea University,OTHER,hepatitis
NCT02375867,Unknown,COMPLETED,2015-01,Fulminant Hepatic Failure,"prednisolone, methylprednisolone",Menoufia - Egypt,2017-08,2015-03-03,2018-12-17,INTERVENTIONAL,PHASE4,"National Liver Institute, Egypt",OTHER,hepatitis
NCT00006301,Unknown,COMPLETED,2000-09-24,Hepatitis C,No interventions listed,"Washington - United States, Bethesda - United States, Silver Spring - United States, Annandale - United States, Falls Church - United States",Unknown Date,2000-09-28,2019-12-03,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02455167,Unknown,TERMINATED,2015-05,Hepatitis C,"Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV)",Denver - United States,2016-07-18,2015-05-27,2021-09-13,INTERVENTIONAL,PHASE3,"University of Colorado, Denver",OTHER,hepatitis
NCT03144440,Unknown,COMPLETED,2016-12-13,Hepatitis C,No interventions listed,No locations listed,2021-01-01,2017-05-08,2023-01-31,OBSERVATIONAL,Not Available,Carmel Medical Center,OTHER,hepatitis
NCT03585101,HEART-C,WITHDRAWN,2018-08,Hepatitis C,Elbasvir/grazoprevir,Los Angeles - United States,2019-06,2018-07-12,2018-08-07,INTERVENTIONAL,PHASE4,"University of California, Los Angeles",OTHER,hepatitis
NCT00580801,Unknown,COMPLETED,2008-01,Hepatitis C,"Telaprevir, Pegylated-interferon-alfa-2a, Placebo, Ribavirin",No locations listed,2010-01,2007-12-27,2013-09-09,INTERVENTIONAL,PHASE2,Tibotec BVBA,INDUSTRY,hepatitis
NCT00696904,Unknown,COMPLETED,2008-06,HCV Infection,"ABT-333, Placebo",No locations listed,2009-02,2008-06-13,2017-11-21,INTERVENTIONAL,PHASE1,AbbVie,INDUSTRY,hepatitis
NCT01427504,Unknown,COMPLETED,2011-08,"Hepatitis C, HIV",boceprevir; etravirine,Aurora - United States,2011-12,2011-09-01,2013-07-09,INTERVENTIONAL,NA,"University of Colorado, Denver",OTHER,hepatitis
NCT02568540,CTracker,TERMINATED,2015-10,Hepatitis C,No interventions listed,Boston - United States,2017-12-04,2015-10-06,2019-02-01,OBSERVATIONAL,Not Available,Boston Children's Hospital,OTHER,hepatitis
NCT02669940,HCV RWE,COMPLETED,2016-04-15,"Chronic Hepatitis C, Genotype 1",No interventions listed,No locations listed,2017-07-04,2016-02-01,2018-11-14,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02569710,Unknown,COMPLETED,2015-10-31,Chronic Hepatitis C,"AL-335, Odalasvir (ODV), Simeprevir (SMV)","Phoenix - Mauritius, Chisinau - Moldova, Republic of, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Havelock North - New Zealand, Wellington - New Zealand, Wellington - New Zealand, Brixton - United Kingdom, Glasgow - United Kingdom, Oldham - United Kingdom",2018-05-11,2015-10-07,2019-07-16,INTERVENTIONAL,PHASE2,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT00976781,Unknown,WITHDRAWN,2008-08,Hepatitis C,No interventions listed,"Detroit - United States, Detroit - United States",2009-04,2009-09-14,2023-04-05,OBSERVATIONAL,Not Available,Henry Ford Health System,OTHER,hepatitis
NCT02258581,Unknown,TERMINATED,2014-12-09,Chronic Hepatitis B,"GS-4774, GS-9620, Tenofovir disoproxil fumarate (TDF)","Sacramento - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Miami - United States, Honolulu - United States, Chicago - United States, Baltimore - United States, Boston - United States, Ann Arbor - United States, Detroit - United States, Saint Louis - United States, Flushing - United States, Manhasset - United States, Philadelphia - United States, Newport News - United States, Camperdown - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Winnepeg - Canada, Toronto - Canada, Lai Chi Kok - Hong Kong, Sha Tin - Hong Kong, Surat - India, Nagpur - India, Kolkata - India, San Giovanni Rotondo - Italy, Caianello - Italy, Milano - Italy, Parma - Italy, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand",2017-08-14,2014-10-07,2017-10-03,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT01462981,COBRA,UNKNOWN,2011-09,Hepatitis B,No interventions listed,Amsterdam - Netherlands,Unknown Date,2011-11-01,2011-11-02,OBSERVATIONAL,Not Available,Public Health Service of Amsterdam,OTHER_GOV,hepatitis
NCT05018481,Unknown,RECRUITING,2022-09-01,Alcoholic Hepatitis,"Sodium Hyaluronate, Placebo",Cleveland - United States,2025-10-01,2021-08-24,2025-01-10,INTERVENTIONAL,PHASE1,The Cleveland Clinic,OTHER,hepatitis
NCT03042481,Unknown,UNKNOWN,2016-04,Chronic Hepatitis b,No interventions listed,Kaohsiung - Taiwan,2019-05,2017-02-03,2017-02-03,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT00302081,Unknown,COMPLETED,2003-08,"Hepatitis C, Chronic","peginterferon alfa-2b (SCH 54031), peginterferon alfa-2b (SCH 54031), peginterferon alfa-2b (SCH 54031), ribavirin (SCH 18908), ribavirin (SCH 18908)",No locations listed,2008-04,2006-03-13,2017-04-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01525810,Unknown,COMPLETED,2012-03,Hepatitis C,Peginterferon Lambda-1a (BMS-914143),"La Jolla - United States, New Haven - United States, Orlando - United States, Marietta - United States, Honolulu - United States, Detroit - United States, Rochester - United States, Durham - United States, Cincinnati - United States, Arlington - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, Murray - United States, Annandale - United States, Seattle - United States, Mar Del Plata - Argentina, Rosario - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Camperdown - Australia, Darlinghurst - Australia, Randwick - Australia, Sydney - Australia, Westmead - Australia, Greenslopes - Australia, Herston - Australia, Woolloongabba - Australia, Adelaide - Australia, Fitzroy - Australia, Heidelberg - Australia, Melbourne - Australia, Parkville - Australia, Wien - Austria, Leuven - Belgium, Liege - Belgium, Vaughan - Canada, Hus - Finland, Clichy Cedex - France, Creteil Cedex - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex 14 - France, Pessac - France, Hamburg - Germany, Heidelberg - Germany, Athens - Greece, Thessaloniki - Greece, Cisanello (pisa) - Italy, Firenze - Italy, Milano - Italy, Milano - Italy, Napoli - Italy, Novara - Italy, Viale Del Policlinico, 155 - Italy, Busan - Korea, Republic of, Guadalajara - Mexico, Amsterdam - Netherlands, Leiden - Netherlands, Auckland - New Zealand, Bialystok - Poland, Krakow - Poland, Wroclaw - Poland, San Juan - Puerto Rico, Bucharest - Romania, Bucuresti - Romania, Iasi - Romania, Timisoara - Romania, Barcelona - Spain, Barcelona - Spain, Valencia - Spain",2014-11,2012-02-03,2015-03-26,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03236610,Unknown,UNKNOWN,2016-01-01,Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48,"tenofovir monotherapy, tenofovir plus entecavir combination","Uijongbu - Korea, Republic of",2018-06-30,2017-08-02,2017-08-02,INTERVENTIONAL,PHASE3,Uijeongbu St. Mary Hospital,OTHER,hepatitis
NCT01416610,PEGHOPE,COMPLETED,2010-04,"Hepatitis C, Chronic",No interventions listed,"Gratwein - Austria, Graz - Austria, Innsbruck - Austria, Klagenfurt - Austria, Linz - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria",2014-10,2011-08-15,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04202081,Unknown,COMPLETED,2019-02-21,"Hepatitis C, Chronic",No interventions listed,Chapel Hill - United States,2020-05-15,2019-12-17,2020-07-01,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT01160081,Unknown,COMPLETED,2010-03,"Viral Hepatitis Vaccines, Hepatitis A, Cytomegalovirus, Varicella-Zoster Virus, Bordetella Pertussis Infection, Herpes Simplex (1 and 2)",Serum sample,Cuernavaca - Mexico,2010-09,2010-07-12,2011-01-25,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05612581,Unknown,ACTIVE_NOT_RECRUITING,2023-05-10,"Hepatitis B, Chronic","VIR-3434, VIR-2218, TDF, PEG-IFNα","Clichy - France, Nice - France, Rennes - France, Toulouse - France, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Busan - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Chisinau - Moldova, Republic of, Bucharest - Romania, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2026-03,2022-11-10,2024-02-20,INTERVENTIONAL,PHASE2,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT00144469,Unknown,COMPLETED,2002-05,Chronic Hepatitis C,"peginterferon alfa-2a, rivavirin",No locations listed,Unknown Date,2005-09-05,2009-02-02,INTERVENTIONAL,PHASE3,Chugai Pharmaceutical,INDUSTRY,hepatitis
NCT02220868,Unknown,COMPLETED,2014-07,"Hepatitis C Infection, HIV Infection","Sofosbuvir, Ribavirin, and Stribild",Newark - United States,2015-08,2014-08-20,2016-08-04,INTERVENTIONAL,PHASE4,Saint Michael's Medical Center,OTHER,hepatitis
NCT04389268,Unknown,COMPLETED,2018-02-01,"Hepatitis C, Cognitive Impairment",Visual Event-Related Potentials,Mansoura - Egypt,2019-01-01,2020-05-15,2020-05-15,OBSERVATIONAL,Not Available,Mansoura University Hospital,OTHER,hepatitis
NCT03420768,Unknown,COMPLETED,2018-02-14,"Hepatic Cirrhosis, Liver Fibrosis","BMS-986263, Placebo",San Antonio - United States,2018-12-10,2018-02-05,2022-02-04,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06803368,Unknown,RECRUITING,2024-11-01,"Chronic Hepatitis b, Hepatitis B Vaccine",baseline anti-HBs titer,Beijing - China,2027-10-30,2025-01-31,2025-01-31,INTERVENTIONAL,NA,Beijing Municipal Administration of Hospitals,OTHER_GOV,hepatitis
NCT05793268,Unknown,ACTIVE_NOT_RECRUITING,2022-12-20,Chronic Hepatitis b,"Nuc Discontinuation, Entecavir or Tenofovir","Chiayi City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taitung - Taiwan, Yilan - Taiwan",2025-12,2023-03-31,2023-03-31,INTERVENTIONAL,NA,E-DA Hospital,OTHER,hepatitis
NCT00433069,Unknown,COMPLETED,2007-01,Chronic Hepatitis C,"Pioglitazone, Interferon Alfa-2a, Ribavirin",Geneva - Switzerland,2007-12,2007-02-09,2015-05-28,INTERVENTIONAL,PHASE2,"University Hospital, Geneva",OTHER,hepatitis
NCT01183169,Unknown,COMPLETED,2010-08,Hepatitis C,"Alisporivir, Peginterferon alfa-2a, Ribavirin, Placebo","San Diego - United States, San Diego - United States, Ventura - United States, Bradenton - United States, Orlando - United States, Tampa - United States, Honolulu - United States, Honolulu - United States, Springfield - United States, Topeka - United States, Springfield - United States, Egg Harbor Twp - United States, Brooklyn - United States, New York - United States, Arlington - United States, Dallas - United States, Houston - United States, San Antonio - United States, Kingswood - Australia, Kogarah - Australia, Westmead - Australia, Clayton - Australia, Fitzroy - Australia, Bruxelles - Belgium, Leuven - Belgium, Nice Cedex 3 - France, Paris - France, Berlin - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Köln - Germany, Leipzig - Germany, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Kaposvár - Hungary, Szekesfehervar - Hungary, Antella - Bagno a Ripoli - Italy, Palermo - Italy, Padova - Italy, Parma - Italy, Roma - Italy, Bologna - Italy, Bialystok - Poland, Lódz - Poland, Warszawa - Poland, San Juan - Puerto Rico, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Iasi - Romania, Sevilla - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Majadahonda - Spain, Madrid - Spain, Taipei - Taiwan, Kaohsiung - Taiwan, Keelung City - Taiwan, Lin-Ko - Taiwan, Niaosong Township - Taiwan, Taipei - Taiwan, Yun-Lin - Taiwan, Ankara - Turkey, Ankara - Turkey, Fatih / Istanbul - Turkey, Izmir - Turkey, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2013-05,2010-08-17,2016-08-25,INTERVENTIONAL,PHASE2,Debiopharm International SA,INDUSTRY,hepatitis
NCT00828269,Unknown,COMPLETED,2009-04,Chronic Hepatitis C,Comparator: Fine needle aspiration biopsy,No locations listed,2010-02,2009-01-23,2015-04-22,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01679769,Unknown,COMPLETED,2012-05,Chronic Hepatitis B,No interventions listed,Bei Jing - China,2015-10,2012-09-06,2015-11-06,OBSERVATIONAL,Not Available,Peking University First Hospital,OTHER,hepatitis
NCT05723068,HDV Describe,COMPLETED,2022-08-24,Chronic Hepatitis D,No interventions listed,"Bari - Italy, Bergamo - Italy, Bergamo - Italy, Bologna - Italy, Brescia - Italy, Caserta - Italy, Catania - Italy, Catanzaro - Italy, Foggia - Italy, Genova - Italy, Marsala - Italy, Messina - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Modena - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Novara - Italy, Padova - Italy, Palermo - Italy, Parma - Italy, Pisa - Italy, Reggio Calabria - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, San Giovanni Rotondo - Italy, Siracusa - Italy, Torino - Italy, Torino - Italy, Udine - Italy, Verona - Italy",2024-06-30,2023-02-10,2025-02-05,OBSERVATIONAL,Not Available,"University of Turin, Italy",OTHER,hepatitis
NCT01949168,HCV-6,UNKNOWN,2013-09,Chronic Hepatitis C,"Victrelis® (boceprevir) 800mg by mouth, TID (200 mg tablets), Peg-Intron® (peginterferon-α-2b), 1.5ug/kg sc injection, Rebetol® (ribavirin), 1000/1200mg by mouth daily","Box Hill - Australia, Clayton - Australia, Fitzroy - Australia, Footscray - Australia",2015-09,2013-09-24,2013-09-24,INTERVENTIONAL,PHASE2,St Vincent's Hospital Melbourne,OTHER,hepatitis
NCT02044068,Unknown,COMPLETED,2014-10,"Vertical Disease Transmission, HBV",No interventions listed,Paris - France,2015-09,2014-01-23,2017-04-28,OBSERVATIONAL,Not Available,Hopital Lariboisière,OTHER,hepatitis
NCT00192569,Unknown,COMPLETED,2004-07,Hepatitis C,"Pegylated Interferon alfa 2a, Ribavirin (HIV conifected patients only)","Camperdown - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Newcastle - Australia, Penrith - Australia, Westmead - Australia, Woolloongabba - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Footscray - Australia, Footscray - Australia, Heidelburg - Australia, Melbourne - Australia, Parkville - Australia, Fremantle - Australia",2010-06,2005-09-19,2011-04-15,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT04695769,Unknown,COMPLETED,2020-11-21,Chronic Hepatitis C,"Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]",Cairo - Egypt,2021-10-21,2021-01-05,2022-09-02,INTERVENTIONAL,PHASE4,Helwan University,OTHER,hepatitis
NCT02796469,Unknown,COMPLETED,2015-05,"Alcoholic Hepatitis, Alcoholic Liver Disease","Pentoxifylline, Corticosteroid, Placebo",No locations listed,2016-05,2016-06-10,2016-06-10,OBSERVATIONAL,Not Available,"University Hospital, Lille",OTHER,hepatitis
NCT01865968,Unknown,COMPLETED,2008-10,Hepatitis A,"Inactivated HAV vaccine, Live attenuated HAV vaccine",Nanchang - China,2011-12,2013-05-31,2015-05-14,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00118768,Unknown,COMPLETED,2005-08,Chronic Hepatitis C,"valopicitabine, Pegylated Interferon Alfa","Phoenix - United States, San Diego - United States, San Mateo - United States, Lakewood - United States, Bradenton - United States, Gainesville - United States, Atlanta - United States, Chicago - United States, Laurel - United States, Worcester - United States, Detroit - United States, Kansas City - United States, Alburquerque - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Germantown - United States, San Antonio - United States, Tacoma - United States",Unknown Date,2005-07-12,2009-03-02,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03463369,Unknown,COMPLETED,2018-04-18,"Hepatitis B, Chronic","JNJ-64300535, Placebo, Nucleos(t)ide Analogs (NA)","Antwerp - Belgium, Brussels - Belgium, Brussels - Belgium, Mannheim - Germany, Hannover - Germany, UK Essen - Germany, Hamburg - Germany, Leipzig - Germany, Regensburg - Germany, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2021-03-23,2018-03-13,2021-04-14,INTERVENTIONAL,PHASE1,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT05905172,Unknown,RECRUITING,2023-08-12,Liver Fibrosis,"Hydronidone capsules, The placebo capsules","Beijing - China, Shanghai - China, Beijing - China, Beijing - China, Bengbu - China, Changsha - China, Changsha - China, Chongqing - China, Chongqing - China, Guizhou - China, Hangzhou - China, Henan - China, Luzhou - China, Nanchang - China, Nanchang - China, Nanjing - China, Ningbo - China, Shanghai - China, Shenzhen - China, Xinxiang - China, Yanbian - China, Zhenjiang - China, Zunyi - China",2028-06-20,2023-06-15,2024-08-09,INTERVENTIONAL,PHASE3,"Beijing Continent Pharmaceutical Co, Ltd.",INDUSTRY,hepatitis
NCT02629172,Unknown,COMPLETED,2016-01-05,Chronic Hepatitis C Virus,No interventions listed,"Nagakute - Japan, Nagoya-shi - Japan, Narita-shi - Japan, Noda - Japan, Matsuyama - Japan, Fukuoka-shi - Japan, Fukuoka-shi - Japan, Kurume-shi - Japan, Gifu-shi - Japan, Fujioka - Japan, Maebashi-shi - Japan, Takasaki-shi - Japan, Fukuyama-shi - Japan, Sapporo-shi - Japan, Sapporo-shi - Japan, Kobe - Japan, Nishinomiya-shi - Japan, Toride City - Japan, Kanazawa - Japan, Morioka-shi - Japan, Kagoshima-shi - Japan, Fujisawa-shi - Japan, Kamakura-shi - Japan, Yokohama-shi - Japan, Yokohama - Japan, Yokohama - Japan, Kumamoto-shi - Japan, Kyoto-shi - Japan, Kyoto-shi - Japan, Kyoto-shi - Japan, Sendai-shi - Japan, Matsumoto-shi - Japan, Nagasaki-shi - Japan, Okayama-shi - Japan, Hirakata-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Takatsuki -shi - Japan, Kawagoe-shi - Japan, Otsu - Japan, Hamamatsu - Japan, Shizuoka-shi - Japan, Shimotsuke-shi - Japan, Tokushima-shi - Japan, Chiyoda-ku - Japan, Komae-shi - Japan, Mitaka-shi - Japan, Shibuya-ku - Japan, Shinagawa-ku - Japan, Shinjuku-ku - Japan, Shinjuku-ku - Japan, Shinjuku-ku - Japan, Yamagata-shi - Japan, Chuo-shi - Japan, Ageo - Japan, Aichi - Japan, Aichi - Japan, Aki-takata - Japan, Akita - Japan, Amagasaki, Hyogo - Japan, Amagasaki - Japan, Amagasaki - Japan, Amagasaki - Japan, Aomori-shi - Japan, Arao - Japan, Asahikawa - Japan, Asakura - Japan, Azumino - Japan, Chiba - Japan, Chiba - Japan, Chiba - Japan, Chiba - Japan, Chiba - Japan, Chiba - Japan, Chichibu - Japan, Chigasaki - Japan, Chigasaki - Japan, Chikugo - Japan, Chitose-shi - Japan, Fuchu - Japan, Fuchu - Japan, Fuji - Japan, Fukuchiyama - Japan, Fukui - Japan, Fukui - Japan, Fukui - Japan, Fukui - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukushima-shi - Japan, Fukushima - Japan, Fukushima - Japan, Fukuyama - Japan, Fukuyama - Japan, Gifu - Japan, Gunma - Japan, Hakodate - Japan, Hamamatsu-shizuoka - Japan, Handa-shi - Japan, Hanno - Japan, Hashima - Japan, Hatsukaichi - Japan, Higashi-omi - Japan, Higashihiroshima - Japan, Higashiibaraki-gun - Japan, Higashiomi, Shiga - Japan, Higashiosaka-shi - Japan, Higashiosaka - Japan, Himeji - Japan, Hiratsuka - Japan, Hirosaki-aomori - Japan, Hirosaki - Japan, Hiroshima-shi - Japan, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Hitachi - Japan, Hita - Japan, Hokkaido - Japan, Hokkaido - Japan, Hyogo - Japan, Hyogo - Japan, Hyogo - Japan, Hyogo - Japan, Ichikawa-shi - Japan, Iizuka - Japan, Ikeda - Japan, IKI - Japan, Ikoma - Japan, Imabari-shi - Japan, Inashiki - Japan, INA - Japan, Inuyama - Japan, Iruma-gun - Japan, Iruma-gun - Japan, Isesaki - Japan, Isesaki - Japan, ISE - Japan, Ishikawa - Japan, Ishikawa - Japan, Iwade - Japan, Iwaki-shi - Japan, Iwaki - Japan, Iwakuni - Japan, Izumiotsu - Japan, Izunokuni-shi - Japan, Joetsu-niigata - Japan, Kagawa - Japan, Kakogawa - Japan, Kaminoyama - Japan, Kanagawa - Japan, Kanagawa - Japan, Kanagawa - Japan, Kanagawa - Japan, Kanonji - Japan, Kashiwa-shi - Japan, Kashiwa - Japan, Kasuga-shi - Japan, Kasugai - Japan, Katori - Japan, Kawagoe - Japan, Kawaguchi-saitama - Japan, Kawasaki-shi, Kanagawa - Japan, Kawasaki - Japan, Kawasaki - Japan, Kazuno - Japan, Kirishima - Japan, Kiryu - Japan, Kisarazu - Japan, Kishima-gun - Japan, Kishiwada, Osaka - Japan, Kitakyushu - Japan, Kitakyusyu - Japan, Kitakyusyu - Japan, Kitamoto - Japan, Kobe - Japan, Kobe - Japan, Kobe - Japan, Kochi - Japan, Kofu - Japan, Koriyama - Japan, Koriyama - Japan, Koshigaya, Saitam - Japan, Kumamoto - Japan, Kumamoto - Japan, Kurashiki - Japan, Kurashiki - Japan, Kurashiki - Japan, Kurayoshi - Japan, Kure, Hiroshima - Japan, Kurihara - Japan, Kuroishi-aomori - Japan, Kushiro - Japan, Kyoto - Japan, Kyoto - Japan, Kyoto - Japan, Kyoto - Japan, Kyoto - Japan, Kyoto - Japan, Kyoto - Japan, Machida - Japan, Maebashi-shi - Japan, Marugame - Japan, Marugame - Japan, Masuda-shimane - Japan, Matsudo - Japan, Matsudo - Japan, Matsudo - Japan, Matsumoto - Japan, Matsuyama - Japan, Matsuyama - Japan, Mimasaka - Japan, Minokamo - Japan, Mito - Japan, Miyakonojo - Japan, Miyazaki - Japan, Miyazaki - Japan, Mooka, Tochigi - Japan, Moriguchi-shi - Japan, Morioka - Japan, Morioka - Japan, Nagano - Japan, Nagano - Japan, Nagaoka - Japan, Nagasaki-shi - Japan, Nagasaki-shi - Japan, Nagoya-shi - Japan, Nagoya - Japan, Nagoya - Japan, Nakatsu - Japan, Namerikawa - Japan, Nara - Japan, Nara - Japan, Nara - Japan, Nayoro - Japan, Nishinomiya, Hyogo - Japan, Nishinomiya - Japan, Nishinomiya - Japan, Nishinomiya - Japan, Noshiro - Japan, Obihiro - Japan, Odawara - Japan, OGI - Japan, Oiso-machi - Japan, Oita - Japan, Oita - Japan, Oita - Japan, Oita - Japan, Oita - Japan, Okayama - Japan, Okayama - Japan, Okinawa - Japan, OME - Japan, Omuta - Japan, Omuta - Japan, Onomichi - Japan, ONO - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Otawara - Japan, Otsu - Japan, Otsu - Japan, Ryugasaki - Japan, Saga-shi, SAGA - Japan, Sagamihara - Japan, Sagamihara - Japan, Sagamihara - Japan, Saga - Japan, Saga - Japan, Saitama - Japan, Saitama - Japan, Sakai-shi - Japan, Sakai - Japan, Sakata-shi - Japan, Sakura - Japan, Sanda - Japan, Sapporo-shi - Japan, Sapporo - Japan, Sapporo - Japan, Sasebo - Japan, Sendai-shi - Japan, Sendai - Japan, Sendai - Japan, Sennan - Japan, Seto - Japan, Shimizu-sho - Japan, Shimonoseki - Japan, Shimotsuga - Japan, Shimotsuga - Japan, Shimotsuke - Japan, Shiogama-miyagi - Japan, Shobara - Japan, Suita-osaka - Japan, Suita - Japan, Suzuka - Japan, Tachikawa - Japan, Tajimi - Japan, Takamatsu - Japan, Takamatsu - Japan, Takaraduka - Japan, Takarazuka - Japan, Takarazuka - Japan, Takatsuki - Japan, Tatebayashi - Japan, Togane, Chiba - Japan, Toki - Japan, Tokushima - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tonami - Japan, Toon - Japan, Tottori - Japan, Toyama - Japan, Toyoake - Japan, Toyohashi - Japan, Toyonaka - Japan, Tsu, Mie - Japan, Tsukuba-shi - Japan, Tsukuba - Japan, Tsuyama - Japan, Tsuyama - Japan, UBE - Japan, Ueda - Japan, Uruma - Japan, USA - Japan, Utsunomiya - Japan, Utsunomiya - Japan, Uwajima - Japan, Wakayama-shi - Japan, Wakayama - Japan, Wakayama - Japan, Wako - Japan, Yamagata-shi - Japan, Yamagata - Japan, Yame - Japan, YAO - Japan, Yashio - Japan, Yatomi-shi - Japan, Yokkaichi - Japan, Yokohama-shi - Japan, Yokohama - Japan, Yokohama - Japan, Yokohama - Japan, Yokohama - Japan, Yokohama - Japan, Yokosuka - Japan, Yokosuka - Japan, Yuki - Japan",2019-02-28,2015-12-14,2020-02-24,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01018381,Unknown,COMPLETED,2006-06,"Hepatocellular Carcinoma, Hepatitis B","PEIT, TOCE, TOCE plus PEIT, TOCE plus RFA, MGN-3, Entecavir",Hanoi - Vietnam,2008-07,2009-11-23,2009-11-23,INTERVENTIONAL,NA,The 108 Military Central Hospital,OTHER_GOV,hepatitis
NCT02791269,Unknown,COMPLETED,2006-01,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Auckland - New Zealand, Hamilton - New Zealand, New Plymouth - New Zealand, Riccarton, Christchurch - New Zealand, Rotorua - New Zealand, Whangarei - New Zealand",2008-07,2016-06-06,2017-02-06,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00287469,Unknown,COMPLETED,2001-07-09,Hepatitis,"Hepatitis E vaccine, recombinant (Sar 56 kDa), Placebo",Kathmandu - Nepal,2004-01-19,2006-02-06,2019-05-29,INTERVENTIONAL,PHASE2,U.S. Army Medical Research and Development Command,FED,hepatitis
NCT02851069,outCome,COMPLETED,2017-02-23,Chronic Hepatitis C,No interventions listed,"Bogotá - Colombia, Cali - Colombia, Cali - Colombia, Cartagena - Colombia, Manizales - Colombia, Medellín - Colombia",2018-08-30,2016-08-01,2019-09-18,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01591668,Unknown,COMPLETED,2012-03,Hepatitis C,"Single Ascending Dose Cohorts GS-9620, Multiple Ascending Dose Cohorts GS-9620","Little Rock - United States, DeLand - United States, Orlando - United States, Kansas City - United States, Berlin - United States, Willingboro - United States, New York - United States, Philadelphia - United States, San Antonio - United States, Salt Lake City - United States, Santurce - Puerto Rico",2012-12,2012-05-04,2013-08-13,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT02969668,INFO,COMPLETED,2016-03,"Hepatitis C, Chronic, Opioid-Related Disorders",No interventions listed,"Munich - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bremen - Germany, Frankfurt - Germany, Hamburg - Germany, Hanover - Germany, Kassel - Germany, Köln - Germany, Muenchen - Germany, Munich - Germany, Munich - Germany, Stuttgart - Germany, Wuppertal - Germany",2018-10,2016-11-21,2021-04-28,OBSERVATIONAL,Not Available,Universitätsklinikum Hamburg-Eppendorf,OTHER,hepatitis
NCT02482272,Unknown,UNKNOWN,2015-05,"Hepatitis B, Chronic","Lamivudine, Adefovir, Entecavir","Seoul - Korea, Republic of",2017-01,2015-06-26,2015-12-30,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT00737568,Unknown,COMPLETED,2008-09,Hepatitis B,"TDF, FTC/TDF, TDF Placebo, FTC/TDF Placebo","Bradenton - United States, Flushing - United States, Philadelphia - United States, Innsbruck - Austria, Wien - Austria, Wien - Austria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnepeg - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Brno - Czech Republic, Plzen - Czech Republic, Prague - Czech Republic, Praha 4 - Czech Republic, Usti Nad Labem - Czech Republic, Ulm - Germany, Berlin - Germany, Duesseldorf - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Stuttgart - Germany, Larissa - Greece, Patras - Greece, Thessaloniki - Greece, Budapest - Hungary, Debrecen - Hungary, Gyula - Hungary, Kasposvar - Hungary, Auckland - New Zealand, Hamilton - New Zealand, Wellington - New Zealand, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Krakow - Poland, Lodz - Poland, Szczecin - Poland, Warszawa - Poland, Warszawa - Poland, Wroclaw - Poland, Lasi - Romania, Timisoara - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucuresti - Romania, Bucuresti - Romania, Bucuresti - Romania, Cluj-Napoca - Romania, Constanta - Romania, Belgrade - Serbia, Kragujevac - Serbia, Nis - Serbia, Novi Sad - Serbia, Sevilla - Spain, Ankara - Turkey, Bursa - Turkey, Izmir - Turkey, Samsun - Turkey, Trabzon - Turkey, Uskudar - Turkey",2011-11,2008-08-19,2016-03-11,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT05442372,Unknown,UNKNOWN,2022-06-15,Hepatitis B,No interventions listed,Sohag - Egypt,2023-02-15,2022-07-05,2022-12-23,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT04426968,Unknown,COMPLETED,2021-06-18,"Hepatitis B, Chronic","Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg, placebo 2.1mg, placebo 4.2mg, placebo 6.3mg, Pegylated Interferon","Beijing - China, Changchun - China, Changchun - China, Chizhou - China, Chongqing - China, Nanchang - China, Nanjing - China, Qingyuan - China, Shanghai - China, Shenyang - China, Zhengzhou - China, Zhenzhou - China",2023-11-01,2020-06-11,2025-01-27,INTERVENTIONAL,PHASE2,"Shanghai HEP Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT04757272,Unknown,COMPLETED,2020-05-01,"Corona Virus Infection, Hepatitis",No interventions listed,Zagazig - Egypt,2022-03-30,2021-02-17,2022-09-30,OBSERVATIONAL,Not Available,Zagazig University,OTHER_GOV,hepatitis
NCT00154869,Unknown,UNKNOWN,2004-06,"Hepatitis B, Chronic, Hepatitis C, Chronic",Peginterferon Alfa-2a plus Ribavirin,Taipei - Taiwan,Unknown Date,2005-09-12,2007-08-13,INTERVENTIONAL,PHASE3,National Taiwan University Hospital,OTHER,hepatitis
NCT03020004,Unknown,COMPLETED,2016-01,Chronic Hepatitis C,"Danoprevir, Ritonavir, peginterferon alfa-2a, Ribavirin (RBV)",No locations listed,2016-11,2017-01-13,2018-07-26,INTERVENTIONAL,PHASE2,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT00529568,Unknown,COMPLETED,2007-10,"Hepatitis C, Chronic","eltrombopag, placebo","Birmingham - United States, Tucson - United States, Anaheim - United States, Arcadia - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Lynwood - United States, Sacramento - United States, San Clemente - United States, San Diego - United States, San Mateo - United States, Aurora - United States, New Haven - United States, Washington - United States, Washington - United States, Bradenton - United States, Jacksonville - United States, Miami - United States, Honolulu - United States, Chicago - United States, Indianapolis - United States, Lexington - United States, New Orleans - United States, Boston - United States, Burlington - United States, Worcester - United States, Detroit - United States, Detroit - United States, Jackson - United States, St. Louis - United States, St. Louis - United States, Lebanon - United States, Bronx - United States, Manhasset - United States, New York - United States, New York - United States, Rochester - United States, Syracuse - United States, Asheville - United States, Durham - United States, Kinston - United States, Morganton - United States, Tulsa - United States, Portland - United States, Hershey - United States, Philadelphia - United States, Germantown - United States, Mountain Home - United States, Nashville - United States, Nashville - United States, Nashville - United States, Dallas - United States, Galveston - United States, Houston - United States, San Antonio - United States, Charlottesville - United States, Richmond - United States, Seattle - United States, Garran - Australia, Camperdown - Australia, Randwick - Australia, Cairns - Australia, Herston - Australia, Clayton - Australia, Fitzroy - Australia, Parkville - Australia, Prahran - Australia, Nedlands - Australia, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Campinas - Brazil, São Paulo - Brazil, Edmonton - Canada, Victoria - Canada, Winnipeg - Canada, Barrie - Canada, Hamilton - Canada, Hamilton - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Hradec Kralove - Czech Republic, Olomouc - Czech Republic, Praha 6 - Czech Republic, Cairo - Egypt, Mansoura - Egypt, Shebeen El-Kom, Menoufeya - Egypt, Besançon - France, Bondy - France, Dijon cedex - France, Grenoble - France, Lille - France, Marseille Cedex 08 - France, Orléans - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Rouen - France, Strasbourg - France, Vandoeuvre Les Nancy - France, Freiburg - Germany, Heidelberg - Germany, Mannheim - Germany, Stuttgart - Germany, Ulm - Germany, Deggendorf - Germany, Hof/Saale - Germany, Muenchen - Germany, Muenchen - Germany, Regensburg - Germany, Wuerzburg - Germany, Beeskow - Germany, Frankfurt - Germany, Frankfurt - Germany, Kassel - Germany, Goettingen - Germany, Hannover - Germany, Hannover - Germany, Rotenburg (Wuemme) - Germany, Aachen - Germany, Bochum - Germany, Bonn - Germany, Dortmund - Germany, Duesseldorf - Germany, Essen - Germany, Herne - Germany, Koeln - Germany, Leverkusen - Germany, Muenster - Germany, Oberhausen - Germany, Siegen - Germany, Mainz - Germany, Halle - Germany, Magdeburg - Germany, Chemnitz - Germany, Leipzig - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany, Hamburg - Germany, Athens - Greece, Athens - Greece, Rio, Patras - Greece, Thessaloniki - Greece, Bangalore - India, Chennai - India, Hyderabad - India, Mumbai - India, Mumbai - India, Mumbai - India, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petach Tikva - Israel, Rehovot - Israel, Safed - Israel, Tel Aviv - Israel, Catanzaro - Italy, Avellino - Italy, Bologna - Italy, Roma - Italy, Genova - Italy, Brescia - Italy, Milano - Italy, Milano - Italy, Bari - Italy, San Giovanni Rotondo (FG) - Italy, Palermo - Italy, Busan - Korea, Republic of, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Lahore - Pakistan, Lahore - Pakistan, Chorzow - Poland, Kielce - Poland, Raciborz - Poland, Szczecin - Poland, Warszawa - Poland, Wroclaw - Poland, Ponce - Puerto Rico, San Juan - Puerto Rico, Bucharest - Romania, Constanta - Romania, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, St.Peterburg - Russian Federation, Bratislava - Slovakia, Bratislava - Slovakia, Kosice - Slovakia, Martin - Slovakia, Alicante - Spain, Barcelona - Spain, Barcelona - Spain, La Coruña - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Málaga - Spain, Palma de Mallorca - Spain, Pontevedra - Spain, Sabadell (Barcelona) - Spain, San Sebastián - Spain, Sevilla - Spain, Valencia - Spain, Valencia - Spain, Changhua - Taiwan, Chia-Yi Hsien - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taiyuan Hsien - Taiwan, Donetsk - Ukraine, Kiev - Ukraine, Vinnitsa - Ukraine",2011-08,2007-09-14,2013-11-05,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00897312,Unknown,TERMINATED,2006-10,Melanoma,"infliximab, pegylated interferon alfa, ticilimumab, ribavirin, high performance liquid chromatography, laboratory biomarker analysis",No locations listed,2008-08,2009-05-12,2016-04-25,OBSERVATIONAL,Not Available,Vanderbilt-Ingram Cancer Center,OTHER,hepatitis
NCT01434212,sIFN-pred1,UNKNOWN,2010-05,Hepatitis,"Interferon Alfa-2b, Ribavirin",Changchun - China,2011-12,2011-09-14,2011-10-28,OBSERVATIONAL,Not Available,The First Hospital of Jilin University,OTHER,hepatitis
NCT01195246,Unknown,COMPLETED,2010-12,End Stage Renal Disease,"HEPLISAV, Engerix-B, Fendrix","Aschaffenburg - Germany, Bamberg - Germany, Berlin - Germany, Dresden - Germany, Dusseldorf - Germany, Essen - Germany, Halle - Germany, Hamburg - Germany, Hannover - Germany, Koln - Germany, Leipzig - Germany, Madgeburg - Germany, Mainz - Germany, Mannheim-Kafertal - Germany, Munchen - Germany, Oberschleißheim - Germany, Rostock - Germany, Trier - Germany, Velbert - Germany",2012-02,2010-09-06,2019-03-20,INTERVENTIONAL,PHASE3,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT03711669,Unknown,UNKNOWN,2018-01-10,Autoimmune Hepatitis,Immunosuppression withdrawal,"Barcelona - Spain, Barcelona - Spain",2021-01,2018-10-18,2020-02-12,OBSERVATIONAL,Not Available,Hospital Clinic of Barcelona,OTHER,hepatitis
NCT01153269,Unknown,COMPLETED,2001-05,Human Immunodeficiency Virus-Infection,Lopinavir/Ritonavir (Kaletra),"Berlin - Germany, Berlin - Germany, Dortmund - Germany, Frankfurt - Germany, Frankfurt - Germany, Hamburg - Germany, Krefeld - Germany, Muenster - Germany",2010-11,2010-06-30,2011-12-19,OBSERVATIONAL,Not Available,Abbott,INDUSTRY,hepatitis
NCT06409169,Unknown,RECRUITING,2025-01-22,Hepatitis C,"DBS TaT, Usual Care",Portland - United States,2025-12,2024-05-10,2025-03-06,INTERVENTIONAL,NA,Oregon Health and Science University,OTHER,hepatitis
NCT03117569,SMART-C,COMPLETED,2017-08-21,"Hepatitis C, Chronic",glecaprevir (300mg)/pibrentasvir (120mg),"Boston - United States, New York - United States, Durham - United States, Madison - United States, Sydney - Australia, Sydney - Australia, Sydney - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Vancouver - Canada, Vancouver - Canada, Brampton - Canada, Hamilton - Canada, Toronto - Canada, Montréal - Canada, Québec - Canada, Créteil - France, Marseille - France, Paris - France, Berlin - Germany, Düsseldorf - Germany, Hanover - Germany, Münster - Germany, Auckland - New Zealand, Auckland - New Zealand, Christchurch - New Zealand, Dunedin - New Zealand, Bern - Switzerland, Zürich - Switzerland, London - United Kingdom, London - United Kingdom, London - United Kingdom",2018-12-19,2017-04-18,2019-12-11,INTERVENTIONAL,PHASE3,Kirby Institute,OTHER_GOV,hepatitis
NCT06279169,Unknown,RECRUITING,2024-04-24,"Pain, Acute, Newborn; Vitality","Heart Sound, White Noise",Bartın - Turkey,2025-08-29,2024-02-26,2024-04-26,INTERVENTIONAL,NA,Bartın Unıversity,OTHER,hepatitis
NCT00703469,MDX1106-02,COMPLETED,2008-10,Hepatitis C,"MDX1106-02, Placebo","Anaheim - United States, San Francisco - United States, Springfield - United States, Baltimore - United States, Philadelphia - United States, Dallas - United States, San Antonio - United States",2009-10,2008-06-23,2010-04-23,INTERVENTIONAL,PHASE1,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02714712,Unknown,COMPLETED,2015-08,Chronic Hepatitis C,Peginterferon alfa-2a,No locations listed,2016-07,2016-03-21,2017-07-14,OBSERVATIONAL,Not Available,"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation",OTHER,hepatitis
NCT03492112,TEMPO,COMPLETED,2019-09-10,Hepatitis C,"HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir",Sydney - Australia,2021-11-30,2018-04-10,2023-01-17,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT02050646,Unknown,COMPLETED,2013-08-27,Autoimmune Hepatitis,"Low Salt Diet, Liberal salt diet",No locations listed,2019-08,2014-01-31,2021-07-28,INTERVENTIONAL,NA,Yale University,OTHER,hepatitis
NCT02431312,Unknown,COMPLETED,2015-01-12,Hepatitis B,"INO-1800, INO-9112, Nucleos(t)ide Analogue Treatment","San Diego - United States, Miami - United States, Manhasset - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Seattle - United States, Kingswood - Australia, South Brisbane - Australia, Adelaide - Australia, Hong Kong - Hong Kong, Auckland - New Zealand, Pasig City - Philippines, Singapore - Singapore, Linkou - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Bangkoknoi - Thailand, Tha Muang - Thailand, Khon Kaen - Thailand",2018-05-22,2015-05-01,2019-10-15,INTERVENTIONAL,PHASE1,Inovio Pharmaceuticals,INDUSTRY,hepatitis
NCT01369212,HBRN,COMPLETED,2012-11,Hepatitis B,"Tenofovir, Peginterferon-alfa 2a and tenofovir","Los Angeles - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Honolulu - United States, Bethesda - United States, Boston - United States, Boston - United States, Ann Arbor - United States, Plymouth - United States, Rochester - United States, Saint Louis - United States, Saint Louis - United States, Chapel Hill - United States, Durham - United States, Dallas - United States, Dallas - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2021-03-08,2011-06-08,2023-04-28,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT04159246,Unknown,UNKNOWN,2019-02-10,HCV Infection,"Optical coherence tomography angiography, Sofosbuvir (Sovaldi)",Cairo - Egypt,2019-11-30,2019-11-12,2019-11-12,OBSERVATIONAL,Not Available,Mohamed Saad,OTHER,hepatitis
NCT01726946,Unknown,COMPLETED,2012-11,Chronic Hepatitis C,"VX-135, ribavirin","La Jolla - United States, Orlando - United States, Marietta - United States, Germantown - United States, Arlington - United States, Houston - United States",2014-02,2012-11-15,2015-04-16,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT00926146,HBV,COMPLETED,2009-07,"Hepatitis B, Hepatitis C, HIV, HIV Infections","NCMIT, SCMIT",Los Angeles - United States,2014-01,2009-06-23,2017-01-30,INTERVENTIONAL,NA,"University of California, Los Angeles",OTHER,hepatitis
NCT00689546,Unknown,UNKNOWN,2007-02,"Acute Viral Hepatitis, Diabetes Mellitus",No interventions listed,New Delhi - India,Unknown Date,2008-06-03,2008-06-03,OBSERVATIONAL,Not Available,"All India Institute of Medical Sciences, New Delhi",OTHER,hepatitis
NCT05827146,Unknown,COMPLETED,2023-10-07,Chronic Hepatitis D Infection,"Hepalatide, Hepalatide Placebo","Urumqi - China, Changchun - China, Ulaanbaatar - Mongolia",2024-01-30,2023-04-24,2024-04-24,INTERVENTIONAL,PHASE2,"Shanghai HEP Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01933412,Unknown,UNKNOWN,2012-03,"Chronic Kidney Disease, Hepatitis B","Sci-B-Vac Hepatitis B Vaccine, Engerix B Hepatitis B Vaccine",Tel Aviv - Israel,2013-08,2013-09-02,2013-09-02,INTERVENTIONAL,PHASE3,Tel-Aviv Sourasky Medical Center,OTHER_GOV,hepatitis
NCT00728546,Unknown,UNKNOWN,2008-06,"Tuberculosis, Hepatotoxicity",Isoniazid (Rifinah),Taipei - Taiwan,2015-11,2008-08-06,2012-12-27,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT04809246,PIVOT,COMPLETED,2019-10-31,Hepatitis C,'One-stop-shop' hepatitis clinic,Kempsey - Australia,2021-04-23,2021-03-22,2022-01-14,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT03453346,SOF_GT2,COMPLETED,2016-08-05,"Hepatitis C, Chronic, Hepatitis C Virus Infection, Response to Therapy of","Sofosbuvir, Ribavirin","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Shijiazhuang - China, Zhengzhou - China, Zhengzhou - China, Nanjing - China, Changchun - China, Shenyang - China, Xi'an - China, Xi'an - China, Qingdao - China, Chengdu - China",2017-03-18,2018-03-05,2018-03-07,INTERVENTIONAL,NA,"Kawin Technology Share-holding Co., Ltd.",INDUSTRY,hepatitis
NCT02182167,NAC in TB DIH,COMPLETED,2014-05,Drug-Induced Liver Injury,"IV N-acetylcysteine (NAC), Water","Cape Town - South Africa, Cape Town - South Africa",2019-02,2014-07-08,2019-02-19,INTERVENTIONAL,PHASE3,University of Cape Town,OTHER,hepatitis
NCT03068767,Unknown,COMPLETED,2016-09,Vitamin D and Hepatitis B Virus,Vitamin D,New Taipei city - Taiwan,2019-01-01,2017-03-03,2020-02-12,INTERVENTIONAL,NA,"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation",OTHER,hepatitis
NCT00142740,Unknown,COMPLETED,2005-10,"HIV Infection, Hepatitis B",No interventions listed,"Los Angeles - United States, San Franciso - United States, Washington - United States, Tampa - United States",2008-06,2005-09-02,2017-02-28,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT06855667,Unknown,NOT_YET_RECRUITING,2025-03-03,Autoimmune Hepatitis,"Plasma Exchange, Steroid, Diet",New Delhi - India,2027-02-28,2025-03-04,2025-03-04,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT00782301,Unknown,WITHDRAWN,2009-03,"Hepatitis B, Human Immunodeficiency Virus, Hepatitis C, Chronic","maraviroc, etravirine","Clearwater - United States, Orlando - United States, Safety Harbor - United States, Wilton Manors - United States, Atlanta - United States, Atlanta - United States, New Orleans - United States, Worcester - United States, Worcester - United States, Mt. Vernon - United States, Tulsa - United States, Bellaire - United States, Conroe - United States, Dallas - United States, Stafford - United States, Vancouver - Canada, Toronto - Canada, Bydgoszcz - Poland",2010-02,2008-10-31,2012-01-19,INTERVENTIONAL,PHASE4,ViiV Healthcare,INDUSTRY,hepatitis
NCT01482767,Unknown,COMPLETED,2012-04,"HIV Infections, Hepatitis C","Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC)","Birmingham - United States, Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, Torrance - United States, Aurora - United States, Denver - United States, Washington - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Boston - United States, Boston - United States, Detroit - United States, Detroit - United States, Saint Louis - United States, Camden - United States, Newark - United States, Bronx - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Cleveland - United States, Columbus - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Nashville - United States, Dallas - United States, Houston - United States, Richmond - United States, Seattle - United States, San Juan - Puerto Rico",2015-04,2011-12-01,2021-11-04,INTERVENTIONAL,PHASE3,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00960167,Unknown,UNKNOWN,2009-09,Hepatocellular Carcinoma,3DCRT or IMRT,Taipei - Taiwan,2011-08,2009-08-17,2009-10-15,INTERVENTIONAL,PHASE1,National Taiwan University Hospital,OTHER,hepatitis
NCT00160940,Unknown,UNKNOWN,2002-02,"Hepatitis C, Hepatitis B, Autoimmune Hepatitis, Liver Cirrhosis, Biliary, Cholangitis, Sclerosing",No interventions listed,Toronto - Canada,Unknown Date,2005-09-12,2005-12-01,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT04847440,Unknown,TERMINATED,2021-03-30,"Hepatitis B, Chronic, Hepatitis D","ATI-2173, Viread, AB-729","Chisinau - Moldova, Republic of, Kyiv - Ukraine",2022-09-01,2021-04-19,2022-11-18,INTERVENTIONAL,PHASE2,"Antios Therapeutics, Inc",INDUSTRY,hepatitis
NCT05019040,Unknown,COMPLETED,2021-09-17,Chronic HBV Infection,PA1010,"Beijing - China, Chongqing - China, Guangzhou - China, Hangzhou - China",2022-11-15,2021-08-24,2023-01-31,INTERVENTIONAL,PHASE2,"Zhejiang Palo Alto Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02044055,Unknown,COMPLETED,2014-10,"Hepatitis D, Transmission",No interventions listed,Paris - France,2017-04,2014-01-23,2017-04-27,OBSERVATIONAL,Not Available,Hopital Lariboisière,OTHER,hepatitis
NCT00801255,Unknown,COMPLETED,2008-11,"Hepatitis C, Chronic","RO5024048, danoprevir, danoprevir, danoprevir, danoprevir, danoprevir","Adelaide - Australia, Heidelberg - Australia, Melbourne - Australia, Christchurch - New Zealand, Grafton - New Zealand",2010-03,2008-12-03,2016-11-02,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00414050,Unknown,COMPLETED,2006-10-06,Hepatitis B,"Modified Process Hepatitis B Vaccine (Experimental), Hepatitis B Vaccine (Recombinant), Hepatitis B Vaccine (Recombinant)",No locations listed,2007-10-22,2006-12-21,2017-05-23,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02604823,Unknown,COMPLETED,2003-11,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Beijing - China, Guangzhou - China, Shanghai - China",2005-11,2015-11-13,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04180150,Unknown,UNKNOWN,2019-11-18,Chronic Hepatitis B,"TQ-A3334, Placebo, Entecavir Tablet","Chongqing - China, Changchun - China",2020-09-30,2019-11-27,2019-12-16,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT04162223,Unknown,COMPLETED,2000-03-29,Hepatitis B Vaccination,"Subcutaneous fat injection of Recombivax-HB, Intramuscular injection of Recombivax-HB",Baltimore - United States,2003-05-20,2019-11-14,2019-11-14,INTERVENTIONAL,PHASE1,"University of Maryland, Baltimore",OTHER,hepatitis
NCT02301650,Unknown,UNKNOWN,2014-10,the Safety of Anti-viral Drugs Used in Late Pregnancy,"Lamivudine, Telbivudine, Tenofovir",No locations listed,2017-10,2014-11-26,2014-11-26,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT03084250,Unknown,UNKNOWN,2017-03-10,Hepatitis B,"Peginterferon Alfa-2A, Adefovir, entecavir,tenofovir, either of them",Shanghai - China,2023-04-01,2017-03-20,2017-05-03,INTERVENTIONAL,PHASE4,Shanghai Nanhui Nanhua Hospital,OTHER,hepatitis
NCT04048850,Unknown,COMPLETED,2019-09-20,"Hepatitis C, Hiv, Coinfection, HIV, Substance Use Disorders",Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER],Chicago - United States,2022-06-01,2019-08-07,2025-01-28,OBSERVATIONAL,Not Available,University of Illinois at Chicago,OTHER,hepatitis
NCT04850950,TAF-PPT,UNKNOWN,2021-04-26,"Chronic Hepatitis B, Mother-to-Child Transmission, Safety, Efficacy, Hepatitis B Virus, Tenofovir Alafenamide Fumarate",Tenofovir Alafenamide fumarate 25mg Oral Tablet,No locations listed,2022-12-31,2021-04-20,2021-04-23,INTERVENTIONAL,PHASE4,The First Affiliated Hospital of Zhengzhou University,OTHER,hepatitis
NCT00474955,Unknown,COMPLETED,2007-07,"Hepatitis C, Chronic",peginterferon alfa-2a [Pegasys],"Chita - Russian Federation, Irkutsk - Russian Federation, Khabarovsk - Russian Federation, Khabarovsk - Russian Federation, Orenburg - Russian Federation",2011-06,2007-05-17,2016-07-25,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01962155,HBV,COMPLETED,2013-08,"Hepatitis B, Liver Fibrosis",No interventions listed,"Hefei - China, Bei Jing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Nanning - China, Qinhuangdao - China, Xinxiang - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Dalian - China, Shenyang - China, Yantai - China, Taiyuan - China, Hang Zhou - China, Beijing - China, Beijing - China, Beijing - China, Chengdu - China, Shanghai - China, Shanghai - China",2015-12,2013-10-14,2016-09-09,OBSERVATIONAL,Not Available,Peking University First Hospital,OTHER,hepatitis
NCT03600714,Unknown,COMPLETED,2018-08-01,"Liver Disease, Hepatitis D","Peg-interferon lambda, Lonafarnib, Ritonavir",Bethesda - United States,2020-02-05,2018-07-26,2021-12-14,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00926614,Unknown,COMPLETED,2008-09,Hepatitis c,"pioglitazone (Actos), atorvastatin (Lipitor)",San Antonio - United States,2011-06,2009-06-23,2012-02-14,INTERVENTIONAL,PHASE4,Brooke Army Medical Center,FED,hepatitis
NCT06537414,B-UNITED,RECRUITING,2024-11-11,"Chronic Hepatitis B Virus Infection, Hepatitis B","Daplusiran/Tomligisiran Dose Level 1, Daplusiran/Tomligisiran Dose Level 2, Bepirovirsen, Placebo","San Francisco - United States, San Jose - United States, Minneapolis - United States, New York - United States, Philadelphia - United States, Camperdown - Australia, Westmead - Australia, Fitzroy - Australia, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Aracaju - Brazil, Curitiba - Brazil, Manaus - Brazil, Sao Paulo - Brazil, Calgary - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Beijing - China, Chengdu - China, Guangzhou - China, Shanghai - China, Zhenjiang - China, Clichy Cedex - France, CrEteil cedex - France, Limoges cedex - France, Lyon - France, Marseille - France, Toulouse Cedex 9 - France, Berlin - Germany, Berlin - Germany, Essen - Germany, Hannover - Germany, Leipzig - Germany, Muenster - Germany, Athens - Greece, Athens - Greece, Pokfulam - Hong Kong, Shatin - Hong Kong, Bergamo - Italy, Firenze - Italy, Milano - Italy, Modena - Italy, Napoli - Italy, Padova - Italy, Pisa - Italy, Roma - Italy, Torino - Italy, Chiba - Japan, Hokkaido - Japan, Hokkaido - Japan, Hyogo - Japan, Kagawa - Japan, Kagawa - Japan, Kumamoto - Japan, Kumamoto - Japan, Osaka - Japan, Osaka - Japan, Tokyo - Japan, Yamanashi - Japan, Ansan - Korea, Republic of, Busan - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Papatoetoe Auckland - New Zealand, Singapore - Singapore, Singapore - Singapore, Johannesburg - South Africa, Reiger Park - South Africa, Soweto Johannesburg - South Africa, Barcelona - Spain, Barcelona - Spain, Leon - Spain, Madrid - Spain, Salamanca - Spain, Santander - Spain, Valencia - Spain, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tau-Yuan - Taiwan, London - United Kingdom, London - United Kingdom, London - United Kingdom, Middlesbrough - United Kingdom",2027-10-29,2024-08-05,2024-12-09,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03020095,Unknown,COMPLETED,2015-08,Chronic Hepatitis C,"Ravidasvir, Danoprevir, Ritonavir, Ribavirin",No locations listed,2016-08,2017-01-13,2020-10-22,INTERVENTIONAL,PHASE2,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT01072695,Unknown,COMPLETED,2010-02,HCV Infection,"GS-9256, GS-9190, Ribavirin, Peginterferon alfa-2a","Brussels - Belgium, Bruxelles - Belgium, Clichy - France, La Tronche - France, Paris - France, Duesseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Wurzburg - Germany, London - United Kingdom, London - United Kingdom",2010-10,2010-02-22,2012-05-31,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT03827395,Unknown,COMPLETED,2019-04-12,"Hepatitis E, Immunisation","HEV 239, Placebo",Atlanta - United States,2020-08-28,2019-02-01,2021-09-24,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00643695,Unknown,COMPLETED,2008-03,"Hepatitis C, Depression","Home-based walking program, Educational intervention",Portland - United States,2014-10,2008-03-26,2016-03-29,INTERVENTIONAL,NA,Portland VA Medical Center,FED,hepatitis
NCT00743795,Unknown,COMPLETED,2008-10,HCV Infection,"placebo, GS-9190, Peginterferon Alfa 2a, Ribavirin","Anaheim - United States, Los Angeles - United States, Newport Beach - United States, San Clemente - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Englewood - United States, Miami - United States, North Miami Beach - United States, Orlando - United States, Sarasota - United States, Tampa - United States, Atlanta - United States, Decatur - United States, Chicago - United States, Bowling Green - United States, Baton Rouge - United States, Baltimore - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Detroit - United States, St. Louis - United States, Cedar Knolls - United States, Johnson City - United States, New York - United States, New York - United States, New York - United States, New York - United States, Plainview - United States, Syracuse - United States, Asheville - United States, Durham - United States, High Point - United States, Cincinatti - United States, Cincinnati - United States, Tulsa - United States, Philadelphia - United States, Philadelphia - United States, Germantown - United States, Dallas - United States, Houston - United States, San Antonio - United States, Annandale - United States, Fairfax - United States, Norfolk - United States, Richmond - United States, Bruxelles - Belgium, Bruxelles - Belgium, Ghent - Belgium, Leuven - Belgium, Liege - Belgium, Berlin - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Koln - Germany, Munchen - Germany, Dublin - Ireland, Dublin - Ireland, Dublin - Ireland, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Czeladz - Poland, Krakow - Poland, Warszawa - Poland, Santurce - Puerto Rico, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom",2009-07,2008-08-29,2013-11-05,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT06153914,Unknown,NOT_YET_RECRUITING,2023-12-01,"Liver Cirrhosis, Liver",Sequential Adult Left Lateral Liver Transplantation,No locations listed,2027-01-01,2023-12-01,2023-12-01,INTERVENTIONAL,NA,RenJi Hospital,OTHER,hepatitis
NCT05482295,Unknown,NOT_YET_RECRUITING,2024-06,"Vaccine Reaction, Vaccine Adverse Reaction","Hepatitis B vaccine lot 1, Hepatitis B vaccine lot 2, Hepatitis B vaccine lot 3, Hepatitis B vaccine (registered)",No locations listed,2024-07,2022-08-01,2024-04-05,INTERVENTIONAL,PHASE3,PT Bio Farma,INDUSTRY,hepatitis
NCT02636595,ENDURANCE-4,COMPLETED,2015-11,Hepatitis C Virus,ABT-493/ABT-530,No locations listed,2016-10,2015-12-22,2021-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01445795,INH-189-006,COMPLETED,2011-09,Hepatitis C,"200 mg INX-08189 Fasted, Placebo QD Fasted, 100 mg INX-08189 QD, Placebo QD, 100 mg INX-08189 with low-fat meal, Placebo with low-fat meal, 100 mg INX-08189 BID Fasted, Placebo BID Fasted, ribavirin","San Antonio - United States, San Juan - Puerto Rico",2012-05,2011-10-04,2016-06-27,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05466981,Unknown,COMPLETED,2020-11-23,"Hepatitis C, Smoking Cessation",Cognitive Behavioral Counseling,Greenville - United States,2021-11-11,2022-07-20,2022-07-20,INTERVENTIONAL,NA,Prisma Health-Upstate,OTHER,hepatitis
NCT06147895,CVI-HBV-002,COMPLETED,2021-09-17,"Vaccine-Preventable Diseases, Hepatitis B",CVI-HBV-002,"Seongnam-si - Korea, Republic of",2023-09-25,2023-11-28,2024-03-25,INTERVENTIONAL,PHASE1,"CHA Vaccine Institute Co., Ltd.",INDUSTRY,hepatitis
NCT03804372,CLL1818,TERMINATED,2020-07-07,"Large-B-cell Diffuse Lymphoma, Chronic Lymphoid Leukemia","Rituximab, Chemotherapy, Tenofovir alafenamide","Alessandria - Italy, Ancona - Italy, Ascoli Piceno - Italy, Aviano - Italy, Bari - Italy, Bari - Italy, Brindisi - Italy, Catania - Italy, Cona - Italy, Foggia - Italy, Lecce - Italy, Messina - Italy, Napoli - Italy, Napoli - Italy, Novara - Italy, Pagani - Italy, Palermo - Italy, Pavia - Italy, Pescara - Italy, Reggio Emilia - Italy, Rimini - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, San Giovanni Rotondo - Italy, Torino - Italy, Verona - Italy, Vicenza - Italy",2024-05-22,2019-01-15,2025-02-27,INTERVENTIONAL,PHASE2,Gruppo Italiano Malattie EMatologiche dell'Adulto,OTHER,hepatitis
NCT00296972,Unknown,TERMINATED,2005-07,"Chronic Hepatitis C, HIV Infections",peg interferon plus ribavirin,Toronto - Canada,Unknown Date,2006-02-27,2007-04-23,INTERVENTIONAL,PHASE3,"University Health Network, Toronto",OTHER,hepatitis
NCT00720668,HBV-HCC,UNKNOWN,2006-06,"Hepatitis B, Hepatocellular Carcinoma",radiofrequency ablation,Guangzhou - China,2009-03,2008-07-23,2009-02-09,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT04180072,Unknown,ACTIVE_NOT_RECRUITING,2020-03-12,"Carcinoma, Hepatocellular","Atezolizumab, Bevacizumab","Linkou - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2025-12-31,2019-11-27,2024-07-05,INTERVENTIONAL,NA,"National Health Research Institutes, Taiwan",OTHER,hepatitis
NCT01447446,Unknown,COMPLETED,2011-09,"Hepatitis C, Chronic","Peg-IFN Alfa-2a, Peg-IFN Alfa-2b, Ribavirin, Boceprevir, Telaprevir","Antwerpen - Belgium, Antwerpen - Belgium, Bouge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Gilly (Charleroi) - Belgium, Hasselt - Belgium, Heusy - Belgium, Kortrijk - Belgium, Leuven - Belgium, Liège - Belgium, Mons - Belgium, Montignies sur Sambre - Belgium, Namur - Belgium, Oostende - Belgium, Roeselare - Belgium, Verviers - Belgium, Alexandria - Egypt, Alexandria - Egypt, Cairo - Egypt, Cairo - Egypt, Giza - Egypt, Tanta - Egypt, Kohtla-Järve - Estonia, Pärnu - Estonia, Tallinn - Estonia, Tallinn - Estonia, Tartu - Estonia, Aix En Provence - France, Amiens - France, Argenteuil - France, Avignon - France, Besancon - France, Besancon - France, Beziers - France, Boulogne Billancourt - France, Bourgoin Jallieu - France, Caen - France, Chambray Les Tours - France, Clichy - France, Creil - France, Creteil - France, Epinay-Sur-Seine - France, Evry - France, Freyming Merlebach - France, Gonesse - France, Grasse - France, Hyeres - France, La Tronche - France, Lagny Sur Marne - France, Lille - France, Limoges - France, Lomme - France, Lyon - France, Mantes La Jolie - France, Marseille - France, Meaux - France, Montpellier - France, Montpellier - France, Nice - France, Nimes - France, Orange - France, Orleans - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Pau - France, Perpignan - France, Pessac - France, Reims - France, Rennes - France, Rouen - France, Saint Nazaire - France, St Laurent Du Var - France, St Priest En Jarez - France, Strasbourg - France, Suresnes - France, Toulon - France, Toulouse - France, Tourcoing - France, Vandoeuvre-les-nancy - France, Vannes - France, Villejuif - France, Villeneuve Maguelone - France, Villeneuve St Georges - France, Aachen - Germany, Berlin - Germany, Berlin - Germany, Burghausen - Germany, Düsseldorf - Germany, Erlangen - Germany, Essen - Germany, Kassel - Germany, Köln - Germany, Lübeck - Germany, Magdeburg - Germany, Mannheim - Germany, Rostock - Germany, Rottenburg - Germany, Tübingen - Germany, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Athens - Greece, Ioannina - Greece, Larissa - Greece, Nea Kifissia - Greece, Patra - Greece, Thessaloniki - Greece, Ajka - Hungary, Balassagyarmat - Hungary, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Debrecen - Hungary, Gyula - Hungary, Kaposvar - Hungary, Kecskemet - Hungary, Miskolc - Hungary, Nyíregyháza - Hungary, Pecs - Hungary, Sopron - Hungary, Szeged - Hungary, Szekesfehervar - Hungary, Szolnok - Hungary, Szombathely - Hungary, Székesfehérvár - Hungary, Tatabánya - Hungary, Zalaegerszeg - Hungary, Zalaegerszeg - Hungary, Dublin - Ireland, Dublin - Ireland, Dublin - Ireland, Chieti - Italy, Reggio Calabria - Italy, Avellino - Italy, Gragnano - Italy, Marcianise - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Nocera Inferiore - Italy, Nola - Italy, Bologna - Italy, Modena - Italy, Parma - Italy, Piacenza - Italy, Udine - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Genova - Italy, Savona - Italy, Busto Arsizio - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Torrette Di Ancona - Italy, Biella - Italy, Cuorgnè (TO) - Italy, Omegna (VB) - Italy, Bari - Italy, Bisceglie - Italy, Castellana Grotte - Italy, San Giovanni Rotondo - Italy, Cagliari - Italy, Cagliari - Italy, Sassari - Italy, Catania - Italy, Catania - Italy, Messina - Italy, Palermo - Italy, Arezzo - Italy, Firenze - Italy, Livorno - Italy, Padova - Italy, Safat - Kuwait, Baabda - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Nabatieh - Lebanon, Tripoli - Lebanon, Skopje - Macedonia, The Former Yugoslav Republic of, Casablanca - Morocco, Casablanca - Morocco, Casablanca - Morocco, Fes - Morocco, Marrakech - Morocco, Rabat - Morocco, Rabat - Morocco, Muscat - Oman, Faisalabad - Pakistan, Gujranwala - Pakistan, Karachi - Pakistan, Lahore - Pakistan, Lahore - Pakistan, Rawalpindi - Pakistan, Almada - Portugal, Amadora - Portugal, Aveiro - Portugal, Beja - Portugal, Coimbra - Portugal, Faro - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Doha - Qatar, Bucharest - Romania, Bucharest - Romania, Cluj-napoca - Romania, Constanta - Romania, Iasi - Romania, Iasi - Romania, Timisoara - Romania, Holy Makkah - Saudi Arabia, Riyadh - Saudi Arabia, Riyadh - Saudi Arabia, Belgrade - Serbia, Novi Sad - Serbia, Gävle - Sweden, Karlstad - Sweden, Uppsala - Sweden, Lugano - Switzerland, St. Gallen - Switzerland, Aleppo - Syrian Arab Republic, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Adana - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Hatay - Turkey, ISTANBULt - Turkey, Istanbul - Turkey, Izmir - Turkey, Kayseri - Turkey, Mersin - Turkey, Tokat - Turkey, Trabzon - Turkey, Al Ain - United Arab Emirates, Dubai - United Arab Emirates, Sharjah - United Arab Emirates, Dundee - United Kingdom, Hull - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom",2015-07,2011-10-06,2017-03-30,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02556372,Unknown,COMPLETED,2016-04-30,Autoimmune Hepatitis,JKB-122,"Los Angeles - United States, Sacramento - United States, San Francisco - United States, Gainesville - United States, Chicago - United States, Indianapolis - United States, New Orleans - United States, Boston - United States, New York - United States, Durham - United States, Dallas - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Seattle - United States, Seattle - United States",2019-01-21,2015-09-22,2020-07-21,INTERVENTIONAL,PHASE2,"TaiwanJ Pharmaceuticals Co., Ltd",INDUSTRY,hepatitis
NCT04094272,Unknown,COMPLETED,2017-07-01,"Pulmonary Artery Hypertension, Chronic Hepatitis c",transthoracic doppler-echocardiography (TTE),Olten - Switzerland,2019-05-01,2019-09-18,2019-09-23,OBSERVATIONAL,Not Available,Kantonsspital Olten,OTHER,hepatitis
NCT03415672,Unknown,COMPLETED,2017-10-11,Hepatitis B,"HBVaxPro, HBAI20","Antwerp - Belgium, Genk - Belgium, Maastricht - Netherlands",2019-01-09,2018-01-30,2019-01-31,INTERVENTIONAL,PHASE2,Maastricht University Medical Center,OTHER,hepatitis
NCT04037046,Unknown,COMPLETED,2019-03-01,Hepatitis C Virus Infection,"Screening HCV attached onto CCR screening, Screening HCV attached onto CCR screening by self-testing, Screening HCV at primary care center",La Laguna - Spain,2019-11-01,2019-07-30,2021-04-30,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT01326546,Unknown,COMPLETED,2010-06,Chronic Hepatitis B,"Therapeutic HBV vaccine, entecavir, placebo","Hefei - China, Beijing - China, Shenzhen - China, WuHan - China, Changsha - China, ChangSha - China, NanJing - China, NanJing - China, Nanjing - China, XiAn - China, Kunming - China, Hangzhou - China, WenZhou - China, Beijing - China, ChongQing - China",2014-01,2011-03-31,2019-06-26,INTERVENTIONAL,PHASE2,Chongqing Jiachen Biotechnology Ltd.,INDUSTRY,hepatitis
NCT02557646,Unknown,COMPLETED,2009-05,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Ajka - Hungary, Balassagyarmat - Hungary, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Debrecen - Hungary, Gyor - Hungary, Gyula - Hungary, Kaposvar - Hungary, Kecskemet - Hungary, Miskolc - Hungary, Miskolc - Hungary, Nyíregyháza - Hungary, Pecs - Hungary, Pecs - Hungary, Sopron - Hungary, Szeged - Hungary, Szekszard - Hungary, Szolnok - Hungary, Szombathely - Hungary, Székesfehérvár - Hungary, Tatabánya - Hungary, Zalaegerszeg - Hungary",2014-03,2015-09-23,2016-03-28,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01500772,Unknown,TERMINATED,2012-03,Hepatitis C,"Alisporivir, Peginterferon alfa-2a, Ribavirin","Phoenix - United States, Bakersfield - United States, Los Angeles - United States, Palo Alto - United States, Sacramento - United States, San Diego - United States, San Diego - United States, Ventura - United States, Bradenton - United States, Bradenton - United States, Miami - United States, Wellington - United States, Chicago - United States, Baltimore - United States, Brockton - United States, Minneapolis - United States, St. Louis - United States, New York - United States, New York - United States, New York - United States, Cincinnati - United States, Providence - United States, Arlington - United States, Dallas - United States, Alexandria - United States, Newport News - United States, Vancouver - Canada, Vancouver - Canada, Clichy - France, Creteil - France, Paris - France, Berlin - Germany, Berlin - Germany, Berlin - Germany, Duesseldorf - Germany, Düsseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Frieburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Kiel - Germany, Koln - Germany, Köln - Germany, Mainz - Germany, Mainz - Germany, Firenze - Italy, Milano - Italy, Modena - Italy, Palermo - Italy, Padova - Italy, Roma - Italy, Torino - Italy, Bologna - Italy, San Juan - Puerto Rico, Majadanonda - Spain, Barcelona - Spain, London - United Kingdom, London - United Kingdom",2012-05,2011-12-28,2016-08-01,INTERVENTIONAL,PHASE3,Debiopharm International SA,INDUSTRY,hepatitis
NCT00475072,Unknown,COMPLETED,2003-06,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin",Mexico City - Mexico,2006-07,2007-05-17,2016-11-01,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04959643,dHEPass,UNKNOWN,2021-10-05,"Hepatitis C, Hepatitis B, Addiction",No interventions listed,Montpellier - France,2023-07,2021-07-13,2022-01-10,OBSERVATIONAL,Not Available,"University Hospital, Montpellier",OTHER,hepatitis
NCT01341743,Unknown,UNKNOWN,2010-12,Hepatitis B,"Entecavir, Entecavir, Adefovir, Entecavir, Adefovir","Beijing - China, Beijing - China, BeiJing - China, Beijing - China, FuZhou - China, FoShan - China, GuangZhou - China, GuangZhou - China, NanNing - China, Wuhan - China, ChangSha - China, ChangChun - China, ShenYang - China, ShangHai - China, ShangHai - China, ShangHai - China",2014-06,2011-04-26,2013-10-30,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT02315638,Unknown,TERMINATED,2014-11,Hepatitis C,No interventions listed,Durham - United States,2018-09-24,2014-12-12,2018-09-26,OBSERVATIONAL,Not Available,"Tacere Therapeutics, Inc.",INDUSTRY,hepatitis
NCT00778843,Unknown,COMPLETED,2008-10,Chronic Hepatitis C,"Viusid, Placebo",Vedado - Cuba,2009-05,2008-10-23,2012-05-04,INTERVENTIONAL,PHASE3,Catalysis SL,INDUSTRY,hepatitis
NCT01366638,Unknown,COMPLETED,2011-05,"Hepatitis C, Chronic","TMC435, Peginterferon alfa-2b (pegIFN alfa-2b), Ribavirin (RBV)","Amagasaki - Japan, Ikeda - Japan, Kawasaki - Japan, Kumamoto - Japan, Niigata - Japan, Ohmura - Japan, Osaka - Japan, Sakai - Japan, Sapporo - Japan, Suita - Japan, Tokyo - Japan",2012-11,2011-06-06,2014-05-05,INTERVENTIONAL,PHASE3,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT00006643,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C",No interventions listed,"Stanford - United States, Miami - United States, Honolulu - United States, New York - United States, Rochester - United States, Rochester - United States, Chapel Hill - United States, Cincinnati - United States, Philadelphia - United States, Dallas - United States, Seattle - United States",Unknown Date,2001-08-31,2008-07-30,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT04177043,Unknown,COMPLETED,2015-06,"Hepatitis C, Chronic","HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests, DAAs",No locations listed,2018-06,2019-11-26,2019-11-26,INTERVENTIONAL,PHASE4,Egyptian Liver Hospital,OTHER,hepatitis
NCT00758043,Unknown,COMPLETED,2008-10,Hepatitis C,"telaprevir, ribavirin, peginterferon alfa-2a","Birmingham - United States, Birmingham - United States, Phoenix - United States, Fresno - United States, La Jolla - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, Farmington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Sarasota - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Downers Grove - United States, Indianapolis - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Hyattsville - United States, Laurel - United States, Boston - United States, Boston - United States, Boston - United States, Worcester - United States, Detroit - United States, Novi - United States, Rochester - United States, Kansas City - United States, Saint Louis - United States, Saint Louis - United States, Lebanon - United States, Atlantic City - United States, Egg Harbor Township - United States, Albuquerque - United States, Bayside - United States, Bronx - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, Chapel Hill - United States, Durham - United States, Statesville - United States, Cincinnati - United States, Cincinnati - United States, Cleveland - United States, Portland - United States, Philadelphia - United States, Providence - United States, Columbia - United States, Germantown - United States, Dallas - United States, Dallas - United States, San Antonio - United States, Salt Lake City - United States, Falls Church - United States, Seattle - United States, Tacoma - United States, Madison - United States, Milwaukee - United States, Brussels - Belgium, Brussels - Belgium, Gent - Belgium, Liège 1 - Belgium, Amsterdam - Netherlands, Amsterdam - Netherlands, Arnhem - Netherlands, Santurce - Puerto Rico",2010-06,2008-09-23,2021-03-26,INTERVENTIONAL,PHASE3,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02991638,Unknown,UNKNOWN,2016-11-01,"Chronic Lymphocytic Leukemia, Indolent B-cell Lymphomas, Chronic Hepatitis B, Lymphoma, Small Lymphocytic, Mantle-Cell Lymphoma, Waldenstrom's Macroglobulinaemia, Follicular Lymphoma",Ibrutinib,Hong Kong - Hong Kong,2020-12,2016-12-13,2018-04-12,INTERVENTIONAL,PHASE3,The University of Hong Kong,OTHER,hepatitis
NCT00749138,Unknown,COMPLETED,2008-11,Chronic Hepatitis C,tamoxifen,Oklahoma City - United States,2009-05,2008-09-09,2010-03-09,INTERVENTIONAL,PHASE1,"Bader, Ted, M.D.",INDIV,hepatitis
NCT00841243,Unknown,UNKNOWN,2009-03,"Hepatitis C, Weight Loss",Nutrison (Nutricia),Utrecht - Netherlands,2010-03,2009-02-11,2009-02-11,INTERVENTIONAL,PHASE4,UMC Utrecht,OTHER,hepatitis
NCT01659567,Unknown,COMPLETED,2011-04-06,"Hepatitis C, Chronic","Pegylated Interferon Alfa-2a, Ribavirin","Tbilisi - Georgia, Tbilisi - Georgia, Tbilisi - Georgia",2015-10-20,2012-08-08,2017-10-03,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05355467,Unknown,COMPLETED,2019-08-21,Chronic Hepatitis B Infection,"Tenofovir disoproxil fumarate, Historical Data",Taichung - Taiwan,2021-07-13,2022-05-02,2022-05-02,INTERVENTIONAL,PHASE4,Mylan (Taiwan) Ltd,INDUSTRY,hepatitis
NCT00629967,Unknown,COMPLETED,2005-04,"Chronic Hepatitis C, Genotype","pegylated interferon alpha 2a and ribavirin, Pegylated interferon alfa-2a and ribavirin",Kaohsiung - Taiwan,2007-05,2008-03-06,2008-03-06,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT04111367,Unknown,UNKNOWN,2019-04-03,Hepatitis C Virus Infection,"Seraprevir, Sofosbuvir","Beijing - China, Liuzhou - China, Changchun - China, Guangxi - China",2020-04-30,2019-10-01,2019-10-01,INTERVENTIONAL,PHASE2,"Ginkgopharma CO., LTD",INDUSTRY,hepatitis
NCT01567540,Unknown,TERMINATED,2013-03,Hepatitis C,Sitagliptin,"Argenteuil - France, Créteil - France, Créteil - France, Paris - France",2014-01,2012-03-30,2014-01-20,INTERVENTIONAL,PHASE1,"Institut National de la Santé Et de la Recherche Médicale, France",OTHER_GOV,hepatitis
NCT01412567,Unknown,COMPLETED,2005-10,Chronic Hepatitis B,"Vaccine+HBIG, Vaccine+Placebo",New Delhi - India,2010-06,2011-08-09,2011-08-09,INTERVENTIONAL,NA,Govind Ballabh Pant Hospital,OTHER_GOV,hepatitis
NCT01648140,HAI115879,COMPLETED,2012-08-01,"Hepatitis C, Chronic","GSK2336805 40 mg, GSK2336805 60 mg, Pegylated interferon alpha-2a, Ribavirin, Telaprevir","Dothan - United States, Anaheim - United States, Los Angeles - United States, DeLand - United States, Orlando - United States, Columbus - United States, Savannah - United States, Baltimore - United States, Brockton - United States, Springfield - United States, Las Vegas - United States, New York - United States, Asheville - United States, Fayetteville - United States, Jenkintown - United States, Houston - United States, Annandale - United States, Norfolk - United States, Brussels - Belgium, Liege - Belgium, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Lyon Cedex 04 - France, Paris Cedex 13 - France, Pessac Cedex - France, Freiburg - Germany, Heidelberg - Germany, Wuerzburg - Germany, Berlin - Germany, Hamburg - Germany, Ponce - Puerto Rico, San Juan - Puerto Rico",2014-07-01,2012-07-24,2017-06-02,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00059267,Unknown,COMPLETED,2001-03,"Hepatitis B, Cirrhosis, Acute Liver Failure, Hepatocellular Carcinoma","HBIG, Epivir, Hepsera",Ann Arbor - United States,2007-11,2003-04-23,2024-11-15,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03210467,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,No interventions listed,Beijing - China,2017-12,2017-07-07,2017-07-07,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT06457438,Unknown,RECRUITING,2022-01-01,Hepatitis E,"Elecsys Anti-HEV IgG, IgM",Ostrava - Czechia,2024-12,2024-06-13,2024-06-13,INTERVENTIONAL,NA,University Hospital Ostrava,OTHER,hepatitis
NCT01005238,SASL28,TERMINATED,2009-09,"Hepatitis, Chronic","Lamivudine, Telbivudine",Basel - Switzerland,2014-12,2009-10-30,2015-03-10,INTERVENTIONAL,PHASE4,"University Hospital, Basel, Switzerland",OTHER,hepatitis
NCT02805738,Unknown,UNKNOWN,2016-04,Chronic Hepatitis B,"CKD-390, viread","Ansan - Korea, Republic of, Bundang - Korea, Republic of, Guri - Korea, Republic of, Ilsan - Korea, Republic of, Incheon - Korea, Republic of, Suwon - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Jeju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2017-11,2016-06-20,2016-06-21,INTERVENTIONAL,PHASE3,Chong Kun Dang Pharmaceutical,INDUSTRY,hepatitis
NCT05897138,Unknown,NOT_YET_RECRUITING,2023-08-01,Hepatocellular Carcinoma,Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle,No locations listed,2025-06-01,2023-06-09,2023-06-13,INTERVENTIONAL,PHASE2,Fujian Cancer Hospital,OTHER_GOV,hepatitis
NCT06743438,Unknown,ACTIVE_NOT_RECRUITING,2022-03-10,"Hepatitis B, Chronic",Tenofovir Amibufenamide（TMF）,Guangzhou - China,2024-06-30,2024-12-19,2024-12-19,INTERVENTIONAL,PHASE4,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01257204,Unknown,COMPLETED,2010-12,Hepatitis C Virus,"Placebo, Daclatasvir, Pegylated interferon alfa-2a, Ribavirin","Los Angeles - United States, Baltimore - United States, Tulsa - United States, San Antonio - United States, Darlinghurst - Australia, Westmead Nsw - Australia, Adelaide - Australia, Clayton Vic - Australia, Fremantle - Australia, Camperdown - Australia, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Toronto - Canada, Hvidovre - Denmark, Creteil - France, Lille Cedex - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 14 - France, Pessac - France, Brescia - Italy, Cisanello (pisa) - Italy, Viale Del Policlinico, 155 - Italy",2012-05,2010-12-09,2015-12-14,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00410072,Unknown,COMPLETED,2007-04,"Hepatitis B, Chronic","Entecavir, Entecavir + Tenofovir","Los Angeles - United States, San Diego - United States, San Jose - United States, New Haven - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Baltimore - United States, Laurel - United States, Boston - United States, Ann Arbor - United States, Flushing - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Ciudad De Buenos Aires - Argentina, Rosario - Argentina, Westmead Nsw - Australia, Clayton Vic - Australia, Fitzroy - Australia, Heidelberg - Australia, Prahan - Australia, Belo Horizonte - Brazil, Porto Alegre Rs - Brazil, Calgary - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Grenoble Cedex 09 - France, Marseille Cedex 08 - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Paris - France, Strasbourg - France, Hyderabad - India, Lucknow - India, Ludhiana - India, Vellore - India, Antella Firenze - Italy, Brescia - Italy, Pisa - Italy, Roma - Italy, Durango - Mexico, Bialystok - Poland, Chorzow - Poland, Krakow - Poland, Lublin - Poland, Warszawa - Poland, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, Pretoria - South Africa, Bellville - South Africa, N1 City Goodwood - South Africa, Bornova Izmir - Turkey, Cebeci Ankara - Turkey, Sihhiye Ankara - Turkey, Trabzon - Turkey",2010-10,2006-12-12,2013-03-15,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02992704,INACTIVE,UNKNOWN,2016-08,"Chronic Hepatitis, B Virus, Carrier of Viral Hepatitis Type B",Peginterferon Alfa-2A,Singapore - Singapore,2019-08,2016-12-14,2019-03-19,INTERVENTIONAL,PHASE3,Seng Gee Lim,OTHER,hepatitis
NCT03444272,Unknown,UNKNOWN,2018-01-01,Hepatitis C,Sofosbuvir and Daklatasuvir,Tanta - Egypt,2022-12,2018-02-23,2020-10-22,INTERVENTIONAL,PHASE3,Sherief Abd-Elsalam,OTHER,hepatitis
NCT02631772,Unknown,COMPLETED,2016-06-01,Hepatitis C,"Sofosbuvir/Ledipasvir x 12 weeks, Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks","Washington - United States, Cleveland - United States, Pittsburgh - United States, Charleston - United States",2018-05-30,2015-12-16,2019-05-07,INTERVENTIONAL,PHASE4,Medical University of South Carolina,OTHER,hepatitis
NCT03643172,Unknown,UNKNOWN,2018-09-01,"Chronic Hepatitis B, HBeAg Negative",No interventions listed,Hannover - Germany,2020-07,2018-08-22,2019-02-25,OBSERVATIONAL,Not Available,Hannover Medical School,OTHER,hepatitis
NCT02569372,Unknown,COMPLETED,2015-11-09,Chronic Hepatitis B,GC1102,"Seoul - Korea, Republic of",2017-10-12,2015-10-06,2017-10-16,INTERVENTIONAL,PHASE1,Green Cross Corporation,INDUSTRY,hepatitis
NCT00530972,PILOT-NR,COMPLETED,2006-03,"Chronic Hepatitis C, HIV Infections",Peginterferon alfa-2a plus ribavirin adjusted to body weight,Madrid. - Spain,2008-12,2007-09-18,2009-09-07,INTERVENTIONAL,PHASE4,"Hospital Carlos III, Madrid",OTHER,hepatitis
NCT01188772,Unknown,COMPLETED,2010-08,Hepatitis C Virus,"Sofosbuvir, Placebo to match sofosbuvir, PEG, RBV","Montgomery - United States, Anaheim - United States, Coronado - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Gainesville - United States, Orlando - United States, Marietta - United States, Chicago - United States, Lutherville - United States, Boston - United States, Kansas City - United States, St. Louis - United States, Manhasset - United States, New York - United States, New York - United States, Chapel Hill - United States, Philadelphia - United States, Columbia - United States, San Antonio - United States, Seattle - United States, Santurce - Puerto Rico",2011-04,2010-08-25,2014-04-21,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02686372,Unknown,COMPLETED,2018-05-16,Hepatocellular Carcinoma,"TCR-T, No intervention and TCR-T (at crossover)",Guangzhou - China,2021-09-28,2016-02-19,2022-06-30,INTERVENTIONAL,PHASE1,Lion TCR Pte. Ltd.,INDUSTRY,hepatitis
NCT03827772,Unknown,UNKNOWN,2019-01,Severe Alcoholic Hepatitis,"Fecal Microbiota Transplantation, Standard of care treatment",Chandigarh - India,2019-12,2019-02-01,2019-02-01,INTERVENTIONAL,NA,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT00213772,Unknown,COMPLETED,1999-05,Porphyria Cutanea Tarda,No interventions listed,No locations listed,Unknown Date,2005-09-21,2005-09-21,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,hepatitis
NCT05106972,Unknown,RECRUITING,2021-12-01,Liver Cirrhosis,UC-MSC infusion,Haikou - China,2024-12-31,2021-11-04,2021-11-04,INTERVENTIONAL,NA,"Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT00408304,Unknown,UNKNOWN,2006-12,Chronic Hepatitis C,omega-3 fatty acid,Haifa - Israel,Unknown Date,2006-12-06,2006-12-06,INTERVENTIONAL,PHASE2,Bnai Zion Medical Center,OTHER_GOV,hepatitis
NCT00005304,Unknown,COMPLETED,1986-09,"Blood Disease, Hepatitis, Viral, Human, Hemophilia A, Liver Diseases",No interventions listed,No locations listed,Unknown Date,2000-05-26,2020-04-07,OBSERVATIONAL,Not Available,Baylor College of Medicine,OTHER,hepatitis
NCT04251572,REINF_HCV,UNKNOWN,2019-07-01,"Hepatitis C Virus Infection, Response to Therapy of, Drug Use","Blood sampling, questionaires","Antwerp - Belgium, Antwerp - Belgium, Bruxelles - Belgium, Genk - Belgium, Gent - Belgium, Hasselt - Belgium, Hasselt - Belgium, Liège - Belgium, Sint-Truiden - Belgium, Tongeren - Belgium",2022-02-28,2020-02-05,2021-08-26,INTERVENTIONAL,NA,Hasselt University,OTHER,hepatitis
NCT04038372,Unknown,COMPLETED,2015-11,"HDV Infection, HBV Infection",No interventions listed,No locations listed,2017-10,2019-07-30,2019-07-30,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01426204,OBSERVER,UNKNOWN,2011-09,Hepatitis C,No interventions listed,No locations listed,2012-06,2011-08-31,2011-08-31,OBSERVATIONAL,Not Available,Closter Pharma,INDUSTRY,hepatitis
NCT04103840,Unknown,UNKNOWN,2019-08-27,"Severe Alcoholic Hepatitis, Chronic Liver Disease and Cirrhosis",Testing stool mycobiota,Chandigarh - India,2022-10-01,2019-09-26,2020-04-01,OBSERVATIONAL,Not Available,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT01163240,EPIC B,COMPLETED,2009-06,"Liver Diseases, Hepatitis, Chronic, Hepatitis, Viral, Human, Hepatitis, Virus Diseases, Digestive System Diseases, Hepatitis B, Chronic, Hepatitis B, DNA Virus Infections",No interventions listed,"Aurora - United States, Gainesville - United States, Boston - United States, Billings - United States, Philadelphia - United States, Buenos Aires - Argentina, Alegre - Brazil, Belém - Brazil, Recife - Brazil, São Paulo - Brazil, São Paulo - Brazil, Beijing - China, Chongqing - China, Chongqing - China, Hebei - China, Henan - China, Hong Kong - China, Hong Kong - China, Hunan - China, Hunan - China, Jiangsu - China, Jilin - China, Kunming - China, Lanzhou - China, Suzhou - China, Wuhan - China, Xi'an - China, Yunnan - China, Aquitaine - France, Lille - France, Paris - France, Strasbourg - France, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Crete - Greece, Goudi - Greece, Bhopal - India, Indore - India, Karna - India, Kolkata - India, Mumbai - India, New Delhi - India, Bologna - Italy, Genova - Italy, Napoli - Italy, Pisa - Italy, Roma - Italy, Lima - Peru, Lima - Peru, Lima - Peru, Ermita - Philippines, Muntinlupa City - Philippines, Quezon City - Philippines, Quezon City - Philippines, Bydgoszcz - Poland, Krakow - Poland, Lodz - Poland, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation, Singapore - Singapore, Singapore - Singapore, Andalucía - Spain, Cataluña - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Valencia - Spain, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Birmingham - United Kingdom, Leeds - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2011-09,2010-07-15,2011-09-27,OBSERVATIONAL,Not Available,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01627340,Unknown,COMPLETED,2012-07-24,Hepatitis B,Engerix™-B vaccine,"Huntsville - United States, Stockbridge - United States, Boise - United States, Mishawaka - United States, Wichita - United States, Endwell - United States, Cleveland - United States, Nashville - United States, Salt Lake City - United States, Wenatchee - United States, Herston - Australia, Box Hill - Australia, St Albans - Australia, Truro - Canada, Kitchener - Canada, Sudbury - Canada, Quebec City - Canada, Ste-Foy - Canada, Hamilton - New Zealand, Rotorua - New Zealand, Takapuna Auckland - New Zealand, Wellington - New Zealand",2013-12-18,2012-06-25,2018-07-31,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03572140,RAVs,UNKNOWN,2018-07-01,HCV,RAVS In relapsed and resistent cases,No locations listed,2020-07-01,2018-06-28,2018-06-29,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT06653140,Unknown,NOT_YET_RECRUITING,2024-12,Hepatitis of Unknown Aetiology,No interventions listed,Beijing - China,2026-06,2024-10-22,2024-10-28,OBSERVATIONAL,Not Available,Minghui Li,OTHER_GOV,hepatitis
NCT03456440,Unknown,UNKNOWN,2019-04,Hepatitis C,MRI,No locations listed,2020-03,2018-03-07,2018-03-07,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00446940,Unknown,COMPLETED,2006-12,Hepatitis C,"rosuvastatin, atorvastatin",OKlahoma City - United States,Unknown Date,2007-03-13,2008-09-09,INTERVENTIONAL,PHASE2,"Bader, Ted, M.D.",INDIV,hepatitis
NCT00527540,Unknown,COMPLETED,2007-02,Hepatitis C,Pegylated Interferon alpha 2a + Ribavirin,"Tehran - Iran, Islamic Republic of",2008-06,2007-09-11,2009-01-21,INTERVENTIONAL,PHASE3,Tehran Hepatitis Center,OTHER,hepatitis
NCT06068140,Unknown,WITHDRAWN,2023-12,Chronic Viral Hepatitis B With Delta-Agent,No interventions listed,"Esik - Kazakhstan, Kaskelen - Kazakhstan, Taldykorgan - Kazakhstan, Aktobe - Kazakhstan, Almaty - Kazakhstan, Astana - Kazakhstan, Turkestan - Kazakhstan",2025-06,2023-10-05,2024-07-11,OBSERVATIONAL,Not Available,Kazakh Association of Internal Medicine Specialists,OTHER,hepatitis
NCT04846491,Unknown,COMPLETED,2019-12-04,Chronic Hepatitis B,"Peginterferon alfa-2b injection, Peginterferon alfa-2b injection, TDF, Peginterferon alfa-2b injection","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Changsha - China, Chengdu - China, Chengdu - China, Fuzhou - China, Fuzhou - China, Fuzhou - China, Guangzhou - China, Guangzhou - China, Harbin - China, Hefei - China, Nanjing - China, Shanghai - China, Shanghai - China, Shenyang - China, Shenzhen - China, Shenzhen - China, Taiyuan - China, Tianjin - China, Tianjin - China, Urumqi - China, Urumqi - China, Wuhan - China, Xi'an - China, Xi'an - China, Xiamen - China, Xiamen - China, Yanbian - China, Zhengzhou - China",2023-11-30,2021-04-15,2024-03-05,INTERVENTIONAL,PHASE3,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT03909191,Unknown,COMPLETED,2016-02-01,"Chronic HBV Infection, Drug Withdrawal",serum HBV RNA,No locations listed,2020-05-01,2019-04-09,2021-02-02,OBSERVATIONAL,Not Available,Changhai Hospital,OTHER,hepatitis
NCT06159062,Unknown,TERMINATED,2024-06-03,Chronic Hepatitis B Virus Infection,"162, Placebo",Melbourne - Australia,2024-07-09,2023-12-06,2024-07-16,INTERVENTIONAL,PHASE1,"Yangshengtang Co., Ltd",INDUSTRY,hepatitis
NCT02565862,DATE-3,COMPLETED,2016-01,"Hepatitis C, Diabetes Mellitus, Insulin Resistance","Daclatasvir, Metformin",Nijmegen - Netherlands,2016-03,2015-10-01,2020-12-07,INTERVENTIONAL,PHASE1,Radboud University Medical Center,OTHER,hepatitis
NCT02150291,Unknown,UNKNOWN,2014-05,Hepatitis C,"Folic acid, Neurobion, placebo",Cairo - Egypt,2015-05,2014-05-29,2014-05-29,INTERVENTIONAL,PHASE4,British University In Egypt,OTHER,hepatitis
NCT02148562,Unknown,UNKNOWN,2014-04,"Hepatitis B, Hepatitis B, Chronic, End Stage Liver Disease, Carcinoma, Hepatocellular",No interventions listed,Leuven - Belgium,2017-12,2014-05-28,2014-05-28,OBSERVATIONAL,Not Available,Universitaire Ziekenhuizen KU Leuven,OTHER,hepatitis
NCT02628691,HCV-Monitoring,TERMINATED,2015-12-17,"Hepatitis C, HIV",Liver fibrosis progression,Phnom Penh - Cambodia,2017-07-12,2015-12-11,2017-08-23,OBSERVATIONAL,Not Available,"Institute of Tropical Medicine, Belgium",OTHER,hepatitis
NCT00383591,Unknown,COMPLETED,2002-03,Hepatitis B,"Hepatitis B adjuvanted vaccine, Engerix-B","Hradec Kralove - Czech Republic, Bandar Tun Razak, Cheras - Malaysia, Barcelona - Spain, Madrid - Spain, Malaga - Spain",Unknown Date,2006-10-03,2017-03-23,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02793791,Unknown,UNKNOWN,2016-09,"Dysplastic Nodule of Liver, Chronic Hepatitis B",minimally invasive ablation therapies,No locations listed,2019-12,2016-06-08,2016-06-08,INTERVENTIONAL,NA,Shandong Cancer Hospital and Institute,OTHER,hepatitis
NCT04356404,Unknown,TERMINATED,2020-05-01,"Occult Hepatitis B, Biological Substance; Adverse Effect, Immunosuppression",No interventions listed,Hong Kong - Hong Kong,2022-01-12,2020-04-22,2022-01-28,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT00701272,Unknown,UNKNOWN,2008-06,"Liver Transplantation, Hepatitis C",No interventions listed,Toronto - Canada,2014-12,2008-06-19,2013-07-25,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT01707472,Unknown,COMPLETED,2012-10-04,"Liver Fibrosis, Hepatitis C, HIV, HIV/HCV Co-infection",Simtuzumab,Bethesda - United States,2014-10-17,2012-10-16,2019-11-05,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00399672,Unknown,COMPLETED,2007-06,Hepatitis C Virus Infection,"Interferon injections and ribavirin, Interferon injections and ribavirin",Vancouver - Canada,2010-08,2006-11-15,2016-11-30,INTERVENTIONAL,NA,University of British Columbia,OTHER,hepatitis
NCT01492504,Unknown,COMPLETED,2012-02-07,Hepatitis C,Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052),"Montgomery - United States, Beverly Hills - United States, Coronado - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, New Haven - United States, Miami - United States, Miami - United States, Orlando - United States, Orlando - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Baltimore - United States, Catonsville - United States, Lutherville - United States, Springfield - United States, Ann Arbor - United States, Saint Louis - United States, Santa Fe - United States, Great Neck - United States, Chapel Hill - United States, Charlotte - United States, Statesville - United States, Tulsa - United States, Tulsa - United States, Portland - United States, Allentown - United States, Philadelphia - United States, Germantown - United States, Nashville - United States, Arlington - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Annandale - United States, Falls Church - United States, Richmond - United States, Richmond - United States, Seattle - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Mar Del Plata - Argentina, Prov. Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Camperdown - Australia, Darlinghurst Nsw - Australia, Darlinghurst - Australia, Randwick - Australia, Westmead - Australia, Woollongabba - Australia, Adelaide - Australia, Clayton Vic - Australia, Melbourne - Australia, Porto Alegre - Brazil, Rio De Janeiro - Brazil, Rio De Janeiro - Brazil, Sao Paulo - Brazil, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Toronto - Canada, Regina - Canada, Hvidovre - Denmark, Odense - Denmark, Clichy Cedex - France, Creteil Cedex - France, La Roche-sur-yon Cedex 9 - France, Lille - France, Limoges - France, Lyon Cedex 04 - France, Marseille Cedex 08 - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Paris Cedex 14 - France, PESSAC Cedex - France, Toulouse Cedex 09 - France, Vandoeuvre Les Nancy - France, Dusseldorf - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Mainz - Germany, Dublin 3 - Ireland, Dublin 8 - Ireland, Brescia - Italy, Cisanello (pisa) - Italy, Milano - Italy, Pavia - Italy, Torino - Italy, Viale Del Policlinico, 155 - Italy, Nagoya-shi - Japan, Chiba-shi - Japan, Fukuoka-shi - Japan, Kurume - Japan, Ogaki-shi - Japan, Hiroshima-shi - Japan, Sapporo-shi - Japan, Amagasaki-shi - Japan, Kanazawa-shi - Japan, Takamatsu-shi - Japan, Kagoshima-shi - Japan, Kawasaki-shi - Japan, Sendai-shi - Japan, Okayama-shi - Japan, Osaka-sayama-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Suita - Japan, Iruma-gun - Japan, Bunkyo-ku - Japan, Minato-ku - Japan, Musashino-shi - Japan, Shinagawa-ku - Japan, Chuo-shi - Japan, Yangsan-si - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Guadalajara - Mexico, Cuernavaca - Mexico, Monterrey - Mexico, Bialystok - Poland, San Juan - Puerto Rico, Alicante - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Malaga - Spain, Santiago De Compostela - Spain, Sevilla - Spain, Valencia - Spain, Gothenburg - Sweden, Stockholm - Sweden, Taichung - Taiwan, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Glasgow - United Kingdom",2018-03-16,2011-12-15,2019-11-27,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01866072,ACLF,UNKNOWN,2013-05,"Acute Severe Viral Hepatitis, Acute on Chronic Liver Failure",No interventions listed,New Delhi - India,2013-11,2013-05-31,2013-06-04,OBSERVATIONAL,Not Available,Sir Ganga Ram Hospital,OTHER,hepatitis
NCT00856804,TRITAL,UNKNOWN,2009-03,Hepatitis C,thalidomide,Sevilla - Spain,2009-06,2009-03-06,2009-03-06,INTERVENTIONAL,PHASE2,Valme University Hospital,OTHER,hepatitis
NCT00703872,Unknown,UNKNOWN,2008-05,Chronic Hepatitis C,"Oral HDV-Interferon + ribavarin, Injectable HDV-Interferon + ribavarin",Lakdi-ka-Pool - India,2009-12,2008-06-24,2009-01-09,INTERVENTIONAL,PHASE2,Hepasome Pharmaceuticals,INDUSTRY,hepatitis
NCT03183492,Unknown,WITHDRAWN,2018-05-07,Hepatitis A,Havrix®,No locations listed,2019-01-28,2017-06-12,2018-03-02,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01277692,Unknown,COMPLETED,2010-11-03,Hepatitis C,"GSK2336805 10mg, GSK2336805 30mg, GSK2236805 100mg, GSK2236805 200mg, GSK2236805 10mg, GSK2236805 dose to be determined up to 100mg, GSK2236805 5mg, GSK2236805 30mg, GSK2236805 100mg","Chula Vista - United States, Lenexa - United States, Willingboro - United States",2011-05-09,2011-01-17,2017-06-28,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01480492,Unknown,COMPLETED,2010-01,HBeAg Positive Chronic Hepatitis B Infection,Telbivudine,Shanghai - China,2011-10,2011-11-29,2011-11-29,INTERVENTIONAL,NA,Cz Li,OTHER,hepatitis
NCT02239562,Unknown,COMPLETED,2014-11-14,Autoimmune Hepatitis,"sPIF, Placebo","Miami - United States, Cherry Hill - United States",2016-04-25,2014-09-12,2019-11-20,INTERVENTIONAL,PHASE1,"Christopher O'Brien, MD",OTHER,hepatitis
NCT01204762,LIRA-B,COMPLETED,2010-11,Hepatitis B Virus,"pegIFN, pegIFNα-2a, PegIFN lambda, Entecavir","Anaheim - United States, Garden Grove - United States, Sacramento - United States, San Diego - United States, New Haven - United States, Atlanta - United States, Baltimore - United States, Colombia - United States, Flushing - United States, Flushing - United States, Durham - United States, Portland - United States, Pittsburgh - United States, Camperdown - Australia, Liverpool - Australia, Westmead Nsw - Australia, Clayton Vic - Australia, Heidelberg Vic - Australia, Melbourne - Australia, Fremantle - Australia, Calgary - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Clichy Cedex - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Rennes Cedex 9 - France, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Tuebingen - Germany, Hong Kong - Hong Kong, Shatin - Hong Kong, Tai Po - Hong Kong, Firenze - Italy, Roma - Italy, Chuncheon - Korea, Republic of, Gyeonggi-Do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Rotterdam - Netherlands, Singapore - Singapore, Singapore - Singapore, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2013-12,2010-09-17,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01849562,Unknown,COMPLETED,2013-04,"Hepatitis C, Chronic","Sovaprevir, ACH-3102, Ribavirin, Placebo",No locations listed,2013-11,2013-05-08,2023-08-29,INTERVENTIONAL,PHASE2,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02039362,Unknown,COMPLETED,2012-07,"Pregnancy, HBV",Tenofovir DF,Paris - France,2016-01,2014-01-17,2017-04-28,INTERVENTIONAL,PHASE4,Hopital Lariboisière,OTHER,hepatitis
NCT00338780,Unknown,COMPLETED,2000-11,Chronic Hepatitis B,Lamivudine/ Placebo 100mg daily,Hong Kong SAR - China,Unknown Date,2006-06-20,2006-10-29,INTERVENTIONAL,PHASE4,Chinese University of Hong Kong,OTHER,hepatitis
NCT05753280,Unknown,COMPLETED,2018-12-01,Chronic Hepatitis b,Vitamin D,Guangzhou - China,2022-06-30,2023-03-03,2023-03-03,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02881762,MAVERIC,COMPLETED,2017-06-01,"Hepatitis C, Human Immunodeficiency Virus",Maraviroc,Baltimore - United States,2019-03-27,2016-08-29,2024-05-01,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,hepatitis
NCT00262210,Unknown,COMPLETED,1995-06,Non-Hodgkin's Lymphoma,Cyclophosphamide Epirubicin Etoposide Prednisolone,Taipei - Taiwan,Unknown Date,2005-12-06,2005-12-06,INTERVENTIONAL,PHASE2,"National Health Research Institutes, Taiwan",OTHER,hepatitis
NCT00792610,Unknown,COMPLETED,2007-08,Hepatitis B,hepatitis B vaccine,Taipei - Taiwan,2009-01,2008-11-18,2009-10-06,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT02621112,Unknown,COMPLETED,2016-01,Renal Failure,"Intradermal HBVv with imiquimod, Intradermal HBVv with aqueous cream, Intramuscular HBVv with aqueous cream",Hong Kong - Hong Kong,2018-12,2015-12-03,2019-10-22,INTERVENTIONAL,PHASE3,The University of Hong Kong,OTHER,hepatitis
NCT00441012,Unknown,COMPLETED,2006-12,"Haemophilus Influenzae Type B, Hepatitis B","Comparator: Modified Process Vaccine, Comparator: COMVAX™",No locations listed,2008-06,2007-02-27,2015-03-19,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03540212,Unknown,UNKNOWN,2017-12-10,Chronic HCV Infection,Daclatasvir and sofosbuvir,Cairo - Egypt,2023-04-01,2018-05-30,2023-03-06,INTERVENTIONAL,PHASE3,Ain Shams University,OTHER,hepatitis
NCT06463912,HCV-PIWD,RECRUITING,2024-05-20,Hepatitis C Virus Infection,Does not apply,Armenia - Colombia,2025-01-30,2024-06-18,2024-06-18,OBSERVATIONAL,Not Available,Asociación Colombiana de Hepatología,OTHER,hepatitis
NCT03091010,Unknown,UNKNOWN,2017-04-08,Severe Alcoholic Hepatitis,"Fecal Microbiota Transplantation, Steroids",New Delhi - India,2019-03-24,2017-03-27,2020-01-22,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT03485846,Unknown,COMPLETED,2017-11-27,Chronic Hepatitis C Genotype 1b,"Narlaprevir, Ritonavir, Daclatasvir","Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation",2018-08-29,2018-04-02,2018-12-19,INTERVENTIONAL,PHASE2,R-Pharm,INDUSTRY,hepatitis
NCT06571981,RUTH,NOT_YET_RECRUITING,2024-09-01,"Hepatitis, Teleradiology","TUP ultraportable US with teleradiology capacities, CUS conventional ultrasound",No locations listed,2025-12-31,2024-08-26,2024-08-26,OBSERVATIONAL,Not Available,Naik Vietti Violi,OTHER,hepatitis
NCT04322981,PHARM-C,UNKNOWN,2022-04-13,Hepatitis C Virus Infection,"Pharmacist-Led care, Standard of Care (Hepatology)",Toronto - Canada,2023-06-01,2020-03-26,2022-04-27,INTERVENTIONAL,PHASE4,"University Health Network, Toronto",OTHER,hepatitis
NCT00887081,IFNRIBAHE,UNKNOWN,2009-01,Hemoglobinopathies,PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin,Palermo - Italy,2013-12,2009-04-23,2009-04-23,INTERVENTIONAL,PHASE4,Azienda Ospedaliera V. Cervello,OTHER,hepatitis
NCT03168412,Unknown,COMPLETED,2017-05-25,Hepatitis E,"Recombinant Hepatitis E Vaccine (Escherichia Coli), Recombinant Hepatitis E Vaccine (Escherichia Coli)",Quzhou - China,2018-07-15,2017-05-30,2019-02-21,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00780910,Unknown,COMPLETED,2008-11,Chronic Hepatitis C,"MP-424, Ribavirin, Peginterferon Alfa-2b",Kawasaki City - Japan,2010-10,2008-10-28,2014-05-02,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT02838810,Unknown,UNKNOWN,2016-06,Chronic Hepatitis B,"peginterferon alfa, Nucleoside analogues",Guangzhou - China,2019-12,2016-07-20,2019-01-15,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT06738810,STEATOGWAD,COMPLETED,2018-06-21,Non-alcoholic Steato-hepatitis,Fibrotest-actitest/NASHtest,Pointe-à-Pitre - Guadeloupe,2022-02-01,2024-12-18,2024-12-18,INTERVENTIONAL,NA,Centre Hospitalier Universitaire de la Guadeloupe,OTHER,hepatitis
NCT01058512,NOV-205,COMPLETED,2010-03,Hepatitis C,NOV-205,"Jacksonville - United States, Miami - United States, Orlando - United States, Framingham - United States, Worcester - United States, Fayetteville - United States",2010-12,2010-01-28,2022-07-25,INTERVENTIONAL,PHASE2,"Cellectar Biosciences, Inc.",INDUSTRY,hepatitis
NCT03359746,Unknown,UNKNOWN,2017-12-15,Hepatitis C,Grazoprevir/Elbasvir,No locations listed,2018-10-31,2017-12-02,2017-12-02,INTERVENTIONAL,PHASE4,King Faisal Specialist Hospital & Research Center,OTHER,hepatitis
NCT02604212,Unknown,TERMINATED,2015-11,Hepatitis B,"ARC-520, Placebo, entecavir, antihistamine, tenofovir","Hong Kong - China, Hong Kong - China, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, Leipzig - Germany, Muenchen - Germany, Tuebingen - Germany, Ulm - Germany, Wuerzburg - Germany, Busan - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan-si Gyeongnam - Korea, Republic of",2016-12,2015-11-13,2019-04-16,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT00635310,Unknown,UNKNOWN,2005-01,"Chronic Hepatitis C, Chronic Hepatitis B, Biopsy, Hemodialysis","Percutaneous liver biopsy, Percutaneous liver biopsy","Chia-Yi - Taiwan, Chia-Yi - Taiwan, Douliou - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2013-06,2008-03-13,2012-12-20,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT00132210,Unknown,COMPLETED,2002-09,"Hepatitis C, HIV Infections",pegylated interferon,"Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Stuttgart - Germany",2010-06,2005-08-19,2010-10-21,INTERVENTIONAL,PHASE4,"University Hospital, Bonn",OTHER,hepatitis
NCT04971512,Unknown,TERMINATED,2021-08-02,Chronic Hepatitis B Virus Infection,"EDP-721, Placebo (Part 1), EDP-721 (Part 2), Placebo (Part 2), EDP-514, Placebo (Part 2)",Auckland - New Zealand,2021-12-20,2021-07-21,2022-02-14,INTERVENTIONAL,PHASE1,"Enanta Pharmaceuticals, Inc",INDUSTRY,hepatitis
NCT01547312,Unknown,WITHDRAWN,2012-05,Chronic Hepatitis C,"Peg-Interferon, Liver Samples from FNA, Liver Samples from CNB, Blood Samples, Ribavirin, 800 mg Grazoprevir, 100 mg Grazoprevir, Liver samples from CNB and FNA",No locations listed,2012-11,2012-03-07,2015-10-14,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00087646,Unknown,COMPLETED,2003-09,"Hepatitis C, Chronic","Ribavirin, Ribavirin, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Mobile - United States, Scottsdale - United States, Los Angeles - United States, Pasadena - United States, San Diego - United States, Ukiah - United States, Farmington - United States, Bradenton - United States, Hollywood - United States, Jacksonville - United States, Atlanta - United States, Atlanta - United States, Savannah - United States, Chicago - United States, Chicago - United States, Des Moines - United States, Baltimore - United States, Boston - United States, Boston - United States, Minneapolis - United States, Rochester - United States, Kansas City - United States, St Louis - United States, Florham Park - United States, Albuquerque - United States, Williamsville - United States, Lancaster - United States, Philadelphia - United States, Cranston - United States, Memphis - United States, Nashville - United States, Austin - United States, Houston - United States, Salt Lake City - United States, Burlington - United States, Richmond - United States, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Rio de Janeiro - Brazil, Vancouver - Canada, Toronto - Canada, Toronto - Canada, Clichy - France, Creteil - France, Lille - France, Lyon - France, Marseille - France, Montpellier - France, Paris - France, Pessac - France, Toulouse - France, Berlin - Germany, Bochum - Germany, Bonn - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Erlangen - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Homburg/saar - Germany, Kassel - Germany, Kiel - Germany, Köln - Germany, Mainz - Germany, Muenchen - Germany, Oberhausen - Germany, Wuerzburg - Germany, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Thessaloniki - Greece, Bari - Italy, Bologna - Italy, Milano - Italy, Padova - Italy, Palermo - Italy, Roma - Italy, Torino - Italy, Coimbra - Portugal, Lisboa - Portugal, Lisboa - Portugal, Alicante - Spain, Barcelona - Spain, Granada - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Málaga - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, Goeteborg - Sweden, Huddinge - Sweden, Lund - Sweden, Zürich - Switzerland, Ankara - Turkey, Istanbul - Turkey, Istanbul - Turkey, Izmir - Turkey, Birmingham - United Kingdom",2008-05,2004-07-14,2016-01-14,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01858012,Unknown,ACTIVE_NOT_RECRUITING,2008-01-01,Insulin Resistance,Moderate alcohol cessation,San Francisco - United States,2026-12-31,2013-05-20,2024-01-16,OBSERVATIONAL,Not Available,"University of California, San Francisco",OTHER,hepatitis
NCT05457946,Unknown,NOT_YET_RECRUITING,2023-04-01,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B Infection","LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)",No locations listed,2025-09-30,2022-07-14,2023-03-10,INTERVENTIONAL,PHASE3,LG Chem,INDUSTRY,hepatitis
NCT04029246,Unknown,UNKNOWN,2019-11-01,"Hepatitis C, Chronic","Follow up phone call, Incentive",Glasgow - United Kingdom,2020-08-01,2019-07-23,2020-07-23,INTERVENTIONAL,NA,Glasgow Royal Infirmary,OTHER,hepatitis
NCT02973646,Unknown,UNKNOWN,2016-01,Chronic Hepatitis b,"Entecavir or Tenofovir, Peginterferon Alfa-2B",Guangzhou - China,2018-12,2016-11-25,2016-11-25,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00100581,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C","Efavirenz, Lamivudine, Lopinavir/ritonavir, Pegylated interferon alfa-2a, Ribavirin, Tenofovir disoproxil fumarate","New York - United States, Dallas - United States",Unknown Date,2005-01-04,2021-11-01,INTERVENTIONAL,NA,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01336010,ATAHC-II,COMPLETED,2011-08,Acute Hepatitis C,"Peginterferon alfa-2a, Ribavirin","Camperdown - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Melbourne - Australia, Penrith - Australia, Adelaide - Australia, Melbourne - Australia, Parkville - Australia",2015-06,2011-04-15,2015-09-02,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT00498212,Unknown,TERMINATED,2007-07,Hepatitis B,"1018 ISS-HBsAg-Single, 1018 ISS-HBsAg-Double","St Johns - Canada, Halifax - Canada, Montreal - Canada",2008-08,2007-07-09,2019-03-26,INTERVENTIONAL,PHASE2,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT02662712,Unknown,COMPLETED,2015-12-17,"Healthy, Hepatitis, Chronic","JNJ-56136379, Placebo","Bruxelles - Belgium, Edegem - Belgium, Mechelen - Belgium, Merksem - Belgium, Sofia - Bulgaria, Clichy - France, La Tronche - France, Lyon - France, Paris - France, Tbilisi - Georgia, Essen - Germany, Hannover - Germany, Wiesbaden - Germany, Kuala Lumpur - Malaysia, Chisinau - Moldova, Republic of, Bucuresti - Romania, Timisoara - Romania, Barcelona - Spain, Madrid - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, Kaohsiung - Taiwan, Keelung - Taiwan, Taichung - Taiwan, Taipei City - Taiwan, Taoyuan - Taiwan",2018-06-29,2016-01-25,2025-02-03,INTERVENTIONAL,PHASE1,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT02655510,TREAT 008,COMPLETED,2016-02,Alcoholic Hepatitis,F-652,Rochester - United States,2018-06-30,2016-01-14,2019-09-09,INTERVENTIONAL,PHASE2,Mayo Clinic,OTHER,hepatitis
NCT01312012,Unknown,UNKNOWN,2011-01,"Hepatitis B Virus Infection, Pregnancy",antiviral therapy,Taipei - Taiwan,2021-12,2011-03-10,2020-11-27,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT01421212,Unknown,COMPLETED,1999-11,Hepatitis B Virus Associated Liver Disease,Hepatitis B Immune Globulin (Boca HBVIg),"San Francisco - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Chicago - United States, Ann Arbor - United States, Rochester - United States, New York - United States, New York - United States, Chapel Hill - United States, Richmond - United States",2002-02,2011-08-22,2019-01-22,INTERVENTIONAL,PHASE2,Biotest Pharmaceuticals Corporation,INDUSTRY,hepatitis
NCT01456312,S-RGT,UNKNOWN,2012-09,"Hepatitis B, Chronic","Peginterferon alfa-2a, Entecavir","Seoul - Korea, Republic of",2016-02,2011-10-20,2012-10-31,INTERVENTIONAL,PHASE4,Gangnam Severance Hospital,OTHER,hepatitis
NCT01016912,Unknown,COMPLETED,2009-12,Hepatitis C Infection,"BMS-790052, BMS-790052, Placebo, Peginterferon alfa-2b, Ribavirin","Hiroshima City - Japan, Sapporo-Shi - Japan, Kawasaki-Shi - Japan, Suita-Shi - Japan, Iruma-Gun - Japan, Minato-Ku - Japan",2010-09,2009-11-20,2015-10-12,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02825212,Unknown,COMPLETED,2016-02,"Hepatitis C, Cryoglobulinemia","Harvoni, Epclusa",New York - United States,2019-07-19,2016-07-07,2020-12-17,INTERVENTIONAL,PHASE3,Icahn School of Medicine at Mount Sinai,OTHER,hepatitis
NCT02480712,ASTRAL-5,COMPLETED,2015-07-01,Hepatitis C Virus Infection,SOF/VEL,"Birmingham - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, Torrance - United States, Atlanta - United States, Chicago - United States, Baltimore - United States, Lutherville - United States, Boston - United States, Bronx - United States, New York - United States, Durham - United States, Cincinnati - United States, Richmond - United States",2016-04-29,2015-06-24,2018-11-16,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT02161510,Unknown,COMPLETED,2014-07,Hepatitis C,MK-2248,No locations listed,2014-11,2014-06-11,2015-06-08,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02118012,Unknown,COMPLETED,2014-03-20,Chronic Hepatitis C,"Chlorcyclizine HCl, Ribavirin",Bethesda - United States,2014-03-20,2014-04-21,2020-06-09,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03762681,Unknown,TERMINATED,2018-12-14,Hepatitis B Virus Infection,"RO7239958, Placebo","Sofia - Bulgaria, Sofia - Bulgaria, Hong Kong - Hong Kong, Busan - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Myslowice - Poland, Kaohsiung - Taiwan, Tainan - Taiwan, Edinburgh - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2020-04-06,2018-12-04,2021-05-11,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06323681,Unknown,RECRUITING,2024-02-04,Chronic Hepatitis b,"Peginterferon α-2b based treatment group, NAs monotherapy group",Shanghai - China,2027-02,2024-03-21,2024-03-21,INTERVENTIONAL,NA,Qing XIe,OTHER,hepatitis
NCT01026610,Unknown,COMPLETED,2009-08,Chronic Hepatitis B,"LB80380 90 mg, LB80380 150 mg, entecavir 0.5 mg","Hong Kong - China, Incheon - Korea, Republic of, Guri - Korea, Republic of, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of",2010-11,2009-12-04,2012-10-05,INTERVENTIONAL,PHASE2,LG Life Sciences,INDUSTRY,hepatitis
NCT00333710,Unknown,COMPLETED,2006-09,"Chronic Disease, Hepatitis C, Stress Disorders, Post-Traumatic","Individual psychotherapy, Telehealth Intervention",Boston - United States,2009-10,2006-06-06,2014-12-15,INTERVENTIONAL,NA,US Department of Veterans Affairs,FED,hepatitis
NCT01588912,TETRA,UNKNOWN,2012-04,Chronic Hepatitis B,"Telbivudine, Tenofovir, Entecavir","Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Jinju - Korea, Republic of, Yangsan - Korea, Republic of",2013-12,2012-05-01,2012-05-02,INTERVENTIONAL,PHASE4,Pusan National University Yangsan Hospital,OTHER,hepatitis
NCT04264312,Unknown,COMPLETED,2017-07-28,Hepatitis B,No interventions listed,"Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China",2019-09-28,2020-02-11,2020-02-11,OBSERVATIONAL,Not Available,Wu Jiang,OTHER_GOV,hepatitis
NCT04411381,Unknown,RECRUITING,2020-05-25,"Hepatitis C, Telemedicine",Telemedicine,La Laguna - Spain,2023-12,2020-06-02,2023-05-18,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT01260610,Unknown,WITHDRAWN,2011-06,Chronic Hepatitis B,"Tenofovir, Telbivudine, Tenofovir plus Telbivudine",New Delhi - India,2011-06,2010-12-15,2015-06-16,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT03366610,Unknown,COMPLETED,2017-04-28,Hepatitis C,Non-interventional,Beijing - China,2019-04-30,2017-12-08,2020-06-18,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00122681,Unknown,COMPLETED,2004-05-06,"Infections, Papillomavirus","Cervarix™, Havrix™-based investigational formulation","Birmingham - United States, Fountain Valley - United States, San Diego - United States, San Francisco - United States, Boulder - United States, Boulder - United States, Denver - United States, Louisville - United States, Clearwater - United States, Coral Gables - United States, Miami - United States, West Palm Beach - United States, Augusta - United States, Honolulu - United States, Iowa City - United States, Arkansas City - United States, Wichita - United States, Wichita - United States, Bardstown - United States, Louisville - United States, Minneapolis - United States, Omaha - United States, Lebanon - United States, Morristown - United States, Albuquerque - United States, New York - United States, Poughkeepsie - United States, Chapel Hill - United States, New Bern - United States, Cleveland - United States, Tulsa - United States, Portland - United States, Carnegie - United States, Erie - United States, Erie - United States, Erie - United States, Erie - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Austin - United States, Houston - United States, Houston - United States, Webster - United States, Salt Lake City - United States, Charlottesville - United States, Spokane - United States, Spokane - United States, Vancouver - United States, Wenatchee - United States, Sydney - Australia, Adelaide - Australia, Hobart - Australia, Carlton, Melbourne - Australia, Melbourne - Australia, Perth - Australia, Brussels - Belgium, Edegem - Belgium, Leuven - Belgium, Curitiba - Brazil, Porto Alegre - Brazil, Campinas - Brazil, Edmonton - Canada, Langley - Canada, Winnipeg - Canada, St. John's - Canada, Truro - Canada, Oshawa - Canada, Ottawa - Canada, Toronto - Canada, Waterloo - Canada, Beauport - Canada, Montreal - Canada, Espoo - Finland, Helsinki - Finland, Helsinki - Finland, Jarvenpaa - Finland, Jyvaskyla - Finland, Kerava - Finland, Kotka - Finland, Kouvola - Finland, Kuopio - Finland, Lahti - Finland, Lappeenranta - Finland, Mikkeli - Finland, Oulu - Finland, Pori - Finland, Rauma - Finland, Seinajoki - Finland, Tampere - Finland, Turku - Finland, Vaasa - Finland, Karlsruhe - Germany, Ravensburg - Germany, Rheinstetten - Germany, Muenchen - Germany, Muenchen - Germany, Wuerzburg - Germany, Dietzenbach - Germany, Frankfurt - Germany, Frankfurt - Germany, Hannover - Germany, Mainz - Germany, Leipzig - Germany, Nordhausen - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Modena - Italy, Milano - Italy, Cuenavaca - Mexico, Cavite - Philippines, Laguna - Philippines, Las Pinas City - Philippines, Los Banos, Laguna - Philippines, Makati City - Philippines, Manila - Philippines, Barcelona - Spain, Barcelona - Spain, L'Hospitalet de Llobregat - Spain, Madrid - Spain, Marid - Spain, Móstoles - Spain, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Aberdeen - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Manchester - United Kingdom, Waterloo, Liverpool - United Kingdom",2006-11-03,2005-07-22,2018-08-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00686881,Unknown,TERMINATED,2006-12,"Hepatitis C, Chronic","Peginterferon alfa-2b (PegIFN-2b), Comparator: Stronger neo minophagen C (SNMC)",No locations listed,2011-02,2008-05-30,2017-04-06,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05414981,Unknown,COMPLETED,2022-08-07,Chronic Hepatitis B,"ABI-H3733, Placebo","Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Hong Kong - Hong Kong, Chisinau - Moldova, Republic of, Grafton - New Zealand, Bucharest - Romania, Singapore - Singapore, Singapore - Singapore",2023-04-24,2022-06-10,2023-06-29,INTERVENTIONAL,PHASE1,Assembly Biosciences,INDUSTRY,hepatitis
NCT00493610,Unknown,SUSPENDED,2006-11,Hepatitis C,N-acetylcysteine(Mucomyst),Dayton - United States,2008-06,2007-06-28,2010-01-08,INTERVENTIONAL,NA,US Department of Veterans Affairs,FED,hepatitis
NCT02964910,Unknown,COMPLETED,2016-08,Hepatitis E,Recombinant Hepatitis E Vaccine (Escherichia Coli),Weihai - China,2017-08,2016-11-16,2019-07-25,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT01272310,Unknown,UNKNOWN,2011-01,Chronic Hepatitis C,"Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin",No locations listed,2012-01,2011-01-07,2011-01-07,INTERVENTIONAL,PHASE2,Sheba Medical Center,OTHER_GOV,hepatitis
NCT06706310,Unknown,RECRUITING,2024-12-04,Chronic Hepatitis B,"Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs)","Chongqing - China, Guangzhou - China, Shenzhen - China, Liuzhou - China, WuHan - China, Changsha - China, Wuxi - China, Changchun - China, Shenyang - China, Xi'an - China, Chengdu - China, Ürümqi - China, Kunming - China, Pu'er - China, Rui'an - China",2025-12,2024-11-26,2025-03-04,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT02123212,Best-C,COMPLETED,2013-02,"Hepatitis C, Chronic Hepatitis C","Mailer, In-person recruitment, EHR Alert","Birmingham - United States, Detroit - United States, New York - United States",2014-03,2014-04-25,2015-03-26,INTERVENTIONAL,NA,National Opinion Research Center,OTHER,hepatitis
NCT02023112,GIFT-II,COMPLETED,2014-01,Hepatitis C Virus,"ABT-450/r/ABT-267, Ribavirin",No locations listed,2015-04,2013-12-30,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT03250910,Unknown,COMPLETED,2016-08-01,"Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus","Sofosbuvir and Velpatasvir, Ribavirin","Douliu - Taiwan, Taipei - Taiwan",2017-07-15,2017-08-16,2017-12-08,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT00202839,Unknown,COMPLETED,2005-03,"Hepatitis C, Chronic","PegIntron (peginterferon alfa-2b; SCH 54031), PegIntron (peginterferon alfa-2b; SCH 54031), Ribavirin, Ribavirin",No locations listed,2008-07,2005-09-20,2017-04-06,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT06316739,Unknown,NOT_YET_RECRUITING,2024-05,"HIV Infections, HCV, Overdose",Ganchero intervention,No locations listed,2025-11,2024-03-18,2024-03-18,INTERVENTIONAL,NA,North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI),OTHER,hepatitis
NCT03732586,Unknown,COMPLETED,2018-09-30,Alcoholic Hepatitis,"Omega 5 fatty acid supplement, PLACEBO","Mexico City - Mexico, Mexico City - Mexico",2023-01-01,2018-11-06,2023-05-23,INTERVENTIONAL,NA,Hospital General Dr. Manuel Gea González,OTHER_GOV,hepatitis
NCT06513286,TherVacB,NOT_YET_RECRUITING,2024-12,Chronic Hepatitis B,"TherVacB (HEPLISAV B), TherVacB (HBsAg ± c-di-AMP)","Hamburg - Germany, Hannover - Germany, Munich - Germany, Munich - Germany",2026-12,2024-07-22,2024-08-06,INTERVENTIONAL,PHASE2,Michael Hoelscher,OTHER,hepatitis
NCT05390424,BUVARD,UNKNOWN,2022-06,"Hepatitis B, Hepatitis C, AIDS",Blood collection using Dried Blood Spot,Rouen - France,2023-09,2022-05-25,2022-05-25,INTERVENTIONAL,NA,"University Hospital, Rouen",OTHER,hepatitis
NCT05902624,Unknown,NOT_YET_RECRUITING,2024-08-01,Cutaneous Warts,Hepatitis B Virus Vaccine(HBV),No locations listed,2025-05-20,2023-06-15,2024-07-31,INTERVENTIONAL,PHASE1,Assiut University,OTHER,hepatitis
NCT03962816,Unknown,UNKNOWN,2019-05-26,Hepatitis B Vaccine,"20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6",Taiyuan - China,2020-02,2019-05-24,2019-05-24,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT03723824,Unknown,TERMINATED,2019-02-14,"Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection","grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®","Taichung - Taiwan, Taichung - Taiwan",2020-11-30,2018-10-30,2021-03-16,INTERVENTIONAL,PHASE4,Taichung Veterans General Hospital,OTHER,hepatitis
NCT05264558,Unknown,COMPLETED,2022-07-25,Hepatitis C,"Xpert HCV Viral load finger stick point of care test (Cepheid), Epclusa 400Mg-100Mg Tablet, Standard of care",Cairns - Australia,2023-08-31,2022-03-03,2023-11-13,INTERVENTIONAL,PHASE4,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT01081158,Unknown,COMPLETED,2007-07,"Hepatitis C, Chronic","Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron), Drug: SCH 900518 Biologic: Peginterferon alfa-2b, Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron), Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)",No locations listed,2008-08,2010-03-05,2015-02-09,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00312858,Unknown,COMPLETED,2006-04,Hepatitis A Virus,"Comparator: VAQTA™ (Hepatitis A vaccine), Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine), Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)",No locations listed,2008-03,2006-04-11,2017-04-13,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00048724,Unknown,COMPLETED,2002-06,"Chronic Hepatitis C, Cirrhosis",peginterferon alfa-2b (SCH 54031),No locations listed,2008-04,2002-11-08,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03471624,Unknown,COMPLETED,2018-05-01,"Hepatitis B, Chronic",Tenofovir Alafenamide,"Palo Alto - United States, San Jose - United States, Fukuoka - Japan, Nagoya - Japan, Osaka - Japan, Saga - Japan, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan",2022-04-19,2018-03-20,2023-11-18,INTERVENTIONAL,PHASE4,Stanford University,OTHER,hepatitis
NCT00449124,Unknown,WITHDRAWN,Unknown Date,Hepatitis C,"Placebo, TG4040","Saint Louis - United States, Cincinnati - United States",2007-09,2007-03-19,2019-01-23,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00071916,Unknown,COMPLETED,2001-03,Hepatitis C,No interventions listed,"Little Rock - United States, Memphis - United States, Nashville - United States",Unknown Date,2003-11-05,2019-01-31,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00356486,Unknown,COMPLETED,2005-10,HIV Infections,"Peginterferon alfa-2a, Ribavirin, epoetin-β, Peginterferon alfa-2a + Ribavirin for 12 weeks","Badalona - Spain, Terrassa - Spain, Vic - Spain, San Sebastián - Spain, Alicante - Spain, Barcelona - Spain, Barcelona - Spain, Cádiz - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain",2009-03,2006-07-26,2019-12-04,INTERVENTIONAL,PHASE4,Germans Trias i Pujol Hospital,OTHER,hepatitis
NCT03693586,Unknown,COMPLETED,2018-10-19,"Chronic Hepatitis c, Vasculitis",No interventions listed,Mexico City - Mexico,2022-03-08,2018-10-03,2022-03-17,OBSERVATIONAL,Not Available,Hospital General de Mexico,OTHER_GOV,hepatitis
NCT02366286,Unknown,COMPLETED,2010-11,"Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular",No interventions listed,Rochester - United States,2017-09-11,2015-02-19,2023-12-14,OBSERVATIONAL,Not Available,Mayo Clinic,OTHER,hepatitis
NCT01128686,LAMGR,COMPLETED,2010-08,"Hepatitis B, Chronic",No intervention,"Kangwon-do - Korea, Republic of",2011-06,2010-05-24,2016-09-13,OBSERVATIONAL,Not Available,ViiV Healthcare,INDUSTRY,hepatitis
NCT01724086,Unknown,COMPLETED,2012-10,Chronic Hepatitis C,"TMC647055, TMC435, Ritonavir, Ribavirin, Pegylated interferon alpha-2a (PegIFN), GSK2336805","Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Liège - Belgium, Berlin - Germany, Hamburg - Germany, Mainz - Germany",2014-09,2012-11-09,2016-01-11,INTERVENTIONAL,PHASE2,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT05376124,Unknown,RECRUITING,2022-01-01,"Hepatitis B, Chronic, Virus Diseases","original therapy, rescue therapy","Ankang - China, Hanzhong - China, Jinan - China, Weinan - China, Wuhan - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Yan'an - China, Zhengzhou - China",2024-12-31,2022-05-17,2023-02-03,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT01181024,Unknown,COMPLETED,2010-04,"Hepatitis C, Chronic, Healthy Volunteer","Placebo, RO5303253, RO5303253, RO5303253",Grafton - New Zealand,2010-10,2010-08-13,2016-11-02,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02886624,SAHIV,COMPLETED,2017-05-31,"Acute Hepatitis C, HIV",Grazoprevir/Elbasvir,"Lyon - France, Nice - France, Paris - France, Paris - France, Paris - France, Paris - France",2018-12-31,2016-09-01,2020-01-29,INTERVENTIONAL,PHASE2,Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba,OTHER,hepatitis
NCT06010524,VOSEVI_Reg,RECRUITING,2023-02-01,Hepatitis C,No interventions listed,Istanbul - Turkey,2023-12-31,2023-08-24,2023-08-29,OBSERVATIONAL,Not Available,Cerrahpasa Medical Faculty Foundation,OTHER,hepatitis
NCT03770624,QL-007,UNKNOWN,2018-10-16,Chronic Hepatitis b,"QL-007 tablet, TDF",Peking - China,2019-03-30,2018-12-10,2018-12-10,INTERVENTIONAL,PHASE1,"Qilu Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT02604017,Unknown,COMPLETED,2015-10,"Chronic Hepatitis C, Hepatitis C Virus, HCV",ABT-493/ABT-530,No locations listed,2017-01,2015-11-13,2021-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT04710641,OUTREACH2,COMPLETED,2022-01-01,"Hepatocellular Carcinoma, Hepatitis B, Hepatitis C","MTL-CEBPA, Sorafenib","Duarte - United States, Singapore - Singapore",2025-01-25,2021-01-15,2025-03-06,INTERVENTIONAL,PHASE2,Mina Alpha Limited,INDUSTRY,hepatitis
NCT02465619,Unknown,WITHDRAWN,Unknown Date,Cirrhosis,No interventions listed,New Delhi - India,2017-06,2015-06-08,2017-11-28,OBSERVATIONAL,Not Available,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT00305019,Unknown,TERMINATED,2002-07,Hepatitis B,clevudine,"Guro-dong - Korea, Republic of, Yeongeon-dong - Korea, Republic of, Gil-dong - Korea, Republic of, Dogok-dong - Korea, Republic of, Ilwon-dong - Korea, Republic of, Pungnab2-dong - Korea, Republic of, Mok-dong - Korea, Republic of, Youido - Korea, Republic of",Unknown Date,2006-03-21,2006-04-12,INTERVENTIONAL,PHASE2,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT05140941,STORC,RECRUITING,2022-04-04,"Hepatitis C, Chronic, Pregnancy; Infection",Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet,"Cincinnati - United States, Columbus - United States, Pittsburgh - United States, Salt Lake City - United States, Huntington - United States, London - Canada, Toronto - Canada, Toronto - Canada",2025-06,2021-12-02,2025-01-13,INTERVENTIONAL,PHASE4,Catherine Anne Chappell,OTHER,hepatitis
NCT00165919,Unknown,WITHDRAWN,2005-09,"Hepatitis C, HIV Infections",None. Not a clinical trial. Specimens taken for basic research in laboratory.,No locations listed,2005-09,2005-09-14,2013-11-13,OBSERVATIONAL,Not Available,Emory University,OTHER,hepatitis
NCT03180619,Unknown,COMPLETED,2017-06-29,Chronic Hepatitis B,TAF,"Los Angeles - United States, San Jose - United States, Detroit - United States, Seattle - United States, Calgary - Canada, Montreal - Canada, Toronto - Canada, Toronto - Canada, Vancouver - Canada, Shatin - Hong Kong, Kowloon - Hong Kong, Tai Po - Hong Kong, Rozzano - Italy, Bologna - Italy, Milan - Italy, Busan - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Grafton - New Zealand, Changhua - Taiwan, Chiayi City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan City - Taiwan, London - United Kingdom, London - United Kingdom",2019-03-27,2017-06-08,2021-09-27,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT04539119,Unknown,UNKNOWN,2020-07-03,"B-cell Lymphoma, HBV","Tenofovir, Entecavir",Shanghai - China,2022-09-01,2020-09-04,2020-09-04,INTERVENTIONAL,PHASE3,Ruijin Hospital,OTHER,hepatitis
NCT02473341,BASH,ACTIVE_NOT_RECRUITING,2017-11-14,Alcoholic Hepatitis,"Bovine Colostrum, Placebo","Ludhiana - India, Chandigarh - India, Hyderabad - India, Jaipur - India, New Delhi - India",2024-08-01,2015-06-16,2024-08-07,INTERVENTIONAL,PHASE3,Dayanand Medical College and Hospital,OTHER,hepatitis
NCT05637541,Unknown,COMPLETED,2023-01-03,Chronic Hepatitis b,GST-HG141,Changchun - China,2024-07-24,2022-12-05,2025-03-05,INTERVENTIONAL,PHASE2,"Fujian Akeylink Biotechnology Co., Ltd.",INDUSTRY,hepatitis
NCT00686517,Unknown,COMPLETED,2003-12,Hepatitis C,"Pegylated interferon alfa-2b, Ribavirin",No locations listed,2010-12,2008-05-30,2017-04-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03088917,Track&Trace,COMPLETED,2017-09-27,Chronic Hepatitis c,No interventions listed,Nijmegen - Netherlands,2019-12-01,2017-03-23,2020-02-10,OBSERVATIONAL,Not Available,Radboud University Medical Center,OTHER,hepatitis
NCT01935817,Unknown,COMPLETED,2010-06,Liver Fibrosis,"Silybin 94 mg + vitamin E 90 mg + phospholipids 194 mg complex, Placebo",Catania - Italy,2012-12,2013-09-05,2013-09-05,INTERVENTIONAL,PHASE3,University of Catania,OTHER,hepatitis
NCT01513941,INSIGHT,COMPLETED,2012-04,Chronic Hepatitis C,"Telaprevir, Ribavirin, Pegylated-Interferon-alfa-2a","Cairns - Australia, Darlinghurst - Australia, Melbourne - Australia, Campinas - Brazil, Rio De Janeiro - Brazil, Santo André - Brazil, Sao Paulo - Brazil, Le Kremlin Bicetre - France, Marseille - France, Nice N/A - France, Paris Cedex 12 - France, Bydgoszcz - Poland, Myslowice - Poland, Warszawa - Poland, Krasnodar - Russian Federation, Perm - Russian Federation, Saint-Petersburg - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Voronezh - Russian Federation, Alicante - Spain, Badalona - Spain, Cordoba - Spain, Elche - Spain, Madrid - Spain, San Sebastian - Spain, Sevilla N/A - Spain, Valencia - Spain, Stockholm - Sweden, Birmingham - United Kingdom, Glasgow - United Kingdom, London - United Kingdom",2014-03,2012-01-20,2016-05-05,INTERVENTIONAL,PHASE3,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT06533319,Unknown,NOT_YET_RECRUITING,2024-08-01,Hepatitis C,sofosbuvir/velpatasvir,No locations listed,2025-02-01,2024-08-01,2024-08-01,INTERVENTIONAL,NA,Eastern Idaho Public Health,OTHER_GOV,hepatitis
NCT02526641,Unknown,COMPLETED,2015-08,Hepatitis C,"Functional Hepatic Nitrogen Clearance (FHNC), Galactose Elimination Capacity (GEC), Liver vein catheterization",Aarhus - Denmark,2019-03,2015-08-18,2020-11-04,OBSERVATIONAL,Not Available,University of Aarhus,OTHER,hepatitis
NCT04019717,Unknown,COMPLETED,2019-06-20,"Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C, Hepatitis C Virus Infection, HCV Infection","AT-527, Daclatasvir","Antwerp - Belgium, Phoenix - Mauritius, Chisinau - Moldova, Republic of",2020-01-29,2019-07-15,2020-05-04,INTERVENTIONAL,PHASE2,"Atea Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT06728917,OBILART,NOT_YET_RECRUITING,2025-01-20,"HBV (Hepatitis B Virus), HIV Infection",No interventions listed,"Bologna - Italy, Milan - Italy, Napoli - Italy",2025-04-30,2024-12-11,2024-12-11,OBSERVATIONAL,Not Available,IRCCS San Raffaele,OTHER,hepatitis
NCT01415141,Unknown,WITHDRAWN,2011-07,Hepatitis C,"Peginterferon alfa-2a, Ribavirin, telaprevir","Atlanta - United States, Burlington - United States",2011-07,2011-08-11,2017-05-09,INTERVENTIONAL,PHASE4,University of Vermont,OTHER,hepatitis
NCT00291941,Unknown,COMPLETED,2006-02,Hepatitis B,"Henogen HBV vaccine, FENDRIX","Aalst - Belgium, ATH - Belgium, Baudour - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Gent - Belgium, La Louvière - Belgium, Leuven - Belgium, Montigny le tilleul - Belgium, Tournai - Belgium, Jihlava - Czech Republic, Liberec - Czech Republic, Ostrava - Poruba - Czech Republic, Prague - Czech Republic, Usti nad Labem - Czech Republic, Budapest - Hungary, Budapest - Hungary, Győr - Hungary, Kistarcsa - Hungary, Szombathely - Hungary",2007-03,2006-02-15,2008-08-28,INTERVENTIONAL,PHASE3,Henogen,INDUSTRY,hepatitis
NCT05117541,Unknown,ACTIVE_NOT_RECRUITING,2021-08-02,"Chronic Viral Hepatitis, Hepatitis B Infection","Interview, Biospecimen Collection, Electronic Health Record Review",Philadelphia - United States,2026-03-30,2021-11-11,2025-01-03,OBSERVATIONAL,Not Available,Thomas Jefferson University,OTHER,hepatitis
NCT04683341,Unknown,RECRUITING,2020-09-01,HBV,Tenofovir Alafenamide Tablets,Kaohsiung - Taiwan,2021-01-31,2020-12-24,2020-12-24,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03241641,Unknown,COMPLETED,2017-10-26,Chronic Hepatitis b,"Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate","Seoul - Korea, Republic of",2021-03-25,2017-08-07,2021-03-29,INTERVENTIONAL,PHASE4,Young-Suk Lim,OTHER,hepatitis
NCT00158717,Unknown,COMPLETED,2003-04,Hepatitis B,Hepsera,No locations listed,2006-04,2005-09-12,2014-01-07,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03423641,Unknown,COMPLETED,2011-01-01,"Hepatitis C, Chronic",Direct Acting Antivirals,No locations listed,2017-12-31,2018-02-06,2019-08-07,OBSERVATIONAL,Not Available,Kaiser Permanente,OTHER,hepatitis
NCT00161941,Unknown,COMPLETED,2003-06,"Meningococcal Meninigitis, Serogroup C",No interventions listed,"Wels - Austria, Augsburg - Germany, Bad Saulgau - Germany, Bietigheim-Bissingen - Germany, Ettenheim - Germany, Heilbronn - Germany, Kehl - Germany, Nördlingen - Germany, Oberndorf / Neckar - Germany, Roding - Germany, Schrammberg - Germany",Unknown Date,2005-09-13,2015-05-21,OBSERVATIONAL,Not Available,Pfizer,INDUSTRY,hepatitis
NCT00124241,Unknown,COMPLETED,Unknown Date,Hepatitis B,"telbivudine, lamivudine","Los Angeles - United States, Toronto - Canada, Hong Kong - China, Paris - France",2003-02,2005-07-27,2015-05-12,INTERVENTIONAL,PHASE2,Novartis,INDUSTRY,hepatitis
NCT04768517,Unknown,UNKNOWN,2021-02-09,"Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus (HIV) Coinfection",No interventions listed,"Douliu - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2024-02-01,2021-02-24,2021-02-26,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT03969017,Unknown,UNKNOWN,2019-06-17,Cirrhosis of Liver Due to Hepatitis B (Disorder),"pegylated interferon (Peg IFN)α-2b, Nucleoside （acid）analogue (NAs)",Guangzhou - China,2022-05-30,2019-05-31,2019-06-20,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT02361541,HCV-Epi,COMPLETED,2014-11,"Hepatitis C, HIV",HCV screening,Phnom Penh - Cambodia,2016-04,2015-02-11,2016-05-16,OBSERVATIONAL,Not Available,"Institute of Tropical Medicine, Belgium",OTHER,hepatitis
NCT01023217,CAESAR,COMPLETED,2009-11,"Hepatitis B, Chronic","Adefovir, Entecavir, Lamivudine","Seoul - Korea, Republic of",2012-07,2009-12-02,2014-02-10,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT03346941,EFINO-C,COMPLETED,2016-05-01,Chronic Hepatitis c,DAA treatment,Lyon - France,2017-09-30,2017-11-20,2017-11-20,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT00973817,SILVER,COMPLETED,2009-09,Acute On Chronic Hepatitis,"ELAD plus standard of care treatment, Standard of care","Los Angeles - United States, San Francisco - United States, Chicago - United States, Indianapolis - United States, New York - United States, New York - United States, Rochester - United States, Valhalla - United States, Cincinnati - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Dallas - United States, Dallas - United States, Charlottesville - United States, Birmingham - United Kingdom, London - United Kingdom, Derby - United Kingdom, Edinburgh - United Kingdom, Leeds - United Kingdom, London - United Kingdom",2011-04,2009-09-09,2013-04-08,INTERVENTIONAL,PHASE3,"Vital Therapies, Inc.",INDUSTRY,hepatitis
NCT02128217,SWIFT-C,COMPLETED,2014-05-30,"HIV-1 Infection, Hepatitis","Sofosbuvir, Ribavirin, Ledipasvir/Sofosbuvir","San Diego - United States, San Francisco - United States, Washington - United States, Chicago - United States, Chicago - United States, Boston - United States, New York - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Dallas - United States, Houston - United States",2017-02-28,2014-05-01,2018-04-27,INTERVENTIONAL,PHASE1,Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,NETWORK,hepatitis
NCT02293941,JKB122,TERMINATED,2014-05,Chronic Hepatitis C,"JKB-122 5mg, JKB-122 15mg, JKB-122 35mg, Placebo","Changhua - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Kaohsiung - Taiwan, Keelung - Taiwan, Tainan - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Yuanlin - Taiwan, Yuanlin - Taiwan",2017-08-30,2014-11-19,2020-07-21,INTERVENTIONAL,PHASE2,"TaiwanJ Pharmaceuticals Co., Ltd",INDUSTRY,hepatitis
NCT00512941,Unknown,COMPLETED,2007-06,"Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted, Hepatitis B, Chronic",No interventions listed,"Botucatu - Brazil, Botucatu - Brazil",Unknown Date,2007-08-08,2008-09-05,OBSERVATIONAL,Not Available,UPECLIN HC FM Botucatu Unesp,OTHER,hepatitis
NCT01892241,Unknown,COMPLETED,2010-01,Antiviral Treatment of Chronic Hepatitis B,"Pegasys(Roche), Entecavir",No locations listed,2012-11,2013-07-04,2013-10-01,INTERVENTIONAL,PHASE3,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02446717,Unknown,COMPLETED,2015-04,"Chronic Hepatitis C, Hepatitis C Virus, HCV, Direct-Acting Antiviral Agent (DAA)-Experienced","ABT-493, ABT-530, ribavirin (RBV), ABT-493/ABT-530",No locations listed,2016-12,2015-05-18,2017-09-15,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01596517,Unknown,COMPLETED,2003-06,Chronic Hepatitis C,"Peginterferon alfa-2a plus ribavirin for HCV genotype 1, Peginterferon alfa-2a plus ribavirin for HCV genotype 2/3","Seoul - Korea, Republic of",2011-12,2012-05-11,2012-05-15,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT02968641,LOWR-5,WITHDRAWN,Unknown Date,Chronic Delta Hepatitis,"Lonafarnib, Ritonavir",No locations listed,2021-02-12,2016-11-18,2021-02-16,INTERVENTIONAL,PHASE2,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT00342641,Unknown,COMPLETED,2005-06-08,Hepatitis C Virus,No interventions listed,Houston - United States,Unknown Date,2006-06-21,2017-07-02,OBSERVATIONAL,Not Available,National Cancer Institute (NCI),NIH,hepatitis
NCT02705534,SL50,COMPLETED,2016-09,"Hepatitis C, Cirrhosis","Sofosbuvir, Ledipasvir, Ribavirin","Tehran - Iran, Islamic Republic of",2017-09,2016-03-10,2018-04-30,INTERVENTIONAL,PHASE3,Tehran University of Medical Sciences,OTHER,hepatitis
NCT01705717,Unknown,COMPLETED,2011-06-01,"Hepatitis C, Chronic",No interventions listed,Bangkok - Thailand,2012-05-01,2012-10-12,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02476617,Unknown,COMPLETED,2015-06,"Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1a","ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin",No locations listed,2016-08,2015-06-19,2017-10-03,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00085917,PIFNPK,COMPLETED,2004-06,"Hepatitis C, HIV Infections","Double dose pegylated interferon with weight based Ribavirin, standard dose pegylated interferon alfa -2a and ribavirin",Bethesda - United States,2008-11,2004-06-17,2011-06-27,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00241917,Unknown,COMPLETED,2005-11,"Hepatitis C, Opiate Dependence","Hepatitis C educational video, Video","Antioch - United States, Richmond - United States, San Francisco - United States",2007-05,2005-10-19,2008-12-09,INTERVENTIONAL,NA,Organization to Achieve Solutions in Substance Abuse (OASIS),OTHER,hepatitis
NCT04676724,B-Together,COMPLETED,2021-01-28,Hepatitis B,"GSK3228836, PegIFN, NA therapy","Sacramento - United States, Iowa City - United States, Detroit - United States, New York - United States, Calgary - Canada, Edmonton - Canada, Montreal - Canada, Changchun - China, Beijing - China, Beijing - China, Hangzhou - China, Shanghai - China, Baggiovara (MO) - Italy, Milano - Italy, Milano - Italy, Monza (MB) - Italy, Aichi - Japan, Fukui - Japan, Gifu - Japan, Hiroshima - Japan, Kumamoto - Japan, Nagasaki - Japan, Tokyo - Japan, Busan - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Ulsan - Korea, Republic of, Lancut - Poland, Lublin - Poland, Myslowice - Poland, Barnaul - Russian Federation, Chelyabinsk - Russian Federation, Krasnojarsk - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Samara - Russian Federation, St. Petersburg - Russian Federation, Ennerdale - South Africa, Johannesburg - South Africa, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Málaga - Spain, Santander - Spain, London - United Kingdom, Newcastle-upon-Tyne - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom",2023-02-17,2020-12-21,2024-05-02,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05423834,Unknown,ACTIVE_NOT_RECRUITING,2022-09-01,Chronic Hepatitis B,"Tenofovir alafenamide, Entecavir",Shatin - Hong Kong,2025-12-21,2022-06-21,2023-02-08,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT01306617,Unknown,COMPLETED,2011-02,"Chronic Hepatitis C Infection, Hepatitis C, Hepatitis C Virus","ABT-450, ABT-333, ribavirin, ritonavir","Los Angeles - United States, Aurora - United States, Gainesville - United States, Springfield - United States, Kansas City - United States, New York - United States, Statesville - United States, San Antonio - United States, Newport News - United States, Seattle - United States, Madison - United States",2011-11,2011-03-02,2015-01-08,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT00575224,Unknown,COMPLETED,2004-10,"Chronic Hepatitis C, Asian Americans, Novel Genotypes, Treatment",Pegylated interferon and ribavirin,"San Diego - United States, San Jose - United States, Westminster - United States, Houston - United States, Plano - United States",2009-09,2007-12-18,2009-11-25,INTERVENTIONAL,PHASE4,Pacific Health Foundation,OTHER,hepatitis
NCT01438424,Unknown,COMPLETED,2001-01,"Hepatitis B Virus, HBV","Entecavir, Lamivudine",No locations listed,2009-12,2011-09-22,2012-08-23,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03485534,HBV,COMPLETED,2018-01-23,"Hepatitis B, Chronic","Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil","Seoul - Korea, Republic of",2019-11-04,2018-04-02,2022-06-09,INTERVENTIONAL,PHASE4,Daewoong Pharmaceutical Co. LTD.,INDUSTRY,hepatitis
NCT03356834,SWITAF,UNKNOWN,2017-12-01,Chronic Hepatitis B,"Tenofovir alafenamide(TAF), Tenofovir disoproxil fumarate(TDF)",Hong Kong - Hong Kong,2023-10,2017-11-29,2022-12-21,INTERVENTIONAL,PHASE4,Humanity and Health Research Centre,OTHER,hepatitis
NCT03530124,Unknown,COMPLETED,2018-07-17,"Apnea, Apnea Neonatal, Prematurity","PCV13, DTaP, HBV, IPV, Hib","Atlanta - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States",2021-11-01,2018-05-21,2024-02-14,INTERVENTIONAL,PHASE4,Duke University,OTHER,hepatitis
NCT04555434,Unknown,UNKNOWN,2019-10-01,Non-Alcoholic Fatty Liver Disease,Probiotics,"Chuncheon - Korea, Republic of",2020-09-11,2020-09-18,2020-09-18,INTERVENTIONAL,NA,Chuncheon Sacred Heart Hospital,OTHER,hepatitis
NCT00446134,Unknown,COMPLETED,2007-03,Chronic Hepatitis C,"Taribavirin, Taribavirin, Taribavirin, Ribavirin",Los Angeles - United States,2008-04,2007-03-12,2012-07-27,INTERVENTIONAL,PHASE2,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT01728324,Unknown,COMPLETED,2012-11,"Hepatitis C, Chronic","BI 207127-placebo: 8-week treatment, Ribavirin: 24-week treatment, BI 207127: 24-week treatment, Faldaprevir: 24-week treatment, Faldaprevir: 24-week treatment, Ribavirin-placebo: 8-week treatment, BI 207127: 24-week treatment, Faldaprevir-placebo: 8-week treatment, Faldaprevir: 16-week treatment, Ribavirin: 16-week treatment, RBV: 24-week treatment, BI 207127: 16-week treatment","North Little Rock - United States, Anaheim - United States, Bakersfield - United States, La Jolla - United States, Los Angeles - United States, Oceanside - United States, San Diego - United States, San Francisco - United States, Bradenton - United States, Deland - United States, Fort Lauderdale - United States, Gainesville - United States, Orlando - United States, Palm Harbor - United States, Zephyrhills - United States, Atlanta - United States, Chicago - United States, Springfield - United States, Valparaiso - United States, Baton Rouge - United States, Tupelo - United States, Kansas City - United States, Hillsborough - United States, Arlington - United States, Austin - United States, Dallas - United States, Murray - United States, Charlottesville - United States, Newport News - United States, Norfolk - United States, Richmond - United States, Camperdown - Australia, Kogarah - Australia, New Lambton - Australia, Randwick - Australia, Herston - Australia, Clayton - Australia, Darlinghurst - Australia, Heidelberg - Australia, Melbourne - Australia, Antwerpen - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Liège - Belgium, Roeselare - Belgium, Calgary - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Clichy Cedex - France, Creteil - France, Grenoble Cedex 9 - France, Paris Cedex 20 - France, Paris - France, Saint Laurent du Var Cedex - France, Toulouse - France, Villejuif Cedex - France, Aachen - Germany, Berlin - Germany, Dortmund - Germany, Düsseldorf - Germany, Erlangen - Germany, Esslingen - Germany, Freiburg - Germany, Hamburg - Germany, Mainz - Germany, Tübingen - Germany, Athens - Greece, Athens - Greece, Patras - Greece, Rhodes - Greece, Antella (fi) - Italy, Bisceglie (bat) - Italy, Bologna - Italy, Milano - Italy, Palermo - Italy, Pavia - Italy, Pescara - Italy, Roma - Italy, San Giovanni Rotondo (fg) - Italy, Auckland NZ - New Zealand, Hamilton - New Zealand, Barreiro - Portugal, Coimbra - Portugal, Lisboa - Portugal, Badalona (Barcelona) - Spain, Barcelona - Spain, Barcelona - Spain, L'Hospitalet Llobregat (BCN) - Spain, Madrid - Spain, Malaga - Spain, Sevilla - Spain, Vigo (Pontevedra) - Spain, Birmingham - United Kingdom, Edinburgh - United Kingdom, Hull - United Kingdom, Leeds - United Kingdom, Leicester - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Newcastle upon Tyne - United Kingdom, Oxford - United Kingdom, Plymouth - United Kingdom",2014-02,2012-11-19,2016-02-12,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT02881034,Unknown,COMPLETED,2014-02,Hepatitis C,Triple therapy,Lyon - France,2015-02,2016-08-26,2016-08-29,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT00157534,Unknown,COMPLETED,2004-10,"Hepatitis C, Chronic",Celgosivir,No locations listed,Unknown Date,2005-09-12,2005-09-12,INTERVENTIONAL,PHASE2,BioWest Therapeutics Inc,INDUSTRY,hepatitis
NCT01732224,Unknown,COMPLETED,2012-11,Spontaneous Reactivation of Hepatitis B,"Tenofovir + Telbivudine, Tenofovir",New Delhi - India,2014-04,2012-11-22,2016-03-23,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT00421434,STEALTHC-1,COMPLETED,2006-06,Chronic Hepatitis C,"Nitazoxanide, Peginterferon alfa-2a, Peginterferon alfa-2a, Ribavirin, Ribavirin","Alexandria - Egypt, Tanta - Egypt",2008-09,2007-01-12,2008-09-25,INTERVENTIONAL,PHASE3,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT02533934,STOP-CO,COMPLETED,2016-08,"HIV, Hepatitis C, Cirrhosis",Harvoni,"San Francisco - United States, Washington - United States, Baltimore - United States, Baltimore - United States, Bethesda - United States, New York - United States, New York - United States, Philadelphia - United States",2019-12-31,2015-08-27,2021-02-02,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,hepatitis
NCT01300234,TDF in CHB,COMPLETED,2011-03-30,Hepatitis B,"Tenofovir disoproxil fumarate (TDF) tablets, Adefovir dipivoxil (ADV) tablets","Guangzhou - China, Guangzhou - China, Guangzhou - China, Wuhan - China, Changsha - China, Nanjing - China, Nanjing - China, Changchun - China, Chengdu - China, Hangzhou - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Fuzhou - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China",2012-10-17,2011-02-21,2018-07-13,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02650024,Unknown,COMPLETED,2016-01,"Hepatitis C, Human Immunodeficiency Virus",No interventions listed,San Diego - United States,2021-04,2016-01-08,2021-04-27,OBSERVATIONAL,Not Available,"University of California, San Diego",OTHER,hepatitis
NCT06311734,Unknown,COMPLETED,2022-06-21,Chronic Hepatitis B,"LW231 tablets, Placebo",Changchun - China,2024-01-01,2024-03-15,2024-10-15,INTERVENTIONAL,PHASE1,"Shanghai Longwood Biopharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT02893124,Unknown,UNKNOWN,2016-08,Chronic Hepatitis B,peginterferon alfa,Guangzhou - China,2019-08,2016-09-08,2018-05-22,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT06650124,Unknown,NOT_YET_RECRUITING,2024-11-01,Autoimmune Hepatitis,"Mycophenolate Mofetil + Prednisolone Participants will receive mycophenolate mofetil in combination., Azathioprine + Prednisolone",No locations listed,2025-12-31,2024-10-21,2024-11-07,INTERVENTIONAL,PHASE3,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT06787534,Unknown,COMPLETED,2015-01-01,Liver Transplantation,No Interventions,No locations listed,2015-06-01,2025-01-22,2025-01-22,OBSERVATIONAL,Not Available,Xiao Xu,OTHER,hepatitis
NCT06425341,Unknown,RECRUITING,2024-06-14,Chronic Hepatitis B,"HRS-5635 Injection, HRS-5635 Injection, HRS-5635 Injection, HRS-5635 Injection",Guangzhou - China,2026-05-15,2024-05-22,2024-06-24,INTERVENTIONAL,PHASE2,"Fujian Shengdi Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT06644417,Unknown,RECRUITING,2024-11-14,HBV Infection With LLV,"TQA3605 tablets plus NAs, TQA3605 Placebo plus NAs","Beijing - China, Beijing - China, Fuzhou - China, Shenzhen - China, Guiyang - China, Zunyi - China, Zhengzhou - China, Changsha - China, Yueyang - China, Nanjing - China, Suzhou - China, Nanchang - China, Shenyang - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Xi'an - China, Hangzhou - China, Lishui - China",2026-04,2024-10-16,2025-03-03,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT00704717,Unknown,COMPLETED,2005-09,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b; SCH 54031) pen, Rebetol (ribavirin; SCH 18908)",No locations listed,2007-12,2008-06-25,2015-04-29,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03226717,Unknown,UNKNOWN,2017-08-10,Hepatitis C,Antiviral agents,Assiut - Egypt,2017-09-10,2017-07-24,2017-07-24,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01391117,Unknown,TERMINATED,2011-06,Hepatitis C Virus,"placebo., placebo., TMC649128., placebo., placebo, TMC649128, TMC649128., TMC649128, TMC649128., placebo.","Zuidlaren - Netherlands, Krakow - Poland, Kraków - Poland, Warszawa - Poland",2011-11,2011-07-11,2012-10-26,INTERVENTIONAL,PHASE1,Tibotec BVBA,INDUSTRY,hepatitis
NCT01362517,Unknown,COMPLETED,2010-04,"Diphtheria, Pertussis, Tetanus, Hepatitis B, Haemophilus Influenzae Infections",Quinvaxem,Ho Chi Minh City - Vietnam,2010-07,2011-05-30,2013-09-09,INTERVENTIONAL,PHASE3,Crucell Holland BV,INDUSTRY,hepatitis
NCT03268317,Unknown,UNKNOWN,2018-01,Hepatitis C,No interventions listed,No locations listed,2019-01,2017-08-31,2017-08-31,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT02600117,Unknown,COMPLETED,2016-01-26,"Hepatitis B, Chronic",Tenofovir disoproxil fumarate,Toronto - Canada,2023-02-28,2015-11-09,2023-05-12,INTERVENTIONAL,PHASE3,"University Health Network, Toronto",OTHER,hepatitis
NCT00001117,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C",No interventions listed,"Los Angeles - United States, Menlo Park - United States, San Diego - United States, San Francisco - United States, San Rafael - United States, Stanford - United States, Stanford - United States, Torrance - United States, Denver - United States, Washington - United States, Miami - United States, Atlanta - United States, Honolulu - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, New Orleans - United States, New Orleans - United States, Baltimore - United States, Boston - United States, Boston - United States, Minneapolis - United States, St Louis - United States, Buffalo - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Chapel Hill - United States, Cincinnati - United States, Cleveland - United States, Columbus - United States, Philadelphia - United States, West Columbia - United States, Galveston - United States, Seattle - United States, San Juan - Puerto Rico",Unknown Date,2001-08-31,2008-08-01,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00381017,Unknown,WITHDRAWN,2006-09,"Hepatitis C, Liver Cirrhosis, HIV Infections",Peg interferon alpha-2b,No locations listed,Unknown Date,2006-09-27,2014-08-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01679834,Unknown,COMPLETED,2014-11-24,"Hepatitis C, Chronic",No interventions listed,"Hannover - Germany, Herne - Germany",2017-07-14,2012-09-06,2018-03-01,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02946034,Unknown,COMPLETED,2017-02-01,"Chronic Kidney Disease, Chronic Hepatitis C","Viekira Pak ± ribavirin, Mavyret",Boston - United States,2020-09-16,2016-10-26,2021-11-05,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT00255034,Unknown,TERMINATED,2005-02,"Hepatitis C, Chronic","Peginterferon alfa-2b, Peginterferon alfa-2b, Ribavirin, Ribavirin",No locations listed,2008-06,2005-11-17,2017-04-06,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00412334,Unknown,COMPLETED,2007-01,"Hepatitis C, Chronic","Copegus, Copegus, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Angers - France, Bobigny - France, Chateauroux - France, Creteil - France, Creteil - France, Grenoble - France, Hyeres - France, Lille - France, Limoges - France, Marseille - France, Marseille - France, Metz - France, Montpellier - France, Nice - France, Paris - France, Paris - France, Pessac - France, Poitiers - France, Strasbourg - France, Toulouse - France, Vandoeuvre-les-nancy - France, Villejuif - France",2010-09,2006-12-18,2016-04-05,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04612634,Unknown,UNKNOWN,2020-11-12,Vaccination,"Hepatitis A (Live) Vaccine, Freeze-dried produced by Changchun, Hepatitis A (Live) Vaccine, Freeze-dried produced by Zhejiang, Hepatitis A (Live) Vaccine, Freeze-dried produced by the Institute of Medical Biology, CAMS","Hanzhong - China, Hanzhong - China",2021-01-13,2020-11-03,2021-02-26,INTERVENTIONAL,PHASE4,China National Biotec Group Company Limited,INDUSTRY,hepatitis
NCT04405024,HOSPI-VHC,RECRUITING,2020-09-21,Hepatitis C,Hepatitis C testing,"Créteil - France, Jossigny - France, Meaux - France, Villeneuve-Saint-Georges - France",2024-06-21,2020-05-28,2023-10-31,INTERVENTIONAL,NA,Centre Hospitalier Intercommunal Creteil,OTHER,hepatitis
NCT01278134,Unknown,COMPLETED,2011-02,"Hepatitis C, Chronic","Copegus placebo, RO5024048, danoprevir, peginterferon alfa-2a [Pegasys], ribavirin [Copegus], ritonavir","La Jolla - United States, Sacramento - United States, Orlando - United States, Marietta - United States, Honolulu - United States, Honolulu - United States, Chicago - United States, Indianapolis - United States, Lutherville - United States, Detroit - United States, Newark - United States, Albuquerque - United States, New York - United States, Providence - United States, Nashville - United States, Houston - United States, Newport News - United States, Vancouver - United States, Clichy - France, Creteil - France, Lille - France, Marseille - France, Montpellier - France, Paris - France, Berlin - Germany, Berlin - Germany, Frankfurt Am Main - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Leipzig - Germany, Grafton - New Zealand",2012-10,2011-01-17,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00473824,Unknown,TERMINATED,2007-05,"Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation",Hepatitis C Immune Globulin Intravenous (Human) 5%,"Phoenix - United States, Jacksonville - United States, Rochester - United States",2009-02,2007-05-16,2021-07-30,INTERVENTIONAL,PHASE2,"ADMA Biologics, Inc.",INDUSTRY,hepatitis
NCT04704024,REVERT-B,RECRUITING,2021-09-03,Hepatitis B Infection,"Tenofovir Disoproxil Fumarate, Lamivudine Oral Solution",Birmingham - United States,2025-12-31,2021-01-11,2024-10-18,INTERVENTIONAL,PHASE3,University of Alabama at Birmingham,OTHER,hepatitis
NCT01564134,Unknown,COMPLETED,2011-08,"Vaccination; Complications, Reaction, Serum",hepatitis B vaccine,"Xicheng District - China, Chifeng - China",2012-03,2012-03-27,2013-07-10,INTERVENTIONAL,NA,Wu Jiang,OTHER_GOV,hepatitis
NCT00720434,Unknown,COMPLETED,2008-08,Hepatitis C,"PF-00868554, PF-00868554, PF-00868554, Placebo","La Jolla - United States, San Francisco - United States, Orlando - United States, Springfield - United States, New York - United States, New York - United States, Tulsa - United States, Nashville - United States, San Antonio - United States, Santurce - Puerto Rico",2010-03,2008-07-22,2013-08-26,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,hepatitis
NCT00221624,PEGARI,COMPLETED,2001-11,"HCV Infection, Hepatitis C, Chronic","Peginterferon alfa-2a, ribavirin, amantadine",Pessac - France,Unknown Date,2005-09-22,2007-06-13,INTERVENTIONAL,PHASE3,"University Hospital, Bordeaux",OTHER,hepatitis
NCT01497834,Unknown,COMPLETED,2012-01,Hepatitis C,"BMS-790052 (Daclatasvir), BMS-650032 (Asunaprevir)","Nagoya-shi - Japan, Chiba-shi - Japan, Fukuoka-shi - Japan, Kurume - Japan, Ogaki-shi - Japan, Hiroshima-shi - Japan, Sapporo-Shi - Japan, Amagasaki-shi - Japan, Kanazawa-shi - Japan, Takamatsu-shi - Japan, Kagoshima-shi - Japan, Kawasaki-Shi - Japan, Sendai-Shi - Japan, Okayama-shi - Japan, Osaka-sayama-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Suita - Japan, Iruma-Gun - Japan, Bunkyo-Ku - Japan, Minato-ku - Japan, Musashino-shi - Japan, Shinagawa-ku - Japan, Chuo-shi - Japan",2013-04,2011-12-23,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03402334,Unknown,COMPLETED,2019-03-11,"Hepatitis C, Atherosclerosis",Patient counseling for HCV associated CVD risk factors,New Orleans - United States,2021-02-15,2018-01-18,2022-09-21,INTERVENTIONAL,NA,Tulane University,OTHER,hepatitis
NCT03525119,Unknown,COMPLETED,2018-05-16,Healthy Volunteers,"TDV, HAV Vaccine, TDV Placebo, HAV Vaccine Placebo","Edgbaston - United Kingdom, Chorley - United Kingdom, Waterloo - United Kingdom, Sheffield - United Kingdom, Cardiff - United Kingdom, Glasgow - United Kingdom, Hexham - United Kingdom, Manchester - United Kingdom, Reading - United Kingdom, Stockton-on-Tees - United Kingdom",2018-10-03,2018-05-15,2022-08-19,INTERVENTIONAL,PHASE3,Takeda,INDUSTRY,hepatitis
NCT01399619,Unknown,COMPLETED,2011-09,"Hepatitis C, Chronic","PegIFN/RBV, PegIFN/RBV, BI201335, BI201335 24W, PegIFN/RBV, Bi 201335","Birmingham - United States, Palm Springs - United States, San Francisco - United States, Washington - United States, Fort Lauderdale - United States, Orlando - United States, Vero Beach - United States, Lutherville - United States, Framingham - United States, Camden - United States, Hillsborough - United States, Albany - United States, New York - United States, New York - United States, New York - United States, Winston-Salem - United States, Philadelphia - United States, Austin - United States, Dallas - United States, Fort Worth - United States, San Antonio - United States, Richmond - United States, Rio de Janeiro - RJ - Brazil, Rio de Janeiro - Brazil, Salvador - Brazil, Sao Paulo - Brazil, São Paulo - SP - Brazil, São Paulo - Brazil, Lyon - France, Marseille Cedex 08 - France, Marseille cedex 9 - France, Paris Cedex 12 - France, Paris - France, Paris - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hamburg - Germany, München - Germany, München - Germany, Würzburg - Germany, Antella (fi) - Italy, Bari - Italy, Brescia - Italy, Milano - Italy, Pavia - Italy, Roma - Italy, Torino - Italy, Badalona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, L'Hospitalet de Llobregat - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Basel - Switzerland, Bern - Switzerland, Lugano - Switzerland, Zürich - Switzerland, Brighton - United Kingdom, Edinburgh - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2013-09,2011-07-22,2016-08-29,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01940341,Unknown,COMPLETED,2013-09-12,HBeAg-negative Chronic Hepatitis B,"TAF, TDF, TAF Placebo, TDF Placebo","Los Angeles - United States, Palo Alto - United States, Pasadena - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Miami - United States, Catonsville - United States, Detroit - United States, Hillsborough - United States, Flushing - United States, Flushing - United States, Philadelphia - United States, Richmond - United States, Clayton - Australia, Fitzroy - Australia, Parkville - Australia, Nedlands - Australia, Perth - Australia, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Lyon cedex 04 - France, Strasbourg - France, Hong Kong - Hong Kong, Kwai Chung - Hong Kong, Shatin - Hong Kong, Tai Po - Hong Kong, Hyderabad - India, Hyderabad - India, New Delhi - India, Surat - India, Mumbai - India, Parel - India, Jaipur - India, Kolkata - India, Chandigarh - India, New Delhi - India, San Giovanni Rotondo - Italy, Bologna - Italy, Foggia - Italy, Pisa - Italy, Kurume-shi - Japan, Fukuoka - Japan, Omura-shi - Japan, Suita - Japan, Kitakyushu - Japan, Kobe - Japan, Musashino - Japan, Nishinomiya - Japan, Osaka - Japan, Sapporo - Japan, Tokyo - Japan, Yangsan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Bialystok - Poland, Chorzow - Poland, Lodz - Poland, Wroclaw - Poland, Bucharest - Romania, Bucuresti - Romania, Bucuresti - Romania, Constanta - Romania, Iasi - Romania, Koltsovo - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Novosibirsk - Russian Federation, Novosibirsk - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Barcelona - Spain, Hualien City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Diyarbakir - Turkey, Ankara - Turkey, Bursa - Turkey, Istanbul - Turkey, Izmir - Turkey, Nottingham - United Kingdom, London - United Kingdom, London - United Kingdom",2015-09-30,2013-09-12,2023-09-25,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01203319,Unknown,COMPLETED,2006-11,Hepatitis b,"60mcg/1.0ml recombinant hepatitis B vaccine, 30mcg/1.0ml recombinant hepatitis B vaccine, 10mcg/1.0ml recombinant hepatitis B vaccine",No locations listed,2010-12,2010-09-16,2012-04-27,INTERVENTIONAL,PHASE3,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT05550519,SALMONS,WITHDRAWN,2022-10-31,"Hepatitis B, Chronic","Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF)","Kolding - Denmark, Odense - Denmark, Roskilde - Denmark, Bobigny - France, La Tronche - France, Lyon - France, Rennes cedex 9 - France, Frankfurt - Germany, Hannover - Germany, Leipzig - Germany, Leipzig - Germany, Tübingen - Germany, Athens - Greece, Athens - Greece, Thessaloniki - Greece, Brescia - Italy, Foggia - Italy, Milano - Italy, Modena - Italy, Pisa - Italy, San Giovanni Rotondo - Italy, Torino - Italy, Braga - Portugal, Coimbra - Portugal, Lisboa - Portugal, Vila Real - Portugal, Barcelona - Spain, Barcelona - Spain, Santander - Spain, València - Spain",2025-08-25,2022-09-22,2022-10-31,INTERVENTIONAL,PHASE1,"Janssen Pharmaceutica N.V., Belgium",INDUSTRY,hepatitis
NCT05705141,Unknown,NOT_YET_RECRUITING,2024-04,Chronic Hepatitis b,No interventions listed,No locations listed,2026-08,2023-01-30,2024-03-19,OBSERVATIONAL,Not Available,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,OTHER,hepatitis
NCT05248919,Unknown,ENROLLING_BY_INVITATION,2023-06-01,Hepatitis C,Epclusa (nucleotide HCV NS5B polymerase inhibitors).,Karachi - Pakistan,2025-09-01,2022-02-21,2024-10-21,INTERVENTIONAL,NA,Queen Mary University of London,OTHER,hepatitis
NCT04199819,OBI,UNKNOWN,2022-01-01,"Occult Hepatitis B, Liver Transplant; Complications",entecavir,Hong Kong - Hong Kong,2023-12-31,2019-12-16,2022-05-23,INTERVENTIONAL,NA,The University of Hong Kong,OTHER,hepatitis
NCT03627819,Unknown,UNKNOWN,2018-05-04,Non-Alcoholic Fatty Liver Disease,"Plant sterol-enriched margarine, Plant stanol-enriched margarine, Control margarine",Maastricht - Netherlands,2019-10,2018-08-13,2018-08-27,INTERVENTIONAL,NA,Maastricht University Medical Center,OTHER,hepatitis
NCT02463019,Unknown,UNKNOWN,2015-01,"Chronic Hepatitis B, Antiviral Treatment",Tenofovir Disoproxil Fumarate,No locations listed,2019-01,2015-06-04,2015-06-04,INTERVENTIONAL,PHASE4,E-DA Hospital,OTHER,hepatitis
NCT00197119,Unknown,COMPLETED,2004-05,"Hepatitis B, Hepatitis A","Twinrix™ Adult, Twinrix™ Junior","Bruxelles - Belgium, Hradec Kralove - Czech Republic",2004-06,2005-09-20,2017-04-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00445419,Unknown,COMPLETED,2006-12,Chronic Hepatitis C,PEV2A PEV2B,Lausanne - Switzerland,Unknown Date,2007-03-09,2010-02-08,INTERVENTIONAL,PHASE1,Pevion Biotech Ltd,INDUSTRY,hepatitis
NCT01153919,Unknown,TERMINATED,2010-06-30,"Hepatitis C Infection, Thrombocytopenia","romiplostim, ribavirin, placebo, PEG-interferon alfa-2a, laboratory biomarker analysis",Los Angeles - United States,2014-07-14,2010-06-30,2017-04-11,INTERVENTIONAL,PHASE2,University of Southern California,OTHER,hepatitis
NCT01579019,Unknown,WITHDRAWN,2012-07,"Hepatitis C, Chronic","RO5024048, RO5024048, danoprevir, peginterferon alfa-2a [Pegasys], ribavirin [Copegus], ritonavir",No locations listed,2014-03,2012-04-17,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03146741,USHER,COMPLETED,2017-05-16,Heart Failure,Zepatier,Philadelphia - United States,2019-09-10,2017-05-10,2021-11-22,INTERVENTIONAL,PHASE2,University of Pennsylvania,OTHER,hepatitis
NCT02565719,Unknown,COMPLETED,2016-03,Chronic Hepatitis B,"REP 2139-Mg, Pegasys, Viread, REP 2165-Mg","Chisinau - Moldova, Republic of, Chisinau - Moldova, Republic of, Chisinau - Moldova, Republic of",2019-05,2015-10-01,2019-09-10,INTERVENTIONAL,PHASE2,Replicor Inc.,INDUSTRY,hepatitis
NCT02412319,Unknown,UNKNOWN,2014-10,HBeAg Positive Chronic Hepatitis B,"Anti-HBV placenta transfer factor injection, Placebo",No locations listed,2016-12,2015-04-09,2015-04-09,INTERVENTIONAL,PHASE4,"Shineway Pharmaceutical Co.,Ltd",INDUSTRY,hepatitis
NCT00611819,Unknown,UNKNOWN,2005-11,"Chronic Hepatitis C, Co-Infection HIV-HCV","Peg interferon + Ribavirin, Peg interferon + Ribavirin","Elche - Spain, Badalona - Spain, Jerez de la Frontera - Spain, Vigo - Spain, Gandia - Spain, Alicante - Spain, Barcelona - Spain, Castellón - Spain, Granada - Spain, Huelva - Spain, Madrid - Spain, Madrid - Spain, Murcia - Spain, Málaga - Spain, Sevilla - Spain, Valencia - Spain, Valencia - Spain, Valencia - Spain",2008-04,2008-02-11,2008-02-11,INTERVENTIONAL,PHASE4,University of Valencia,OTHER,hepatitis
NCT06357819,Unknown,COMPLETED,2023-10-12,Hepatitis C,INSTI HCV Self Test,Richmond - Canada,2023-12-17,2024-04-10,2024-04-10,OBSERVATIONAL,Not Available,bioLytical Laboratories,INDUSTRY,hepatitis
NCT00086541,Unknown,COMPLETED,2004-06,Chronic Hepatitis C,"Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks",No locations listed,Unknown Date,2004-07-07,2019-11-25,INTERVENTIONAL,PHASE3,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT04442841,Unknown,UNKNOWN,2020-09,Hepatitis B Reactivation,Hepatitis B vaccine,Barcelona - Spain,2022-01,2020-06-23,2020-07-31,INTERVENTIONAL,PHASE2,Hospital Clinic of Barcelona,OTHER,hepatitis
NCT00077649,Unknown,COMPLETED,2004-01,"Hepatitis C, Chronic","ribavirin [Copegus], ribavirin [Copegus], peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys], peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]","La Jolla - United States, Long Beach - United States, San Diego - United States, San Diego - United States, Farmington - United States, Bradenton - United States, Gainesville - United States, Jacksonville - United States, Wellington - United States, Honolulu - United States, Chicago - United States, Iowa City - United States, Boston - United States, St Louis - United States, Manhasset - United States, Chapel Hill - United States, Statesville - United States, Cincinnati - United States, Philadelphia - United States, Pittsburgh - United States, Houston - United States, Salt Lake City - United States, Charlottesville - United States, Richmond - United States, Santurce - Puerto Rico",2005-12,2004-02-13,2016-04-18,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02485106,Unknown,UNKNOWN,2015-07,Severe Alcoholic Hepatitis,"Rifaximin, Corticosteroid or pentoxifylline",No locations listed,2016-12,2015-06-30,2015-06-30,INTERVENTIONAL,PHASE3,"Saint Vincent's Hospital, Korea",OTHER,hepatitis
NCT01322906,Unknown,UNKNOWN,2011-03,Liver Failure,"Group 1, Group 2, Group 3",No locations listed,2011-11,2011-03-25,2011-04-11,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT05123599,OSPREY,COMPLETED,2021-12-06,"Hepatitis B, Chronic","JNJ-73763989, JNJ-64300535, ETV monohydrate, Tenofovir disoproxil, TAF","Edegem - Belgium, Edegem - Belgium, Clichy - France, Lyon - France, Milano - Italy, Pisa - Italy, Auckland - New Zealand, Myslowice - Poland, Barcelona - Spain, Santander - Spain, Kaohsiung City - Taiwan, Tao Yuan - Taiwan, London - United Kingdom",2023-07-31,2021-11-17,2025-02-28,INTERVENTIONAL,PHASE1,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT06356506,Unknown,NOT_YET_RECRUITING,2024-05-01,Autoimmune Hepatitis,No interventions listed,Beijing - China,2034-05-01,2024-04-10,2024-04-19,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT02862106,Unknown,COMPLETED,2010-09,Chronic Hepatitis B,εPA-44,"WuHan - China, Changsha - China, ChangSha - China, NanJing - China, XiAn - China, WenZhou - China, Beijing - China, Beijing - China, ChongQing - China",2013-03,2016-08-10,2019-08-20,INTERVENTIONAL,PHASE2,Chongqing Jiachen Biotechnology Ltd.,INDUSTRY,hepatitis
NCT03435406,Unknown,UNKNOWN,2017-07-27,Hepatopulmonary Syndrome,No interventions listed,Chongqing - China,2018-04-01,2018-02-19,2018-02-19,OBSERVATIONAL,Not Available,"Southwest Hospital, China",OTHER,hepatitis
NCT03303599,Unknown,COMPLETED,2017-11-13,Hepatitis C,No interventions listed,"Klagenfurt Am Woerthersee - Austria, St. Pölten - Austria, Linz - Austria, Graz - Austria, Hall in Tirol - Austria, Innsbruck - Austria, Wels - Austria, Wien - Austria, Edegem - Belgium, Woluwe-Saint-Lambert - Belgium, Aalst - Belgium, Gent - Belgium, Leuven - Belgium, Tournai - Belgium, Antwerpen - Belgium, Brussels - Belgium, Brussels - Belgium, Bruxelles - Belgium, Genk - Belgium, Gent - Belgium, Hasselt - Belgium, Kortrijk - Belgium, Liege - Belgium, Liege - Belgium, Mons - Belgium, Uccle - Belgium, Yvoir - Belgium, Orleans CEDEX 2 - France, Niort CEDEX - France, Besancon - France, Limoges CEDEX 1 - France, Pessac CEDEX - France, TOULOUSE Cedex 9 - France, TOULOUSE Cedex 9 - France, Epagny Metz Tessy - France, Limoges - France, Beziers CEDEX - France, Montpellier CEDEX 5 - France, Clichy - France, St Malo CEDEX - France, Vandoeuvre les Nancy CEDEX - France, Marseille CEDEX 05 - France, Rouen CEDEX - France, Creteil - France, Aix En Provence - France, Angers - France, Bordeaux - France, Bourgoin Jallieu - France, Brest - France, Clamart - France, Clermont Ferrand - France, Creteil - France, Grenoble - France, Hyeres - France, Le Port - France, Lorient - France, Lyon - France, Lyon - France, Marseille - France, Marseille - France, Nanterre - France, Nice - France, Nimes Cedex 9 - France, Paris Cedex 12 - France, Paris - France, Paris - France, Perpignan - France, Reims - France, Saint Laurent Du Var - France, St Jean de Vedas - France, Toulon - France, Toulouse - France, Toulouse - France, Tourcoing - France, Tourcoing - France, Villejuif - France, Athens - Greece, Kifissia - Greece, Piraeus - Greece, Nea Efkarpia - Greece, Alexandroupolis - Greece, Athens - Greece, Pireaus - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Be'er Sheva - Israel, Afula - Israel, Be'er Ya'akov - Israel, Gush Dan - Israel, Hadera - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Petakh Tikva - Israel, Ramat Gan - Israel, Tel Aviv - Israel, Naples - Italy, Bologna - Italy, Modena - Italy, Milano - Italy, Milano - Italy, Milan - Italy, Rozzano - Italy, Turin - Italy, Rome - Italy, Rome - Italy, Palermo - Italy, Bari - Italy, Cagliari - Italy, Ferrara - Italy, Foggia - Italy, Latina - Italy, Messina - Italy, Milan - Italy, Milan - Italy, Milan - Italy, Naples - Italy, Napoli - Italy, Napoli - Italy, Novara - Italy, Padua - Italy, Padua - Italy, Pisa - Italy, Rome - Italy, Salerno - Italy, Walbrzych - Poland, Zielona Gora - Poland, Zychlin - Poland, Krakow - Poland, Opole - Poland, Bialystok - Poland, Chorzow - Poland, Katowice - Poland, Myslowice - Poland, Bydgoszcz - Poland, Kielce - Poland, Lodz - Poland, Lodz - Poland, Warsaw - Poland, Barreiro - Portugal, Vila Nova De Gaia - Portugal, Almada - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Genève - Switzerland, St. Gallen - Switzerland, Bern - Switzerland, Lugano - Switzerland, Neuchatel - Switzerland, Zurich - Switzerland",2020-01-24,2017-10-06,2021-05-19,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01369199,HBRN,TERMINATED,2012-05,Hepatitis B,Entecavir and peginterferon,"Los Angeles - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Honolulu - United States, Bethesda - United States, Boston - United States, Boston - United States, Ann Arbor - United States, Minneapolis - United States, Rochester - United States, Saint Louis - United States, Saint Louis - United States, Chapel Hill - United States, Durham - United States, Dallas - United States, Dallas - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2017-02-14,2011-06-08,2022-05-26,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00502099,Unknown,COMPLETED,2006-01,Hepatitis C,"Pegylated interferon alpha 2a, Ribavirin, Pegylated interferon alpha 2 b plus ribavirin",No locations listed,2009-05,2007-07-17,2012-10-23,INTERVENTIONAL,PHASE4,Amr Hafez,OTHER,hepatitis
NCT02808299,LISHBV,UNKNOWN,2016-12,"Liver Injury, Hepatitis B Virus Infection History",HBV infection history,Nanjing - China,2020-12,2016-06-21,2016-06-21,OBSERVATIONAL,Not Available,The First Affiliated Hospital with Nanjing Medical University,OTHER,hepatitis
NCT02313649,Unknown,COMPLETED,2014-12,Liver Fibrosis,No interventions listed,"Beijing - China, Chengdu - China, GuangZhou - China, Guangzhou - China, GuangZhou - China, Haerbin - China, HangZhou - China, KunMing - China, LanZhou - China, NanJing - China, Shanghai - China, ShenYang - China, XiAn - China, XiAn - China, ZhengZhou - China",2016-04,2014-12-10,2016-04-19,OBSERVATIONAL,Not Available,SuperSonic Imagine,INDUSTRY,hepatitis
NCT00203606,Unknown,COMPLETED,2004-01,Hepatitis c,pegylated interferon alfa-2a ( Roche) and ribavirin,"Calgary - Canada, Vancouver - Canada",2009-01,2005-09-20,2011-08-04,INTERVENTIONAL,PHASE4,University of Calgary,OTHER,hepatitis
NCT02888106,Unknown,COMPLETED,2016-04,Chronic Viral Hepatitis B With Delta-agent,"Myrcludex B, PEG IFN alfa-2a, Tenofovir","Chelyabinsk - Russian Federation, Krasnodar - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation, Stavropol' - Russian Federation",2019-11-22,2016-09-02,2021-04-30,INTERVENTIONAL,PHASE2,Hepatera Ltd.,INDUSTRY,hepatitis
NCT00606099,Unknown,WITHDRAWN,2007-11,Chronic Hepatitis B,"telbivudine, adefovir dipivoxil","Atlanta - United States, Flushing - United States, Sterling - United States",2009-11,2008-02-01,2012-05-02,INTERVENTIONAL,PHASE4,Novartis,INDUSTRY,hepatitis
NCT03850899,Unknown,COMPLETED,2019-04-17,Alcoholic Hepatitis,No interventions listed,"Indianapolis - United States, Louisville - United States, Boston - United States, Worcester - United States, Rochester - United States, Cleveland - United States, Pittsburgh - United States, Dallas - United States, Richmond - United States",2024-06-21,2019-02-22,2025-02-14,OBSERVATIONAL,Not Available,Indiana University,OTHER,hepatitis
NCT01609049,STANDART,COMPLETED,2011-12-07,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Busan - Korea, Republic of, Barnaul - Russian Federation, Barnaul - Russian Federation, Chelyabinsk - Russian Federation, Chita - Russian Federation, Ekaterinburg - Russian Federation, Irkutsk - Russian Federation, Kaluga - Russian Federation, Kazan - Russian Federation, Kemerovo - Russian Federation, Khabarovsk - Russian Federation, Khabarovsk - Russian Federation, Kirov - Russian Federation, Krasnodar - Russian Federation, Krasnodar - Russian Federation, Krasnoyarsk - Russian Federation, Krasnoyarsk - Russian Federation, Lipetsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizniy Novgorod - Russian Federation, Novosibirsk - Russian Federation, Petrozavodsk - Russian Federation, Rostov-na-donu - Russian Federation, Rostov-na-donu - Russian Federation, Rostov-na-donu - Russian Federation, Ryazan - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Samara - Russian Federation, Saratov - Russian Federation, Saratov - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St. Petersburg - Russian Federation, Stavropol - Russian Federation, Tumen - Russian Federation, UFA - Russian Federation, Vladivostok - Russian Federation, Vladivostok - Russian Federation, Volgograd - Russian Federation, Voronezh - Russian Federation, Yakutsk - Russian Federation, Yoshkar-Ola - Russian Federation",2015-06-22,2012-05-31,2017-04-12,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03022006,Unknown,UNKNOWN,2017-01-15,Chronic Hepatitis C,"elbasvir, grazoprevir",Sapporo - Japan,2019-03,2017-01-16,2017-04-12,INTERVENTIONAL,PHASE4,Norte Study Group,OTHER,hepatitis
NCT01289106,Unknown,UNKNOWN,2011-01,HIV Infection,"Hepavax-Gene, Hepavax-Gene, Hepavax-Gene",Muang - Thailand,2011-10,2011-02-03,2011-02-03,INTERVENTIONAL,PHASE3,Chiang Mai University,OTHER,hepatitis
NCT05922306,EPCP,RECRUITING,2023-07,"Hepatitis B, Chronic","PEGylated recombinant human interferon alpha-2b injection, PEGylated recombinant human interferon alpha-2b injection",Hefei - China,2027-06,2023-06-28,2023-06-28,INTERVENTIONAL,PHASE1,Anhui Medical University,OTHER,hepatitis
NCT02971306,Unknown,UNKNOWN,2014-07,Alcoholic Hepatitis,"standard medical therapy, G-CSF, n-Acetylcysteine",Chandigarh - India,2017-12,2016-11-22,2017-09-19,INTERVENTIONAL,PHASE4,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT04157699,Unknown,UNKNOWN,2019-07-26,Chronic Hepatitis b,"TDF tablet, QL-007","Guangzhou - China, Changchun - China",2020-12,2019-11-08,2019-11-12,INTERVENTIONAL,PHASE2,"Qilu Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT02717949,Optimal,TERMINATED,2016-02-25,Liver Disease,"sofosbuvir/ledipasvir, sofosbuvir, Ribavirin","New York - United States, New York - United States, Dallas - United States",2017-06-05,2016-03-24,2019-01-08,INTERVENTIONAL,PHASE4,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT00519649,Unknown,COMPLETED,2007-08-31,Hepatitis B Vaccine,Engerix™-B Kinder,"Birkenfeld - Germany, Ettenheim - Germany, Heidelberg - Germany, Karlsruhe - Germany, Oberkirch - Germany, Oberstenfeld - Germany, Offenburg - Germany, Pforzheim - Germany, Stuttgart - Germany, Tuttlingen - Germany, Bindlach - Germany, Kaufering - Germany, Lohr - Germany, Muenchen - Germany, Muenchen - Germany, Tegernsee - Germany, Loehne - Germany, Minden - Germany, Muenster - Germany, Porta Westfalica - Germany, Frankenthal - Germany, Mainz - Germany, Trier - Germany, Worms - Germany, Leipzig - Germany, Bredstedt - Germany, Flensburg - Germany, Flensburg - Germany, Flensburg - Germany, Husum - Germany, Kiel - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany",2007-12-31,2007-08-22,2018-08-17,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00814606,Unknown,WITHDRAWN,2010-02,"Hepatitis C, Hepatitis C Virus","Fluvastatin, Peginterferon alfa2a, ribavirin",No locations listed,2010-10,2008-12-25,2013-07-01,INTERVENTIONAL,PHASE2,University of Chicago,OTHER,hepatitis
NCT01878799,Unknown,COMPLETED,2013-06,"Hepatitis C, HIV",GS-7977/GS- 5885 FDC,Bethesda - United States,2014-09,2013-06-17,2016-09-15,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00378599,Unknown,COMPLETED,2006-05,"Liver Transplantation, Hepatitis C, Chronic, Liver Cirrhosis",Combination of (a) pegylated interferon alfa-2b and (b) rebetol,No locations listed,2009-07,2006-09-20,2017-04-06,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00656006,Unknown,COMPLETED,2005-11,Chronic Hepatitis C,"Albuferon, Ribavirin","Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Saskatoon - Canada",2007-04,2008-04-10,2013-08-02,INTERVENTIONAL,PHASE2,Human Genome Sciences Inc.,INDUSTRY,hepatitis
NCT01592006,Unknown,TERMINATED,2012-04,Hepatitis C,"Peginterferon alfa-2a, Ribavirin, telaprevir",Chicago - United States,2014-09,2012-05-04,2016-06-15,INTERVENTIONAL,PHASE4,University of Chicago,OTHER,hepatitis
NCT00110799,Unknown,COMPLETED,2005-04,"Hepatitis C, Chronic, Hepatitis C, Thrombocytopenia","SB497115, Placebo","Denver - United States, Boston - United States, Detroit - United States, St. Louis - United States, New York - United States, Durham - United States, San Antonio - United States, Fairfax - United States, Richmond - United States, Clermont Ferrand Cédex 1 - France, Clichy Cedex - France, Lyon Cedex 02 - France, Lyon - France, Marseille Cedex 08 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Pessac Cedex - France, Vandoeuvre Les Nancy - France, Heidelberg - Germany, Frankfurt - Germany, Hannover - Germany, Homburg - Germany, Berlin - Germany, Hamburg - Germany, San Juan - Puerto Rico, Bristol - United Kingdom, Glasgow - United Kingdom, Nottingham - United Kingdom, London - United Kingdom, London - United Kingdom",2006-10,2005-05-16,2012-06-04,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02065999,SEARCH-C,COMPLETED,2012-11,Chronic Hepatitis C Infection,No interventions listed,"Sydney - Australia, Melbourne - Australia",2022-06,2014-02-19,2024-03-06,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT01419899,InVITED,COMPLETED,2011-01,"Drug Use, HIV, Hepatitis C",Brief motivational intervention,Providence - United States,2012-01,2011-08-18,2013-08-07,INTERVENTIONAL,PHASE3,Rhode Island Hospital,OTHER,hepatitis
NCT02604199,Unknown,TERMINATED,2015-09,Hepatitis B,"ARC-520 Injection, placebo, entecavir, tenofovir, antihistamine","Hong Kong - China, Hong Kong - China, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, Leipzig - Germany, Muenchen - Germany, Tuebingen - Germany, Ulm - Germany, Wuerzburg - Germany, Busan - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan-si Gyeongnam - Korea, Republic of",2017-01,2015-11-13,2019-04-16,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT02511743,Unknown,COMPLETED,2015-04,Hepatitis B,physicians,Beijing - China,2015-11,2015-07-30,2015-11-06,OBSERVATIONAL,Not Available,Peking University First Hospital,OTHER,hepatitis
NCT00200343,Unknown,COMPLETED,2002-07,Chronic Hepatitis C,"Ursodeoxycholic acid 150mg / day, Ursodeoxycholic acid 600mg / day, Ursodeoxycholic acid 900mg / day","hongo, bunkyo-ku, Tokyo - Japan",Unknown Date,2005-09-20,2012-03-12,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00990938,Unknown,COMPLETED,2009-09,"Hepatitis C, Treatment Naïve, Genotype 1 Patients","IMO-2125, Saline",Rennes - France,2010-05,2009-10-07,2019-02-15,INTERVENTIONAL,PHASE1,"Idera Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02704338,Treg,UNKNOWN,2016-04,Autoimmune Diseases,Regulatory T cells,No locations listed,2018-03,2016-03-10,2016-03-10,INTERVENTIONAL,PHASE2,Nanjing Medical University,OTHER,hepatitis
NCT06515938,Unknown,COMPLETED,2013-01-01,Vaccine Reaction,"20μg Engerix-B hepatitis B vaccine, 20μg Kangtai hepatitis B vaccine, 60μg Kangtai hepatitis B vaccine, 20μg CHO","Huaibei - China, Xuanhua - China",2014-06-30,2024-07-23,2024-07-24,INTERVENTIONAL,NA,Wu Jiang,OTHER_GOV,hepatitis
NCT00483938,IMPROVE,COMPLETED,2007-06,"Hepatitis C, Chronic","Pegylated-interferon Alfa-2a, Ribavirin","Milwaukee - United States, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Abbotsford - Canada, Vancouver - Canada, Vancouver - Canada, Vernon - Canada, Victoria - Canada, Halifax - Canada, East York - Canada, Hamilton - Canada, Kingston - Canada, London - Canada, Mississauga - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Woodbridge - Canada, Montreal - Canada, Montreal - Canada, Saskatoon - Canada",2010-05,2007-06-08,2017-01-23,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00277238,Unknown,COMPLETED,2006-02,"Hepatitis, Chronic Active","CPG10101, CPG10101, Control, CPG10101","Chicago - United States, Indianapolis - United States, New Orleans - United States, Detroit - United States, Kansas City - United States, St. Louis - United States, New York - United States, Durham - United States, Cleveland - United States, Hershey - United States, Germantown - United States, Dallas - United States, San Antonio - United States, Richmond - United States",2007-07,2006-01-16,2017-03-08,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,hepatitis
NCT04662138,Unknown,UNKNOWN,2020-08-24,"Hepatitis C, Relapse, Antivirals",directly acting antivirals,Alexandria - Egypt,2022-05-28,2020-12-10,2020-12-10,OBSERVATIONAL,Not Available,Alexandria University,OTHER,hepatitis
NCT03780543,Unknown,TERMINATED,2018-12-20,Chronic Hepatitis B,standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI),"Beverly Hills - United States, Coronado - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Stanford - United States, Miami - United States, Baltimore - United States, Catonsville - United States, Hillsborough - United States, Flushing - United States, New York - United States, New York - United States, Philadelphia - United States, Philadelphia - United States, Vancouver - Canada, Toronto - Canada, Toronto - Canada, Hong Kong - Hong Kong, Auckland - New Zealand, Hamilton - New Zealand, London - United Kingdom",2021-04-26,2018-12-19,2023-04-19,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT00031343,Unknown,COMPLETED,2002-02,"HIV Infections, Hepatitis C",highly active antiretroviral therapy (HAART),Bethesda - United States,Unknown Date,2002-03-04,2008-03-04,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01532843,PEGON,COMPLETED,2012-06,Chronic Hepatitis B,PegIFN alfa-2b,"Shanghai - China, Shanghai - China, Shanghai - China, Rotterdam - Netherlands",2015-08,2012-02-15,2019-01-04,INTERVENTIONAL,PHASE4,Foundation for Liver Research,OTHER,hepatitis
NCT02584543,Unknown,COMPLETED,2015-10,"Hepatitis E, Hepatitis B","HEV vaccine, HBV vaccine",Beijing - China,2016-08-25,2015-10-22,2017-12-04,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT02605538,Unknown,WITHDRAWN,2015-09-01,"Cystic Fibrosis, Hepatitis A, Hepatitis B, Tuberculosis",Vaccination with vaccine against hepatitis A and B,Stockholm - Sweden,2023-12,2015-11-16,2024-03-18,INTERVENTIONAL,NA,Karolinska University Hospital,OTHER,hepatitis
NCT00375895,Unknown,TERMINATED,2006-06,"Chronic Hepatitis C, Evidence of Liver Transplantation",ciclosporin,"Besançon - France, Clichy - France, Créteil - France, Lille - France, Lyon - France, Marseille - France, Montpellier - France, Nice - France, Paris - France, Rennes - France, Strasbourg - France, Toulouse - France, Villejuif - France",2008-10,2006-09-13,2012-03-02,INTERVENTIONAL,PHASE3,Rennes University Hospital,OTHER,hepatitis
NCT05841095,HEB-PEP,RECRUITING,2023-08-04,Chronic Hepatitis b,"ISA104, Placebo",Rotterdam - Netherlands,2024-09-01,2023-05-03,2024-02-20,INTERVENTIONAL,PHASE2,Erasmus Medical Center,OTHER,hepatitis
NCT00265395,Unknown,COMPLETED,2004-12,"Hepatitis C, Chronic","Combination of pegylated interferon alfa-2b (PEG-Intron®) and ribavirin (Rebetol®), Combination of pegylated interferon alfa-2b and ribavirin",No locations listed,2008-05,2005-12-14,2017-04-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02397395,Unknown,WITHDRAWN,2015-05,"Renal Impairment, End-stage Renal Disease","Simeprevir (SMV) 150 mg, Daclatasvir (DCV) 60 mg","Paris - France, Toulouse Cedex 9 - France, Villejuif - France, Barcelona - Spain, Madrid - Spain, Santander - Spain",2016-02,2015-03-25,2015-07-17,INTERVENTIONAL,PHASE2,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT02966795,ENDURANCE-5 6,COMPLETED,2017-01-25,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir,"San Diego - United States, San Diego - United States, San Francisco - United States, West Hollywood - United States, Philadelphia - United States, Seattle - United States, Kingswood - Australia, Herston - Australia, Parkville - Australia, Kortrijk - Belgium, Leuven - Belgium, Calgary - Canada, Toronto - Canada, Pessac CEDEX - France, Clichy - France, Clermont Ferrand - France, Paris - France, Auckland - New Zealand, Singapore - Singapore, Singapore - Singapore, Johannesburg - South Africa, Cape Town - South Africa, Hanoi - Vietnam, Ho Chi Minh - Vietnam, Ho Chi Minh - Vietnam",2018-06-06,2016-11-17,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01777295,Unknown,COMPLETED,2013-02-25,Hepatitis B,"Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A., EngerixTM-B, Placebo",Antwerpen - Belgium,2016-05-17,2013-01-28,2019-01-04,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00200746,Unknown,WITHDRAWN,2006-04,Alcoholic Hepatitis,Arginine,Torrance - United States,2009-07,2005-09-20,2013-03-12,INTERVENTIONAL,PHASE2,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT01010646,COAT IFN,UNKNOWN,2010-03,Chronic Hepatitis C,"IFN alfa-2b XL 27 MUI + Ribavirin, IFN alfa-2b XL 36 MUI + Ribavirin, IFN peg alfa-2b 1.5 µg/kg + Ribavirin",Lyon - France,2012-09,2009-11-10,2013-09-20,INTERVENTIONAL,PHASE2,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03601546,CoViet-C,UNKNOWN,2018-09-13,Hepatitis C Infection,Clinical examination,"Nîmes - France, Hai Phong - Vietnam",2021-08-31,2018-07-26,2021-08-09,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de Nīmes,OTHER,hepatitis
NCT01671046,Unknown,COMPLETED,2012-07,"Hepatitis C, Chronic",No interventions listed,"Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Botucatu - Brazil, Campinas - Brazil, Campinas - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil",2015-12,2012-08-23,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02005146,Unknown,COMPLETED,2013-12,Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues,No interventions listed,"Badalona - Spain, L'Hospitalet de Llobregat - Spain, Santiago de Compostela - Spain, Leganés - Spain, Almería - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Córdoba - Spain, Madrid - Spain, Oviedo - Spain, Pamplona - Spain, San Sebastián - Spain, Santander - Spain, Sevilla - Spain, Sevilla - Spain, Sevilla - Spain, Toledo - Spain, Valencia - Spain, Valencia - Spain, Zaragoza - Spain, Zaragoza - Spain",2014-12,2013-12-09,2015-05-01,OBSERVATIONAL,Not Available,Fundación Pública Andaluza Progreso y Salud,OTHER,hepatitis
NCT00771446,ELAD,COMPLETED,2008-10,"Acute Hepatitis, Chronic Hepatitis","ELAD plus standard of care treatment, Standard of care treatment","La Jolla - United States, San Francisco - United States, Chicago - United States, Boston - United States, Ann Arbor - United States, New York - United States",2009-04,2008-10-13,2013-04-12,INTERVENTIONAL,PHASE2,"Vital Therapies, Inc.",INDUSTRY,hepatitis
NCT04510246,Unknown,UNKNOWN,2020-09-08,Hepatitis C,Enhanced case management,Hobart - Australia,2022-03-01,2020-08-12,2022-03-02,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT05967650,Unknown,NOT_YET_RECRUITING,2023-09-01,Inflammatory Bowel Diseases,"standard hepatitis B vaccine, accelerated HBV Vaccine",No locations listed,2024-09-01,2023-08-01,2023-08-01,INTERVENTIONAL,NA,Assiut University,OTHER,hepatitis
NCT02092350,C-SURFER,COMPLETED,2014-03-17,Hepatitis C Virus,"Grazoprevir, Elbasvir, Placebo to Grazoprevir, Placebo to Elbasvir",No locations listed,2015-03-11,2014-03-20,2018-09-24,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02993250,Unknown,COMPLETED,2016-12-21,"Hepatitis C, Chronic","AL-335, Odalasvir (ODV), Simeprevir (SMV)","Amagasaki-shi - Japan, Bunkyo-ku - Japan, Hiroshima-shi - Japan, Kagoshima-shi - Japan, Kurume-shi - Japan, Musashino-shi - Japan, Nagoya-shi - Japan, Omura-shi - Japan, Osaka-shi - Japan, Saitama - Japan, Sakai-shi - Japan, Sapporo-shi - Japan, Suita-shi - Japan, Yokohama-shi - Japan",2018-05-07,2016-12-15,2019-09-11,INTERVENTIONAL,PHASE2,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT00313950,Unknown,COMPLETED,2006-09,"Measles, Mumps, Rubella, Hepatitis A","Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella, Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine, Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella",Izmir - Turkey,2009-12,2006-04-12,2014-01-22,INTERVENTIONAL,PHASE4,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT02956850,Unknown,COMPLETED,2016-12-12,"Hepatitis B, Chronic","Placebo, RO7020531","Sofia - Bulgaria, Sofia - Bulgaria, Hong Kong - Hong Kong, Shatin - Hong Kong, Modena - Italy, Bergamo - Italy, Rozzano - Italy, Amsterdam - Netherlands, Auckland - New Zealand, Tainan - Taiwan, Taipei City - Taiwan, Taoyuan - Taiwan, Xitun Dist. - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Liverpool - United Kingdom, London - United Kingdom",2021-06-15,2016-11-06,2024-02-08,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02856243,Unknown,UNKNOWN,2013-11,"Vasculitis, Cryoglobulinemia, Hepatitis C",new antiviral therapy,Paris - France,2016-12,2016-08-04,2016-09-29,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT02268864,COMMIT,COMPLETED,2015-01,"Hepatitis C, Chronic","Simeprevir, Daclatasvir","Antwerpen - Belgium, Brussel - Belgium, Gent - Belgium, Creteil - France, Lyon - France, Montpellier - France, Nice N/A - France, Paris Cedex 12 - France, Paris - France, Vandoeuvre Les Nancy - France, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Tübingen - Germany, Würzburg - Germany, Budapest - Hungary, Debrecen - Hungary, Badalona - Spain, Barcelona - Spain, Santander - Spain, Valencia - Spain, Birmingham - United Kingdom, London - United Kingdom",2016-01,2014-10-20,2017-03-16,INTERVENTIONAL,PHASE2,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT01273064,Unknown,TERMINATED,2011-01,Hepatitis C,"CTS-1027, pegylated interferon, Ribavirin, Placebo","Birmingham - United States, Coronado - United States, La Jolla - United States, Loma Linda - United States, Pasadena - United States, San Diego - United States, San Diego - United States, Aurora - United States, New Haven - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Maywood - United States, Indianapolis - United States, Kansas City - United States, Louisville - United States, New Orleans - United States, New Orleans - United States, Boston - United States, Worcester - United States, Detroit - United States, Rochester - United States, St. Louis - United States, Bronx - United States, New York - United States, New York - United States, New York - United States, New York - United States, Valhalla - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Fort Worth - United States, Galveston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Fairfax - United States, Newport News - United States, Richmond - United States, Seattle - United States",2011-09,2011-01-10,2012-06-11,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT06696664,Unknown,RECRUITING,2024-08-01,Chronic Hepatitis B,PEG-IFN-α,Beijing - China,2026-03-31,2024-11-20,2024-11-20,OBSERVATIONAL,Not Available,Minghui Li,OTHER_GOV,hepatitis
NCT00724464,Unknown,COMPLETED,2007-12,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b, pegylated interferon alfa-2b), Rebetol (ribavirin)",No locations listed,2010-10,2008-07-29,2015-10-19,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00590564,Unknown,COMPLETED,2002-10,Hepatitis C,Sho-saiko-to,New York - United States,2011-02,2008-01-10,2016-01-15,INTERVENTIONAL,PHASE2,Memorial Sloan Kettering Cancer Center,OTHER,hepatitis
NCT04597164,Unknown,RECRUITING,2020-12-22,"Hepatitis B, Chronic, Acute-On-Chronic Liver Failure",Artificial liver support system,Guangzhou - China,2024-12-31,2020-10-22,2024-11-29,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00196664,Unknown,COMPLETED,2005-10,Chronic Hepatitis C,Paroxetine,Vandoeuvre - France,Unknown Date,2005-09-20,2009-05-13,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT00004850,Unknown,COMPLETED,1991-03-15,"Hepatitis C, Hepatitis B",No interventions listed,Bethesda - United States,Unknown Date,2000-03-03,2025-03-11,OBSERVATIONAL,Not Available,National Institutes of Health Clinical Center (CC),NIH,hepatitis
NCT02253550,Unknown,COMPLETED,2014-10,Chronic Hepatitis C,"Simeprevir, Sofosbuvir",Los Angeles - United States,2016-01,2014-10-01,2016-02-24,INTERVENTIONAL,PHASE2,"Peter J. Ruane, M.D.",OTHER,hepatitis
NCT03501550,Unknown,COMPLETED,2018-06-26,Chronic Hepatitis C,"CDI-31244, SOF/VEL",Baltimore - United States,2019-01-08,2018-04-18,2021-04-28,INTERVENTIONAL,PHASE2,"Cocrystal Pharma, Inc.",INDUSTRY,hepatitis
NCT00221650,ROCO2,COMPLETED,2002-04,"HIV Infections, Hepatitis C, Chronic, Treatment Failure","Peginterferon alfa2a, Ribavirin",Bordeaux - France,Unknown Date,2005-09-22,2007-06-13,INTERVENTIONAL,PHASE2,"University Hospital, Bordeaux",OTHER,hepatitis
NCT02985450,Unknown,COMPLETED,2016-08,"Non-Alcoholic Fatty Liver Disease, Hepatitis B, Vaccine Reaction",Engerix-B,Calgary - Canada,2021-01,2016-12-07,2021-11-03,OBSERVATIONAL,Not Available,University of Calgary,OTHER,hepatitis
NCT01389323,Unknown,COMPLETED,2011-09,Hepatitis C,"Daclatasvir, Peg-Interferon Alfa-2a, Ribavirin","Montgomery - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, Maimi - United States, Miami - United States, Orlando - United States, Tampa - United States, Wellington - United States, West Palm Beach - United States, Atlanta - United States, Atlanta - United States, Maywood - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Springfield - United States, Ocean Springs - United States, Bronx - United States, Chapel Hill - United States, Charlotte - United States, Statesville - United States, Portland - United States, Arlington - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Annandale - United States, Richmond - United States, San Juan - Puerto Rico",2013-09,2011-07-08,2015-10-12,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06745895,MATCHES,RECRUITING,2024-10-21,"Colorectal Cancer Screening, Hepatitis C Virus",MATCHES,Tampa - United States,2026-10,2024-12-20,2024-12-20,INTERVENTIONAL,NA,H. Lee Moffitt Cancer Center and Research Institute,OTHER,hepatitis
NCT01012895,Unknown,COMPLETED,2009-12,Chronic Hepatitis C,"BMS-790052, BMS-650032, BMS-650032, BMS-650032, Pegylated-interferon alfa-2a, Ribavirin","Anaheim - United States, Coronado - United States, San Jose - United States, Aurora - United States, Baltimore - United States, Ann Arbor - United States, Statesville - United States, Arlington - United States, San Antonio - United States, Fairfax - United States, Clichy Cedex - France, Creteil Cedex - France, Marseille Cedex 08 - France, Paris Cedex 12 - France, Paris Cedex 13 - France, Paris Cedex 14 - France, Pessac - France, San Juan - Puerto Rico",2012-10,2009-11-13,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01097395,Unknown,COMPLETED,2010-02,Hepatitis C Virus,ribavirin,Aurora - United States,2015-08,2010-04-01,2021-09-16,INTERVENTIONAL,PHASE4,"University of Colorado, Denver",OTHER,hepatitis
NCT03088995,OPDEP,COMPLETED,2017-04-01,"HIV Infections, Hepatitis B, Hepatitis C",Pilot study,Paris - France,2017-09-01,2017-03-24,2017-12-08,OBSERVATIONAL,Not Available,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,OTHER,hepatitis
NCT04868981,Unknown,COMPLETED,2021-05-31,Hepatitis B,"GST-HG141 tablets, Matching Placebos for GST-HG141 tablets",Changchun - China,2022-02-23,2021-05-03,2022-06-07,INTERVENTIONAL,PHASE1,Fujian Cosunter Pharmaceutical Co. Ltd,INDUSTRY,hepatitis
NCT00511095,Unknown,COMPLETED,2007-06,Hepatitis B,HEPLISAV,"Boardman - United States, Grove City - United States, Pittsburgh - United States, Pittsburgh - United States, Upper Saint Clair - United States, Washington - United States, Fairfax - United States",2007-10,2007-08-03,2019-04-30,INTERVENTIONAL,PHASE2,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT01051414,Unknown,COMPLETED,2010-04,Hepatitis C Infection,"BMS-790052, BMS-650032","Hiroshima City - Japan, Sapporo-Shi - Japan, Kawasaki-Shi - Japan, Minato-Ku - Japan",2011-09,2010-01-18,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00838214,Unknown,COMPLETED,2001-03,Autoimmune Hepatitis,"budesonide, prednisone",Hannover - Germany,2008-12,2009-02-06,2019-05-07,INTERVENTIONAL,PHASE3,Dr. Falk Pharma GmbH,INDUSTRY,hepatitis
NCT01776814,Unknown,UNKNOWN,2013-02,Chronic Hepatitis B,No interventions listed,"Incheon - Korea, Republic of",2013-02,2013-01-28,2013-01-28,OBSERVATIONAL,Not Available,Gachon University Gil Medical Center,OTHER,hepatitis
NCT05949814,Easy-Tests,RECRUITING,2023-07-30,"HIV Infections, STI",acceptability of a PrEP program among HIV-negative MSM and TG,Paris - France,2025-02-15,2023-07-18,2024-02-28,OBSERVATIONAL,Not Available,Centre de santé sexuelle Le 190,OTHER,hepatitis
NCT01491295,Unknown,UNKNOWN,2012-09,Chronic Hepatitis B,"Tenofovir disoproxil fumarate, Lamivudine plus adefovir",Taipei - Taiwan,2019-12,2011-12-13,2016-04-01,INTERVENTIONAL,PHASE4,"Taipei Veterans General Hospital, Taiwan",OTHER_GOV,hepatitis
NCT02900443,CAMARO,UNKNOWN,2017-01,Autoimmune Hepatitis,"Mycophenolate mofetil, Azathioprine","Antwerpen - Belgium, Heerlen - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Arnhem - Netherlands, Den Bosch - Netherlands, Enschede - Netherlands, Groningen - Netherlands, Leiden - Netherlands, Maastricht - Netherlands, Nieuwegein - Netherlands, Nijmegen - Netherlands, Rotterdam - Netherlands, Uden - Netherlands",2023-06,2016-09-14,2023-06-22,INTERVENTIONAL,PHASE4,Radboud University Medical Center,OTHER,hepatitis
NCT06104046,Unknown,NOT_YET_RECRUITING,2023-10-26,Hepatitis C Virus,No interventions listed,No locations listed,2024-12-31,2023-10-27,2023-10-27,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT04428346,AMPLIFY,UNKNOWN,2022-10,"Hepatitis C, Chronic",Incentive payment,No locations listed,2023-09,2020-06-11,2022-04-14,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT00317746,PICCO,COMPLETED,2006-11,"Depression, HIV Infections, Hepatitis C","Citalopram, Placebos",Montreal - Canada,2012-03,2006-04-25,2017-05-22,INTERVENTIONAL,PHASE3,Marina Klein,OTHER,hepatitis
NCT01358864,Unknown,COMPLETED,2011-06,"Hepatitis C, Chronic","BI 201335, Pegylated Interferon-alpha (IFN), Ribavirin (RBV), Placebo","North Little Rock - United States, Englewood - United States, Palm Harbor - United States, Columbus - United States, Chicago - United States, Vaiparaiso - United States, Baton Rouge - United States, Baton Rouge - United States, New Orleans - United States, Framingham - United States, New York - United States, Winston-Salem - United States, Portland - United States, Arlington - United States, Austin - United States, Dallas - United States, Houston - United States, San Antonio - United States, Linz - Austria, Wien - Austria, Wien - Austria, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Jette - Belgium, Leuven - Belgium, Liège - Belgium, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Clichy - France, Lille - France, Marseille - France, Montpellier - France, Nice Cedex 3 - France, Paris - France, Paris - France, Pessac Cedex - France, Reims - France, Rennes Cedex 09 - France, Strasbourg - France, Vandoeuvre Cedex - France, Berlin - Germany, Berlin - Germany, Dortmund - Germany, Düsseldorf - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Leipzig - Germany, Mainz - Germany, München - Germany, Chiba, Chiba - Japan, Gifu, Gifu - Japan, Itabashi-ku, Tokyo - Japan, Izunokuni, Shizuoka - Japan, Kamakura, Kanagawa - Japan, Kita-gun, Kagawa - Japan, Kofu, Yamanashi - Japan, Kurashiki, Okayama - Japan, Kurume, Fukuoka - Japan, Matsumoto, Nagano - Japan, Matsuyama, Ehime - Japan, Nagoya, Aichi - Japan, Namegata, Ibaraki - Japan, Nishinomiya, Hyogo - Japan, Ogaki, Gifu - Japan, Omura, Nagasaki - Japan, Omuta, Fukuoka - Japan, Osaka, Osaka - Japan, Sapporo, Hokkaido - Japan, Sendai, Miyagi - Japan, Tanabe, Wakayama - Japan, Toyama,Toyama - Japan, Tsu, Mie - Japan, Tsuchiura, Ibaraki - Japan, Aveiro - Portugal, Barreiro - Portugal, Coimbra - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, San Juan - Puerto Rico, A Coruña - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Majadahonda-Madrid - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, Vigo (Pontevedra) - Spain, Bern - Switzerland, La Chaux-de-Fonds - Switzerland, Lugano - Switzerland, St. Gallen - Switzerland, Zürich - Switzerland, Bristol - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom",2013-02,2011-05-24,2016-08-29,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT02474043,Hep-Net,COMPLETED,2014-08,Hepatitis C,"Hep-Net Intervention, Usual Care",No locations listed,2016-08,2015-06-17,2019-01-11,INTERVENTIONAL,NA,"University of Wisconsin, Madison",OTHER,hepatitis
NCT00695019,Unknown,COMPLETED,2009-06,"Hepatitis C, Chronic","interferon-alpha lozenges, placebo lozenges","Dalin - Taiwan, Niaosong - Taiwan, Changhua - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Keelung - Taiwan, Taichung - Taiwan, Taipei City - Taiwan, Taipei - Taiwan",2011-11,2008-06-11,2024-02-21,INTERVENTIONAL,PHASE2,"Ainos, Inc. (f/k/a Amarillo Biosciences Inc.",INDUSTRY,hepatitis
NCT00136318,CIPPAD,COMPLETED,2004-01,Depression,"Escitalopram, Placebo, Peginterferon alfa-2a, Ribavirin",Leipzig - Germany,2008-09,2005-08-29,2013-03-21,INTERVENTIONAL,PHASE3,"Charite University, Berlin, Germany",OTHER,hepatitis
NCT00139113,Unknown,COMPLETED,1996-09,Hepatitis A,hepatitis A vaccine,"Anchorage - United States, Anchorage - United States",2001-06,2005-08-31,2024-08-20,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,hepatitis
NCT03719313,D-LIVR,COMPLETED,2018-12-01,Hepatitis Delta Virus,"Lonafarnib, Ritonavir, PEG IFN-alfa-2a, Placebo Lonafarnib, Placebo Ritonavir","Fresno - United States, Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, Sacramento - United States, Sacramento - United States, New Haven - United States, Miami - United States, Chicago - United States, Iowa City - United States, Bethesda - United States, Detroit - United States, New York - United States, New York - United States, Rochester - United States, Norman - United States, Dallas - United States, Houston - United States, Antwerpen - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Liège - Belgium, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Calgary - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Nice Cedex 3 - France, Strasbourg Cedex - France, Pessac - France, Clichy cedex - France, La Tronche - France, Lyon - France, Bondy - France, Villejuif - France, Freiburg - Germany, Tuebingen - Germany, Frankfurt - Germany, Hannover - Germany, Essen - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany, Athens - Greece, Afula - Israel, Beer-Sheva - Israel, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Jerusalem - Israel, Nahariya - Israel, Ramat Gan - Israel, San Giovanni Rotondo - Italy, Rozzano - Italy, Brescia - Italy, Foggia - Italy, Messina - Italy, Milano - Italy, Milano - Italy, Modena - Italy, Napoli - Italy, Parma - Italy, Pisa - Italy, Roma - Italy, Torino - Italy, Chisinau - Moldova, Republic of, Chisinau - Moldova, Republic of, Ulaanbaatar - Mongolia, Grafton - New Zealand, Karachi - Pakistan, Bucuresti - Romania, Bucuresti - Romania, Bucuresti - Romania, Bucuresti - Romania, Bucuresti - Romania, Cluj-Napoca - Romania, Chelyabinsk - Russian Federation, Krasnodar - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Pyatigorsk - Russian Federation, Samara - Russian Federation, Samara - Russian Federation, Stavropol - Russian Federation, Yakutsk - Russian Federation, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Falun - Sweden, Huddinge - Sweden, Malmö - Sweden, Bern - Switzerland, Changhua - Taiwan, Chia-Yi City - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan County - Taiwan, Diyarbakir - Turkey, Istanbul - Turkey, Izmir - Turkey, Kharkiv - Ukraine, Kyiv - Ukraine, Kyiv - Ukraine, Kyiv - Ukraine, Poltava - Ukraine, Sumy - Ukraine, Vinnytsia - Ukraine, London - United Kingdom, Glasgow - United Kingdom",2022-10-06,2018-10-25,2023-04-14,INTERVENTIONAL,PHASE3,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT00395018,Unknown,COMPLETED,2007-04,"Hepatitis B, Chronic",entecavir,"Chicago - United States, New Orleans - United States, Rochester - United States, Omaha - United States, Rochester - United States, Cincinnati - United States, Cleveland - United States, Dallas - United States, Houston - United States, Buenos Aires - Argentina, Woolloongabba - Australia, Heidelberg - Australia, Fortaleza - Brazil, Porto Alegre - Brazil, Sao Paulo - Brazil, Clichy Cedex - France, Paris Cedex 12 - France, Villejuif - France, Bologna - Italy, Roma - Italy, Roma - Italy, Torrette Di Ancona - Italy, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Kaohsiung - Taiwan, Taipei - Taiwan",2011-03,2006-11-02,2012-05-31,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00179413,COPILOT,COMPLETED,2000-01-15,"Hepatitis C Virus, Advanced Fibrosis, Cirrhosis","PEG -Intron, Colchicine","Birmingham - United States, Little Rock - United States, Bakersfield - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, Denver - United States, Danbury - United States, Manchester - United States, New Haven - United States, Washington, D.C. - United States, Washington, D.C. - United States, Bradenton - United States, Hollywood - United States, South Miami - United States, Downers Grove - United States, Baltimore - United States, Boston - United States, Burlington - United States, Florence - United States, Worcester - United States, Detroit - United States, Minneapolis - United States, Plymouth - United States, Rochester - United States, Kansas City - United States, Lebanon - United States, East Orange - United States, Egg Harbor - United States, Florham Park - United States, Santa Fe - United States, Forest Hills - United States, New York - United States, New York - United States, New York - United States, Poughkeepsie - United States, Syracuse - United States, Philadelphia - United States, Philadelphia - United States, Sayre - United States, Providence - United States, Providence - United States, Nashville - United States, Austin - United States, Granbury - United States, San Antonio - United States, San Antonio - United States, Salt Lake City - United States, Milwaukee - United States",2009-12-31,2005-09-16,2017-07-11,INTERVENTIONAL,PHASE4,Beth Israel Deaconess Medical Center,OTHER,hepatitis
NCT02405013,TAC,COMPLETED,2015-10,"Hepatitis C, HIV Infection","Sofosbuvir, Ribavirin, Sofosbuvir, Ledipasvir","Yaoundé - Cameroon, Abidjan - Côte D'Ivoire, Abidjan - Côte D'Ivoire, Dakar - Senegal",2017-07,2015-04-01,2017-12-13,INTERVENTIONAL,PHASE2,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03932513,Unknown,TERMINATED,2019-04-11,"HBV, Hepatitis B, Hepatitis B, Chronic",inarigivir soproxil,Singapore - Singapore,2019-12-21,2019-04-30,2020-04-29,INTERVENTIONAL,PHASE2,"F-star Therapeutics, Inc.",INDUSTRY,hepatitis
NCT03038113,Unknown,COMPLETED,2017-02-06,Chronic Hepatitis B,"RO7062931, Placebo, Immune Modulator","Parkville - Australia, Nedlands - Australia, Hong Kong - Hong Kong, Shatin, New Territories - Hong Kong, Gangwon-Do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Auckland - New Zealand, Singapore - Singapore, Singapore - Singapore, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taipei City - Taiwan, Taoyuan City - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand",2019-10-18,2017-01-31,2020-12-24,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00310336,Unknown,COMPLETED,2006-08,Hepatitis C,"S-adenosyl-L-methionine, betaine, pegylated interferon alpha2b, ribavirin",Basel - Switzerland,2009-08,2006-04-03,2010-10-28,INTERVENTIONAL,PHASE3,"University Hospital, Basel, Switzerland",OTHER,hepatitis
NCT05490836,Unknown,UNKNOWN,2022-09,Chronic Hepatitis B,"PEG IFN α-2b; TAF, PEG IFN α-2b; TAF",No locations listed,2024-08,2022-08-08,2022-08-08,INTERVENTIONAL,NA,Huashan Hospital,OTHER,hepatitis
NCT00353418,Unknown,COMPLETED,2006-06,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin, Ribavirin",No locations listed,2009-04,2006-07-18,2010-08-03,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00201318,Unknown,COMPLETED,2001-09,Non-Hodgkin's Lymphoma,Cyclophosphamide Doxorubicin Vincristine Lamivudine,Taipei - Taiwan,Unknown Date,2005-09-20,2005-09-20,INTERVENTIONAL,PHASE2,"National Health Research Institutes, Taiwan",OTHER,hepatitis
NCT03426618,Unknown,COMPLETED,2018-01-12,Hepatitis B,Non-interventional,"Seoul - Korea, Republic of",2019-03-13,2018-02-08,2019-06-03,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01459913,CONCISE,TERMINATED,2011-11,"Hepatitis C, Chronic","Telaprevir, Pegylated Interferon Alfa-2a, Ribavirin","Birmingham - United States, Birmingham - United States, Phoenix - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Farmington - United States, New Haven - United States, Bradenton - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Orlando - United States, Atlanta - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Baltimore - United States, Baltimore - United States, Columbia - United States, Boston - United States, Brockton - United States, Burlington - United States, Worcester - United States, Novi - United States, Kansas City - United States, Lebanon - United States, Egg Harbor Township - United States, Vineland - United States, Flushing - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Chapel Hill - United States, Charlotte - United States, Durham - United States, Hershey - United States, Arlington - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Falls Church - United States, Norfolk - United States, Richmond - United States, Seattle - United States, Madison - United States, Madison - United States, Milwaukee - United States, Linz - Austria, Vienna - Austria, Vienna - Austria, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Berlin - Germany, Dusseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Koeln - Germany, Leipzig - Germany, Munich - Germany, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petah Tikva - Israel, Tel Hashomer - Israel, Bialystok - Poland, Czeladz - Poland, Myslowice - Poland, Wroclaw - Poland",2014-01,2011-10-26,2015-06-10,INTERVENTIONAL,PHASE3,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT05382013,Unknown,UNKNOWN,2022-04-27,"Thrombocytopenia, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure","Avatrombopag, Artificial Liver Support System, Comprehensive internal medical treatment.",Guangzhou - China,2024-02-29,2022-05-19,2022-11-10,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04202536,Unknown,UNKNOWN,2019-05-29,"Hepatitis B, Besifovir Dipivoxil Maleate, Tenofovir Disoproxil Fumarate","Besifovir Dipivoxil Maleate, Tenofovir disoproxil fumarate(TDF)","Ansan - Korea, Republic of",2021-06,2019-12-17,2019-12-17,INTERVENTIONAL,PHASE4,IlDong Pharmaceutical Co Ltd,INDUSTRY,hepatitis
NCT01701336,HCV004,COMPLETED,2012-03,Hepatitis C,"Ad6NSmut, MVA-NSmut","Pisa - Italy, Pisa - Italy",2012-10,2012-10-05,2013-08-29,INTERVENTIONAL,PHASE1,ReiThera Srl,INDUSTRY,hepatitis
NCT04483518,Unknown,COMPLETED,2019-06-03,Observe and Describe the Prevalence of Hepatitis D Infection Among HBsAg Positive People,No interventions listed,Changchun - China,2020-07-07,2020-07-23,2020-07-23,OBSERVATIONAL,Not Available,The First Hospital of Jilin University,OTHER,hepatitis
NCT01159613,Unknown,COMPLETED,2008-04,Chronic Hepatitis C Viral Infection,"Responders, Non Responders","Safed, Israel - Israel",2008-10,2010-07-09,2010-07-09,OBSERVATIONAL,Not Available,Ziv Hospital,OTHER_GOV,hepatitis
NCT04395118,STOP-HCC,WITHDRAWN,2020-08-15,"Hepatitis C, Hepatocellular Carcinoma",Mailed Outreach,Dallas - United States,2021-06-01,2020-05-20,2020-07-02,INTERVENTIONAL,NA,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT01861613,Unknown,COMPLETED,2009-09,"Hepatitis B, Immune Response, Seroprevalence","HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)",Nanning - China,2011-11,2013-05-23,2013-05-24,INTERVENTIONAL,PHASE4,Hui Zhuang,OTHER,hepatitis
NCT00077636,Unknown,COMPLETED,2003-12,"Hepatitis C, Chronic","Copegus, Copegus, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Birmingham - United States, Mobile - United States, Anchorage - United States, Phoenix - United States, Scottsdale - United States, Little Rock - United States, La Jolla - United States, Long Beach - United States, Los Angeles - United States, Palo Alto - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Luis Obispo - United States, Littleton - United States, Farmington - United States, Bradenton - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Pensacola - United States, Tampa - United States, Wellington - United States, Atlanta - United States, Austell - United States, Honolulu - United States, Boise - United States, Moline - United States, Indianapolis - United States, Iowa City - United States, Iowa City - United States, Baton Rouge - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Boston - United States, Burlington - United States, Worcester - United States, Ann Arbor - United States, Detroit - United States, Minneapolis - United States, Plymouth - United States, St Louis - United States, Albuquerque - United States, Bayside - United States, Binghamton - United States, Bronx - United States, Manhasset - United States, New York - United States, New York - United States, Williamsville - United States, Chapel Hill - United States, Durham - United States, Fayetteville - United States, Statesville - United States, Cincinnati - United States, Cleveland - United States, Portland - United States, Hershey - United States, Lancaster - United States, Pittsburgh - United States, Cranston - United States, Providence - United States, Germantown - United States, Dallas - United States, Dallas - United States, Fort Sam Houston - United States, Houston - United States, Salt Lake City - United States, White River Junction - United States, Charlottesville - United States, Chesapeake - United States, Falls Church - United States, Richmond - United States, Bellevue - United States, Kirkland - United States, Puyallup - United States, Seattle - United States, Seattle - United States, Spokane - United States, Madison - United States, Cheyenne - United States, Adelaide - Australia, Brisbane - Australia, Kingswood - Australia, Melbourne - Australia, Woolloongabba - Australia, Edmonton - Canada, Downsview - Canada, Mississauga - Canada, Clichy - France, Creteil - France, La Tronche - France, Marseille - France, Nice - France, Rennes - France, Strasbourg - France, Toulouse - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Düsseldorf - Germany, Freiburg - Germany, Hannover - Germany, Homburg/saar - Germany, Kiel - Germany, Bergamo - Italy, Bologna - Italy, Milano - Italy, Napoli - Italy, Pavia - Italy, Pisa - Italy, Otahuhu - New Zealand, Ponce - Puerto Rico, San Juan - Puerto Rico, San Juan - Puerto Rico, Santurce - Puerto Rico, Badalona - Spain, Barakaldo - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain",2006-03,2004-02-13,2016-02-23,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06137313,EVE,RECRUITING,2023-12-15,Hepatitis E,questionnaire,Toulouse - France,2024-10-15,2023-11-18,2024-05-16,OBSERVATIONAL,Not Available,"University Hospital, Toulouse",OTHER,hepatitis
NCT02532413,Unknown,UNKNOWN,2015-07,Chronic Hepatitis B,"Poly IC, Entecavir",Wuhan - China,2016-08,2015-08-25,2015-08-25,INTERVENTIONAL,PHASE4,"Wuhan Union Hospital, China",OTHER,hepatitis
NCT03316313,Unknown,COMPLETED,2016-06,Hepatitis C,Hepatitis C Antibody,No locations listed,2016-10,2017-10-20,2018-11-19,OBSERVATIONAL,Not Available,New York Institute of Technology,OTHER,hepatitis
NCT03770936,Unknown,RECRUITING,2018-10-01,Liver Fibroses,"Candesartan, Ramipril",Tanta - Egypt,2026-10,2018-12-10,2018-12-10,INTERVENTIONAL,PHASE3,Sherief Abd-Elsalam,OTHER,hepatitis
NCT00466336,Unknown,COMPLETED,2003-01,"Chronic Hepatitis C, Hepatic Fibrosis, Cirrhosis",No interventions listed,Taipei - Taiwan,2006-12,2007-04-27,2008-03-06,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT03519113,Unknown,UNKNOWN,2018-03-29,Hepatitis B Infection,"GC1102 80,000 IU, GC1102 100,000 IU, I.V HBIG","Seoul - Korea, Republic of",2022-03-31,2018-05-08,2020-01-30,INTERVENTIONAL,PHASE3,Green Cross Corporation,INDUSTRY,hepatitis
NCT00197236,Unknown,COMPLETED,2003-11-11,Hepatitis A,"Havrix™, Infanrix™, ActHIB™","Phoenix - United States, Oakland - United States, San Ramon - United States, Wilmington - United States, Pembroke Pines - United States, Martinez - United States, Waterloo - United States, Bossier City - United States, Long Branch - United States, Ithaca - United States, Bismarck - United States, Youngstown - United States, Bellevue - United States, Hershey - United States, Pittsburgh - United States, Pittsburgh - United States, Charleston - United States, Beaumont - United States, Dallas - United States, Danville - United States, Mechanicsville - United States, La Crosse - United States",2007-12-03,2005-09-20,2018-08-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00704106,ADVPR,COMPLETED,2008-05,Hepatitis B,Entecavir,"Palo Alto - United States, San Jose - United States, San Jose - United States, Chicago - United States, Houston - United States, Plano - United States",2011-10,2008-06-24,2022-11-14,OBSERVATIONAL,Not Available,Pacific Health Foundation,OTHER,hepatitis
NCT02023099,GIFT I,COMPLETED,2013-12,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, Placebo",No locations listed,2014-10,2013-12-30,2018-06-06,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01641536,Unknown,COMPLETED,2011-11,"Hepatitis B, Chronic",HB-110,"Seoul - Korea, Republic of",2012-12,2012-07-16,2013-06-20,INTERVENTIONAL,PHASE1,"Genexine, Inc.",INDUSTRY,hepatitis
NCT01973049,Unknown,COMPLETED,2013-12,Hepatitis C,"Daclatasvir, Asunaprevir, BMS-791325, Ribavirin, Placebo matching Ribavirin","La Jolla - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Jacksonville - United States, Orlando - United States, South Miami - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Kansas City - United States, Kansas City - United States, Binghamton - United States, New York - United States, Asheville - United States, Durham - United States, Statesville - United States, Cleveland - United States, Allentown - United States, Nashville - United States, Houston - United States, San Antonio - United States, Alexandria - United States, Falls Church - United States, Norfolk - United States, Madison - United States, Darlinghurst - Australia, Greenslopes - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Heidelberg - Australia, Fremantle - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Hamilton - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Creteil - France, Marseille Cedex 08 - France, Montpellier - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex - France",2014-08,2013-10-31,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01341106,INFIRE,TERMINATED,2011-04,"Hepatitis B, Chronic, Liver Fibrosis",Treatment with entecavir(Baraclude®),Aachen - Germany,2015-01,2011-04-25,2015-09-23,INTERVENTIONAL,PHASE4,RWTH Aachen University,OTHER,hepatitis
NCT06155006,HCVLINKAGE,RECRUITING,2023-12-16,Hepatitis C Virus Infection,rapid diagnostic test HCV Ab Plus Rapid test,"Medellín - Colombia, Santa Marta - Colombia",2024-10-30,2023-12-04,2024-06-10,OBSERVATIONAL,Not Available,Asociación Colombiana de Hepatología,OTHER,hepatitis
NCT01307436,Unknown,COMPLETED,2007-03-14,Hepatitis A,"Epaxal, Havrix 720","Beer-Sheva - Israel, Petach-Tikva - Israel",2013-07-08,2011-03-03,2019-04-08,INTERVENTIONAL,PHASE3,Crucell Holland BV,INDUSTRY,hepatitis
NCT01473849,VHENUS,UNKNOWN,2010-05,"Cytomegalovirus Infection, Hepatitis C",No interventions listed,"Santiago de Compostela - Spain, Oviedo - Spain, L'Hospitalet de Llobregat - Spain, Pamplona - Spain, Barcelona - Spain, Córdoba - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Málaga - Spain, Sevilla - Spain, Valladolid - Spain, Zaragoza - Spain",2013-03,2011-11-17,2012-12-20,OBSERVATIONAL,Not Available,Sociedad Española de Trasplante Hepático,NETWORK,hepatitis
NCT05326906,Unknown,COMPLETED,2018-05-01,Lung Cancer,PD-1/PD-L1 inhibitors,Changsha - China,2021-05-01,2022-04-14,2022-05-16,OBSERVATIONAL,Not Available,Hunan Province Tumor Hospital,OTHER,hepatitis
NCT01707849,Unknown,COMPLETED,2012-10,Hepatitis C Recurrence After Liver Transplant,"EVL arm, MMF arm",Barcelona - Spain,2016-08,2012-10-16,2018-02-07,INTERVENTIONAL,PHASE3,Hospital Vall d'Hebron,OTHER,hepatitis
NCT03155906,INTRO-HCV,ACTIVE_NOT_RECRUITING,2017-05-18,"Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy",Health care delivery,"Bergen - Norway, Stavanger - Norway",2020-03-15,2017-05-16,2023-10-17,INTERVENTIONAL,NA,Haukeland University Hospital,OTHER,hepatitis
NCT01937806,Unknown,UNKNOWN,2013-10,Chronic Hepatitis B,"besifovir 150mg, tenofovir 300mg","Cheonan - Korea, Republic of, ChunCheon - Korea, Republic of, Wonju - Korea, Republic of, Ansan - Korea, Republic of, Guri - Korea, Republic of, Suwon, - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of",2016-02,2013-09-10,2020-01-27,INTERVENTIONAL,PHASE3,IlDong Pharmaceutical Co Ltd,INDUSTRY,hepatitis
NCT00862706,Unknown,WITHDRAWN,2009-04,Compensated Chronic Hepatitis B,Telbivudine/LDT600A,"Chicago - United States, Boston - United States, Bayside - United States, Houston - United States, Houston - United States, San Juan - Puerto Rico",2011-04,2009-03-17,2016-09-23,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02292706,Unknown,TERMINATED,2014-12-29,Hepatitis C Virus Infection,"Sofosbuvir, Ribavirin, LDV/SOF, SOF/VEL, SOF/VEL/VOX, Other SOF-Based Regimen, Ineligible parent treatment","Birmingham - United States, La Jolla - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Pasadena - United States, Rialto - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, Stanford - United States, Aurora - United States, Washington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Tampa - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Kansas City - United States, Monroe - United States, New Orleans - United States, Baltimore - United States, Catonsville - United States, Lutherville - United States, Boston - United States, Boston - United States, Ann Arbor - United States, Detroit - United States, Minneapolis - United States, Rochester - United States, Saint Paul - United States, Kansas City - United States, Saint Louis - United States, Hillsborough - United States, Santa Fe - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Charlotte - United States, Durham - United States, Fayetteville - United States, Cleveland - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Germantown - United States, Nashville - United States, Nashville - United States, Arlington - United States, Dallas - United States, Dallas - United States, Houston - United States, San Antonio - United States, Murray - United States, Annandale - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Seattle - United States, Camperdown - Australia, Sydney - Australia, Westmead - Australia, Herston - Australia, Woolloongabba - Australia, Fitzroy - Australia, Heidelberg - Australia, Melbourne - Australia, Prahran - Australia, Fremantle - Australia, Perth - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, London - Canada, Toronto - Canada, Montréal - Canada, Edmonton - Canada, Rennes - France, Paris - France, Montpellier Cedex 05 - France, Limoges Cedex - France, Toulouse - France, Marseille Cedex 08 - France, Nice Cedex 3 - France, Bordeaux - France, Clermont Ferrand - France, Clichy - France, Creteil Cedex - France, Grenoble Cedex 9 - France, Paris, Cedex 14 - France, Paris - France, Paris - France, Strasbourg - France, Vandoeuvre les Nancy - France, Villejuif - France, Frankfurt am Main - Germany, Hamburg - Germany, Hamburg - Germany, Koln - Germany, Mücheln - Germany, Milano - Italy, Milano - Italy, San Giovanni Rotondo - Italy, Torino - Italy, Auckland - New Zealand, Hamilton - New Zealand, Christchurch - New Zealand, San Juan - Puerto Rico, Majadahonda - Spain, Barcelona - Spain, Barcelona - Spain, Sevilla - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Glasgow - United Kingdom, Portsmouth - United Kingdom",2021-12-31,2014-11-17,2023-10-04,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03772249,Unknown,COMPLETED,2018-12-28,"Hepatitis B, Chronic","DCR-HBVS, Placebo for DCR-HBVS","Clayton - Australia, Fitzroy - Australia, Hong Kong - Hong Kong, Seoul - Korea, Republic of, Soeul - Korea, Republic of, Auckland - New Zealand, Auckland - New Zealand, Bangkok - Thailand, Khon Kaen - Thailand",2022-07-12,2018-12-11,2024-09-19,INTERVENTIONAL,PHASE1,"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",INDUSTRY,hepatitis
NCT01735006,Unknown,COMPLETED,2012-11-22,"Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia, Vulvar Intraepithelial Neoplasia, Persistent Infection","HPV Vaccine, HEV vaccine",Beijing - China,2019-08-01,2012-11-28,2020-02-24,INTERVENTIONAL,PHASE3,Xiamen University,OTHER,hepatitis
NCT02486406,ZIRCON,COMPLETED,2015-10-28,Chronic Hepatitis C Infection,"Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin, Ombitasvir mini tablet, Paritaprevir mini tablet, Ritonavir mini tablet, Dasabuvir mini tablet, Ribavirin solution","San Francisco - United States, Aurora - United States, Gainesville - United States, Orlando - United States, Indianapolis - United States, Boston - United States, Boston - United States, New York - United States, Philadelphia - United States, Houston - United States, Seattle - United States, Brussels - Belgium, Leuven - Belgium, Berlin - Germany, Freiburg - Germany, Wuppertal - Germany, San Juan - Puerto Rico, Esplugues de Llobregat - Spain, Barcelona - Spain, Madrid - Spain, Valencia - Spain",2020-11-19,2015-07-01,2021-10-05,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT03210506,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,Peginterferon Alfa-2a,Beijing - China,2017-12,2017-07-07,2017-07-12,INTERVENTIONAL,NA,Beijing Ditan Hospital,OTHER,hepatitis
NCT00328549,Unknown,COMPLETED,2001-10,"Hepatitis C, Anemia",Pegylated Interferon and Ribavirin,No locations listed,Unknown Date,2006-05-22,2011-05-19,INTERVENTIONAL,PHASE2,"Ortho Biotech Products, L.P.",INDUSTRY,hepatitis
NCT03105349,C-RESCUE,WITHDRAWN,2017-07-01,HCV,"elbasvir/grazoprevir, Sofosbuvir, Ribavirin","Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain",2017-12,2017-04-07,2018-06-08,INTERVENTIONAL,PHASE4,Fundacion SEIMC-GESIDA,OTHER,hepatitis
NCT02781649,EXPANDER-1,COMPLETED,2016-07-20,"End-Stage Renal Disease, Hepatitis C","Zepatier, Ribavirin, Sofosbuvir",Baltimore - United States,2017-05-03,2016-05-24,2018-09-06,INTERVENTIONAL,PHASE4,Johns Hopkins University,OTHER,hepatitis
NCT04371718,Unknown,UNKNOWN,2020-11,Autoimmune Hepatitis,"JKB-122, Placebo",No locations listed,2023-11,2020-05-01,2020-09-01,INTERVENTIONAL,PHASE2,"TaiwanJ Pharmaceuticals Co., Ltd",INDUSTRY,hepatitis
NCT03939013,CT2,COMPLETED,2019-01-30,Hepatitis C,Xpert HCV VL,"Yangon - Myanmar, Yangon - Myanmar",2020-08-31,2019-05-06,2021-02-02,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT01856413,ZEUS,COMPLETED,2012-12,Hepatitis B,Zutectra,"Lyon - France, Villejuif - France, Bari - Italy, Bologna - Italy, Cagliari - Italy, Milano - Italy, Modena - Italy, Padova - Italy, Pisa - Italy, Roma - Italy, Torino - Italy, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Birmingham - United Kingdom, London - United Kingdom",2014-09,2013-05-17,2015-03-25,INTERVENTIONAL,PHASE3,Biotest,INDUSTRY,hepatitis
NCT02309918,Unknown,COMPLETED,2014-11,Acute Hepatitis C,LDV/SOF FDC,"Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Homburg - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, München - Germany, München - Germany, Offenburg - Germany, Tübingen - Germany, Würzburg - Germany",2016-08,2014-12-05,2017-08-28,INTERVENTIONAL,PHASE2,"HepNet Study House, German Liverfoundation",NETWORK,hepatitis
NCT00890318,Unknown,COMPLETED,2009-04,HCV Infection,"ABT-072, ketoconazole, Placebo",Waukegan - United States,2009-07,2009-04-29,2010-10-21,INTERVENTIONAL,PHASE1,Abbott,INDUSTRY,hepatitis
NCT01333813,Unknown,COMPLETED,2011-04-26,Hepatitis B,Engerix-B™ Kinder,"Bad Saulgau - Germany, Kehl - Germany, Oberstenfeld - Germany, Stuttgart - Germany, Tuttlingen - Germany, Bindlach - Germany, Kempten - Germany, Braunatal - Germany, Muenster - Germany, Frankenthal - Germany, Worms - Germany, Berlin - Germany",2011-09-28,2011-04-12,2018-06-06,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00144313,Unknown,COMPLETED,2005-08,Hepatitis,hepatitis B vaccine,Anchorage - United States,Unknown Date,2005-09-05,2007-09-21,INTERVENTIONAL,PHASE4,Centers for Disease Control and Prevention,FED,hepatitis
NCT02167113,HBVQuant,COMPLETED,2014-03,"Hepatitis B, Chronic",No interventions listed,"Phoenix - United States, Phoenix - United States, Garden Grove - United States, Lancaster - United States, Los Angeles - United States, Palo Alto - United States, Rialto - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Torrance - United States, New Haven - United States, Miami - United States, Atlanta - United States, Marietta - United States, Baltimore - United States, Catonsville - United States, Boston - United States, Newton - United States, Springfield - United States, Detroit - United States, Newark - United States, Flushing - United States, Manhasset - United States, Charlotte - United States, Statesville - United States, Oklahoma City - United States, Philadelphia - United States, Philadelphia - United States, Providence - United States, Nashville - United States, Austin - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Norfolk - United States, Seattle - United States, Madison - United States, Kingswood - Australia, Sydney - Australia, Fitzroy - Australia, PLeven - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Calgary - Canada, Vancouver, - Canada, Vancouver - Canada, Vancouver - Canada, London - Canada, Toronto - Canada, Berlin - Germany, Berlin - Germany, Berlin - Germany, Essen - Germany, Hamburg - Germany, Hamburg - Germany, Mainz - Germany, Mannheim - Germany, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Gyula - Hungary, Salerno - Italy, Sassari - Italy, Sassari - Italy, Grafton - New Zealand, Hamilton West - New Zealand, Newton - New Zealand, Sector 1 - Romania, Sector 2 - Romania, Sector 2 - Romania, Sector 5 - Romania, Sibiu - Romania, Timisoara - Romania, Constanta - Romania, Istanbul - Turkey, Ankara - Turkey, Ankara - Turkey, Aydin - Turkey, Bursa - Turkey, Diyarbakir - Turkey, Eskişehir - Turkey, Istanbul - Turkey, Izmir - Turkey, Kocaeli - Turkey, Konya - Turkey, Samsun - Turkey, Trabzon - Turkey",2016-02,2014-06-18,2018-08-01,OBSERVATIONAL,Not Available,"Hologic, Inc.",INDUSTRY,hepatitis
NCT01734018,Unknown,COMPLETED,2011-08,"Hepatitis B, Chronic",No interventions listed,"Berlin - Germany, Leipzig - Germany",2012-08,2012-11-27,2016-11-02,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03702218,Unknown,WITHDRAWN,2019-07-01,Hepatitis C,Direct Acting Antivirals,Baltimore - United States,2019-07-01,2018-10-11,2023-05-06,INTERVENTIONAL,PHASE1,"University of Maryland, Baltimore",OTHER,hepatitis
NCT02031913,Unknown,COMPLETED,2013-01,"Chronic Hepatitis B, Hepatic Fibrosis, Fatty Liver",No interventions listed,"Seoul - Korea, Republic of",2022-11,2014-01-09,2023-04-12,OBSERVATIONAL,Not Available,Seoul National University Boramae Hospital,OTHER,hepatitis
NCT01465919,Unknown,TERMINATED,2011-08,Depression,"Mirtazapine, Supportive psychotherapy","Seoul - Korea, Republic of",2017-12,2011-11-06,2020-03-20,INTERVENTIONAL,PHASE4,Seoul National University Boramae Hospital,OTHER,hepatitis
NCT06740318,A-HEP,RECRUITING,2024-11-25,Alcoholic Hepatitis (AH),Motivational enhancement therapy,Hvidovre - Denmark,2028-12-31,2024-12-18,2025-02-27,INTERVENTIONAL,NA,Nina Kimer,OTHER,hepatitis
NCT01329913,Unknown,COMPLETED,2011-05,Hepatitis C,"MK-6325, Placebo to MK-6325, MK-6325, Placebo to MK-6325, MK-6325, Placebo to MK-6325",No locations listed,2012-04,2011-04-06,2015-02-05,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03201718,HCV PMS,COMPLETED,2017-08-17,Hepatitis C Virus (HCV),No interventions listed,"Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Jung-gu - Korea, Republic of, Buncheon - Korea, Republic of, Goyang - Korea, Republic of, Seongnam - Korea, Republic of, Suwon-si - Korea, Republic of, Suwon - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Jung-gu - Korea, Republic of, Gwangju - Korea, Republic of, Gwangju - Korea, Republic of, Daegu - Korea, Republic of, Dongjak-gu - Korea, Republic of, Jongno-Gu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bucheon - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Cheonan - Korea, Republic of, Chuncheon - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Goyang - Korea, Republic of, Goyang - Korea, Republic of, Gumi - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Hwaseong - Korea, Republic of, Incheon - Korea, Republic of, Jeonju - Korea, Republic of, Seongnam - Korea, Republic of, Seongnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suncheon - Korea, Republic of, Uijeongbu - Korea, Republic of, Ulsan - Korea, Republic of, Wonju - Korea, Republic of, Yangsan-si - Korea, Republic of, Yeosu - Korea, Republic of",2019-10-11,2017-06-28,2020-10-08,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00209118,Unknown,COMPLETED,Unknown Date,"Hepatitis C, Depression, Interferon-alpha Associated Side Effects",paroxetine,No locations listed,Unknown Date,2005-09-21,2016-04-11,INTERVENTIONAL,NA,Emory University,OTHER,hepatitis
NCT00973219,LVL,COMPLETED,2009-09,Chronic Hepatitis B,"Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate",Amsterdam - Netherlands,2019-10,2009-09-09,2021-03-29,INTERVENTIONAL,NA,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),OTHER,hepatitis
NCT02901418,Unknown,UNKNOWN,2015-07,Chronic Hepatitis B,200 IU HBIG,Beijing - China,2018-06,2016-09-15,2016-09-20,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00960518,TACE,UNKNOWN,2009-08,"Hepatitis B Virus, Hepatocellular Carcinoma","adefovir, TACE","Ha'er'bin - China, Shanghai - China",2012-08,2009-08-17,2009-08-17,INTERVENTIONAL,PHASE2,Tongji University,OTHER,hepatitis
NCT06596213,Unknown,NOT_YET_RECRUITING,2024-10-01,"Chronic Hepatitis B, HEPATITIS C VIRUS CHRONIC INFECTION",No interventions listed,No locations listed,2030-12-31,2024-09-19,2024-09-19,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT02324218,Unknown,COMPLETED,2014-10,Hepatitis B,Data collection,No locations listed,2015-01,2014-12-24,2016-07-19,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01957618,CTEAM,UNKNOWN,2011-10,Hepatitis B Virus-Related Hepatocellular Carcinoma,No interventions listed,Taipei - Taiwan,2012-01,2013-10-08,2013-10-08,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT04106518,COMADHAA,RECRUITING,2019-10-23,"Alcoholic Liver Disease, Severe Alcoholic Hepatitis, Alcoholic Cirrhosis",No interventions listed,"Angers - France, Besançon - France, Bondy - France, Caen - France, La Tronche - France, Lille - France, Marseille - France, Montpellier - France, Paris - France",2025-04,2019-09-27,2023-11-29,OBSERVATIONAL,Not Available,"University Hospital, Lille",OTHER,hepatitis
NCT03920618,HBV,RECRUITING,2019-02-21,"Hepatitis B, Acute-On-Chronic Liver Failure","Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide",Guangzhou - China,2024-12-31,2019-04-19,2024-11-29,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00895713,Unknown,COMPLETED,2004-11,"Hepatitis B, Chronic",intramuscular hepatitis B virus immune globulin,"Pisa - Italy, Torino - Italy",2005-06,2009-05-08,2009-05-08,INTERVENTIONAL,PHASE2,"Instituto Grifols, S.A.",INDUSTRY,hepatitis
NCT02732236,Unknown,UNKNOWN,2013-03,"Lymphoma, B-Cell, Marginal Zone",Rituximab,"Busan - Korea, Republic of",2020-02,2016-04-08,2018-04-18,OBSERVATIONAL,Not Available,Dong-A University Hospital,OTHER,hepatitis
NCT00728936,Unknown,COMPLETED,2007-09,Hepatitis C,"IMO-2125, Saline placebo","Aurora - United States, Marietta - United States, Novi - United States, Durham - United States, Dallas - United States, San Antonio - United States, Santurce - Puerto Rico",2009-12,2008-08-06,2019-02-15,INTERVENTIONAL,PHASE1,"Idera Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT01274013,Unknown,WITHDRAWN,2009-10,Chronic Hepatitis C,No interventions listed,Sioux Falls - United States,2018-12,2011-01-11,2019-01-10,OBSERVATIONAL,Not Available,Avera McKennan Hospital & University Health Center,OTHER,hepatitis
NCT06082336,MAGICIEN,RECRUITING,2023-01-23,"Combined Point of Care Diagnostic of HIV, HBV and HCV","MagIA IBC test in capillary blood, MagIA IBC test in other matrices",Marseille - France,2024-06-30,2023-10-13,2023-10-13,INTERVENTIONAL,NA,MagIA Diagnostics,INDUSTRY,hepatitis
NCT02364336,Unknown,COMPLETED,2015-02-14,Chronic Hepatitis B,Peginterferon alfa-2a,Bethesda - United States,2018-05-21,2015-02-18,2019-09-04,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00947349,Unknown,COMPLETED,2009-07,"Hepatitis C, Pharmacokinetics","ribavirin (RBV), pegylated interferon (PegIFN) alfa-2a, pegylated interferon (PegIFN) alfa-2a, ribavirin (RBV), BI 201335 NA low placebo, pegylated interferon (PegIFN) alfa-2a, ribavirin (RBV), BI 201335 NA high, BI 201335 NA low, BI 201335 NA high placebo, BI 201335 NA high, Placebo","Kurashiki, Okayama - Japan, Minato-ku, Tokyo - Japan, Nishinomiya, Hyogo - Japan",2011-08,2009-07-28,2015-07-07,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT02064049,SToP-C,COMPLETED,2014-10,Hepatitis C,Sofosbuvir/velpatasvir,"Goulburn - Australia, Lithgow - Australia, Windsor - Australia, Windsor - Australia",2019-11,2014-02-17,2019-12-09,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT02375906,HDIN,COMPLETED,2013-11,Hepatitis D,No interventions listed,"Vienna - Austria, Edegem - Belgium, Rondonia - Brazil, Tiflis - Georgia, Berlin - Germany, Berlin - Germany, Gießen - Germany, Hannover - Germany, Larissa - Greece, Bologna - Italy, San Giovanni Rotondo - Italy, Torino - Italy, Chisinau - Moldova, Republic of, Karachi - Pakistan, Karachi - Pakistan, Bucharest - Romania, Barcelona - Spain, Hanoi - Vietnam",2022-05-31,2015-03-03,2022-06-02,OBSERVATIONAL,Not Available,"HepNet Study House, German Liverfoundation",NETWORK,hepatitis
NCT03682549,Unknown,COMPLETED,2019-12-01,Hepatitis C Viral,Oral microbiome analysis,Cairo - Egypt,2020-03-14,2018-09-24,2020-11-25,OBSERVATIONAL,Not Available,Cairo University,OTHER,hepatitis
NCT01100749,Unknown,TERMINATED,2010-02,Chronic Hepatitis C - Genotype 3,No interventions listed,"Toronto - Canada, Toronto - Canada",2013-06,2010-04-09,2015-05-28,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT00697749,Unknown,COMPLETED,1999-04,Hepatitis B,"HBV-MPL vaccine 208129, Engerix™-B",No locations listed,2000-01,2008-06-16,2016-09-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01623336,BIP48II/III,UNKNOWN,2012-01,Chronic Hepatitis C,"BIP 48 (Peginterferon alfa 2b 48kDA), Peginterferon alfa 2a 40kDA, BIP 48 (Peginterferon alfa 2b 48kDA)",Porto Alegre - Brazil,2016-08,2012-06-20,2012-06-20,INTERVENTIONAL,PHASE3,The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz),OTHER,hepatitis
NCT00587249,Unknown,COMPLETED,2002-07,Plasmodium Falciparum Malaria,"Malaria ICC-1132, Alhydrogel",Baltimore - United States,2005-07,2008-01-07,2013-04-12,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT06357806,Unknown,RECRUITING,2024-06-06,Chronic Hepatitis B,"Sintilimab, Peg-IFNα-2b, NAs",Beijing - China,2025-12-05,2024-04-10,2024-06-12,INTERVENTIONAL,NA,Beijing 302 Hospital,OTHER,hepatitis
NCT00877149,Unknown,COMPLETED,2009-03,Compensated Chronic Hepatitis B,telbivudine/LDT600,"Beijing - China, Peking - China, Peking - China, Shanghai - China",2011-04,2009-04-07,2012-05-04,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02203149,Unknown,COMPLETED,2014-08-01,Hepatitis C,"Grazoprevir, Elbasvir, Placebo to Grazoprevir, Placebo to Elbasvir",No locations listed,2015-10-02,2014-07-29,2018-09-24,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05871749,Unknown,COMPLETED,2023-06-07,"Hepatic Steatosis, Hepatic Fibrosis, Chronic Hepatitis b",No interventions listed,"Seoul - Korea, Republic of, Seoul - Korea, Republic of",2024-02-16,2023-05-23,2024-07-31,OBSERVATIONAL,Not Available,So Yeon Kim,OTHER,hepatitis
NCT03724149,SHELTER,COMPLETED,2018-12-12,Lung Diseases,"Zepatier, Epclusa",Philadelphia - United States,2021-12-31,2018-10-30,2023-04-14,INTERVENTIONAL,PHASE2,University of Pennsylvania,OTHER,hepatitis
NCT01079806,Unknown,COMPLETED,2010-06-30,"Chronic Hepatitis B Virus, Pediatric","Entecavir, Placebo","San Francisco - United States, Hartford - United States, Washington - United States, Gainesville - United States, Atlanta - United States, Indianapolis - United States, Baltimore - United States, Boston - United States, Boston - United States, New York - United States, Charlotte - United States, Philadelphia - United States, Providence - United States, Houston - United States, Fairfax - United States, Bunos Aires - Argentina, Bruxelles - Belgium, Toronto - Canada, Mainz - Germany, Starnberg - Germany, Wuppertal - Germany, Thesaloniki - Greece, Guwahati - India, Hyderabad - India, Beer-sheva - Israel, Petach Tikva - Israel, Zefat - Israel, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bydgoszcz - Poland, Krakow - Poland, Wroclaw - Poland, Bucharest - Romania, Iasi - Romania, Timisoara - Romania, Moscow - Russian Federation, Moscow - Russian Federation, Novokuznetsk - Russian Federation, St. Petersburg - Russian Federation, Tainan - Taiwan, Taipei - Taiwan, London - United Kingdom, Birmingham - United Kingdom",2013-03-31,2010-03-03,2019-05-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00227149,Unknown,COMPLETED,2005-07,"Hepatitis C, Chronic",No interventions listed,Wuerzburg - Germany,Unknown Date,2005-09-27,2009-02-04,OBSERVATIONAL,Not Available,University of Wuerzburg,OTHER,hepatitis
NCT02798549,Unknown,COMPLETED,2015-01-12,Hepatitis B Virus Infection,blood draw,Lyon - France,2018-01,2016-06-14,2018-09-12,INTERVENTIONAL,NA,Hospices Civils de Lyon,OTHER,hepatitis
NCT00219999,Unknown,COMPLETED,2001-09,Hepatitis C Virus,No interventions listed,New York - United States,2013-05,2005-09-22,2013-08-09,OBSERVATIONAL,Not Available,Rockefeller University,OTHER,hepatitis
NCT04747106,Unknown,UNKNOWN,2020-07-01,28 Day Mortality,plasma exchange,Guangzhou - China,2021-04-30,2021-02-10,2021-02-10,INTERVENTIONAL,NA,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT02991599,Unknown,COMPLETED,2014-10,Hepatitis B Vaccine,"60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine",No locations listed,2015-07,2016-12-13,2021-12-23,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT02402699,Yervoy RMP,COMPLETED,2015-12-15,"Advanced Melanoma, Hepatitis B, Hepatitis C",No interventions listed,Taipei 105 - Taiwan,2017-03-23,2015-03-30,2022-01-26,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05473806,Unknown,UNKNOWN,2020-09-18,"Hepatitis B, Chronic, Fibrosis, Liver, Diabetes Mellitus, Type 2","Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg","Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2023-01-19,2022-07-26,2022-07-26,INTERVENTIONAL,PHASE4,Seung Up Kim,OTHER,hepatitis
NCT03379506,Unknown,COMPLETED,2018-01-25,HCV Infection,"EBR/GZR FDC Tablet, Placebo, Grazoprevir Oral Granules, Elbasvir Oral Granules","San Francisco - United States, Orlando - United States, Atlanta - United States, Boston - United States, Cincinnati - United States, Pittsburgh - United States, San Antonio - United States, Seattle - United States, Hannover - Germany, Starnberg - Germany, Wuppertal - Germany, Bydgoszcz - Poland, Lodz - Poland, Poznan - Poland, Stockholm - Sweden",2019-10-28,2017-12-20,2023-05-31,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00546442,TRIC-1,COMPLETED,2006-05,Chronic Hepatitis C,"Metformine, Placebo of metformine","Badalona - Spain, Sabadell - Spain, San Sebastian - Spain, Alcorcón - Spain, Barcelona - Spain, Ciudad Real - Spain, Córdoba - Spain, Granada - Spain, Granada - Spain, Leon - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Málaga - Spain, Sevilla - Spain, Sevilla - Spain, Valencia - Spain",Unknown Date,2007-10-19,2007-10-19,INTERVENTIONAL,PHASE4,Valme University Hospital,OTHER,hepatitis
NCT00107042,Unknown,COMPLETED,2004-02,Hepatitis B,"Recombivax, Twinrix","Los Angeles - United States, San Diego - United States, San Francisco - United States, Washington - United States, Tampa - United States, Chicago - United States, New Orleans - United States, Baltimore - United States, Bronx - United States, Memphis - United States, San Juan - Puerto Rico",2008-07,2005-04-05,2017-03-29,INTERVENTIONAL,PHASE2,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT00081770,Unknown,COMPLETED,2004-03,"Hepatitis C, Chronic","PegIntron (peginterferon alfa-2b; SCH 54031), PegIntron (peginterferon alfa-2b; SCH 54031), REBETOL (ribavirin; SCH 18908), PEGASYS (peginterferon alfa-2a), COPEGUS (ribavirin)",No locations listed,2007-11,2004-04-22,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01273142,Unknown,UNKNOWN,2011-01,"HIV Infections, Liver Toxicity, Hepatitis Co-infection",No interventions listed,No locations listed,2012-10,2011-01-10,2011-01-10,OBSERVATIONAL,Not Available,Henan Provincial People's Hospital,OTHER,hepatitis
NCT03706742,Unknown,COMPLETED,2018-09-10,"Hepatitis C, HepatoCellular Carcinoma",Mailed outreach,Dallas - United States,2019-08-18,2018-10-16,2021-04-20,INTERVENTIONAL,NA,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT01054742,Unknown,COMPLETED,2009-12,Hepatitis C,"Standard of Care PegIntron, Standard of Care Ribavirin",No locations listed,2011-06,2010-01-22,2015-01-16,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00823342,Unknown,TERMINATED,2008-12-14,"HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection","CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN ASSOCIATION TENOFOVIR, TENOFOVIR + CLEVUDINE PLACEBO",Marseille - France,2008-12-14,2009-01-15,2023-01-31,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT03441542,EZ-C,TERMINATED,2018-07-23,Hepatitis C,"Data-assisted Case Navigation, Standard of Care",Atlanta - United States,2018-12-15,2018-02-22,2022-05-25,INTERVENTIONAL,NA,National Opinion Research Center,OTHER,hepatitis
NCT01360970,Unknown,COMPLETED,2009-09,Response to Hepatitis A Vaccine,hepatitis A vaccine ( HAVRIX or EPAXAL),"Helsingfors - Finland, Eskilstuna - Sweden, Karlstad - Sweden, Stockholm - Sweden",2011-05,2011-05-26,2015-11-18,INTERVENTIONAL,PHASE2,Lars Rombo,OTHER,hepatitis
NCT03528941,LLC1618,COMPLETED,2018-11-28,Chronic Lymphocytic Leukemia,"Lamivudine, No prophylaxis","Cona - Italy, Bari - Italy, Brescia - Italy, Cagliari - Italy, Catania - Italy, Catanzaro - Italy, Cosenza - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Modena - Italy, Novara - Italy, Pavia - Italy, Pescara - Italy, Pisa - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Siena - Italy, Torino - Italy, Verona - Italy",2021-03-26,2018-05-18,2022-05-12,OBSERVATIONAL,Not Available,Gruppo Italiano Malattie EMatologiche dell'Adulto,OTHER,hepatitis
NCT01590641,Unknown,COMPLETED,2012-04,"Hepatitis B, HBV","Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts","Phoenix - United States, Costa Mesa - United States, San Diego - United States, Indianapolis - United States, New Orleans - United States, Boston - United States, Detroit - United States, Kansas City - United States, New York - United States, Cleveland - United States, Philadelphia - United States, Houston - United States, Salt Lake City - United States, Kingswood - Australia, Herston - Australia, Clayton - Australia, Nedlands - Australia, Calgary - Canada, Edmonton - Canada, Montreal - Canada, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Grafton - New Zealand",2013-09,2012-05-03,2013-11-14,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT00926419,InjHepAVar,UNKNOWN,2009-06,"Varicella, Hepatitis A","Varicella Vaccine, Hepatitis A Vaccine",São Paulo - Brazil,2009-11,2009-06-23,2009-06-23,INTERVENTIONAL,PHASE3,University of Sao Paulo General Hospital,OTHER,hepatitis
NCT02195518,Unknown,COMPLETED,2015-03-18,"Hepatitis B, Chronic",Tenofovir disoproxil fumarate,"Guangzhou - China, Guangzhou - China, Changchun - China, Chengdu - China, Hangzhou - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Shanghai - China, Shanghai - China, Zhengzhou - China",2018-08-14,2014-07-21,2019-11-04,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02075918,InTeam,COMPLETED,2014-05,"Alcoholic Hepatitis, Control Patients",No interventions listed,Pittsburgh - United States,2019-05,2014-03-03,2019-06-10,OBSERVATIONAL,Not Available,University of Pittsburgh,OTHER,hepatitis
NCT04982718,Unknown,UNKNOWN,2021-09-14,"Hepatitis C, Diagnostic Self Evaluation","OraQuick® HCV Self-Test, First Response® HCV Self-Test",Nationally - Malaysia,2022-03,2021-07-29,2022-02-11,INTERVENTIONAL,NA,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT01516918,Unknown,COMPLETED,2012-02,Chronic Hepatitis C Virus,"VX-222, telaprevir, ribavirin, peginterferon-alfa-2a","Birmingham - United States, San Diego - United States, Englewood - United States, Bradenton - United States, Jacksonville - United States, Tampa - United States, Marietta - United States, Chicago - United States, Indianapolis - United States, Boston - United States, Detroit - United States, Lebanon - United States, Egg Harbor Township - United States, Manhasset - United States, New York - United States, Rochester - United States, Asheville - United States, Charlotte - United States, Durham - United States, Cincinnati - United States, Providence - United States, Germantown - United States, Arlington - United States, Houston - United States, San Antonio - United States, Norfolk - United States, Madison - United States, Milwaukee - United States, Vancouver - Canada, London - Canada, Montreal - Canada, Hamburg - Germany, Heidelberg - Germany, Hessen - Germany, Koeln - Germany, Saschen - Germany, Stuttgart - Germany, Bialystok - Poland, Myslowice - Poland, Wroclaw - Poland, London - United Kingdom, Plymouth - United Kingdom, Scotland - United Kingdom",2013-09,2012-01-25,2014-10-20,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01066819,Unknown,COMPLETED,2008-01,"Hepatitis C, Chronic","Peginterferon alfa-2a [Pegasys], Peginterferon alfa-2b [PegIntron®]","Birmingham - United States, Birmingham - United States, Birmingham - United States, Dothan - United States, Fresno - United States, La Jolla - United States, Lancaster - United States, Loma Linda - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Clemente - United States, San Diego - United States, San Francisco - United States, San Mateo - United States, Torrance - United States, Aurora - United States, Hartford - United States, Gainesville - United States, Maitland - United States, Orlando - United States, Orlando - United States, Atlanta - United States, Decatur - United States, Macon - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Iowa City - United States, Kansas City - United States, Lexington - United States, Baton Rouge - United States, New Orleans - United States, Opelousas - United States, Annapolis - United States, Baltimore - United States, Boston - United States, Springfield - United States, Springfield - United States, Worcester - United States, Detroit - United States, Grand Rapids - United States, Jackson - United States, Tupelo - United States, St Louis - United States, St Louis - United States, Topeka - United States, Lebanon - United States, Egg Harbour Township - United States, Hackensack - United States, Hillsborough - United States, Roseland - United States, Voorhees - United States, Albuquerque - United States, Bayside - United States, Catskill - United States, Flushing - United States, New York - United States, New York - United States, Poughkeepsie - United States, Syracuse - United States, Asheville - United States, Chapel Hill - United States, Charlotte - United States, Fayetteville - United States, Rocky Mount - United States, Winston-salem - United States, Winston-salem - United States, Cincinnati - United States, Cleveland - United States, Cleveland - United States, Cleveland - United States, Oklahoma City - United States, Tulsa - United States, Medford - United States, Portland - United States, Portland - United States, Camp Hill - United States, DuBois - United States, Pittsburgh - United States, Bristol - United States, Chattanooga - United States, Germantown - United States, Kingsport - United States, Nashville - United States, West Nashville - United States, Dallas - United States, Galveston - United States, Harlingen - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Salt Lake City - United States, Charlottesville - United States, Fairfax - United States, Norfolk - United States, Richmond - United States, Seattle - United States, Huntington - United States, Casper - United States, Santurce - Puerto Rico",2011-08,2010-02-10,2016-08-08,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00703118,Unknown,COMPLETED,2008-10,"Hepatitis C, Chronic","Telaprevir, Peg-IFN-alfa-2a, Ribavirin, Placebo","Birmingham - United States, Coronado - United States, La Jolla - United States, Los Angeles - United States, San Francisco - United States, Aurora - United States, Bradenton - United States, Gainesville - United States, Miami - United States, Atlanta - United States, Indianapolis - United States, Baltimore - United States, Boston - United States, Worcester - United States, Detroit - United States, Plymouth - United States, Kansas City - United States, Egg Harbor Twp - United States, Albuquerque - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Durham - United States, Philadelphia - United States, Columbia - United States, Dallas - United States, Houston - United States, San Antonio - United States, Falls Church - United States, Norfolk - United States, Richmond - United States, Adelaide - Australia, Camperdown - Australia, Clayton - Australia, Darlinghurst - Australia, Kingswood - Australia, Melbourne - Australia, Parkville - Vic - Australia, Perth - Australia, Graz N/A - Austria, Wien - Austria, Brussels - Belgium, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Distrito Barao Geraldo-Campina - Brazil, Salvador - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Vancouver - Canada, Ottawa - Canada, Montreal - Canada, Clichy - France, Creteil N/A - France, Grenoble - France, Lille Cedex - France, Lyon Cedex 02 - France, Lyon - France, Marseille - France, Paris - France, Pessac - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Frankfurt N/A - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Koln - Germany, München - Germany, Haifa - Israel, Jerusalem - Israel, Petah Tiqva - Israel, Tel-Aviv - Israel, Zefat - Israel, Amsterdam Zuidoost - Netherlands, Leiden - Netherlands, Nijmegen - Netherlands, Bialystok - Poland, Czeladz - Poland, Kielce - Poland, Lodz - Poland, Warszawa - Poland, Santurce - Puerto Rico, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain, Stockholm - Sweden, St Gallen - Switzerland, Zurich N/A - Switzerland, Birmingham - United Kingdom, London - United Kingdom",2010-07,2008-06-23,2014-01-22,INTERVENTIONAL,PHASE3,Tibotec BVBA,INDUSTRY,hepatitis
NCT01836718,Unknown,UNKNOWN,2013-06,"Hepatitis C Virus, Liver Transplantation",No interventions listed,New York - United States,2017-12,2013-04-22,2017-01-30,OBSERVATIONAL,Not Available,"Schiano, Thomas D., MD",OTHER,hepatitis
NCT00788918,Unknown,COMPLETED,2008-11,"Hepatitis C, Chronic, Cognition Disorders, Fatigue Syndrome, Chronic, Major Depressive Disorder",Interferon and ribavirin,Aarhus - Denmark,2012-11,2008-11-11,2013-01-11,INTERVENTIONAL,NA,Aarhus University Hospital,OTHER,hepatitis
NCT01779518,Unknown,APPROVED_FOR_MARKETING,Unknown Date,Post-transplant Hepatitis C,"Sofosbuvir, Ribavirin, Pegylated Interferon",No locations listed,Unknown Date,2013-01-30,2014-01-16,EXPANDED_ACCESS,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT00289718,Unknown,COMPLETED,2004-11-01,"Hepatitis B, Hepatitis A",Twinrix™ adult,Gent - Belgium,2005-03-02,2006-02-10,2018-02-15,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01965418,Unknown,UNKNOWN,2013-09,"Liver Fibrosis, Chronic Hepatitis B","Fufang Biejia Ruangan Tablet, Placebo",Beijing - China,2015-12,2013-10-18,2015-08-17,INTERVENTIONAL,PHASE4,Beijing 302 Hospital,OTHER,hepatitis
NCT02826018,Unknown,TERMINATED,2016-06-24,"Hepatitis B, Chronic Hepatitis B, Hepatitis B, Chronic, Hepatitis B Infection, HBV","ALN-HBV, Sterile Normal Saline (0.9% NaCl)","Adelaide - Australia, Fitzroy - Australia, Parkville - Australia, Hong Kong - Hong Kong, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Singapore - Singapore, London - United Kingdom",2017-10,2016-07-07,2018-09-24,INTERVENTIONAL,PHASE1,Alnylam Pharmaceuticals,INDUSTRY,hepatitis
NCT02979613,Unknown,COMPLETED,2016-12-29,Chronic Hepatitis B,"TAF, TDF, TAF Placebo, TDF Placebo","Los Angeles - United States, Palo Alto - United States, Pasadena - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Baltimore - United States, Boston - United States, Novi - United States, Flushing - United States, Flushing - United States, New York - United States, New York - United States, Philadelphia - United States, Philadelphia - United States, Nashville - United States, Sugar Land - United States, Edmonton - Canada, Toronto - Canada, Vancouver - Canada, Hong Kong - Hong Kong, Kowloon - Hong Kong, Milan - Italy, Goyang - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Barcelona - Spain, Majadahonda - Spain, Chiayi City - Taiwan, Kaohsiung - Taiwan, Taipei City - Taiwan, London - United Kingdom, London - United Kingdom",2018-09-10,2016-12-01,2020-09-14,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT03792919,Unknown,RECRUITING,2018-12-01,Chronic Hepatitis B,"Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides)",Hong Kong - Hong Kong,2025-12-31,2019-01-04,2024-02-28,INTERVENTIONAL,PHASE4,Humanity & Health Medical Group Limited,OTHER,hepatitis
NCT03383419,TROJAN-C,UNKNOWN,2018-03-20,Heart Failure,Epclusa,"Los Angeles - United States, Durham - United States, Dallas - United States",2023-12-30,2017-12-26,2023-01-26,INTERVENTIONAL,PHASE2,Baylor Research Institute,OTHER,hepatitis
NCT01459419,Unknown,UNKNOWN,2011-11,Chronic Hepatitis C,"anti-CD3 monoclonal antibody, Sodium Chloride placebo","Wien - Austria, Bydgoszcz - Poland",2013-05,2011-10-25,2011-10-25,INTERVENTIONAL,PHASE2,Inspira Medical AB,INDUSTRY,hepatitis
NCT00487318,Unknown,COMPLETED,2007-06,Chronic Hepatitis C,"standard of care, fluvastatin",Oklahoma City - United States,2010-10,2007-06-18,2012-08-21,INTERVENTIONAL,PHASE2,"Bader, Ted, M.D.",INDIV,hepatitis
NCT03125213,Unknown,WITHDRAWN,2017-09-12,"Hepatitis B, Chronic","AL-3778, Peginterferon Alfa-2A, Placebo Oral Tablet",No locations listed,2019-02-15,2017-04-24,2017-10-16,INTERVENTIONAL,PHASE2,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT05713136,Unknown,RECRUITING,2023-01-25,Hepatitis C,Diagnostic Test: Point-of-Care Testing,"Canberra - Australia, Sydney - Australia, Bowen Hills - Australia, Brisbane - Australia, Cairns - Australia, Townsville - Australia, Woodford - Australia, Adelaide - Australia, Hackney - Australia, Hobart - Australia, Melbourne - Australia, Perth - Australia",2025-01,2023-02-06,2024-07-03,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT02404636,ADDUP,UNKNOWN,2012-01,"Hepatitis, Alcoholic",Interview,Birmingham - United Kingdom,2018-01,2015-03-31,2017-04-10,OBSERVATIONAL,Not Available,University Hospital Birmingham,OTHER,hepatitis
NCT02065336,Unknown,TERMINATED,2014-03,"Hepatitis B, Chronic","ARC-520, Placebo, entecavir, chlorpheniramine","Pokfulam - Hong Kong, Shatin - Hong Kong",2017-01,2014-02-19,2019-07-05,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT00494936,Unknown,COMPLETED,2006-05,"HIV Infections, Hepatitis C",No interventions listed,New York - United States,2009-07,2007-07-02,2015-05-25,OBSERVATIONAL,Not Available,Icahn School of Medicine at Mount Sinai,OTHER,hepatitis
NCT03181113,Unknown,COMPLETED,2016-05-18,Hepatitis B,"Peginterferon Alfa-2B, Peginterferon Alfa-2A","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Fuzhou - China, Xiamen - China, Xiamen - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Shijiazhuang - China, Zhengzhou - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Nanchang - China, Shenyang - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Tianjin - China, Wenzhou - China",2020-09-21,2017-06-08,2021-04-13,OBSERVATIONAL,Not Available,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT00186836,Unknown,COMPLETED,2004-11,Hepatitis B,Engerix-B and Twinrix,Hamilton - Canada,Unknown Date,2005-09-16,2007-04-20,INTERVENTIONAL,PHASE4,St. Joseph's Health Care London,OTHER,hepatitis
NCT03425513,HBVBE,COMPLETED,2017-05-12,Hepatitis B,"Hepatitis B serology, Questionnaire",Genk - Belgium,2017-11-27,2018-02-07,2020-01-27,OBSERVATIONAL,Not Available,Hasselt University,OTHER,hepatitis
NCT01144936,Unknown,COMPLETED,2010-06,Chronic Hepatitis C,"VX-985 or matching placebo, VX-985 or matching placebo, VX-985 or matching placebo","Overland Park - United States, Baltimore - United States, Tacoma - United States",2010-10,2010-06-16,2011-03-09,INTERVENTIONAL,PHASE1,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT00289913,Unknown,COMPLETED,2006-04,Hepatitis A Virus,"Comparator: VAQTA™, Comparator: Infanrix™, Comparator: PedvaxHIB™",No locations listed,2010-06,2006-02-10,2017-04-13,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01627236,Unknown,UNKNOWN,2012-12,Severe Acute Exacerbation of Chronic Hepatitis B,methylprednisolone,Guangzhou - China,2014-08,2012-06-25,2013-10-10,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT03481036,Unknown,UNKNOWN,2016-06-18,Chronic Hepatitis c,"Direct Acting Antivirals, DAAs in Cirrhotics Genotype 2/3, DAAs in Cirrhotics Genotye 1,4,5,6",Chandigarh - India,2020-12-31,2018-03-29,2019-06-17,INTERVENTIONAL,NA,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT02049736,Unknown,WITHDRAWN,2013-12,Chronic Hepatitis B,Telbivudine,Hong Kong - Hong Kong,2015-06,2014-01-30,2016-07-28,INTERVENTIONAL,NA,Chinese University of Hong Kong,OTHER,hepatitis
NCT02103699,Unknown,COMPLETED,2014-02,Hepatitis C Virus,No intervention,"Phoenix - United States, Bakersfield - United States, Beverly Hills - United States, Los Angeles - United States, Daytona Beach - United States, Deland - United States, Miami - United States, Tampa - United States, West Palm Beach - United States, Crestview Hills - United States, Baltimore - United States, Springfield - United States, Newark - United States, Vineland - United States, Brooklyn - United States, Flushing - United States, New York - United States, Ny - United States, Durham - United States, Fayetteville - United States, Rocky Mount - United States, Statesville - United States, Winston Salem - United States, Cincinnati - United States, Doylestown - United States, Philadelphia - United States, Nashville - United States, Austin - United States, Dallas - United States, Fort Worth - United States, Houston - United States, Murray - United States, Norfolk - United States",2015-11,2014-04-04,2016-02-22,OBSERVATIONAL,Not Available,"Janssen Scientific Affairs, LLC",INDUSTRY,hepatitis
NCT06162299,Unknown,TERMINATED,2024-07-01,Chronic Hepatitis B,YS-HBV-002,Iloilo - Philippines,2024-09-30,2023-12-08,2025-02-24,INTERVENTIONAL,PHASE1,Yisheng Biopharma (Singapore) Pte. Ltd.,INDUSTRY,hepatitis
NCT02487199,Unknown,COMPLETED,2015-09-30,Hepatitis C Virus (HCV),"ombitasvir/paritaprevir/ritonavir and dasabuvir, ombitasvir/paritaprevir/ritonavir",No locations listed,2016-12-05,2015-07-01,2017-12-04,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00736242,Unknown,COMPLETED,2005-12,"Chronic Hepatitis C, Hepatitis C, HIV Infections","PEG-IFN alfa-2b, RBV",No locations listed,2011-12,2008-08-15,2015-02-19,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01098006,Unknown,COMPLETED,2010-04-29,Immunologic Tests,Blood withdrawal,"Brussels - Belgium, Bruxelles - Belgium",2012-02-20,2010-04-02,2020-02-25,INTERVENTIONAL,NA,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03740906,SHARP-P,COMPLETED,2019-09-06,"Hepatitis C, Chronic",No interventions listed,Sydney - Australia,2022-01-31,2018-11-14,2022-04-14,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT04758806,FMTH7,UNKNOWN,2018-04-01,Alcoholic Hepatitis,Fecal microbial transplantation,Banska Bystrica - Slovakia,2021-12-30,2021-02-17,2022-08-03,INTERVENTIONAL,PHASE3,F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica,OTHER,hepatitis
NCT02753699,Unknown,COMPLETED,2011-12,Hepatitis C,Alisporivir,"La Jolla - United States, San Diego - United States, Ventura - United States, Bradenton - United States, Honolulu - United States, Springfield - United States, Indianapolis - United States, Arlington - United States, Dallas - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Kingswood - Australia, Kogarah - Australia, Westmead - Australia, Greenslopes - Australia, Fitzroy - Australia, Gent - Belgium, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Torono - Canada, Clichy - France, Creteil - France, Lyon Cedex 04 - France, Nice Cedex 3 - France, Paris - France, Berlin - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Koeln - Germany, Leipzig - Germany, Mainz - Germany, Hong Kong - Hong Kong, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Kaposvár - Hungary, Pecs - Hungary, Szekesfehervar - Hungary, Hyderabad - India, Mumbai - India, Ludhiana - India, Delhi - India, Bologna - Italy, Brescia - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Rozzano - Italy, Palermo - Italy, Parma - Italy, Pavia - Italy, Roma - Italy, Roma - Italy, Torino - Italy, Bologna - Italy, Napoli - Italy, Seongnam-si - Korea, Republic of, Yangsan-si - Korea, Republic of, Seoul - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, México - Mexico, Monterrey - Mexico, Bialystok - Poland, Bydgoszcz - Poland, Lódz - Poland, Warszawa - Poland, Zawiercie - Poland, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Iasi - Romania, Iasi - Romania, Moscow - Russian Federation, St.- Petersburg - Russian Federation, Sevilla - Spain, Barcelona - Spain, Barcelona - Spain, Valencia - Spain, Majadahonda - Spain, Chia-Yi - Taiwan, Kaohsiung - Taiwan, Keelung City - Taiwan, Lin-Kou - Taiwan, Niaosong Township - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Yun-Lin - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Songkla - Thailand, Fatih / Istanbul - Turkey, Izmir - Turkey, Birmingham - United Kingdom, Glasgow - Scotland - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom, Hanoi - Vietnam, Hanoi - Vietnam, Ho Chi Minh - Vietnam",2015-05,2016-04-28,2016-08-26,INTERVENTIONAL,PHASE3,Debiopharm International SA,INDUSTRY,hepatitis
NCT00251199,Unknown,COMPLETED,2005-10,Hepatitis C,"VX-950, peginterferon","Homburg/Saar - Germany, Amsterdam - Netherlands",Unknown Date,2005-11-09,2007-12-21,INTERVENTIONAL,PHASE1,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02877199,Unknown,COMPLETED,2014-06,Hepatitis C,Triple therapy,Lyon - France,2015-04,2016-08-24,2016-08-26,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT01046799,Unknown,COMPLETED,2008-03,"Liver Transplantation, Hepatitis B, Liver Disease",Entecavir,"Essen - Germany, Hannover - Germany, Heidelberg - Germany",2014-06,2010-01-12,2014-11-05,INTERVENTIONAL,PHASE3,"HepNet Study House, German Liverfoundation",NETWORK,hepatitis
NCT00005306,Unknown,COMPLETED,1988-03,"Hepatitis, Viral, Human, Blood Transfusion, Liver Diseases",No interventions listed,No locations listed,Unknown Date,2000-05-26,2016-04-14,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT04490499,Unknown,COMPLETED,2020-09-02,Hepatitis B,HBVAXPRO™,"Kokkola - Finland, Tampere - Finland, Seinajoki - Finland, Oulu - Finland, Pori - Finland, Espoo - Finland, Helsinki - Finland, Helsinki - Finland, Jarvenpaa - Finland, Turku - Finland",2020-12-29,2020-07-29,2022-07-27,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01943799,Unknown,COMPLETED,2013-09-13,Chronic HBV Infection,"GS-4774, OAV Regimen","Los Angeles - United States, Pasadena - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Miami - United States, Chicago - United States, Baltimore - United States, Boston - United States, Ann Arbor - United States, Detroit - United States, Saint Louis - United States, Flushing - United States, Manhasset - United States, Newport News - United States, Grafton - New Zealand",2014-09-09,2013-09-17,2019-11-01,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02637999,Unknown,COMPLETED,2014-02-13,Chronic Hepatitis D Infection,"PEG IFN alfa-2a, Myrcludex B",No locations listed,2016-01-21,2015-12-22,2018-04-13,INTERVENTIONAL,PHASE2,Hepatera Ltd.,INDUSTRY,hepatitis
NCT02504099,GEODE - I,TERMINATED,2015-07,Chronic Hepatitis C Infection,"ombitasvir/paritaprevir/ritonavir and dasabuvir, ombitasvir/paritaprevir/ritonavir, ribavirin",No locations listed,2016-09,2015-07-21,2017-12-12,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00141999,Unknown,COMPLETED,2001-05,Hepatitis,hepatitis B vaccine,Anchorage - United States,2005-03,2005-09-02,2012-09-27,OBSERVATIONAL,Not Available,Centers for Disease Control and Prevention,FED,hepatitis
NCT03235349,VOYAGE-2,COMPLETED,2017-09-29,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir,"Beijing - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Nanjing - China, Nanjing - China, Changchun - China, Shenyang - China, Shanghai - China, Shanghai - China, Shanghai - China, Chengdu - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Fuzhou - China, Nanjing - China, Shenyang - China, Urumqi - China, Xi'an - China, Xi'an - China, Zhengzhou, Henan - China, Busan - Korea, Republic of, Seongnam - Korea, Republic of, Busan - Korea, Republic of, Yangsan-si, - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2018-11-15,2017-08-01,2019-11-21,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT05766449,Unknown,RECRUITING,2022-06-01,"Chronic Hepatitis b, Non-alcoholic Fatty Liver Disease",No interventions listed,Nanjing - China,2027-03-01,2023-03-13,2023-03-13,OBSERVATIONAL,Not Available,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,OTHER,hepatitis
NCT05583006,Unknown,RECRUITING,2023-11-06,"Patient Satisfaction, Drug Adherence, Efficacy, Self, Safety Issues",tenofovir alafenamide (TAF),Taichung - Taiwan,2026-12-30,2022-10-17,2025-01-09,OBSERVATIONAL,Not Available,Taichung Veterans General Hospital,OTHER,hepatitis
NCT02836249,Unknown,COMPLETED,2015-06-19,"HBV, Chronic HBV Infection","TAF, TDF, TAF Placebo, TDF Placebo","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guiyang - China, Haikou - China, Hunan - China, Jiangxi - China, Jilin - China, Jinan - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenyang - China, Shenyang - China, Shijiazhuang - China, Sichuan - China, Xi'an - China, Yunnan - China",2017-03-21,2016-07-18,2024-10-15,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01481649,Unknown,COMPLETED,2011-11,Exposure to Hepatitis B Virus,No interventions listed,Hong Kong - Hong Kong,2015-02,2011-11-29,2016-04-14,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT03163849,Unknown,UNKNOWN,2019-09-01,Chronic Hepatitis c,"Sofosbuvir , daclatasvir, Placebos","Assiut - Egypt, Assuit - Egypt",2020-06-01,2017-05-23,2019-09-12,INTERVENTIONAL,PHASE3,Assiut University,OTHER,hepatitis
NCT00197249,Unknown,COMPLETED,2002-05,Hepatitis A,Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix,No locations listed,2003-06,2005-09-20,2016-09-09,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01178749,Unknown,UNKNOWN,2007-09,Chronic Hepatitis C,No interventions listed,Taipei - Taiwan,2010-07,2010-08-10,2010-08-10,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02836236,Unknown,COMPLETED,2015-06-19,"HBV, Chronic HBV Infection","TAF, TDF, TAF Placebo, TDF Placebo","Beijing - China, Guangzhou - China, Nanning - China, Guiyang - China, Shijiazhuang - China, Wuhan - China, Nanjing - China, Nanchang - China, Changchun - China, Shenyang - China, Jinan - China, Chengdu - China, Kunming - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Changsha - China, Guangzhou - China, Guangzhou - China, Haikou - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenyang - China, Xi'an - China",2017-04-05,2016-07-18,2024-10-02,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00205049,Unknown,TERMINATED,2005-03,"Hepatitis, Alcoholic",pentoxifylline,No locations listed,2006-11,2005-09-20,2014-05-13,INTERVENTIONAL,PHASE1,"University of Wisconsin, Madison",OTHER,hepatitis
NCT00767936,Unknown,TERMINATED,2008-03,"Liver Cancer, Hepatitis B, Hepatitis C, Hepatobiliary Cancers Liver, Hepatobiliary Cancers",No interventions listed,Stanford - United States,2013-03,2008-10-07,2016-06-29,OBSERVATIONAL,Not Available,Stanford University,OTHER,hepatitis
NCT02084719,Unknown,TERMINATED,2014-03,"Active or Ex-injection Drug Users, Indication of Hepatitis C Screening","Oraquick HCV Rapid Antibody Test, Standard algorithm",Montréal - Canada,2016-04,2014-03-12,2017-01-20,INTERVENTIONAL,NA,Centre hospitalier de l'Université de Montréal (CHUM),OTHER,hepatitis
NCT03002818,HEMATITE,COMPLETED,2017-03-01,Chronic Hepatitis C Virus (HCV),No interventions listed,"St. Gallen - Switzerland, Bern - Switzerland, Lugano - Switzerland, Neuchatel - Switzerland, Zurich - Switzerland",2018-04-25,2016-12-26,2019-10-23,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00199719,CINAM,COMPLETED,2003-06,Chronic Hepatitis C,Ribavirine,"Angers - France, Limoges - France",Unknown Date,2005-09-20,2007-10-31,INTERVENTIONAL,PHASE2,"University Hospital, Limoges",OTHER,hepatitis
NCT02894918,Unknown,UNKNOWN,2016-09,Chronic Hepatitis B,Peginterferon alfa-2a,"Kaifeng - China, Kaifeng - China, Luoyang - China, Shangqiu - China, Zhengzhou - China",2018-06,2016-09-09,2016-09-12,INTERVENTIONAL,PHASE4,Henan Provincial People's Hospital,OTHER,hepatitis
NCT03158818,HUTCH,ACTIVE_NOT_RECRUITING,2016-08-23,"HBV, Fibrosis, Liver, Cirrhosis, Liver, Alcoholic Hepatitis, Hepatocellular Carcinoma, Hepatitis, Delta",Standard of care,Lusaka - Zambia,2025-06,2017-05-18,2024-07-17,OBSERVATIONAL,Not Available,University of Alabama at Birmingham,OTHER,hepatitis
NCT00587119,PBC,WITHDRAWN,2007-12,"Primary Biliary Cirrhosis, Autoimmune Hepatitis",Budesonide,No locations listed,2009-07,2008-01-07,2010-10-05,INTERVENTIONAL,NA,Mayo Clinic,OTHER,hepatitis
NCT00241618,Unknown,COMPLETED,2002-01,Hepatitis C,"Pegylated interferon alpha 2, Ribavirin","Cairo - Egypt, Cairo - Egypt, Cairo - Egypt",Unknown Date,2005-10-19,2006-09-11,INTERVENTIONAL,PHASE4,Ain Shams University,OTHER,hepatitis
NCT00558818,Unknown,COMPLETED,2007-06,Chronic Hepatitis B,Clevudine,"Seoul - Korea, Republic of",2011-09,2007-11-15,2012-07-26,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT02402218,CHAMPS,COMPLETED,2015-08,"Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus","Usual care plus peer-mentors, Usual care plus incentives, Usual Care",Baltimore - United States,2017-01-04,2015-03-30,2020-04-14,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT00466219,Unknown,COMPLETED,2002-05,Hepatitis C,"Ribavirin, Pegylated interferon alpha2a",No locations listed,Unknown Date,2007-04-27,2007-04-27,INTERVENTIONAL,PHASE3,"University Hospital, Geneva",OTHER,hepatitis
NCT04191018,GOVaSViR,UNKNOWN,2019-11-26,"Liver Diseases, Hepatitis C","Liver elastography, Splenic elastography, Gastrointestinal endoscopy","Rio de Janeiro - Brazil, Rio De Janeiro - Brazil",2022-08-14,2019-12-09,2019-12-09,OBSERVATIONAL,Not Available,Oswaldo Cruz Foundation,OTHER,hepatitis
NCT06870019,Unknown,NOT_YET_RECRUITING,2025-03-01,Hepatitis C Virus Infection,GPS tracker device,"Alhambra - United States, Ventura - United States",2025-04-15,2025-03-11,2025-03-11,INTERVENTIONAL,NA,University of Southern California,OTHER,hepatitis
NCT05248555,Unknown,RECRUITING,2021-12-01,Hepatitis C,Point-of-Care Testing,"Sydney - Australia, Cairns - Australia, Coorparoo - Australia, Ipswich - Australia, Townsville - Australia, Woodford - Australia, Marden - Australia, Mount Gambier - Australia, Fitzroy - Australia, Melbourne - Australia, Ravenhall - Australia",2024-12,2022-02-21,2024-06-13,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT01070550,Unknown,COMPLETED,2007-06,"Hepatitis C, Chronic",Peginterferon alfa-2a (Pegasys®),"Gratwein - Austria, Graz - Austria, Innsbruck - Austria, Linz - Austria, Linz - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Salvador - Brazil, Goiania - Brazil, Belo Horizonte - Brazil, Belem - Brazil, Recife - Brazil, Recife - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Porto Alegre - Brazil, Rio Grande - Brazil, Botucatu - Brazil, Campinas - Brazil, Campinas - Brazil, Ribeirao Preto - Brazil, Santos - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Calgary - Canada, Edmonton - Canada, Kelowna - Canada, Nanaimo - Canada, New Westminster - Canada, Prince George - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, St John's - Canada, Barrie - Canada, Brampton - Canada, Etobicoke - Canada, Guelph - Canada, London - Canada, Newmarket - Canada, North Bay - Canada, Oakville - Canada, Oshawa - Canada, Oshawa - Canada, Ottawa - Canada, Scarborough - Canada, Sudbury - Canada, Toronto - Canada, Toronto - Canada, Windsor - Canada, Levis - Canada, Montreal - Canada, Montreal - Canada, Quebec City - Canada, Quebec City - Canada, Quebec City - Canada, Saint-jean Sur Richelieu - Canada, St-charles Borromee - Canada, Osijek - Croatia, Pula - Croatia, Split - Croatia, Zadar - Croatia, Zagreb - Croatia, Agen - France, Aix En Provence - France, Albi - France, Amiens - France, Angers - France, Annecy - France, Antibes - France, Argenteuil - France, Argenteuil - France, Aulnay Sous Bois - France, Aulnay Sous Bois - France, Bastia - France, Beaumont - France, Beausoleil - France, Beauvais - France, Besancon - France, Besancon - France, Beziers - France, Beziers - France, Bordeaux - France, Bordeaux - France, Boulogne Billancourt - France, Bourgoin Jallieu - France, Caen - France, Chambery - France, Clermont Ferrand - France, Clichy - France, Colmar - France, Cornebarrieu - France, Creil - France, Creteil - France, Creteil - France, Dijon - France, Dijon - France, Druex - France, Evreux - France, Frejus - France, Freyming Merlebach - France, Grasse - France, Grenoble - France, Herouville St Clair - France, Hyeres - France, La Rochelle - France, La Valette du Var - France, Lagny Sur Marne - France, Le Chesnay - France, Le Havre - France, Le Kremlin Bicetre - France, Lille - France, Limoges - France, Lomme - France, Lorient - France, Lyon - France, Lyon - France, Lyon - France, Marseille - France, Marseille - France, Marseille - France, Marseille - France, Marseille - France, Martigues - France, Meaux - France, Melun - France, Menton - France, Metz - France, Metz - France, Monaco - France, Montauban - France, Montpellier - France, Montpellier - France, Mulhouse - France, Muret - France, Nanterre - France, Nantes - France, Nantes - France, Nice - France, Nice - France, Nimes - France, Nimes - France, Ollioules - France, Orange - France, Orleans - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Perigueux - France, Perpignan - France, Pessac - France, Poissy - France, Poitiers - France, Pont a Mousson - France, Reims - France, Rennes - France, Rouen - France, Saint Laurent Du Var - France, Sete - France, St Dizier - France, St Jean De Verges - France, St Mande - France, Ste Maxime - France, Strasbourg - France, Tarbes - France, Toulon - France, Toulouse - France, Toulouse - France, Toulouse - France, Toulouse - France, Tourcoing - France, Valenciennes - France, Vandoeuvre-les-nancy - France, Villejuif - France, Ajka - Hungary, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Debrecen - Hungary, Eger - Hungary, Gyor - Hungary, Gyula - Hungary, Kaposvar - Hungary, Kecskemet - Hungary, Kistarcsa - Hungary, Miskolc - Hungary, Miskolc - Hungary, Nyíregyháza - Hungary, Pecs - Hungary, Pecs - Hungary, Szeged - Hungary, Szekszard - Hungary, Szolnok - Hungary, Szombathely - Hungary, Székesfehérvár - Hungary, Tatabánya - Hungary, Zalaegerszeg - Hungary, Zalaegerszeg - Hungary, Skopje - Macedonia, The Former Yugoslav Republic of, Chihuahua - Mexico, Chihuahua - Mexico, Culiacan - Mexico, Guadalajara - Mexico, Hermosillo - Mexico, Mexicali - Mexico, Mexico City - Mexico, Mexico DF - Mexico, Monterrey - Mexico, Puebla - Mexico, Puebla - Mexico, Casablanca - Morocco, Casablanca - Morocco, Rabat - Morocco, Bydgoszcz - Poland, Lodz - Poland, Warszawa - Poland, Warszawa - Poland, Wroclaw - Poland, Arad - Romania, Brasov - Romania, Brasov - Romania, Brasov - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Cluj Napoca - Romania, Cluj-napoca - Romania, Constanta - Romania, Constanta - Romania, Constanta - Romania, Iasi - Romania, Iasi - Romania, Sector 2 - Romania, Targu-Mures - Romania, Timisoara - Romania, Timisoara - Romania, Belgrade - Serbia, NIS - Serbia, Novi Sad - Serbia, Celje - Slovenia, Ljubljana - Slovenia, Maribor - Slovenia, Novo Mesto - Slovenia, Eskilstuna - Sweden, Halmstad - Sweden, Huddinge - Sweden, Linkoeping - Sweden, Lund - Sweden, Oerebro - Sweden",2011-07,2010-02-18,2016-06-15,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05330455,Unknown,RECRUITING,2022-04-14,Hepatitis B,"GSK3965193, Placebo to match GSK3965193, Bepirovirsen","Calgary - Canada, Ottawa - Canada, Grenoble cedex 9 - France, Lyon - France, Nantes cedex 1 - France, Rennes - France, Milano - Italy, Monza MB - Italy, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Bangkok - Thailand, Cambridge - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2027-10-06,2022-04-15,2024-11-08,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06150014,Unknown,ACTIVE_NOT_RECRUITING,2023-12-07,Chronic Hepatitis b,"Placebo, TQA3605 tablets, Entecavir dispersible tablets, Tenofovir disoproxil fumarate tablet, Tenofovir alafenamide fumarate tablet","Chongqing - China, Chongqing - China, Xi'an - China",2025-12,2023-11-29,2024-11-14,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT05693714,Unknown,NOT_YET_RECRUITING,2023-01-20,Observational,Pcr,No locations listed,2024-12-31,2023-01-23,2023-01-23,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT02263755,Unknown,COMPLETED,2014-09-02,Chronic Hepatitis B,No interventions listed,No locations listed,2015-06-25,2014-10-13,2017-01-25,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT03197155,RECAR,COMPLETED,2016-06-01,"Hepatocellular Carcinoma, Hepatitis C, Direct Acting Antivirals",Direct Acting Antivirals against hepatitis C virus infection,No locations listed,2017-01-31,2017-06-23,2017-06-23,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT02074514,Unknown,COMPLETED,2014-03,Chronic HCV Infection,"Sofosbuvir, RBV","Hyderabad - India, New Delhi - India, New Delhi - India, Surat - India, Gurgaon - India, Kochi - India, Mumbai - India, Ludhiana - India, Jaipur - India, Coimbatore - India, Lucknow - India, Kolkata - India, Chandigarh - India",2015-09,2014-02-28,2016-10-25,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT02452814,Unknown,COMPLETED,2014-05-07,HCV,No interventions listed,"Dallas - United States, Houston - United States, San Juan - Puerto Rico",2017-05-03,2015-05-25,2018-02-06,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04684914,Unknown,TERMINATED,2020-12-26,"Hepatitis B, Chronic","HepTcell, Placebo","Garden Grove - United States, Redwood City - United States, San Jose - United States, Kansas City - United States, Oklahoma City - United States, Calgary - Canada, Edmonton - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Frankfurt am Main - Germany, Hamburg - Germany, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2024-03-27,2020-12-28,2024-05-29,INTERVENTIONAL,PHASE2,"Altimmune, Inc.",INDUSTRY,hepatitis
NCT03290755,HEPCSEX,COMPLETED,2017-11-08,"Human Immunodeficiency Virus (HIV), Hepatitis c",semi-directed interviews,Bordeaux - France,2018-03-13,2017-09-25,2018-11-14,OBSERVATIONAL,Not Available,"University Hospital, Bordeaux",OTHER,hepatitis
NCT02558114,Unknown,TERMINATED,2015-12,Hepatitis E,Ribavirin,Barcelona - Spain,2018-11,2015-09-23,2019-04-16,INTERVENTIONAL,PHASE4,Hospital Universitari Vall d'Hebron Research Institute,OTHER,hepatitis
NCT02963714,Unknown,COMPLETED,2014-12,Hepatitis B Vaccine,"60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine",No locations listed,2015-07,2016-11-15,2022-02-14,INTERVENTIONAL,PHASE4,Suping Wang,OTHER,hepatitis
NCT05797714,Promote,ACTIVE_NOT_RECRUITING,2022-06-08,"HBV Infection, Chronic Hepatitis b",Tenofovir Amibufenamide（TMF）,"Changsha - China, Beijing - China, Dongyang - China, Fuyang - China, Hangzhou - China, LiShui - China, Nanchang - China, Nanjin - China, Shanghai - China, Shanghai - China, Suzhou - China, Wuxi - China",2024-06-15,2023-04-04,2024-05-23,INTERVENTIONAL,NA,Ruijin Hospital,OTHER,hepatitis
NCT01704755,TURQUOISE-II,COMPLETED,2012-10,"Chronic Hepatitis C Infection, Compensated Cirrhosis","ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV)",No locations listed,2014-01,2012-10-11,2021-07-12,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT00047814,Unknown,COMPLETED,2002-10,Hepatitis C,FK788,"Pasadena - United States, Lakewood - United States, Gainsville - United States, Boston - United States, Kansas City - United States, Charlotte - United States, Durham - United States, Philadelphia - United States, Tacoma - United States",Unknown Date,2002-10-24,2011-12-09,INTERVENTIONAL,PHASE2,Astellas Pharma Inc,INDUSTRY,hepatitis
NCT03300414,Unknown,COMPLETED,2017-03-20,"Hepatocellular Carcinoma, Hepatitis B, Chronic",One time blood draw,Sacramento - United States,2018-12-14,2017-10-03,2019-04-11,OBSERVATIONAL,Not Available,"University of California, Davis",OTHER,hepatitis
NCT02576314,Unknown,COMPLETED,2015-05,Chronic Hepatitis C Infection,"sofosbuvir and daclatasvir, ledipasvir/sofosbuvir","Beijing - China, Hong Kong - China",2017-12-31,2015-10-15,2018-03-19,INTERVENTIONAL,PHASE3,Humanity and Health Research Centre,OTHER,hepatitis
NCT00136214,Unknown,COMPLETED,2004-03,Hepatitis C,MR brain and neuropsychiatric tests,Boston - United States,2008-01,2005-08-29,2018-07-12,OBSERVATIONAL,Not Available,Beth Israel Deaconess Medical Center,OTHER,hepatitis
NCT00209755,Unknown,TERMINATED,2003-10,Chronic Hepatitis C,therapeutic drug monitoring of ribavirin and dose adaptation,Grenoble - France,Unknown Date,2005-09-21,2005-09-21,INTERVENTIONAL,NA,Hopital A Michallon,OTHER,hepatitis
NCT00363155,Unknown,COMPLETED,2003-03,"Hepatitis B, Chronic",KRN7000,Rotterdam - Netherlands,Unknown Date,2006-08-15,2006-08-15,INTERVENTIONAL,PHASE2,Foundation for Liver Research,OTHER,hepatitis
NCT02493855,Unknown,COMPLETED,2015-06,"Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1a","Ombitasvir/ABT-450/Ritonavir, Dasabuvir, Ribavirin (RBV)",No locations listed,2016-04,2015-07-10,2017-10-31,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT03791814,MATCH-D,WITHDRAWN,2019-01-01,Hepatitis C,Zepatier,No locations listed,2019-06-30,2019-01-03,2020-02-26,INTERVENTIONAL,PHASE4,Albert Einstein Healthcare Network,OTHER,hepatitis
NCT00245414,Unknown,COMPLETED,2005-10,Chronic Hepatitis C,"Pegasys®, Pegasys®","Fukuoka - Japan, Okayama - Japan, Osaka - Japan, Sapporo - Japan, Tokyo - Japan, Yamanashi - Japan",2010-07,2005-10-28,2010-11-17,INTERVENTIONAL,PHASE4,Chugai Pharmaceutical,INDUSTRY,hepatitis
NCT00412750,Unknown,TERMINATED,2006-12,Hepatitis B,"Telbivudine (LdT), peginterferon alpha-2a",San Francisco - United States,2009-02,2006-12-18,2011-07-13,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT00263614,Unknown,COMPLETED,2005-12,Chronic Hepatitis B,No interventions listed,Foster City - United States,Unknown Date,2005-12-09,2009-02-03,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT04391608,Unknown,UNKNOWN,2019-11-09,"Renal Insufficiency, Tenofovir",Switching to Tenofovir Alafenamide,Bangkok Noi - Thailand,2022-07-31,2020-05-18,2022-03-08,INTERVENTIONAL,PHASE4,Mahidol University,OTHER,hepatitis
NCT02288208,Unknown,TERMINATED,2014-11,Hepatitis B,"Antiviral Therapy (tenofovir or entecavir), Birinapant, Placebo (for birinapant)","Adelaide - Australia, Melbourne - Australia, Nedlands - Australia",2015-05,2014-11-11,2016-02-05,INTERVENTIONAL,PHASE1,TetraLogic Pharmaceuticals,INDUSTRY,hepatitis
NCT04961723,Unknown,UNKNOWN,2021-12-10,"Hepatitis C, Diagnostic Self Evaluation",(OraQuick® HCV Self-Test,"Batumi - Georgia, Batumi - Georgia, Batumi - Georgia, Tbilisi - Georgia, Tbilisi - Georgia, Tbilisi - Georgia",2022-06,2021-07-14,2022-02-28,INTERVENTIONAL,NA,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT01627223,NUC115132,TERMINATED,2012-07,Chronic Hepatitis B,"Lamivudine, Entecavir","Changhua - Taiwan, ChiaYi - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, YuLin - Taiwan",2016-04,2012-06-25,2016-10-18,INTERVENTIONAL,PHASE4,Taichung Veterans General Hospital,OTHER,hepatitis
NCT03373123,rEndosc,WITHDRAWN,2017-12-18,Esophageal Varices in Cirrhosis of the Liver,"Endoscopy, CTA","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Xingtai - China, Jinan - China",2018-12-18,2017-12-14,2019-06-19,INTERVENTIONAL,NA,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT04142723,Unknown,UNKNOWN,2019-06-20,"Hepatitis, Alcoholic",blood withdraw,Santiago - Chile,2022-06-20,2019-10-29,2019-10-29,OBSERVATIONAL,Not Available,Pontificia Universidad Catolica de Chile,OTHER,hepatitis
NCT00637923,STEALTHC-3,COMPLETED,2008-03,Chronic Hepatitis C,"Nitazoxanide, Placebo, Peginterferon alfa-2a, Ribavirin","Palo Alto - United States, New Haven - United States, Bay Pines - United States, Largo - United States, Atlanta - United States, Boston - United States, Boston - United States, New York - United States, Nashville - United States, Fairfax - United States",2010-04,2008-03-18,2014-02-10,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT03241823,Unknown,UNKNOWN,2017-12-01,"Hepatitis C, Liver Cirrhosis","Abdominal ultrasound ., Model for End-Stage Liver Disease, Fibro Scan., Child-Turcotte-Pugh score.",Assuit - Egypt,2019-01,2017-08-08,2017-08-08,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT03753438,Unknown,COMPLETED,2016-08-02,Liver Cirrhosis,Intragstric Ballooning,New Delhi - India,2020-05-31,2018-11-27,2021-06-23,OBSERVATIONAL,Not Available,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT02682108,Unknown,COMPLETED,2014-04,"Fibrosis, Liver",Diffusion-weighted magnetic resonance imaging (DW-MRI),Bangkoknoi - Thailand,2016-06,2016-02-15,2016-09-14,INTERVENTIONAL,NA,Mahidol University,OTHER,hepatitis
NCT02634008,TARGET3D,COMPLETED,2016-06,"Hepatitis C, Acute","Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin, Glecaprevir/pibrentasvir","Sydney - Australia, Adelaide - Australia, Melbourne - Australia, Auckland - New Zealand, Christchurch - New Zealand, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2021-04-30,2015-12-17,2022-08-22,INTERVENTIONAL,PHASE3,Kirby Institute,OTHER_GOV,hepatitis
NCT05062408,Hepatitis,COMPLETED,2021-03-01,"Hepatitis C, Chronic",No interventions listed,Sevilla - Spain,2021-04-01,2021-09-30,2021-11-17,OBSERVATIONAL,Not Available,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,OTHER,hepatitis
NCT02738008,Unknown,TERMINATED,2016-03,Hepatitis B,"ARC-520 Injection, entecavir, tenofovir, antihistamine","Hong Kong - China, Leipzig - Germany, Busan - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2016-12,2016-04-14,2019-04-16,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT02058108,Unknown,TERMINATED,2014-10-31,Chronic Hepatitis B,"Telbivudine, Placebo","Sofia - Bulgaria, Pleven - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Goudi-Athens - Greece, Athens - Greece, Jerusalem - Israel, Jerusalem - Israel, Nahariya - Israel, Nazareth - Israel, Seoul - Korea, Republic of, Cluj Napoca - Romania, Craiova - Romania, Timisoara - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Iasi - Romania, Ankara - Turkey, Antalya - Turkey, Diyarbakir - Turkey, Elazig - Turkey, Eskisehir - Turkey, Mersin - Turkey, Dnipropetrovsk - Ukraine, Kiev - Ukraine, Kyiv - Ukraine, Odesa - Ukraine, Vinnytsia - Ukraine",2019-01-09,2014-02-07,2019-09-10,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01803308,Unknown,COMPLETED,2013-03,Hepatitis C Infection,"SB9200, SB9200, Placebo","Heidelberg - Australia, Melbourne - Australia, Nedlands - Australia, Christchurch - New Zealand",2014-08,2013-03-04,2019-09-18,INTERVENTIONAL,PHASE1,Syneos Health,OTHER,hepatitis
NCT05275023,OCTOPUS-1,COMPLETED,2022-06-30,"Hepatitis B, Chronic","JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil, Tenofovir Alafenamide, Entecavir","Toronto - Canada, Hradec Kralove - Czechia, Prague 4 - Czechia, Clichy - France, Marseille - France, Rennes - France, Vandoeuvre-les-nancy - France, Milano - Italy, Pisa - Italy, Rome - Italy, Barcelona - Spain, Madrid - Spain, Pontevedra - Spain, Valencia - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taoyuan - Taiwan, Ankara - Turkey, Istanbul - Turkey, Izmir - Turkey, Kocaeli - Turkey, Trabzon - Turkey, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom",2023-12-12,2022-03-11,2025-03-04,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT02006823,Unknown,COMPLETED,2012-03,Chronic Hepatitis C,No interventions listed,"Durham - United States, Rocky Mount - United States",2014-07,2013-12-10,2014-12-15,OBSERVATIONAL,Not Available,Duke University,OTHER,hepatitis
NCT01835938,Unknown,UNKNOWN,2013-05,"Chronic Hepatitis C Infection, HCV Genotype 1b","1- Erlotinib, placebo",Strasbourg Cedex - France,2015-05,2013-04-19,2014-06-17,INTERVENTIONAL,PHASE2,"University Hospital, Strasbourg, France",OTHER,hepatitis
NCT01698723,HEVRibavirin,UNKNOWN,2012-09,"Acute on Chronic Hepatic Failure, Liver Failure, Hepatitis E Infection","Ribavirin, Placebo","Delhi - India, Delhi - India",2016-06,2012-10-03,2016-04-26,INTERVENTIONAL,PHASE2,"All India Institute of Medical Sciences, New Delhi",OTHER,hepatitis
NCT01374308,NASVAC,UNKNOWN,2011-06,Chronic Hepatitis B,"NASVAC, Pegylated interferon alpha 2b",Dhaka - Bangladesh,2013-06,2011-06-15,2012-12-12,INTERVENTIONAL,PHASE3,"Clinical Research Organization, Dhaka, Bangladesh",OTHER,hepatitis
NCT04153708,Unknown,UNKNOWN,2019-11-03,Hepatitis C,"Retrieval patients lost to follow-up with positive HCV antibodies without RNA request or positive RNA by phone call., Retrieval patients lost to follow-up with positive HCV antibodies without RNA request or positive RNA by mail letter",La Laguna - Spain,2021-09-01,2019-11-06,2021-04-30,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT00951223,REACHSVR,WITHDRAWN,2009-08,Hepatitis C,Infergen® (Interferon alfacon-1),No locations listed,2010-11,2009-08-04,2015-09-03,OBSERVATIONAL,Not Available,"Kadmon Corporation, LLC",INDUSTRY,hepatitis
NCT05756738,TGSS_CIS,RECRUITING,2023-03-10,Hepatitis C Virus,Dried blood spot testing,San Cristobal de La laguna - Spain,2024-01-10,2023-03-06,2023-12-05,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT01724723,HBV,UNKNOWN,2012-12,"Hepatitis, Tuberculosis, hepatitisB",entecavir (BARACLUDE®),Taipei - Taiwan,2014-06,2012-11-12,2012-11-12,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT00051038,Unknown,COMPLETED,2002-09,Hepatitis B,Entecavir,"New Haven - United States, Altamonte Springs - United States, Lousiville - United States, Charlotte - United States, Pittsburgh - United States",2005-10,2003-01-03,2011-04-14,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00522808,CP104,TERMINATED,2007-08,Chronic Hepatitis C,A-831,"Auckland - New Zealand, Birmingham - United Kingdom, Dundee - United Kingdom",2008-03,2007-08-30,2008-09-29,INTERVENTIONAL,PHASE2,Arrow Therapeutics,INDUSTRY,hepatitis
NCT00393523,Unknown,COMPLETED,2006-09,Hepatitis B,"Comparator: Modified Process Hepatitis B Vaccine, Comparator: Comparator: ENGERIX-B",No locations listed,2008-06,2006-10-27,2017-04-12,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05200338,PROTECT,RECRUITING,2021-06-08,Sickle Cell Disease,Engerix-B,Amsterdam - Netherlands,2024-01,2022-01-20,2023-06-08,INTERVENTIONAL,NA,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),OTHER,hepatitis
NCT04719338,Unknown,COMPLETED,2021-03-01,Hepatitis C,presence of HCV RNA in peripheral blood mononuclear cells (PBMCs) .,Alexandria - Egypt,2021-08-01,2021-01-22,2022-04-15,INTERVENTIONAL,NA,Alexandria University,OTHER,hepatitis
NCT01011738,Unknown,COMPLETED,2009-04-11,"Hepatitis B, Chronic",No interventions listed,"Graz - Austria, Innsbruck - Austria, Linz - Austria, Wien - Austria, Wien - Austria, Manama - Bahrain, Dhaka - Bangladesh, Dhaka - Bangladesh, Banja Luka - Bosnia and Herzegovina, Bihac - Bosnia and Herzegovina, Mostar - Bosnia and Herzegovina, Sarajevo - Bosnia and Herzegovina, Tuzla - Bosnia and Herzegovina, Tuzla - Bosnia and Herzegovina, Zenica - Bosnia and Herzegovina, Sofia - Bulgaria, Varna - Bulgaria, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chengdu - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Harbin - China, Jinan - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shen Zhen - China, ShenYang - China, Shi Jiazhuang - China, Shijiazhuang - China, Urumqi - China, Wenzhou - China, Xi'an - China, Cairo - Egypt, Cairo - Egypt, Cairo - Egypt, Cairo - Egypt, Cairo - Egypt, Giza - Egypt, Giza - Egypt, Mansoura - Egypt, Aix En Provence - France, Amiens - France, Amiens - France, Angers - France, Argenteuil - France, Argenteuil - France, Avignon - France, Besancon - France, Bobigny - France, Bondy - France, Bordeaux - France, Bourgoin Jallieu - France, Caen - France, Chambray Les Tours - France, Clamart - France, Clermont Ferrand - France, Clichy - France, Clichy - France, Corbeil Essonnes - France, Creil - France, Creteil - France, Dijon - France, Evry - France, Grasse - France, La Tronche - France, Lagny Sur Marne - France, Le Kremlin Bicetre - France, Le Mans - France, Lille - France, Limoges - France, Lyon - France, Lyon - France, Lyon - France, Marseille - France, Marseille - France, Marseille - France, Metz - France, Montauban - France, Montivilliers - France, Montpellier - France, Montpellier - France, Mulhouse - France, Nantes - France, Nantes - France, Nimes - France, Niort - France, Orleans - France, Paris - France, Paris - France, Paris - France, Paris - France, Perpignan - France, Pessac - France, Reims - France, Rennes - France, Rouen - France, Saint Laurent Du Var - France, St Maurice - France, Strasbourg - France, Toulon - France, Toulon - France, Toulouse - France, Toulouse - France, Vandoeuvre-les-nancy - France, Villejuif - France, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Erlangen - Germany, Essen - Germany, Frankfurt am Main - Germany, Freiburg - Germany, Giessen - Germany, Hamburg - Germany, Hamburg - Germany, Hamm - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Jena - Germany, Kiel - Germany, Lübeck - Germany, Magdeburg - Germany, Mainz - Germany, München - Germany, Münster - Germany, Münster - Germany, Nürnberg - Germany, Offenburg - Germany, Salzgitter - Germany, Stuttgart - Germany, Ulm - Germany, Wuerzburg - Germany, Wuppertal - Germany, Tuen Mun - Hong Kong, New Delhi - India, Gurgaon - India, Guwahati - India, Mumbai - India, Pune - India, Pune - India, Pune - India, Trivandrum - India, Bandung - Indonesia, Bandung - Indonesia, Bandung - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Jakarta - Indonesia, Surabaya - Indonesia, Tangerang - Indonesia, Dublin - Ireland, Dublin - Ireland, Amman - Jordan, Amman - Jordan, Irbid - Jordan, Anyang - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Chooncheon - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Incheon - Korea, Republic of, Jeollabuk-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoungnamsi - Korea, Republic of, Ulsan - Korea, Republic of, Beirut - Lebanon, Beirut - Lebanon, Beirut - Lebanon, Skopje - Macedonia, The Former Yugoslav Republic of, Skopje - Macedonia, The Former Yugoslav Republic of, Casablanca - Morocco, Fes - Morocco, Rabat - Morocco, Auckland - New Zealand, Hamilton - New Zealand, Whakatane - New Zealand, Faisalabad - Pakistan, Islamabad - Pakistan, Karachi - Pakistan, Karachi - Pakistan, Karachi - Pakistan, Lahore - Pakistan, Lahore - Pakistan, Peshawar - Pakistan, Rawalpindi - Pakistan, Rawalpindi - Pakistan, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Gdansk - Poland, Krakow - Poland, Lancut - Poland, Lodz - Poland, Lodz - Poland, Warszawa - Poland, Warszawa - Poland, Wroclaw - Poland, Zielona Góra - Poland, Łodz - Poland, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Craiova - Romania, Alkhobar - Saudi Arabia, Riyadh - Saudi Arabia, Riyadh - Saudi Arabia, Riyadh - Saudi Arabia, Tabuk - Saudi Arabia, Bangkok - Thailand, Chiang Mai - Thailand, Songkhla - Thailand, Dubai - United Arab Emirates, Hull - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2014-11-18,2009-11-11,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02540538,Unknown,COMPLETED,2015-09,Hepatitis B,"HBVaxPro, HBAI20",Maastricht - Netherlands,2016-07,2015-09-04,2018-12-19,INTERVENTIONAL,PHASE1,Maastricht University Medical Center,OTHER,hepatitis
NCT05091008,Unknown,COMPLETED,2018-03-01,"Hepatitis C, Chronic",Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet,Mansoura - Egypt,2019-08-30,2021-10-25,2021-10-25,INTERVENTIONAL,PHASE2,Mansoura University Children Hospital,OTHER,hepatitis
NCT01749150,Unknown,COMPLETED,2013-04,"Hepatitis C, Chronic","danoprevir + ritonavir, danoprevir + ritonavir, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], ribavirin [Copegus], ribavirin [Copegus]","Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Chiayi County - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Yunlin County - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand",2015-02,2012-12-13,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01446250,Unknown,TERMINATED,2011-12,Hepatitis C,"Alisporivir, Boceprevir, Peginterferon alfa-2a, Ribavirin","Beverly Hills - United States, Baltimore - United States",2013-05,2011-10-05,2017-01-16,INTERVENTIONAL,PHASE3,Debiopharm International SA,INDUSTRY,hepatitis
NCT01180790,Unknown,COMPLETED,2010-09,Hepatitis C,"ACH-0141625 (Sovaprevir), ACH-0141625 (Sovaprevir), ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a, Ribavirin","Los Angeles - United States, Los Angeles - United States, San Francisco - United States, Bradenton - United States, Orlando - United States, Chicago - United States, Overland Park - United States, Saint Louis - United States, Las Vegas - United States, New York - United States, Philadelphia - United States, Arlington - United States, San Antonio - United States, Newport News - United States, Norfolk - United States, Edegem - Belgium, Haine-Saint-Paul - Belgium, Gent - Belgium",2012-03,2010-08-12,2023-08-30,INTERVENTIONAL,PHASE2,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT06616103,Unknown,NOT_YET_RECRUITING,2024-09-26,"Chronic Hepatitis B, Steatosis of Liver, Fibrosis and Cirrhosis of Liver",computerized tomography,"Seoul - Korea, Republic of",2025-08-31,2024-09-27,2024-09-27,OBSERVATIONAL,Not Available,Seoul National University Hospital,OTHER,hepatitis
NCT01848743,HBSAE,UNKNOWN,2013-04,Chronic HBV With Severe Exacerbation,"Tenofovir, lamivudine","Kaohsiung - Taiwan, Kaohsiung - Taiwan",2016-04,2013-05-07,2014-09-16,INTERVENTIONAL,PHASE3,Kaohsiung Veterans General Hospital.,OTHER,hepatitis
NCT03166943,Unknown,UNKNOWN,2017-05-10,Hepatitis,"Systolic function by echocardiography, Diastolic function by echocardiography",Assiut - Egypt,2020-12,2017-05-25,2020-01-22,INTERVENTIONAL,NA,Assiut University,OTHER,hepatitis
NCT03804814,Unknown,TERMINATED,2019-05-21,Hepatitis C,Motivational Interviewing Training,Halifax - Canada,2021-10-04,2019-01-15,2023-02-10,INTERVENTIONAL,NA,Nova Scotia Health Authority,OTHER,hepatitis
NCT02645955,MHD HEV,COMPLETED,2016-05,Hepatitis E Virus Infection,No interventions listed,No locations listed,2018-03,2016-01-05,2020-09-16,OBSERVATIONAL,Not Available,Xiamen University,OTHER,hepatitis
NCT02275195,Unknown,RECRUITING,2013-11,Hepatitis,No interventions listed,Basildon - United Kingdom,2024-12,2014-10-27,2024-01-12,OBSERVATIONAL,Not Available,Mid and South Essex NHS Foundation Trust,OTHER,hepatitis
NCT04885855,Unknown,COMPLETED,2021-03-23,Hepatitis C,"Sofosbuvir 400 MG, Ravidasvir 200mg",Alor Star - Malaysia,2023-12-29,2021-05-13,2025-03-13,INTERVENTIONAL,PHASE3,Muhammad Radzi Abu Hassan,OTHER_GOV,hepatitis
NCT02777814,Unknown,UNKNOWN,2015-05-01,Colorectal Neoplasms,Entecavir,Guangzhou - China,2018-10,2016-05-19,2019-01-22,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT00298714,Unknown,COMPLETED,2003-03,"Chronic Hepatitis C, Liver Fibrosis",Losartan,No locations listed,Unknown Date,2006-03-03,2007-11-22,INTERVENTIONAL,PHASE4,Hospital Clinic of Barcelona,OTHER,hepatitis
NCT03524014,VHENE,UNKNOWN,2018-05-15,Hepatitis E Infection in Humans and in Environment,Only advice for diagnosis and prevention,Vandoeuvre Les Nancy - France,2019-06-30,2018-05-14,2018-07-18,OBSERVATIONAL,Not Available,"Central Hospital, Nancy, France",OTHER,hepatitis
NCT01580995,HSV1/HCV,COMPLETED,2012-04,Chronic Hepatitis C Infection,"Valacyclovir, Placebo",Jackson - United States,2014-12,2012-04-19,2016-09-21,INTERVENTIONAL,PHASE2,VA Office of Research and Development,FED,hepatitis
NCT02024295,Unknown,UNKNOWN,2013-12,"Hepatitis, Alcoholic","Ademethionine, Polyene Phosphatidyl choline, Ademethionine","Beijing - China, Beijing - China",2015-12,2013-12-31,2014-05-29,INTERVENTIONAL,PHASE4,Zhejiang Hisun Pharmaceutical Co. Ltd.,INDUSTRY,hepatitis
NCT05295914,Unknown,UNKNOWN,2022-04-10,Chronic Hepatitis B,TREAT-B score,Bangkok - Thailand,2022-05-30,2022-03-25,2022-04-04,OBSERVATIONAL,Not Available,Mahidol University,OTHER,hepatitis
NCT03587714,Unknown,COMPLETED,2017-01-01,Hepatitis C,HCV RT-PCR,Assiut - Egypt,2017-12-01,2018-07-16,2018-07-16,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00274495,Unknown,TERMINATED,2006-01,"Chronic Hepatitis C Infection, Fatty Liver",Rosiglitazone and Pegasys/Ribavirin,New York - United States,Unknown Date,2006-01-11,2007-11-01,INTERVENTIONAL,PHASE4,Beth Israel Medical Center,OTHER,hepatitis
NCT01782495,CORAL-I,COMPLETED,2013-02-25,Chronic Hepatitis C Infection,"ombitasvir/paritaprevir/ritonavir and dasabuvir, ombitasvir/paritaprevir/ritonavir, ribavirin",No locations listed,2016-11-02,2013-02-04,2017-11-07,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT00036608,Unknown,COMPLETED,2002-01,Chronic Hepatitis B,Entecavir,"Birmingham - United States, Tucson - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Orange - United States, San Diego - United States, San Francisco - United States, Farmington - United States, Miami Beach - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Iowa City - United States, New Orleans - United States, Dundalk - United States, Boston - United States, Worcester - United States, Ann Arbor - United States, Royal Oak - United States, St Paul - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Charlotte - United States, Durham - United States, Cleveland - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Nashville - United States, Dallas - United States, Fairfax - United States, Richmond - United States",2005-02,2002-05-13,2011-04-14,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01640808,Unknown,COMPLETED,2012-04,Hepatic Neoplasm Malignant Recurrent,"NIK-333(peretinoin), Placebo","Nagoya - Japan, Nagoya - Japan, Kashiwa - Japan, Matsuyama - Japan, Iizuka - Japan, Kurume - Japan, Ogaki - Japan, Sapporo - Japan, Sapporo - Japan, Sapporo - Japan, Himeji - Japan, Kobe - Japan, Nishinomiya - Japan, Kanazawa - Japan, Kawasaki - Japan, Sagamihara - Japan, Sagamihara - Japan, Yokohama - Japan, Yokohama - Japan, Nankoku - Japan, Kurashiki - Japan, Ikeda - Japan, Moriguchi - Japan, Osakasayama - Japan, Sakai - Japan, Suita - Japan, Iruma - Japan, Sunto-gun - Japan, Shimotsuke - Japan, Musashino - Japan, Bunkyo-ku, - Japan, Bunkyo-ku - Japan, Bunkyo-ku - Japan, Chiyoda-ku - Japan, Chuo-ku - Japan, Minato-ku - Japan, Ota-ku - Japan, Setagaya-ku - Japan, Shibuya-ku - Japan, Shinjuku-ku - Japan, Shimonoseki - Japan, Ube - Japan, Kofu - Japan, Chiba - Japan, Fukuoka - Japan, Fukuoka - Japan, Gifu - Japan, Gifu - Japan, Hiroshima - Japan, Hiroshima - Japan, Kagoshima - Japan, Kumamoto - Japan, Nagasaki - Japan, Niigata - Japan, Oita - Japan, Okayama - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Saga - Japan, Saga - Japan, Tokushima - Japan, Tokushima - Japan, Wakayama - Japan",2016-10,2012-07-16,2020-12-02,INTERVENTIONAL,PHASE3,"Kowa Company, Ltd.",INDUSTRY,hepatitis
NCT00663208,Unknown,COMPLETED,2008-05,Chronic Hepatitis C,"Daclatasvir, Placebo","Anaheim - United States, Cypress - United States, New Haven - United States, Miami - United States, Orlando - United States, Baltimore - United States, San Antonio - United States, Santurce - Puerto Rico",2009-06,2008-04-22,2015-10-14,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01074008,Champion2,COMPLETED,2010-03,"Hepatitis C, HCV, Chronic Hepatitis C Infection, Hepatitis C Genotype 1","ABT-450, ABT-072, ABT-333, Ritonavir, Peginterferon alpha-2a, Ribavirin, Placebo","Phoenix - United States, Anaheim - United States, La Jolla - United States, Los Angeles - United States, Aurora - United States, Orlando - United States, Orlando - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Baton Rouge - United States, New Orleans - United States, Baltimore - United States, Detroit - United States, St. Paul - United States, New York - United States, New York - United States, Chapel Hill - United States, Durham - United States, Dallas - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Seattle - United States, Madison - United States, Ponce - Puerto Rico",2011-06,2010-02-24,2015-01-08,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT04201808,Unknown,UNKNOWN,2021-05-01,"Hepatitis B, Chronic",Tenofovir Alafenamide 25 MG,"Bengbu - China, Beijing - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Wuhan - China, Shengyang - China, Xi'an - China, Jing'an - China, Hebei - China",2023-09-30,2019-12-17,2020-11-17,INTERVENTIONAL,PHASE4,New Discovery LLC,INDUSTRY,hepatitis
NCT01341808,Unknown,COMPLETED,2011-04,"Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, Hepatitis A",Epaxal Berna (virosomal hepatitis A vaccine),"Seoul - Korea, Republic of",2013-02,2011-04-26,2013-03-19,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT00115908,Unknown,COMPLETED,2005-05,"Hepatitis C, Chronic","Albuferon, Ribavirin, PEG-IFNalfa2a","Camperdown - Australia, Concord - Australia, New Lambton Heights - Australia, Westmead - Australia, Brisbane - Australia, Herston - Australia, Adelaide - Australia, Clayton - Australia, East Melbourne - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Melbourne - Australia, Fremantle - Australia, Nedlands - Australia, Perth - Australia, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Halifax - Canada, Hamilton - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Saskatoon - Canada, Brno - Czech Republic, Hradec Kralove - Czech Republic, Melnik - Czech Republic, Opava - Czech Republic, Prague - Czech Republic, Prague - Czech Republic, Prague - Czech Republic, Usti nad labem - Czech Republic, Angers - France, Clichy - France, Creteil - France, Grenoble - France, Lille - France, Lyon - France, Marseille - France, Nice - France, Orleans - France, Paris - France, Paris - France, Paris - France, Pessac - France, Toulouse - France, Vandoeuvre - France, Berlin - Germany, Bochum - Germany, Duesseldorf - Germany, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Homburg - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, Tuebingen - Germany, Haifa - Israel, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petah Tiqwa - Israel, Tel Aviv - Israel, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Kielce - Poland, Krakow - Poland, Lodz - Poland, Poznan - Poland, Szczecin - Poland, Warsaw - Poland, Warsaw - Poland, Wroclaw - Poland, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Cluj-Napoca - Romania, Iasi - Romania",2007-05,2005-06-27,2013-11-07,INTERVENTIONAL,PHASE2,Human Genome Sciences Inc.,INDUSTRY,hepatitis
NCT05416008,Unknown,ENROLLING_BY_INVITATION,2021-07-01,Hepatic Steatosis,No interventions listed,Chongqing - China,2022-12-31,2022-06-13,2022-06-13,OBSERVATIONAL,Not Available,The Second Affiliated Hospital of Chongqing Medical University,OTHER,hepatitis
NCT03588923,Unknown,COMPLETED,2018-07-07,HCV Infection,"SH229, Placebos, SH229, Placebos, SH229, Placebos",Changchun - China,2018-08-10,2018-07-17,2018-08-28,INTERVENTIONAL,PHASE1,"Nanjing Sanhome Pharmaceutical, Co., Ltd.",INDUSTRY,hepatitis
NCT02339038,Unknown,COMPLETED,2015-01-07,HCV HIV,Ledipasvir 90 mg and Sofosbuvir 400 mg,"Washington - United States, Washington - United States",2016-06-15,2015-01-15,2018-08-14,INTERVENTIONAL,PHASE4,National Institutes of Health Clinical Center (CC),NIH,hepatitis
NCT02881008,Unknown,COMPLETED,2012-11-14,Chronic Hepatitis B,"Entecavir, Myrcludex B","Chelyabinsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Samara - Russian Federation, Stavropol' - Russian Federation",2014-10-04,2016-08-26,2018-09-19,INTERVENTIONAL,PHASE2,Hepatera Ltd.,INDUSTRY,hepatitis
NCT04301908,Unknown,UNKNOWN,2020-04-01,Chronic Hepatitis b,interferon,Beijing - China,2021-04-01,2020-03-10,2020-03-10,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT02371408,Unknown,UNKNOWN,2015-01,Chronic Hepatitis C,"ravidasvir hydrochloride, sofosbuvir, ribavirin","Cairo - Egypt, Cairo - Egypt, Menoufiya - Egypt",2016-01,2015-02-25,2016-04-07,INTERVENTIONAL,PHASE3,Pharco Pharmaceuticals,INDUSTRY,hepatitis
NCT01464008,Unknown,COMPLETED,2004-01,Chronic Hepatitis C,Pegylated interferon alfa-2a and ribavirin,Beijing - China,2011-05,2011-11-02,2016-09-27,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00674908,Unknown,COMPLETED,2008-03,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus Influenzae Type B","Shan 5, Easy Five","Ahmedabad - India, Bangalore - India, Pune - India",2009-03,2008-05-08,2009-06-25,INTERVENTIONAL,PHASE4,Shantha Biotechnics Limited,INDUSTRY,hepatitis
NCT02738138,EXPEDITION-2,COMPLETED,2016-05-17,"Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis and Non-cirrhotics",ABT-493 coformulated with ABT-530,No locations listed,2017-03-15,2016-04-14,2021-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT04330508,Unknown,COMPLETED,2018-03-01,Depression in Chronic Hepatitis C,Depression and Cognitive Tests,Chandigarh - India,2021-10-31,2020-04-01,2024-02-13,OBSERVATIONAL,Not Available,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT06307808,VITAMIN,NOT_YET_RECRUITING,2024-03-15,"HBV, Kidney Transplantation, Liver Transplantation","Tacrolimus, Belatacept",Grenoble - France,2025-09-30,2024-03-13,2024-03-13,OBSERVATIONAL,Not Available,"University Hospital, Grenoble",OTHER,hepatitis
NCT02366208,PEG-Tα1,COMPLETED,2011-05,"Hepatitis B, Chronic","PEG-Tα1, Placebo to match PEG-Tα1, Adefovir","Beijing - China, Haikou - China, Shijiazhuang - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Changchun - China, Shenyang - China, Xi'an - China, Xi'an - China, Chengdu - China",2013-06,2015-02-19,2015-02-19,INTERVENTIONAL,PHASE2,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01402908,PATRON,TERMINATED,2011-08,"Cancer, Liver Cancer, Hepatocellular Carcinoma","PI-88, Placebo","Changsha - China, Beijing - China, Beijing - China, Shanghai - China, Hong Kong - Hong Kong, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of, Changhua City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei City - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2014-07,2011-07-26,2022-06-23,INTERVENTIONAL,PHASE3,Cellxpert Biotechnology Corp.,INDUSTRY,hepatitis
NCT03209908,Unknown,UNKNOWN,2017-01-01,Chronic Hepatitis B,Tenofovir Disoproxil Fumarate,Beijing - China,2019-12-30,2017-07-06,2017-07-12,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT03575208,Unknown,WITHDRAWN,2019-02-13,Chronic Hepatitis B,"hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN)",Bethesda - United States,2022-03-29,2018-07-02,2022-04-06,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00255008,Unknown,TERMINATED,2005-03,"Hepatitis C, Chronic","peginterferon alfa-2b, ribavirin, peginterferon alfa-2b, ribavirin",No locations listed,2007-12,2005-11-17,2017-04-06,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03547908,Alliance,COMPLETED,2018-05-30,HIV-1/HBV Co-Infection,"B/F/TAF, Placebo to match DTG, Placebo to match F/TDF, DTG, F/TDF, Placebo to match B/F/TAF","Fort Pierce - United States, West Palm Beach - United States, Berkley - United States, Houston - United States, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Chengdu - China, Guangzhou - China, Hangzhou - China, Nanjing - China, Shanghai - China, Shenzhen - China, Santo Domingo - Dominican Republic, Lyon - France, Athens - Greece, Athens - Greece, Athens - Greece, Thessaloniki - Greece, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Kowloon - Hong Kong, Aichi - Japan, Okinawa - Japan, Osaka - Japan, Osaka - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Yokohama - Japan, Busan - Korea, Republic of, Seoul - Korea, Republic of, Ipoh - Malaysia, Kota Bahru - Malaysia, Kota Kinabalu - Malaysia, Kuala Lumpur - Malaysia, Kuala Lumpur - Malaysia, Kuala Terengganu - Malaysia, Kuching - Malaysia, Pulau Pinang - Malaysia, Sungai Buloh - Malaysia, San Juan - Puerto Rico, Barcelona - Spain, Cartagena - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Santa Cruz de Tenerife - Spain, Valencia - Spain, Vigo - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, New Taipei City - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei City - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan City - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Chiang Rai - Thailand, Khon Kaen - Thailand, Nonthaburi - Thailand, Istanbul - Turkey, Istanbul - Turkey",2022-02-25,2018-06-06,2024-03-19,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01379508,Unknown,COMPLETED,2011-03-21,Chronic Hepatitis B,"telbivudine, tenofovir disoproxil fumarate","Innsbruck - Austria, Wien - Austria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Leipzig - Germany, Wurzburg - Germany, Alexandroupolis - Greece, Athens - Greece, Thessaloniki - Greece, Athens - Greece, Caserta - Italy, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Barcelona - Spain, Barcelona - Spain, Tarragona - Spain, Majadahonda - Spain, Istanbul - Turkey, Diyarbakir - Turkey, Izmir - Turkey, Trabzon - Turkey",2015-12-10,2011-06-23,2018-11-05,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01274208,Unknown,UNKNOWN,2011-01,"Gaucher Disease, Hepatitis C",No interventions listed,"Jerusalem - Israel, Jerusalem - Israel",2016-03,2011-01-11,2014-11-19,OBSERVATIONAL,Not Available,Shaare Zedek Medical Center,OTHER,hepatitis
NCT00388323,RIHTA,COMPLETED,2006-11,"Alcoholic Hepatitis, Alcoholic Cirrhosis",blood and biopsies,Clamart - France,2011-01,2006-10-16,2012-12-11,INTERVENTIONAL,NA,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT05256823,Unknown,UNKNOWN,2022-02-24,To Evaluate the Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues in Nucleos(t)Ide-treated Patients With Chronic Hepatitis B,"Celecoxib, nucleos(t)ide analogue","Beijing - China, Beijing - China, Beijing - China, Tianjin - China",2023-11-30,2022-02-25,2022-08-03,INTERVENTIONAL,PHASE2,Lai Wei,OTHER,hepatitis
NCT00275938,Unknown,COMPLETED,1998-10,Chronic Hepatitis B,"interferon alpha 2b plus ribavirin, interferon alpha 2b plus placebo",No locations listed,Unknown Date,2006-01-12,2006-01-12,INTERVENTIONAL,PHASE3,National Taiwan University Hospital,OTHER,hepatitis
NCT01820208,Unknown,COMPLETED,2014-03-01,Severe Alcoholic Hepatitis,"G-CSF, Placebo",New Delhi - India,2017-06-01,2013-03-28,2017-11-14,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT01443923,Unknown,TERMINATED,2011-09,"Hepatitis, HIV/AIDS","Boceprevir, Peg-Interferon-alfa 2B, Ribavirin","Washington, DC - United States, Bethesda - United States",2013-09,2011-09-30,2015-07-13,INTERVENTIONAL,PHASE4,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT05394623,Unknown,UNKNOWN,2022-11-01,"Hepatitis D, Hepatitis B, Antibodies; Anti-D, RNA Virus Infections","HDV-Ab (IgG), HDV-RNA, RNA genotype",No locations listed,2023-04-01,2022-05-27,2022-11-02,OBSERVATIONAL,Not Available,The First Affiliated Hospital with Nanjing Medical University,OTHER,hepatitis
NCT00422838,CIRES,COMPLETED,2007-01,"Hepatitis C, Liver, Immunology, Regulation",fine-needle aspiration biopsy,Rotterdam - Netherlands,2010-06,2007-01-17,2017-01-27,OBSERVATIONAL,Not Available,Foundation for Liver Research,OTHER,hepatitis
NCT01532908,MBL-HCV1,TERMINATED,2012-11-21,Hepatitis C Infection,"MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2)","Boston - United States, Boston - United States, Saint Louis - United States, New York - United States, Dallas - United States",2015-08-27,2012-02-15,2021-02-05,INTERVENTIONAL,PHASE2,MassBiologics,OTHER,hepatitis
NCT04001608,Unknown,UNKNOWN,2018-10-17,Hepatitis C Virus Infection,"Seraprevir, Sofosbuvir","Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Liuzhou - China, Zunyi - China, Shijiazhuang - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Wuxi - China, Xuzhou - China, Changchun - China, Guangxi - China, Taiyuan - China, Luzhou - China, Chendu - China, Chengdu - China, Ürümqi - China, Ürümqi - China, Huzhou - China",2019-07-31,2019-06-28,2019-06-28,INTERVENTIONAL,PHASE3,"Ginkgopharma CO., LTD",INDUSTRY,hepatitis
NCT03312023,APOSTLE,COMPLETED,2018-02-01,Hepatitis B,"Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi], Ledipasvir 90 MG",Baltimore - United States,2020-08-10,2017-10-17,2021-09-20,INTERVENTIONAL,PHASE2,"University of Maryland, Baltimore",OTHER,hepatitis
NCT04998838,Unknown,UNKNOWN,2018-07-01,Hepatitis B,"Tenofovir Disoproxil Fumarate 300 mg daily; HBV birth dose vaccine; hepatitis B immune globulin (HBIG), Regular Myanmar treatment",Yangon - Myanmar,2021-12-30,2021-08-10,2021-08-10,INTERVENTIONAL,NA,Myanmar Liver Foundation,OTHER,hepatitis
NCT01730508,Unknown,COMPLETED,2012-11-20,"Hepatitis B, Chronic",Pegylated Interferon Alfa (Peginterferon Alfa),"Baoding - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changchun - China, Changsha - China, Changsha - China, Changzhou - China, Chengdu - China, Chongqing - China, Chongqing - China, Chongqing - China, Dalian - China, Foshan - China, Foushan - China, Fuzhou - China, Guangzhou City - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Haikou - China, Hangzhou - China, Hangzhou - China, Harbin - China, Harbin - China, Hefei - China, Huai'an - China, Jiangmen - China, Jiangyin - China, Jinan - China, Kunming - China, Lanzhou - China, Lianyungang - China, Liuzhou - China, LuZhou - China, Nanchang - China, Nanjing - China, Nanjing - China, Nanjing - China, Nanning - China, Nanning - China, Ningbo - China, Ordos - China, Qingdao - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shantou - China, Shen Zhen - China, ShenYang - China, Shenyang - China, Shijiazhuang - China, Shijiazhuang - China, Suining - China, Suzhou - China, Taiyuan - China, Taizhou - China, Tianjin - China, Tianjin - China, Urumqi - China, Urumqi - China, Wenzhou - China, Wenzhou - China, Wenzhou - China, Wuhan - China, Wuxi - China, Xi'an - China, Xiamen - China, Xingtai - China, Xuzhou - China, Yancheng - China, Yangzhou - China, Yichang - China, Zhaoqing - China, Zhengzhou - China, Zhenjiang - China, Zhoushan - China, Zhuhai - China",2017-06-25,2012-11-21,2017-07-14,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00971308,Unknown,COMPLETED,2009-10,Chronic Hepatitis C,"BMS-824393, BMS-824393, BMS-824393, BMS-824393, BMS-824393","Anaheim - United States, Cypress - United States, Miami - United States, Orlando - United States, Baltimore - United States, San Antonio - United States",2010-08,2009-09-03,2011-01-25,INTERVENTIONAL,PHASE1,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02803138,CITRINE,COMPLETED,2016-07-07,Chronic Hepatitis C,"Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin, Patient support program","Be'er Sheva - Israel, Petakh Tikva - Israel, Petakh Tikva - Israel, Tel Aviv-Yafo - Israel, Afula - Israel, Be'er Sheva - Israel, Be'er Ya'akov - Israel, Gush Dan - Israel, Hadera - Israel, Haifa - Israel, Haifa - Israel, Haifa - Israel, Holon - Israel, Jerusalem - Israel, Jerusalem - Israel, Kfar Saba - Israel, Nahariya - Israel, Ramat Gan - Israel",2018-10-21,2016-06-16,2019-10-11,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01146808,Unknown,COMPLETED,2006-03,"Hepatitis B, Liver Transplantation",Adefovir dipivoxil and hepatitis B vaccination,New York - United States,2011-09,2010-06-22,2021-08-10,INTERVENTIONAL,PHASE2,Columbia University,OTHER,hepatitis
NCT00433108,Unknown,COMPLETED,2007-03,Chronic Hepatitis C,Mitoquinone mesylate (MitoQ),"Auckland - New Zealand, Hamilton - New Zealand",Unknown Date,2007-02-09,2008-08-14,INTERVENTIONAL,PHASE2,"Antipodean Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02909023,Unknown,COMPLETED,2016-07,Hepatitis B,blood samples are performed to measure active T cellular immune response during a routine visit,Lyon - France,2016-09,2016-09-21,2016-12-29,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT01770223,Unknown,WITHDRAWN,2014-01,Hepatitis C,"boceprevir, PegIFN-2b, RBV",No locations listed,2015-12,2013-01-17,2017-03-20,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04188223,Unknown,COMPLETED,2019-12-03,Hepatitis B,"Recombinant Hepatitis B (Bio Farma) Vaccine, Recombinant Hepatitis B (Bio Farma) Vaccine®",Bandung - Indonesia,2020-07-16,2019-12-05,2022-08-01,INTERVENTIONAL,PHASE1,PT Bio Farma,INDUSTRY,hepatitis
NCT04139850,Unknown,RECRUITING,2015-09-25,Chronic Hepatitis B,Discontinuation of antiviral treatment in chronic hepatitis B cohort patients,"Seoul - Korea, Republic of",2026-08,2019-10-25,2019-10-25,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT01838590,Unknown,COMPLETED,2013-03,Hepatitis C Virus,"SOF, RBV","Cairo - Egypt, Mansoura - Egypt",2014-05,2013-04-24,2015-05-22,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01425203,Unknown,COMPLETED,2011-11-23,Chronic Hepatitis C Genotype 1,"Boceprevir, Placebo, peginterferon alfa-2b, Ribavirin",No locations listed,2013-10-21,2011-08-29,2021-02-08,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04863703,IMPHROVE-D,UNKNOWN,2021-05-07,"Hepatitis D, Hepatitis B, Portal Hypertension, Liver Cirrhosis",Bulevirtide,Hannover - Germany,2024-10-31,2021-04-28,2023-03-10,OBSERVATIONAL,Not Available,Hannover Medical School,OTHER,hepatitis
NCT00230503,Unknown,COMPLETED,2004-06,"Hepatitis B, Chronic","pradefovir mesylate, adefovir dipivoxyl",No locations listed,2006-12,2005-09-30,2012-06-22,INTERVENTIONAL,PHASE2,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT02505243,RIBACOP,COMPLETED,2015-06,"HCV Coinfection, Hepatitis C",No interventions listed,Nijmegen - Netherlands,2016-06,2015-07-22,2020-12-07,OBSERVATIONAL,Not Available,Radboud University Medical Center,OTHER,hepatitis
NCT00142103,Unknown,COMPLETED,2005-09,"Hepatitis, Chronic Active","CPG10101, CPG10101, CPG10101, CPG10101, Control, CPG10101","Miami - United States, Chicago - United States, Indianapolis - United States, Detroit - United States, Kansas City - United States, New York - United States, Cleveland - United States, Hershey - United States, Charleston - United States, Jackson - United States, Dallas - United States, San Antonio - United States, Richmond - United States",2007-02,2005-09-02,2011-05-16,INTERVENTIONAL,PHASE1,Pfizer,INDUSTRY,hepatitis
NCT02692703,Unknown,COMPLETED,2016-04-22,"Chronic Hepatitis C, HCV, Hepatitis C Virus",glecaprevir/pibrentasvir,No locations listed,2017-04-13,2016-02-26,2021-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00596843,Unknown,COMPLETED,2003-09,"HIV, Hepatitis C","Motivational interviewing, Educational intervention",Durham - United States,2006-11,2008-01-17,2017-03-01,INTERVENTIONAL,PHASE3,National Institute on Drug Abuse (NIDA),NIH,hepatitis
NCT00325143,Unknown,COMPLETED,2003-12-01,"Haemophilus Influenzae Type b, Diphtheria, Tetanus, Poliomyelitis, Acellular Pertussis","DTPa-HBV-IPV/Hib, DTPa-IPV/Hib vaccine","Singapore - Singapore, Singapore - Singapore, Singapore - Singapore",2007-02-01,2006-05-12,2018-06-06,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05361603,SCANVIR,RECRUITING,2017-05-24,"Hepatitis C, Transmission, Intravenous Drug Abuser, Addiction, Alcohol, Addiction Opiate, Hepatitis C Virus Infection, Response to Therapy of",No interventions listed,Limoges - France,2022-12-09,2022-05-04,2022-05-04,OBSERVATIONAL,Not Available,"University Hospital, Limoges",OTHER,hepatitis
NCT04326803,Unknown,UNKNOWN,2020-06-01,Hepatitis B,Hepatitis B recombinant vaccine,No locations listed,2022-06-30,2020-03-30,2020-03-31,INTERVENTIONAL,PHASE4,Pontificia Universidad Catolica de Chile,OTHER,hepatitis
NCT05560503,Unknown,COMPLETED,2017-01-01,Liver Fibrosis,No interventions listed,No locations listed,2022-04-30,2022-09-29,2022-09-29,OBSERVATIONAL,Not Available,Xiangya Hospital of Central South University,OTHER,hepatitis
NCT00155103,Unknown,UNKNOWN,2004-08,"Hepatitis B, Carcinoma, Hepatocellular, Polymorphism, Genetic",No interventions listed,Taipei - Taiwan,Unknown Date,2005-09-12,2007-03-21,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02003703,CORE-HIV,COMPLETED,2015-05,"Hepatitis B, HIV",Recombinant Hepatitis B Virus Vaccine,Viña del Mar - Chile,2018-06,2013-12-06,2019-01-31,INTERVENTIONAL,PHASE3,Universidad de Valparaiso,OTHER,hepatitis
NCT00725803,Unknown,COMPLETED,2008-04,HCV Infection,"GS-9450, GS-9450 Placebo","Anaheim - United States, Washington - United States, Orlando - United States, Dallas - United States, San Antonio - United States, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Mainz - Germany, Wurzburg - Germany, Amsterdam - Netherlands",2008-10,2008-07-31,2014-06-19,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT04222803,VIRGAD,UNKNOWN,2020-01-15,"Gallstone Attack, Viral Hepatitis",No interventions listed,No locations listed,2021-01-15,2020-01-10,2020-01-18,OBSERVATIONAL,Not Available,Göteborg University,OTHER,hepatitis
NCT00241943,Unknown,COMPLETED,2005-11,"Hepatitis C, Opiate Dependence",Hepatitis C educational video,Oakland - United States,2007-08,2005-10-19,2008-12-09,INTERVENTIONAL,NA,Organization to Achieve Solutions in Substance Abuse (OASIS),OTHER,hepatitis
NCT06298708,HAV-RCT,ACTIVE_NOT_RECRUITING,2024-04-27,"HAV, Hepatitis A, Hep A, Vaccine-Preventable Diseases","Mevac-A vaccine, Havrix 720 Junior",Chiang Mai - Thailand,2025-03,2024-03-07,2024-08-20,INTERVENTIONAL,PHASE3,Chiang Mai University,OTHER,hepatitis
NCT03818308,Unknown,COMPLETED,2019-05-28,"Hepatitis C, Acute Hepatitis C",Sofosbuvir and Velpatasvir,"Berlin-Friedrichshain - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Köln - Germany, Leipzig - Germany, München - Germany, Stuttgart - Germany, Würzburg - Germany",2021-06-08,2019-01-28,2021-07-06,INTERVENTIONAL,PHASE2,Hannover Medical School,OTHER,hepatitis
NCT01603108,Rifaximin,UNKNOWN,2012-03,Hepatitis C,"Rifaximin, Placebo",New York - United States,2016-12,2012-05-22,2016-04-22,INTERVENTIONAL,PHASE2,Columbia University,OTHER,hepatitis
NCT04378608,Unknown,COMPLETED,2017-01-05,Hepatitis C Virus Infection,OBV/PTV/r) ± ribavirin (RBV),No locations listed,2017-09-08,2020-05-07,2020-05-12,INTERVENTIONAL,PHASE2,Beni-Suef University,OTHER,hepatitis
NCT04017338,Unknown,UNKNOWN,2018-08-06,"Lung Transplant Infection, Heart Transplant Infection, Kidney Transplant Infection, Kidney Pancreas Infection, Hepatitis C","Glecaprevir 300 MG / Pibrentasvir 120 MG Oral Tablet, Ezetimibe 10Mg Oral Tablet, Ex Vivo Lung Perfusion",Toronto - Canada,2020-12-31,2019-07-12,2019-07-12,INTERVENTIONAL,PHASE3,Jordan Feld,OTHER,hepatitis
NCT03111108,Unknown,COMPLETED,2017-06-20,Hepatitis C Virus (HCV) Infection,EBR/GZR (50 mg/100 mg) FDC,"Amiens - France, Besancon - France, Creteil - France, Genoble - France, Limoges - France, Montpellier - France, Nice - France, Orleans - France, Paris - France, Paris - France, Paris - France, Toulouse - France, Vandoeuvre les Nancy - France",2018-10-15,2017-04-12,2020-06-09,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02323308,ANRSHBEP03,COMPLETED,2010-12,"HIV Infection, Hepatitis B",blood sampling,Dijon - France,2014-06,2014-12-23,2014-12-23,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT01517308,Unknown,WITHDRAWN,2012-05,Chronic Hepatitis C,pegylated interferon alpha 2a + ribavirin,Naples - Italy,2015-11,2012-01-25,2012-03-19,INTERVENTIONAL,PHASE3,Federico II University,OTHER,hepatitis
NCT03349008,MAGIC-101,UNKNOWN,2017-11-25,"Chronic Hepatitis b, Liver Inflammation","Entecavir, Magnesium Isoglycyrrhizinate, Diammonium Glycyrrhizinate, Magnesium Isoglycyrrhizinate Placebo, Diammonium Glycyrrhizinate Placebo",No locations listed,2019-12-31,2017-11-21,2017-11-21,INTERVENTIONAL,PHASE4,Cttq,INDUSTRY,hepatitis
NCT00260208,Unknown,TERMINATED,2006-01,"Liver Transplant, Hepatitis C","Cyclosporine A, Tacrolimus","East Hanover - United States, Zurich - Switzerland",2010-09,2005-12-01,2011-12-06,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT05102838,Unknown,NOT_YET_RECRUITING,2021-11-01,"Hepatitis B, Hepatitis C",Anti-virus treatment,No locations listed,2025-08-30,2021-11-02,2021-11-02,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT02636608,VERITAS,COMPLETED,2015-11-27,Chronic Hepatitis C,No interventions listed,No locations listed,2018-05-23,2015-12-22,2019-07-26,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT03801538,Unknown,UNKNOWN,2019-01-01,Chronic Hepatitis B,"Peginterferon Alfa, Nucleoside Analog (Substance)",Guangzhou - China,2020-12,2019-01-11,2019-01-15,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04971538,Unknown,UNKNOWN,2021-11-29,"Hepatitis C, Diagnostic Self Evaluation",OraQuick® HCV Self-Test,Karachi - Pakistan,2022-03,2021-07-21,2022-02-28,INTERVENTIONAL,NA,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT00823550,Unknown,UNKNOWN,2009-01,"Hepatitis B, Chronic","Entecavir, Lamivudine","Seoul - Korea, Republic of",2014-07,2009-01-15,2010-12-16,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT01331850,Unknown,COMPLETED,2011-05,"Hepatitis C, Chronic","Copegus, Copegus, Pegasys, Pegasys, RO5024048, danoprevir, ritonavir","La Jolla - United States, Long Beach - United States, Sacramento - United States, San Diego - United States, Aurora - United States, Orlando - United States, Decatur - United States, Chicago - United States, New Orleans - United States, Detroit - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Medford - United States, Providence - United States, Nashville - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Darlinghurst - Australia, Kingswood - Australia, Westmead - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Wien - Austria, Porto Alegre - Brazil, Ribeirao Preto - Brazil, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, La Tronche - France, Paris - France, Paris - France, Pessac - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Essen - Germany, Kiel - Germany, Tübingen - Germany, Napoli - Italy, Milano - Italy, Pavia - Italy, Pisa - Italy, Guadalajara - Mexico, Guadalajara - Mexico, Bydgoszcz - Poland, Czeladz - Poland, Kielce - Poland, Warszawa - Poland, Łodz - Poland, San Juan - Puerto Rico, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Birmingham - United Kingdom, Dundee - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2013-01,2011-04-08,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01429155,Unknown,COMPLETED,2011-08,Hepatitis C,Interleukin 28B genotype,Detroit - United States,2013-01,2011-09-05,2014-09-17,OBSERVATIONAL,Not Available,Henry Ford Health System,OTHER,hepatitis
NCT03831555,Unknown,COMPLETED,2017-06-05,Hepatitis C,PREP-C,Atlanta - United States,2018-05-01,2019-02-06,2019-02-06,INTERVENTIONAL,NA,Emory University,OTHER,hepatitis
NCT00155155,Unknown,COMPLETED,2005-05,Hepatitis B,No interventions listed,Taipei - Taiwan,2008-04,2005-09-12,2008-12-02,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02259855,Unknown,COMPLETED,2006-01-01,Hepatic Insufficiency,"Tipranavir, Ritonavir, Pegylated interferon, Ribavirin",No locations listed,2008-10-01,2014-10-09,2025-01-22,INTERVENTIONAL,PHASE1,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT02932150,Unknown,RECRUITING,2016-11,Chronic Hepatitis B,"TAF, Placebo","Los Angeles - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Miami - United States, Orlando - United States, Atlanta - United States, Indianapolis - United States, Baltimore - United States, Minneapolis - United States, Kansas City - United States, Omaha - United States, Bronx - United States, Cincinnati - United States, Columbus - United States, Nashville - United States, Dallas - United States, Fort Worth - United States, Houston - United States, San Antonio - United States, Seattle - United States, Morgantown - United States, Brussels - Belgium, Toronto - Canada, Vancouver - Canada, Shatin - Hong Kong, Ahmedabad - India, Jaipur - India, Kanpur - India, Kolkata - India, Lucknow - India, Mumbai - India, Mumbai - India, Nagpur - India, Nagpur - India, Nagpur - India, New Delhi - India, Surat - India, Varanasi - India, Bologna - Italy, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Bucharest - Romania, Bucharest - Romania, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Tatarstan - Russian Federation, Tolyatti - Russian Federation, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2025-08,2016-10-13,2024-11-20,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT03905655,Unknown,COMPLETED,2019-10-22,Chronic Hepatitis B,"Placebo Oral Tablet, Nitazoxanide",Singapore - Singapore,2021-03-10,2019-04-05,2023-11-07,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT05567614,Unknown,UNKNOWN,2022-10-20,"Fibrosis, Liver",Liver Fibroscan,Assiut - Egypt,2023-08-15,2022-10-05,2022-10-05,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT03313414,Unknown,WITHDRAWN,2019-08-13,Hepatitis C,Sofosbuvir/Velpatasvir Treatment for 14 days,Boston - United States,2020-01,2017-10-18,2020-01-21,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT04896255,OASIS,RECRUITING,2021-05-10,Chronic Hepatitis b,"peginterferon alpha based regimen, nucleos(t)ide",Shanghai - China,2025-07-25,2021-05-21,2021-05-21,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT01457755,Unknown,COMPLETED,2012-04-13,"Hepatitis C, Chronic",No interventions listed,"Birmingham - United States, Birmingham - United States, Dothan - United States, Phoenix - United States, Tucson - United States, Anaheim - United States, Bakersfield - United States, Coronado - United States, Costa Mesa - United States, La Jolla - United States, La Mesa - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Oceanside - United States, Palo Alto - United States, Pasadena - United States, Rialto - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Jose - United States, Torrance - United States, Aurora - United States, Englewood - United States, Hamden - United States, New Haven - United States, Washington - United States, Washington - United States, Washington - United States, Bradenton - United States, Coral Gables - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, New Port Richey - United States, Orlando - United States, Orlando - United States, Orlando - United States, Tampa - United States, Tampa - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Decatur - United States, Decatur - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Kansas City - United States, Bowling Green - United States, Bastrop - United States, Baton Rouge - United States, Baton Rouge - United States, Baltimore - United States, Baltimore - United States, College Park - United States, Lutherville - United States, Boston - United States, Boston - United States, Boston - United States, Burlington - United States, Springfield - United States, Worcester - United States, Worcester - United States, Ann Arbor - United States, Detroit - United States, Rochester - United States, Saint Paul - United States, Tupelo - United States, Kansas City - United States, Kansas City - United States, Saint Louis - United States, Saint Louis - United States, Berlin - United States, Hillsborough - United States, Morristown - United States, Newark - United States, Vineland - United States, Albuquerque - United States, Santa Fe - United States, Binghamton - United States, Bronx - United States, Manhasset - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Yonkers - United States, Asheville - United States, Chapel Hill - United States, Chapel Hill - United States, Charlotte - United States, Durham - United States, Fayetteville - United States, Statesville - United States, Winston-Salem - United States, Cincinnati - United States, Tulsa - United States, Medford - United States, Portland - United States, Allentown - United States, Lancaster - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Pittsburgh - United States, Providence - United States, Providence - United States, Germantown - United States, Germantown - United States, Nashville - United States, Nashville - United States, Nashville - United States, Arlington - United States, Austin - United States, Dallas - United States, Dallas - United States, Dallas - United States, Dallas - United States, Dallas - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, Live Oak - United States, San Antonio - United States, Murray - United States, Salt Lake City - United States, Salt Lake City - United States, Annandale - United States, Falls Church - United States, Newport News - United States, Norfolk - United States, Richmond - United States, Seattle - United States, Seattle - United States, Madison - United States, Canberra - Australia, Camperdown - Australia, Concord - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Darlinghurst - Australia, Kogarah - Australia, Liverpool - Australia, Westmead - Australia, Adelaide - Australia, Bedford Park - Australia, Clayton - Australia, Fitzroy - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Melbourne - Australia, Parkville - Australia, Fremantle - Australia, Murdoch - Australia, Greenslopes - Australia, Herston - Australia, Nedlands - Australia, Perth - Australia, Woolloongabba - Australia, Graz - Austria, Wien - Austria, Wien - Austria, Antwerpen - Belgium, Brussels - Belgium, Brussels - Belgium, Kortrijk - Belgium, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Opava - Czechia, Praha 4 - Czechia, Praha 6 - Czechia, Talinn - Estonia, Tartu - Estonia, Clermont-Ferrand - France, CRETEIL Cedex - France, Paris Cedex 12 - France, Paris cedex 12 - France, Paris Cedex 13 - France, Paris cedex 18 - France, Paris Cedex 20 - France, Villejuif Cedex - France, Vandoeuvre-les-Nancy - France, Limoges Cedex - France, Toulouse - France, Toulouse - France, Lille - France, Marseille cedex 08 - France, Nice - France, Cedex 9 - France, Clichy Cedex - France, Montpellier - France, Nice cedex 3 - France, Paris, Cedex 14 - France, Paris - France, Paris - France, Pessac Cedex - France, Rennes Cedex 9 - France, Strasbourg - France, Freiburg im Breisgau - Germany, Freiburg - Germany, Heidelberg - Germany, München - Germany, Frankfurt am Main - Germany, Frankfurt am Main - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Essen - Germany, Herne - Germany, Köln - Germany, Muenster - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Frankfurt - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, San Giovanni Rotondo - Italy, Bergamo - Italy, Bologna - Italy, Bologna - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Padova - Italy, Palermo - Italy, Parma - Italy, Roma - Italy, Roma - Italy, Torino - Italy, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Nijmegen - Netherlands, Grafton - New Zealand, Grafton - New Zealand, Tauranga - New Zealand, Newtown - New Zealand, Christchurch - New Zealand, Dunedin - New Zealand, Hamilton - New Zealand, Wroclaw - Poland, Warszawa - Poland, Bialystok - Poland, Chorzów - Poland, Myslowice - Poland, Lodz - Poland, San Juan - Puerto Rico, San Juan - Puerto Rico, Majadahonda - Spain, Málaga - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Santander - Spain, Sevilla - Spain, Sevilla - Spain, Valencia - Spain, Göteborg - Sweden, Lund - Sweden, Malmö - Sweden, Stockholm - Sweden, Birmingham - United Kingdom, Bristol - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Plymouth - United Kingdom, Portsmouth - United Kingdom, Southampton - United Kingdom",2017-03-28,2011-10-24,2018-08-31,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT02603055,Unknown,COMPLETED,2015-07,Hepatitis E,"30μg/0.5ml Hepatitis E vaccine, 30μg/0.5ml Recombinant Hepatitis E vaccine",Nanjing - China,2016-04,2015-11-11,2016-09-01,INTERVENTIONAL,PHASE1,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT05203055,Unknown,UNKNOWN,2021-12-10,Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia,"Peginterferon alpha-2b, Nucleotide Analog, pulse peginterferon alpha-2b",Fuzhou - China,2022-12-10,2022-01-24,2022-01-24,INTERVENTIONAL,PHASE2,Fuzhou General Hospital,OTHER,hepatitis
NCT02604355,Unknown,TERMINATED,2015-11-28,"Hepatitis B, Chronic","Matching Placebo, RO7020322","Hong Kong - Hong Kong, Grafton - New Zealand, Tauranga - New Zealand, Kaohsiung - Taiwan",2016-05-09,2015-11-13,2017-05-25,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00571714,Unknown,WITHDRAWN,2008-04-01,Chronic Hepatitis C,"Peginterferon alpha-2a and ribavirin, Peginterferon alpha-2a , ribavirin and betaine",No locations listed,2010-03-04,2007-12-12,2023-08-15,INTERVENTIONAL,NA,University of Nebraska,OTHER,hepatitis
NCT00371150,Unknown,COMPLETED,2006-11,Hepatitis B Infection,Entecavir,"Montgomery - United States, Tucson - United States, Washington - United States, Miami - United States, Miami - United States, Chicago - United States, College Park - United States, Boston - United States, Springfield - United States, New York - United States, Yonkers - United States, Philadelphia - United States, San Antonio - United States, Richmond - United States, Salvador - Brazil, Belo Horizonte - Mg - Brazil, Rio De Janeiro - Rj - Brazil, Campinas - Brazil, Sao Paulo - Sp - Brazil, Df - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Guadalajara - Mexico, Zapopan - Mexico, Santurce - Puerto Rico, Belville - South Africa, Goodwood - South Africa",2011-03,2006-09-01,2012-04-16,INTERVENTIONAL,PHASE4,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03461250,(CHINCHERO),UNKNOWN,2018-04-01,HCV Infection,HCV serology,No locations listed,2018-06-30,2018-03-12,2018-04-03,OBSERVATIONAL,Not Available,Asociacion para el Estudio del Higado,OTHER,hepatitis
NCT00546455,Unknown,SUSPENDED,2007-12,"Obesity, Insulin Resistance","Fenretinide, Placebo",San Diego - United States,2012-01,2007-10-19,2021-02-10,INTERVENTIONAL,PHASE2,"University of California, San Diego",OTHER,hepatitis
NCT04674423,Unknown,RECRUITING,2020-05-14,Chronic Hepatitis b,Tenofovir Alafenamide,Tainan - Taiwan,2025-12-31,2020-12-19,2020-12-22,INTERVENTIONAL,PHASE4,National Cheng-Kung University Hospital,OTHER,hepatitis
NCT00722423,HCV,COMPLETED,2009-05,Hepatitis C,"Integrated care model, Usual Care Model","Palo Alto - United States, San Diego - United States, Bronx - United States",2013-07,2008-07-25,2015-10-15,INTERVENTIONAL,NA,US Department of Veterans Affairs,FED,hepatitis
NCT03063723,Unknown,COMPLETED,2016-01-01,Chronic Hepatitis C (Disorder),"Ledipasvir-Sofosbuvir, Daclatasvir-Sofosbuvir",No locations listed,2016-12-01,2017-02-24,2017-02-24,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00755950,Unknown,TERMINATED,2008-10,"Acute Hepatitis A, Acute Hepatitis B, Acute Hepatitis C, Acute Hepatitis E, Acute EBV Hepatitis, Acute CMV Hepatitis","Silymarin, Silymarin, Lactose monohydrate","Alexandria - Egypt, Tanta - Egypt, Benha - Egypt",2011-11,2008-09-19,2021-04-23,INTERVENTIONAL,PHASE3,"University of Maryland, Baltimore",OTHER,hepatitis
NCT00707850,Unknown,COMPLETED,2007-05,"Hepatitis C, Thalassemia",PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin),"Tehran - Iran, Islamic Republic of",2009-09,2008-07-01,2010-08-31,INTERVENTIONAL,PHASE4,Baqiyatallah Medical Sciences University,OTHER,hepatitis
NCT02706223,SuperDOT-C,COMPLETED,2016-12,Hepatitis C,"Pharmacist Led, Nurse led","Aberdeen - United Kingdom, Dundee - United Kingdom, Glasgow - United Kingdom",2019-01,2016-03-11,2019-08-30,INTERVENTIONAL,NA,University of Dundee,OTHER,hepatitis
NCT00460850,Unknown,TERMINATED,2007-09,"Hepatitis B, Chronic",peginterferon alfa-2a (40KD) [PEGASYS],"Ankara - Turkey, Antalya - Turkey, Istanbul - Turkey, Izmir - Turkey",Unknown Date,2007-04-17,2008-06-30,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00882908,PILLAR,COMPLETED,2009-06,Hepatitis C,"TMC435, Ribavirin (R), PegIFNα-2a (P), Placebo","Los Angeles - United States, Jacksonville - United States, Orlando - United States, Palm Harbor - United States, Chicago - United States, New Orleans - United States, Saint Paul - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Germantown - United States, Charlottesville - United States, Concord - Australia, Darlinghurst - Australia, Fitzroy - Australia, Melbourne - Australia, Sydney - Australia, Woolloongabba N/A - Australia, Wien - Austria, Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Roeselare - Belgium, Calgary - Canada, Toronto - Canada, Montreal - Canada, Aarhus - Denmark, Copenhagen - Denmark, Hvidovre N/A - Denmark, Kolding - Denmark, Odense N/A - Denmark, Clichy - France, Creteil N/A - France, Grenoble - France, Lyon - France, Nice - France, Paris - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Frankfurt A. M. - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Köln - Germany, Stuttgart - Germany, Würzburg - Germany, Auckland - New Zealand, Christchurch - New Zealand, Hamilton - New Zealand, Bergen - Norway, Nordbyhagen - Norway, Oslo - Norway, Tromsø - Norway, Bialystok - Poland, Bydgoszcz - Poland, Czeladz - Poland, Kielce - Poland, Lodz - Poland, Warschau - Poland, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain",2010-04,2009-04-17,2014-06-16,INTERVENTIONAL,PHASE2,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT03358108,Unknown,UNKNOWN,2018-02-27,"Hepatitis B, Chronic",No interventions listed,"Beijing - China, Fuzhou - China, Nanning - China, Zhejiang - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Shantou - China, Wenzhou - China",2020-12-01,2017-11-30,2018-10-19,OBSERVATIONAL,Not Available,Qin Ning,OTHER,hepatitis
NCT03685708,Unknown,COMPLETED,2018-12-07,"Hepatitis, Safety and Tolerability",HEPLISAV-B,Bethesda - United States,2020-12-16,2018-09-26,2022-02-08,INTERVENTIONAL,PHASE2,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT05138523,Unknown,COMPLETED,2019-11-21,Chronic Hepatitis c,Sofosdac®,"Boufarik - Algeria, Algiers - Algeria, Khenchla - Algeria, Oran - Algeria",2020-11-18,2021-12-01,2021-12-01,OBSERVATIONAL,Not Available,Beker Laboratories,INDUSTRY,hepatitis
NCT03891550,Unknown,UNKNOWN,2019-05-13,Hepatitis C,Epclusa,Kaohsiung - Taiwan,2024-04-15,2019-03-27,2020-07-10,INTERVENTIONAL,PHASE3,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT04246723,Unknown,COMPLETED,2019-05-06,Chronic Hepatitis c Genotype 1,"Narlaprevir, Ritonavir, Sofosbuvir","Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation",2020-04-08,2020-01-29,2022-10-31,INTERVENTIONAL,PHASE2,R-Pharm,INDUSTRY,hepatitis
NCT03000023,Unknown,COMPLETED,2016-10,"Hepatitis C, Hepatitis C, Chronic",No interventions listed,Chapel Hill - United States,2018-07,2016-12-21,2018-10-24,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT02972723,Unknown,COMPLETED,2011-03,Chronic Hepatitis C Infection,Metformin,Nottingham - United Kingdom,2011-09,2016-11-23,2016-11-23,INTERVENTIONAL,PHASE4,Nottingham University Hospitals NHS Trust,OTHER,hepatitis
NCT04457050,Unknown,COMPLETED,2017-10-30,"Insulin Resistance, Hepatitis C","Sofosbuvir 400 milligram, Daclatasvir 60 milligram, Ribavirin 400 milligram, Ledipasvir 90milligram/Sofosbuvir 400 milligram Tab",Alexandria - Egypt,2019-11-01,2020-07-07,2020-07-07,INTERVENTIONAL,PHASE4,Alexandria University,OTHER,hepatitis
NCT01195181,Unknown,COMPLETED,2005-09,"Hepatitis C Virus, Chronic Liver Disease, Viral Hepatitis, Therapeutic Uses, Antiviral Agents",peginterferon plus ribavirin,Padua - Italy,2009-12,2010-09-06,2010-09-06,INTERVENTIONAL,PHASE4,Azienda Ospedaliera di Padova,OTHER,hepatitis
NCT05343481,Unknown,ACTIVE_NOT_RECRUITING,2022-09-21,Chronic Hepatitis B,"ChAdOx1-HBV, MVA-HBV, Nivolumab","Hong Kong - Hong Kong, Hong Kong - Hong Kong, Chiayi City - Taiwan, Chiayi City - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung City - Taiwan, Tainan City - Taiwan, Taipei - Taiwan, Taoyuan City - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Mueang Nonthaburi - Thailand",2025-02,2022-04-25,2024-11-20,INTERVENTIONAL,PHASE2,Barinthus Biotherapeutics,INDUSTRY,hepatitis
NCT02985281,Unknown,UNKNOWN,2016-12,Pharmacological Action,"Sofosbuvir Oral Product, Ribavirin",Segin el Kom - Egypt,2017-06,2016-12-07,2016-12-19,INTERVENTIONAL,PHASE3,"National Liver Institute, Egypt",OTHER,hepatitis
NCT00946010,Unknown,COMPLETED,2008-04,"Hepatitis B, Hepatitis C",blood sampling and abdominal sonography,Taipei - Taiwan,2010-08,2009-07-24,2011-01-24,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT01732081,Unknown,UNKNOWN,2011-01,Hepatitis B,No interventions listed,Strasbourg - France,2021-01,2012-11-22,2012-11-22,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,hepatitis
NCT05760781,Unknown,TERMINATED,2023-04-25,Chronic Hepatitis b,STSG-0002 Injection,"Beijing - China, Beijing - China, Beijing - China, Chongqing - China",2023-12-11,2023-03-08,2023-12-19,INTERVENTIONAL,PHASE2,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",INDUSTRY,hepatitis
NCT01590381,Unknown,UNKNOWN,2011-12,Hepatitis b Vaccine,No interventions listed,Tel Aviv - Israel,2013-01,2012-05-02,2012-05-02,OBSERVATIONAL,Not Available,"Medical Corps, Israel Defense Force",OTHER,hepatitis
NCT03419481,Unknown,ACTIVE_NOT_RECRUITING,2018-04-30,HCC,pembrolizumab,Hong Kong - Hong Kong,2025-12-30,2018-02-05,2024-12-12,INTERVENTIONAL,PHASE2,CCTU,OTHER,hepatitis
NCT06864481,CO-CHILI,NOT_YET_RECRUITING,2025-03-25,"Liver Injury, Secondary to Immune Checkpoint Inhibitors, Cancer Patients",Blood samples,Montpellier - France,2028-03-25,2025-03-07,2025-03-07,OBSERVATIONAL,Not Available,"University Hospital, Montpellier",OTHER,hepatitis
NCT00335881,Unknown,COMPLETED,2006-06,Hepatitis B,hepatitis B vaccine,"Bad Saulgau - Germany, Boennigheim - Germany, Ettenheim - Germany, Kehl - Germany, Oberkirch - Germany, Offenburg - Germany, Schwaebisch-Hall - Germany, Stuttgart - Germany, Tuttlingen - Germany, Cham - Germany, Freising - Germany, Kaufering - Germany, Landsberg - Germany, Muenchen - Germany, Muenchen - Germany, Muenchen - Germany, Noerdlingen - Germany, Tutzing - Germany, Weilheim - Germany, Waren - Germany, Salzgitter - Germany, Erkrath - Germany, Heiligenhaus - Germany, Kleve-Materborn - Germany, Krefeld - Germany, Willich - Germany, Schoeneberg - Kuebelberg - Germany, Trier - Germany, Trier - Germany, Altenholz - Germany, Bredstedt - Germany, Flensburg - Germany, Flensburg - Germany, Flensburg - Germany, Husum - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany",Unknown Date,2006-06-12,2016-10-07,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02430181,LOWR-1,COMPLETED,2014-11,Chronic Hepatitis D Infection,"lonafarnib, peginterferon alfa-2a, ritonavir",Ankara - Turkey,2015-09,2015-04-30,2022-11-29,INTERVENTIONAL,PHASE2,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT03962881,Unknown,UNKNOWN,2019-05-25,Hepatitis B Vaccine,"20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2,and 6","Linfen - China, Linfen - China",2020-02,2019-05-24,2019-05-24,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT01667081,Unknown,COMPLETED,2012-10-17,Hepatitis C,Grazoprevir,No locations listed,2021-03-31,2012-08-17,2022-06-06,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01243281,Unknown,UNKNOWN,2011-03,Chronic Hepatitis B,PEG-IFN and entecavir,Bangkok - Thailand,2013-05,2010-11-18,2011-06-28,INTERVENTIONAL,NA,Chulalongkorn University,OTHER,hepatitis
NCT02799355,GCNI-CHC,COMPLETED,2016-05,"Hepatitis, Chronic","Sofosbuvir, Ribavirin, With or Without Pegylated Interferon",Ludhiana - India,2016-09,2016-06-14,2016-09-27,OBSERVATIONAL,Not Available,Dayanand Medical College and Hospital,OTHER,hepatitis
NCT00380614,Unknown,COMPLETED,2002-01,Hepatitis B,Lamivudine,New Delhi - India,Unknown Date,2006-09-26,2006-09-26,INTERVENTIONAL,PHASE4,Maulana Azad Medical College,OTHER,hepatitis
NCT01766895,Unknown,UNKNOWN,2011-01,"Uremia, Viral Hepatitis",blood sampling,Kaohsiung - Taiwan,2021-01,2013-01-11,2019-03-05,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT02760355,Unknown,COMPLETED,2016-03,Insulin Resistance,"Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin",Geneva - Switzerland,2018-06-01,2016-05-03,2019-05-01,INTERVENTIONAL,NA,"University Hospital, Geneva",OTHER,hepatitis
NCT02008214,Unknown,UNKNOWN,2013-12,"Hepacivirus, HIV Infections","Pentoxifylline, Placebo",Guadalajara - Mexico,2015-03,2013-12-11,2013-12-11,INTERVENTIONAL,PHASE4,"Centro Universitario de Ciencias de la Salud, Mexico",OTHER,hepatitis
NCT03362814,Unknown,COMPLETED,2017-07-01,HCV,"Ravidasvir, Danoprevir, Ritonavir, Ribavirin 100 MG, Ravidasvir Placebo, Danoprevir Placebo, Ritonavir Placebo, Ribavirin Placebo",Beijing - China,2018-12-12,2017-12-05,2020-07-28,INTERVENTIONAL,PHASE3,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT00350714,Unknown,TERMINATED,2006-07,Hepatitis C,MBT and BreathID,"New York - United States, Houston - United States, Richmond - United States, Richmond - United States, Jerusalem - Israel",2007-02,2006-07-11,2022-12-20,INTERVENTIONAL,PHASE2,"Meridian Bioscience, Inc.",INDUSTRY,hepatitis
NCT01440595,Unknown,TERMINATED,2011-11-28,"Hepatitis C, Chronic","Grazoprevir, Placebo to Grazoprevir, Peginterferon alfa-2b (Peg-IFN), Ribavirin (RBV)",No locations listed,2012-05-01,2011-09-26,2024-05-22,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00591214,Unknown,COMPLETED,2007-12,Chronic Hepatitis C,MP-424 (Telaprevir),Kawasaki City - Japan,2008-10,2008-01-11,2014-05-01,INTERVENTIONAL,PHASE1,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00930995,Unknown,WITHDRAWN,Unknown Date,Hepatitis C,"Candesartan, Placebo","Roseville - United States, Sacramento - United States",Unknown Date,2009-07-02,2012-04-25,INTERVENTIONAL,PHASE2,Kaiser Permanente,OTHER,hepatitis
NCT01113814,Unknown,COMPLETED,Unknown Date,Chronic Hepatitis C,"FibroScan, Acoustic Radiation Force Impulse (ARFI)- Imaging","Bordeaux - France, Düsseldorf - Germany, Erlangen - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, München - Germany, Rotterdam - Netherlands",Unknown Date,2010-04-30,2012-05-22,INTERVENTIONAL,NA,Johann Wolfgang Goethe University Hospital,OTHER,hepatitis
NCT05770895,Unknown,ACTIVE_NOT_RECRUITING,2023-04-03,Chronic Hepatitis B,"GS-2829, GS-6779, Placebo for GS-2829, Placebo for GS-6779","Auckland - New Zealand, Chiayi City - Taiwan, Chiayi City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Tainan City - Taiwan, Taipei City - Taiwan, Taoyuan City - Taiwan",2025-01,2023-03-16,2024-10-08,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT01120795,Unknown,COMPLETED,2004-02,Chronic Hepatitis C,"Pegylated interferon and ribavirin, Pegylated interferon and ribavirin","Sydney - Australia, Sydney - Australia, Footscray - Australia, Melbourne - Australia",2006-01,2010-05-11,2024-01-30,INTERVENTIONAL,PHASE4,Melbourne Health,OTHER,hepatitis
NCT01922895,NTAH-Mod,TERMINATED,2013-08-01,Acute Alcoholic Hepatitis,"Lactobacillus Rhamnosus GG, Placebo for Probiotic","Louisville - United States, Cleveland - United States, Dallas - United States",2018-07-01,2013-08-14,2022-03-02,INTERVENTIONAL,NA,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT00724295,Unknown,COMPLETED,2005-04,"Hepatitis C, Chronic, Hepatitis C","peginterferon alfa-2b, ribavirin",No locations listed,2008-12,2008-07-29,2015-02-04,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02027116,VGX-6150-01,COMPLETED,2014-01,"Hepatitis C, Chronic",VGX-6150,"Pusan - Korea, Republic of, Seoul - Korea, Republic of",2015-07,2014-01-03,2017-08-07,INTERVENTIONAL,PHASE1,"GeneOne Life Science, Inc.",INDUSTRY,hepatitis
NCT05357235,Unknown,UNKNOWN,2022-01-01,Chronic Hepatitis B,PEG-IFN,Beijing - China,2024-12,2022-05-02,2022-05-12,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT06779058,Unknown,RECRUITING,2025-01-01,"Chronic Hepatitis B, Liver Fibrosis","MRE, Liver biopsy",Shenyang - China,2025-07-01,2025-01-16,2025-01-16,OBSERVATIONAL,Not Available,Shengjing Hospital,OTHER,hepatitis
NCT03752658,TRUE,UNKNOWN,2019-01-25,Chronic Hepatitis b,Tenofovir Alafenamide,"Wuhan - China, Hangzhou - China, Nanchang - China, Shanghai - China, Wuhan - China, Wuhan - China, Xiangya - China",2023-05-01,2018-11-26,2019-11-26,OBSERVATIONAL,Not Available,Tongji Hospital,OTHER,hepatitis
NCT00146016,Unknown,COMPLETED,2000-02,Chronic Hepatitis C,Amantadine,Utrecht - Netherlands,Unknown Date,2005-09-05,2005-09-05,INTERVENTIONAL,PHASE3,UMC Utrecht,OTHER,hepatitis
NCT01330316,Unknown,COMPLETED,2011-07,Hepatitis C,"BI 201335, PegIFN/RBV","Birmingham - United States, North Little Rock - United States, Los Angeles - United States, Oceanside - United States, Fort Lauderdale - United States, Palm Harbor - United States, Columbus - United States, Chicago - United States, Baton Rouge - United States, Framingham - United States, Springfield - United States, Tupelo - United States, Neptune - United States, New York - United States, Portland - United States, Arlington - United States, Austin - United States, Dallas - United States, Dallas - United States, Forth Worth - United States, Wien - Austria, Wien - Austria, Bruxelles - Belgium, Edegem - Belgium, Liège - Belgium, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, Clichy Cedex - France, Lille Cedex - France, Marseille Cedex 08 - France, Montpellier Cedex 5 - France, Nice Cedex 3 - France, Pessac Cedex - France, Saint Laurent du Var - France, Berlin - Germany, Berlin - Germany, Dortmund - Germany, Düsseldorf - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Kiel - Germany, Mainz - Germany, München - Germany, Chiba, Chiba - Japan, Kita-gun, Kagawa - Japan, Kurashiki, Okayama - Japan, Kurume, Fukuoka - Japan, Nagoya, Aichi - Japan, Nishinomiya, Hyogo - Japan, Omura, Nagasaki - Japan, Osaka, Osaka - Japan, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Aveiro - Portugal, Barreiro - Portugal, Lisboa - Portugal, Porto - Portugal, Bucharest - Romania, Moscow - Russian Federation, Moscow - Russian Federation, A Coruña - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Majadahonda-Madrid - Spain, Sevilla - Spain, Valencia - Spain, Bern - Switzerland, Taichung - Taiwan, Bristol - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom, Tooting, London - United Kingdom",2014-06,2011-04-06,2016-06-30,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT05769816,Unknown,NOT_YET_RECRUITING,2023-06-01,"Chronic Hepatitis b, Anti-PD-1 Antibody","Anti-PD-1 antibody, NAs",Chongqing - China,2025-12-31,2023-03-15,2023-04-27,INTERVENTIONAL,PHASE4,The Second Affiliated Hospital of Chongqing Medical University,OTHER,hepatitis
NCT00119119,Unknown,TERMINATED,2002-02,"Hepatitis C, Chronic, Liver Fibrosis","pentoxyphilline, tocopherol",Paris - France,Unknown Date,2005-07-13,2007-01-12,INTERVENTIONAL,PHASE3,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT04970836,IRHBRVD,UNKNOWN,2021-08-01,"Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine",recombinant hepatitis B vaccine,Taipei - Taiwan,2024-07-31,2021-07-21,2022-06-27,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT00570336,Unknown,COMPLETED,2007-12,Chronic Hepatitis C Virus Infection,"CTS-1027, Placebo","Birmingham - United States, La Jolla - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Miami - United States, Atlanta - United States, New Orleans - United States, Boston - United States, West Bloomfield - United States, Rochester - United States, Bronx - United States, New York - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Houston - United States, Houston - United States, Richmond - United States",2009-07,2007-12-10,2010-09-16,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT00076336,Unknown,COMPLETED,2003-12,"Hepatitis, Hepatitis B, Chronic, Cirrhosis","Telbivudine, Lamivudine, Placebo","Phoenix - United States, Los Angeles - United States, Denver - United States, Indianapolis - United States, Rochester - United States, New York - United States, Houston - United States, Madison - United States, Heidelburg - Australia, Winnipeg - Canada, Hong Kong - China, Villejuif Cedex - France, Hannover - Germany, New Delhi - India, Tel Aviv - Israel, Seoul - Korea, Republic of, Riga - Latvia, Kuala Lumpur - Malaysia, Auckland - New Zealand, Krakow - Poland, Moscow - Russian Federation, Singapore - Singapore, Barcelona - Spain, Taipei - Taiwan, Bangkok - Thailand, Istanbul - Turkey, London - United Kingdom, Hanoi - Vietnam",2009-12,2004-01-22,2011-09-05,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01872936,Unknown,UNKNOWN,2013-06,"Hepatitis C, Chronic","Miravirsen, Telaprevir, Ribavirin","Dallas - United States, Houston - United States, San Juan - Puerto Rico",2015-01,2013-06-07,2014-11-18,INTERVENTIONAL,PHASE2,Santaris Pharma A/S,INDUSTRY,hepatitis
NCT00727259,SATISFACTION,COMPLETED,2004-10,"Hepatitis C, Chronic","Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908)",No locations listed,2008-04,2008-08-01,2015-04-29,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04201275,Unknown,COMPLETED,2019-12-18,Chronic Hepatitis C,"HEC74647PA capsule, placebo",Changchun - China,2020-01-17,2019-12-17,2020-03-19,INTERVENTIONAL,PHASE1,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,hepatitis
NCT02269059,Unknown,COMPLETED,2014-12,Hepatitis C,MK-7680,No locations listed,2015-02,2014-10-20,2015-07-27,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00680342,SyNCH,COMPLETED,2008-04,Chronic Hepatitis C,"Silymarin, Silymarin, Placebo","Boston - United States, Chapel Hill - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States",2011-01,2008-05-20,2013-03-18,INTERVENTIONAL,PHASE2,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT03020342,Unknown,UNKNOWN,2016-05,"Carcinoma, Hepatocellular",No interventions listed,Taipei - Taiwan,2019-01,2017-01-13,2017-01-13,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT00755742,Unknown,COMPLETED,2008-11,"Obesity, Insulin Resistance, Metabolic Syndrome, Hepatitis C",Lifestyle intervention,Toronto - Canada,2011-01,2008-09-19,2011-09-22,INTERVENTIONAL,NA,"University Health Network, Toronto",OTHER,hepatitis
NCT02705742,Unknown,UNKNOWN,2016-01,Liver Cirrhosis,Mesenchymal Stem Cells,Ankara - Turkey,2017-07,2016-03-10,2016-06-07,INTERVENTIONAL,PHASE2,Saglik Bilimleri Universitesi Gulhane Tip Fakultesi,OTHER,hepatitis
NCT00328042,Unknown,COMPLETED,2007-05,"Hepatitis C, Chronic Disease","Self-Management Workshop, Information Only",San Diego - United States,2010-08,2006-05-19,2015-04-24,INTERVENTIONAL,NA,US Department of Veterans Affairs,FED,hepatitis
NCT00697242,Unknown,COMPLETED,1994-01,Hepatitis B,"Engerix™-B, Recombinant HBsAg with different concentrations of Aluminium Salts and/or MPL","Wien - Austria, Gent - Belgium, Hvidovre - Denmark, Reykjavik - Iceland",1995-11,2008-06-13,2008-06-13,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02075242,OPTIMUS-A,UNKNOWN,2014-01,HEPATITIS,"Mycophenolate Mofetil, Tacrolimus","Seoul - Korea, Republic of",2016-01,2014-03-03,2014-03-03,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT05787899,Unknown,COMPLETED,2023-05-18,"Hypoxic-Ischemic Encephalopathy, Hepatitis B Vaccination, Hypothermia, Newborn",Hypothermia Protocol,Charleston - United States,2024-10-01,2023-03-28,2024-10-28,OBSERVATIONAL,Not Available,Medical University of South Carolina,OTHER,hepatitis
NCT02112799,Unknown,COMPLETED,2014-04-30,Chronic Hepatitis B,"NVR 3-778, Placebo for NVR 3-778, Pegasys","Hamilton - New Zealand, Auckland - New Zealand",2016-05-18,2014-04-14,2017-10-18,INTERVENTIONAL,PHASE1,"Novira Therapeutics, Inc.",INDUSTRY,hepatitis
NCT05903742,DREAM-2,RECRUITING,2024-01-22,Hepatitis D,No interventions listed,Rotterdam - Netherlands,2030-09-01,2023-06-15,2024-04-03,OBSERVATIONAL,Not Available,Erasmus Medical Center,OTHER,hepatitis
NCT00049842,Unknown,COMPLETED,2002-10,"Chronic Hepatitis C, Liver Fibrosis",peginterferon alfa-2b (SCH 54031),No locations listed,2009-10,2002-11-15,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02278419,Unknown,COMPLETED,2014-12,Hepatitis C,"Simeprevir, Sofosbuvir","Cairo - Egypt, Menoufiya - Egypt",2015-10,2014-10-30,2016-10-14,INTERVENTIONAL,PHASE2,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT02292719,Quartz II/III,COMPLETED,2014-12-19,Chronic Hepatitis C Virus Infection,"OBV/PTV/r, Sofosbuvir, Ribavirin (RBV)",No locations listed,2017-07-14,2014-11-17,2021-07-12,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT01634919,Unknown,COMPLETED,2012-07,Chronic Hepatitis C,chronic hepatitis C,"Seoul - Korea, Republic of, Seoul - Korea, Republic of",2017-02-17,2012-07-06,2024-12-03,OBSERVATIONAL,Not Available,Seoul National University Boramae Hospital,OTHER,hepatitis
NCT00316719,Unknown,COMPLETED,2006-01,Chronic Hepatitis B,"LAM group, ADV group",No locations listed,2008-01,2006-04-21,2009-10-06,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01999699,Unknown,COMPLETED,2013-11,Hepatitis B,HEPLISAV,Lenexa - United States,2015-02,2013-12-03,2019-03-20,INTERVENTIONAL,PHASE1,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT02044042,Unknown,UNKNOWN,2014-10,"Hepatitis C, Transmission",No interventions listed,Paris - France,2016-07,2014-01-23,2015-10-02,OBSERVATIONAL,Not Available,Hopital Lariboisière,OTHER,hepatitis
NCT00959699,Unknown,COMPLETED,2009-11,"HIV Infections, Hepatitis C, HCV Infection","PegIFN-2b, RBV, Placebo to Boceprevir, Boceprevir",No locations listed,2012-05,2009-08-17,2017-04-07,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00359099,Unknown,TERMINATED,1980-01,Congenital Heart Disease,No interventions listed,Atlanta - United States,Unknown Date,2006-08-01,2013-11-27,OBSERVATIONAL,Not Available,Emory University,OTHER,hepatitis
NCT05435599,Unknown,COMPLETED,2020-08-01,"Chronic Hepatitis b, Liver Fibrosis",Serum regucalcin level,Konya - Turkey,2020-12-31,2022-06-28,2022-06-28,INTERVENTIONAL,NA,Konya Meram State Hospital,OTHER,hepatitis
NCT03627299,Unknown,COMPLETED,2018-09-25,"End Stage Renal Disease, Hepatitis C",300mg glecaprevir/pibrentasivir 120mg,Baltimore - United States,2019-12-19,2018-08-13,2021-10-19,INTERVENTIONAL,PHASE4,Johns Hopkins University,OTHER,hepatitis
NCT05115942,Unknown,COMPLETED,2021-12-30,Liver Fibrosis,"Hydronidone capsules, The placebo capsules","Bengbu - China, Hefei - China, Beijing - China, Beijing - China, Beijing - China, Peking - China, Chongqing - China, Chongqing - China, Chongqing - China, Fujian - China, Xiamen - China, Lanzhou - China, Shenzhen - China, Guizhou - China, Zunyi - China, Hangzhou - China, Hebei - China, Harbin - China, Henan - China, Xinxiang - China, Zhengzhou - China, Changsha - China, Changsha - China, Changsha - China, Yueyang - China, Nanjing - China, Suzhou - China, Taizhou - China, Wuxi - China, Xuzhou - China, Zhenjiang - China, Nanchang - China, Nanchang - China, Jilin - China, Jilin - China, Yanbian - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Chengdu - China, Luzhou - China, Ningbo - China",2024-10-22,2021-11-10,2024-12-20,INTERVENTIONAL,PHASE3,"Beijing Continent Pharmaceutical Co, Ltd.",INDUSTRY,hepatitis
NCT03798119,Unknown,UNKNOWN,2019-02-25,"Hepatitis B, Fibrosis and Cirrhosis of Liver",Tenofovir Alafenamide,Kaohsiung - Taiwan,2020-08-31,2019-01-09,2019-04-26,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT05404919,INHIBITOR,WITHDRAWN,2022-09-06,"Lung Transplant, Hepatitis B","Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide",Philadelphia - United States,2024-08-01,2022-06-03,2024-08-06,INTERVENTIONAL,PHASE2,University of Pennsylvania,OTHER,hepatitis
NCT05906459,STAT,RECRUITING,2023-06-26,Hepatitis C Virus Infection,Anti-HCV antibody and HCV core antigen testing,"Shanghai - China, Shanghai - China, Kunming - China",2023-12-30,2023-06-15,2023-07-17,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT04954859,B-Sure,RECRUITING,2021-12-14,Hepatitis B,"Bepirovirsen, Placebo","Sacramento - United States, Boston - United States, Detroit - United States, Buenos Aires - Argentina, Sliven - Bulgaria, Sofia - Bulgaria, Calgary - Canada, Victoria - Canada, Toronto - Canada, Hangzhou - China, Shanghai - China, Wuhan - China, Clichy Cedex - France, Strasbourg - France, Pokfulam - Hong Kong, Milano - Italy, Milano - Italy, Modena - Italy, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Ishikawa - Japan, Kagawa - Japan, Kumamoto - Japan, Miyagi - Japan, Osaka - Japan, Tokyo - Japan, Tokyo - Japan, Ansan-si Gyenggi-do - Korea, Republic of, Busan - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Lancut - Poland, Lublin - Poland, Craiova Dolj - Romania, Galati - Romania, Chelyabinsk - Russian Federation, Krasnojarsk - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, St Petersburg - Russian Federation, Singapore - Singapore, Singapore - Singapore, Durban - South Africa, Johannesburg - South Africa, Madrid - Spain, Santander - Spain, Bangkok - Thailand, Kho Hong Hat Yai - Thailand, London - United Kingdom, Plymouth - United Kingdom",2029-02-08,2021-07-08,2024-09-27,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02609659,GEODE II,COMPLETED,2015-10-28,Hepatitis C Virus (HCV),"ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin",No locations listed,2016-10-07,2015-11-20,2019-12-10,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00439959,Unknown,TERMINATED,2006-10,"Hepatitis C, Chronic, Hepatitis C",GSK625433/placebo,Evansville - United States,2007-03,2007-02-26,2012-06-04,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00034359,Unknown,COMPLETED,2002-02,"Hepatitis B, Chronic","ACH-126,443, Lamivudine, Placebo","Sofia - Bulgaria, Belgrade - Former Yugoslavia, Novi Sad - Former Yugoslavia",2003-01,2002-04-29,2021-02-18,INTERVENTIONAL,PHASE2,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT00127959,Unknown,COMPLETED,2004-03,"HIV Infections, Hepatitis B","tenofovir, emtricitabine, zidovudine, efavirenz",Amsterdam - Netherlands,Unknown Date,2005-08-09,2007-04-24,INTERVENTIONAL,PHASE4,International Antiviral Therapy Evaluation Center,OTHER,hepatitis
NCT00597259,Unknown,UNKNOWN,2008-01,Chronic Hepatitis B,"Pegasys plus Entecavir, Entecavir",Taipei - Taiwan,2014-02,2008-01-18,2010-06-29,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT04133259,Unknown,UNKNOWN,2019-12-31,"Hepatitis B, Chronic","Recombinant anti-programmed death-1 (PD-1) humanized monoclonal antibody, Nucleoside/nucleotide analogues","Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan",2022-04-30,2019-10-21,2020-10-20,INTERVENTIONAL,PHASE2,"Henlix, Inc",INDUSTRY,hepatitis
NCT02953600,Unknown,UNKNOWN,2016-11,HBV Carrier,"Standard Dose Spirulina Platensis, Zero Spirulina Platensis, Double Dose Spirulina Platensis",Tainan - Taiwan,2017-06,2016-11-03,2016-11-11,INTERVENTIONAL,NA,Taipei Medical University WanFang Hospital,OTHER,hepatitis
NCT02308319,POWER,UNKNOWN,2015-01,"Carcinoma, Hepatocellular",Tenofovir disoproxil fumarate,No locations listed,2018-12,2014-12-04,2014-12-04,INTERVENTIONAL,PHASE4,Samsung Medical Center,OTHER,hepatitis
NCT00409019,Unknown,WITHDRAWN,Unknown Date,Chronic Hepatitis B,"Telbivudine, Adefovir, Tenofovir",No locations listed,2011-03,2006-12-08,2015-03-09,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02039219,TREAT,TERMINATED,2014-11-03,Alcoholic Hepatitis,"Placebo, 10 mg Obeticholic Acid (OCA)","Indianapolis - United States, Rochester - United States, Philadelphia - United States, Richmond - United States",2017-07-30,2014-01-17,2020-01-28,INTERVENTIONAL,PHASE2,Naga P. Chalasani,OTHER,hepatitis
NCT02053519,ViaDUCT,COMPLETED,2014-02,Hepatitis C,"Active Comparator: Vigantol Oil (Vitamin D3), Mygliol Oil","Aberdeen - United Kingdom, Dundee - United Kingdom, Edinburgh - United Kingdom, Edinburgh - United Kingdom, Falkirk - United Kingdom, Glasgow - United Kingdom, Glasgow - United Kingdom, Paisley - United Kingdom",2016-04,2014-02-03,2016-10-26,INTERVENTIONAL,PHASE3,University of Dundee,OTHER,hepatitis
NCT02117934,Unknown,COMPLETED,2014-04,Healthy,"HEPLISAV, Engerix-B","Birmingham - United States, Chandler - United States, Chandler - United States, Glendale - United States, Mesa - United States, Mesa - United States, Phoenix - United States, Phoenix - United States, Phoenix - United States, Scottsdale - United States, Tempe - United States, Tucson - United States, Tucson - United States, Santa Rosa - United States, Vista - United States, Centennial - United States, Colorado Springs - United States, Denver - United States, Pinellas Park - United States, Atlanta - United States, Chicago - United States, Evansville - United States, Council Bluffs - United States, Edina - United States, Saint Louis - United States, Elkhorn - United States, Fremont - United States, Omaha - United States, Henderson - United States, Las Vegas - United States, Akron - United States, Cincinnati - United States, Columbus - United States, Anderson - United States, Anderson - United States, Greer - United States, Dallas - United States, Plano - United States, San Antonio - United States, Murray - United States",2015-10,2014-04-21,2019-03-20,INTERVENTIONAL,PHASE3,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT02776059,Unknown,COMPLETED,2017-01-21,Alcoholic Hepatitis,"Standard of care + pegfiltrastim, Standard of care","Loma Linda - United States, Long Beach - United States, Los Angeles - United States, Torrance - United States, Albuquerque - United States",2020-03-31,2016-05-18,2021-09-29,INTERVENTIONAL,PHASE2,"Timothy Morgan, MD",OTHER,hepatitis
NCT02304159,Unknown,COMPLETED,2015-01,"Hepatitis C, Cirrhosis","daclatasvir, Sofosbuvir, Sovaldi, Ribavirin",Coronado - United States,2017-08,2014-12-01,2019-04-24,INTERVENTIONAL,PHASE4,"Tarek I. Hassanein, M.D., FACP, FAG, AGAF",OTHER,hepatitis
NCT02712359,Unknown,COMPLETED,2016-06-01,Hepatitis A Vaccine,Blood sample collection,"Chiriquí - Panama, Juán Diaz - Panama, Panama - Panama, Panamá - Panama",2018-08-22,2016-03-18,2019-11-19,INTERVENTIONAL,NA,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06421259,Unknown,NOT_YET_RECRUITING,2024-05-20,"Hiv Infection, Hepatitis B",No interventions listed,Nice - France,2026-05-20,2024-05-20,2024-05-20,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de Nice,OTHER,hepatitis
NCT01055821,HCVac,COMPLETED,2010-05,Chronic Hepatitis C Infection,"pegylated interferon and ribavirin, TG4040 + SOC, TG4040 + SOC",Hannover - Germany,2012-10,2010-01-26,2013-08-13,INTERVENTIONAL,PHASE2,Transgene,INDUSTRY,hepatitis
NCT03365921,Unknown,COMPLETED,2018-10-27,Hepatitis E,"Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month.",Dongtai - China,2019-06-16,2017-12-07,2020-05-07,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT03307902,Unknown,COMPLETED,2016-10-01,Hepatitis B,"Imiquimod + ID HBVv, Aqueous + ID HBVv, Imiquimod + IM HBVv",Hong Kong - Hong Kong,2019-03-31,2017-10-12,2019-10-22,INTERVENTIONAL,PHASE3,The University of Hong Kong,OTHER,hepatitis
NCT01263002,Unknown,COMPLETED,2010-06,Hepatitis B Associated Hepatocellular Carcinoma,"clevudine, Adefovir","Seoul - Korea, Republic of",2013-01,2010-12-20,2014-12-18,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT04870021,HepB-BirD,COMPLETED,2015-03-15,"Hepatitis B, Immunization; Infection","recombinant hepatitis B vaccine ENGERIX 10 micrograms (µ gm),, Short text messages and calls to parents for compliance to routine immunization schedule",Hyderabad - Pakistan,2015-11-30,2021-05-03,2021-05-03,INTERVENTIONAL,PHASE4,Quaid-e-Azam University,OTHER,hepatitis
NCT06833021,Unknown,NOT_YET_RECRUITING,2025-04-01,Colitis-associated Colorectal Cancer (CAC),"Transcriptomic Analysis, Transcriptomic Analysis",Milan - Italy,2026-04-01,2025-02-18,2025-02-20,OBSERVATIONAL,Not Available,IRCCS San Raffaele,OTHER,hepatitis
NCT04798521,Unknown,COMPLETED,2020-06-30,Hepatitis C,"Tele-HCV, Community Linkage to Care","Portland - United States, Portland - United States, Roseburg - United States",2023-08-25,2021-03-15,2024-10-08,INTERVENTIONAL,NA,Oregon Health and Science University,OTHER,hepatitis
NCT05282121,Unknown,TERMINATED,2022-06-28,"Liver Diseases, Hypertension, Portal","Avenciguat (BI 685509), Empagliflozin","Pasadena - United States, Rialto - United States, Miami Lakes - United States, San Antonio - United States, Caba - Argentina, Caba - Argentina, Wien - Austria, Edegem - Belgium, Montreal - Canada, Beijing - China, Guangzhou - China, Hangzhou - China, Shanghai - China, Hvidovre - Denmark, Clichy - France, Toulouse - France, Hannover - Germany, Mainz - Germany, Münster - Germany, Haifa - Israel, Nahariya - Israel, Baggiovara (MO) - Italy, Modena - Italy, Palermo - Italy, Kanagawa, Yokohama - Japan, Osaka, Osaka - Japan, Amsterdam - Netherlands, Cluj-Napoca - Romania, Singapore - Singapore, Barcelona - Spain, Madrid - Spain",2024-04-23,2022-03-16,2024-12-27,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00854802,Unknown,COMPLETED,2009-01,Chronic Hepatitis C,"Debio 025, Peg-IFNα2a, Ribavirin, Debio 025 placebo","Brussels - Belgium, Gent - Belgium, Creteil - France, Lyon - France, Nice - France, Paris - Saint Antoine - France, Paris - France, Pessac - France, Vandoeuvre-les-Nancy - France, Berlin - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Essen - Germany, Frankfurt am Main - Germany, Freiburg - Germany, Hannover - Germany, Heidelberg - Germany, Mainz - Germany, Bologna - Italy, Milano - Italy, Napoli - Italy, Palermo - Italy, Torino - Italy, Bialystok - Poland, Bydgoszcz - Poland, Chorzów - Poland, Kielce - Poland, Krakow - Poland, Lódz - Poland, Warszawa - Poland, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Cluj Napoca - Romania, Iasi - Romania, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain",2010-09,2009-03-03,2016-02-17,INTERVENTIONAL,NA,Debiopharm International SA,INDUSTRY,hepatitis
NCT02115321,Unknown,COMPLETED,2014-05-09,Chronic Hepatitis C,"Grazoprevir, Elbasvir, MK-5172A",No locations listed,2015-03-05,2014-04-16,2019-06-26,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04198584,VC-CBCS,COMPLETED,2020-04-10,Chronic Hepatitis C,VC-CBCS,Chapel Hill - United States,2021-01-12,2019-12-13,2022-10-24,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT01468584,Unknown,COMPLETED,2011-11,Chronic Hepatitis C,"MP-424 (generic name:Telaprevir), Ribavirin, Peginterferon alfa-2b",Minato-ku - Japan,2013-09,2011-11-09,2014-11-02,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00441584,Unknown,TERMINATED,2005-07,"Hepatitis C, Chronic","PegIntron (peginterferon alfa-2b), Rebetol (ribavirin)",No locations listed,2008-06,2007-03-01,2017-04-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03772002,Unknown,UNKNOWN,2019-01-01,"Hepatitis C, Chronic",HCV screening,"Changzhou - China, Nanjing - China",2020-06-30,2018-12-11,2018-12-13,INTERVENTIONAL,NA,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,OTHER,hepatitis
NCT03274102,Unknown,COMPLETED,2017-04-22,"Hand, Foot and Mouth Disease","Concomitant administration of EV71 vaccine with EPI vaccines, Single injection of EPI vaccine, EV71 Vaccine only",Dongguan - China,2017-11-01,2017-09-06,2021-07-29,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT02327702,Unknown,UNKNOWN,2015-01,"Hepatitis B, Chronic, Pregnancy",Emtricitabine,No locations listed,2015-07,2014-12-30,2014-12-30,INTERVENTIONAL,PHASE4,"Asian-Pacific Alliance of Liver Disease, Beijing",OTHER,hepatitis
NCT00529321,Unknown,COMPLETED,2006-12,"Hepatitis C, Chronic",MVA-HCV (Immunotherapy),"Créteil - France, La Tronche - France, Lyon - France, Nantes - France, Strasbourg - France, Vandoeuvre - France",2009-09,2007-09-14,2010-09-03,INTERVENTIONAL,PHASE1,Transgene,INDUSTRY,hepatitis
NCT00944684,Unknown,COMPLETED,2007-11,Chronic Hepatitis C,"High ribavirin dose, Standard ribavirin dose","Basel - Switzerland, Bern - Switzerland, Lausanne - Switzerland, St. Gallen - Switzerland, Zürich - Switzerland",2011-04,2009-07-23,2011-11-11,INTERVENTIONAL,PHASE2,University of Bern,OTHER,hepatitis
NCT03625102,Unknown,COMPLETED,2018-08-01,HBV,"Antroquinonol, placebo",Taichung - Taiwan,2023-06-16,2018-08-10,2023-09-13,INTERVENTIONAL,PHASE2,Golden Biotechnology Corporation,INDUSTRY,hepatitis
NCT05771402,Unknown,UNKNOWN,2023-06-01,"Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNα","Anti-PD-1 antibody, NAs, Peg-IFNα",Chongqing - China,2023-12-31,2023-03-16,2023-04-27,INTERVENTIONAL,PHASE4,The Second Affiliated Hospital of Chongqing Medical University,OTHER,hepatitis
NCT00602784,Unknown,COMPLETED,2002-11,Chronic Hepatitis C,IC41,No locations listed,2004-05,2008-01-28,2012-10-19,INTERVENTIONAL,PHASE2,Valneva Austria GmbH,INDUSTRY,hepatitis
NCT00292084,Unknown,COMPLETED,2006-02,"Hepatitis C, Chronic",Celgosivir,Halifax - Canada,Unknown Date,2006-02-15,2008-01-21,INTERVENTIONAL,PHASE2,BioWest Therapeutics Inc,INDUSTRY,hepatitis
NCT05649202,HEPAPRIS,NOT_YET_RECRUITING,2023-01,Chronic HIV Infection,"Xpert® HCV Viral test, FibroScan® test",Paris - France,2025-01,2022-12-13,2022-12-13,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT00013702,Unknown,COMPLETED,2001-03,"Hepatitis B, HIV Infection",Adefovir,Bethesda - United States,Unknown Date,2001-03-29,2008-03-04,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT06413121,Unknown,RECRUITING,2024-05-06,"Diptheria Immunization, Tetanus Immunization, Pertussis Immunization, Hepatitis B Immunization, Haemophilus Influenzae Type B Immunization, Polio Immunization","Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV, Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV","Dhaka - Bangladesh, New Delhi - India, Mangalore - India, Mysore - India, Pune - India, Pune - India, Chennai - India, Kolkata - India, Chandigarh - India",2025-08-31,2024-05-14,2024-09-19,INTERVENTIONAL,PHASE3,Serum Institute of India Pvt. Ltd.,INDUSTRY,hepatitis
NCT03820102,Unknown,UNKNOWN,2019-03,HCV,No interventions listed,No locations listed,2019-09,2019-01-29,2019-02-05,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT06190002,Unknown,NOT_YET_RECRUITING,2024-01-20,Acute-on-chronic Hepatitis B Liver Failure,No interventions listed,No locations listed,2024-05-31,2024-01-05,2024-01-05,OBSERVATIONAL,Not Available,Qilu Hospital of Shandong University,OTHER,hepatitis
NCT00886964,Unknown,COMPLETED,2009-04,HIV Infections,"Intradermal HBV 1 course, Intramuscular HBV I course","Bangkok - Thailand, Bangkok - Thailand",2010-05,2009-04-23,2020-07-17,INTERVENTIONAL,PHASE2,The HIV Netherlands Australia Thailand Research Collaboration,OTHER,hepatitis
NCT00496002,QUASH 1,TERMINATED,2007-08,"Chronic Hepatitis, Hepatitis B","Clevudine, Adefovir","Birmingham - United States, Anaheim - United States, Anaheim - United States, Fresno - United States, Fresno - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, San Clemente - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Francisco - United States, San Mateo - United States, Norwich - United States, Norwich - United States, Tampa - United States, Tampa - United States, Tampa - United States, Honolulu - United States, Germantown - United States, Des Moines - United States, New Orleans - United States, New Orleans - United States, College Park - United States, Boston - United States, Tupelo - United States, St. Louis - United States, Hillsborough - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Asheville - United States, Durham - United States, Cincinnati - United States, Cincinnati - United States, Portland - United States, Portland - United States, Portland - United States, Portland - United States, Nashville - United States, Austin - United States, Austin - United States, Dallas - United States, Dallas - United States, Galveston - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Salt Lake City - United States, Charlottesville - United States, Fairfax - United States, Fairfax - United States, Richmond - United States, Seattle - United States, Tacoma - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Cordoba - Argentina, Mar del Plata - Argentina, Concord - Australia, Sydney - Australia, Brisbane - Australia, Brisbane - Australia, Adelaide - Australia, Fitzroy - Australia, Footscray - Australia, Melbourne - Australia, Fremantle - Australia, Perth - Australia, Curitiba - PR - Brazil, Porte Alegro - Brazil, Rio de Janeiro - Brazil, Campinas - Brazil, Ribeirao Preto - Brazil, Sorocaba - Brazil, Santo Andre - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Belo Horizonte - Brazil, Sao Paulo - Brazil, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Halifax - Canada, Hamilton - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Pok fu lam - China, Shatin - China, Tai Po - China, Athens - Greece, Athens - Greece, Athens - Greece, Santurce - Puerto Rico, Santurce - Puerto Rico, Alicante - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Hat Yai - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Khon Kaen - Thailand, Phitsanulok - Thailand, Glasgow - United Kingdom, London - United Kingdom",Unknown Date,2007-07-04,2009-04-27,INTERVENTIONAL,PHASE3,Pharmasset,INDUSTRY,hepatitis
NCT00095121,Unknown,COMPLETED,2004-06,Chronic Hepatitis B,"Placebo (PLB), Adefovir Dipivoxil (ADV), Lamivudine",Boston - United States,2006-05,2004-11-01,2012-05-22,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT02275221,Unknown,RECRUITING,2013-08,"Hepatitis B, Hepatitis C",No interventions listed,Basildon - United Kingdom,2024-12,2014-10-27,2024-01-12,OBSERVATIONAL,Not Available,Mid and South Essex NHS Foundation Trust,OTHER,hepatitis
NCT01655121,Unknown,COMPLETED,2012-01,"Autoimmune Hepatitis, Cirrhosis",High protein high fiber diet,Mexico City - Mexico,2014-07,2012-08-01,2014-08-20,INTERVENTIONAL,NA,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,OTHER,hepatitis
NCT02196064,hEPAtic,COMPLETED,2014-05,Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects,No interventions listed,Sevilla - Spain,2015-07,2014-07-21,2015-08-05,OBSERVATIONAL,Not Available,Fundación Pública Andaluza Progreso y Salud,OTHER,hepatitis
NCT01743521,DARE-C,COMPLETED,2013-01,"Hepatitis C, Chronic",TPV/PEG-IFN/RBV,"Sydney - Australia, Adelaide - Australia",2015-11,2012-12-06,2017-03-29,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT04759521,Unknown,COMPLETED,2019-01-03,"Chronic Hepatitis B, Sonoelastography, Fibrosis, Liver",No interventions listed,Diyarbakır - Turkey,2020-10-30,2021-02-18,2021-02-18,OBSERVATIONAL,Not Available,Seyhmus Kavak,OTHER,hepatitis
NCT03254121,HEPCASUS,COMPLETED,2017-01-01,"Hepatocellular Carcinoma, Hepatitis C",No interventions listed,Stockholm - Sweden,2020-09-01,2017-08-18,2021-02-18,OBSERVATIONAL,Not Available,Karolinska Institutet,OTHER,hepatitis
NCT01062321,Unknown,COMPLETED,2009-08,"Hepatitis, Cytokines, Pregnancy",No interventions listed,New Delhi - India,2012-07,2010-02-04,2015-04-13,OBSERVATIONAL,Not Available,Maulana Azad Medical College,OTHER,hepatitis
NCT01054664,Unknown,UNKNOWN,2010-02,Hemodialysed Patients With Impaired Liver Enzymes,No interventions listed,Kfar Saba - Israel,Unknown Date,2010-01-22,2010-01-22,OBSERVATIONAL,Not Available,Meir Medical Center,OTHER,hepatitis
NCT00760721,Unknown,COMPLETED,2006-09,Hepatitis B,Educational Small Group Session,Los Angeles - United States,2011-08,2008-09-26,2016-11-28,INTERVENTIONAL,PHASE3,"University of California, Los Angeles",OTHER,hepatitis
NCT03601221,Unknown,COMPLETED,2018-05-29,Hepatitis E,Sample collection,"Lugano, - Switzerland",2018-12-31,2018-07-26,2020-03-31,OBSERVATIONAL,Not Available,"Ente Ospedaliero Cantonale, Bellinzona",OTHER,hepatitis
NCT00383864,Unknown,COMPLETED,2001-07,Hepatitis C,Pegylated interferon and ribavirin,Barcelona - Spain,Unknown Date,2006-10-04,2006-10-06,INTERVENTIONAL,PHASE4,Hospital Clinic of Barcelona,OTHER,hepatitis
NCT04090164,Unknown,COMPLETED,2019-09-01,"Breast Cancer, Hepatitis C",No interventions listed,Mansourah - Egypt,2020-06-01,2019-09-16,2020-10-19,OBSERVATIONAL,Not Available,Mansoura University,OTHER,hepatitis
NCT00284921,Unknown,TERMINATED,2004-04,De Novo Kidney Transplant,Enteric-coated Mycophenolate sodium (EC-MPS),No locations listed,2006-08,2006-02-01,2011-11-02,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT04182321,Unknown,COMPLETED,2020-03-13,Chronic Hepatitis B,"Metformin & Entecavir, Placebo & Entecavir",Tai'an - China,2021-07-02,2019-12-02,2021-12-07,INTERVENTIONAL,NA,Fu-Sheng Wang,OTHER,hepatitis
NCT05523921,Unknown,UNKNOWN,2022-09-01,HBV Transmission,No interventions listed,No locations listed,2023-09-01,2022-09-01,2022-09-01,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT03083821,Unknown,COMPLETED,2017-05-16,Hepatitis B Virus,Baraclude,Hachioji-shi - Japan,2017-12-19,2017-03-20,2023-11-18,INTERVENTIONAL,PHASE1,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01574521,Unknown,COMPLETED,2008-01,Hepatitis B,No interventions listed,LinHai - China,2010-12,2012-04-10,2012-04-10,OBSERVATIONAL,Not Available,YiYang Zhu,OTHER,hepatitis
NCT02422264,Unknown,COMPLETED,2016-01-22,"Acellular Pertussis, Tetanus, Poliomyelitis, Diphtheria, Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines","Infanrix hexa, Prevnar13","Carlton - Australia, Calgary - Canada, Halifax - Canada, Montreal - Canada, Brno - Czechia, Hradec Kralove - Czechia, Ostrava - Vitkovice - Czechia, Praha 4 - Czechia, Praha - Czechia, Kokkola - Finland, Oulu - Finland, Seinajoki - Finland, Tampere - Finland, Turku - Finland, Milano - Italy, Milano - Italy, Milano - Italy, Novara - Italy, Torino - Italy, Malaga - Spain, Antequera/Málaga - Spain, Aravaca - Spain, Burgos - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, Móstoles - Spain, Santiago de Compostela - Spain, Sevilla - Spain",2018-03-07,2015-04-21,2019-07-09,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02966964,Unknown,UNKNOWN,2015-04,"Hepatitis; Virus, Chronic, Type B","DWPUR001, Placebo","Ansan-si - Korea, Republic of, Bundang - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Suwon-si - Korea, Republic of, Uijongbu - Korea, Republic of",2018-11,2016-11-17,2017-09-25,INTERVENTIONAL,PHASE2,Uijeongbu St. Mary Hospital,OTHER,hepatitis
NCT01711164,Unknown,COMPLETED,2014-01,Chronic Hepatitis C Infection,No interventions listed,Toronto - Canada,2016-05,2012-10-22,2016-11-29,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT03212521,Unknown,COMPLETED,2017-08-07,Hepatitis C Virus (HCV),Glecaprevir/Pibrentasvir,"Birmingham - United States, North Little Rock - United States, Sacramento - United States, New Haven - United States, Baltimore - United States, Baltimore - United States, Ann Arbor - United States, Portland - United States, Houston - United States, Burlington - United States, Norfolk - United States, София - Bulgaria, Varna - Bulgaria, Calgary - Canada, Moncton - Canada, Brampton - Canada, Toronto - Canada, Marseille CEDEX 08 - France, Rennes - France, Besancon - France, Vandoeuvre les Nancy - France, Frankfurt am Main - Germany, Mainz - Germany, Berlin - Germany, Hamburg - Germany, Wrocław - Poland, Lublin - Poland, Bialystok - Poland, Myslowice - Poland, San Juan - Puerto Rico, Kazan - Russian Federation, Chelyabinsk - Russian Federation, Moscow - Russian Federation, Alcorcon - Spain, Barcelona - Spain, Barcelona - Spain, Malaga - Spain, Pontevedra - Spain, Bradford - United Kingdom, Glasgow - United Kingdom, Gloucester - United Kingdom, Newcastle Upon Tyne - United Kingdom",2018-08-13,2017-07-11,2019-09-04,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT06307964,HepMAH,RECRUITING,2024-07-23,"Cirrhosis, Alcoholic Liver Disease, Alcoholic Hepatitis",Biological sampling,Lyon - France,2026-01,2024-03-13,2025-03-13,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT04023721,Unknown,TERMINATED,2019-06-18,"Hepatitis B, HBV, Hepatitis B, Chronic","Inarigivir soproxil, Nucleoside/nucleotide (NUC) analogue inhibitors","Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Toronto - Canada, London - United Kingdom, London - United Kingdom",2020-07-16,2019-07-17,2020-07-22,INTERVENTIONAL,PHASE2,"F-star Therapeutics, Inc.",INDUSTRY,hepatitis
NCT03459521,Unknown,COMPLETED,2017-09-01,"Liver Disease Chronic, Hepatitis B Virus",Fendrix or HBVAXPRO 40,Terrassa - Spain,2021-08-01,2018-03-09,2022-07-11,INTERVENTIONAL,NA,Corporacion Parc Tauli,OTHER,hepatitis
NCT02749864,PREVHEP,COMPLETED,2015-07-01,"Hepatitis C, Hepatitis B",No interventions listed,"Santander - Spain, Valencia - Spain, Madrid - Spain",2017-04-01,2016-04-25,2018-09-26,OBSERVATIONAL,Not Available,Instituto de Investigación Marqués de Valdecilla,OTHER,hepatitis
NCT01519921,Unknown,COMPLETED,2005-10,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Busan - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2008-06,2012-01-27,2016-04-21,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03018821,Unknown,UNKNOWN,2017-01,Hepatitis B， Chronic,"Standard - Yinchengao Decoction plus Ganlu Detoxification Pill, Entecavir or Tenofovir, Standard - Ge Xia Zhu Yu Decoction, Advanced - Supplemented Taohong Huazhuo Decoction, Standard - Chaihu Shugan San, Advanced - Soothe the liver and regulate qi Decoction, Standard - Xiaoyao powder, Advanced - Supplemented Ganbi Decoction, Standard - Yiguan Decoction, Advanced - Supplemented Zimu Dan, Standard - Fuzilizhong Decoction plus Jinkui Shenqi Bolus, Advanced - Guifu Erxian Decoction, Advanced - Supplemented Ganji Decoction",Xi'an - China,2017-10,2017-01-12,2017-01-12,INTERVENTIONAL,NA,Xi'an Traditional Medicine Hospital,OTHER,hepatitis
NCT03038802,HBV003,NOT_YET_RECRUITING,2024-09-30,Chronic Hepatitis b,"Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine",Adelaide - Australia,2025-12-31,2017-02-01,2024-04-09,INTERVENTIONAL,PHASE2,Vaxine Pty Ltd,INDUSTRY,hepatitis
NCT03546621,Unknown,COMPLETED,2016-02-16,Chronic Hepatitis D Infection With Hepatitis B,"Myrcludex B, Myrcludex-B, Myrcludex-B, Tenofovir","Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Chelyabinsk - Russian Federation, Kazan - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Samara - Russian Federation, Stavropol' - Russian Federation, Yakutsk - Russian Federation",2018-01-31,2018-06-06,2021-05-10,INTERVENTIONAL,PHASE2,Hepatera Ltd.,INDUSTRY,hepatitis
NCT03887702,Unknown,TERMINATED,2020-01-17,"Hepatitis B Infection, Malignant Solid Neoplasm","Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate","Fort Smith - United States, Anaheim - United States, Antioch - United States, Baldwin Park - United States, Bellflower - United States, Dublin - United States, Dublin - United States, Emeryville - United States, Emeryville - United States, Fontana - United States, Fremont - United States, Fresno - United States, Fresno - United States, Harbor City - United States, Irvine - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Martinez - United States, Modesto - United States, Newport Beach - United States, Oakland - United States, Oakland - United States, Oakland - United States, Oakland - United States, Ontario - United States, Panorama City - United States, Pasadena - United States, Rancho Cordova - United States, Redwood City - United States, Richmond - United States, Riverside - United States, Rohnert Park - United States, Roseville - United States, Roseville - United States, Sacramento - United States, Sacramento - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, San Jose - United States, San Leandro - United States, San Marcos - United States, San Rafael - United States, San Rafael - United States, Santa Clara - United States, Santa Rosa - United States, South San Francisco - United States, South San Francisco - United States, Stockton - United States, Vacaville - United States, Vallejo - United States, Walnut Creek - United States, Walnut Creek - United States, Woodland Hills - United States, Deerfield Beach - United States, Fort Lauderdale - United States, Savannah - United States, 'Aiea - United States, 'Aiea - United States, 'Aiea - United States, 'Aiea - United States, 'Ewa Beach - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Honolulu - United States, Kailua - United States, Lihue - United States, Boise - United States, Caldwell - United States, Coeur d'Alene - United States, Emmett - United States, Meridian - United States, Nampa - United States, Post Falls - United States, Sandpoint - United States, Alton - United States, Aurora - United States, Chicago - United States, Danville - United States, Effingham - United States, Mattoon - United States, Mount Vernon - United States, Urbana - United States, Urbana - United States, Yorkville - United States, Chanute - United States, Dodge City - United States, El Dorado - United States, Garden City - United States, Great Bend - United States, Independence - United States, Kingman - United States, Lawrence - United States, Lenexa - United States, Lenexa - United States, Liberal - United States, Manhattan - United States, McPherson - United States, Newton - United States, Overland Park - United States, Parsons - United States, Pratt - United States, Salina - United States, Wellington - United States, Wichita - United States, Wichita - United States, Wichita - United States, Winfield - United States, Monroe - United States, Shreveport - United States, Burnsville - United States, Burnsville - United States, Cambridge - United States, Coon Rapids - United States, Edina - United States, Fridley - United States, Maple Grove - United States, Maplewood - United States, Maplewood - United States, Minneapolis - United States, Minneapolis - United States, Minneapolis - United States, Monticello - United States, New Ulm - United States, Princeton - United States, Robbinsdale - United States, Saint Louis Park - United States, Saint Paul - United States, Saint Paul - United States, Shakopee - United States, Stillwater - United States, Waconia - United States, Willmar - United States, Woodbury - United States, Wyoming - United States, Jackson - United States, Ballwin - United States, Bolivar - United States, Branson - United States, Independence - United States, Joplin - United States, Joplin - United States, Kansas City - United States, Rolla - United States, Rolla - United States, Saint Joseph - United States, Saint Louis - United States, Saint Louis - United States, Saint Louis - United States, Springfield - United States, Springfield - United States, Washington - United States, Anaconda - United States, Billings - United States, Bozeman - United States, Great Falls - United States, Great Falls - United States, Helena - United States, Kalispell - United States, Missoula - United States, New York - United States, Oklahoma City - United States, Baker City - United States, Ontario - United States, Portland - United States, Boiling Springs - United States, Easley - United States, Greenville - United States, Greenville - United States, Greenville - United States, Greenville - United States, Greer - United States, Seneca - United States, Houston - United States, Seattle - United States, New Richmond - United States, Cody - United States, Sheridan - United States, Tamuning - Guam",2022-12-20,2019-03-25,2024-05-20,INTERVENTIONAL,PHASE3,SWOG Cancer Research Network,NETWORK,hepatitis
NCT01772121,Unknown,COMPLETED,2012-05,"Hepatitis B, Hepatitis C",No interventions listed,"Hyderabad - India, Hyderabad - India, Guwahati - India, Surat - India, Gurgaon - India, Bangalore - India, Mumbai - India, Mumbai - India, Nagpur - India, Sangli - India, Aizawl - India, Cuttack - India, Ludhiana - India, Jaipur - India, Chennai - India, Coimbatore - India, Kolkata - India, Bilaspur - India, New Delhi - India",2012-10,2013-01-21,2015-07-09,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03963921,PANASH,COMPLETED,2019-04-09,NASH - Nonalcoholic Steatohepatitis,HepaStem,"Brussels - Belgium, Brussel - Belgium, Edegem - Belgium, Gent - Belgium, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Bordeaux - France, Villejuif - France, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain",2020-05-28,2019-05-28,2020-10-14,INTERVENTIONAL,PHASE2,Cellaion SA,INDUSTRY,hepatitis
NCT01037621,Unknown,UNKNOWN,2010-04,"Hepatitis C Virus Infection, Infection, Herpesvirus 2, Human",Valacyclovir,Jackson - United States,2012-02,2009-12-23,2011-11-06,INTERVENTIONAL,PHASE1,G.V. (Sonny) Montgomery VA Medical Center,FED,hepatitis
NCT01981421,Unknown,UNKNOWN,2013-06,Liver Fibrosis,No interventions listed,"Seoul - Korea, Republic of",2015-12,2013-11-11,2013-11-11,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT00983164,HepCAntSup,COMPLETED,2007-01,"Hepatitis C, Oxidative Stress",Antioxidant Supplementation,"Florianópolis - Brazil, Florianópolis - Brazil, Florianópolis - Brazil",2007-12,2009-09-23,2009-09-23,INTERVENTIONAL,NA,Universidade do Sul de Santa Catarina,OTHER_GOV,hepatitis
NCT00560690,Unknown,COMPLETED,2007-12,Hepatitis C,"Metformin, pegylated interferon, Ribavirin","Tehran - Iran, Islamic Republic of",2010-09,2007-11-20,2015-04-06,INTERVENTIONAL,PHASE4,Tehran University of Medical Sciences,OTHER,hepatitis
NCT00925990,Unknown,COMPLETED,2009-06,Hepatitis C,"ribavirin, CTS-1027, Placebo for ribavirin","Birmingham - United States, San Diego - United States, San Diego - United States, San Diego - United States, Denver - United States, Washington - United States, Gainsville - United States, New Orleans - United States, Worchester - United States, Novi - United States, Plymouth - United States, Rochester - United States, St. Louis - United States, New York City - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Houston - United States, Richmond - United States, Santurce - Puerto Rico",2010-05,2009-06-23,2012-03-27,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT03219203,Unknown,UNKNOWN,2017-07-01,Hepatitis B,Hepatitis B vaccine,"Muang, Chiang Mai - Thailand",2018-07-01,2017-07-17,2017-07-17,INTERVENTIONAL,PHASE4,Chiang Mai University,OTHER,hepatitis
NCT01482390,Unknown,COMPLETED,2011-11-30,Hepatitis C,"Ribavirin, Mericitabine, Peginterferon Alfa-2a, Placebo, Telaprevir","Birmingham - United States, Long Beach - United States, Sacramento - United States, San Diego - United States, New Haven - United States, Naples - United States, Lutherville - United States, Framingham - United States, Saint Louis - United States, New York - United States, Statesville - United States, Cincinnati - United States, Dallas - United States, Richmond - United States, Seattle - United States, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Toronto - Canada, Woodbridge - Canada, Montreal - Canada, Lille - France, Marseille - France, Toulouse - France, Frankfurt Am Main - Germany, Freiburg - Germany, Kiel - Germany, Bologna - Italy, Milano - Italy, Pisa - Italy, La Laguna - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Dorset - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2014-01-31,2011-11-30,2017-04-24,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02112890,Unknown,COMPLETED,2014-12-10,"Hepatitis A, Viral Hepatitis Vaccines",Data collection,Cuernavaca - Mexico,2016-05-02,2014-04-14,2019-06-27,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06573190,Faraday,COMPLETED,2023-01-02,"Chronic Hepatitis B, Hepatic Steatosis","Transient elastography, Tenofovir Disoproxil Fumarate",Ankara - Turkey,2023-04-25,2024-08-27,2024-08-27,OBSERVATIONAL,Not Available,"Yaşar Bayındır, MD",OTHER,hepatitis
NCT02904603,IMHC,UNKNOWN,2014-11,Hepatitis C,No interventions listed,Regensburg - Germany,2016-11,2016-09-19,2016-09-21,OBSERVATIONAL,Not Available,University of Regensburg,OTHER,hepatitis
NCT01074203,Unknown,COMPLETED,2009-02,Hepatitis C Recurrence,Nitazoxanide,Rochester - United States,2011-01,2010-02-24,2012-07-31,INTERVENTIONAL,PHASE1,Mayo Clinic,OTHER,hepatitis
NCT00998621,ADHEPTA,COMPLETED,2009-10,"Hepatitis C, Chronic, HIV Infection",Adherence questionnaire,Barcelona - Spain,2010-09,2009-10-20,2015-10-16,OBSERVATIONAL,Not Available,Fundacion IMIM,OTHER,hepatitis
NCT01223664,Unknown,UNKNOWN,2010-10,Liver Cirrhosis,"Allogenic bone marrow stem cells transplantation, Conserved therapy",Guangzhou - China,2011-11,2010-10-19,2010-10-19,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT03654664,VITHA-C,COMPLETED,2017-06-20,Hepatitis A Vaccine,"Inactivated hepatitis A vaccine, Havrix Inj","Incheon - Korea, Republic of, Suwon-si - Korea, Republic of, Ansan - Korea, Republic of, Changwon - Korea, Republic of, Daegu - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Wonju - Korea, Republic of",2019-06-24,2018-08-31,2023-07-07,INTERVENTIONAL,PHASE3,"Boryung Pharmaceutical Co., Ltd",INDUSTRY,hepatitis
NCT05473403,PRO-SURFASA,NOT_YET_RECRUITING,2024-06-01,"Liver Failure, Acute, Hepatitis, Autoimmune, Organ Dysfunction Scores, Risk Factors",Corticosteroid therapy,"Angers - France, Besançon - France, Bobigny - France, Brest - France, Caen - France, Chambray-lès-Tours - France, Dijon - France, Lille - France, Limoges - France, Lyon - France, Lyon - France, Marseille - France, Montpellier - France, Nice - France, Orléans - France, Paris - France, Paris - France, Paris - France, Pessac - France, Poitiers - France, Reims - France, Rennes - France, Rouen - France, Strasbourg - France, Toulouse - France, Villejuif - France",2027-05-31,2022-07-25,2024-03-13,INTERVENTIONAL,NA,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT00222664,Unknown,COMPLETED,1983-09,"Hepatitis B, Liver Neoplasms, Liver Diseases",Hep-V Vax,"Qidong - China, Beijing - China, Oxford - United Kingdom",Unknown Date,2005-09-22,2005-09-22,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,hepatitis
NCT02251990,Unknown,COMPLETED,2015-01-28,Hepatitis C,"Grazoprevir/Elbasvir, Placebo",No locations listed,2016-09-27,2014-09-29,2019-01-30,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01271790,Unknown,COMPLETED,2010-10,"Hepatitis C, Chronic","Tegobuvir (GS-9190), GS-9451, Pegasys®, Copegus®, GS-9451, Tegobuvir placebo, Pegasys®, Copegus®, Tegobuvir placebo, GS-9451 placebo, Pegasys®, Copegus®","Dothan - United States, Montgomery - United States, Phoenix - United States, Tucson - United States, Beverly Hills - United States, Chula Vista - United States, La Jolla - United States, La Mesa - United States, Los Angeles - United States, National City - United States, Oceanside - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, Englewood - United States, Washington - United States, Bradenton - United States, Deland - United States, Gainesville - United States, Hialeah - United States, Miami - United States, North Miami - United States, Orlando - United States, Orlando - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Decatur - United States, Decatur - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Bowling Green - United States, Louisville - United States, Baton Rouge - United States, Baltimore - United States, Baltimore - United States, Boston - United States, Boston - United States, Worcester - United States, Novi - United States, Plymouth - United States, Jackson - United States, Tupelo - United States, St. Louis - United States, Berlin - United States, Hillsborough - United States, Morristown - United States, Newark - United States, Albuquerque - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Durham - United States, Cincinnati - United States, Cincinnati - United States, Cleveland - United States, Tulsa - United States, Philadelphia - United States, Germantown - United States, Mountain Home - United States, Nashville - United States, Arlington - United States, Dallas - United States, Houston - United States, Houston - United States, Houston - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Fairfax - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Madison - United States, Graz - Austria, Graz - Austria, Innsbruck - Austria, Linz - Austria, Vienna - Austria, Vienna - Austria, Antwerpen - Belgium, Brussels - Belgium, Brussels - Belgium, Edegem - Belgium, Liège - Belgium, Clichy - France, Créteil - France, Lyon - France, Marseille - France, Nice - France, Orléans - France, Paris - France, Pessac - France, Strasbourg - France, Vandoeuvre - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt/M - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Leipzig - Germany, Mainz - Germany, Amsterdam - Netherlands, Nijmegen - Netherlands, Rotterdam - Netherlands, Utrecht - Netherlands, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Czeladź - Poland, Kielce - Poland, Krakow - Poland, Lodz - Poland, Lublin - Poland, Radom - Poland, Warszawa - Poland, Warszawa - Poland, Wrocław - Poland, Birmingham - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom",2013-01,2011-01-07,2014-02-06,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01139203,Unknown,UNKNOWN,2009-08,"Liver Transplantation, Hepatitis B",lamivudine adefovir entecavir HBIG,Shanghai - China,2012-12,2010-06-08,2010-06-28,INTERVENTIONAL,NA,Shanghai Jiao Tong University School of Medicine,OTHER,hepatitis
NCT03619590,Unknown,COMPLETED,2001-05-18,Hepatitis,Data Collection,No locations listed,2017-09-15,2018-08-08,2019-02-04,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01651403,Unknown,ACTIVE_NOT_RECRUITING,2012-12-06,Chronic Hepatitis B,"Tenofovir DF, TDF Placebo","Phoenix - United States, San Francisco - United States, Aurora - United States, Cincinnati - United States, Houston - United States, Surat - India, Gurgaon - India, Nagpur - India, Jaipur - India, Lucknow - India, Bangalore - India, Yangsan - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Taipei - Taiwan, Taipei - Taiwan",2017-08-07,2012-07-27,2025-01-08,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00006164,HALT-C,COMPLETED,2000-06,"Chronic Hepatitis c, Cirrhosis, Liver, Fibrosis, Liver, Hepatic Cirrhosis","Peginterferon alfa-2a + Ribavirin, Peginterferon alfa-2a","Long Beach - United States, Los Angeles - United States, Denver - United States, Farmington - United States, Bethesda - United States, Boston - United States, Worcester - United States, Ann Arbor - United States, Saint Louis - United States, Dallas - United States, Richmond - United States",2007-04,2000-08-09,2020-05-12,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT04247490,Unknown,COMPLETED,2019-12-17,Autoimmune Hepatitis,pediatric AIH,Cona - Italy,2019-12-31,2020-01-30,2020-01-30,OBSERVATIONAL,Not Available,University Hospital of Ferrara,OTHER,hepatitis
NCT04812990,Unknown,COMPLETED,2021-03-01,"Hepatitis C, Oral Manifestations, in Egyptian Population",No interventions listed,Giza - Egypt,2021-07-04,2021-03-24,2023-03-20,OBSERVATIONAL,Not Available,Misr University for Science and Technology,OTHER,hepatitis
NCT00043303,Unknown,COMPLETED,2001-09,"Liver Fibrosis, Cirrhosis",interferon gamma-1b,No locations listed,Unknown Date,2002-08-09,2007-11-01,INTERVENTIONAL,PHASE2,InterMune,INDUSTRY,hepatitis
NCT00106964,Unknown,COMPLETED,2004-01,"HIV Infection, Hepatitis B","Engerix-B 20 mcg, Engerix-B 40 mcg, Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg","Los Angeles - United States, San Fransisco - United States, Washington - United States, New Orleans - United States, Belo Horizonte - Brazil, Ribeirao Preto - Brazil, Sao Paulo - Brazil, Rio de Janeiro - Brazil, Rio de Janeiro - Brazil, Bellville - South Africa, Johannesburg - South Africa",2008-01,2005-04-04,2017-03-29,INTERVENTIONAL,PHASE4,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT03949764,KeY Treat,ACTIVE_NOT_RECRUITING,2019-09-23,"Hepatitis C, Opioid-Related Disorders, Injection Drug Use",Sofosbuvir/velpatasvir (Epclusa®),Hazard - United States,2025-04-01,2019-05-14,2024-08-22,INTERVENTIONAL,PHASE4,Jennifer Havens,OTHER,hepatitis
NCT00444002,Unknown,COMPLETED,2005-07,"Hepatitis C, Hepatic Steatosis",No interventions listed,Toronto - Canada,2008-07,2007-03-07,2014-01-10,OBSERVATIONAL,Not Available,Johane Allard,OTHER,hepatitis
NCT04546802,HATCHeT,WITHDRAWN,2019-09,"Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma, Hepatitis C",Elbasvir / Grazoprevir Oral Tablet,No locations listed,2021-06,2020-09-14,2020-09-14,INTERVENTIONAL,PHASE3,Bayside Health,OTHER_GOV,hepatitis
NCT00395421,Unknown,COMPLETED,2006-10,Chronic Hepatitis C,NM283 plus Peg-IFNα-2a,"Atlanta - United States, Fairfax - United States",2008-06,2006-11-02,2010-06-10,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01480284,Unknown,COMPLETED,2011-11,"Hepatitis B, Chronic","GSK548470 300 mg tablet, ETV 0.5 mg capsule","Aichi - Japan, Aichi - Japan, Chiba - Japan, Fukui - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Gifu - Japan, Hiroshima - Japan, Hyogo - Japan, Hyogo - Japan, Kagawa - Japan, Kagoshima - Japan, Kagoshima - Japan, Kanagawa - Japan, Kumamoto - Japan, Miyagi - Japan, Miyazaki - Japan, Nagasaki - Japan, Nagasaki - Japan, Nara - Japan, Okayama - Japan, Okayama - Japan, Osaka - Japan, Osaka - Japan, Saga - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan",2013-01,2011-11-28,2016-08-10,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01292421,Unknown,WITHDRAWN,2013-02,"Healthy, no Evidence of Disease","hepatitis B antigen peptide, placebo, immunoenzyme technique",No locations listed,2013-12,2011-02-09,2022-10-03,INTERVENTIONAL,NA,Roswell Park Cancer Institute,OTHER,hepatitis
NCT01373684,PAS,COMPLETED,2012-05-25,Chronic Hepatitis B,"Peginterferon alfa-2a, Nucleos(t)ide analogue","Toronto - Canada, Rotterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Arnhem - Netherlands, Delft - Netherlands, Haarlem - Netherlands, Utrecht - Netherlands",2019-10-28,2011-06-15,2019-11-08,INTERVENTIONAL,PHASE4,Foundation for Liver Research,OTHER,hepatitis
NCT03551002,Unknown,UNKNOWN,2018-01-01,"Hepatitis C, Hepatitis C, Chronic, HIV/AIDS",No interventions listed,San Diego - United States,2021-12-31,2018-06-11,2021-09-05,OBSERVATIONAL,Not Available,"University of California, San Diego",OTHER,hepatitis
NCT06049602,Unknown,RECRUITING,2023-01-15,Hepatitis B Reactivation,No interventions listed,Istanbul - Turkey,2023-12-31,2023-09-22,2023-09-22,OBSERVATIONAL,Not Available,Viral Hepatitis Society,OTHER,hepatitis
NCT00207402,Unknown,COMPLETED,2005-10,Hepatitis C,rosiglitazone,Ft. Sam Houston - United States,2010-01,2005-09-21,2012-02-14,INTERVENTIONAL,PHASE4,Brooke Army Medical Center,FED,hepatitis
NCT02765802,LIMT,COMPLETED,2016-10-19,"Hepatitis D, Chronic",Peginterferon Lambda-1A,"Beersheba - Israel, Jerusalem - Israel, Grafton - New Zealand, Karachi - Pakistan",2018-07-20,2016-05-09,2023-01-17,INTERVENTIONAL,PHASE2,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT00410202,DEFINE,COMPLETED,2008-03,"Hepatitis B, Chronic","Entecavir, Tenofovir, Adefovir, Lamivudine","Farmington - United States, Concord - Australia, Randwick - Australia, Porto Alegre Rs - Brazil, Calgary - Canada, Athens - Greece, Shatin - Hong Kong, Hong Kong - Hong Kong, Tai Po - Hong Kong, Lucknow - India, Ahmedabad - India, Chandigarh - India, Indore - India, Ludhiana - India, New Delhi - India, Vellore - India, Jakarta - Indonesia, Antella, Firenze - Italy, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Ansan-Si - Korea, Republic of, Anyang-Si - Korea, Republic of, Bucheon-Si - Korea, Republic of, Seongnam-Si - Korea, Republic of, Suwon-Si - Korea, Republic of, Koyang - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Chuncheon-Si - Korea, Republic of, Daegu - Korea, Republic of, Gangneung - Korea, Republic of, Incheon - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of, Yangsan-Si - Korea, Republic of, Kota Kinabalu - Malaysia, Kuala Lumpur - Malaysia, Cebu City - Philippines, Manila - Philippines, Chorzow - Poland, Kielce - Poland, Lodzi - Poland, Lublin - Poland, Warszawa - Poland, Moscow - Russian Federation, Moscow - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, Singapore - Singapore, Kaohsiung - Taiwan, Tainan R.O.C. - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Bornova Izmir - Turkey, Trabzon - Turkey",2011-01,2006-12-12,2013-11-21,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06196502,Unknown,NOT_YET_RECRUITING,2024-02-01,Pain,"Gentle Human Touch (GHT), Kangaroo Care, Lactation",Kırşehir - Turkey,2024-07-30,2024-01-09,2024-01-09,INTERVENTIONAL,NA,Kirsehir Ahi Evran Universitesi,OTHER,hepatitis
NCT00447902,Unknown,TERMINATED,2007-03,HIV Infections,"tipranavir, ritonavir","Beverly Hills - United States, Fort Lauderdale - United States, Providence - United States, Austin - United States, Houston - United States, Capital Federal - Argentina, Sacomã - São Paulo - Brazil, Santo André - Brazil, Sao Paulo - Brazil, Vila Mariana - Sao Paulo - Brazil, Garches - France, Nantes - France, Nantes - France, Nice cedex 3 - France, Nice cedex 3 - France, Nice cedex 3 - France, Nice cedex 3 - France, Nice cedex 3 - France, Nice cedex 3 - France, Paris - France, Paris - France, Perpignan - France, Düsseldorf - Germany, Ancona - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Pavia - Italy, Barcelona - Spain, Madrid - Spain",2008-10,2007-03-15,2014-05-14,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01841502,ROLEX,TERMINATED,2013-05,"Hepatitis C Infection, Depression","Paroxetine, telaprevir","Amsterdam - Netherlands, Amsterdam - Netherlands, Delft - Netherlands, Groningen - Netherlands, Nijmegen - Netherlands, Rotterdam - Netherlands, Utrecht - Netherlands",2014-09,2013-04-26,2020-12-08,INTERVENTIONAL,PHASE2,Radboud University Medical Center,OTHER,hepatitis
NCT02348502,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,No interventions listed,Beijing - China,2016-12,2015-01-28,2016-08-19,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00197002,Unknown,COMPLETED,2003-09-11,Hepatitis A,"GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix), Prevnar™","Centennial - United States, Bardstown - United States, Louisville - United States, Boston - United States, Boston - United States, Kalamazoo - United States, Omaha - United States, Las Vegas - United States, North Las Vegas - United States, Stony Brook - United States, Chapel Hill - United States, University Heights - United States, Pittsburgh - United States, Dallas - United States, San Antonio - United States, Salt Lake City - United States, Salt Lake City - United States, Vancouver - United States",2006-01-16,2005-09-20,2018-08-06,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05823584,Unknown,COMPLETED,2019-12-22,Hepatocellular Carcinoma,No interventions listed,Taipei - Taiwan,2023-07-21,2023-04-21,2024-04-10,OBSERVATIONAL,Not Available,TCM Biotech International Corp.,INDUSTRY,hepatitis
NCT00147784,Unknown,COMPLETED,2006-03,"Opiate Dependence, Hepatitis","Ribavirin, Pegylated Interferon","Kristiansand - Norway, Kristiansand - Norway",2007-06,2005-09-07,2008-03-28,INTERVENTIONAL,PHASE3,Sorlandet Hospital HF,OTHER_GOV,hepatitis
NCT03164902,DASH,UNKNOWN,2017-07-21,"Hepatitis C, Chronic, Nonadherence, Patient",Digital Medicine,"Birmingham - United States, San Francisco - United States, Colorado Springs - United States, Denver - United States, Washington - United States, Orlando - United States, Tampa - United States, Chicago - United States, Baltimore - United States, Springfield - United States, Detroit - United States, Detroit - United States, Santa Fe - United States, Durham - United States, Seattle - United States, Madison - United States",2019-04-30,2017-05-24,2018-12-13,INTERVENTIONAL,NA,"Proteus Digital Health, Inc.",INDUSTRY,hepatitis
NCT02365402,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,Entecavir,Beijing - China,2016-12,2015-02-18,2016-08-19,INTERVENTIONAL,PHASE4,Beijing Ditan Hospital,OTHER,hepatitis
NCT01884402,OPTIM,COMPLETED,2010-10,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin",Sevilla - Spain,2014-05,2013-06-24,2014-09-04,OBSERVATIONAL,Not Available,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,OTHER,hepatitis
NCT05542979,Unknown,COMPLETED,2019-08-05,Chronic HBV Infection,"HH-003 injection, Placebo","Beijing - China, Beijing - China, Beijing - China, Fuzhou - China, Lanzhou - China, Zhengzhou - China, Zhengzhou - China, Changchun - China, Yanji - China, Jinan - China, Hangzhou - China",2022-03-15,2022-09-16,2022-09-16,INTERVENTIONAL,PHASE1,Huahui Health,INDUSTRY,hepatitis
NCT01756079,Unknown,COMPLETED,2013-02-06,Hepatitis C,"boceprevir, PegIFN-2b, RBV",No locations listed,2015-11-17,2012-12-24,2018-09-05,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01164384,Unknown,UNKNOWN,2010-10,Chronic HCV Hepatitis C,Baminercept,Zurich - Switzerland,Unknown Date,2010-07-16,2010-07-16,INTERVENTIONAL,PHASE1,University of Zurich,OTHER,hepatitis
NCT00371579,Unknown,WITHDRAWN,2006-10,Hepatitis C,rosuvastatin,Utrecht - Netherlands,2007-10,2006-09-04,2015-06-03,INTERVENTIONAL,NA,UMC Utrecht,OTHER,hepatitis
NCT00605384,Unknown,TERMINATED,2008-08,Chronic Hepatitis B,"Entecavir + Tenofovir, Adefovir + continuing Lamivudine","Los Angeles - United States, San Francisco - United States, Chicago - United States, New York - United States, Bruxelles - Belgium, Leuven - Belgium, Berlin - Germany, Bonn - Germany, Duesseldorf - Germany, Mainz - Germany, Messina - Italy, Modena - Italy, Naples - Italy, Padova - Italy, San Giovanni Rotondo - Italy, Chorzow - Poland, Krakow - Poland, Lublin - Poland, Ankara - Turkey, Ankara - Turkey, Istanbul - Turkey, Istanbul - Turkey, Istanbul - Turkey, Istanbul - Turkey, Istanbul - Turkey, Izmir - Turkey, Kocaeli - Turkey, Sihhiye Ankara - Turkey, Trabzon - Turkey",2009-02,2008-01-31,2010-11-23,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00723879,Unknown,TERMINATED,2004-10,"Hepatitis C, Chronic, Hepacivirus","Peginterferon alfa-2b (SCH 54031), Ribavirin (SCH 18908), Patient assistance program",No locations listed,2008-07,2008-07-29,2015-11-03,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02537379,Unknown,COMPLETED,2015-09-15,Hepatitis C Virus Infection,"SOF, COPE","Amagasaki-shi - Japan, Asahi-shi - Japan, Asahikawa-shi - Japan, Beppu-shi - Japan, Chichibu-shi - Japan, Fujioka-shi - Japan, Fukui-shi - Japan, Hamamatsu-shi - Japan, Iizuka-shi - Japan, Inzai-shi - Japan, Ishinomaki-shi - Japan, Iwaki-shi - Japan, Izunokuni-shi - Japan, Kahoku-gun - Japan, Kanazawa-shi - Japan, Kirishima-shi - Japan, Kisarazu-shi - Japan, Kitamoto-shi - Japan, Kobe-shi - Japan, Koshigaya-shi - Japan, Kure-shi - Japan, Moriguchi-shi - Japan, Nagakute-shi - Japan, Nagaoka-shi - Japan, Nagasaki-shi - Japan, Nagoya-shi - Japan, Nakagami-gun - Japan, Nanto-shi - Japan, Nishinomiya-shi - Japan, Ogi-shi - Japan, Okayama-shi - Japan, Ome-shi - Japan, Osaka-shi - Japan, Ota-ku - Japan, Sapporo-shi - Japan, Sasebo-Shi - Japan, Sendai-shi - Japan, Shinagawa-ku - Japan, Shinjuku-ku - Japan, Tokorozawa-shi - Japan, Tokushima-shi - Japan, Wakayama-shi - Japan, Yachiyo-shi - Japan, Yokohama-shi - Japan, Yufu-shi - Japan",2017-06-05,2015-09-01,2017-06-27,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT00361179,Unknown,COMPLETED,2006-05,"Coinfection With Hepatitis B Virus and Hepatitis C Virus, Monoinfection With Hepatitis C Virus",No interventions listed,Taipei city - China,Unknown Date,2006-08-07,2006-08-07,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT03933384,Unknown,RECRUITING,2019-08-19,"Hepatitis B, Viral Hepatitis","Tenofovir alafenamide, Entecavir",Taichung - Taiwan,2027-12-31,2019-05-01,2025-01-09,INTERVENTIONAL,PHASE4,Taichung Veterans General Hospital,OTHER,hepatitis
NCT01467479,Unknown,TERMINATED,2011-12,Hepatitis C,"Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a, Highly Active Antiretroviral Therapy (HAART)","Birmingham - United States, Bakersfield - United States, Beverly Hills - United States, Coronado - United States, Los Angeles - United States, Oakland - United States, Palo Alto - United States, Sacremento - United States, San Diego - United States, San Francisco - United States, New Haven - United States, Washington DC - United States, Washington - United States, Bay Pines - United States, Jacksonville - United States, Miami - United States, Orlando - United States, West Palm Beach - United States, Atlanta - United States, Decatur - United States, Chicago - United States, Portland - United States, Baltimore - United States, Lutherville - United States, Springfield - United States, Detroit - United States, Minneapolis - United States, Kansas City - United States, Saint Louis - United States, Newark - United States, Santa Fe - United States, Bronx - United States, New York - United States, Rochester - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Portland - United States, Philadelphia - United States, Providence - United States, Columbia - United States, Dallas - United States, Houston - United States, Salt Lake City - United States, Richmond - United States, Seattle - United States, Edmonton - Canada, Vancouver - Canada, Hamilton - Canada, Toronto - Canada, Montreal - Canada, Bonn - Germany, Essen - Germany, Hamburg - Germany, Munchen - Germany, San Juan - Puerto Rico, Badalona - Spain, Barcelona - Spain, Madrid - Spain",2014-02,2011-11-08,2015-03-17,INTERVENTIONAL,PHASE3,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01337479,Unknown,COMPLETED,2003-02,Hepatitis B,No interventions listed,No locations listed,2010-09,2011-04-19,2011-04-19,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05956379,Unknown,ENROLLING_BY_INVITATION,2023-08-01,"Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease",exercise,Taipei - Taiwan,2027-07-31,2023-07-21,2023-07-21,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT05988879,Unknown,RECRUITING,2023-08-02,"AIDS, Hepatitis B",Peginterferon alfa-2b Injection,Guangzhou - China,2026-08-02,2023-08-14,2023-08-14,OBSERVATIONAL,Not Available,Guangzhou 8th People's Hospital,OTHER,hepatitis
NCT01787279,Unknown,COMPLETED,2006-01,"Hepatitis B, Chronic",Peginterferon alfa-2a [Pegasys],"Casablanca - Morocco, Casablanca - Morocco, Rabat - Morocco, Rabat - Morocco",2009-05,2013-02-08,2016-07-22,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01743079,Unknown,COMPLETED,2009-01,"Chronic Hepatitis B, Late Pregnancy, Transmission, Complication","Telbivudine, Lamivudine",Beijing - China,2013-07,2012-12-06,2013-07-30,INTERVENTIONAL,PHASE4,Beijing YouAn Hospital,OTHER,hepatitis
NCT00247884,Unknown,COMPLETED,2005-06,Hepatitis C Virus Infection,No interventions listed,"Vancouver - Canada, Victoria - Canada",Unknown Date,2005-11-02,2009-10-14,OBSERVATIONAL,Not Available,University of British Columbia,OTHER,hepatitis
NCT00237484,Pegade,COMPLETED,2005-07-18,"Hepatitis C, Chronic","Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin, Combination of (a) pegylated interferon alfa-2b and (b) ribavirin",No locations listed,2011-06-30,2005-10-12,2020-08-26,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03236584,Unknown,UNKNOWN,2015-09-01,Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48,"lamivudine plus adefovir combination, Tenofovir Disoproxil Fumarate",No locations listed,2018-03-30,2017-08-02,2017-08-02,INTERVENTIONAL,PHASE3,Uijeongbu St. Mary Hospital,OTHER,hepatitis
NCT02574884,VINTAGE VHC,COMPLETED,2011-08,Hepatitis C,Blood sample (act specific of blood withdrawal for the study),Tours - France,2013-01,2015-10-14,2015-10-14,INTERVENTIONAL,NA,"University Hospital, Tours",OTHER,hepatitis
NCT03200184,SD1000,COMPLETED,2016-09-01,Hepatitis C,sofosbuvir and daclatasvir,"Tehran - Iran, Islamic Republic of",2018-04-01,2017-06-27,2019-02-15,INTERVENTIONAL,PHASE4,Tehran University of Medical Sciences,OTHER,hepatitis
NCT01272479,Unknown,COMPLETED,2008-08,"Renal Failure Chronic Requiring Hemodialysis, Hepatitis C",No interventions listed,Istanbul - Turkey,2010-03,2011-01-07,2011-01-07,OBSERVATIONAL,Not Available,Istanbul University,OTHER,hepatitis
NCT01052090,ENCHAMP,TERMINATED,2009-09,Hepatitis C Virus Infection,PHN121,"Kaohsiung - Taiwan, Taipei - Taiwan",2013-11,2010-01-20,2013-11-26,INTERVENTIONAL,PHASE2,PhytoHealth Corporation,INDUSTRY,hepatitis
NCT01455090,Unknown,COMPLETED,2011-11-30,Chronic Hepatitis C,"BMS-650032, BMS-790052, BMS-791325, Ribavirin","Birmingham - United States, Coronado - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Diego - United States, Aurora - United States, Washington, D.C. - United States, Orlando - United States, South Miami - United States, Atlanta - United States, Baltimore - United States, Lutherville - United States, Hillsborough - United States, Santa Fe - United States, The Bronx - United States, Tulsa - United States, Tulsa - United States, Arlington - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Fairfax - United States, Falls Church - United States, Madison - United States, Clichy Cedex - France, Creteil Cedex - France, Limoges - France, Marseille Cedex 08 - France, Paris Cedex 14 - France, San Juan - Puerto Rico",2014-03-31,2011-10-19,2017-04-27,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01425190,Unknown,TERMINATED,2012-01-04,"Hepatitis C, Chronic",Boceprevir,No locations listed,2013-03-20,2011-08-29,2018-09-11,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05856890,Unknown,RECRUITING,2023-08-07,"Hepatitis B Virus, Hepatitis B","HepB mAb19, Sterile Saline","New York - United States, New York - United States",2027-12-01,2023-05-12,2025-01-27,INTERVENTIONAL,PHASE1,Rockefeller University,OTHER,hepatitis
NCT02015403,Unknown,COMPLETED,2013-12,Ischemic Hepatitis,"Standard Care + NAC (N -ACETYLCYSTEINE), Standard Care (in control arm)",New Delhi - India,2015-05,2013-12-19,2019-09-13,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT01980290,INTEGRATE,COMPLETED,2013-05,"Hepatitis, Chronic",No interventions listed,"Antwerpen - Belgium, Brussels - Belgium, Bruxelles - Belgium, Genk - Belgium, Haine-Saint-Paul - Belgium, Lomme - France, Montpellier - France, Perpignan Cedex - France, Berlin - Germany, Biberach - Germany, Kassel - Germany, München - Germany, Münster - Germany, Maastricht - Netherlands, Lausanne - Switzerland, Zürich - Switzerland, Dundee - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2015-02,2013-11-08,2017-03-03,OBSERVATIONAL,Not Available,"Janssen Pharmaceutica N.V., Belgium",INDUSTRY,hepatitis
NCT02795403,Unknown,COMPLETED,2011-01,Hepatitis C,"blood draw of 150ml, twice",Lyon - France,2015-07,2016-06-10,2016-06-10,INTERVENTIONAL,NA,Hospices Civils de Lyon,OTHER,hepatitis
NCT00051090,Unknown,WITHDRAWN,Unknown Date,"HIV Infections, Hepatitis B","Telbivudine, Lamivudine, Efavirenz, Didanosine, Abacavir",No locations listed,Unknown Date,2003-01-06,2021-11-01,INTERVENTIONAL,NA,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01413490,HepRiACT,COMPLETED,2012-05,Hepatitis C,rimantadine,Leeds - United Kingdom,2015-03,2011-08-10,2015-03-31,OBSERVATIONAL,Not Available,The Leeds Teaching Hospitals NHS Trust,OTHER,hepatitis
NCT02362490,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,peginterferon alpha 2a,Beijing - China,2016-12,2015-02-13,2016-09-13,INTERVENTIONAL,PHASE4,Beijing Ditan Hospital,OTHER,hepatitis
NCT02167503,Unknown,UNKNOWN,2014-05,Chronic Hepatitis B,No interventions listed,"Beijing - China, Beijing - China, BeiJing - China, Beijing - China, Beijing - China, Guangzhou - China, GuangZhou - China, Wuhan - China, ChangSha - China, ChangChun - China, ShenYang - China, ShangHai - China, ShangHai - China, HangZhou - China",2020-05,2014-06-19,2014-06-19,OBSERVATIONAL,Not Available,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT03407703,Unknown,UNKNOWN,2018-03-27,Hepatitis C,Elbasvir / Grazoprevir Oral Tablet [Zepatier],"San Francisco - United States, San Francisco - United States",2019-12-31,2018-01-23,2018-04-18,OBSERVATIONAL,Not Available,San Francisco Veterans Affairs Medical Center,FED,hepatitis
NCT02641379,Unknown,COMPLETED,2003-05,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Feldkirch - Austria, Gratwein - Austria, Graz - Austria, Graz - Austria, Innsbruck - Austria, Krems - Austria, Linz - Austria, Linz - Austria, Oberndorf - Austria, Oberpullendorf - Austria, Ried-innkreis - Austria, Salzburg - Austria, Villach - Austria, Wels - Austria, Wiener Neustadt - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Wien - Austria",2013-11,2015-12-29,2016-08-04,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00197184,Unknown,COMPLETED,2003-11-01,"Hepatitis B, Hepatitis A","Twinrix™ Adult, Twinrix™ Junior","North Adelaide - Australia, Carlton - Australia, Bruxelles - Belgium, Barcelona - Spain, Blanes (Girona) - Spain, Cerdanyola Del Vallés / Barcelona - Spain, Valencia - Spain",2004-03-10,2005-09-20,2018-08-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05147090,Unknown,RECRUITING,2022-01-02,"Chronic Hepatitis b, NAFLD, Cirrhosis, Fibrosis, Liver, Empagliflozin, SGLT2 Inhibitors","Empagliflozin 10 MG, Placebo pills",Hong Kong - Hong Kong,2025-12-31,2021-12-07,2023-12-07,INTERVENTIONAL,PHASE4,The University of Hong Kong,OTHER,hepatitis
NCT05037890,Unknown,UNKNOWN,2020-02-20,NASH - Nonalcoholic Steatohepatitis,Margarine,Maastricht - Netherlands,2022-12-31,2021-09-08,2021-09-08,INTERVENTIONAL,NA,Maastricht University Medical Center,OTHER,hepatitis
NCT00686790,Unknown,COMPLETED,2005-12,"Hepatitis D, Chronic, Hepatitis B, Chronic","Peginterferon alfa-2b (PegIntron, SCH 54031)",No locations listed,2009-05,2008-05-30,2017-04-06,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01293279,HCV,COMPLETED,2011-02,Hepatitis C,No interventions listed,Beijing - China,2011-06,2011-02-10,2011-10-07,OBSERVATIONAL,Not Available,Peking University People's Hospital,OTHER,hepatitis
NCT00851890,Unknown,COMPLETED,2009-03,Chronic Hepatitis C Virus Infection,"ABT-333, Placebo for ABT-333, Pegylated interferon, Ribavirin","Anaheim - United States, Los Angeles - United States, Orlando - United States, Baton Rouge - United States, Chapel Hill - United States, Dallas - United States, San Antonio - United States, Santurce - Puerto Rico",2009-07,2009-02-26,2018-07-02,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT04071379,Unknown,COMPLETED,2020-10-13,"Immunogenicity, Safety","Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered)","Bandung - Indonesia, Bandung - Indonesia, Bandung - Indonesia",2021-04-06,2019-08-28,2022-01-18,INTERVENTIONAL,PHASE3,PT Bio Farma,INDUSTRY,hepatitis
NCT03200379,Unknown,RECRUITING,2017-06-15,"Hepatitis C, Chronic",directly acting antivirals (DAAs),Kaohsiung - Taiwan,2037-06-15,2017-06-27,2022-04-08,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT00922779,Unknown,COMPLETED,2002-06,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin","Arkhangelsk - Russian Federation, Barnaul - Russian Federation, Barnaul - Russian Federation, Blagoveshchensk - Russian Federation, Cheboksary - Russian Federation, Chelyabinsk - Russian Federation, Chelyabinsk - Russian Federation, Chelyabinsk - Russian Federation, Cherepovets - Russian Federation, Chita - Russian Federation, Ekaterinburg - Russian Federation, Ekaterinburg - Russian Federation, Ekaterinburg - Russian Federation, Irkutsk - Russian Federation, Irkutsk - Russian Federation, Irkutsk - Russian Federation, Izhevsk - Russian Federation, Kazan - Russian Federation, Kemerovo - Russian Federation, Kemerovo - Russian Federation, Kemerovo - Russian Federation, Khabarovsk - Russian Federation, Khabarovsk - Russian Federation, Khabarovsk - Russian Federation, Kirov - Russian Federation, Krasnodar - Russian Federation, Krasnodar - Russian Federation, Krasnodar - Russian Federation, Krasnoyarsk - Russian Federation, Krasnoyarsk - Russian Federation, Lipetsk - Russian Federation, Makhachkala - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Novokuznetsk - Russian Federation, Novokuznetsk - Russian Federation, Novosibirsk - Russian Federation, Novouralsk - Russian Federation, Omsk - Russian Federation, Orenburg - Russian Federation, Petropavlovsk-Kamchatskiy - Russian Federation, Rostov-na-donu - Russian Federation, Salekhard - Russian Federation, Samara - Russian Federation, Samara - Russian Federation, Saratov - Russian Federation, Saratov - Russian Federation, Saratov - Russian Federation, Soshi - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St Petersburg - Russian Federation, St. Petersburg - Russian Federation, Stavropol - Russian Federation, Surgut - Russian Federation, Tjumen - Russian Federation, Tomsk - Russian Federation, Tumen - Russian Federation, Tumen - Russian Federation, Tumen - Russian Federation, UFA - Russian Federation, UFA - Russian Federation, Ulan-ude - Russian Federation, Vladivostok - Russian Federation, Vladivostok - Russian Federation, Volgograd - Russian Federation, Volgograd - Russian Federation, Yakutsk - Russian Federation, Yujno-sakhalinsk - Russian Federation, Yujno-sakhalinsk - Russian Federation",2012-06,2009-06-17,2016-01-20,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02937779,TA-PROHM,UNKNOWN,2017-10-04,"Hepatitis B Chronic Infection, Pregnancy","Tenofovir disoproxil fumarate, Rapid tests HBe Ag","Kampong Cham - Cambodia, Phnom Penh - Cambodia, Phnom Penh - Cambodia",2020-03-31,2016-10-19,2019-10-16,INTERVENTIONAL,PHASE4,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT02515279,Unknown,COMPLETED,2008-11,Hepatitis C,"Peginterferon alfa-2a, Ribavirin",Ried-innkreis - Austria,2014-12,2015-08-04,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04605679,Unknown,ACTIVE_NOT_RECRUITING,2020-05-06,Kidney Failure,Kidney Transplantation,Loma Linda - United States,2025-12,2020-10-28,2025-03-06,INTERVENTIONAL,NA,Loma Linda University,OTHER,hepatitis
NCT01290679,QUEST-2,COMPLETED,2011-03,Hepatitis C,"Placebo, TMC435, Peginterferon alpha-2a or Peginterferon alpha-2b (PegIFNα-2a/b), Ribavirin (RBV)","Los Angeles - United States, Jacksonville - United States, Orlando - United States, Atlanta - United States, Crestview Hills - United States, New Orleans - United States, Saint Paul - United States, Germantown - United States, Houston - United States, San Antonio - United States, Falls Church - United States, Buenos Aires - Argentina, Rosario, Santa Fe - Argentina, Wien - Austria, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Brussel - Belgium, Gent - Belgium, Leuven - Belgium, Salvador - Brazil, Sao Paulo - Brazil, São Paulo - Brazil, Plovdiv - Bulgaria, Sofia - Bulgaria, Clichy - France, Creteil N/A - France, Nice N/A - France, Paris - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Freiburg - Germany, Halle (Saale) - Germany, Hannover - Germany, Kiel - Germany, Leipzig - Germany, Munchen - Germany, Münster - Germany, Ulm - Germany, Amsterdam Zuidoost - Netherlands, Leiden - Netherlands, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Czeladz - Poland, Kielce - Poland, Krakow - Poland, Warszawa - Poland, Coimbra - Portugal, Lisboa - Portugal, Porto - Portugal, Santurce - Puerto Rico, Bratislava - Slovakia, Martin - Slovakia, Barcelona - Spain, Madrid - Spain, Sevilla N/A - Spain, Valencia - Spain, Ankara - Turkey, Istanbul - Turkey, Izmir - Turkey",2013-02,2011-02-07,2014-06-13,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT04014179,TEMPO,RECRUITING,2022-07-27,"Hepatitis C, Hepatitis C, Chronic","Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay","Bankstown - Australia, Blacktown - Australia, Coffs Harbour - Australia, Gosford - Australia, Grafton - Australia, Kempsey - Australia, Lismore - Australia, Liverpool - Australia, Mount Druitt - Australia, Tweed Heads - Australia, Wollongong - Australia, Brisbane - Australia, Cairns - Australia, Inala - Australia, Toowoomba - Australia, Adelaide - Australia, Adelaide - Australia, Elizabeth - Australia, Noarlunga - Australia",2025-12-31,2019-07-10,2024-03-06,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT01524679,PADD-ON,COMPLETED,2012-08,Chronic Hepatitis B,Pegylated interferon alfa-2a plus nucleos(t)ide(s),"Wiesbaden - Germany, Aachen - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Frankfurt - Germany, Frankfurt - Germany, Freiburg - Germany, Gießen - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Homburg - Germany, Kiel - Germany, Köln - Germany, Leipzig - Germany, Mainz - Germany, Mannheim - Germany, München - Germany, Regensburg - Germany, Tübingen - Germany, Ulm - Germany, Würzburg - Germany",2017-08-28,2012-02-02,2020-02-18,INTERVENTIONAL,PHASE2,Johannes Gutenberg University Mainz,OTHER,hepatitis
NCT02461979,Unknown,UNKNOWN,2015-02,Liver Cancer,The VDR genotype,Tanta - Egypt,2022-12,2015-06-03,2018-01-03,INTERVENTIONAL,NA,Sherief Abd-Elsalam,OTHER,hepatitis
NCT04318379,Unknown,UNKNOWN,2021-04-20,Chronic Hepatitis C Infection,HCVax,Richmond - United States,2023-02,2020-03-24,2021-09-29,INTERVENTIONAL,PHASE1,GeneCure Biotechnologies,INDUSTRY,hepatitis
NCT02647879,TraPHepC,RECRUITING,2016-01,Hepatitis C,No interventions listed,Reykjavik - Iceland,2021-12,2016-01-06,2020-09-25,OBSERVATIONAL,Not Available,Landspitali University Hospital,OTHER,hepatitis
NCT02387684,Unknown,UNKNOWN,2012-04,Chronic Hepatitis B,No interventions listed,Beijing - China,2016-12,2015-03-13,2016-08-19,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00451984,HEPVACHIV,UNKNOWN,2007-03,"HIV Infections, Hepatitis A, Hepatitis B","Twinrix, interleukin-2","Aalborg - Denmark, Aarhus - Denmark",Unknown Date,2007-03-26,2007-11-01,INTERVENTIONAL,PHASE3,Aalborg University Hospital,OTHER,hepatitis
NCT00322179,Unknown,COMPLETED,2005-11,"Chronic Hepatitis C, Obesity",No interventions listed,Palo Alto - United States,2007-11,2006-05-05,2020-03-04,OBSERVATIONAL,Not Available,Palo Alto Veterans Institute for Research,OTHER,hepatitis
NCT00001879,Unknown,COMPLETED,1999-03,Hepatitis,No interventions listed,Bethesda - United States,Unknown Date,2002-12-10,2024-03-22,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT00491179,Unknown,COMPLETED,2006-06,"Chronic Hepatitis C, Hemodialysis","Pegylated interferon alfa-2a and ribavirin, Pegylated interferon alfa-2a and ribavirin",Taipei - Taiwan,2008-06,2007-06-26,2009-11-13,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT04066179,Unknown,UNKNOWN,2019-09-07,Alcoholic Hepatitis,"Gcsf, Prednisolone",New Delhi - India,2021-02-27,2019-08-26,2019-09-09,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT00084279,Unknown,COMPLETED,2004-04,Chronic Hepatitis C,"Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirin",Brisbane - United States,Unknown Date,2004-06-11,2009-07-03,INTERVENTIONAL,PHASE2,InterMune,INDUSTRY,hepatitis
NCT02716779,Unknown,COMPLETED,2007-04,"Hepatitis C, Chronic","Pegylated Interferon (PEG-IFN) alfa-2a, Placebo, Ribavirin","Berlin - Germany, Frankfurt Am Main - Germany, Frankfurt Am Main - Germany, Hannover - Germany, Homburg/ Saar - Germany",2010-04,2016-03-23,2016-08-22,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02465203,Unknown,TERMINATED,2012-09-06,"Hepatitis C, Chronic",Previous treatment in DEB025 study,"San Diego - United States, Ventura - United States, Honolulu - United States, Springfield - United States, Arlington - United States, Houston - United States, San Antonio - United States, Westmead - Australia, Leuven - Belgium, Torono - Canada, Koeln - Germany, Berlin - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Budapest - Hungary, Mumbai - India, Parma - Italy, Pavia - Italy, Roma - Italy, Torino - Italy, Busan - Korea, Republic of, Pusan - Korea, Republic of, Bialystok - Poland, Warszawa - Poland, San Juan - Puerto Rico, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Iasi - Romania, Barcelona - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Lin-Kou - Taiwan, Taichung - Taiwan, Yun-Lin - Taiwan, Songkla - Thailand, Ho Chi Minh - Vietnam",2014-01-23,2015-06-08,2018-01-12,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT00351403,Unknown,COMPLETED,2006-07,"Hepatitis C, Chronic","Ribavirin, Peginterferon alfa 2b","Freiburg - Germany, Heidelberg - Germany, Ulm - Germany, Erlangen - Germany, München - Germany, München - Germany, Würzburg - Germany, Frankfurt - Germany, Frankfurt - Germany, Hannover - Germany, Bochum - Germany, Dusseldorf - Germany, Essen - Germany, Köln - Germany, Aachen - Germany, Mainz - Germany, Homburg / Saar - Germany, Leipzig - Germany, Kiel - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany",2010-01,2006-07-12,2010-02-08,INTERVENTIONAL,PHASE4,FGK Clinical Research GmbH,INDUSTRY,hepatitis
NCT03962803,Unknown,UNKNOWN,2019-06-05,Hepatitis B Vaccine,"20 µg recombinant hepatitis B vaccine at months 0, 1, and 6, 20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6, 60 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6",Taiyuan - China,2020-02,2019-05-24,2019-05-24,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT02772003,Unknown,ACTIVE_NOT_RECRUITING,2016-06-06,"Chronic Hepatitis, Hepatitis C Infection, Hepatocellular Carcinoma","Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid","Jacksonville - United States, Rochester - United States, Cleveland - United States, Philadelphia - United States, San Juan - Puerto Rico",2020-03-04,2016-05-13,2025-03-10,INTERVENTIONAL,PHASE1,National Cancer Institute (NCI),NIH,hepatitis
NCT01215643,Unknown,COMPLETED,2010-10,"Hepatitis C, Chronic Pain","Alisporivir, Peginterferon alfa-2a, Ribavirin","La Jolla - United States, San Diego - United States, San Diego - United States, Ventura - United States, Honolulu - United States, Topeka - United States, Springfield - United States, St. Louis - United States, Lebanon - United States, New York - United States, New York - United States, New York - United States, Arlington - United States, Houston - United States, Houston - United States, San Antonio - United States, Kingswood - Australia, Kogarah - Australia, Westmead - Australia, Greenslopes - Australia, Clayton - Australia, Fitzroy - Australia, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Vancouver - Canada, Toronto - Canada, Clichy Cedex - France, Creteil - France, Marseille - France, Paris - France, Berlin - Germany, Frankfurt - Germany, Freiburg - Germany, Hannover - Germany, Leipzig - Germany, Trivandrum - India, Mumbai - India, Ludhiana - India, Lucknow - India, Guwahati - India, Haryana - India, Hyderabad - Andhra Pradesh - India, Mumbai - India, New Delhi - India, Bologna - Italy, Brescia - Italy, Pavia - Italy, Roma - Italy, Torino - Italy, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bialystok - Poland, Lódz - Poland, Warsaw - Poland, San Juan - Puerto Rico, Kaohsiung - Taiwan, Niaosong Township - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Yun-Lin - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Songkla - Thailand, Glasgow - Scotland - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2012-05,2010-10-06,2016-08-30,INTERVENTIONAL,PHASE2,Debiopharm International SA,INDUSTRY,hepatitis
NCT02445703,Unknown,COMPLETED,2014-05,"Hepatitis A, Hepatitis B","Inactivated Hepatitis A vaccine (HAV), Combined hepatitis A and hepatitis B vaccine (HABV)",Changsha - China,2015-01,2015-05-15,2021-07-27,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT01694264,Unknown,TERMINATED,2012-09-01,"Chronic Hepatitis B, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis","Entecavir, Placebo","Anyang - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejun - Korea, Republic of, Daejun - Korea, Republic of, Gwangju - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jeonju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of",2015-08-31,2012-09-27,2017-03-06,INTERVENTIONAL,PHASE3,Seoul National University Hospital,OTHER,hepatitis
NCT00078403,Unknown,COMPLETED,2004-07,"HIV Infections, Hepatitis C, Liver Disease","Peginterferon alfa-2a, Ribavirin","Birmingham - United States, Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Aurora - United States, Washington - United States, Honolulu - United States, Chicago - United States, Indianapolis - United States, Indianapolis - United States, Baltimore - United States, Boston - United States, Boston - United States, Boston - United States, Saint Louis - United States, Omaha - United States, New York - United States, New York - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Rochester - United States, Rochester - United States, Chapel Hill - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Nashville - United States, Dallas - United States, Galveston - United States, San Juan - Puerto Rico",2007-05,2004-02-25,2021-11-08,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01997203,VD-HCV,TERMINATED,2012-04,Chronic Hepatitis C,Vitamin D,"Bny swif - Egypt, Cairo - Egypt",2013-04,2013-11-28,2013-11-28,INTERVENTIONAL,PHASE3,Dr. Nadia AbdelAaty AbdelKader,OTHER,hepatitis
NCT00646503,Unknown,COMPLETED,2008-03,"Hepatitis B, Chronic",Telbivudine,Beijing - China,2009-09,2008-03-28,2017-06-22,INTERVENTIONAL,PHASE4,Novartis,INDUSTRY,hepatitis
NCT02094443,Unknown,COMPLETED,2014-03,"Hepatitis C, Liver Disease","Alisporivir, Ribavirin","Bakersfield - United States, Lancaster - United States, San Diego - United States, San Diego - United States, St. Louis - United States, Arlington - United States, Houston - United States, San Antonio - United States, Newport News - United States, Seattle - United States, Seattle - United States, Clichy - France, Creteil - France, Lyon Cedex 04 - France, Nice Cedex 3 - France, Paris - France",2015-04,2014-03-21,2016-10-13,INTERVENTIONAL,PHASE2,Debiopharm International SA,INDUSTRY,hepatitis
NCT03867643,Unknown,RECRUITING,2021-07-09,Hepatitis B Vaccine Adverse Reaction,hepatitis B vaccine(HepB),Chongqing - China,2021-09-09,2019-03-08,2022-03-10,OBSERVATIONAL,Not Available,Children's Hospital of Chongqing Medical University,OTHER,hepatitis
NCT01320943,FINITE CHB,COMPLETED,2011-04-26,Chronic Hepatitis B,"TDF, Stop TDF","Berlin - Germany, Berlin - Germany, Duesseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Leipzig - Germany, Leverkusen - Germany, Muenchen - Germany, Ulm - Germany",2016-07-28,2011-03-23,2017-08-29,INTERVENTIONAL,PHASE4,Gilead Sciences,INDUSTRY,hepatitis
NCT05639543,FRESH,RECRUITING,2022-12-15,Alcohol Associated Hepatitis,"INT-787, Placebo","Palo Alto - United States, Miami - United States, Tampa - United States, Chicago - United States, Baltimore - United States, Boston - United States, Worcester - United States, Detroit - United States, Rochester - United States, Newark - United States, Manhasset - United States, New York - United States, Philadelphia - United States, Charleston - United States, Nashville - United States, Dallas - United States, Dallas - United States, Dallas - United States, Houston - United States, Salt Lake City - United States, Richmond - United States, Angers - France, Clichy - France, Lille - France, Paris - France, Toulouse - France, Cambridge - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2024-12-31,2022-12-06,2024-12-24,INTERVENTIONAL,PHASE2,Intercept Pharmaceuticals,INDUSTRY,hepatitis
NCT00633243,Unknown,COMPLETED,2007-04,"Hepatitis C, Opiate Dependence","Modified Directly Observed Therapy (mDOT), Self-Administered Therapy (SAT)",New Haven - United States,2011-09,2008-03-11,2013-01-03,INTERVENTIONAL,NA,Yale University,OTHER,hepatitis
NCT01581138,Unknown,COMPLETED,2012-07,Chronic Hepatitis C Virus,"VX-222, telaprevir, ribavirin","Birmingham - United States, Anaheim - United States, Riverside - United States, San Diego - United States, Englewood - United States, Orlando - United States, Marietta - United States, Baltimore - United States, New York - United States, Asheville - United States, Winston-Salem - United States, Cincinatti - United States, Pittsburgh - United States, Germantown - United States, Nashville - United States, Austin - United States, San Antonio - United States, Norfolk - United States",2013-06,2012-04-20,2014-07-04,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT00582738,REVERT,TERMINATED,2007-12,Recurrent Hepatitis C,"CsA-TAC (standard Treatment), Everolimus",Buenos Aires - Argentina,2010-01,2007-12-28,2012-09-06,INTERVENTIONAL,PHASE2,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02116543,Unknown,COMPLETED,2014-05,"Hepatitis C, HCV","TD-6450, Placebo",San Antonio - United States,2014-10,2014-04-17,2021-01-19,INTERVENTIONAL,PHASE1,Theravance Biopharma,INDUSTRY,hepatitis
NCT01816490,THISTLE,COMPLETED,2013-04,"HIV, Hepatitis C",Intravenous Silibinin (iSIL),Zurich - Switzerland,2014-04,2013-03-22,2015-03-05,INTERVENTIONAL,PHASE2,University of Zurich,OTHER,hepatitis
NCT05345990,HBIG,RECRUITING,2022-08-15,Chronic Hepatitis B,Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®),Hannover - Germany,2025-05,2022-04-26,2025-03-07,INTERVENTIONAL,PHASE2,Hannover Medical School,OTHER,hepatitis
NCT04525690,Unknown,COMPLETED,2020-09-21,Hepatitis C,Nudge,Philadelphia - United States,2021-04-10,2020-08-25,2021-08-17,INTERVENTIONAL,NA,University of Pennsylvania,OTHER,hepatitis
NCT03086564,Unknown,COMPLETED,2017-05-01,Hepatocellular Carcinoma,"ADCC & TACE, TACE",Guangzhou - China,2020-05-01,2017-03-22,2020-10-30,INTERVENTIONAL,PHASE2,Yuehua Huang,OTHER,hepatitis
NCT04465890,Unknown,COMPLETED,2020-07-17,Chronic Hepatitis b,"ASC22, sodium chloride",Beijing - China,2024-08-09,2020-07-10,2024-12-02,INTERVENTIONAL,PHASE2,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT00516321,Unknown,COMPLETED,2007-10,"Hepatitis C, Chronic","eltrombopag, placebo","Birmingham - United States, Tucson - United States, Little Rock - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, San Clemente - United States, Aurora - United States, New Haven - United States, Washington - United States, Washington - United States, Bradenton - United States, Gainsville - United States, Miami - United States, Orlando - United States, Atlanta - United States, Honolulu - United States, Louisville - United States, Baltimore - United States, Burlington - United States, Worcester - United States, Ann Arbor - United States, Detroit - United States, Jackson - United States, St. Louis - United States, Bronx - United States, Manhasset - United States, New York - United States, Rochester - United States, Syracuse - United States, Valhalla - United States, Asheville - United States, Durham - United States, Tulsa - United States, Portland - United States, Hershey - United States, Philadelphia - United States, Jackson - United States, Nashville - United States, Nashville - United States, Nashville - United States, Galveston - United States, Houston - United States, San Antonio - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Garran - Australia, Camperdown - Australia, Randwick - Australia, Fitzroy - Australia, Heidelberg - Australia, Melbourne - Australia, Nedlands - Australia, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Campinas - Brazil, São Paulo - Brazil, Calgary - Canada, Victoria - Canada, Winnipeg - Canada, Barrie - Canada, Hamilton - Canada, Hamilton - Canada, Ottawa - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Praha 4 - Czech Republic, Praha 6 - Czech Republic, Besançon - France, Dijon cedex - France, Marseille - France, Montpellier - France, Nice - France, Pessac Cedex - France, Strasbourg - France, Toulouse cedex 9 - France, Toulouse - France, Freiburg - Germany, Heidelberg - Germany, Stuttgart - Germany, Ulm - Germany, Deggendorf - Germany, Hof/Saale - Germany, Muenchen - Germany, Regensburg - Germany, Wuerzburg - Germany, Beeskow - Germany, Frankfurt - Germany, Kassel - Germany, Goettingen - Germany, Hannover - Germany, Hannover - Germany, Aachen - Germany, Bochum - Germany, Bonn - Germany, Dortmund - Germany, Duesseldorf - Germany, Essen - Germany, Herne - Germany, Koeln - Germany, Leverkusen - Germany, Muenster - Germany, Siegen - Germany, Mainz - Germany, Halle - Germany, Magdeburg - Germany, Leipzig - Germany, Leipzig - Germany, Berlin - Germany, Berlin - Germany, Pokfulam - Hong Kong, Bangalore - India, Chennai - India, Mumbai - India, Haifa - Israel, Jerusalem - Israel, Petach Tikva - Israel, Safed - Israel, Tel Aviv - Israel, Catanzaro - Italy, Avellino - Italy, Bologna - Italy, Roma - Italy, Genova - Italy, Brescia - Italy, Milano - Italy, Milano - Italy, Bari - Italy, San Giovanni Rotondo (FG) - Italy, Palermo - Italy, Busan - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Amsterdam - Netherlands, Nijmegen - Netherlands, Rotterdam - Netherlands, Lahore - Pakistan, Lahore - Pakistan, Bydgoszcz - Poland, Chorzow - Poland, Kielce - Poland, Szczecin - Poland, Wroclaw - Poland, Ponce - Puerto Rico, San Juan - Puerto Rico, Bucharest - Romania, Constanta - Romania, Moscow - Russian Federation, Moscow - Russian Federation, Mosocow - Russian Federation, Smolensk - Russian Federation, Bratislava - Slovakia, Bratislava - Slovakia, Kosice - Slovakia, Martin - Slovakia, Barcelona - Spain, Granada - Spain, L'Hospitalet de Llobregat. Barcelona - Spain, La Coruña - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, San Sebastián - Spain, Sevilla - Spain, Valencia - Spain, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiangmai - Thailand, Khon Kaen - Thailand, Songkla - Thailand, Donetsk - Ukraine, Kyiv - Ukraine, Kyiv - Ukraine, Vinnytsia - Ukraine, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2011-04,2007-08-15,2013-11-05,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01607021,Unknown,UNKNOWN,2012-04,Chronic Hepatitis C,No interventions listed,Beijing - China,2015-12,2012-05-28,2015-08-17,OBSERVATIONAL,Not Available,Beijing 302 Hospital,OTHER,hepatitis
NCT01051921,CTS-1027-04,COMPLETED,2010-01,Hepatitis C,"CTS-1027, Pegylated interferon, Ribavirin","La Jolla - United States, San Diego - United States, Denver - United States, Englewood - United States, Atlanta - United States, New Orleans - United States, Novi - United States, Plymouth - United States, St. Louis - United States, Cincinnati - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Newport News - United States, Santurce - Puerto Rico",2011-11,2010-01-20,2012-04-16,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT06868264,Unknown,NOT_YET_RECRUITING,2025-04,HEPATITIS C VIRUS CHRONIC INFECTION,"Bemnifosbuvir-Ruzasvir (BEM/RZR), Sofosbuvir-Velpatasvir (SOF/VEL)",No locations listed,2026-09,2025-03-10,2025-03-10,INTERVENTIONAL,PHASE3,"Atea Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT03941821,Unknown,UNKNOWN,2019-06-30,Chronic Hepatitis c,Glecaprevir/Pibrentasvir,No locations listed,2021-06-30,2019-05-08,2019-05-08,OBSERVATIONAL,Not Available,Tongji Hospital,OTHER,hepatitis
NCT02951364,Unknown,COMPLETED,2016-12-05,Hepatitis C Virus,LDV/SOF,"Seongnam-si - Korea, Republic of, Anyang-si - Korea, Republic of, Bucheon-si - Korea, Republic of, Bucheon-si - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Changwon - Korea, Republic of, Cheonan - Korea, Republic of, Cheonan - Korea, Republic of, Chuncheon-si - Korea, Republic of, Chungju-si - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Daejeon - Korea, Republic of, Gangneung-si - Korea, Republic of, Goyang-si - Korea, Republic of, Goyang - Korea, Republic of, Goyang - Korea, Republic of, Gumi - Korea, Republic of, Gwangju - Korea, Republic of, Gwangju - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeongju-si - Korea, Republic of, Hwaseong-si - Korea, Republic of, Hwasun - Korea, Republic of, Iksan - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jeju-si - Korea, Republic of, Jeonju-si - Korea, Republic of, Jeonju - Korea, Republic of, Jinju-si - Korea, Republic of, Seongnam-si - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon-si - Korea, Republic of, Uijeongbu-si - Korea, Republic of, Ulsan - Korea, Republic of, Ulsan - Korea, Republic of, Ulsan - Korea, Republic of, Wonju-si - Korea, Republic of, Yangsan - Korea, Republic of",2021-06-11,2016-11-01,2021-11-29,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT06779864,HBV IMDR,RECRUITING,2024-02-01,Chronic Hepatitis B,No interventions listed,Beijing - China,2025-12-30,2025-01-17,2025-01-17,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT01959321,HCV,COMPLETED,2012-10,Hepatitis C,No interventions listed,"Birmingham - United States, Stanford - United States, Denver - United States, Chicago - United States, Boston - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cleveland - United States, Columbus - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Dallas - United States, Galveston - United States, Houston - United States, Salt Lake City - United States",2021-06-30,2013-10-10,2024-02-05,OBSERVATIONAL,Not Available,The George Washington University Biostatistics Center,OTHER,hepatitis
NCT00356564,Unknown,COMPLETED,2006-07,Hepatitis B,hepatitis B vaccine,"Ettenheim - Germany, Kehl - Germany, Oberkirch - Germany, Offenburg - Germany, Aichach - Germany, Bobingen - Germany, Erding - Germany, Kaufering - Germany, Kempten - Germany, Landsberg - Germany, Lohr - Germany, Muenchen - Germany, Muenchen - Germany, Noerdlingen - Germany, Pegnitz - Germany, Tutzing - Germany, Weilheim - Germany, Marburg/Lahn - Germany, Salzgitter - Germany, Erkrath - Germany, Krefeld - Germany, Willich - Germany, Bad Sobernheim - Germany, Mainz - Germany, Schoeneberg - Kuebelberg - Germany, Trier - Germany, Bischofswerda - Germany, Dresden - Germany, Altenholz - Germany, Bredstedt - Germany, Flensburg - Germany, Flensburg - Germany, Husum - Germany, Kiel - Germany, Niebuell - Germany, Lobenstein - Germany, Rudolstadt - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany",Unknown Date,2006-07-26,2016-10-12,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00815464,CHB,UNKNOWN,2009-03,"Hepatitis B, Chronic, Liver Diseases, Virus Diseases, Hepatitis, Diffuse Hepatic Disease",Liquid Acupuncture (Herb Acupoint Injection),No locations listed,2009-09,2008-12-30,2008-12-30,INTERVENTIONAL,NA,Yu Medical Garden,OTHER,hepatitis
NCT05070364,LIMT-2,ACTIVE_NOT_RECRUITING,2021-12-21,Hepatitis Delta Virus,Peginterferon Lambda-1a,"Los Angeles - United States, Los Angeles - United States, Redwood City - United States, San Francisco - United States, Chicago - United States, New York - United States, New York - United States, Edegem - Belgium, Brussels - Belgium, Brussels - Belgium, Sofia - Bulgaria, Stara Zagora - Bulgaria, Clermont-Ferrand - France, Montpellier - France, Bobigny - France, Clichy - France, Creteil - France, Grenoble - France, Rouen - France, Toulouse - France, Tbilisi - Georgia, Tbilisi - Georgia, Tbilisi - Georgia, Frankfurt - Germany, Hanover - Germany, Mainz - Germany, Ramat Gan - Israel, Afula - Israel, Beer-Sheba - Israel, Haifa - Israel, Jerusalem - Israel, Foggia - Italy, Milan - Italy, Pisa - Italy, Chisinau - Moldova, Republic of, Bucharest - Romania, Bucharest - Romania, Bucuresti - Romania, Galati - Romania, Barcelona - Spain, Madrid - Spain, Sevilla - Spain, Ankara - Turkey, Ankara - Turkey, Bornova - Turkey, Diyarbakır - Turkey, Istanbul - Turkey, Istanbul - Turkey",2024-06-15,2021-10-07,2023-08-25,INTERVENTIONAL,PHASE3,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT01433887,Unknown,COMPLETED,2011-11,Chronic Hepatitis C,"48-weeks course, Ribavirin, Peginterferon alfa2a, Ribavirin","Guangzhou - China, Guangzhou - China, Zhongshan - China",2014-06,2011-09-14,2014-11-18,INTERVENTIONAL,PHASE3,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT03483987,Unknown,TERMINATED,2018-02-10,Chronic Hepatitis C,"Sof+Ledi+R arm, Sof+Ledi+R+Peg-IFN arm, Sof+Dacla+R arm, Sof+Dacla+R+Peg-IFN arm, Sof+Velpa+R arm, Sof+Velpa+R+Peg-IFN arm","Lucknow - India, Lucknow - India",2022-04-30,2018-03-30,2022-05-10,INTERVENTIONAL,NA,Sanjay Gandhi Postgraduate Institute of Medical Sciences,OTHER_GOV,hepatitis
NCT03896087,Unknown,COMPLETED,2019-04-01,"Hepatitis C, Chronic","Abbott RealTime HCV assay from DBS, HCV for use on the cobas® 6800/8800 Systems from PSC and DBS, Aptima® HCV Quant Dx Assay from DBS, HCV for use on the cobas® 4800Systems from PSC and DBS","Victoria Park - Australia, Yaoundé - Cameroon, Tbilisi - Georgia, Athens - Greece, Kigali - Rwanda",2020-11-30,2019-03-29,2020-12-17,INTERVENTIONAL,NA,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT03866187,Unknown,TERMINATED,2019-03-28,"Hepatitis B, Chronic","ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo","Antwerpen - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Clichy Cedex - France, CrEteil Cedex - France, Lyon - France, Strasbourg - France, Aachen - Germany, Berlin - Germany, Bonn - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Mainz - Germany, Tuebingen - Germany, Pokfulam - Hong Kong, Krakow - Poland, Lancut - Poland, Myslowice - Poland, Poznan - Poland, Barcelona - Spain, Barcelona - Spain, COrdoba - Spain, Granada - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Palma de Mallorca - Spain, Santander - Spain, Sevilla - Spain, TorrejOn Ardoz Madrid - Spain, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Chiangmai - Thailand, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2024-10-07,2019-03-07,2024-11-29,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00977054,Unknown,TERMINATED,2009-09,Hepatitis C,"DFPP + Peg-IFN + RBV, Peg-IFN + RBV","Chiayi - Taiwan, Chiayi - Taiwan, Douliou - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2012-12,2009-09-15,2012-12-20,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT05461170,Unknown,RECRUITING,2022-09-17,"Hepatitis D, Chronic","VIR-2218, VIR-3434, NRTI","Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Clichy - France, Pessac - France, Rennes - France, Toulouse - France, Frankfurt - Germany, Hannover - Germany, Tübingen - Germany, Milano - Italy, Pisa - Italy, Chisinau - Moldova, Republic of, Rotterdam - Netherlands, Auckland - New Zealand, Bucharest - Romania, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2029-08,2022-07-18,2024-08-09,INTERVENTIONAL,PHASE2,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT00502970,STAR,COMPLETED,2004-05,"Hepatitis C, Chronic Disease, Treatment","16 weeks Interferon Tiw with Ribavirin, 24 weeks Interferon",Karachi - Pakistan,2007-11,2007-07-18,2008-01-11,INTERVENTIONAL,PHASE4,Aga Khan University,OTHER,hepatitis
NCT01661842,Unknown,UNKNOWN,2011-10,Autoimmune Hepatitis,"conventional plus UC-MSC treatment, Conventional plus placebo treatment",Beijing - China,2014-10,2012-08-10,2013-05-31,INTERVENTIONAL,PHASE2,Beijing 302 Hospital,OTHER,hepatitis
NCT04584242,Unknown,UNKNOWN,2020-09-03,Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes,"gluconon tab 15mg, suganon tab 5mg","Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2022-05,2020-10-12,2020-10-12,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT05904470,Unknown,COMPLETED,2023-05-30,"Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C, Hepatic Cirrhosis, HCV","Bemnifosbuvir, Ruzasvir","San Antonio - United States, Manaus - Brazil, Salvador - Brazil, Brasília - Brazil, Rio De Janeiro - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Porto Velho - Brazil, Boa Vista - Brazil, Botucatu - Brazil, Ijuí - Brazil, Sorocaba - Brazil, São José Do Rio Preto - Brazil, São Paulo - Brazil, São Paulo - Brazil, Vancouver - Canada, Toronto - Canada, Rājkot - India, Sūrat - India, Belgaum - India, Nagpur - India, Kolkata - India, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Quatre Bornes - Mauritius, Chisinau - Moldova, Republic of, Karachi - Pakistan, Karachi - Pakistan, Baguio - Philippines, Iloilo City - Philippines, Mabalacat - Philippines, Bucuresti - Romania, Bucuresti - Romania, Constanţa - Romania, Craiova - Romania, Bucuresti - Romania, Bloemfontein - South Africa, Johannesburg - South Africa, Randburg - South Africa, Somerset West - South Africa, Adana - Turkey, Ankara - Turkey, Ankara - Turkey, Ankara - Turkey, Denizli - Turkey, İzmir - Turkey, Kayseri - Turkey",2024-12-09,2023-06-15,2025-02-07,INTERVENTIONAL,PHASE2,"Atea Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT00252642,Unknown,COMPLETED,2005-11,"Hepatitis C, Cirrhosis, Fibrosis",Peginterferon Alpha-2a,Richmond - United States,2007-09,2005-11-11,2017-03-20,INTERVENTIONAL,NA,Virginia Commonwealth University,OTHER,hepatitis
NCT00725842,RE-CHUT,TERMINATED,2009-01,"Hepatitis C, Hepatitis C, Chronic","Peg-IFN alfa-2b, Ribavirin",No locations listed,2011-06,2008-07-31,2015-09-21,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00697970,Unknown,COMPLETED,1993-11,Hepatitis B,"HBsAg formulated with different concentrations of MPL and Aluminium Salts, Engerix™-B",Vienna - Austria,1995-04,2008-06-16,2008-06-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02597270,MAPPING,COMPLETED,2016-03,Hepatitis C Virus,No interventions listed,"Belém - Brazil, Goiânia - Brazil, Porto Alegre - Brazil, Porto Velho - Brazil, Salvador - Brazil, Sao Paulo - Brazil",2016-11,2015-11-05,2017-02-06,OBSERVATIONAL,Not Available,Janssen-Cilag Ltd.,INDUSTRY,hepatitis
NCT01392742,Unknown,COMPLETED,2011-05-31,"Hepatitis C, Chronic",No interventions listed,"Pleven - Bulgaria, Plovdiv - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Varna - Bulgaria",2014-07-31,2011-07-12,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01370642,Unknown,COMPLETED,2011-06-27,"Hepatitis C, Chronic","vaniprevir, Placebo to vaniprevir, Peg-IFN, ribavirin",No locations listed,2013-07-31,2011-06-10,2018-10-18,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01773070,Unknown,COMPLETED,2013-06,Hepatitis C,"ABT-450/ritonavir, ABT-333, ABT-267",No locations listed,2016-10,2013-01-23,2017-12-06,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT02864199,Unknown,COMPLETED,2004-02,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Birmingham - United States, Kansas City - United States, New Orleans - United States, Kansas City - United States, St Louis - United States, New York - United States, Syracuse - United States, Cleveland - United States, Portland - United States, Pittsburgh - United States, Dallas - United States, Galveston - United States, Sao Paulo - Brazil, Marseille - France, Christchurch - New Zealand, Riccarton, Christchurch - New Zealand, Huddinge - Sweden",2007-09,2016-08-11,2016-08-11,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00489099,Unknown,COMPLETED,2005-06,Hepatitis B Infection,"V232 Modified Process Hepatitis B Vaccine: Lot A, V232 Modified Process Hepatitis B Vaccine: Lot B, V232 Modified Process Hepatitis B Vaccine: Lot C, V232 Current Process Hepatitis B Vaccine",No locations listed,2006-05,2007-06-21,2017-03-16,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00687999,Unknown,COMPLETED,2005-12,"Chronic Hepatitis C, Insulin Resistance",pegylated interferon alpha and ribavirin,Kaohsiung - Taiwan,2008-06,2008-06-02,2009-08-06,INTERVENTIONAL,NA,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT02959359,Unknown,WITHDRAWN,2016-11,Hepatocellular Carcinoma,"Ledipasvir 90mg/Sofosbuvir 400 mg, Ribavirin",No locations listed,2022-06,2016-11-09,2017-08-07,INTERVENTIONAL,PHASE4,"Taipei Veterans General Hospital, Taiwan",OTHER_GOV,hepatitis
NCT01066559,HEPADIAL,COMPLETED,2010-04,"Chronic Renal Failure, Humoral Immune Alterations","High flux polymethylmetacrylate membrane, Polysulfone membrane, Hepatitis B serological control, Seric sCD40 level","Annonay - France, Bayonne - France, Besançon - France, Bordeaux - France, Bordeaux - France, Toulouse - France",2015-01,2010-02-10,2015-06-25,INTERVENTIONAL,NA,"University Hospital, Bordeaux",OTHER,hepatitis
NCT00205075,Unknown,COMPLETED,2004-08,"Hepatic Fibrogenesis, Hepatitis C",No interventions listed,Madison - United States,2008-06,2005-09-20,2015-12-09,OBSERVATIONAL,Not Available,"University of Wisconsin, Madison",OTHER,hepatitis
NCT00962975,Unknown,COMPLETED,2009-09,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Los Angeles - United States, San Francisco - United States, Grafton - New Zealand, Singapore - Singapore, Singapore - Singapore, Taipei - Taiwan",2013-05,2009-08-20,2014-04-08,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04203875,Unknown,TERMINATED,2020-03-09,Autoimmune Hepatitis,Orencia® (Abatacept),Durham - United States,2020-07-23,2019-12-18,2021-11-29,INTERVENTIONAL,PHASE1,"Stuart Knechtle, M.D.",OTHER,hepatitis
NCT00805675,Unknown,COMPLETED,2008-11,Hepatitis B Virus,"Telbivudine, Tenofovir, Telbivudine plus tenofovir",Hong Kong - China,2010-12,2008-12-10,2012-02-28,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT05256459,Unknown,UNKNOWN,2022-05-10,Time,Long term follow-up,No locations listed,2024-12-15,2022-02-25,2022-05-09,OBSERVATIONAL,Not Available,"Zhang Dazhi,MD",OTHER,hepatitis
NCT00578175,Unknown,COMPLETED,2007-11-20,"Varicella, Rubella, Mumps, Measles","Priorix-Tetra™ (MMRV vaccine 208136), ProQuad®, Havrix®, Prevnar®","Birmingham - United States, Birmingham - United States, Tuscaloosa - United States, Phoenix - United States, Benton - United States, Jonesboro - United States, Little Rock - United States, Anaheim - United States, Anaheim - United States, Buena Park - United States, Downey - United States, Fountain Valley - United States, Fremont - United States, Fresno - United States, Hayward - United States, Huntington Beach - United States, Lakewood - United States, Oakland - United States, Paramount - United States, Pleasanton - United States, San Francisco - United States, San Jose - United States, Torrance - United States, Vacaville - United States, West Covina - United States, Centennial - United States, Thornton - United States, Westminster - United States, Boynton Beach - United States, Opa-locka - United States, Plantation - United States, West Palm Beach - United States, Carrollton - United States, Dalton - United States, Marietta - United States, Tifton - United States, Tucker - United States, Woodstock - United States, Honolulu - United States, Honolulu - United States, Nampa - United States, DeKalb - United States, Fishers - United States, Indianapolis - United States, Lafayette - United States, New Albany - United States, Dubuque - United States, Dubuque - United States, Waukee - United States, West Des Moines - United States, Arkansas City - United States, Overland Park - United States, Topeka - United States, Wichita - United States, Bardstown - United States, Lexington - United States, Louisville - United States, Louisville - United States, Louisville - United States, Owensboro - United States, Springfield - United States, Baltimore - United States, Frederick - United States, Fall River - United States, Woburn - United States, Kalamazoo - United States, Niles - United States, Portage - United States, Richland - United States, Stevensville - United States, Brainerd - United States, Saint Paul - United States, Bridgeton - United States, Columbia - United States, Kansas City - United States, Bellevue - United States, Omaha - United States, Omaha - United States, Henderson - United States, Las Vegas - United States, White House Station - United States, Johnson City - United States, Lake Success - United States, Mineola - United States, Rochester - United States, Stony Brook - United States, Syracuse - United States, Utica - United States, Boone - United States, Cary - United States, Raleigh - United States, Sylva - United States, Fargo - United States, Minot - United States, Cincinnati - United States, Dayton - United States, Fairfield - United States, Huber Heights - United States, Tulsa - United States, Eugene - United States, Gresham - United States, Altoona - United States, East Norriton - United States, Kittanning - United States, Latrobe - United States, Pittsburgh - United States, Pittsburgh - United States, Pittsburgh - United States, Sellersville - United States, Uniontown - United States, Wexford - United States, Charleston - United States, Brentwood - United States, Bristol - United States, Kingsport - United States, Nashville - United States, Amarillo - United States, Bryan - United States, Corpus Christi - United States, Lubbock - United States, San Antonio - United States, San Antonio - United States, San Antonio - United States, San Antonio - United States, Sugar Land - United States, Layton - United States, Ogden - United States, Provo - United States, Saint George - United States, South Jordan - United States, West Jordan - United States, Charlottesville - United States, Charlottesville - United States, Chesapeake - United States, Midlothian - United States, Vienna - United States, Virginia Beach - United States, Huntington - United States, La Crosse - United States, Madison - United States, Marshfield - United States",2009-02-24,2007-12-21,2018-10-09,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01165359,Unknown,COMPLETED,2010-09,Hepatitis C,"ITX 5061, Placebo ITX 5061","Birmingham - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, Baltimore - United States, Rochester - United States, Durham - United States, Cincinnati - United States, Philadelphia - United States, San Juan - Puerto Rico",2012-02,2010-07-19,2021-11-01,INTERVENTIONAL,PHASE1,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT04073459,Unknown,UNKNOWN,2019-11,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type b Infection","DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV",No locations listed,2020-04,2019-08-29,2019-09-06,INTERVENTIONAL,PHASE2,LG Chem,INDUSTRY,hepatitis
NCT05769400,Unknown,NOT_YET_RECRUITING,2023-07-01,"Hepatitis C, Osteoporosis, Osteoporosis Risk",Patient Participation Form,No locations listed,2023-12-01,2023-03-15,2023-05-23,OBSERVATIONAL,Not Available,Uskudar State Hospital,OTHER_GOV,hepatitis
NCT00759200,Unknown,COMPLETED,2008-10,Chronic Hepatitis C,"alb-interferon alfa 2b, alb-interferon alfa 2b, alb-interferon alfa 2b, alb-interferon alfa 2b, peg-interferon","Clayton - Australia, Fitzroy - Australia, Greenslopes - Australia, Kingswood - Australia, Melbourne - Australia, Westmead - Australia, Calgary - Canada, Downsview - Canada, Montreal - Canada, Toronto - Canada, Vancouver - Canada, Cretail - France, Nice - France, Paris - France, Villejuif - France, Berlin - Germany, Düsseldorf - Germany, Essen - Germany, Freiburg - Germany, Hamburg - Germany, Köln - Germany, Heraklion - Greece, Loannina - Greece, Patra-Rio - Greece, Piraeurs - Greece, Thessaloniki - Greece, Chandigarh - India, Hyderabad - India, Lucknow - India, Ludhiana - India, Mumbai - India, New Delhi - India, Bologna - Italy, Milano - Italy, Napoli - Italy, Pavia - Italy, Pisa - Italy, Polermo - Italy, Torino - Italy, Bialystok - Poland, Lodz - Poland, Barcelona - Spain, Madrid - Spain, Malaga - Spain, Oviedo - Spain, Sevilla - Spain, Valencia - Spain, Kaohsiung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Chaingmai - Thailand, Hat Yai - Thailand, Muang - Thailand, Glasgow - United Kingdom",2010-12,2008-09-25,2016-11-16,INTERVENTIONAL,PHASE2,Novartis,INDUSTRY,hepatitis
NCT00708500,Unknown,COMPLETED,2008-08,"Hepatitis C, Chronic","Boceprevir (SCH 503034), Pegylated interferon alfa-2b (SCH 54031), Ribavirin (SCH 18908), Boceprevir placebo",No locations listed,2010-04,2008-07-02,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00423800,Unknown,TERMINATED,2006-12,"Hepatitis C, Chronic",Combination of pegylated interferon alfa-2b (PEG) and ribavirin (RBV),No locations listed,2009-10,2007-01-18,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01921400,Unknown,COMPLETED,2013-01,"Hepatitis C, Infection Transmission, Maternal-Fetal",No interventions listed,"Chapel Hill - United States, Giza - Egypt",2017-12,2013-08-13,2018-04-09,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT00362700,Unknown,TERMINATED,2003-07,Hepatitis B,Clevudine,"Seoul - Korea, Republic of, Seoul - Korea, Republic of, Dogok-dong, Kangnam-gu - Korea, Republic of, Ilwon-dong, Songpa-gu - Korea, Republic of, Mok-dong, Yangcheon-gu - Korea, Republic of, Pungnap-dong, Kangnam-gu - Korea, Republic of, Pungnab2-dong - Korea, Republic of",Unknown Date,2006-08-10,2017-02-01,INTERVENTIONAL,PHASE2,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT01142700,Unknown,WITHDRAWN,2010-07,Chronic Hepatitis C Virus Genotype 1,"BMS-824393, BMS-824393, BMS-824393, Placebo, Peginterferon Alpha-2a, Ribavirin","Coronado - United States, San Diego - United States, Washington - United States, Bradenton - United States, Orlando - United States, Tamarac - United States, Mareitta - United States, Laurel - United States, Philadelphia - United States, Dallas - United States, Newport News - United States",2010-12,2010-06-11,2011-03-15,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03069300,NACAH,RECRUITING,2015-10-01,"Alcoholic Hepatitis, Infection",N-acetyl cysteine (NAC),London - United Kingdom,2022-04-01,2017-03-03,2021-11-09,INTERVENTIONAL,PHASE3,Imperial College London,OTHER,hepatitis
NCT06617000,Unknown,RECRUITING,2022-10-25,"HCC, Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma",SCG101,"Beijing - China, Guangzhou - China, Zhengzhou - China, Chang chun - China, Shenyang - China, Ji'nan - China, Shanghai - China",2025-12-31,2024-09-27,2024-09-27,INTERVENTIONAL,PHASE1,SCG Cell Therapy Pte. Ltd.,INDUSTRY,hepatitis
NCT05928000,HERACLIS-BLV,RECRUITING,2023-05-01,Hepatitis D,Bulevirtide,Athens - Greece,2023-11-30,2023-07-03,2023-07-03,OBSERVATIONAL,Not Available,University of Athens,OTHER,hepatitis
NCT01790100,Unknown,COMPLETED,2013-02-28,Chronic Hepatitis C,"VX-135, Ribavirin","Chisinau - Moldova, Republic of",2014-06-30,2013-02-13,2017-12-18,INTERVENTIONAL,PHASE2,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT05717400,Unknown,TERMINATED,2023-03-17,Liver Cancer,"Bevacizumab, Atezolizumab, Sofosbuvir, Velpatasvir, Voxilaprevir, Ribavirin",Houston - United States,2024-08-29,2023-02-08,2024-12-31,INTERVENTIONAL,PHASE4,M.D. Anderson Cancer Center,OTHER,hepatitis
NCT02545400,Unknown,COMPLETED,2013-11,Hepatitis C,No interventions listed,Graz - Austria,2014-06,2015-09-10,2015-10-05,OBSERVATIONAL,Not Available,Medical University of Graz,OTHER,hepatitis
NCT06017375,Unknown,NOT_YET_RECRUITING,2023-09-01,"Hepatitis, Delta",Questionnaire based intervention,No locations listed,2024-02-28,2023-08-30,2023-08-30,OBSERVATIONAL,Not Available,King's College Hospital NHS Trust,OTHER,hepatitis
NCT01337375,Unknown,COMPLETED,2011-03,"Hepatitis C, Chronic","peginterferon alfa 2a [Pegasys], peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Berlin - Germany, Frankfurt Am Main - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany",2012-04,2011-04-18,2016-11-02,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06865859,Unknown,RECRUITING,2023-11-01,HBV Related Acute-on-chronic Liver Failure,No interventions listed,Jinan - China,2025-05,2025-03-10,2025-03-10,OBSERVATIONAL,Not Available,Qilu Hospital of Shandong University,OTHER,hepatitis
NCT00874770,Unknown,COMPLETED,2009-06,Hepatitis C Infection,"Daclatasvir, Daclatasvir, Daclatasvir, Placebo, Peginterferon alpha-2a, ribavirin","Montgomery - United States, Aurora - United States, New Haven - United States, Baltimore - United States, Springfield - United States, Bronx - United States, Statesville - United States, Tulsa - United States, Tulsa - United States, Arlington - United States, Fairfax - United States, Creteil - France, Paris Cedex 14 - France, Vandoeuvre Les Nancy - France",2009-11,2009-04-03,2015-10-23,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00028275,Unknown,COMPLETED,2001-12,Chronic Hepatitis C,Gamma Interferon 1b,Bethesda - United States,Unknown Date,2001-12-19,2008-03-04,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00810875,Unknown,TERMINATED,2009-04,Hepatitis C,No interventions listed,San Francisco - United States,2010-08,2008-12-18,2014-08-25,OBSERVATIONAL,Not Available,"University of California, San Francisco",OTHER,hepatitis
NCT01453075,Unknown,COMPLETED,2011-11,Chronic Hepatitis C Infection,"Valacyclovir, Placebo",Jackson - United States,2015-07,2011-10-17,2016-11-22,INTERVENTIONAL,PHASE1,VA Office of Research and Development,FED,hepatitis
NCT02959775,Unknown,COMPLETED,2014-08,Hepatitis B Vaccination,"60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine",No locations listed,2015-05,2016-11-09,2022-02-18,INTERVENTIONAL,PHASE4,Shanxi Medical University,OTHER,hepatitis
NCT01062659,Unknown,WITHDRAWN,2010-02,"Hepatitis C, Chronic, Liver Diseases, Virus Diseases",No interventions listed,Ulm - Germany,2012-12,2010-02-04,2014-04-01,OBSERVATIONAL,Not Available,University of Ulm,OTHER,hepatitis
NCT00222859,Unknown,COMPLETED,2005-03,HIV Infections,No interventions listed,Pittsburgh - United States,2011-12,2005-09-22,2013-07-30,OBSERVATIONAL,Not Available,University of Pittsburgh,OTHER,hepatitis
NCT06263959,Unknown,RECRUITING,2023-12-26,Chronic Hepatitis B,"GST-HG131, Placebo to match GST-HG131",Beijing - China,2025-04-01,2024-02-16,2025-03-05,INTERVENTIONAL,PHASE2,"Fujian Akeylink Biotechnology Co., Ltd.",INDUSTRY,hepatitis
NCT01088659,Unknown,COMPLETED,2010-02-16,"Hepatitis D, Chronic","peginterferon alfa-2a [Pegasys], placebo, tenofovir","Ankara - Turkey, Bursa - Turkey, Diyarbakir - Turkey, Istanbul - Turkey, Izmir - Turkey, Izmir - Turkey",2017-12-29,2010-03-17,2019-01-14,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01430000,Unknown,WITHDRAWN,Unknown Date,Hepatitis C,Subcutan implantation of autologus skin graft after ex-vivo treatment,Jerusalem - Israel,Unknown Date,2011-09-07,2014-04-17,INTERVENTIONAL,PHASE2,Medgenics Medical Israel Ltd.,INDUSTRY,hepatitis
NCT00015652,Unknown,COMPLETED,Unknown Date,"HIV Infections, Hepatitis C","Ribavirin, Aldesleukin, Peginterferon alfa-2b","Los Angeles - United States, Aurora - United States, Chicago - United States, Iowa City - United States, Baltimore - United States, New York - United States, Cincinnati - United States, Dallas - United States",Unknown Date,2001-08-31,2021-11-01,INTERVENTIONAL,NA,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01888900,Unknown,COMPLETED,2013-05,"Cirrhosis, Chronic Hepatitis C, Hepatitis C, Hepatitis C, Chronic","DUAL, QUAD",Bethesda - United States,2015-11,2013-06-28,2017-02-07,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02076100,Unknown,COMPLETED,2014-03-27,Hepatitis C Infection,Ruzasvir,No locations listed,2015-11-15,2014-03-03,2018-12-24,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04904900,Unknown,RECRUITING,2021-05-06,Chronic Hep B,No interventions listed,Shatin - Hong Kong,2025-03-31,2021-05-27,2023-09-13,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT00240500,Unknown,COMPLETED,2003-10,Hepatitis B,Engerix™-B,Bangkok - Thailand,2007-11,2005-10-18,2016-12-21,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01428700,Unknown,COMPLETED,2011-08,Liver Transplantation,No interventions listed,No locations listed,2013-01,2011-09-05,2023-03-22,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01134952,Unknown,COMPLETED,2010-06,Hepatitis C,Mycophenolate to sirolimus switch,London - Canada,2014-12,2010-06-02,2015-02-26,INTERVENTIONAL,PHASE4,London Health Sciences Centre,OTHER,hepatitis
NCT01606800,START 4,TERMINATED,2013-01-01,"Hepatitis C, Chronic","PEG-IFN alfa-2b, ribavirin",No locations listed,2015-01-26,2012-05-28,2018-10-25,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05476900,Unknown,RECRUITING,2022-10-06,Autoimmune Hepatitis,HR19042 Capsules,Shanghai - China,2023-12-30,2022-07-27,2023-08-21,INTERVENTIONAL,PHASE2,"Jiangsu HengRui Medicine Co., Ltd.",INDUSTRY,hepatitis
NCT02707952,CERTAIN-1,COMPLETED,2016-02-22,"Chronic Hepatitis C Virus, Hepatitis C Virus","ABT-493/ABT-530, OBV/PTV/r",No locations listed,2016-11-14,2016-03-14,2021-07-16,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02589652,Unknown,UNKNOWN,2015-10,Chronic Hepatitis B,"Pegylated interferon alfa-2a, Pegylated interferon alfa-2a plus Entecavir, Entecavir","Hefei - China, Hefei - China, Beijing - China, Fuzhou - China, Guangzhou - China, Shenzhen - China, Shijiazhuang - China, Suzhou - China, Xuzhou - China, Shenyang - China, Jinan - China, Xi'an - China, Luzhou - China, Sichuan - China, Hangzhou - China, Ningbo - China, Rui'an - China",2017-10,2015-10-28,2015-10-28,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT00376259,Unknown,TERMINATED,2007-01,Hepatitis B,"telbivudine, adefovir dipivoxil","San Diego - United States, San Mateo - United States, Pok Fu Lam - Hong Kong, Seoul - Korea, Republic of, Kaohsuing - Taiwan, Bangkok - Thailand",2008-08,2006-09-14,2011-06-30,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT01890200,Unknown,WITHDRAWN,2015-06,Chronic Hepatitis C,"Peginterferon alfa-2a, Ribavirin, TCM-700C, Placebo","Beijing - China, Taoyuan - Taiwan",2018-03,2013-07-01,2017-04-28,INTERVENTIONAL,PHASE3,TCM Biotech International Corp.,INDUSTRY,hepatitis
NCT04209400,Unknown,COMPLETED,2014-04-18,Hepatitis B,"Sci-B-Vac®, Engerix-B®",Saint Petersburg - Russian Federation,2015-04-20,2019-12-24,2022-07-25,INTERVENTIONAL,PHASE3,VBI Vaccines Inc.,INDUSTRY,hepatitis
NCT01448200,Unknown,COMPLETED,2011-10,"Hepatitis C, Chronic","PPI-668, Placebo","Costa Mesa - United States, Sacramento - United States, San Francisco - United States, San Antonio - United States, Canberra - Australia, Auckland - New Zealand, Christchurch - New Zealand",2012-11,2011-10-07,2012-11-16,INTERVENTIONAL,PHASE1,"Presidio Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT01401400,GIANT-B,COMPLETED,2010-05,Chronic Hepatitis B,No interventions listed,Rotterdam - Netherlands,2015-06,2011-07-25,2015-08-14,OBSERVATIONAL,Not Available,Foundation for Liver Research,OTHER,hepatitis
NCT01537900,Unknown,COMPLETED,2013-10-01,Hepatitis C,Grazoprevir,No locations listed,2014-07-31,2012-02-23,2018-09-14,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04357600,Unknown,UNKNOWN,2018-05-17,Liver Cirrhoses,Allogeneic Umbilical Cord Mesenchymal Stem Cell,Jakarta - Indonesia,2023-06-20,2020-04-22,2022-06-15,INTERVENTIONAL,PHASE2,PT. Prodia Stem Cell Indonesia,INDUSTRY,hepatitis
NCT01329952,Unknown,UNKNOWN,2011-05,Hepatitis C,No interventions listed,Manchester - United Kingdom,2013-05,2011-04-06,2011-04-06,OBSERVATIONAL,Not Available,Pennine Acute Hospitals NHS Trust,OTHER,hepatitis
NCT04392700,Unknown,UNKNOWN,2019-07-25,Hepatocellular Carcinoma Recurrent,"Tenofovir disoproxil fumarate 300mg, Entecavir 0.5 mg",Guangzhou - China,2021-07-25,2020-05-19,2020-05-19,INTERVENTIONAL,PHASE3,Sun Yat-sen University,OTHER,hepatitis
NCT02120300,Unknown,COMPLETED,2014-04,Chronic HCV Infection,"LDV/SOF, SOF, RBV","Sacramento - United States, San Diego - United States, San Francisco - United States, Washington - United States, Atlanta - United States, Boston - United States, Boston - United States, Minneapolis - United States, Newark - United States, New York - United States, Rochester - United States, Chapel Hill - United States, Philadelphia - United States",2015-08,2014-04-22,2016-12-06,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02510300,Unknown,TERMINATED,2015-10-21,Hepatitis C Virus Infection,"Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir (SOF/VEL), Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX)","Phoenix - United States, Los Angeles - United States, San Francisco - United States, Aurora - United States, Washington - United States, Gainesville - United States, Orlando - United States, Atlanta - United States, Indianapolis - United States, Louisville - United States, Baltimore - United States, Boston - United States, Kansas City - United States, Saint Louis - United States, Omaha - United States, New York - United States, Chapel Hill - United States, Cincinnati - United States, Columbus - United States, Philadelphia - United States, Nashville - United States, Dallas - United States, Fort Worth - United States, Houston - United States, San Antonio - United States, Seattle - United States, Morgantown - United States, New Lambton Heights - Australia, Westmead - Australia, Parkville - Australia, Brussels - Belgium, Berlin - Germany, Wuppertal - Germany, San Giovanni Rotondo - Italy, Bologna - Italy, Firenze - Italy, Milano - Italy, Napoli - Italy, Padova - Italy, Torino - Italy, Auckland - New Zealand, Bydgoszcz - Poland, Poznan - Poland, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Tolyatti - Russian Federation, Birmingham - United Kingdom, Glasgow - United Kingdom, Leeds - United Kingdom, London - United Kingdom",2023-01-06,2015-07-29,2023-01-27,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03420300,Unknown,COMPLETED,2018-06-05,Hepatitis C,EBR/GZR,"Douliu - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taipei county - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2019-11-02,2018-02-05,2020-03-11,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT01332552,Unknown,TERMINATED,2011-01-14,Hepatitis C,"GSK2485852 70 mg, GSK2485852 420 mg, placebo, placebo, GSK2485852 420 mg, GSK2485852 420 mg, GSK2485852 630 mg, GSK2485852 70 mg + Ritonavir 100mg, GSK2485852 210 mg + Ritonavir 100mg, GSK2485852 210 mg +Ritonavir 100mg","Anaheim - United States, Orlando - United States, Lenexa - United States, Las Vegas - United States, Willingboro - United States",2011-04-06,2011-04-11,2017-07-07,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01886300,Unknown,TERMINATED,2012-09,"Hepatitis B, Chronic",No interventions listed,"Hanoi - Vietnam, Ho Chi Minh City - Vietnam, Hochiminh city - Vietnam",2013-05,2013-06-25,2016-06-22,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01263600,Unknown,COMPLETED,2010-12,Hepatitis B,No interventions listed,"San Francisco - United States, Baltimore - United States, Minneapolis - United States, Saint Louis - United States, Dallas - United States, Seattle - United States, Toronto - Canada",2021-06-09,2010-12-20,2022-05-31,OBSERVATIONAL,Not Available,University of Pittsburgh,OTHER,hepatitis
NCT01323452,Unknown,COMPLETED,2010-11,Entecavir for Chronic Hepatitis B Patients,Entecavir,Rotterdam - Netherlands,2011-01,2011-03-25,2011-03-25,OBSERVATIONAL,Not Available,Foundation for Liver Research,OTHER,hepatitis
NCT04539652,Unknown,COMPLETED,2018-09-20,Chronic Hepatitis B,Experimental,"Daegu - Korea, Republic of",2021-06-22,2020-09-07,2021-07-28,INTERVENTIONAL,PHASE4,Chong Kun Dang Pharmaceutical,INDUSTRY,hepatitis
NCT03733652,Unknown,UNKNOWN,2018-11-15,"Chronic Hepatitis b, Efficacy, Self",Interferon Alfa 2a,Guangzhou - China,2021-09-30,2018-11-07,2018-11-23,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02995252,Unknown,RECRUITING,2014-12,"Hepatitis B， Chronic, Hepatitis C","Blood draws, Tenofovir Alafenamide, Knowledge Index Questionnaire, Liver transient elastography (FibroScan), Liver Biopsy","Baltimore - United States, Falls Church - United States",2025-01,2016-12-16,2024-04-03,OBSERVATIONAL,Not Available,"University of Maryland, Baltimore",OTHER,hepatitis
NCT04843852,BOOST-9,WITHDRAWN,2022-07,Hepatitis B,"Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]","Baltimore - United States, Falls Church - United States",2023-12,2021-04-14,2022-07-22,INTERVENTIONAL,PHASE1,"University of Maryland, Baltimore",OTHER,hepatitis
NCT05326152,Unknown,COMPLETED,2020-11-25,Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts,"hepatitis B vaccine immunotherapy of common warts (GeneVac-B 10 ml vial, Serum Institute of India Ltd., Pune, India), Intralesional saline",Zagazig - Egypt,2021-06-20,2022-04-13,2022-04-13,INTERVENTIONAL,PHASE2,Zagazig University,OTHER_GOV,hepatitis
NCT03036852,SOF/VEL ESRD,COMPLETED,2017-03-22,Chronic Hepatitis C,SOF/VEL,"Adelaide - Australia, Edmonton - Canada, Vancouver - Canada, Brampton - Canada, Hamilton - Canada, Ottawa - Canada, Montréal - Canada, Jerusalem - Israel, Ramat Gan - Israel, Tel Aviv - Israel, Grafton - New Zealand, Alcorcón - Spain, Barcelona - Spain, Majadahonda - Spain, Sevilla - Spain, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Plymouth - United Kingdom",2018-08-13,2017-01-30,2020-03-06,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01289652,PROBE-C,UNKNOWN,2011-05,"Acute Hepatitis C, HIV",No interventions listed,Bonn - Germany,2016-05,2011-02-04,2014-04-23,OBSERVATIONAL,Not Available,Benedetta Mattioli,OTHER,hepatitis
NCT00709059,PRACTICE,COMPLETED,2004-12,"Hepatitis C, Chronic","PegIntron (peginterferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2009-12,2008-07-03,2015-11-04,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03381859,CLEAR-C4,WITHDRAWN,2019-12-01,"Hepatitis C Virus Infection, Response to Therapy of",Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER],Cairo - Egypt,2020-06-01,2017-12-22,2020-04-20,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,hepatitis
NCT00275652,Unknown,COMPLETED,2004-06,"Hepatitis B, Cirrhosis",LdT (Telbivudine) and lamivudine,Rochester - United States,2007-08,2006-01-12,2011-03-23,INTERVENTIONAL,PHASE3,Mayo Clinic,OTHER,hepatitis
NCT02605252,Unknown,UNKNOWN,2016-03,"Hepatitis B, Chronic",Peginterferon alfa-2b,Guangzhou - China,2017-09,2015-11-16,2016-09-20,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01589952,Bangabandhu,UNKNOWN,2012-03,Chronic Hepatitis B,"Pegalyted interferon, Entecavir",Dhaka - Bangladesh,2013-02,2012-05-02,2012-05-02,INTERVENTIONAL,PHASE2,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",OTHER,hepatitis
NCT02752152,Napneung-1,COMPLETED,2015-12-09,"HIV, Hepatitis B, Hepatitis C and Syphilis Infections","Computer-assisted counseling, On-demand counseling, Standard counseling, Appointment + reminder, Reminder, No appointment and no reminder","Chiang Mai - Thailand, Chiang Mai - Thailand, Chiang Rai - Thailand",2018-07-01,2016-04-26,2021-02-16,INTERVENTIONAL,NA,Institut de Recherche pour le Developpement,OTHER_GOV,hepatitis
NCT01354652,ETV,TERMINATED,2011-05,Lactic Acidosis,"entecavir, lamivudine",No locations listed,2013-09,2011-05-17,2018-05-09,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT00104052,Unknown,COMPLETED,2005-02,"Hepatitis C, Chronic","peginterferon alfa-2b (PEG2b) (SCH 54031), ribavirin (SCH 18908)",No locations listed,2007-11,2005-02-23,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00804752,Unknown,UNKNOWN,Unknown Date,Chronic Hepatitis C,"Adding vitamin D, Vitamin D",Hadera - Israel,Unknown Date,2008-12-09,2008-12-09,INTERVENTIONAL,NA,Hillel Yaffe Medical Center,OTHER_GOV,hepatitis
NCT01727934,Unknown,UNKNOWN,2012-11,Hepatitis C,Miravirsen sodium,San Juan - Puerto Rico,2014-01,2012-11-16,2014-01-06,INTERVENTIONAL,PHASE2,Santaris Pharma A/S,INDUSTRY,hepatitis
NCT00696917,Unknown,COMPLETED,1999-04,Hepatitis B,"HBV-MPL vaccine 208129, Engerix™-B","Parkville - Australia, Hradec Kralové - Czech Republic, München - Germany, Bari - Italy, Utrecht - Netherlands, Lausanne - Switzerland, London - United Kingdom",2000-02,2008-06-13,2008-06-13,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00629824,Unknown,COMPLETED,2007-02,Chronic Hepatitis C,"pegylated interferon alpha and plus ribavirin, pegylated interferon alpha and plus ribavirin, pegylated interferon alpha and plus ribavirin",Kaohsiung - Taiwan,2009-04,2008-03-06,2010-09-08,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT06379334,Unknown,ACTIVE_NOT_RECRUITING,2020-12-06,"Hepatocellular Carcinoma, Hepatitis B",Urine test,Beijing - China,2024-12-06,2024-04-23,2024-04-23,OBSERVATIONAL,Not Available,Peking Union Medical College Hospital,OTHER,hepatitis
NCT03056924,Unknown,COMPLETED,2017-07-05,Inflammatory Bowel Diseases,"Pneumococcal Pneumonia vaccine, Influenza vaccine, Hepatitis B vaccine",Boston - United States,2019-01-15,2017-02-17,2019-12-30,OBSERVATIONAL,Not Available,Boston Medical Center,OTHER,hepatitis
NCT04139941,Unknown,COMPLETED,2019-07-31,Hepatitis C Virus Infection,Test for HCV antibodies with an RDT,"Phnom Penh - Cambodia, Tbilisi - Georgia",2019-12-31,2019-10-25,2020-07-07,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT01567735,RESTORE,COMPLETED,2012-03-27,Hepatitis C,TMC435,"Antwerpen - Belgium, Brussel - Belgium, Edegem - Belgium, Clichy - France, Creteil - France, Lyon - France, Paris - France, Villejuif Cedex - France",2014-03-20,2012-03-30,2017-07-07,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT00277758,Unknown,TERMINATED,2004-03,Hepatitis C,"Interleukin 2, Ribavirin, Pegylated Interferon Alpha, Inteleukin-2, Ribavirin + Pegylated interferon-alpha",New York - United States,2006-07,2006-01-16,2008-03-07,INTERVENTIONAL,PHASE1,Weill Medical College of Cornell University,OTHER,hepatitis
NCT05905458,Unknown,COMPLETED,2023-07-28,Chronic Hepatitis B,"HRS9950 tablets, HRS9950 tablets, HRS9950 placebo tablets",Guangzhou - China,2024-11-22,2023-06-15,2024-12-03,INTERVENTIONAL,PHASE2,"Chengdu Suncadia Medicine Co., Ltd.",INDUSTRY,hepatitis
NCT03396458,HBVTR,UNKNOWN,2017-09-01,Hepatitis B,"Hepatitis B serology, Questionnaire",Genk - Belgium,2020-08-31,2018-01-11,2020-01-27,OBSERVATIONAL,Not Available,Hasselt University,OTHER,hepatitis
NCT00055341,Unknown,COMPLETED,2002-03,"HIV Infections, Hepatitis C, Hemophilia","Peginterferon alfa-2a, Ribavirin",Cincinnati - United States,Unknown Date,2003-02-27,2008-07-30,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT04670419,Unknown,COMPLETED,2010-01-01,Hepatitis E,Viral clade,No locations listed,2018-06-30,2020-12-17,2020-12-17,OBSERVATIONAL,Not Available,"University Hospital, Antwerp",OTHER,hepatitis
NCT03852719,Unknown,COMPLETED,2019-04-17,Chronic Hepatitis Delta,Bulevirtide,"New York - United States, New York - United States, Essen - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Milan - Italy, Modena - Italy, Pisa - Italy, Chelyabinsk - Russian Federation, Krasnodar - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation, Stavropol' - Russian Federation, Stockholm - Sweden",2020-11-26,2019-02-25,2024-12-17,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT04465916,Unknown,TERMINATED,2020-05-12,"Hepatitis B, Chronic","EYP001a, Placebo, Nucleotide analogue (Entecavir or Tenofovir Disoproxil)","Brisbane - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Hong Kong - Hong Kong, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Seongnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Séoul - Korea, Republic of, Białystok - Poland, Kielce - Poland, Lublin - Poland, Warszawa - Poland, Zawiercie - Poland, Łódź - Poland",2021-06-17,2020-07-10,2022-11-02,INTERVENTIONAL,PHASE2,Enyo Pharma,INDUSTRY,hepatitis
NCT00856024,ATHENAS,TERMINATED,2008-07,"Hepatitis C, Chronic","Peginterferon alfa-2b, Ribavirin",No locations listed,2010-10,2009-03-05,2015-07-01,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01653236,Unknown,UNKNOWN,2013-12,Genotype 4 Chronic Hepatitis C Infection,"Boceprevir, Peginterferon alfa-2b, ribavirin",Giza - Egypt,2015-12,2012-07-30,2014-12-30,INTERVENTIONAL,PHASE3,Theodor Bilharz Research Institute,OTHER,hepatitis
NCT01063036,Unknown,COMPLETED,2010-05,Chronic Hepatitis B,"Entecavir, Tenofovir","Clichy - France, Lyons Cedex 04 - France, Orleans Cedex 2 - France, Strasbourg - France, Berlin - Germany, Berlin - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Heindelberg - Germany, Munchen - Germany, Tubingen - Germany, Bagno A Ripoli (Fi) - Italy, Bari - Italy, Foggia - Italy, Milano - Italy, Amsterdam - Netherlands, Arnhem - Netherlands, Rotterdam - Netherlands, Kielce - Poland, Krakow - Poland, Lodz - Poland, Wroclaw - Poland, Bucuresti - Romania, Burcuresti - Romania, Timisoara - Romania, Barcelona - Spain, Valencia - Spain",2012-11,2010-02-05,2014-12-15,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00645736,CHARM,COMPLETED,2008-02,Chronic Hepatitis B,No intervention,East Melbourne - Australia,2008-10,2008-03-28,2011-11-22,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03057236,Unknown,COMPLETED,2014-03-01,"Hepatitis C, Hepatitis C, Chronic",Cognitive Behavior Coping Skills,Chapel Hill - United States,2014-12-31,2017-02-20,2017-02-20,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT04886336,HBV,UNKNOWN,2020-06-04,HBV,No interventions listed,Tainan - Taiwan,2022-12-31,2021-05-14,2021-05-14,OBSERVATIONAL,Not Available,National Cheng-Kung University Hospital,OTHER,hepatitis
NCT05401136,HepC:CAC,UNKNOWN,2020-03-01,"Hepatitis C, Chronic, Substance Use Disorders",No interventions listed,Nijmegen - Netherlands,2023-12-01,2022-06-02,2022-06-02,OBSERVATIONAL,Not Available,Radboud University Medical Center,OTHER,hepatitis
NCT00881036,Unknown,COMPLETED,2006-08,Hepatitis B,No interventions listed,Kyoto - Japan,2015-07,2009-04-14,2015-09-03,OBSERVATIONAL,Not Available,Kyoto University,OTHER,hepatitis
NCT00299936,Unknown,COMPLETED,Unknown Date,Chronic Hepatitis C,"Ribavirin, PEG-Intron",No locations listed,Unknown Date,2006-03-07,2006-03-07,INTERVENTIONAL,PHASE3,Weill Medical College of Cornell University,OTHER,hepatitis
NCT00962936,Unknown,TERMINATED,2009-09,Chronic Hepatitis C,CT-011,Jerusalem - Israel,2011-10,2009-08-20,2014-08-29,INTERVENTIONAL,PHASE2,CureTech Ltd,INDUSTRY,hepatitis
NCT02040636,Unknown,COMPLETED,1999-01,"Pertussis, Tetanus, Diphtheria, Poliomyelitis, Hepatitis B","Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV, Hepatitis B vaccine",Winnipeg - Canada,2000-05,2014-01-20,2015-03-25,INTERVENTIONAL,PHASE2,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT02693652,Unknown,COMPLETED,2014-10-28,"Hepatitis B, Chronic",CVI-HBV-002,"Seongnam-si - Korea, Republic of",2017-08-22,2016-02-29,2023-11-18,INTERVENTIONAL,PHASE2,"CHA Vaccine Institute Co., Ltd.",INDUSTRY,hepatitis
NCT03097952,Unknown,RECRUITING,2008-01,Hepatitis B， Chronic,No interventions listed,"Changzhou - China, Huai'an - China, Nanjing - China, Nanjing - China, Suqian - China, Suzhou - China",2030-12,2017-03-31,2017-03-31,OBSERVATIONAL,Not Available,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,OTHER,hepatitis
NCT02798952,Unknown,COMPLETED,2016-08-23,Hepatitis B,Engerix-B Kinder,"Kehl - Germany, Mannheim - Germany, Stuttgart - Germany, Tuttlingen - Germany, Bindlach - Germany, Cham - Germany, Wuerzburg - Germany, Goch - Germany, Frankenthal - Germany, Wurzen - Germany, Berlin - Germany, Bramsche - Germany, Moenchengladbach - Germany, Neumuenster - Germany",2017-07-05,2016-06-14,2020-01-18,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00722332,Unknown,COMPLETED,2008-02,"Hepatitis B, Liver Transplantation",HepaGam B,"Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, Atlanta - United States, Chicago - United States, Burlington - United States, Minneapolis - United States, Newark - United States, New York - United States, New York - United States, New York - United States, Cleaveland - United States, Pittsburgh - United States, Dallas - United States, Houston - United States, Montreal - Canada",2013-10,2008-07-25,2013-11-01,INTERVENTIONAL,PHASE4,Cangene Corporation,INDUSTRY,hepatitis
NCT02335632,Unknown,UNKNOWN,2012-12,Alcoholic Liver Disease,"Probiotics (Lacidofil®), Placebo",No locations listed,2015-02,2015-01-12,2015-01-28,INTERVENTIONAL,PHASE4,Chuncheon Sacred Heart Hospital,OTHER,hepatitis
NCT01316237,Unknown,COMPLETED,2011-01,"Hepatitis C, Chronic","GS-6620, GS-6620, GS-6620, GS-6620, GS-6620, GS-6620, GS-6620 tablet, 450 mg BID, GS-6620 tablet, GS-6620 tablet","Anaheim - United States, Los Angeles - United States, Deland - United States, Gainesville - United States, Orlando - United States, Orlando - United States, St. Louis - United States, Philadelphia - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Tacoma - United States, Puerto Rico - Puerto Rico",2011-10,2011-03-16,2012-03-26,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT03456037,Unknown,UNKNOWN,2018-04-01,Intensive Care Unit,hepatitis viruses,Sakarya - Turkey,2019-05-01,2018-03-07,2018-03-07,OBSERVATIONAL,Not Available,Sakarya University,OTHER,hepatitis
NCT04035837,Unknown,RECRUITING,2018-05-16,"Hepatitis B, Chronic",pegylated interferon-alfa,Guangzhou - China,2023-06-30,2019-07-29,2023-04-14,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT02745132,CICHepC,UNKNOWN,2016-06,Hepatitis C,Neuropsychological evaluation and Brain MRI,Santander - Spain,2017-12,2016-04-20,2016-04-21,INTERVENTIONAL,PHASE4,Instituto de Investigación Marqués de Valdecilla,OTHER,hepatitis
NCT01455337,Unknown,UNKNOWN,2009-01,Alcoholic Hepatitis,"pentoxifylline, Prednisolone",No locations listed,2011-12,2011-10-19,2011-10-19,INTERVENTIONAL,PHASE3,Inje University,OTHER,hepatitis
NCT01608737,Unknown,WITHDRAWN,2012-09,"Hepatitis C, Chronic","PegIFN/RBV, BI 201335, BI 201335, PegIFN/RBV, BI 201335",No locations listed,2015-10,2012-05-31,2013-02-26,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01801332,Unknown,COMPLETED,2010-02,Severe Alcoholic Hepatitis,"intensive nutrition, usual meals","Antwerp - Belgium, Brugge - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Gent - Belgium, La Louvière - Belgium, Leuven - Belgium, Liège - Belgium, Liège - Belgium, Liège - Belgium, Mons - Belgium, Mons - Belgium, Ottignies-Louvain-La-Neuve - Belgium, Caen - France, Lille - France",2013-02,2013-02-28,2013-02-28,INTERVENTIONAL,NA,Erasme University Hospital,OTHER,hepatitis
NCT02304315,Unknown,COMPLETED,2015-02,Hepatitis B Infection,"GC1102 50,000 IU, GC1102 80,000 IU","Seoul - Korea, Republic of",2016-05,2014-12-01,2016-06-30,INTERVENTIONAL,PHASE2,Green Cross Corporation,INDUSTRY,hepatitis
NCT01030432,Unknown,COMPLETED,2010-02,Hepatitis C Virus,"BMS-650032, BMS-650032, Placebo, Placebo, Placebo, Peginterferon Alfa-2a, Peginterferon Alfa-2a, Ribavirin, Ribavirin","Birmingham - United States, Montgomery - United States, Orlando - United States, Baltimore - United States, Springfield - United States, Worcester - United States, Bronx - United States, Chapel Hill - United States, Tulsa - United States, Portland - United States, Philadelphia - United States, Germantown - United States, Fairfax - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Prov. Buenos Aires - Argentina, Prov De Santa Fe - Argentina, Buenos Aires - Argentina, Creteil Cedex - France, Marseille Cedex 08 - France, Montpellier Cedex 5 - France, Paris Cedex 13 - France, Paris Cedex 14 - France, Vandoeuvre Les Nancy - France, Frankfurt - Germany, Heidelberg - Germany, Mainz - Germany, Wurzburg - Germany, Dublin - Ireland, Torino - Italy, Alicante - Spain, Barcelona - Spain, Madrid - Spain, Malaga - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Glasgow - United Kingdom",2012-10,2009-12-11,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01194037,Unknown,COMPLETED,2011-06,"Chronic Hepatitis C Infection, Genotype 1","recombinant variant of interferon-alpha 2b, Peginterferon alfa-2a","Los Angeles - United States, National City - United States, Miami - United States, Atlanta - United States, Lexington - United States, New Orleans - United States",2012-05,2010-09-02,2014-02-25,INTERVENTIONAL,PHASE2,"HanAll BioPharma Co., Ltd.",INDUSTRY,hepatitis
NCT01457937,MEN_BOC,UNKNOWN,2011-11,"Chronic Hepatitis C, Menopause","Pegylated Interferon, Ribavirin, Boceprevir",Modena - Italy,2013-12,2011-10-24,2012-10-02,INTERVENTIONAL,PHASE3,University of Modena and Reggio Emilia,OTHER,hepatitis
NCT01887275,Unknown,COMPLETED,2010-03,Chronic Hepatitis B,"medical ozone therapy with humares, conventional interferon-α",GuangZhou - China,2013-02,2013-06-26,2013-06-26,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT00147459,Unknown,UNKNOWN,2005-09,"Liver Transplantation, Hepatitis B",HBV vaccine booster,Taipei - Taiwan,2006-12,2005-09-07,2012-12-06,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT02982837,RC14/055,UNKNOWN,2015-03,Hepatitis B,"PEG-IFN & Nucleos(t)tide analogues, Nucleos(t)tide analogues","Jeddah - Saudi Arabia, Jeddah - Saudi Arabia, Riyadh - Saudi Arabia",2019-03,2016-12-06,2018-03-09,INTERVENTIONAL,PHASE4,King Abdullah International Medical Research Center,OTHER,hepatitis
NCT00399815,Unknown,UNKNOWN,2006-06,"Hepatitis C, Chronic",No interventions listed,Brussels - Belgium,2009-05,2006-11-15,2009-09-18,OBSERVATIONAL,Not Available,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,OTHER,hepatitis
NCT00307242,Unknown,COMPLETED,2005-06-17,Chronic Hepatitis B,Adefovir Dipivoxil,No locations listed,2009-02,2006-03-27,2021-11-12,INTERVENTIONAL,PHASE4,Thomas Jefferson University,OTHER,hepatitis
NCT00131742,Unknown,COMPLETED,2004-07,Chronic Hepatitis B,"telbivudine, lamivudine",Beijing - China,2007-01,2005-08-19,2015-05-12,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT00485342,RIBAJUSTE,UNKNOWN,2006-04,Chronic Hepatitis C,"Peg-interferon alpha 2a and ribavin, ribavirin with adaptation dose",Lyon - France,2013-03,2007-06-12,2012-01-09,INTERVENTIONAL,PHASE3,Hospices Civils de Lyon,OTHER,hepatitis
NCT02562742,Unknown,COMPLETED,2015-11-12,Hepatitis C,"SOF, REB","Ageo-shi - Japan, Bunkyo-ku - Japan, Chuo-shi - Japan, Fujioka-shi - Japan, Fukui-shi - Japan, Fukuoka-shi - Japan, Hakodate-shi - Japan, Handa-shi - Japan, Ichihara-shi - Japan, Inashiki-gun - Japan, Iruma-gun - Japan, Kamogawa-shi - Japan, Karatsu-shi - Japan, Kashiwa-shi - Japan, Katsushika-ku - Japan, Kawagoe-shi - Japan, Kawasaki-shi - Japan, Kitamoto-shi - Japan, Kobe-shi - Japan, Kodaira-shi - Japan, Koto-ku - Japan, Kurume-shi - Japan, Kyoto-shi - Japan, Matsue-shi - Japan, Matsuyama-shi - Japan, Minato-ku - Japan, Miyazaki-shi - Japan, Morioka-shi - Japan, Nagoya-shi - Japan, Osaka-shi - Japan, Osakasayama-shi - Japan, Saitama-shi - Japan, Sakai-shi - Japan, Sapporo-shi - Japan, Shibuya-ku - Japan, Shimotsuke-shi - Japan, Shinjuku-ku - Japan, Sumida-ku - Japan, Tagawa-shi - Japan, Tondabayashi-shi - Japan, Toyama-shi - Japan, Toyoake-shi - Japan, Utsunomiya-shi - Japan, Yanagawa-shi - Japan, Yokohama-shi - Japan",2017-06-12,2015-09-29,2017-08-01,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT04596475,Unknown,COMPLETED,2021-05-28,"Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of",glecaprevir/pibrentasvir (GLE/PIB),San Diego - United States,2022-04-21,2020-10-22,2022-05-24,INTERVENTIONAL,PHASE2,"University of California, San Diego",OTHER,hepatitis
NCT04779970,COIN-B,ACTIVE_NOT_RECRUITING,2021-07-28,Chronic Hepatitis B,Cessation of ongoing treatment,"Aalst - Belgium, Antwerp - Belgium, Antwerp - Belgium, Antwerp - Belgium, Brasschaat - Belgium, Brugge - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussels - Belgium, Brussel - Belgium, Charleroi - Belgium, Genk - Belgium, Gent - Belgium, Gent - Belgium, Hasselt - Belgium, Kortrijk - Belgium, La Louvière - Belgium, Leuven - Belgium, Liège - Belgium, Liège - Belgium, Namur - Belgium, Ostend - Belgium, Roeselare - Belgium, Sint-Niklaas - Belgium, Turnhout - Belgium",2025-12,2021-03-03,2024-06-24,INTERVENTIONAL,NA,"University Hospital, Antwerp",OTHER,hepatitis
NCT01157975,Unknown,WITHDRAWN,2008-10,Hepatitis C,"Pioglitazone, Prednisone","San Diego - United States, Giza - Egypt",2014-02,2010-07-08,2019-12-02,INTERVENTIONAL,PHASE2,"University of California, San Diego",OTHER,hepatitis
NCT01706575,Unknown,COMPLETED,2013-01,"Hepatitis B, Chronic","Pegylated Interferon (Peginterferon) Alfa-2a, Nucleos(t)ide Analogues (NA)","Napoli - Italy, Napoli - Italy, Bologna - Italy, Bologna - Italy, Udine - Italy, Udine - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Genova - Italy, Genova - Italy, Milano - Italy, Milano - Italy, Torino - Italy, Torino - Italy, Foggia - Italy, Foggia - Italy, Cagliari - Italy, Cagliari - Italy, Cagliari - Italy, Messina - Italy, Messina - Italy, Palermo - Italy, Palermo - Italy, Pisa - Italy, Pisa - Italy, Padova - Italy",2013-09,2012-10-15,2017-02-20,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03876470,CHIME,UNKNOWN,2019-05-15,Hepatitis C,Hepatitis C treatment as chosen by provider,No locations listed,2020-11,2019-03-15,2019-04-17,OBSERVATIONAL,Not Available,University of Virginia,OTHER,hepatitis
NCT00423670,Unknown,COMPLETED,2007-01,Chronic Hepatitis C,"boceprevir (SCH 503034), peginterferon-alfa 2b (PegIntron), ribavirin, ribavirin (low-dose)",No locations listed,2008-08,2007-01-18,2017-04-05,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01521975,STEN,COMPLETED,2011-01-01,"Hepatitis B, Chronic","Telbivudine, Adefovir dipivoxil",Guangzhou - China,2014-02-28,2012-01-31,2017-10-24,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01017575,Unknown,COMPLETED,2009-12,Hepatitis C Infection,"Daclatasvir, Daclatasvir, Placebo, Peginterferon alfa-2a, Ribavirin","Chiba-Shi - Japan, Kurume-Shi - Japan, Okayama-Shi - Japan, Osaka-Shi - Japan, Osaka-Shi - Japan, Musashino-Shi - Japan",2011-10,2009-11-20,2015-09-11,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01437475,Unknown,UNKNOWN,2011-11,HIV,Sci-B-Vac,Tel Aviv - Israel,2013-03,2011-09-21,2011-10-06,INTERVENTIONAL,NA,Tel-Aviv Sourasky Medical Center,OTHER_GOV,hepatitis
NCT01841775,Unknown,COMPLETED,2009-05,"Hepatitis C, Chronic",interferon α 2b + ribavirin,"Rio de Janeiro - Brazil, Rio de Janeiro - Brazil",2012-09,2013-04-29,2013-04-29,INTERVENTIONAL,PHASE4,The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz),OTHER,hepatitis
NCT00723242,Unknown,COMPLETED,2002-04,Chronic Hepatitis C Infection,Viraferon-peg and Rebetol,London - United Kingdom,2004-12,2008-07-28,2008-07-28,INTERVENTIONAL,NA,"University College, London",OTHER,hepatitis
NCT02692170,Unknown,COMPLETED,2012-12-07,Healthy,"CVI-HBV-001, Conventional Hepatitis B vaccine (20 μg)",No locations listed,2015-05-28,2016-02-25,2023-11-18,INTERVENTIONAL,PHASE2,"CHA Vaccine Institute Co., Ltd.",INDUSTRY,hepatitis
NCT01687270,Unknown,COMPLETED,2012-11,"Recurrent Chronic Hepatitis C Virus, Post Liver Transplant","Sofosbuvir, RBV","San Francisco - United States, Indianapolis - United States, Kansas City - United States, Boston - United States, Ann Arbor - United States, Rochester - United States, New York - United States, New York - United States, Villejuif - France, Hannover - Germany, Grafton - New Zealand, Barcelona - Spain",2013-12,2012-09-18,2014-12-19,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT03193775,Unknown,COMPLETED,2011-08-01,HBV,HBV vaccine,No locations listed,2015-10-01,2017-06-21,2017-06-21,INTERVENTIONAL,NA,Zagazig University,OTHER_GOV,hepatitis
NCT06047275,Unknown,COMPLETED,2023-05-01,Hepatitis C,No interventions listed,Kingston upon Hull - United Kingdom,2024-03-31,2023-09-21,2024-07-10,OBSERVATIONAL,Not Available,University of Hull,OTHER,hepatitis
NCT01753570,Unknown,COMPLETED,2012-12,Chronic Hepatitis C(CHC),"MP-424, RBV(24 weeks), IFN beta(24 weeks), RBV(48 weeks), IFN beta(48 weeks)",Kawasaki City - Japan,2015-10,2012-12-20,2018-10-26,INTERVENTIONAL,PHASE3,Mitsubishi Tanabe Pharma Corporation,INDUSTRY,hepatitis
NCT00857675,Unknown,COMPLETED,2002-12,Chronic Hepatitis B,"AAAA, AAPA, PAAA","Guangzhou - China, Guangzhou - China, Changchun - China, Jinan - China, Hangzhou - China, Beijing - China, Beijing - China, Chongqing - China, Chongquin - China, Shanghai - China",2008-03,2009-03-09,2009-04-03,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00234975,Unknown,COMPLETED,2002-10,HIV Infection,Lopinavir/Ritonavir,"Bayamon - Puerto Rico, Bayamon - Puerto Rico, Juana Diaz - Puerto Rico, Las Piedras - Puerto Rico, Mayaguez - Puerto Rico, Playa de Ponce - Puerto Rico, Ponce - Puerto Rico, Ponce - Puerto Rico, Rio Piedras - Puerto Rico, San Juan - Puerto Rico, Santurce - Puerto Rico",2008-01,2005-10-10,2013-01-03,INTERVENTIONAL,PHASE4,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT02233075,Unknown,COMPLETED,2014-09,Chronic HBV Infection (HBeAg Negative),REP 2139-Ca + Pegasys (TM),"Chisinau - Moldova, Republic of",2016-11,2014-09-08,2017-09-28,INTERVENTIONAL,PHASE2,Replicor Inc.,INDUSTRY,hepatitis
NCT02032875,ALLY 1,COMPLETED,2014-03,Hepatitis C,"Daclatasvir, Sofosbuvir, Ribavirin","Miami - United States, Ann Arbor - United States, Houston - United States, San Antonio - United States, Seattle - United States",2014-11,2014-01-10,2017-02-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01531075,HBV VIP,COMPLETED,2012-04,Inflammatory Bowel Disease,"ENGERIX-B (HBV Vaccine), Sci-B-Vac",Beer- Sheva - Israel,2015-08,2012-02-10,2020-04-21,INTERVENTIONAL,NA,Soroka University Medical Center,OTHER,hepatitis
NCT05569759,Unknown,ACTIVE_NOT_RECRUITING,2023-05-23,Autoimmune Hepatitis,"zetomipzomib, placebo, zetomipzomib in open-label extension","Phoenix - United States, Los Angeles - United States, Los Angeles - United States, Redwood City - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, New Haven - United States, Jacksonville - United States, Miami - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, New Orleans - United States, Boston - United States, Boston - United States, Ann Arbor - United States, Saint Louis - United States, Manhasset - United States, New York - United States, Durham - United States, Cleveland - United States, Philadelphia - United States, Richmond - United States",2025-02,2022-10-06,2024-09-19,INTERVENTIONAL,PHASE2,"Kezar Life Sciences, Inc.",INDUSTRY,hepatitis
NCT01297270,Unknown,COMPLETED,2011-04,Hepatitis C,"BI201335, PegIFN/RBV, BI201335, Placebo","Birmingham - United States, Birmingham - United States, Dothan - United States, Phoenix - United States, North Little Rock - United States, Bakersfield - United States, Chula Vista - United States, Coronado - United States, La Jolla - United States, La Mesa - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Oceanside - United States, Poway - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Englewood - United States, New Haven - United States, Bradenton - United States, Fort Lauderdale - United States, Fort Lauderdale - United States, Hialeah - United States, Miami - United States, Orlando - United States, Orlando - United States, Palm Harbor - United States, Tampa - United States, Atlanta - United States, Columbus - United States, Decatur - United States, Chicago - United States, Chicago - United States, Vaiparaiso - United States, Baton Rouge - United States, Baton Rouge - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Chevy Chase - United States, Lutherville - United States, Framingham - United States, Springfield - United States, Tulepo - United States, Las Vegas - United States, Neptune - United States, Bronx - United States, Brooklyn - United States, New York - United States, New York - United States, New York - United States, New York - United States, Charlotte - United States, Winston-Salem - United States, Tulsa - United States, Portland - United States, Portland - United States, Germantown - United States, Jackson - United States, Nashville - United States, Nashville - United States, Arlington - United States, Austin - United States, Dallas - United States, Dallas - United States, Dallas - United States, Fort Worth - United States, Forth Worth - United States, Houston - United States, Houston - United States, San Antonio - United States, Burlington - United States, Annandale - United States, Falls Church - United States, Richmond - United States, Seattle - United States, Milwaukee - United States, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Hamilton - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, Pusan - Korea, Republic of, Pusan - Korea, Republic of, Seongnam - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, San Juan - Puerto Rico, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2014-04,2011-02-16,2015-09-18,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT02204475,Unknown,WITHDRAWN,2014-11,Hepatitis C,"Grazoprevir/Elbasvir, Boceprevir, PegIntron, Ribavarin",No locations listed,2016-06,2014-07-30,2015-10-14,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04088370,Unknown,RECRUITING,2019-10-08,Alcoholic Hepatitis,Blood Draw,Cleveland - United States,2025-12,2019-09-12,2025-01-10,OBSERVATIONAL,Not Available,The Cleveland Clinic,OTHER,hepatitis
NCT00289770,Unknown,COMPLETED,2004-11-01,"Hepatitis B, Hepatitis A",Twinrix™,Wilrijk - Belgium,2004-12-20,2006-02-10,2018-08-17,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00125775,Unknown,COMPLETED,2005-05,"Peritoneal Dialysis, Renal Disease, End-Stage",Engerix-B,New Territories - Hong Kong,2009-12,2005-08-02,2010-01-07,INTERVENTIONAL,PHASE4,Chinese University of Hong Kong,OTHER,hepatitis
NCT02025842,HBV/HCC,COMPLETED,2000-01,"Hepatocellular Carcinoma, Hepatitis B",No interventions listed,No locations listed,2013-12,2014-01-01,2014-01-01,OBSERVATIONAL,Not Available,Azienda Ospedaliera San Camillo Forlanini,OTHER,hepatitis
NCT01838070,Unknown,COMPLETED,2013-04,Hepatitis A,No interventions listed,"Seoul - Korea, Republic of",2015-11,2013-04-23,2016-07-26,OBSERVATIONAL,Not Available,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT02950870,Unknown,UNKNOWN,2016-12,"Chronic Hepatitis, C Virus","Ombitasvir-Paritaprevir-Ritonavir, Dasabuvir, Ribavirin",Modena - Italy,2017-12,2016-11-01,2016-11-01,INTERVENTIONAL,PHASE4,University of Modena and Reggio Emilia,OTHER,hepatitis
NCT01483742,Unknown,COMPLETED,2012-04,"Hepatitis C, Chronic","RO5024048, danoprevir, peginterferon alfa-2a [Pegasys], ribavirin, ritonavir","Birmingham - United States, Anaheim - United States, Coronado - United States, La Jolla - United States, Long Beach - United States, DeLand - United States, Miami - United States, Orlando - United States, Atlanta - United States, Atlanta - United States, New Orleans - United States, Detroit - United States, Hillsborough - United States, New York - United States, San Antonio - United States, Fitzroy - Australia, Melbourne - Australia, Vancouver - Canada, Toronto - Canada, Montpellier - France, Auckland - New Zealand, Christchurch - New Zealand, Chorzów - Poland, Myslowice - Poland, Warszawa - Poland, Wrocław - Poland, Bratislava - Slovakia",2013-09,2011-12-01,2016-08-01,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00216775,Unknown,COMPLETED,2004-12,"Hepatitis C, Chronic",interferon-alfa-2b and ribavirin,"Kyoto - Japan, Osaka - Japan, Osaka - Japan, Wakayama - Japan",2008-05,2005-09-22,2015-09-02,OBSERVATIONAL,Not Available,Kyoto University,OTHER,hepatitis
NCT04782375,ADAPT,ACTIVE_NOT_RECRUITING,2021-09-01,"Hepatitis B, Chronic",Stop group,"Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of",2024-08-19,2021-03-04,2025-01-29,INTERVENTIONAL,PHASE4,Asan Medical Center,OTHER,hepatitis
NCT02555475,Unknown,COMPLETED,2016-03,Hepatitis C,community based hepatitis C care and treatment,"Melbourne - Australia, Melbourne - Australia, Greenlane - New Zealand, Pt Chevalier - New Zealand, Sydenham - New Zealand, Auckland - New Zealand, Auckland - New Zealand, Auckland - New Zealand",2017-12-22,2015-09-21,2018-05-24,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT03434470,Unknown,UNKNOWN,2018-02-02,Hepatitis C Virus Infection,No interventions listed,Bergen - Norway,2019-07-30,2018-02-15,2018-02-15,OBSERVATIONAL,Not Available,Haukeland University Hospital,OTHER,hepatitis
NCT04891770,Unknown,COMPLETED,2021-08-14,Chronic Hepatitis B,"Tenofovir Alafenamide, VIR-2218, Nivolumab, Selgantolimod","Liverpool - Australia, Parkville - Australia, Aalborg - Denmark, Aarhus N - Denmark, Hvidovre - Denmark, Odense - Denmark, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Shatin - Hong Kong, Tai Po - Hong Kong, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Grafton - New Zealand, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Muang - Thailand, London - United Kingdom",2024-01-23,2021-05-18,2024-10-01,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01341275,REACH,UNKNOWN,2010-04,Hepatitis B,"hepatitis B vaccine, hepatitis B vaccine","Houston - United States, Houston - United States",2011-11,2011-04-25,2011-04-25,INTERVENTIONAL,PHASE4,Baylor College of Medicine,OTHER,hepatitis
NCT00962442,Unknown,COMPLETED,2000-09,Alcoholic Hepatitis,"N-Acetylcysteine, placebo",Brussels - Belgium,2006-01,2009-08-20,2009-08-20,INTERVENTIONAL,PHASE3,Erasme University Hospital,OTHER,hepatitis
NCT02826070,Unknown,UNKNOWN,2015-04,"Hepatitis B, Chronic","Telbivudine, Adefovir dipivoxil, off-treatment follow-up","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Wuhan - China, Changsha - China, Nanjing - China, Changchun - China, Shengyang - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, XiAn - China, Hangzhou - China",2016-10,2016-07-07,2016-07-07,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT03092375,Unknown,COMPLETED,2017-04-20,"Hepatitis C, HCV","Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet","Palo Alto - United States, San Francisco - United States, Washington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Baltimore - United States, Catonsville - United States, Boston - United States, Ann Arbor - United States, Minneapolis - United States, Jackson - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Chapel Hill - United States, Durham - United States, Columbus - United States, Oklahoma City - United States, Philadelphia - United States, Charleston - United States, Richmond - United States, Richmond - United States, Seattle - United States, Seattle - United States",2018-12-28,2017-03-27,2020-02-26,INTERVENTIONAL,PHASE3,University of Florida,OTHER,hepatitis
NCT00910975,TTG1,COMPLETED,2007-11,"Chronic Hepatitis C, Genotype 1","Peg-interferon-alfa2a (Pegasys), Ribavirin (Copegus)",Gothenburg - Sweden,2010-06,2009-06-01,2012-09-05,INTERVENTIONAL,PHASE4,Göteborg University,OTHER,hepatitis
NCT06216470,Unknown,RECRUITING,2024-03-13,"Hepatitis B, Chronic",VIR-3434,Toronto - Canada,2029-12,2024-01-22,2024-11-06,INTERVENTIONAL,PHASE2,"University Health Network, Toronto",OTHER,hepatitis
NCT02156570,DARE-C II,COMPLETED,2014-10,Hepatitis C,Sofosbuvir and ribavirin,"Sydney - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Auckland - New Zealand",2017-08,2014-06-05,2018-09-21,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT02498275,Unknown,TERMINATED,2014-07,"Hepatitis B, Chronic",No interventions listed,"Shanghai - China, Shanghai - China, Shanghai - China",2014-08,2015-07-15,2016-11-06,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02868242,Unknown,COMPLETED,2016-08-28,Hepatitis C Virus Infection,LDV/SOF,Cairo - Egypt,2018-11-12,2016-08-16,2020-03-02,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00265642,Fibrosar,COMPLETED,2006-10,"Hepatitis C, Chronic","Irbesartan, placebo",Angers - France,2013-04,2005-12-15,2014-02-07,INTERVENTIONAL,PHASE3,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT02758509,Unknown,COMPLETED,2010-01-01,"Chronic Hepatitis C, Cirrhosis","Pegylated interferon alfa-2a + Ribavirin, Pegylated interferon alfa-2a + Ribavirin + Boceprevir, Pegylated interferon alfa-2a + Ribavirin +Telaprevir, Ledipasvir/Sofosbuvir, Ombitasvir/paritaprevir/ritonavir+Dasabuvir, Daclatasvir+Sofosbuvir, Simeprevir+Sofosbuvir",No locations listed,2017-06-15,2016-05-02,2018-05-21,OBSERVATIONAL,Not Available,Parc de Salut Mar,OTHER,hepatitis
NCT00301509,Unknown,COMPLETED,2002-01,"Liver Cirrhosis, Experimental",peginterferon and ribavirin,San Giovanni Rotondo - Italy,Unknown Date,2006-03-13,2006-03-13,INTERVENTIONAL,PHASE3,Casa Sollievo della Sofferenza IRCCS,OTHER,hepatitis
NCT05734807,Unknown,COMPLETED,2022-07-20,Chronic HBV Infection,"Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003, NrtIs and PEG-IFN-α","Beijing - China, Beijing - China, Beijing - China, Fuzhou - China, Guangzhou - China, Zhengzhou - China, Changchun - China, Jinan - China",2024-04-17,2023-02-21,2024-10-15,INTERVENTIONAL,PHASE2,Huahui Health,INDUSTRY,hepatitis
NCT01264107,Unknown,COMPLETED,2009-04,Chronic Hepatitis B,No interventions listed,"Wonju, Kangwon-do 162 Ilsan-dong, Wonju, Kangwon-do - Korea, Republic of",2012-01,2010-12-21,2012-07-26,OBSERVATIONAL,Not Available,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT02254707,Unknown,COMPLETED,2004-07,"Hepatitis C, Chronic","BILB 1941 ZW, Placebo",No locations listed,2006-04,2014-10-02,2014-10-02,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00514709,Unknown,COMPLETED,2007-09,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Influenza","DTaP-HB PRP~T Combined Vaccine, DTaP-HB-PRP~T vaccine, Oral Polio Vaccine","Muntinlupa City - Philippines, Muntinlupa City - Philippines, Muntinlupa City - Philippines, Muntinlupa City - Philippines, Muntinlupa City - Philippines, Muntinlupa City - Philippines, Muntinlupa City - Philippines",2008-12,2007-08-10,2016-08-02,INTERVENTIONAL,PHASE3,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT00295607,CHASE,COMPLETED,2005-06,"Hepatitis C, Liver Transplantation","Tacrolimus, steroids, monoclonal anti-IL2R antibody","Praha - Czech Republic, Besancon - France, Lyon - France, Nice - France, Villejuif - France, Berlin - Germany, Hamburg - Germany, Mainz - Germany, Bologna - Italy, Genova - Italy, Modena - Italy, Warszawa - Poland, Barakaldo - Spain, Madrid - Spain, Santiago - Spain, Goteborg - Sweden, London - United Kingdom",2008-06,2006-02-24,2013-04-11,INTERVENTIONAL,PHASE2,Astellas Pharma Inc,INDUSTRY,hepatitis
NCT06250309,Unknown,RECRUITING,2023-10-23,Autoimmune Hepatitis,Dietary assignment,Indianapolis - United States,2027-12-31,2024-02-09,2024-02-21,INTERVENTIONAL,NA,Indiana University,OTHER,hepatitis
NCT03221309,ANCHOR,ACTIVE_NOT_RECRUITING,2017-05-01,"HCV, Buprenorphine, PreP",Evaluate model of care for HCV-infected adults with on-going opioid misuse,"Washington - United States, Baltimore - United States",2021-01-22,2017-07-18,2024-09-03,OBSERVATIONAL,Not Available,"University of Maryland, Baltimore",OTHER,hepatitis
NCT04508907,Unknown,RECRUITING,2020-09-10,"Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection",Mavyret,Phoenix - United States,2024-12-31,2020-08-11,2024-03-12,INTERVENTIONAL,PHASE4,Mayo Clinic,OTHER,hepatitis
NCT02063607,Unknown,COMPLETED,2013-12,Hepatitis C,Peginterferon lambda,Hanoi - Vietnam,2015-02,2014-02-14,2016-12-15,INTERVENTIONAL,PHASE1,Nanogen Pharmaceutical Biotechnology Joint Stock Company,INDUSTRY,hepatitis
NCT00863109,VIDA,COMPLETED,2009-04,"Hepatitis C, Chronic, Genotype 1, HCV-1","Peginterferon alfa-2b (PEG), Ribavirin (RBV)",No locations listed,2013-05,2009-03-17,2017-04-07,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00517309,FUTURE,COMPLETED,2001-12-28,"Cervical Cancer, Genital Warts","V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years, Comparator: placebo (concomitant-vaccine matched) / Duration of Treatment : 4 Years",No locations listed,2004-06-08,2007-08-16,2017-03-22,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04211909,Unknown,COMPLETED,2020-01-03,Hepatitis C Virus Infection,"SOF/VEL, SOF/VEL/VOX","Seongnam-si - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Gwangju - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Jeonju - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Yangsan - Korea, Republic of",2020-11-12,2019-12-26,2021-10-27,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00065507,Unknown,COMPLETED,2003-08,Hepatitis B,"Entecavir (ETV), Adefovir (ADV)","San Diego - United States, San Francisco - United States, New Haven - United States, Miami - United States, Atlanta - United States, Honolulu - United States, Indianapolis - United States, Louisville - United States, Baltimore - United States, Detroit - United States, New York - United States, New York - United States, Oklahoma City - United States, Dallas - United States, Dallas - United States, Richmond - United States, Porto Alegre - Rs - Brazil, Sao Paulo - Sp - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Calgary - Canada, Vancouver - Canada, Clichy Cedex - France, Strasbourg - France, Athens - Greece, Athens - Greece, Athens - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Tai Po - Hong Kong, Hyderabad - India, Kolkata - India, Lucknow - India, New Delhi - India, Jakarta - Indonesia, Cebu - Philippines, Manila - Philippines, Bydgoszcz - Poland, Chorzow - Poland, Krakow - Poland, Lodz - Poland, Moscow - Russian Federation, Moscow - Russian Federation, Smolensk - Russian Federation, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Observatory - South Africa, Paarl - South Africa, Changhua - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Tianan - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Hatyai - Thailand, Adana - Turkey, Izmir - Turkey, London - United Kingdom",2008-10,2003-07-29,2013-06-24,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01441609,Unknown,UNKNOWN,2011-08,Hepatitis B,No interventions listed,Chifeng - China,2012-04,2011-09-27,2011-09-28,OBSERVATIONAL,Not Available,Beijing Municipal Science & Technology Commission,OTHER,hepatitis
NCT02847507,VIhVhEpb,COMPLETED,2016-07,"HIV, Hepatitis E",No interventions listed,Bayonne - France,2018-01-31,2016-07-28,2018-07-17,OBSERVATIONAL,Not Available,Centre Hospitalier de la côte Basque,OTHER,hepatitis
NCT01896609,Quadritherapy,UNKNOWN,2013-06,Chronic Hepatitis c,"Reiferon Retard in Arm 1, Bon one in Arm 3, Xerovirinc in Arm 2, Ribavirin in Arm 1",Cairo - Egypt,2015-01,2013-07-11,2013-07-11,INTERVENTIONAL,PHASE4,MinaPharm Pharmaceuticals,INDUSTRY,hepatitis
NCT00803309,OPTEX2/3,TERMINATED,2008-11,"Hepatitis C, Chronic","pegylated interferon alpha-2b, Ribavirin, pegylated Interferon alpha-2b, Ribavirin","Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Bremen - Germany, Burghausen/Altötting - Germany, Dortmund - Germany, Dresden - Germany, Düsseldorf - Germany, Essen - Germany, Frankfurt - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Hannover - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Homburg - Germany, Jena - Germany, Kiel - Germany, Kiel - Germany, Leipzig - Germany, Leverkusen - Germany, Lübeck - Germany, Magdeburg - Germany, Mainz - Germany, Mannheim - Germany, Minden - Germany, München - Germany, Münster - Germany, Nürnberg - Germany, Oberhausen - Germany, Offenbach - Germany, Offenburg - Germany, Regensburg - Germany, Rotenburg (Wuemme) - Germany, Stuttgart - Germany, Tübingen - Germany, Ulm - Germany, Würzburg - Germany",2013-08,2008-12-05,2017-08-28,INTERVENTIONAL,PHASE4,"HepNet Study House, German Liverfoundation",NETWORK,hepatitis
NCT02417207,Unknown,UNKNOWN,2015-04,"Hepatitis B, Liver Transplantation","Entecavir combined long-term low-dose HBIG group intramuscular, Entecavir combined HBIG group short-term high-dose intravenous",Guangzhou - China,2018-04,2015-04-15,2015-04-15,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04682509,Unknown,COMPLETED,2022-03-20,ESRD,Glecaprevir/pibrentasvir,New York - United States,2023-05-16,2020-12-23,2024-06-25,INTERVENTIONAL,PHASE1,NYU Langone Health,OTHER,hepatitis
NCT03882307,Unknown,UNKNOWN,2022-10,"Hepatitis C, Chronic",sofosbuvir and daclatasvir,Assiut - Egypt,2022-11,2019-03-20,2022-07-26,INTERVENTIONAL,PHASE1,Assiut University,OTHER,hepatitis
NCT01070407,Unknown,COMPLETED,2007-07,Hepatitis C,"Ad6NSmut; AdCh3NSmut, Ad6NSmut; AdCh3NSmut, Ad6NSmut; AdCh3NSmut, AdCh3NSmut; Ad6NSmut, AdCh3NSmut; Ad6NSmut, AdCh3NSmut; Ad6NSmut, Ad6NSmut; AdCh3NSmut, AdCh3NSmut; Ad6NSmut, AdCh3NSmut; Ad6NSmut","Oxford - United Kingdom, Birmingham - United Kingdom",2010-08,2010-02-18,2015-04-23,INTERVENTIONAL,PHASE1,ReiThera Srl,INDUSTRY,hepatitis
NCT00347009,Unknown,COMPLETED,2005-05,"Hepatitis B, Chronic, Cirrhosis, Fibrosis, Chronic Hepatitis B",adefovir dipivoxil,"Pokfulam - Hong Kong, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Sungnam-City - Korea, Republic of, Singapore - Singapore, Kaohsiung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Ho Chi Minh City - Vietnam",2009-09,2006-07-04,2012-06-04,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01645007,Unknown,WITHDRAWN,Unknown Date,Hepatitis B,No interventions listed,No locations listed,Unknown Date,2012-07-19,2014-06-18,OBSERVATIONAL,Not Available,Western Galilee Hospital-Nahariya,OTHER_GOV,hepatitis
NCT02332707,Unknown,COMPLETED,2015-01-22,Hepatitis C,"Grazoprevir, Uprifosbuvir, Elbasvir, Ruzasvir, Uprifosbuvir (+) Grazoprevir (+) Ruzasvir, Ribavirin",No locations listed,2016-09-16,2015-01-07,2019-07-23,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00705107,Unknown,TERMINATED,2004-11,"Hepatitis C, Chronic, Hepatitis C","PegIntron pen (peginterferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2007-11,2008-06-25,2015-06-30,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01766115,Unknown,WITHDRAWN,2013-04,Viral Hepatitis C,Telaprevir,Boston - United States,2014-05,2013-01-11,2014-08-13,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT05103085,TROCENDO,UNKNOWN,2022-01-24,Hepatitis C,Rapid diagnostic orientation test (TROD) for Hepatitis C,Marseille - France,2023-03,2021-11-02,2022-02-10,OBSERVATIONAL,Not Available,Hôpital Européen Marseille,OTHER,hepatitis
NCT01957085,Unknown,COMPLETED,2014-06,Hepatitis C,observation only,Philadelphia - United States,2015-12,2013-10-08,2020-04-24,OBSERVATIONAL,Not Available,Temple University,OTHER,hepatitis
NCT02809885,HEV,UNKNOWN,2013-12-19,Transplantation,Hepatitis E serology,Bron - France,2017-12-19,2016-06-22,2017-08-09,INTERVENTIONAL,NA,Hospices Civils de Lyon,OTHER,hepatitis
NCT00445315,Unknown,COMPLETED,2007-01,Hepatitis C,"PF-00868554, PF-00868554, PF-00868554, PF-00868554, Placebo","Bruxelles - Belgium, Berlin - Germany, Berlin - Germany, Dundee - United Kingdom",2008-06,2007-03-08,2014-02-17,INTERVENTIONAL,PHASE1,Pfizer,INDUSTRY,hepatitis
NCT01121185,MBL-HCV1,TERMINATED,2010-06,"HCV Infection, Liver Transplantation","MBL-HCV1, 0.9% Sodium chloride Placebo","New Haven - United States, Boston - United States, Boston - United States, Burlington - United States, Detroit - United States, New York - United States, Cleveland - United States, Memphis - United States",2011-06,2010-05-12,2016-06-14,INTERVENTIONAL,PHASE2,MassBiologics,OTHER,hepatitis
NCT01018615,Unknown,COMPLETED,2009-11,"Chronic Hepatitis C, Oxidative Stress","silymarin, green tea extract (EGCG)",Chapel Hill - United States,2013-04,2009-11-23,2017-04-18,INTERVENTIONAL,PHASE1,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT04672915,Unknown,UNKNOWN,2020-12-21,Chronic Hepatitis b,test of HBV DNA,Xi'an - China,2022-11-15,2020-12-17,2022-03-31,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT00197015,Unknown,COMPLETED,2003-10-06,Hepatitis A,"Havrix®, M-M-R®II, VARIVAX®","Cabot - United States, Jonesboro - United States, North Little Rock - United States, Huntington Beach - United States, Oakland - United States, Rolling Hills Estates - United States, Norwich - United States, Jacksonville - United States, Marietta - United States, Waterloo - United States, Waukee - United States, Lexington - United States, Bossier City - United States, Baltimore - United States, Henderson - United States, Las Vegas - United States, Albany - United States, Brooklyn - United States, Rochester - United States, Syracuse - United States, Lumberton - United States, Sylva - United States, Cleveland - United States, University Heights - United States, Tulsa - United States, Beaver Falls - United States, Norristown - United States, Pittsburgh - United States, Pittsburgh - United States, Rydal - United States, Sellersville - United States, Warwick - United States, Bristol - United States, Kingsport - United States, Kingsport - United States, Austin - United States, San Antonio - United States, Temple - United States, Layton - United States, South Jordan - United States, Norfolk - United States, Marshfield - United States",2009-06-09,2005-09-20,2018-07-31,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00561015,Unknown,COMPLETED,2007-12,"Hepatitis C, Chronic","Telaprevir, Peg-IFN-alfa-2a + Ribavirin (Standard Treatment), Placebo","Clichy - France, Creteil N/A - France, Lyon - France, Paris - France, Vandoeuvre Les Nancy - France, Stockholm - Sweden, London - United Kingdom",2008-06,2007-11-20,2013-06-17,INTERVENTIONAL,PHASE2,Tibotec BVBA,INDUSTRY,hepatitis
NCT06650852,Unknown,ACTIVE_NOT_RECRUITING,2024-10-31,Chronic Hepatitis B Virus (HBV) Infection,"BRII-179, BRII-835 (VIR-2218), PEG-IFNα, Placebo of BRII-179, Placebo of BRII-835","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Guangzhou - China, Guangzhou - China, Shenzhen - China, Shanghai - China, Shanghai - China, Chengdu - China, Chengdu - China, Chengdu - China, Hangzhou - China",2026-05,2024-10-21,2025-02-11,INTERVENTIONAL,PHASE2,Brii Biosciences Limited,INDUSTRY,hepatitis
NCT03714152,Unknown,COMPLETED,2018-11-13,Chronic Hepatitis B,"ABI-H2158, Placebo for ABI-H2158","Coronado - United States, San Diego - United States, San Francisco - United States, Hillsborough - United States, Clayton - Australia, Melbourne - Australia, Nedlands - Australia, Jilin - China, Hong Kong - Hong Kong, Chuncheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, London - United Kingdom",2020-11-23,2018-10-22,2021-01-27,INTERVENTIONAL,PHASE1,Assembly Biosciences,INDUSTRY,hepatitis
NCT00132652,Unknown,COMPLETED,2005-02,Chronic Hepatitis B,"Lamivudine, Telbivudine","San Diego - United States, New York - United States, Philadelphia - United States, Westmead - Australia, Toronto - Canada, Montreal - Canada, Beijing - China, Nice - France, Tel Aviv - Israel, Auckland - New Zealand, Singapore - Singapore, Tainan - Taiwan, Chiang Mai - Thailand, London - United Kingdom",2006-12,2005-08-22,2017-02-23,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT02401737,Unknown,COMPLETED,2015-01-31,Chronic Hepatitis B,"NVR 3-778, Placebo for NVR 3-778, Pegasys","Costa Mesa - United States, Pasadena - United States, San Diego - United States, San Francisco - United States, Hong Kong - China, Chuncheon - Korea, Republic of, Seongnam - Korea, Republic of, Singapore - Singapore, Kaohsiung - Taiwan, Keelung - Taiwan",2016-05-18,2015-03-30,2017-10-18,INTERVENTIONAL,PHASE1,"Novira Therapeutics, Inc.",INDUSTRY,hepatitis
NCT03215732,AMBASS,COMPLETED,2017-10-19,Chronic Hepatitis b,HBV testing with dried blood spots (DBS) technique,Niakhar - Senegal,2019-07-31,2017-07-12,2019-09-09,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT02206932,Unknown,WITHDRAWN,2014-08,"Hepatitis C, Chronic, HIV CDC Category A1",Sofosbuvir + Simeprevir,San Francisco - United States,2015-09,2014-08-01,2019-06-13,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,hepatitis
NCT03510637,HepNile,UNKNOWN,2018-01-22,Chronic Hepatitis C,No interventions listed,"Cairo - Egypt, Cairo - Egypt, Cairo - Egypt",2020-08,2018-04-27,2019-07-29,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT02224456,Unknown,COMPLETED,2015-03-25,"Hepatitis B, Chronic",Tenofovir disoproxil fumarate,"Guangzhou - China, Wuhan - China, Nanjing - China, Nanjing - China, Changchun - China, Xian - China, Chengdu - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Hangzhou - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Taiyuan - China, Xi'an - China, Zhengzhou - China",2020-12-04,2014-08-25,2022-02-14,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03361956,Unknown,COMPLETED,2018-02-13,Hepatitis B,"JNJ-56136379, Placebo, NA (ETV or TDF)","Bakersfield - United States, Orlando - United States, Chicago - United States, New Orleans - United States, Hillsborough - United States, New York - United States, Pittsburgh - United States, Antwerpen - Belgium, Bruxelles - Belgium, Edegem - Belgium, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Montreal - Canada, Toronto - Canada, Beijing - China, Beijing - China, Changchun - China, Guangzhou - China, Clichy - France, Lyon - France, Paris - France, Villejuif - France, Berlin - Germany, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Hong Kong - Hong Kong, Shatin - Hong Kong, Milano - Italy, Milano - Italy, Pisa - Italy, Hiroshima-shi - Japan, Musashino - Japan, Nagasaki - Japan, Nagoya - Japan, Suita-shi - Japan, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Alor Setar - Malaysia, Kuala Lumpur - Malaysia, Chorzow - Poland, Kielce - Poland, Myslowice - Poland, Wroclaw - Poland, Ekaterinburg - Russian Federation, Novosibirsk - Russian Federation, Samara - Russian Federation, Stavropol - Russian Federation, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Santander - Spain, Sevilla - Spain, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Tao-Yuan - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Songkla - Thailand, Istanbul - Turkey, İstanbul - Turkey, Izmir - Turkey, Trabzon - Turkey, Kharkiv - Ukraine, Kharkiv - Ukraine, Odessa - Ukraine, Vinnytsya - Ukraine, Crumpsall - United Kingdom, London - United Kingdom, Newcastle upon Tyne - United Kingdom, Nottingham - United Kingdom",2019-09-05,2017-12-05,2022-11-17,INTERVENTIONAL,PHASE2,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT00659256,Unknown,COMPLETED,2008-04-08,"Chronic Hepatitis C, Atherosclerosis",No interventions listed,Bethesda - United States,Unknown Date,2008-04-16,2019-12-12,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00546715,Unknown,COMPLETED,2007-11,Chronic Hepatitis C,"Daclatasvir, Placebo","Anaheim - United States, Orlando - United States, Baltimore - United States, Rochester - United States, Hamilton - United States, Philadelphia - United States, Charlottesville - United States",2008-05,2007-10-19,2015-11-18,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00372385,Unknown,COMPLETED,2006-08,Chronic Hepatitis C,"Ribavirin, Pegylated Interferon Alfa 2a, Placebo, Telaprevir","Call For Information - Austria, Call For Information - France, Call For Information - Germany, Call for Information - United Kingdom",2008-05,2006-09-06,2014-07-23,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01086085,Unknown,COMPLETED,2010-04,"Hepatitis B, Chronic","Adefovir, peginterferon alfa-2a [PEGASYS], peginterferon alfa-2a [PEGASYS], peginterferon alfa-2a [PEGASYS]","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Guangzhou - China, Shanghai - China, Shanghai - China, Shanghai - China, Wuhan - China, Xi'an - China",2013-03,2010-03-12,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03903185,Unknown,COMPLETED,2019-03-01,"Hepatitis C, Chronic, Hematologic Malignancy",Ledipasvir / Sofosbuvir Oral Product,"Cairo - Egypt, Cairo - Egypt",2023-07-01,2019-04-04,2023-08-22,INTERVENTIONAL,PHASE2,Ain Shams University,OTHER,hepatitis
NCT02124785,Unknown,WITHDRAWN,2015-05,Hepatitis A,Blood sampling,Wilrijk - Belgium,2019-07,2014-04-28,2015-11-18,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00830609,DARGEN-3,COMPLETED,2008-11,Chronic Hepatitis C,"Peginterferon alfa 2 A, Peginterferon alfa 2 A, ribavirin + Epo Beta, ribavirin, ribavirin, Peginterferon alfa 2, ribavirin","Badalona - Spain, L´Hospitalet de Llobregat - Spain, Sabadell - Spain, San Sebastian - Spain, Alcorcón - Spain, Getafe - Spain, Majadahonda - Spain, Marbella - Spain, Barcelona - Spain, Barcelona - Spain, Córdoba - Spain, Granada - Spain, Granada - Spain, León - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Málaga - Spain, Oviedo - Spain, Salamanca - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, Valladolid - Spain, Vitoria - Spain, Zaragoza - Spain, Zaragoza - Spain",2011-09,2009-01-28,2012-03-13,INTERVENTIONAL,PHASE4,Dr. Conrado Fernandez,OTHER,hepatitis
NCT02527707,LOWR-4,COMPLETED,2015-09,Chronic Delta Hepatitis,"lonafarnib, Ritonavir",No locations listed,2016-08,2015-08-19,2023-06-22,INTERVENTIONAL,PHASE2,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT01288209,Unknown,COMPLETED,2011-02,"Hepatitis C, Chronic","TMC435, Peginterferon alfa-2a (PegIFNα-2a ), Ribavirin (RBV)","Amagasaki - Japan, Ichikawa - Japan, Kagoshima - Japan, Kanazawa - Japan, Kawasaki - Japan, Kitakyushu - Japan, Kumamoto - Japan, Kurume - Japan, Kyoto - Japan, Matsumoto - Japan, Musashino - Japan, Nishinomiya - Japan, Osaka-Sayama - Japan, Osaka - Japan, Sakai - Japan, Sapporo - Japan, Suita - Japan, Tokyo - Japan, Yokohama - Japan",2012-09,2011-02-02,2014-01-24,INTERVENTIONAL,PHASE3,Janssen Pharmaceutical K.K.,INDUSTRY,hepatitis
NCT06525909,Unknown,RECRUITING,2024-01-20,"Hepatitis B, Chronic",No interventions listed,"Wuhan - China, Beijing - China, Changchun - China, Chongqing - China, Nanjing - China",2026-12-01,2024-07-29,2024-07-29,OBSERVATIONAL,Not Available,Tongji Hospital,OTHER,hepatitis
NCT00824707,Unknown,COMPLETED,2008-12,Primary Liver Cancer,"Entecavir, conventional therapy",Shanghai - China,2010-11,2009-01-19,2016-04-01,INTERVENTIONAL,NA,Eastern Hepatobiliary Surgery Hospital,OTHER,hepatitis
NCT03415009,Unknown,COMPLETED,2014-06,Hepatitis C,No interventions listed,Singapore - Singapore,2016-06,2018-01-30,2018-01-30,OBSERVATIONAL,Not Available,Changi General Hospital,OTHER,hepatitis
NCT01951209,Unknown,TERMINATED,2016-11-17,"Liver Cirrhosis, Chronic Hepatitis C","Rifaximin, Placebo",Philadelphia - United States,2016-11-17,2013-09-26,2021-03-11,INTERVENTIONAL,NA,"David E. Kaplan, MD MSc",FED,hepatitis
NCT04352309,EASY,COMPLETED,2020-05-29,Hepatitis C Virus (HCV),No interventions listed,"Chelyabinsk - Russian Federation, Irkutsk - Russian Federation, Oryol - Russian Federation, Samara - Russian Federation, Stavropol - Russian Federation, Ulyanovsk - Russian Federation",2021-06-11,2020-04-20,2022-06-09,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT03316807,HIV,COMPLETED,2014-10,Hepatitis B Vaccine,"60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine",No locations listed,2015-07,2017-10-20,2022-03-11,INTERVENTIONAL,PHASE4,Suping Wang,OTHER,hepatitis
NCT01818856,Unknown,COMPLETED,2012-12,"Hepatitis C, Chronic, HIV Infection","Ritonavir withdrawal, atazanavir 200 mg/12h, Telaprevir interactions",Seville - Spain,2013-04,2013-03-27,2013-04-22,INTERVENTIONAL,PHASE1,Hospitales Universitarios Virgen del Rocío,OTHER,hepatitis
NCT02201407,Unknown,COMPLETED,2014-12-18,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Belgrade - Serbia, Belgrade - Serbia, Belgrade - Serbia, Kragujevac - Serbia, NIS - Serbia, Novi Sad - Serbia",2017-04-10,2014-07-28,2017-08-31,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03775109,ISAIAH,COMPLETED,2019-02-12,Alcoholic Hepatitis,"Canakinumab 150mg/ml solution for injection, Placebo","Bristol - United Kingdom, Glasgow - United Kingdom, Glasgow - United Kingdom, Leeds - United Kingdom, Liverpool - United Kingdom, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Plymouth - United Kingdom, Southampton - United Kingdom",2023-03-31,2018-12-13,2025-03-11,INTERVENTIONAL,PHASE2,Imperial College London,OTHER,hepatitis
NCT04385407,Unknown,COMPLETED,2015-04,Chronic Hepatitis C Virus Infection,Sofosbuvir + Simeprevir + Ribavirin,No locations listed,2016-07,2020-05-12,2020-05-12,INTERVENTIONAL,PHASE2,Beni-Suef University,OTHER,hepatitis
NCT03226509,Unknown,COMPLETED,2016-09-01,"Hepatitis C, Chronic",No interventions listed,Pittsburgh - United States,2019-09-30,2017-07-21,2021-01-19,OBSERVATIONAL,Not Available,University of Pittsburgh,OTHER,hepatitis
NCT02625909,REACT,COMPLETED,2017-03-09,Hepatitis C,"SOF/VEL for 6 weeks, SOF/VEL for 12 weeks","Baltimore - United States, Boston - United States, Sydney - Australia, Sydney - Australia, Sydney - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Montreal - Canada, Berlin - Germany, Berlin - Germany, Bonn - Germany, Frankfurt - Germany, Amsterdam - Netherlands, Auckland - New Zealand, Zürich - Switzerland, Bern - Switzerland, Lugano - Switzerland, Brighton - United Kingdom, Manchester - United Kingdom, London - United Kingdom, London - United Kingdom",2020-03-23,2015-12-09,2021-11-24,INTERVENTIONAL,PHASE3,Kirby Institute,OTHER_GOV,hepatitis
NCT00172809,Unknown,COMPLETED,2005-07,"Chronic Hepatitis C, End Stage Renal Disease","Peginterferon alfa-2a, Interferon alfa-2a",Douliou - Taiwan,2006-06,2005-09-15,2008-03-06,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT05446532,Unknown,UNKNOWN,2022-06-15,Hepatitis B,No interventions listed,Sabadell - Spain,2022-10-31,2022-07-06,2022-07-06,OBSERVATIONAL,Not Available,Corporacion Parc Tauli,OTHER,hepatitis
NCT03122132,3D8,COMPLETED,2017-02-20,Hepatitis C Infection,"ombitasvir/paritaprevir/ritonavir 8 weeks, dasabuvir 8 weeks",Barcelona - Spain,2018-01-01,2017-04-20,2018-05-21,OBSERVATIONAL,Not Available,Hepa C,OTHER,hepatitis
NCT02774837,DUAL,UNKNOWN,2016-04,Chronic Hepatitis B,"Tenofovir disoproxil, Telbivudine",Singapore - Singapore,2020-07,2016-05-17,2019-03-18,INTERVENTIONAL,PHASE4,Seng Gee Lim,OTHER,hepatitis
NCT01629732,Unknown,WITHDRAWN,2013-03,Hepatitis C Virus,"Daclatasvir, Daclatasvir, BMS-986094, BMS-986094, BMS-986094, Ribavirin, Placebo for BMS-986094",Orlando - United States,2014-02,2012-06-28,2014-05-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT06196632,Unknown,RECRUITING,2024-01-06,"Hepatitis B, Chronic",Peginterferon-α; Nucleoside analogs,Jinan - China,2024-07-31,2024-01-09,2024-02-07,OBSERVATIONAL,Not Available,Qilu Hospital of Shandong University,OTHER,hepatitis
NCT01667432,Unknown,COMPLETED,2011-07-08,"Hepatitis B, Chronic",Peginterferon alfa-2a,"Pleven - Bulgaria, Plovdiv - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Varna - Bulgaria",2014-08-12,2012-08-17,2017-04-10,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00148837,Unknown,UNKNOWN,2004-09,"Hepatitis C, Chronic, Fibrosis","Peg-interferon alpha 2b (drug), Ribavirin (drug), Prazosin (drug)",Pessac - France,Unknown Date,2005-09-08,2008-02-08,INTERVENTIONAL,PHASE2,French National Agency for Research on AIDS and Viral Hepatitis,OTHER_GOV,hepatitis
NCT02457637,Ch-CANONIC,COMPLETED,2015-01-01,"Liver Failure, Acute on Chronic",Standary therapy,"Beijing - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Tianjing - China, Zhengzhou - China, Shiyan - China, Wuhan - China, Changsha - China, Changchun - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Ürümqi - China",2016-12-31,2015-05-29,2020-08-11,OBSERVATIONAL,Not Available,Hai Li,OTHER,hepatitis
NCT02642432,EXPEDITION-1,COMPLETED,2015-12-07,"Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis",ABT-493/ABT-530,No locations listed,2016-10-27,2015-12-30,2021-07-13,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02265237,AGATE-1,COMPLETED,2014-10-28,Hepatitis C Virus,"ombitasvir/paritaprevir/ritonavir, ribavirin",No locations listed,2016-07-28,2014-10-15,2017-08-31,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02994537,Unknown,UNKNOWN,2013-10,"Hepatitis, Autoimmune",Different biochemical results or pathogenesis.,Chengdu - China,2022-06-01,2016-12-16,2022-04-29,OBSERVATIONAL,Not Available,Li Yang,OTHER,hepatitis
NCT03061032,HepCC-2,UNKNOWN,2017-03,Hepatitis C,"Sofosbuvir/Ledipasvir 12W, Sofosbuvir/Ledipasvir plus Ribavirin 12W, Sofosbuvir/Ledipasvir 24W, Sofosbuvir/Ledipasvir plus Ribavirin 24W",No locations listed,2018-12,2017-02-23,2017-02-23,INTERVENTIONAL,PHASE3,Iran Hepatitis Network,OTHER,hepatitis
NCT00199732,DNA-EVAL,COMPLETED,2004-12,Chronic Hepatitis B,No interventions listed,"Limoges - France, Limoges - France, Limoges - France, Limoges - France",2009-07,2005-09-20,2013-04-17,OBSERVATIONAL,Not Available,"University Hospital, Limoges",OTHER,hepatitis
NCT01217632,Unknown,TERMINATED,2010-08,Liver Fibrosis Due to Chronic Hepatitis B Infection,"FG-3019, Placebo, Entecavir","Pokfulam - Hong Kong, Wanchai - Hong Kong, Shatin - Hong Kong, Kowloon - Hong Kong, New Territories - Hong Kong, Tai Po - Hong Kong, Siriaj - Thailand, Amphur Muang - Thailand, Amphur Hatyai - Thailand",2015-06,2010-10-08,2016-08-16,INTERVENTIONAL,PHASE2,FibroGen,INDUSTRY,hepatitis
NCT00315432,Unknown,COMPLETED,2000-09,"Hepatitis C, HIV, Anemia",Pegylated Interferon and Ribavirin,No locations listed,Unknown Date,2006-04-18,2011-05-19,INTERVENTIONAL,PHASE2,"Ortho Biotech Products, L.P.",INDUSTRY,hepatitis
NCT06755632,DEP-CB,NOT_YET_RECRUITING,2025-02-01,Liver Pathology,TROD (rapid diagnostic orientation test) and FibroScan®,Bobigny - France,2026-02-01,2025-01-01,2025-01-01,INTERVENTIONAL,NA,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT02011932,Unknown,ACTIVE_NOT_RECRUITING,2010-07,"Hepatitis C, Chronic, Disease Progression, Liver Cirrhosis",No interventions listed,No locations listed,2011-06,2013-12-16,2013-12-17,OBSERVATIONAL,Not Available,Beijing YouAn Hospital,OTHER,hepatitis
NCT04724785,REACH,UNKNOWN,2020-12-01,"Sustained Virologic Response, Hepatitis B, Chronic","only monitoring, monitoring and regimen change if necessary, regimen change",Chongqing - China,2022-07-01,2021-01-26,2021-08-05,OBSERVATIONAL,Not Available,The Second Affiliated Hospital of Chongqing Medical University,OTHER,hepatitis
NCT00709085,Unknown,UNKNOWN,2008-04,Liver Cirrhosis,No interventions listed,Taipei - Taiwan,2009-12,2008-07-03,2009-11-25,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT02106156,Unknown,COMPLETED,2008-01,Chronic Hepatitis C,"Pegylated interferon alfa-2a, Ribavirin",Herne - Germany,2013-09,2014-04-08,2016-09-23,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01911156,Stop,UNKNOWN,2013-07,Chronic Hepatitis B,"Continue NA treatment, Discontinue NA Treatment","Toronto - Canada, Toronto - Canada",2016-01,2013-07-30,2015-05-28,INTERVENTIONAL,PHASE4,"University Health Network, Toronto",OTHER,hepatitis
NCT01554085,Unknown,TERMINATED,2011-12-31,"Hepatitis C, Chronic","ALS-002158, Placebo","Brisbane - Australia, Adelaide - Australia, Perth - Australia, Auckland - New Zealand, Christchurch - New Zealand",2012-09-30,2012-03-14,2017-10-31,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT01508156,Unknown,COMPLETED,2012-01,"Hepatitis C, Chronic","IDX719, Placebo",No locations listed,2012-07,2012-01-11,2015-04-27,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00704756,PEGIMPACT,WITHDRAWN,2009-01,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b; SCH 54031), Rebetol (ribavirin; SCH 18908)",No locations listed,2010-03,2008-06-25,2014-08-11,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04028856,Unknown,COMPLETED,2018-06-01,Chronic Hepatitis B,interferon,Beijing - China,2019-06-30,2019-07-23,2019-07-23,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT02945956,Unknown,UNKNOWN,2018-04-05,Portal Hypertension,"Entecavir, Entecavir + Fuzheng Huayu","Shanghai - China, Shanghai - China, Shanghai - China",2020-06,2016-10-26,2020-02-13,INTERVENTIONAL,PHASE4,ShuGuang Hospital,OTHER,hepatitis
NCT05181956,Unknown,UNKNOWN,2022-01-03,Chronic Hepatitis D Infection With Hepatitis B,No interventions listed,Los Angeles - United States,2022-12-31,2022-01-10,2022-01-10,OBSERVATIONAL,Not Available,Asian Pacific Liver Center at Coalition of Inclusive Medicine,OTHER,hepatitis
NCT00096785,Unknown,COMPLETED,2004-12,"Hepatitis B, Chronic Disease","entecavir, adefovir","San Diego - United States, San Francisco - United States, Torrance - United States, Miami - United States, North Miami Beach - United States, Baltimore - United States, New York - United States, New York - United States, Philadelphia - United States, Dallas - United States, Galveston - United States, Edmonton - Canada, Vancouver - Canada, Toronto - Canada, Chai Wan - Hong Kong, Pokfulham - Hong Kong, Tai Po - Hong Kong, Jakarta - Indonesia, Cebu - Philippines, Manila - Philippines, Singapore - Singapore, Taichung - Taiwan, Taoyan - Taiwan, Bankok - Thailand",2006-01,2004-11-16,2010-08-10,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01595685,TERESA,COMPLETED,2012-05,Chronic Viral Hepatitis B Without Delta-agent,"Telbivudine, Entecavir","Seoul - Korea, Republic of",2014-12,2012-05-10,2017-01-26,INTERVENTIONAL,PHASE3,Asan Medical Center,OTHER,hepatitis
NCT02817685,Unknown,UNKNOWN,2016-05,Chronic Hepatitis B,"3 months, 6 months, 3 month ultrasound(US)+3 month CT/MRI+3 month US+3 month CT/MRI",Guangzhou - China,2020-05,2016-06-29,2016-06-29,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04717856,Unknown,UNKNOWN,2020-10-21,"Drug Use, Hepatitis C",screening: HCV RNA test and risk factors questionaire,Diepenbeek - Belgium,2021-10-21,2021-01-22,2021-01-22,INTERVENTIONAL,NA,Hasselt University,OTHER,hepatitis
NCT01276756,Unknown,COMPLETED,2010-12,Chronic Hepatitis c,"Pegylated interferon alfa-2a, Nitazoxanide, Ribavirin",Cairo - Egypt,2012-11,2011-01-13,2013-05-03,INTERVENTIONAL,PHASE3,Cairo University,OTHER,hepatitis
NCT00629356,Unknown,WITHDRAWN,2007-07,Dengue,dengue fever,Kaoshiung - Taiwan,Unknown Date,2008-03-06,2015-04-03,OBSERVATIONAL,Not Available,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT01316185,Unknown,TERMINATED,2011-01,Hepatitis D,EBP921,"San Francisco - United States, Detroit - United States",2013-04,2011-03-16,2016-08-08,INTERVENTIONAL,PHASE1,Eiger BioPharmaceuticals,INDUSTRY,hepatitis
NCT04391985,Unknown,COMPLETED,2017-03-01,Chronic Hepatitis C Virus Infection,SOF plus (OBV/PTV/r) plus RBV,Beni-Suef - Egypt,2017-10-31,2020-05-18,2020-05-18,INTERVENTIONAL,PHASE2,Beni-Suef University,OTHER,hepatitis
NCT03244085,Unknown,UNKNOWN,2017-08-20,Chronic Hepatitis b,QL-007 tablet,Wellington - New Zealand,2018-10-30,2017-08-09,2018-07-16,INTERVENTIONAL,PHASE1,"Qilu Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01495585,Unknown,COMPLETED,2011-12,Hepatitis D,"Lonafarnib, Placebo",Bethesda - United States,2015-04,2011-12-20,2016-08-31,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01716585,Unknown,COMPLETED,2012-11,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267, Placebo for ABT-333, Placebo for ribavirin",No locations listed,2013-10,2012-10-30,2021-07-12,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT01829685,Dragon-Ex,UNKNOWN,2013-03,"Chronic Hepatitis B, Inadequate Response, Nucleos(t)Ide Analogues Treatment","Entecavir, Adefovir","Beijing - China, Beijing - China, Beijing - China, Beijing - China, FuZhou - China, FoShan - China, Guangzhou - China, GuangZhou - China, NanNing - China, Wuhan - China, Changsha - China, Changchun - China, Shengyang - China, Shanghai - China, Shanghai - China, Shanghai - China",2016-06,2013-04-11,2014-06-19,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT05867056,Unknown,WITHDRAWN,2020-08-12,"Hepatitis B, Chronic","IMC-I109V Single Ascending Dose, IMC-I109V Multiple Ascending Doses, HBV HCC Module MAD","Los Angeles - United States, Cleveland - United States, Fitzroy - Australia, Melbourne - Australia, Aarhus - Denmark, Hong Kong - Hong Kong, Busan - Korea, Republic of, Bucharest - Romania, Barcelona - Spain, Madrid - Spain, Kaohsiung City - Taiwan, Taipei city - Taiwan, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2024-09-10,2023-05-19,2024-10-15,INTERVENTIONAL,PHASE1,Immunocore Ltd,INDUSTRY,hepatitis
NCT04544956,B-Fine,COMPLETED,2020-10-06,Hepatitis B,"GSK3228836, Nucleos(t)ide therapy","Boston - United States, Toronto - Canada, Rotterdam - Netherlands, London - United Kingdom",2023-11-30,2020-09-10,2024-12-19,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00218556,Unknown,COMPLETED,2004-01,"Depressive Disorder, Major, Hepatitis C",Cognitive behavioral treatment for depression,Providence - United States,2008-06,2005-09-22,2017-01-12,INTERVENTIONAL,NA,National Institute on Drug Abuse (NIDA),NIH,hepatitis
NCT01280656,Unknown,COMPLETED,2010-01,"Hepatitis C, Chronic","Conventional Interferon, Peginterferon Alfa-2a, Peginterferon Alfa-2b, Ribavirin","Rio Branco - Brazil, Manaus - Brazil, Salvador - Brazil, Vitoria - Brazil, Goiania - Brazil, Sao Luis - Brazil, Pouso Alegre - Brazil, Uberaba - Brazil, Campo Grande - MS - Brazil, Belem - Brazil, Recife - Brazil, Recife - Brazil, Curitiba - Brazil, Curitiba - Brazil, Niteroi - Brazil, Nova Iguacu - Brazil, Rio de Janeiro - Brazil, Porto Velho - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Rio Grande - Brazil, Sao Jose Do Rio Preto - Brazil, Aracaju - Brazil, Botucatu - Brazil, Campinas - Brazil, Ribeirao Preto - Brazil, Ribeirao Preto - Brazil, Santo Andre - Brazil, Santos - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil",2012-11,2011-01-21,2016-11-29,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03013556,Unknown,UNKNOWN,2016-11,Chronic Hepatitis,"Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and Peginterferon alfa-2a then TDF","Hangzhou - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China",2021-12-30,2017-01-06,2021-09-22,INTERVENTIONAL,PHASE4,Ruijin Hospital,OTHER,hepatitis
NCT04810156,I-HEP,RECRUITING,2021-04-07,"Hepatitis, Drug-Induced","Mycophenolate Mofetil, Solu-Medrol, Ursodeoxycholic acid, Prednisone tablet","Herlev - Denmark, Aalborg - Denmark, Aarhus - Denmark, Copenhagen - Denmark, Odense - Denmark",2025-04-07,2021-03-22,2022-12-14,INTERVENTIONAL,PHASE2,Inge Marie Svane,OTHER,hepatitis
NCT01716156,Unknown,COMPLETED,2013-01-18,Hepatitis C,"Grazoprevir, Ribavirin",No locations listed,2013-12-09,2012-10-29,2018-09-24,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04633356,Unknown,UNKNOWN,2020-11-12,"Portal Hypertension, Cirrhosis",EUS-portal pressure gradient measurement (PPGM),Hong Kong - China,2024-11-11,2020-11-18,2023-02-08,INTERVENTIONAL,PHASE2,Chinese University of Hong Kong,OTHER,hepatitis
NCT04732832,Unknown,UNKNOWN,2021-02-01,"Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of, Hemodialysis Complication",No interventions listed,"Douliu - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2024-02,2021-02-01,2021-02-24,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT00225537,Unknown,UNKNOWN,2005-09,"Chronic Hepatitis C, Chronic Hepatitis B",4-Methylumbelliferone (Heparvit®),San Antonio - United States,Unknown Date,2005-09-23,2006-09-11,INTERVENTIONAL,PHASE2,MTmedical Institute of Health,OTHER,hepatitis
NCT06680232,ELIMINATE-B,RECRUITING,2024-11-14,HEPATITIS B CHRONIC,PBGENE-HBV,"Pok Fu Lam - Hong Kong, Chisinau - Moldova, Republic of, Auckland - New Zealand",2025-12,2024-11-08,2025-02-10,INTERVENTIONAL,PHASE1,"Precision BioSciences, Inc.",INDUSTRY,hepatitis
NCT03681132,Nuc-Stop,COMPLETED,2018-09-20,"Hepatitis B, Chronic",Stop of therapy,"København - Denmark, Addis Abeba - Ethiopia, Bodø - Norway, Drammen - Norway, Lørenskog - Norway, Oslo - Norway, Sandvika - Norway, Stavanger - Norway, Tønsberg - Norway, Ålesund - Norway, Stockholm - Sweden",2023-01-31,2018-09-21,2023-03-20,INTERVENTIONAL,PHASE4,Oslo University Hospital,OTHER,hepatitis
NCT02965859,Unknown,UNKNOWN,2012-12,Chronic Hepatitis B,"Metacavir Enteric-coated Capsules 80mg, Metacavir Enteric-coated Capsules 160mg, Metacavir Enteric-coated Capsules 320mg, Metacavir Enteric-coated Capsules Placebo 240mg, Metacavir Enteric-coated Capsules Placebo 160mg, Metacavir Enteric-coated Capsules Placebo 320mg, Adefovir Dipivoxil Capsule10mg, Adefovir Dipivoxil Capsule Placebo 10mg",Nanjing - China,2018-12,2016-11-17,2016-11-22,INTERVENTIONAL,PHASE2,"Guangzhou Yipinhong Pharmaceutical CO.,LTD",INDUSTRY,hepatitis
NCT00100659,Unknown,COMPLETED,2004-12,Chronic Hepatitis C,Pegylated Interferon/ribavirin,"San Francisco - United States, Denver - United States, Washington - United States, Gainesville - United States, Indianapolis - United States, Baltimore - United States, Boston - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Seattle - United States",2008-08,2005-01-05,2018-10-24,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT05718700,Unknown,RECRUITING,2023-02-07,Chronic Hepatitis D Infection,Bulevirtide,"Graz - Austria, Hall in Tirol - Austria, Innsbruck - Austria, Wien - Austria, Angers - France, Bobigny - France, Clichy - France, Creteil - France, Grenoble - France, Lille - France, Limoges - France, Lyon - France, Montpellier - France, Paris - France, Pessac - France, Pringy - France, Périgueux - France, Rennes - France, Rouen - France, Toulouse - France, Berlin - Germany, Berlin - Germany, Bonn - Germany, Duesseldorf - Germany, Essen - Germany, Frankfurt - Germany, Gießen - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Munich - Germany, Wiesbaden - Germany, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Iasi - Romania, Iasi - Romania, Timisoara - Romania, Timisoara - Romania, Almeria - Spain, Barcelona - Spain, Barcelona - Spain, Córdoba - Spain, Madrid - Spain, Madrid - Spain, Santa Cruz de Tenerife - Spain, London - United Kingdom, London - United Kingdom, London - United Kingdom",2027-11,2023-02-08,2025-02-21,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT00143000,Unknown,COMPLETED,2004-04,Hepatitis C Virus,Peginterferon alfa-2a 40KD and Ribavirin,Göteborg - Sweden,Unknown Date,2005-09-02,2008-04-07,INTERVENTIONAL,PHASE4,NORDynamIC Study Group,OTHER,hepatitis
NCT02125500,Unknown,COMPLETED,2014-08,"Viral Hepatitis C, HIV",Sofosbuvir/Ledipasvir fixed dose,Rennes - France,2015-12,2014-04-29,2017-06-29,INTERVENTIONAL,PHASE2,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT06306300,HCVPCL05/20,RECRUITING,2022-07-04,Hepatitis C,"Specialist - Epclusa 400Mg-100Mg Tablet, Non- specialist - Epclusa 400Mg-100Mg Tablet","Rio de Janeiro - Brazil, Rio De Janeiro - Brazil",2025-12-31,2024-03-12,2024-03-25,INTERVENTIONAL,PHASE4,Oswaldo Cruz Foundation,OTHER,hepatitis
NCT01726400,Unknown,COMPLETED,2012-12,Hepatitis C,"Pegylated interferon alpha, Ribavirin",Fremantle - Australia,2014-01,2012-11-14,2015-11-10,OBSERVATIONAL,Not Available,Fremantle Hospital and Health Service,OTHER,hepatitis
NCT00239252,Unknown,COMPLETED,Unknown Date,Hepatitis C,Interferon alfacon-1,"Chubu region - Japan, Chugoku region - Japan, Kinki region - Japan, Kyushu region - Japan, Tohoku region - Japan",Unknown Date,2005-10-17,2014-08-26,INTERVENTIONAL,PHASE3,Astellas Pharma Inc,INDUSTRY,hepatitis
NCT00603252,Unknown,COMPLETED,2008-01,"Hepatitis B, Hepatitis A","Twinrix, Engerix-B, Havrix, HBVAXPRO, Vaqta","Wilrijk - Belgium, Finsterwalde - Germany, Dresden - Germany, Geringswalde - Germany, Pirna - Germany, Bad Bramstedt - Germany, Bad Segeberg - Germany, Elmshorn - Germany",2008-06,2008-01-29,2017-03-14,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02226952,Unknown,COMPLETED,2001-11,"Hepatitis C, Chronic","BILN 2061 W, low dose, BILN 2061 W, medium dose, BILN 2061 W, high dose, Placebo",No locations listed,2002-04,2014-08-27,2014-08-27,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01309932,D-LITE,COMPLETED,2011-03,Hepatitis C,"Pegylated Interferon Lambda (pegIFNλ), BMS-790052 (NS5A Inhibitor), Ribavirin (RBV), BMS-650032 (NS3 Protease Inhibitor), Pegylated Interferon Alfa-2a (pegIFNα-2a), Pegylated Interferon Lambda (pegIFNλ), Ribavirin (RBV), Pegylated Interferon Lambda (pegIFNλ), Ribavirin (RBV), BMS-790052 (NS5A Inhibitor), BMS-650032 (NS3 Protease Inhibitor), Placebo (PBO) for BMS-650032 (Placebo for NS3 Protease Inhibitor), Placebo (PBO) for BMS-790052 (Placebo for NS5A Inhibitor), Placebo for Ribavirin (RBV), Placebo for Ribavirin (RBV)","Phoenix - United States, Palm Springs - United States, Aurora - United States, New Haven - United States, Lutherville - United States, Detroit - United States, Manhasset - United States, Charlotte - United States, Statesville - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Seattle - United States, Adelaide - Australia, Clayton Vic - Australia, Heidelberg - Australia, Perth - Australia, Clichy Cedex - France, Creteil - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex 14 - France, Essen - Germany, Frankfurt - Germany, Hamburg - Germany, Pisa - Italy, Roma - Italy, Hiroshima-shi - Japan, Sapporo-shi - Japan, Kawasaki-shi - Japan, Osaka-shi - Japan, Iruma-gun - Japan, Minato-ku - Japan, Musashino-shi - Japan, Grafton - New Zealand, Christchurch - New Zealand, San Juan - Puerto Rico, Barcelona - Spain, Valencia - Spain",2014-07,2011-03-07,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00407732,Unknown,COMPLETED,2007-01,"Hepatitis C, Substance Use Disorders, Mental Disorder",psychosocial intervention,Chapel Hill - United States,2010-02,2006-12-05,2012-01-25,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT04536532,Unknown,TERMINATED,2020-10-09,"Hepatitis B, Chronic","HEC121120 tablets, HEC121120 placebo tablets, entecavir tablets, entecavir placebo tablets",Jilin - China,2023-03-12,2020-09-02,2024-06-24,INTERVENTIONAL,PHASE2,"Sunshine Lake Pharma Co., Ltd.",INDUSTRY,hepatitis
NCT05653232,PREVENT-HCV,RECRUITING,2023-04-19,HCV,"Prophylaxis (P2W), Transmit and Treat (T&T)","La Jolla - United States, Baltimore - United States, New York - United States, New York - United States, Salt Lake City - United States, Richmond - United States, Madison - United States",2026-09,2022-12-16,2025-02-11,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT05417932,TCR-T,RECRUITING,2022-10-26,"Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent",SCG101,"New York - United States, New York - United States, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Singapore - Singapore, Singapore - Singapore",2025-09,2022-06-14,2025-02-18,INTERVENTIONAL,PHASE2,SCG Cell Therapy Pte. Ltd.,INDUSTRY,hepatitis
NCT01311232,Unknown,COMPLETED,2010-11-01,"Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma, Patients Treated With Rituximab-CHOP or Rituximab-CVP",No interventions listed,"Hing Kong - China, Seoul - Korea, Republic of, Kuala Lumpur - Malaysia, Singapore - Singapore",2012-12-01,2011-03-09,2017-10-27,OBSERVATIONAL,Not Available,Samsung Medical Center,OTHER,hepatitis
NCT02588937,Unknown,UNKNOWN,2015-10,"Hepatitis B, Chronic","EntecaBell ODT. 0.5mg, Baraclude Tab. 0.5mg","Chungju - Korea, Republic of, Cheonan - Korea, Republic of, Daejeon - Korea, Republic of, Daegu - Korea, Republic of, Guri - Korea, Republic of, Daegu - Korea, Republic of, Jeju - Korea, Republic of, Jeonju - Korea, Republic of, Gwangju - Korea, Republic of",2017-02,2015-10-28,2016-12-14,INTERVENTIONAL,PHASE4,Chong Kun Dang Pharmaceutical,INDUSTRY,hepatitis
NCT00705432,SPRINT-2,COMPLETED,2008-08,"Hepatitis C, Chronic","Peginterferon alfa-2b (PEG), Ribavirin (RBV), Placebo, Boceprevir",No locations listed,2010-05,2008-06-26,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00537537,Unknown,COMPLETED,2007-08,"Hepatitis B, Chronic",Telbivudine,"Hyderabad - India, Mumbai - India, Vellore - India",2011-06,2007-10-01,2017-06-23,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT02126137,EZE-1,UNKNOWN,2013-10,Chronic Hepatitis C,Ezetimibe,Santiago - Chile,2016-01,2014-04-29,2015-11-04,INTERVENTIONAL,PHASE1,Pontificia Universidad Catolica de Chile,OTHER,hepatitis
NCT03480932,Unknown,COMPLETED,2018-02-02,"Hepatitis C, Chronic","Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a",Bilaspur - India,2018-11-02,2018-03-29,2021-05-18,INTERVENTIONAL,PHASE3,Johns Hopkins Bloomberg School of Public Health,OTHER,hepatitis
NCT01090232,Unknown,COMPLETED,2010-02,Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection,"blood samples, blood samples",Marseille - France,2012-02,2010-03-19,2014-09-01,INTERVENTIONAL,NA,Assistance Publique Hopitaux De Marseille,OTHER,hepatitis
NCT02722837,Unknown,COMPLETED,2016-04-04,Hepatitis C Virus Infection,SOF/VEL,"Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Saint Petersburg - Russian Federation, Samara - Russian Federation, Göteborg - Sweden, Stockholm - Sweden",2017-06-26,2016-03-30,2018-11-16,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT06277037,Unknown,RECRUITING,2024-07-11,Long Term Follow-up,Non-interventional,"San Diego - United States, Miami - United States, Hillsborough - United States, Melbourne - Australia, Murdoch - Australia, Shatin - Hong Kong, Hong Kong - Hong Kong, Seoul - Korea, Republic of, Chisinau - Moldova, Republic of, Changhua city - Taiwan, Chiayi City - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taoyuan - Taiwan, Cardiff - United Kingdom, London - United Kingdom, London - United Kingdom",2029-08-30,2024-02-26,2024-11-27,OBSERVATIONAL,Not Available,Arbutus Biopharma Corporation,INDUSTRY,hepatitis
NCT04225715,Piranga,COMPLETED,2020-07-05,"Hepatitis B, Chronic","Nucleos(t)ide (NUC), CpAM (RO7049389), TLR7 (RO7020531), siRNA (RO7445482), PEG-IFN, PD-L1 LNA (RO7191863)","Rialto - United States, San Francisco - United States, Sofia - Bulgaria, Sofia - Bulgaria, Stara Zagora - Bulgaria, Calgary - Canada, Edmonton - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, La Serena - Chile, Beijing - China, Beijing - China, Changchun City - China, Chengdu - China, Guangzhou - China, Hangzhou City - China, Shanghai City - China, Shanghai City - China, Clichy - France, Lyon - France, Vandoeuvre-les-nancy - France, Hong Kong - Hong Kong, Shatin, New Territories - Hong Kong, Busan - Korea, Republic of, Busan - Korea, Republic of, Gangwon-Do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Auckland - New Zealand, Cluj-Napoca - Romania, Majadahonda - Spain, Vigo - Spain, Barcelona - Spain, Pontevedra - Spain, Chang Hua - Taiwan, Kaohsiung City - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Liverpool - United Kingdom, London - United Kingdom, London - United Kingdom",2024-07-19,2020-01-13,2024-08-20,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04536337,Unknown,UNKNOWN,2020-10-22,Chronic Hepatitis B,"ALG-000184, Placebo, Entecavir","Fitzroy - Australia, Footscray - Australia, Chongqing - China, Guangzhou - China, Changchun - China, Hong Kong - Hong Kong, Shatin - Hong Kong, Quatre Bornes - Mauritius, Chisinau - Moldova, Republic of, Auckland - New Zealand, London - United Kingdom, London - United Kingdom",2023-11-24,2020-09-02,2023-04-28,INTERVENTIONAL,PHASE1,Aligos Therapeutics,INDUSTRY,hepatitis
NCT01298037,Unknown,ACTIVE_NOT_RECRUITING,2011-02-01,Hepatitis B,No interventions listed,"San Francisco - United States, San Francisco - United States, Boston - United States, Boston - United States, Plymouth - United States, Rochester - United States, Chapel Hill - United States, Dallas - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2025-12-01,2011-02-17,2025-01-15,OBSERVATIONAL,Not Available,University of Pennsylvania,OTHER,hepatitis
NCT05942937,HepPEd,RECRUITING,2023-09-04,HCV,Education Intervention (The HepPEd Program),"Rockhampton - Australia, Hobart - Australia",2024-07,2023-07-12,2024-03-06,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT01750515,Unknown,UNKNOWN,2013-01,"Hepatitis C (HCV), Acupuncture",Acupuncture,Safed - Israel,2014-01,2012-12-17,2012-12-17,INTERVENTIONAL,NA,Assy Nimer,OTHER_GOV,hepatitis
NCT06690515,Unknown,NOT_YET_RECRUITING,2025-03-01,"Vaccine Adverse Reaction, Vaccine Reaction","DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A, DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B, Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)®","Bandung - Indonesia, Bandung - Indonesia, Bandung - Indonesia",2025-10-31,2024-11-15,2024-11-15,INTERVENTIONAL,PHASE2,PT Bio Farma,INDUSTRY,hepatitis
NCT00124215,Unknown,COMPLETED,2005-06,Hepatitis C,GI-5005,"Pasadena - United States, Denver - United States, Miami - United States, Chicago - United States, New York City - United States",2007-06,2005-07-27,2010-05-05,INTERVENTIONAL,PHASE1,GlobeImmune,INDUSTRY,hepatitis
NCT04199715,Unknown,COMPLETED,2019-12-03,Hepatitis B,Heplisav-B,Dallas - United States,2022-01-20,2019-12-16,2022-03-11,INTERVENTIONAL,PHASE1,Baylor Research Institute,OTHER,hepatitis
NCT05542615,Unknown,RECRUITING,2019-08-01,"Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder",Prolonged-Release Pirfenidone,"Guadalajara - Mexico, Mexico City - Mexico",2023-12-01,2022-09-15,2023-07-06,INTERVENTIONAL,PHASE2,University of Guadalajara,OTHER,hepatitis
NCT00343915,Unknown,COMPLETED,2004-04-21,Hepatitis B,"Engerix™-B (thiomersal-free) 20µg, 10 μg Engerix™-B (preservative-free), placebo","Sydney - Australia, Bruxelles - Belgium, Wilrijk - Belgium, Kyiv - Ukraine",2008-01-10,2006-06-23,2019-06-10,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05768737,Unknown,NOT_YET_RECRUITING,2023-08-01,"Hepatitis B, Osteoporosis, Osteoporosis Risk",Patient Participation Form,No locations listed,2023-12-01,2023-03-14,2023-05-23,OBSERVATIONAL,Not Available,Uskudar State Hospital,OTHER_GOV,hepatitis
NCT02517515,Unknown,COMPLETED,2015-07,Hepatitis C Virus (HCV),"ombitasvir/paritaprevir/ritonavir and dasabuvir, Placebo for ombitasvir/paritaprevir/ritonavir and dasabuvir",No locations listed,2016-10,2015-08-07,2017-10-27,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT04113915,Unknown,UNKNOWN,2019-11,"ITP - Immune Thrombocytopenic Purpura, Viral Hepatitis","triple therapy, Steroids",No locations listed,2020-11,2019-10-03,2019-11-01,OBSERVATIONAL,Not Available,Safaa AA Khaled,OTHER,hepatitis
NCT00050115,Unknown,COMPLETED,2003-03-10,Hepatitis-Associated Aplastic Anemia,No interventions listed,Bethesda - United States,2019-06-24,2002-11-20,2021-02-08,OBSERVATIONAL,Not Available,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT02786537,PRIORITIZE,COMPLETED,2016-06,Chronic Hepatitis C,"SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only), EBR/GZR (elbasvir/grazoprevir), Ribavirin","Little Rock - United States, Palo Alto - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, New Haven - United States, Washington - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Lutherville - United States, Boston - United States, Ann Arbor - United States, Minneapolis - United States, Flowood - United States, Saint Louis - United States, Omaha - United States, Santa Fe - United States, New York - United States, New York - United States, New York - United States, New York - United States, Valatie - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Philadelphia - United States, Houston - United States, Richmond - United States, Richmond - United States, Seattle - United States, Seattle - United States",2019-06-13,2016-06-01,2021-12-06,INTERVENTIONAL,PHASE4,University of Florida,OTHER,hepatitis
NCT01768715,SETH-HA,SUSPENDED,2013-01,Alcoholic Hepatitis,No interventions listed,"Oviedo - Spain, Santander - Spain, Santiago de Compostela - Spain, Majadahonda - Spain, Pamplona - Spain, Barcelona - Spain, Córdoba - Spain, Granada - Spain, La Coruña - Spain, Madrid - Spain, Madrid - Spain, Murcia - Spain, Málaga - Spain, Sevilla - Spain, Valencia - Spain, Valladolid - Spain, Zaragoza - Spain",2014-12,2013-01-15,2014-06-03,OBSERVATIONAL,Not Available,Sociedad Española de Trasplante Hepático,NETWORK,hepatitis
NCT03080415,Unknown,COMPLETED,2017-03-18,Hepatitis C Genotype 4,Combined Therapy SOF and DCV,Nasr City - Egypt,2018-02-18,2017-03-15,2018-06-06,INTERVENTIONAL,PHASE3,Yassin Abdelghaffar Charity Center for Liver Disease and Research,OTHER,hepatitis
NCT05690607,TINIES,UNKNOWN,2023-01-23,"HIV Infections, Hepatitis B",Doctors Laboratory TINIES small volume blood testing kit,No locations listed,2023-09-30,2023-01-19,2023-01-19,OBSERVATIONAL,Not Available,Central and North West London NHS Foundation Trust,OTHER,hepatitis
NCT03627507,Unknown,COMPLETED,2018-07-29,Hepatitis B Infection,"Hepa-B, Engerix B",Dhaka - Bangladesh,2019-05-27,2018-08-13,2022-02-11,INTERVENTIONAL,PHASE3,"International Centre for Diarrhoeal Disease Research, Bangladesh",OTHER,hepatitis
NCT00507507,Unknown,COMPLETED,2007-09,Chronic Hepatitis B,"Tenofovir DF, FTC, Placebo","Los Angeles - United States, San Diego - United States, San Francisco - United States, Miami - United States, Detroit - United States, Manhasset - United States, New York - United States, New York - United States, Germantown - United States, Seattle - United States, Camperdown - Australia, Westmead - Australia, Heidelburg - Australia, Melbourne - Australia, Calgary - Canada, Vancouver - Canada, Toronto - Canada, Lille - France, Lyon - France, Strasbourg - France, Berlin - Germany, Berlin - Germany, Duesseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Herne - Germany, Mainz - Germany, Pokfulam - Hong Kong, Shatin - Hong Kong, Tai Po - Hong Kong, Grafton - New Zealand, Hamilton - New Zealand, Bydgoszcz - Poland, Chorzow - Poland, Warszawa - Poland, Singapore - Singapore, Singapore - Singapore, Kaohsiung - Taiwan, Kaoshiung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, London - United Kingdom, Sheffield - United Kingdom",2012-02,2007-07-26,2015-07-17,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00213707,Unknown,UNKNOWN,2003-05,HCV Infection,No interventions listed,Strasbourg - France,2010-05,2005-09-21,2009-02-25,OBSERVATIONAL,Not Available,"University Hospital, Strasbourg, France",OTHER,hepatitis
NCT05630807,B-Well 1,ACTIVE_NOT_RECRUITING,2022-12-07,"Chronic Hepatitis B, Hepatitis B, Chronic","Bepirovirsen, Placebo","Chandler - United States, Tucson - United States, Los Angeles - United States, Palo Alto - United States, Sacramento - United States, San Jose - United States, Littleton - United States, Homestead - United States, Miami - United States, Iowa City - United States, Baltimore - United States, Novi - United States, Richmond - United States, Richmond - United States, CABA-Ciudad De Buenos Aires - Argentina, Caba - Argentina, Caba - Argentina, Ciudad Autonoma de Buenos Aires - Argentina, Derqui, Pilar - Argentina, Rosario - Argentina, Manaus - Brazil, Curitiba - Brazil, Porto Alegre - Brazil, Santa Maria - Brazil, Aracaju - Brazil, Campinas - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, São Paulo - Brazil, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Veliko Tarnovo - Bulgaria, Vancouver - Canada, Victoria - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Montreal - Canada, St-Jerome - Canada, Québec - Canada, Guangzhou - China, Guangzhou - China, Wuhan - China, Nanjing - China, Zhenjiang - China, Changchun - China, Shenyang - China, Chengdu - China, Chongqing - China, Urumqi - China, Kunming - China, Beijing - China, Beijing - China, Beijing - China, Fuzhou - China, Guangzhou - China, Hangzhou - China, Hangzhou - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenzhen - China, Xi'an - China, Zhengzhou - China, Clermont-Ferrand - France, Clichy Cedex - France, Dijon Cedex - France, Lille cedex - France, Pessac cedex - France, Poitiers - France, Rennes cedex 09 - France, Strasbourg Cedex - France, Toulouse cedex - France, Munchen - Germany, Bochum - Germany, Duesseldorf - Germany, Koeln - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Alexandroupolis - Greece, Athens - Greece, Athens - Greece, Rio - Greece, Lai King - Hong Kong, Pokfulam - Hong Kong, Shatin - Hong Kong, Budapest - Hungary, Eger - Hungary, Gyula - Hungary, Miskolc - Hungary, Guhawati - India, Surat - India, Belagavi - India, Mumbai - India, Chennai - India, Coimbatore - India, Hyderabad - India, Chandigarh - India, Hyderabad - India, Jaipur - India, Ludhiana - India, Manipal - India, Mumbai - India, Mumbai - India, Pune - India, Baggiovara (MO) - Italy, Brescia - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Foggia - Italy, Messina - Italy, Chiba - Japan, Ehime - Japan, Fukuoka - Japan, Fukuoka - Japan, Gifu - Japan, Gifu - Japan, Hiroshima - Japan, Hiroshima - Japan, Hokkaido - Japan, Hyogo - Japan, Kumamoto - Japan, Miyagi - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Busan - Korea, Republic of, Daegu-si - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Kuantan - Malaysia, Georgetown - Malaysia, Johor Bahru - Malaysia, Kota Bharu - Malaysia, Kota Kinabalu - Malaysia, Kuala Lumpur, - Malaysia, Guadalajara - Mexico, Monterrey - Mexico, Oaxaca - Mexico, Ciudad de Panama - Panama, Bytom - Poland, Krakow - Poland, Lancut - Poland, Bucharest - Romania, Bucuresti - Romania, Cluj Napoca - Romania, Iasi - Romania, Suceava - Romania, Timisoara - Romania, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Barcelona - Spain, León - Spain, Madrid - Spain, Málaga - Spain, Pontevedra - Spain, Salamanca - Spain, Santander - Spain, Valencia - Spain, Valladolid - Spain, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Ankara - Turkey, Birmingham - United Kingdom, Edinburgh - United Kingdom, Leeds - United Kingdom, London - United Kingdom, London - United Kingdom, Hanoi - Vietnam, Ho Chi Minh City - Vietnam",2025-11-24,2022-11-30,2024-06-04,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05282407,Unknown,COMPLETED,2017-11-20,Chronic Hepatitis B,"Tenofovir disoproxil 245mg, Tenofovir disoproxil fumarate 300mg","Seoul - Korea, Republic of",2019-04-17,2022-03-16,2022-04-01,INTERVENTIONAL,PHASE4,"Samjin Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT05962307,HEP4Di,COMPLETED,2023-04-01,Hepatitis D,Bulevirtide,Milan - Italy,2023-04-30,2023-07-27,2023-07-27,OBSERVATIONAL,Not Available,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",OTHER,hepatitis
NCT06347588,Unknown,NOT_YET_RECRUITING,2024-05,Occult Hepatitis B Infection in Cancer Patients,"Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA",Pavia - Italy,2026-05,2024-04-04,2024-04-05,OBSERVATIONAL,Not Available,Fondazione IRCCS Policlinico San Matteo di Pavia,OTHER,hepatitis
NCT01343888,Unknown,COMPLETED,2011-04,Hepatitis C,"PegIFN/RBV, BI 201335, BI 201335, Placebo","Linz - Austria, Wien - Austria, Wien - Austria, Wien - Austria, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Liège - Belgium, Clermont-Ferrand - France, Clichy - France, Lille - France, Marseille - France, Montpellier - France, Nice Cedex 3 - France, Paris Cedex 20 - France, Paris - France, Pessac Cedex - France, Rennes Cedex 09 - France, Saint Laurent du Var - France, Toulouse - France, Aachen - Germany, Berlin - Germany, Berlin - Germany, Bonn - Germany, Dortmund - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Erlangen - Germany, Frankfurt am Main - Germany, Hamburg - Germany, Herne - Germany, Kiel - Germany, Leipzig - Germany, Mainz - Germany, München - Germany, Ulm - Germany, Chiba, Chiba - Japan, Gifu, Gifu - Japan, Itabashi-ku, Tokyo - Japan, Izunokuni, Shizuoka - Japan, Kamakura, Kanagawa - Japan, Kita-gun, Kagawa - Japan, Kofu, Yamanashi - Japan, Kurashiki, Okayama - Japan, Kurume, Fukuoka - Japan, Matsumoto, Nagano - Japan, Nagoya, Aichi - Japan, Namegata, Ibaraki - Japan, Nishinomiya, Hyogo - Japan, Omura, Nagasaki - Japan, Omuta, Fukuoka - Japan, Osaka, Osaka - Japan, Sapporo, Hokkaido - Japan, Sendai, Miyagi - Japan, Tanabe, Wakayama - Japan, Tsuchiura, Ibaraki - Japan, Aveiro - Portugal, Barreiro - Portugal, Coimbra - Portugal, Lisboa - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Vila Real - Portugal, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Chelyabinsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, A Coruña - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, Vigo (Pontevedra) - Spain, Bern - Switzerland, La Chaux-de-Fonds - Switzerland, Lugano - Switzerland, St. Gallen - Switzerland, Zürich - Switzerland, Bristol - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom, Oxford - United Kingdom, Southampton - United Kingdom, Whitechapel, London - United Kingdom",2014-03,2011-04-28,2015-09-18,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01926288,Unknown,COMPLETED,2008-10,Chronic Hepatitis B,"Entecavir maleate tablets, blank Baraclude tablets, Blank maleate entecavir tablets, Baraclude tablets","Beijing - China, Beijing - China, Chongqing - China, Wuhan - China, Nanjing - China, Shanghai - China, Chongqing - China, Chongqing - China, Hangzhou - China",2014-03,2013-08-20,2017-12-29,INTERVENTIONAL,PHASE4,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT00800007,Unknown,TERMINATED,2008-11,Chronic Hepatitis C,"ANZ-521, Placebo","Anaheim - United States, San Antonio - United States",2009-02,2008-12-01,2009-02-20,INTERVENTIONAL,PHASE2,"Anza Therapeutics, Inc.",INDUSTRY,hepatitis
NCT02249988,Unknown,COMPLETED,2014-12,Chronic Hepatitis B,ABX203 therapeutic Hepatitis B vaccine treatment arm,"Camperdown - Australia, Clayton - Australia, Fitzroy - Australia, Heidelberg - Australia, Liverpool - Australia, Melbourne - Australia, Parkville - Australia, Perth - Australia, Westmead - Australia, Auckland - New Zealand, Hamilton West - New Zealand, Wellington - New Zealand",2016-12,2014-09-26,2017-01-24,INTERVENTIONAL,PHASE3,Abivax S.A.,INDUSTRY,hepatitis
NCT04470388,Unknown,COMPLETED,2020-09-09,Chronic HBV Infection,"EDP-514, Placebo","Hong Kong - Hong Kong, Changhua - Taiwan, Chiayi - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2021-08-30,2020-07-14,2022-01-11,INTERVENTIONAL,PHASE1,"Enanta Pharmaceuticals, Inc",INDUSTRY,hepatitis
NCT03801707,Unknown,COMPLETED,2019-03-22,"Kidney Transplant, Hepatitis C, HCV","Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]",Columbus - United States,2021-04-28,2019-01-11,2023-09-13,INTERVENTIONAL,PHASE3,Ohio State University,OTHER,hepatitis
NCT04774107,Unknown,COMPLETED,2020-11-26,"Hepatitis C, Chronic",P1101 + Ribavirin,"Chiayi City - Taiwan, Chiayi City - Taiwan, Chiayi City - Taiwan, Kaohsiung - Taiwan, Tainan City - Taiwan",2022-07-18,2021-03-01,2022-08-30,INTERVENTIONAL,PHASE1,PharmaEssentia,INDUSTRY,hepatitis
NCT00452088,MSP3LSP,UNKNOWN,2007-04,Malaria,"MSP 3 Long Synthetic Peptide, Hepatitis B vaccine, Hepatitis B control vaccince",Ouagadougou - Burkina Faso,2008-05,2007-03-26,2008-05-07,INTERVENTIONAL,PHASE1,African Malaria Network Trust,NETWORK,hepatitis
NCT05965388,Unknown,NOT_YET_RECRUITING,2023-12-01,"HBV, HCC",nucleoside analogues or interferon,"Hefei - China, Fuzhou - China, Wuhan - China, Nanjing - China, Xuzhou - China, Jinan - China, Taiyuan - China, Xi'an - China, Kunming - China, Shanghai - China",2029-02-01,2023-07-28,2023-07-28,OBSERVATIONAL,Not Available,Wen-hong Zhang,OTHER,hepatitis
NCT03157388,Unknown,COMPLETED,2017-06-01,Alcoholic Hepatitis,Combined Vancomycin and Gentamycin and Meropenem,Aarhus - Denmark,2018-06-01,2017-05-17,2019-05-23,INTERVENTIONAL,NA,University of Aarhus,OTHER,hepatitis
NCT05002907,MaHeVi,COMPLETED,2018-01-01,"Hepatitis B, Hepatitis C, Hepatitis D, HIV Infections, Prevalence, Epidemiology","Questionnaire, Biocollection, Delivery of results, Results and advices on transmission prevention methods, Confirmation of results on a blood test (In the event of a positive result), Information for care, Monitoring and treatment","Cayenne - French Guiana, Paramaribo - Suriname",2019-02-08,2021-08-12,2023-06-07,OBSERVATIONAL,Not Available,Centre Hospitalier de Cayenne,OTHER,hepatitis
NCT02368288,Unknown,UNKNOWN,2013-01,Chronic Hepatitis B,entecavir,Beijing - China,2016-12,2015-02-23,2016-08-18,INTERVENTIONAL,PHASE4,Beijing Ditan Hospital,OTHER,hepatitis
NCT02032888,Unknown,COMPLETED,2014-02,Hepatitis C,"Daclatasvir, Sofosbuvir","Birmingham - United States, Beverly Hills - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Washington - United States, Washington - United States, Washington - United States, Fort Pierce - United States, Miami - United States, Orlando - United States, Decatur - United States, Indianapolis - United States, Baltimore - United States, Lutherville - United States, Detroit - United States, Saint Louis - United States, Sante Fe - United States, Binghamton - United States, New York - United States, Cincinnati - United States, Tulsa - United States, Portland - United States, Allentown - United States, Providence - United States, Providence - United States, Fort Worth - United States, Houston - United States, Houston - United States, Murray - United States, Richmond - United States, Seattle - United States",2014-10,2014-01-10,2015-10-27,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02792088,HBV,COMPLETED,2015-07,Chronic Hepatitis B,"Besifovir 150mg, Tenofovir 300mg","Seoul - Korea, Republic of",2020-02,2016-06-07,2023-02-21,INTERVENTIONAL,PHASE3,IlDong Pharmaceutical Co Ltd,INDUSTRY,hepatitis
NCT05107778,Unknown,COMPLETED,2022-01-10,"Hepatitis B, Chronic","ASC42 10mg, ASC42 15mg, ih PEG-IFN α-2a, Entecavir, Placebo",Guangzhou - China,2023-11-14,2021-11-04,2024-04-04,INTERVENTIONAL,PHASE2,"Ascletis Pharmaceuticals Co., Ltd.",INDUSTRY,hepatitis
NCT01783678,Unknown,COMPLETED,2013-01,"Chronic Hepatitis C, Human Immunodeficiency Virus","Sofosbuvir, RBV","Darlinghurst - Australia, Sydney - Australia, Melbourne - Australia, Parkville - Australia, Lyon - France, Nice - France, Paris - France, Berlin - Germany, Bonn - Germany, Duesseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Würzburg - Germany, Bergamo - Italy, Milano - Italy, Napoli - Italy, Rome - Italy, Torino - Italy, Barcelona - Spain, Madrid - Spain, Seville - Spain, Glasgow - United Kingdom, London - United Kingdom, Sussex - United Kingdom",2014-04,2013-02-05,2015-04-30,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00869778,Unknown,COMPLETED,2009-04,Chronic Hepatitis B,"εPA-44, Placebo","BeiJing - China, Harbin - China, WuHan - China, Changsha - China, ChangSha - China, ChangSha - China, NanJing - China, ChangChun - China, Xi'An - China, XiAn - China, ChengDu - China, WenZhou - China, Beijing - China, Beijing - China, ChongQing - China",2011-11,2009-03-26,2019-10-01,INTERVENTIONAL,PHASE2,Chongqing Jiachen Biotechnology Ltd.,INDUSTRY,hepatitis
NCT01492478,Unknown,UNKNOWN,2012-01,"Depression, Hepatitis c",No interventions listed,Lisbon - Portugal,2015-07,2011-12-15,2011-12-15,OBSERVATIONAL,Not Available,Centro Hospitalar Lisboa Norte,OTHER,hepatitis
NCT02613871,Unknown,COMPLETED,2015-12-22,Hepatitis C Virus Infection,LDV/SOF,"Changhua - Taiwan, Chiayi City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung - Taiwan, Keelung - Taiwan, Taichung - Taiwan, Tainan City - Taiwan, Tainan - Taiwan, Taipei City - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2017-01-04,2015-11-25,2020-03-06,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01788371,Unknown,COMPLETED,2009-03,"Hepatitis B Infection, Chronic Infection, Viremia","Telbivudine, Lamivudine",No locations listed,2012-07,2013-02-11,2013-07-30,INTERVENTIONAL,PHASE4,Hua Zhang,OTHER,hepatitis
NCT00838071,Unknown,COMPLETED,2003-10,"Hepatitis B, Chronic",Specific intravenous anti-hepatitis B immunoglobulin,"Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Sevilla - Spain",2004-07,2009-02-06,2009-02-06,INTERVENTIONAL,PHASE3,"Instituto Grifols, S.A.",INDUSTRY,hepatitis
NCT00932971,HIDIT-II,COMPLETED,2009-06,Hepatitis D,"PEG-IFN alfa-2a, Tenofovir, PEG-IFN alfa-2a, placebo","Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Frankfurt - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Athens - Greece, Bucharest - Romania, Timisoara - Romania",2017-08,2009-07-07,2018-01-29,INTERVENTIONAL,PHASE2,"HepNet Study House, German Liverfoundation",NETWORK,hepatitis
NCT03366571,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B,Nucleos(t)ide Analogues,"Beijing - China, Beijing - China, Beijing - China, Beijing - China",2023-12,2017-12-08,2021-04-14,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT01446978,Unknown,UNKNOWN,2011-09,Vaccine Response Impaired,"hepatitis A vaccine, hepatitis A vaccine","Eskilstuna - Sweden, Stockholm - Sweden, Uppsala - Sweden, Örebro - Sweden",2016-08,2011-10-05,2015-11-18,INTERVENTIONAL,PHASE2,"Sormland County Council, Sweden",OTHER,hepatitis
NCT02442271,Unknown,COMPLETED,2015-04-27,Chronic Hepatitis C Infection,"ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin",No locations listed,2016-07-04,2015-05-13,2017-08-01,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00201578,Unknown,UNKNOWN,Unknown Date,Acute Hepatitis,No interventions listed,Taipei - Taiwan,Unknown Date,2005-09-20,2006-04-27,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT03341871,Unknown,COMPLETED,2017-12-27,Hepatitis C Virus (HCV),No interventions listed,Tokyo - Japan,2020-09-15,2017-11-14,2021-09-20,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02125071,LT,COMPLETED,2013-11,"Liver Cirrhosis, Chronic Hepatitis B",Blood Sample Collection,"Seoul - Korea, Republic of",2015-08,2014-04-29,2016-10-18,OBSERVATIONAL,Not Available,Dong-Gu Kim,OTHER,hepatitis
NCT06154278,i-LIVER,RECRUITING,2024-07-25,Chronic Hepatitis B,Imdusiran (AB-729),Baltimore - United States,2026-12-01,2023-12-04,2024-07-29,INTERVENTIONAL,PHASE2,"University of Maryland, Baltimore",OTHER,hepatitis
NCT01658878,CheckMate040,COMPLETED,2012-10-30,Hepatocellular Carcinoma,"Nivolumab, Sorafenib, Ipilimumab, Cabozantinib","Los Angeles - United States, Washington - United States, Pensacola - United States, Atlanta - United States, Boston - United States, Ann Arbor - United States, Hackensack - United States, Paterson - United States, Portland - United States, Houston - United States, Halifax - Canada, Toronto - Canada, Montréal - Canada, Angers - France, Creteil Cedex - France, Marseille Cedex 5 - France, Marseille Cedex 9 - France, Paris Cedex 13 - France, Reims Cedex - France, Vandoeuvre les Nancy - France, Essen - Germany, Frankfurt - Germany, Hannover - Germany, Heidelberg - Germany, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Bologna - Italy, Firenze - Italy, Meldola (FC) - Italy, Milano - Italy, Napoli - Italy, Padova - Italy, Rozzano - Italy, Kashiwa-shi - Japan, Kurume-shi - Japan, Yokohama - Japan, Kyoto-shi - Japan, Osaka-Sayama - Japan, Saga - Japan, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, San Juan - Puerto Rico, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Pamplona - Spain, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, London - United Kingdom, Manchester - United Kingdom, Glasgow - United Kingdom, Wirral - United Kingdom, Birmingham - United Kingdom, London - United Kingdom",2024-11-12,2012-08-07,2024-11-19,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00007371,Unknown,COMPLETED,1999-09,"Blood Disease, Hemophilia A, Hepatitis, Viral, Human",No interventions listed,No locations listed,2004-08,2000-11-28,2016-09-26,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT00351871,Unknown,COMPLETED,2002-04,Chronic Hepatitis C,PEG-Intron Plus REBETOL,No locations listed,2007-11,2006-07-13,2009-02-04,INTERVENTIONAL,PHASE4,Louisiana State University Health Sciences Center in New Orleans,OTHER,hepatitis
NCT01944878,Unknown,COMPLETED,2013-05,"Cirrhosis, Chronic Liver Disease",No interventions listed,"Chuncheon - Korea, Republic of",2013-08,2013-09-18,2014-07-24,OBSERVATIONAL,Not Available,Chuncheon Sacred Heart Hospital,OTHER,hepatitis
NCT01903278,Unknown,COMPLETED,2013-06,Chronic Hepatitis c,"PEG-IFN-SA /RBV, Pegasys /RBV","Lanzhou - China, Guangzhou - China, Guangzhou - China, Nanning - China, Shijiazhuang - China, Harbin - China, Xinxiang - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Nanchang - China, Changchun - China, Yanji - China, Shenyang - China, Xi'an - China, Xi'an - China, Xi'an - China, Jinan - China, Jinan - China, Qingdao - China, Taiyuan - China, Chengdu - China, Chengdu - China, Urumqi - China, Wenzhou - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Shanghai - China, Tianjin - China",2015-08,2013-07-19,2015-09-25,INTERVENTIONAL,PHASE3,"Beijing Kawin Technology Share-Holding Co., Ltd.",INDUSTRY,hepatitis
NCT06658678,HBV,COMPLETED,2021-04-03,"Hepatitis B, Chronic",Receiving an educational intervention,Hong Kong - Hong Kong,2021-12-31,2024-10-26,2024-10-26,INTERVENTIONAL,NA,The University of Hong Kong,OTHER,hepatitis
NCT01329978,ATOMIC,COMPLETED,2011-03,"Hepatitis C, Chronic","Sofosbuvir, RBV, PEG","Montgomery - United States, Jonesboro - United States, Anaheim - United States, Burbank - United States, Coronado - United States, Los Angeles - United States, Oceanside - United States, San Diego - United States, San Diego - United States, San Diego - United States, Aurora - United States, Englewood - United States, Bradenton - United States, Deland - United States, Gainesville - United States, Orlando - United States, Orlando - United States, Trinity - United States, Wellington - United States, Atlanta - United States, Marietta - United States, Chicago - United States, Annapolis - United States, Reisterstown - United States, Boston - United States, Worcester - United States, Novi - United States, St. Louis - United States, Albuquerque - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Durham - United States, Cincinnati - United States, Columbia - United States, Arlington - United States, Austin - United States, Dallas - United States, Houston - United States, San Antonio - United States, Norfolk - United States, Seattle - United States, San Juan - Puerto Rico, San Juan - Puerto Rico",2012-08,2011-04-06,2014-05-26,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01296971,Unknown,WITHDRAWN,2009-12,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin [Copegus], ribavirin [Copegus]",No locations listed,2009-12,2011-02-16,2016-11-02,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03099278,Unknown,UNKNOWN,2017-01,Chronic Hepatitis D,Ezetimibe,Karachi - Pakistan,2017-06,2017-04-04,2017-04-04,INTERVENTIONAL,PHASE2,Ziauddin Hospital,OTHER,hepatitis
NCT02582671,REACH,COMPLETED,2015-11-05,Chronic Hepatitis C,"Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin",No locations listed,2017-11-29,2015-10-21,2019-05-06,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT02496078,Unknown,COMPLETED,2015-08,Hepatitis C,"Daclatasvir, Asunaprevir","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Guangzhou - China, Guangzhou - China, Shi Jia Zhuang - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Zhenjiang - China, Changchun - China, Shenyang - China, Shenyang - China, Qingdao - China, Shanghai - China, Shanghai - China, Shanghai - China, Xi'an - China, Xi'an - China, Chengdu - China, Beijing - China, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Moscow - Russian Federation, St. Petersburg - Russian Federation, St.petersburg - Russian Federation",2016-08,2015-07-14,2017-04-19,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT04240678,Unknown,COMPLETED,2016-01-01,Hepatitis B,Electronic HBV Alert,No locations listed,2019-07-01,2020-01-27,2021-08-11,INTERVENTIONAL,NA,"University of California, Davis",OTHER,hepatitis
NCT03568578,Unknown,UNKNOWN,2018-01-28,"Hepatitis B, Liver Fibrosis","Entecavir 0.5 mg, Anluohuaxian Pill 12g","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Guangzhou - China, Nanning - China, Zhengzhou - China, Nanjing - China, Wuxi - China, Shanghai - China, Shanghai - China, Chengdu - China, Hangzhou - China",2020-12-31,2018-06-26,2018-06-27,INTERVENTIONAL,NA,Peking University First Hospital,OTHER,hepatitis
NCT00962871,Unknown,COMPLETED,2009-08,"Hepatitis B, Chronic","peginterferon alfa-2a [Pegasys], tenofovir","Los Angeles - United States, San Francisco - United States, Grafton - New Zealand, Singapore - Singapore, Singapore - Singapore, Taipei - Taiwan",2012-02,2009-08-20,2016-02-08,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02650271,Unknown,COMPLETED,2021-02-02,Hepatocellular Carcinoma,"Entecavir, Tenofovir",Nanning - China,2023-12-25,2016-01-08,2024-01-23,INTERVENTIONAL,PHASE3,Guangxi Medical University,OTHER,hepatitis
NCT05466071,Unknown,RECRUITING,2021-07-01,"Chronic Hepatitis b, Pregnancy Related",No interventions listed,Guangzhou - China,2024-06-30,2022-07-20,2023-12-29,OBSERVATIONAL,Not Available,Xingfei Pan,OTHER,hepatitis
NCT03919578,Unknown,COMPLETED,2019-09-11,Immunogenicity,"Recombinant Hepatitis B vaccine, Recombinant Hepatitis B (Bio Farma)",Semarang - Indonesia,2020-01-30,2019-04-18,2022-09-19,INTERVENTIONAL,PHASE3,PT Bio Farma,INDUSTRY,hepatitis
NCT01995071,Unknown,COMPLETED,2013-11,"Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis","ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV)",No locations listed,2015-06,2013-11-26,2021-07-12,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT00614471,Unknown,COMPLETED,2007-08,"Hepatitis B, Chronic","Entecavir, Entecavir, peginterferon alfa-2a [Pegasys], peginterferon alfa-2a [Pegasys]","Beijing - China, Hangzhou - China, Shanghai - China, Shanghai - China, Shanghai - China, Xi'an - China, Zhengzhou - China, Hong Kong - Hong Kong",2009-10,2008-02-13,2016-11-02,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01193478,Unknown,COMPLETED,2010-08,HCV Infection,"GS-5885, Placebo, GS-5885, Placebo, GS-5885, Placebo, GS-5885, Placebo, GS-5885, Placebo, GS-5885, Placebo","Anaheim - United States, Cypress - United States, National City - United States, Washington - United States, Deland - United States, Miami - United States, Orlando - United States, St. Louis - United States, Portland - United States, Philadelphia - United States, Houston - United States, San Antonio - United States, Tacoma - United States",2011-01,2010-09-02,2013-01-21,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT01270178,Unknown,UNKNOWN,2011-01,"Chronic Hepatitis B, Hepatocellular Carcinoma",Entecavir,Taipei - Taiwan,Unknown Date,2011-01-05,2011-01-05,OBSERVATIONAL,Not Available,"Taipei Veterans General Hospital, Taiwan",OTHER_GOV,hepatitis
NCT02069678,Unknown,COMPLETED,2012-03,Chronic Hepatitis B,No interventions listed,Hong Kong - Hong Kong,2013-09,2014-02-24,2014-02-24,OBSERVATIONAL,Not Available,Chinese University of Hong Kong,OTHER,hepatitis
NCT00787371,Unknown,COMPLETED,2005-06,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b), PegIntron (peginterferon alfa-2b), PegIntron (peginterferon alfa-2b)",No locations listed,2006-07,2008-11-07,2017-03-13,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02971488,Unknown,COMPLETED,2017-01-15,"Hepatitis C, Drug Users, Harm Reduction, HIV",Screening for HCV in PWID and Linkage-To-Care,No locations listed,2018-12-31,2016-11-23,2019-09-13,OBSERVATIONAL,Not Available,Hospital Universitario Infanta Leonor,OTHER,hepatitis
NCT04943588,Unknown,RECRUITING,2021-11-01,"Hepatitis C, Chronic","HCV RNA (PCR), HCV Antibody test (Point of care), AST/ALT and platelets measurement",Karachi - Pakistan,2024-11-20,2021-06-29,2024-02-20,OBSERVATIONAL,Not Available,Queen Mary University of London,OTHER,hepatitis
NCT02105688,C-EDGE CO-STAR,COMPLETED,2014-09-02,Chronic Hepatitis C,"Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet",No locations listed,2015-06-10,2014-04-07,2019-12-05,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00502788,HepC,COMPLETED,2003-05,"Hepatitis C, Thalassemia","Peginterferon Alfa-2a and Ribavirin, Ribavirin","Oakland - United States, New York - United States, Philadelphia - United States, Toronto - Canada, London - United Kingdom",2006-06,2007-07-18,2014-03-04,INTERVENTIONAL,PHASE2,Carelon Research,OTHER,hepatitis
NCT03672188,Unknown,COMPLETED,2018-11-14,Chronic Hepatitis B,"VIR-2218, Placebo","Birtinya - Australia, Clayton - Australia, Fitzroy - Australia, Hong Kong - Hong Kong, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Auckland - New Zealand, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Hat Yai - Thailand, Khon Kaen - Thailand",2020-09-03,2018-09-14,2021-12-13,INTERVENTIONAL,PHASE2,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT01623778,Unknown,COMPLETED,2009-01,"Australia Antigen Positive, Hepatitis B, Adverse Effects",Interferon Alfa-2a add on ADV,Shanghai - China,2011-12,2012-06-20,2012-06-20,OBSERVATIONAL,Not Available,Changhai Hospital,OTHER,hepatitis
NCT01727271,Unknown,WITHDRAWN,2013-08,Hepatitis B,"Tenofovir, Pegylated interferon alpha-2b",No locations listed,2017-08,2012-11-15,2013-09-19,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00671671,Unknown,COMPLETED,2008-04,"Hepatitis, Chronic, Hepatitis C Virus","Small Molecule Agent (PF-868554), Small Molecule Agent (PF-868554)",Gainesville - United States,2008-12,2008-05-05,2014-01-14,INTERVENTIONAL,PHASE1,Pfizer,INDUSTRY,hepatitis
NCT00128271,Unknown,COMPLETED,2005-08,Hepatitis C,Bavituximab,Bradenton - United States,2006-08,2005-08-09,2008-05-07,INTERVENTIONAL,PHASE1,Peregrine Pharmaceuticals,INDUSTRY,hepatitis
NCT05792878,Unknown,UNKNOWN,2022-09-01,"Chronic Hepatitis B, COVID-19 Infection","Interferon, nucleoside analogues",Beijing - China,2023-12-01,2023-03-31,2023-03-31,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT03523871,Unknown,COMPLETED,2018-05-12,Hepatitis C,Mavyret,New York - United States,2020-09-01,2018-05-14,2021-09-05,INTERVENTIONAL,PHASE2,NYU Langone Health,OTHER,hepatitis
NCT03253471,Unknown,TERMINATED,2017-07-07,Hepatitis C,"AL-611, Placebo",Antwerp - Belgium,2017-09-18,2017-08-18,2017-10-25,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT01636778,Unknown,COMPLETED,2012-07,"Hepatitis C, Chronic",SB-497115-GR,"Aichi - Japan, Fukui - Japan, Fukuoka - Japan, Fukuoka - Japan, Gunma - Japan, Hyogo - Japan, Ibaraki - Japan, Kagawa - Japan, Kagawa - Japan, Kagoshima - Japan, Kanagawa - Japan, Nagasaki - Japan, Oita - Japan, Osaka - Japan, Tokyo - Japan, Wakayama - Japan",2014-05,2012-07-10,2016-03-01,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02014571,Unknown,COMPLETED,2013-12-26,"Hepatitis C, Chronic","GSK2878175, Placebo",San Juan - Puerto Rico,2014-07-03,2013-12-18,2018-07-24,INTERVENTIONAL,PHASE1,GlaxoSmithKline,INDUSTRY,hepatitis
NCT05376371,CJC-TraC,ACTIVE_NOT_RECRUITING,2022-11-29,"HIV, Hepatitis C, Substance Use Disorders",CJC-TraC,"Oregon - United States, Union Grove - United States",2025-02-28,2022-05-17,2024-10-30,INTERVENTIONAL,NA,"University of Wisconsin, Madison",OTHER,hepatitis
NCT06834178,HEAL-S,NOT_YET_RECRUITING,2025-04,"HBV, HCV, HDV, Coinfection, Hepatitis B Coinfection, Hepatitis B",No interventions listed,Graz - Austria,2026-10,2025-02-19,2025-03-05,OBSERVATIONAL,Not Available,"Vanessa Stadlbauer-Koellner, MD",OTHER,hepatitis
NCT02997878,Merlin,ACTIVE_NOT_RECRUITING,2018-12-07,"Cholangitis, Sclerosing, Hepatitis, Autoimmune",Orbcel-C,Birmingham - United Kingdom,2023-11-23,2016-12-20,2024-07-11,INTERVENTIONAL,PHASE2,University of Birmingham,OTHER,hepatitis
NCT01045278,Unknown,COMPLETED,2008-04,Hepatitis C,Pegylated interferon-alfa-2b and ribavirin,Malmö - Sweden,2013-09,2010-01-11,2013-10-07,INTERVENTIONAL,PHASE4,Region Skane,OTHER,hepatitis
NCT02166671,Unknown,TERMINATED,2014-04-25,Hepatitis B Vaccination,HBV booster vaccination 1dose,"Seoul - Korea, Republic of",2015-12-31,2014-06-18,2017-05-15,INTERVENTIONAL,NA,Seoul National University Hospital,OTHER,hepatitis
NCT05255978,Unknown,RECRUITING,2022-02-24,the Effect of NAFLD on CHB,No interventions listed,Wuhan - China,2023-06-24,2022-02-25,2022-02-25,OBSERVATIONAL,Not Available,Qin Ning,OTHER,hepatitis
NCT00512278,PARTNER,COMPLETED,2007-07,Hepatitis C,"Infliximab, Placebo","Los Angeles - United States, Port Orange - United States, Louisville - United States, Cleveland - United States, Cleveland - United States, Dallas - United States, San Antonio - United States",2012-05,2007-08-07,2017-09-13,INTERVENTIONAL,PHASE2,Nizar Zein,OTHER,hepatitis
NCT04452578,Unknown,COMPLETED,2020-06-10,Heart Failure,Procedure: Heart Transplantation,Loma Linda - United States,2022-06-17,2020-06-30,2022-12-01,INTERVENTIONAL,NA,Loma Linda University,OTHER,hepatitis
NCT03377478,Unknown,COMPLETED,2019-07-30,"Hepatitis C, Lung Transplant",Epclusa,Pittsburgh - United States,2021-09-21,2017-12-19,2022-12-16,INTERVENTIONAL,PHASE1,Pablo Sanchez,OTHER,hepatitis
NCT01371578,Unknown,COMPLETED,2011-07,"Hepatitis C, Chronic","GS-5885 tablet, GS-9451 tablet, peginterferon alfa-2a, ribavirin tablet","Dothan - United States, Montgomery - United States, Beverly Hills - United States, La Jolla - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, Aurora - United States, Englewood - United States, Bradenton - United States, Gainesville - United States, Miami - United States, Orlando - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Decatur - United States, Marietta - United States, Indianapolis - United States, Indianapolis - United States, Bowling Green - United States, Baton Rouge - United States, Baltimore - United States, Boston - United States, Worcester - United States, Detroit - United States, Jackson - United States, Tupelo - United States, Hillsborough - United States, Morristown - United States, Santa Fe - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, Asheville - United States, Durham - United States, Fayetteville - United States, Cincinnati - United States, Tulsa - United States, Providence - United States, Germantown - United States, Nashville - United States, Nashville - United States, Nashville - United States, Arlington - United States, Dallas - United States, Houston - United States, Houston - United States, Fairfax - United States, Norfolk - United States, Richmond - United States, Seattle - United States, San Juan - Puerto Rico",2013-03,2011-06-13,2014-02-11,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00986778,Unknown,WITHDRAWN,2009-12,"Hepatitis B, Chronic","Lamivudine, Entecavir, Adefovir",No locations listed,2012-12,2009-09-30,2015-09-01,INTERVENTIONAL,PHASE4,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05937178,Unknown,RECRUITING,2023-01-31,"Hepatitis B, Chronic","ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF","Hefei - China, Hefei - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Fuzhou - China, Xiamen - China, Lanzhou - China, Nanning - China, Guiyang - China, Ha'erbin - China, Haikou - China, Shijiazhuang - China, Zhengzhou - China, Zhengzhou - China, Wuhan - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Nanjing - China, Nanjing - China, Nanjing - China, Xuzhou - China, Nanchang - China, Chang chun - China, Shenyang - China, Xi'an - China, Xi'an - China, Jinan - China, Jinan - China, Qingdao - China, Shanghai - China, Taiyuan - China, Chengdu - China, Chengdu - China, Tianjin - China, Meizhou - China, Ürümqi - China, Kunming - China, Hangzhou - China, Shanghai - China",2029-01-31,2023-07-10,2023-07-10,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT02781571,Unknown,COMPLETED,2016-07-27,Hepatitis C Virus Infection,SOF/VEL,"Barcelona - Spain, Barcelona - Spain, Córdoba - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain, Zaragoza - Spain, Bern - Switzerland, Zürich - Switzerland, Cambridge - United Kingdom, Edinburgh - United Kingdom, Leeds - United Kingdom, London - United Kingdom, London - United Kingdom",2017-07-28,2016-05-24,2018-11-14,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT05725109,Unknown,COMPLETED,2023-01-16,Hepatitis C,"Hepatitis C Treatment Alerts in CHORUS™, Standard of Care",Los Angeles - United States,2023-10-17,2023-02-13,2024-02-16,OBSERVATIONAL,Not Available,Epividian,INDUSTRY,hepatitis
NCT02073656,Unknown,COMPLETED,2014-02,"Hepatitis C Virus, HIV","LDV/SOF, RBV","Birmingham - United States, Los Angeles - United States, Newport Beach - United States, Palo Alto - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, Torrance - United States, Denver - United States, Washington - United States, Bradenton - United States, Miami - United States, Orlando - United States, Tampa - United States, Atlanta - United States, Decatur - United States, Chicago - United States, Lutherville - United States, Boston - United States, Kansas City - United States, Santa Fe - United States, Bronx - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Allentown - United States, Philadelphia - United States, Providence - United States, Dallas - United States, Houston - United States, Annandale - United States, Richmond - United States, Seattle - United States, Vancouver - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Auckland - New Zealand, Christchurch - New Zealand, San Juan - Puerto Rico",2014-11,2014-02-27,2018-11-16,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01088009,EXPLORE,COMPLETED,2010-03,Compensated Chronic Hepatitis B,"lamivudine, lamivudine, lamivudine, adefovir","Beijing - China, Beijing - China, BeiJing - China, BeiJing - China, Beijing - China, ChongQing - China, FuZhou - China, FoShan - China, GuangZhou - China, GuangZhou - China, NanNing - China, Wuhan - China, ChangSha - China, ChangChun - China, ShenYang - China, JINan - China, ShangHai - China, ShangHai - China, ShangHai - China, ShangHai - China, XiAn - China, ChengDu - China, Hangzhou - China, HangZhou - China",2013-02,2010-03-16,2013-10-30,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT00759109,Unknown,COMPLETED,2002-03,"Carcinoma, Hepatocellular","Peginterferon alfa-2b, Observation (no treatment)",No locations listed,2009-11,2008-09-25,2017-04-07,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01168856,Unknown,TERMINATED,2010-09,"Hepatitis C, Chronic",No interventions listed,"La Jolla - United States, Long Beach - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Englewood - United States, Bradenton - United States, Atlanta - United States, Decatur - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Indianapolis - United States, Kansas City - United States, New Orleans - United States, Detroit - United States, Kansas City - United States, Lebanon - United States, Hillsborough - United States, Newark - United States, Manhasset - United States, New York - United States, New York - United States, Providence - United States, Nashville - United States, Dallas - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Newport News - United States, Richmond - United States, Vancouver - United States, Darlinghurst - Australia, Kingswood - Australia, Sydney - Australia, Westmead - Australia, Greenslopes - Australia, Herston - Australia, Woolloongabba - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Wien - Austria, Salvador - Brazil, Porto Alegre - Brazil, Ribeirao Preto - Brazil, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Clichy - France, Creteil - France, Lille - France, Marseille - France, Montpellier - France, Montpellier - France, Nice - France, Paris - France, Paris - France, Pessac - France, Rennes - France, Toulouse - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Berlin - Germany, Frankfurt Am Main - Germany, Hamburg - Germany, Hannover - Germany, Muenchen - Germany, Napoli - Italy, Bologna - Italy, Milano - Italy, Milano - Italy, Pavia - Italy, Torino - Italy, Bari - Italy, Pisa - Italy, Guadalajara - Mexico, Guadalajara - Mexico, Monterrey - Mexico, Christchurch - New Zealand, Dunedin - New Zealand, Grafton - New Zealand, Bydgoszcz - Poland, Chorzow - Poland, Lodz - Poland, Myslowice - Poland, Warszawa - Poland, Warszawa - Poland, Wrocław - Poland, Łodz - Poland, San Juan - Puerto Rico, Bratislava - Slovakia, Badalona - Spain, Santander - Spain, Palma de Mallorca - Spain, La Coruna - Spain, La Laguna - Spain, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Pontevedra - Spain, Sevilla - Spain, Valencia - Spain, Dorset - United Kingdom, Dundee - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, Nottingham - United Kingdom",2015-04,2010-07-23,2016-03-11,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06023056,Unknown,RECRUITING,2022-11-01,"Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn, Blood Transfusion Complication, Hepatitis B Vaccine Adverse Reaction",No interventions listed,Chongqing - China,2030-11-01,2023-09-05,2023-09-11,OBSERVATIONAL,Not Available,Children's Hospital of Chongqing Medical University,OTHER,hepatitis
NCT03995485,KW-136_III,COMPLETED,2017-06-07,"Hepatitis C, Chronic","KW-136 capsule, Sofosbuvir","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Wanzhou - China, Guangzhou - China, Guanzhou - China, Liuzhou - China, Zhengzhou - China, Wuhan - China, Nanjing - China, Changchun - China, Yanbian - China, Shenyang - China, Xi'an - China, Ji'nan - China, Chengdu - China, Ürümqi - China",2018-01-25,2019-06-24,2019-06-25,INTERVENTIONAL,PHASE3,"Kawin Technology Share-holding Co., Ltd.",INDUSTRY,hepatitis
NCT02019056,Unknown,COMPLETED,2010-11,"Alcoholic Fatty Liver Disease, Alcoholic Hepatitis","Placebo /bid P.O, MG-1, MG-2 : MG1000mg, Placebo /bid P.O, metadoxine","Guri city - Korea, Republic of",2014-12,2013-12-24,2015-04-29,INTERVENTIONAL,PHASE2,PharmaKing,INDUSTRY,hepatitis
NCT03488485,Unknown,UNKNOWN,2016-06-18,Chronic Hepatitis c,Direct Acting Antivirals,Chandigarh - India,2020-12,2018-04-05,2019-06-14,INTERVENTIONAL,NA,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT01473056,Unknown,COMPLETED,2010-08,"Hepatitis C Virus Infection, Response to Therapy of","JTK-853, Dose 2 JTK-853, Dose 3 JTK-853, Dose 4 JTK-853, Placebo",San Juan - Puerto Rico,2010-10,2011-11-17,2011-11-21,INTERVENTIONAL,PHASE1,Akros Pharma Inc.,INDUSTRY,hepatitis
NCT00940485,Unknown,COMPLETED,2009-04,"Hepatitis B, Chronic","entecavir, entecavir, peginterferon alfa-2a [Pegasys]","Changsha - China, Chengdu - China, Fu Zhou - China, Guangzhou - China, Hangzhou - China, Wuhan - China, Xi'an - China",2011-12,2009-07-16,2016-03-25,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05854511,Unknown,RECRUITING,2022-06-05,HCV,Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets,Cairo - Egypt,2023-12-31,2023-05-11,2023-05-11,INTERVENTIONAL,PHASE3,Ain Shams University,OTHER,hepatitis
NCT00857311,Unknown,COMPLETED,2004-05,Hepatitis C,"MRKAd5 HIV-1 gag vaccine (V520), Comparator: Placebo, Comparator: Open Label Tetanus and Diptheria Toxoids Adsorbed, MRKAd5 HIV-1 gag vaccine (V520)",No locations listed,2006-01,2009-03-06,2015-08-25,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05221411,TAILOR,UNKNOWN,2022-01-19,Autoimmune Hepatitis,"Mycophenolate Mofetil, Tacrolimus","Delft - Netherlands, Den Bosch - Netherlands, Enschede - Netherlands, Leiden - Netherlands, Maastricht - Netherlands, Utrecht - Netherlands",2023-01,2022-02-03,2022-02-03,INTERVENTIONAL,PHASE4,Leiden University Medical Center,OTHER,hepatitis
NCT01066793,Unknown,COMPLETED,2007-10,"Hepatitis C, Chronic","Peginterferon alfa-2a [Pegasys], Peginterferon alfa-2b [PegIntron®]","Aalst - Belgium, Antwerpen - Belgium, Antwerpen - Belgium, Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Genk - Belgium, Gent - Belgium, Gilly (Charleroi) - Belgium, Godinne - Belgium, Haine-Saint-Paul - Belgium, Kortrijk - Belgium, Leuven - Belgium, Liège - Belgium, Namur - Belgium, Oostende - Belgium, Roeselare - Belgium, Seraing - Belgium, Sijsele - Belgium, Tielt - Belgium, Verviers - Belgium, Dublin - Ireland, Dublin - Ireland, Dublin - Ireland, Pescara - Italy, Catanzaro - Italy, Vibo Valentia - Italy, Barra - Italy, Benevento - Italy, Gragnano - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Napoli - Italy, Nola - Italy, Bologna - Italy, Ferrara - Italy, Parma - Italy, Basovizza (TS) - Italy, Udine - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Roma - Italy, Savona - Italy, Brescia - Italy, Busto Arsizio - Italy, Cremona - Italy, Lecco - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Milano - Italy, Monza - Italy, Saronno - Italy, Treviglio - Italy, Fermo - Italy, Isernia - Italy, Alessandria - Italy, Asti - Italy, Biella - Italy, Novara - Italy, Torino - Italy, Torino - Italy, Bisceglie - Italy, Brindisi - Italy, Casarano - Italy, Castellana Grotte - Italy, Foggia - Italy, Galatina - Italy, Taranto - Italy, Cagliari - Italy, Catania - Italy, Comiso - Italy, Palermo - Italy, Arezzo - Italy, Firenze - Italy, Grosseto - Italy, Bolzano - Italy, Trento - Italy, Perugia - Italy, Mestre (VE) - Italy, Padova - Italy, Treviso - Italy, Venezia - Italy, Verona - Italy, London - United Kingdom",2011-03,2010-02-10,2016-05-09,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00793793,Unknown,COMPLETED,2007-09,"Hepatitis C, Chronic","BI201335, BI201335, BI201335, BI201335, Placebo","San Francisco - United States, San Francisco - United States, Baltimore - United States, New York - United States, New York - United States, Austin - United States, Lyon - France, Marseille - France, Paris - France, Paris - France, Berlin - Germany, Düsseldorf - Germany, Hannover - Germany, Kiel - Germany, Mainz - Germany, Madrid - Spain",2011-01,2008-11-19,2018-09-05,INTERVENTIONAL,PHASE1,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT00882193,Unknown,TERMINATED,2009-05-01,"Chronic Hepatitis C, Genotype 1, Relapse","Betaine, Peginterferon alpha 2a, Ribavirin",Omaha - United States,2011-01-12,2009-04-16,2023-11-30,INTERVENTIONAL,PHASE1,University of Nebraska,OTHER,hepatitis
NCT00794911,Unknown,COMPLETED,2007-09,Chronic HCV,"Quality of Life Therapy, Supportive Therapy",Boston - United States,2010-12,2008-11-20,2017-03-15,INTERVENTIONAL,NA,Beth Israel Deaconess Medical Center,OTHER,hepatitis
NCT06671093,Unknown,RECRUITING,2024-11-29,"Chronic Hep B, Chronic Hepatitis b, Chronic Hepatitis, HBV",Tune-401,"Hong Kong - Hong Kong, Auckland - New Zealand",2028-06-28,2024-11-04,2025-01-27,INTERVENTIONAL,PHASE1,"Tune Therapeutics, Inc.",INDUSTRY,hepatitis
NCT02982993,Unknown,COMPLETED,2016-12,Hepatitis C Infection,No interventions listed,New York - United States,2018-07-12,2016-12-06,2019-02-04,OBSERVATIONAL,Not Available,Icahn School of Medicine at Mount Sinai,OTHER,hepatitis
NCT00724893,Unknown,COMPLETED,2005-08,"Hepatitis C, Chronic, Hepatitis C","PegIFN-2b, Ribavirin",No locations listed,2012-08,2008-07-30,2015-08-14,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00272493,Unknown,COMPLETED,Unknown Date,HIV Infections,"Hepatitis B virus vaccine with GM-CSF adjuvant, Hepatitis B virus vaccine","Chicago - United States, Chicago - United States, Saint Louis - United States, New York - United States, Rochester - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Cleveland - United States, Columbus - United States, Seattle - United States",2007-11,2006-01-06,2021-10-25,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00096811,Unknown,NO_LONGER_AVAILABLE,2003-09,"Hepatitis B, Chronic Disease",Entecavir,"Jerusalem - Israel, Nazareth - Israel, Petach Tikva - Israel, Tel Aviv - Israel, Zefat - Israel",2008-08,2004-11-16,2016-09-21,EXPANDED_ACCESS,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00954993,Unknown,TERMINATED,2010-01-13,Chronic Hepatitis C Infection,Vaniprevir,No locations listed,2011-03-04,2009-08-07,2018-10-18,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05168293,Unknown,UNKNOWN,2022-02-01,"Hepatitis B, Chronic",Detection of HBV-DNA in Peripheral Blood Mononuclear cells,No locations listed,2023-02-01,2021-12-23,2021-12-23,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00564811,Unknown,COMPLETED,2003-03,"Hepatitis C, Nutritional Status, Hepatitis, Viral, Human",Agaricus blazei (Murrill) ss. Heinemann (sun mushroom),Botucatu - Brazil,Unknown Date,2007-11-28,2015-05-29,INTERVENTIONAL,NA,UPECLIN HC FM Botucatu Unesp,OTHER,hepatitis
NCT03985085,ANRS 12381,UNKNOWN,2019-11-26,"HIV Infections, Viral Hepatitis B, Sexually Transmitted Diseases, Contraception",Comprehensive package of sexual and reproductive health services,San Pedro - Côte D'Ivoire,2023-06,2019-06-13,2022-06-07,INTERVENTIONAL,NA,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT06122285,D-SHIELD,RECRUITING,2023-05-01,Hepatitis D,Bulevirtide,Milan - Italy,2023-11-01,2023-11-08,2025-01-10,OBSERVATIONAL,Not Available,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",OTHER,hepatitis
NCT02377856,Unknown,COMPLETED,2007-06,Acute Hepatitis C,"pegylated interferon alpha 2a, ribavirin",Kaohsiung - Taiwan,2016-02,2015-03-04,2016-03-02,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT00998985,Unknown,COMPLETED,2010-02-23,Hepatitis C,"Grazoprevir, Placebo",No locations listed,2012-11-08,2009-10-21,2018-07-17,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02791256,Unknown,TERMINATED,2005-06,"Hepatitis C, Chronic","Ribavirin, peginterferon alfa-2a","Antwerpen - Belgium, Antwerpen - Belgium, Brugge - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Gent - Belgium, Gilly - Belgium, Haine-saint-paul - Belgium, Kortrijk - Belgium, Leuven - Belgium, Liege - Belgium, Namur - Belgium, Roeselare - Belgium, Yvoir - Belgium",2008-06,2016-06-06,2016-06-08,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00158756,Unknown,COMPLETED,2005-09-12,Hepatitis B,"Tritanrix™-HepB, Rotarix™, Zilbrix™, Triple Antigen™, Engerix™-B, Placebo","Barnaul - Russian Federation, Ekaterinburg - Russian Federation, Ivanteevka Moscow Region - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation, St Petersburg - Russian Federation, Tomsk - Russian Federation",2006-11-01,2005-09-12,2018-06-06,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT01189656,Unknown,UNKNOWN,2009-01,Chronic Hepatitis B Patients With HBeAg-positive,HBV DNA Vaccine,Beijing - China,2010-11,2010-08-27,2010-08-27,INTERVENTIONAL,PHASE2,The 458 Hospital of Chinese PLA,OTHER,hepatitis
NCT02116556,RIFA-AAH,UNKNOWN,2013-04,Alcoholic Hepatitis,"Prednisone, Rifaximin","Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain",2016-12,2014-04-17,2016-11-04,INTERVENTIONAL,PHASE2,Hospital Universitari Vall d'Hebron Research Institute,OTHER,hepatitis
NCT03887637,Unknown,UNKNOWN,2019-03-30,Chronic Hepatitis C,DAAs,No locations listed,2019-08-30,2019-03-25,2019-03-25,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01405937,Unknown,COMPLETED,2011-08-29,"Hepatitis C, Chronic","vaniprevir, peg-IFN, ribavirin",No locations listed,2013-02-26,2011-07-29,2018-10-18,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02339337,Unknown,COMPLETED,2010-06,HBV/HCV Co-infection,Abbreviation of treatment duration,No locations listed,2014-06,2015-01-15,2015-01-15,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03209037,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,Peginterferon Alfa-2a,Beijing - China,2017-12,2017-07-06,2017-07-12,INTERVENTIONAL,PHASE4,Beijing Ditan Hospital,OTHER,hepatitis
NCT00987337,FITNESS,COMPLETED,2009-11,"Hepatitis, Hepatitis C","Filibuvir, Filibuvir, Placebo","Anaheim - United States, Anaheim - United States, Coronado - United States, La Jolla - United States, Mather - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, Aurora - United States, Englewood - United States, DeLand - United States, Jacksonville - United States, Jacksonville - United States, Orlando - United States, Orlando - United States, South Miami - United States, Winter Park - United States, Chicago - United States, Indianapolis - United States, New Orleans - United States, Boston - United States, New York - United States, Durham - United States, Durham - United States, Philadelphia - United States, Nashville - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Richmond - United States, Bruxelles - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Haine St. Paul - Belgium, Leuven - Belgium, Edmonton - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Halifax - Canada, Halifax - Canada, Montreal - Canada, Montreal - Canada, Montreal - Canada, Clichy - France, Creteil cedex - France, Marseille cedex 8 - France, Paris Cedex 12 - France, Pessac Cedex - France, Rennes cedex 9 - France, Vandoeuvre Les Nancy Cedex - France, Berlin - Germany, Bonn - Germany, Duesseldorf - Germany, Hamburg - Germany, Hamburg - Germany, Kiel - Germany, Koeln - Germany, Bekescsaba - Hungary, Budapest - Hungary, Debrecen - Hungary, Gyula - Hungary, Kaposvar - Hungary, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Rio Piedras - Puerto Rico, Majadahonda - Spain, Barcelona - Spain, Barcelona - Spain, Cordoba - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain",2012-01,2009-09-30,2014-01-27,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,hepatitis
NCT00715715,Unknown,WITHDRAWN,2008-04,Chronic Hepatitis B,Prednisone Priming,Brooklyn - United States,2011-02,2008-07-15,2012-04-20,INTERVENTIONAL,NA,Maimonides Medical Center,OTHER,hepatitis
NCT01590615,Unknown,COMPLETED,2012-04-26,Hepatitis B,Anti-HBV nucleoside/nucleotide therapy,"Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, San Francisco - United States, New Haven - United States, Washington, D.C. - United States, Miami - United States, Orlando - United States, Atlanta - United States, Chicago - United States, Kansas City - United States, Boston - United States, Detroit - United States, Saint Louis - United States, Omaha - United States, New York - United States, Portland - United States, Memphis - United States, Nashville - United States, Fort Worth - United States, Houston - United States, Richmond - United States, Seattle - United States, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada",2017-04-04,2012-05-03,2017-04-24,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT03549832,Unknown,COMPLETED,2018-01-01,HCV Coinfection,"Sofosbuvir, Simeprevir, Daclatasvir, Ribavirin, Ombitasvir/paritaprevir/ritonavir",Assiut - Egypt,2019-01-30,2018-06-08,2019-03-19,INTERVENTIONAL,NA,Assiut University,OTHER,hepatitis
NCT01809132,Unknown,COMPLETED,2013-09,Acute Alcoholic Hepatitis,"Anakinra, Pentoxifylline, Zinc Sulfate, Methylprednisolone","Louisville - United States, Worcester - United States, Cleveland - United States, Dallas - United States",2018-10,2013-03-12,2021-11-01,INTERVENTIONAL,PHASE3,Mack Mitchell,OTHER,hepatitis
NCT02582632,GARNET,COMPLETED,2015-11-24,"Hepatitis C Infection, Hepatitis C Virus","ombitasvir/paritaprevir/ritonavir, dasabuvir",No locations listed,2016-08-24,2015-10-21,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00237432,Unknown,COMPLETED,2003-04,Hepatitis C,No interventions listed,New York - United States,Unknown Date,2005-10-12,2010-12-10,OBSERVATIONAL,Not Available,Rockefeller University,OTHER,hepatitis
NCT00723632,Unknown,COMPLETED,2005-09,"Hepatitis C, Chronic, Hepatitis C","peginterferon alfa-2b, ribavirin",No locations listed,2010-12,2008-07-29,2015-10-02,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04170452,Unknown,UNKNOWN,2019-10-10,"Chronic Hepatitis Delta, Liver Biopsy",liver biopsy,Tashkent - Uzbekistan,2020-06-01,2019-11-20,2019-11-21,OBSERVATIONAL,Not Available,Tokhirbek Dolimov,OTHER_GOV,hepatitis
NCT02759315,Unknown,TERMINATED,2016-05-03,"Hepatitis C, Chronic","Uprifosbuvir 450 mg, Ruzasvir 60 mg",No locations listed,2017-07-27,2016-05-03,2019-06-26,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02639585,ESDAC,UNKNOWN,2015-12,"Hepatitis C, Chronic",Daclinza and Sunvepra,"Busan - Korea, Republic of, Yangsan - Korea, Republic of",2017-02,2015-12-24,2015-12-28,INTERVENTIONAL,PHASE4,Pusan National University Hospital,OTHER,hepatitis
NCT00534885,Unknown,COMPLETED,2006-03,Hepatitis A,"Healive® Lot 1, Healive® Lot 2, Healive® Lot 3, Havrix",Changzhou - China,2017-10,2007-09-26,2019-09-04,INTERVENTIONAL,PHASE4,"Sinovac Biotech Co., Ltd",INDUSTRY,hepatitis
NCT00403585,Unknown,COMPLETED,2006-07,"Hepatitis B, Chronic, Chronic Hepatitis B",adefovir dipivoxil 10mg,"Seoul - Korea, Republic of",2008-04,2006-11-27,2010-12-15,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02076685,Unknown,UNKNOWN,2007-11,Hepatotoxicity,isoniazid,Taipei - Taiwan,2015-11,2014-03-03,2014-03-17,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT05413785,Unknown,RECRUITING,2022-08-23,"Hepatitis C, HCV",Telehealth in Parole/Probation Office,Lexington - United States,2024-12-31,2022-06-10,2024-09-23,INTERVENTIONAL,NA,Jens Rosenau,OTHER,hepatitis
NCT02498015,D3FEAT,COMPLETED,2016-08,"Hepatitis C, Chronic","""3D"" regimen, ""3D"" regimen with ribavirin",Sydney - Australia,2017-08,2015-07-15,2019-06-13,INTERVENTIONAL,PHASE4,Kirby Institute,OTHER_GOV,hepatitis
NCT00963885,Unknown,COMPLETED,2009-08,"Hepatitis C, Chronic","Copegus, Pegasys, Placebo, Placebo, RO5190591 (Danoprevir), RO5190591 (Danoprevir), RO5190591 (Danoprevir), RO5190591 (Danoprevir)","Phoenix - United States, Long Beach - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Diego - United States, Aurora - United States, Gainesville - United States, Jacksonville - United States, Orlando - United States, Lombard - United States, New Orleans - United States, Ann Arbor - United States, Detroit - United States, Manhasset - United States, New York - United States, Asheville - United States, Chapel Hill - United States, Medford - United States, Lancaster - United States, San Antonio - United States, Salt Lake City - United States, Vancouver - United States, Milwaukee - United States, Kingswood - Australia, Adelaide - Australia, Heidelberg - Australia, Wien - Austria, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Ottawa - Canada, Toronto - Canada, Clichy - France, Marseille - France, Montpellier - France, Paris - France, Frankfurt Am Main - Germany, Hamburg - Germany, Napoli - Italy",2012-01,2009-08-24,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01342185,EMOTCHB,UNKNOWN,2010-03,Chronic Hepatitis B,"medical ozone therapy with tianyi, medical ozone therapy with humares, Diammonium glycyrrhizinate Capsules",GuangZhou - China,2013-07,2011-04-27,2012-10-18,INTERVENTIONAL,PHASE3,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT04856085,MARCH,ACTIVE_NOT_RECRUITING,2021-07-11,"Hepatitis B, Chronic","VIR-2218, VIR-3434, PEG-IFNα","San Francisco - United States, Miami - United States, Orlando - United States, Baltimore - United States, Hillsborough - United States, Toronto - Canada, Toronto - Canada, Vancouver - Canada, Frankfurt - Germany, Hannover - Germany, Mannheim - Germany, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Kuala Lumpur - Malaysia, Chisinau - Moldova, Republic of, Auckland - New Zealand, Auckland - New Zealand, Hamilton - New Zealand, Tauranga - New Zealand, Wellington - New Zealand, Bucharest - Romania, Chiayi City - Taiwan, Kaohsiung City - Taiwan, Kaohsiung City - Taiwan, Taichung City - Taiwan, Taipei City - Taiwan, Taoyuan City - Taiwan, Kyiv - Ukraine, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2027-06,2021-04-22,2024-11-21,INTERVENTIONAL,PHASE2,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT00545233,Unknown,COMPLETED,2008-01,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], ribavirin [Copegus], Pioglitazone","Birmingham - United States, Tucson - United States, Anaheim - United States, Fresno - United States, La Jolla - United States, Loma Linda - United States, Los Angeles - United States, Merced - United States, Palo Alto - United States, Pasadena - United States, San Clemente - United States, San Mateo - United States, Englewood - United States, Littleton - United States, Hartford - United States, Atlanta - United States, Chicago - United States, Downers Grove - United States, Indianapolis - United States, Indianapolis - United States, Iowa City - United States, Louisville - United States, New Orleans - United States, Portland - United States, Baltimore - United States, Boston - United States, Burlington - United States, Detroit - United States, Detroit - United States, Duluth - United States, Tupelo - United States, Kansas City - United States, St Louis - United States, Lebanon - United States, Egg Harbour Township - United States, Hackensack - United States, Bayside - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Asheville - United States, Charlotte - United States, Durham - United States, Cincinnati - United States, Cincinnati - United States, Cincinnati - United States, Cleveland - United States, Dayton - United States, Tulsa - United States, Portland - United States, Portland - United States, Philadelphia - United States, Philadelphia - United States, Columbia - United States, Nashville - United States, Nashville - United States, West Nashville - United States, Dallas - United States, Fort Sam Houston - United States, Houston - United States, Lubbock - United States, Salt Lake City - United States, Charlottesville - United States, Tacoma - United States, San Juan - Puerto Rico",2010-12,2007-10-17,2012-05-07,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01769833,Unknown,UNKNOWN,2013-05,Chronic Hepatitis B,"PEG-interferon-Alfa-2A, Nucleosides","Busan - Korea, Republic of",2015-05,2013-01-17,2014-11-04,INTERVENTIONAL,PHASE3,Pusan National University Hospital,OTHER,hepatitis
NCT01889433,Unknown,COMPLETED,2013-07-10,"Hepatitis, Hepatitis C","Algeron, Pegasys","Gomel - Belarus, Vitebsk - Belarus, Indore - India, Lucknow - India, Mumbai - India, Pune - India, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation, Saratov - Russian Federation, Smolensk - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation, St. Petersburg - Russian Federation, Stavropol - Russian Federation, Tyumen - Russian Federation, Bangkok - Thailand, Chiang Mai - Thailand",2015-12-02,2013-06-28,2018-07-16,INTERVENTIONAL,PHASE3,Biocad,INDUSTRY,hepatitis
NCT04310787,Unknown,RECRUITING,2020-05-15,"Hepatitis B, Acute-On-Chronic Liver Failure",No interventions listed,Guangzhou - China,2024-12-31,2020-03-17,2024-11-29,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT03212833,Unknown,UNKNOWN,2017-05-01,Hepatitis C,fasting serum insulin,Assiut - Egypt,2018-07-01,2017-07-11,2017-07-11,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT02971033,Unknown,TERMINATED,2018-04-16,Chronic Hepatitis C,"20mg ezetimibe, Placebo, 40mg ezetimibe",Hines - United States,2021-03-31,2016-11-22,2022-06-06,INTERVENTIONAL,PHASE2,VA Office of Research and Development,FED,hepatitis
NCT04168333,Unknown,COMPLETED,2018-01-08,Hepatitis B Virus (HBV),"T101 Group, Placebo Group",Changchun - China,2019-10-14,2019-11-19,2019-12-04,INTERVENTIONAL,PHASE1,"Tasly Tianjin Biopharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01813487,Unknown,COMPLETED,2013-02,Chronic Hepatitis B,HBsAg vaccine with Entecavir,"Seoul - Korea, Republic of",2013-07,2013-03-19,2013-12-30,INTERVENTIONAL,NA,"Genexine, Inc.",INDUSTRY,hepatitis
NCT01572233,Unknown,UNKNOWN,2011-12,"Hepatitis C Virus Infection, Response to Therapy of",Personalized Physical Activity and Psycho-Education (PPAPE) Program,Taipei - Taiwan,2017-12,2012-04-06,2012-12-27,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT03351933,GamaSTAN,COMPLETED,2017-10-31,Anti-Hepatitis A Antibody Levels in Heathy Subjects,Immune Globulin (Human),Overland Park - United States,2018-04-27,2017-11-24,2019-07-30,INTERVENTIONAL,PHASE4,Grifols Therapeutics LLC,INDUSTRY,hepatitis
NCT03809533,Unknown,ACTIVE_NOT_RECRUITING,2019-05-29,"Kidney Transplantation, Hepatitis C",sofosbuvir/velpatasvir,Pittsburgh - United States,2026-03-01,2019-01-18,2024-08-23,INTERVENTIONAL,PHASE2,"Amit D Tevar, MD",OTHER,hepatitis
NCT05452187,MIC project,COMPLETED,2021-03-12,"Inflammatory Bowel Diseases, Hepatitis C Virus Infection","Assess the effectiveness and safety of DAAs in patients with IBD., Evaluate the interaction of DAAs with IBD drugs, particularly immunosuppressants and/or biologics., Assessment of the impact of DAAs on the course of IBD.",Terrassa - Spain,2021-07-30,2022-07-11,2022-07-11,OBSERVATIONAL,Not Available,Hospital Mutua de Terrassa,OTHER,hepatitis
NCT00100633,Unknown,COMPLETED,2004-12,"HIV Infections, Hepatitis B","CpG7909 oligodeoxynucleotides (ODN), Hepatitis B virus vaccine",Cleveland - United States,2007-02,2005-01-05,2008-10-01,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00317187,Unknown,COMPLETED,2004-06-08,"Hepatitis B, Diphtheria, Whole Cell Pertussis, Tetanus, Haemophilus Influenzae Type b","Tritanrix-HepB/Meningitec conjugate vaccine, Tritanrix/Hiberix vaccine",Bangkok - Thailand,2005-01-16,2006-04-24,2018-08-15,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00752687,Unknown,COMPLETED,2008-09,Hepatitis C,"ABT-072, placebo",Abbott Park - United States,2009-05,2008-09-15,2010-10-21,INTERVENTIONAL,PHASE1,Abbott,INDUSTRY,hepatitis
NCT04365933,Unknown,COMPLETED,2020-05-25,"Hepatitis B, Chronic","EYP001a, Entecavir, Pegylated interferon alpha2a","Hong Kong - Hong Kong, Busan - Korea, Republic of, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2021-06-16,2020-04-28,2022-08-25,INTERVENTIONAL,PHASE2,Enyo Pharma,INDUSTRY,hepatitis
NCT03324633,CO13Hepavih,COMPLETED,2005-06,"HIV, Hepatitis C",No interventions listed,No locations listed,2017-09,2017-10-30,2023-08-02,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03597633,Unknown,UNKNOWN,2013-06-01,Chronic Hepatitis b With Multidrug Resistance,No interventions listed,"Ansan - Korea, Republic of",2018-12-31,2018-07-24,2018-07-24,OBSERVATIONAL,Not Available,Korea University,OTHER,hepatitis
NCT01671787,Unknown,COMPLETED,2012-03,Chronic Hepatitis B,"GS-7340, Tenofovir disoproxil fumarate","San Diego - United States, Baltimore - United States, Detroit - United States, Houston - United States, Melborne - Australia, Melbourne - Australia, Melbourne - Australia, Nedlands - Australia, Vancouver - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, St. Romuald - Canada, Auckland - New Zealand, Birmingham - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2013-04,2012-08-24,2018-10-23,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT04289987,Unknown,COMPLETED,2020-02-19,"Hepatitis B, Chronic","CVI-HBV-002, Normal Saline(placebo)","Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seongnam-si - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2023-12-04,2020-02-28,2024-02-13,INTERVENTIONAL,PHASE2,"CHA Vaccine Institute Co., Ltd.",INDUSTRY,hepatitis
NCT00558493,Unknown,COMPLETED,2007-11,Chronic Hepatitis B,Clevudine,"Daegu - Korea, Republic of",Unknown Date,2007-11-15,2012-07-26,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00514111,Unknown,COMPLETED,2007-08,"Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted","pegylated-interferon, conventional-interferon, ribavirin",Botucatu - Brazil,2008-07,2007-08-09,2009-03-20,OBSERVATIONAL,Not Available,UPECLIN HC FM Botucatu Unesp,OTHER,hepatitis
NCT02375711,IVVI,TERMINATED,2014-03,Chronic Renal Disease,Blood sample,Besançon - France,2016-09,2015-03-03,2018-04-05,INTERVENTIONAL,NA,Centre Hospitalier Universitaire de Besancon,OTHER,hepatitis
NCT00093093,VISER2,COMPLETED,2004-06,Chronic Hepatitis C,"Viramidine, Ribavirin, pegylated interferon alfa-2a","Tucson - United States, Fresno - United States, Los Angeles - United States, Los Angeles - United States, Newport Beach - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, San Mateo - United States, Denver - United States, Lakewood - United States, Farmington - United States, Washington - United States, Washington - United States, Bradenton - United States, Jacksonville - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Louisville - United States, New Orleans - United States, New Orleans - United States, Baltimore - United States, Baltimore - United States, Laurel - United States, Springfield - United States, Worcester - United States, Rochester - United States, Kansas City - United States, St. Louis - United States, Egg Harbor Township - United States, Bronx - United States, Bronx - United States, Johnson City - United States, Manhasset - United States, New York - United States, Syracuse - United States, Chapel Hill - United States, Winston-Salem - United States, Cincinnati - United States, Cleveland - United States, Tulsa - United States, Philadelphia - United States, Austin - United States, Dallas - United States, Houston - United States, Annadale - United States, Falls Church - United States, Richmond - United States, Tacoma - United States, Buenos Aires - Argentina, Buenos Aires - Argentina, Buenos Aires - Argentina, Pilar - Argentina, Rosario - Argentina, Westmead - Australia, Adelaide - Australia, Parkville - Australia, Prahran - Australia, Nedlands - Australia, Calgary - Canada, Edmonton - Canada, Winnipeg - Canada, Toronto - Canada, Grenoble - France, Marseille - France, Nice - France, Paris - France, Vandouevre les Nancy - France, Haifa - Israel, Nazareth - Israel, Tel Aviv - Israel, Busto Arsizio - Italy, Palermo - Italy, Pavia - Italy, Rome - Italy, Torino - Italy, Bydgoszcz - Poland, Chorzow - Poland, Krakow - Poland, Szczecin - Poland, Warszawa - Poland, Warszawa - Poland, Santurce - Puerto Rico, Moscow - Russian Federation, Smolensk - Russian Federation, St.Petersburg - Russian Federation, St.Petersburg - Russian Federation, St.Petersburg - Russian Federation, St.Petersburg - Russian Federation, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Valencia - Spain, Birmingham - United Kingdom, Edinburgh - United Kingdom",2006-05,2004-10-04,2012-06-22,INTERVENTIONAL,PHASE3,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT02243293,Unknown,COMPLETED,2014-09-19,"Chronic Hepatitis C, Hepatitis C Virus","ABT-493, ABT-530, ribavirin (RBV), ABT-493/ABT-530",No locations listed,2016-10-25,2014-09-17,2021-07-30,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00042393,Unknown,APPROVED_FOR_MARKETING,Unknown Date,Chronic Hepatitis B,Adefovir Dipivoxil,No locations listed,Unknown Date,2002-08-01,2014-01-07,EXPANDED_ACCESS,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT01353911,Unknown,COMPLETED,2011-06-27,"Hepatitis C, Chronic","Grazoprevir, Boceprevir, Placebo for Grazoprevir, Placebo for Boceprevir, Peg-interferon alfa-2b, Ribavirin",No locations listed,2013-01-20,2011-05-16,2024-05-22,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01442311,Unknown,COMPLETED,2007-10,"Hepatitis C, Medication Adherence","enhanced DOT (both pegylated interferon alfa-2a and ribavirin), standard DOT (PEG-DOT control arm)",Bronx - United States,2013-03,2011-09-28,2015-06-26,INTERVENTIONAL,NA,Albert Einstein College of Medicine,OTHER,hepatitis
NCT06452693,Unknown,NOT_YET_RECRUITING,2024-06,"Hepatitis B, Chronic","TQA3038 injection/placebo, Nucleotide drugs Control group","Bengbu - China, Fuzhou - China, Lanzhou - China, Guangzhou - China, Nanning - China, Guiyang - China, Harbin - China, Shiyan - China, Wuhan - China, Changsha - China, Nanchang - China, Changchun - China, Changchun - China, Shenyang - China, Shenyang - China, Jinan - China, Chengdu - China, Urumqi - China, Chongqing - China, Chongqing - China, Shanghai - China, Tianjin - China",2026-09,2024-06-11,2024-06-11,INTERVENTIONAL,PHASE2,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",INDUSTRY,hepatitis
NCT01928511,SWAP,COMPLETED,2014-01,Chronic Hepatitis B,"peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly, Nucleos(t)ide analogue therapy","Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore",2018-12,2013-08-26,2019-09-24,INTERVENTIONAL,PHASE4,Seng Gee Lim,OTHER,hepatitis
NCT03210493,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,Peginterferon Alfa-2a,Beijing - China,2017-12,2017-07-07,2017-07-12,INTERVENTIONAL,NA,Beijing Ditan Hospital,OTHER,hepatitis
NCT02578693,Unknown,UNKNOWN,2015-05,Chronic Hepatitis C Infection,No interventions listed,"Beijing - China, Hong Kong - China, Kofu-city - Japan",2023-12,2015-10-19,2022-12-21,OBSERVATIONAL,Not Available,Humanity and Health Research Centre,OTHER,hepatitis
NCT01265511,Unknown,COMPLETED,2010-11,Hepatitis C Infection,"Placebo, SCY-635, Pegasys, Copegus","San Francisco - United States, Durham - United States, San Antonio - United States, San Juan - Puerto Rico",2011-10,2010-12-23,2017-08-18,INTERVENTIONAL,PHASE2,"Scynexis, Inc.",INDUSTRY,hepatitis
NCT02457611,Unknown,COMPLETED,2015-06,Hepatitis C Infection With HIV Co-Infection,LDV/SOF,"Berlin - Germany, Bonn - Germany, Frankfurt am Main - Germany, London - United Kingdom",2016-01,2015-05-29,2018-11-16,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT02027493,Unknown,COMPLETED,2009-02,"Hepatitis C, Chronic","Reiferon R, Ribavirin","Menoufiya - Egypt, Cairo - Egypt, Cairo - Egypt",2011-01,2014-01-06,2014-01-06,INTERVENTIONAL,NA,"National Liver Institute, Egypt",OTHER,hepatitis
NCT00207311,HCVNASH,COMPLETED,2005-08,"Fatty Liver, Hepatitis C","Xenical, Pegasys, Copegus, Xenicare Program",Ft. Sam Houston - United States,2009-05,2005-09-21,2012-02-14,INTERVENTIONAL,PHASE4,Brooke Army Medical Center,FED,hepatitis
NCT04503993,Unknown,COMPLETED,2020-02-25,Hepatitis B,"Hepatitis B surface antigen, Hepatitis B core antibody, and Hepatitis B surface antibody",Sacramento - United States,2021-07-24,2020-08-07,2022-05-10,INTERVENTIONAL,NA,"University of California, Davis",OTHER,hepatitis
NCT01335711,Unknown,UNKNOWN,2011-04,Chronic Hepatitis C,"ChronVac-C + SOC, SOC","Huddinge - Sweden, Linköping - Sweden",2012-06,2011-04-14,2011-10-12,INTERVENTIONAL,PHASE2,ChronTech Pharma AB,INDUSTRY,hepatitis
NCT00980161,Unknown,UNKNOWN,2009-09,Hepatitis C,No interventions listed,"Douliou - Taiwan, Kimmen - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2010-09,2009-09-18,2010-03-26,OBSERVATIONAL,Not Available,National Taiwan University Hospital,OTHER,hepatitis
NCT01770483,HEP-C-FM,COMPLETED,2011-07,"Hepatitis C, Chronic, DIABETES MELLITUS Type 2","nitazoxanide, conventional interferon alfa, Ribavirin",Lahore - Pakistan,2013-03,2013-01-17,2013-09-20,INTERVENTIONAL,PHASE4,"Services Institute of Medical Sciences, Pakistan",OTHER_GOV,hepatitis
NCT03067883,Unknown,UNKNOWN,2016-11-09,Chronic Hepatitis c,"Ombitasvir, Paritaprevir and Ritonavir",Cairo - Egypt,2018-01,2017-03-01,2018-01-18,INTERVENTIONAL,PHASE2,Ain Shams University,OTHER,hepatitis
NCT01858961,Unknown,WITHDRAWN,2013-05,"Hepatitis C, Chronic","BI 201335, ribavirin, BI 207127, Telaprevir, ribavirin, Pegylated Interferon","Westmead - Australia, Adelaide - Australia, Fitzroy - Australia, Alzira - Spain, Barcelona - Spain, L'Hospitalet Llobregat (BCN) - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Valencia - Spain, Lund - Sweden, Stockholm - Sweden",2016-07,2013-05-21,2014-01-23,INTERVENTIONAL,PHASE3,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01405183,Unknown,COMPLETED,2011-01,"Hepatitis C, Renal Cell Carcinoma, Colorectal Cancer",Hepatitis C testing,Detroit - United States,2013-08,2011-07-29,2014-09-17,OBSERVATIONAL,Not Available,Henry Ford Health System,OTHER,hepatitis
NCT03252483,Unknown,COMPLETED,2012-12,"Hepatitis C, Hiv, HIV/AIDS, HCV Coinfection, HIV/AIDS and Infections","Bundled HCV/HIV Screening, HIV Screening",The Bronx - United States,2013-05,2017-08-17,2017-08-17,INTERVENTIONAL,NA,New York City Health and Hospitals Corporation,OTHER,hepatitis
NCT02441283,Unknown,COMPLETED,2015-06-22,Hepatitis C,"ABT-493, ABT-530","Dothan - United States, Bakersfield - United States, Coronado - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, Fort Pierce - United States, Bastrop - United States, Shreveport - United States, Detroit - United States, Binghamton - United States, Statesville - United States, Portland - United States, Germantown - United States, Nashville - United States, Arlington - United States, Baytown - United States, San Antonio - United States, Richmond - United States, Darlinghurst - Australia, East Lismore - Australia, Westmead - Australia, Herston - Australia, Adelaide - Australia, Parkville - Australia, Woluwe-Saint-Lambert - Belgium, Brussels - Belgium, Leuven - Belgium, Calgary - Canada, Toronto - Canada, Frankfurt am Main - Germany, Dusseldorf - Germany, Kiel - Germany, Auckland - New Zealand, Ponce - Puerto Rico, San Juan - Puerto Rico, San Juan - Puerto Rico, London - United Kingdom, London - United Kingdom, London - United Kingdom, Plymouth - United Kingdom",2019-10-15,2015-05-12,2020-09-21,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00317161,Unknown,COMPLETED,2004-08,"Diphtheria, Hepatitis B, Haemophilus Influenzae Type b, Whole Cell Pertussis, Tetanus",DTPw-HBV/Hib-MenAC conjugate vaccine,"Bangkok - Thailand, Khon Kaen - Thailand, Songkla - Thailand",2005-04,2006-04-24,2016-09-20,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00513461,Unknown,COMPLETED,2007-10,"Adult Primary Liver Cancer, Hepatitis C Infection","S-adenosyl-L-methionine disulfate p-toluene-sulfonate, placebo, laboratory biomarker analysis, immunoenzyme technique, high performance liquid chromatography","Tucson - United States, Long Beach - United States, Los Angeles - United States, Orange - United States, San Diego - United States",2012-08,2007-08-08,2018-08-10,INTERVENTIONAL,PHASE2,Chao Family Comprehensive Cancer Center,OTHER,hepatitis
NCT00371761,Unknown,COMPLETED,2006-09,"Hepatitis B, Chronic (CHB)","Pegylated interferon alfa-2b (PegIntron), Adefovir dipivoxil (adefovir)",No locations listed,2009-02,2006-09-04,2017-04-06,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01292161,Unknown,COMPLETED,2006-03,Hepatitis C,Silymarin,"Isfahan - Iran, Islamic Republic of",2006-09,2011-02-09,2011-02-09,INTERVENTIONAL,PHASE2,Isfahan University of Medical Sciences,OTHER,hepatitis
NCT00324961,Unknown,COMPLETED,2006-01,Chronic Hepatitis B,adefovir dipivoxil tablets,"Guangzhou - China, Guangzhou - China, Wuhan - China, Nanjing - China, Changchun - China, Hangzhou - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Chongqing - China, Chongquin - China, Jinan - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China",2009-01,2006-05-11,2009-10-28,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00383383,Unknown,COMPLETED,1999-12,Hepatitis B,"Hepatitis B adjuvanted vaccine, Engerix-B","Hradec - Czech Republic, Kuala Lumpur - Malaysia, Malaga - Spain",Unknown Date,2006-10-03,2006-10-03,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02687061,Unknown,UNKNOWN,2016-02,"Hepatitis B, Hepatitis C",No interventions listed,No locations listed,2016-09,2016-02-22,2016-02-22,OBSERVATIONAL,Not Available,Stichting MDL Holland-Noord,OTHER,hepatitis
NCT01107483,OCEHBV,COMPLETED,2009-12,"Hepatitis B, Chronic",No interventions listed,Guangzhou - China,2010-02,2010-04-21,2010-05-07,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT06264583,Unknown,RECRUITING,2024-05-01,Hepatitis D,HDV screening,Bonn - Germany,2024-12-31,2024-02-20,2024-05-24,OBSERVATIONAL,Not Available,"University Hospital, Bonn",OTHER,hepatitis
NCT05071261,Unknown,NOT_YET_RECRUITING,2024-09-01,Hepatitis C Virus Infection,Hepatitis C Virus Screening,No locations listed,2030-10-01,2021-10-08,2024-08-27,OBSERVATIONAL,Not Available,Liver Institute PLLC,OTHER,hepatitis
NCT00000583,Unknown,COMPLETED,1978-11,"Hepatitis B, Hepatitis, Viral, Human, Liver Diseases",hepatitis B vaccines,No locations listed,Unknown Date,1999-10-28,2013-11-26,INTERVENTIONAL,PHASE3,"National Heart, Lung, and Blood Institute (NHLBI)",NIH,hepatitis
NCT01672983,Unknown,COMPLETED,2012-07,Chronic Hepatitis C Infection,"ABT-450/ritonavir, ABT-267",No locations listed,2014-05,2012-08-27,2018-05-30,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT00313261,Unknown,TERMINATED,2003-06,Hepatitis B,Clevudine,"Guro-dong - Korea, Republic of, Yeongeon-dong - Korea, Republic of, Dogok-dong - Korea, Republic of, Ilwon-dong - Korea, Republic of, Pungnab2-dong - Korea, Republic of, Mok-dong - Korea, Republic of, Youido - Korea, Republic of",Unknown Date,2006-04-12,2012-10-17,INTERVENTIONAL,PHASE2,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT03476083,Unknown,UNKNOWN,2018-06-10,"Hepatitis B Infection, Congenital Malformation, Birth Defect, Viremia, Chronic Infection",Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily.,"Beijing - China, Chongqing - China, Guangzhou - China, Shijiazhuang - China, Shijiazhuang - China, Xi'an - China, Shenzhen - China",2021-05,2018-03-23,2019-12-12,INTERVENTIONAL,PHASE4,New Discovery LLC,INDUSTRY,hepatitis
NCT06586983,Unknown,RECRUITING,2024-09-04,Hepatitis B,Tenofovir Disoproxil Fumarate,Addis Ababa - Ethiopia,2028-09-05,2024-09-19,2024-09-19,OBSERVATIONAL,Not Available,Oslo University Hospital,OTHER,hepatitis
NCT00917761,Unknown,UNKNOWN,2007-02,"Hepatitis B, Chronic","Entecavir and peginterferon (Pegasys) (52 weeks), Peginterferon (Pegasys) (96 weeks), Peginterferon (Pegasys) (48 weeks)","Douliou - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2013-12,2009-06-10,2012-12-20,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT02768961,JAILFREE-C,COMPLETED,2016-05-10,Hepatitis C,"sofosbuvir, ledipasvir",Santoña - Spain,2017-05-10,2016-05-11,2017-05-18,INTERVENTIONAL,PHASE4,Instituto de Investigación Marqués de Valdecilla,OTHER,hepatitis
NCT03680183,Unknown,UNKNOWN,2018-05-22,"Non Small Cell Lung Cancer, Hepatitis B",Entecavir 1Mg Oral Tablet,Guangzhou - China,2019-03-01,2018-09-21,2018-09-28,OBSERVATIONAL,Not Available,Affiliated Cancer Hospital & Institute of Guangzhou Medical University,OTHER,hepatitis
NCT03581383,CARE-C,COMPLETED,2018-08-21,Hepatitis C,"PREP-C, Modified ECHO, Patient Telemedicine Questionnaire",Lexington - United States,2022-12-31,2018-07-10,2023-02-01,INTERVENTIONAL,NA,Jens Rosenau,OTHER,hepatitis
NCT03634683,Unknown,WITHDRAWN,2018-08,Recurrent Hepatocellular Carcinoma,LioCyx,"Guangzhou - China, Guangzhou - China, Singapore - Singapore",2022-08,2018-08-16,2022-06-30,INTERVENTIONAL,PHASE2,Lion TCR Pte. Ltd.,INDUSTRY,hepatitis
NCT01713283,Unknown,COMPLETED,2012-10,Hepatitis C Virus,"SOF, RBV",Los Angeles - United States,2013-11,2012-10-24,2014-11-25,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT05357183,Unknown,UNKNOWN,2022-01-01,Chronic Hepatitis B,PEG-IFN,Beijing - China,2024-12,2022-05-02,2022-05-12,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00305383,Unknown,TERMINATED,2005-11,"Hepatitis C, Chronic","Viramidine, Peginterferon alfa-2b","Los Angeles - United States, San Mateo - United States, Bradenton - United States, Miami - United States, Atlanta - United States, Laurel - United States, Egg Harbor Township - United States, Plainview - United States, Philadelphia - United States, Salt Lake City - United States, Fairfax - United States",Unknown Date,2006-03-21,2012-06-22,INTERVENTIONAL,PHASE2,"Bausch Health Americas, Inc.",INDUSTRY,hepatitis
NCT00120861,Unknown,COMPLETED,2005-01,Chronic Hepatitis C,"valopicitabine, pegylated interferon, ribavirin","Birmingham - United States, Los Angeles - United States, San Francisco - United States, Miami - United States, Baltimore - United States, Boston - United States, Detroit - United States, New York - United States, Dallas - United States, Houston - United States, San Antonio - United States",Unknown Date,2005-07-19,2010-06-10,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01183611,Unknown,COMPLETED,2007-04,"Virus Disease, DNA Virus Infections, Hepadnaviridae Infections","Experimental recombinant hepatitis B vaccine, HBIG, Active Comparator hepatitis B vaccine, Experimental recombinant hepatitis B vaccine, Active Comparator recombinant hepatitis B vaccine., Placebo Comparator recombinant hepatitis B vaccine",Nanjing - China,2010-06,2010-08-17,2010-09-17,INTERVENTIONAL,PHASE3,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT01525628,Unknown,COMPLETED,2012-04,"Hepatitis C, Chronic","midazolam, BI 201335, tenofovir, caffeine, tolbutamide, tolbutamide, midazolam, caffeine, pegylated interferon, BI 201335, BI 201335, BI 207127, BI 207127, BI 201335, BI 207127, ribavirin, ribavirin, ribavirin, pegylated interferon, ribavirin, caffeine, tolbutamide, BI 207127, midazolam, BI 201335, BI 207127, ribavirin","La Mesa - United States, Rockville - United States, Marlton - United States, Philadelphia - United States, Salt Lake City - United States, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, London - Canada, Ottawa - Canada, Montreal - Canada, Frankfurt am Main - Germany, Köln - Germany, Leipzig - Germany, Mainz - Germany",2013-12,2012-02-03,2016-06-10,INTERVENTIONAL,PHASE1,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01182311,Unknown,COMPLETED,2010-09-08,Hepatitis B,No interventions listed,Bethesda - United States,2013-05-01,2010-08-16,2020-12-11,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01854528,MALACHITE II,COMPLETED,2013-06,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Pegylated Interferon a-2a (PegINF), Telaprevir",No locations listed,2014-11,2013-05-15,2018-06-06,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT01833611,Unknown,UNKNOWN,2008-09,Chronic Hepatitis,"Entecavir, placebo","Chia-Yi - Taiwan, Chia-Yi - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan",2014-11,2013-04-17,2013-04-17,INTERVENTIONAL,PHASE4,National Cheng-Kung University Hospital,OTHER,hepatitis
NCT01937728,Unknown,COMPLETED,2010-03,Hepatitis C,"A: Peg-interferon alpha-2a & Ribavirin, B: Peg-interferon alpha-2a & Ribavirin, C: Peg-interferon alpha-2a & Ribavirin, D: Peg-interferon alpha-2a & Ribavirin, E: Peg-interferon alpha-2a & Ribavirin, F: Peg-interferon alpha-2a & Ribavirin",Kaohsiung - Taiwan,2016-10,2013-09-10,2016-12-29,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03640728,Unknown,UNKNOWN,2019-01-25,"Hepatitis B, Virus Diseases, Liver Failure","Tenofovir Alafenamide, Entecavir, Tenofovir disoproxil fumarate","Ankang - China, Hanzhong - China, Hanzhong - China, Weinan - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Yan'an - China",2021-04-30,2018-08-21,2023-02-09,OBSERVATIONAL,Not Available,First Affiliated Hospital Xi'an Jiaotong University,OTHER,hepatitis
NCT02452528,Unknown,TERMINATED,2015-08,Chronic Hepatitis B,"ARC-520, Placebo, Entecavir, Tenofovir, diphenhydramine","San Francisco - United States, Miami - United States, New York - United States, San Antonio - United States",2016-12,2015-05-22,2017-12-05,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT01222611,FOSTER-C,COMPLETED,2011-03,"Chronic HIV Infection, HCV Coinfection",Fosamprenavir,"Alcalá de Henares - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain",2013-06,2010-10-18,2014-05-30,INTERVENTIONAL,PHASE4,Fundacion SEIMC-GESIDA,OTHER,hepatitis
NCT05494528,Unknown,UNKNOWN,2021-05-04,Chronic Hepatitis B Virus Infection,"Ropeginterferon alfa-2b, Entecavir","Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan",2023-12-30,2022-08-10,2022-12-27,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT00161928,Unknown,COMPLETED,2002-04,"Meningitis, Meningococcal",Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT),"Linz - Austria, Wels - Austria, Augsburg - Germany, Bad Saulgau - Germany, Berlin - Germany, Bietigheim-Bissingen - Germany, Ettenheim - Germany, Heilbronn - Germany, Kehl - Germany, Nördlingen - Germany, Oberndorf / Neckar - Germany, Offenburg - Germany, Roding - Germany, Weingarten - Germany",Unknown Date,2005-09-13,2015-05-21,INTERVENTIONAL,PHASE3,Pfizer,INDUSTRY,hepatitis
NCT01534728,TETRA,COMPLETED,2012-02,Hepatitis C,No interventions listed,Paris - France,2014-03,2012-02-17,2015-01-13,OBSERVATIONAL,Not Available,"Institut National de la Santé Et de la Recherche Médicale, France",OTHER_GOV,hepatitis
NCT01854697,MALACHITE 1,COMPLETED,2013-03,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Telaprevir, Pegylated Interferon alpha 2-a (PegIFN)",No locations listed,2014-11,2013-05-15,2018-06-06,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT05276297,Unknown,ACTIVE_NOT_RECRUITING,2022-03-22,"Hepatitis B, Chronic","GSK3228836, GSK3528869A, Control","Edegem - Belgium, Sliven - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Veliko Tarnovo - Bulgaria, Vratsa - Bulgaria, Clichy Cedex - France, Créteil cedex - France, Lyon cedex 04 - France, Strasbourg cedex - France, Frankfurt - Germany, Leipzig - Germany, Berlin - Germany, Pokfulam - Hong Kong, Roma - Italy, Bergamo - Italy, Milano - Italy, Milano - Italy, Rozzano (MI) - Italy, Makati City - Philippines, Pasig - Philippines, Krakow - Poland, Lancut - Poland, Myslowice - Poland, Craiova - Romania, Cluj Napoca - Romania, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Majadahonda (Madrid) - Spain, Pontevedra - Spain, Santander - Spain, Sevilla - Spain, Chiayi City - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Ankara - Turkey, Rize - Turkey, Leicester - United Kingdom, Cottingham, Hull - United Kingdom",2026-02-11,2022-03-11,2024-02-22,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00774397,Unknown,COMPLETED,2008-10,"Hepatitis C, Chronic","BI 201335 NA 240 mg QD / LI, PegIFN/RBV, BI 201335 NA 120mg QD / LI, PegIFN/RBV, BI 201335 NA 240 mg QD, PegIFN/RBV, BI 201335 NA 240 mg QD, PegIFN/RBV, BI 201335 NA 240 mg BID, PegIFN/RBV, PegIFN/RBV, BI 201335 NA 240 mg QD, PegIFN/RBV, Placebo","San Francisco - United States, San Francisco - United States, Chicago - United States, Lutherville - United States, New York - United States, New York - United States, Philadelphia - United States, Germantown - United States, Nashville - United States, Austin - United States, Capital Federal - Argentina, Capital Federal - Argentina, Derqui, Pilar - Argentina, Rosario - Argentina, Rosario - Argentina, Camperdown - Australia, Kogarah - Australia, Randwick - Australia, Westmead - Australia, Herston - Australia, Woolloongabba - Australia, Clayton - Australia, Fitzroy - Australia, Parkville - Australia, Linz - Austria, Wien - Austria, Wien - Austria, Edmonton - Canada, Vancouver - Canada, Hamilton - Canada, Ottawa - Canada, Toronto - Canada, Montreal - Canada, Melnik - Czech Republic, Opava - Czech Republic, Clichy - France, Creteil - France, Lyon - France, Marseille - France, Montpellier - France, Paris Cedex 20 - France, Paris - France, Paris - France, Vandoeuvre Cedex - France, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bochum - Germany, Bonn - Germany, Dortmund - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Frankfurt/Main - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, Mainz - Germany, Tübingen - Germany, Busan - Korea, Republic of, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoungnam - Korea, Republic of, Sungnam - Korea, Republic of, Suwon - Korea, Republic of, Yangsan - Korea, Republic of, Amsterdam - Netherlands, Leiden - Netherlands, Coimbra - Portugal, Coimbra - Portugal, Lisboa - Portugal, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Bern - Switzerland, La Chaux-de-Fonds - Switzerland, Lugano - Switzerland, Zürich - Switzerland, Zürich - Switzerland, Bristol - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom, Southampton - United Kingdom",2011-11,2008-10-17,2015-11-16,INTERVENTIONAL,PHASE2,Boehringer Ingelheim,INDUSTRY,hepatitis
NCT01151397,Unknown,UNKNOWN,2011-08,Chronic Hepatitis C,"Peg + Vitamin D + Ribavirin, Peg + Ribavirin","Safed, Israel - Israel",2012-02,2010-06-28,2011-04-28,INTERVENTIONAL,NA,Ziv Hospital,OTHER_GOV,hepatitis
NCT03401697,Unknown,COMPLETED,2018-01-23,"Hepatitis C, HIV, Type2 Diabetes",No interventions listed,New York - United States,2021-03-01,2018-01-17,2021-03-24,OBSERVATIONAL,Not Available,Icahn School of Medicine at Mount Sinai,OTHER,hepatitis
NCT03829683,CITRIS-AH,COMPLETED,2019-04-16,"Alcoholic Hepatitis, Sepsis","Vitamin C, Dextrose 5% in water",Richmond - United States,2022-03-31,2019-02-04,2023-08-28,INTERVENTIONAL,PHASE2,Virginia Commonwealth University,OTHER,hepatitis
NCT01098097,POMOSCH,COMPLETED,2009-06,"Hepatitis C, Chronic","Peginterferon alpha, Ribavirin",No locations listed,2011-10,2010-04-02,2014-11-26,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00059397,Unknown,COMPLETED,2003-04,Hepatitis,No interventions listed,Philadelphia - United States,Unknown Date,2003-04-25,2010-03-18,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01767597,OPTISCREEN-B,COMPLETED,2012-02,"Hepatitis B, Liver Cirrhosis, Carcinoma, Hepatocellular","ELISA testing, Rapid testing","Paris - France, Paris - France, Paris - France, Paris - France, Paris - France",2012-07,2013-01-14,2016-12-13,INTERVENTIONAL,NA,Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba,OTHER,hepatitis
NCT02743897,THINKER,COMPLETED,2016-05-01,End Stage Renal Disease,"Zepatier, Mavyret",Philadelphia - United States,2022-03,2016-04-19,2023-06-15,INTERVENTIONAL,PHASE2,University of Pennsylvania,OTHER,hepatitis
NCT02551861,Unknown,WITHDRAWN,2015-12,Hepatitis C,"Daclatasvir, Sofosbuvir, Ribavirin","Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Creteil Cedex - France, Limoges - France, Montpellier Cedex 5 - France, Paris Cedex 14 - France, Pessac - France, Vandoeuvre Les Nancy - France",2016-06,2015-09-16,2016-01-15,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00326183,Unknown,COMPLETED,2007-03-26,"Hepatitis A, Measles, Mumps, Rubella, Chickenpox","VAQTA®, ProQuad",No locations listed,2008-01-15,2006-05-16,2019-02-04,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02168361,Unknown,COMPLETED,2013-12,Chronic Hepatitis C,"Pegylated Interferon alfa-2b, Simeprevir, Ribavirin, Sofosbuvir",Atlanta - United States,2014-12,2014-06-20,2016-03-14,INTERVENTIONAL,PHASE4,"Center For Hepatitis C, Atlanta, GA",OTHER,hepatitis
NCT01314261,Unknown,COMPLETED,2011-03,"Chronic Hepatitis C, Hepatitis C Virus (HCV) Infection","ABT-267, Pegylated interferon (pegIFN), Ribavirin (RBV), Placebo for ABT-267","Birmingham - United States, Los Angeles - United States, Orlando - United States, Honolulu - United States, Indianapolis - United States, Kansas City - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Seattle - United States, San Juan - Puerto Rico",2012-01,2011-03-14,2018-07-02,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT00943761,Unknown,COMPLETED,2009-10-23,"Hepatitis C, Chronic","Vaniprevir 600 mg b.i.d., Vaniprevir 300 mg b.i.d., Pegylated interferon, Ribavirin",No locations listed,2013-05-29,2009-07-22,2021-02-08,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00230061,Unknown,COMPLETED,2004-04,"HIV Infections, Hepatitis B","HBVAXPRO, Hepatitis B (Recombinant) vaccine, 10 mcg/ml",Rotterdam - Netherlands,2008-05,2005-09-30,2010-06-02,INTERVENTIONAL,PHASE4,Erasmus Medical Center,OTHER,hepatitis
NCT00660361,Unknown,UNKNOWN,2008-04,"HIV Infections, Hepatitis B Virus",No interventions listed,Melbourne - Australia,2010-04,2008-04-17,2008-04-17,OBSERVATIONAL,Not Available,Bayside Health,OTHER_GOV,hepatitis
NCT00262483,Unknown,COMPLETED,2005-12,Hepatitis C,"VX-950, ribavirin, peginterferon alfa-2a","San Antonio - United States, Santurce - Puerto Rico",Unknown Date,2005-12-06,2007-12-21,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02759861,Unknown,COMPLETED,2016-08-01,Genotype 1 Hepatitis C Virus,harvoni,Omaha - United States,2020-08-01,2016-05-03,2023-12-29,INTERVENTIONAL,PHASE4,University of Nebraska,OTHER,hepatitis
NCT02052661,Unknown,COMPLETED,2014-02-18,Hepatitis B,Engerix™-B Kinder,"Kehl - Germany, Tuttlingen - Germany, Bindlach - Germany, Goch - Germany, Loehne - Germany, Frankenthal - Germany, Leipzig - Germany, Radebeul - Germany, Flensburg - Germany, Berlin - Germany, Neumuenster - Germany",2014-09-23,2014-02-03,2018-06-06,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03342261,Unknown,COMPLETED,2017-03-01,"Hepatitis C, Chronic, Mixed Cryoglobulinemia",DAA treatment,Lyon - France,2017-11-01,2017-11-14,2017-11-14,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT00354861,Unknown,COMPLETED,2005-05,Healthy,"hepatitis B antigen (without alum) plus IMP321, hepatitis B antigen alone (without alum), Engerix B",Paris - France,2005-11,2006-07-20,2008-04-25,INTERVENTIONAL,PHASE1,Immutep S.A.S.,INDUSTRY,hepatitis
NCT05792761,Unknown,RECRUITING,2021-05-06,Chronic HBV Infection,Peginterferon alfa-2b combined and ETV,Shenzhen - China,2025-12-31,2023-03-31,2023-03-31,INTERVENTIONAL,NA,Fang Wang,OTHER,hepatitis
NCT02364661,Unknown,UNKNOWN,2015-03,"Starvation, Infection",Over night starvation (fasting),No locations listed,2016-03,2015-02-18,2015-02-18,INTERVENTIONAL,NA,Rabin Medical Center,OTHER,hepatitis
NCT02528461,Unknown,COMPLETED,2015-01,Hepatitis C,"Galactose, Gastroscopy, Liver biopsy, Fibroscan, Liver vein catheterization, Sofosbuvir",Aarhus C - Denmark,2019-01,2015-08-19,2020-04-07,OBSERVATIONAL,Not Available,University of Aarhus,OTHER,hepatitis
NCT00322361,Unknown,COMPLETED,2006-05,"Hepatitis B, Hepatocellular Carcinoma","Comparator: RECOMBIVAX HB™, Comparator: Modified process Hepatitis B Vaccine",No locations listed,2007-07,2006-05-05,2017-03-16,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00869661,Unknown,COMPLETED,2001-02,"Hepatitis C, Chronic","Copegus, Copegus, Pegasys, Pegasys, RO5024048, RO5024048, RO5024048, RO5024048","Birmingham - United States, La Jolla - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, Washington - United States, Bradenton - United States, Gainesville - United States, Marietta - United States, Chicago - United States, Lutherville - United States, Kansas City - United States, Newark - United States, New York - United States, Hershey - United States, Providence - United States, Columbia - United States, Nashville - United States, Houston - United States, San Antonio - United States, Richmond - United States, Sydney - Australia, Greenslopes - Australia, Herston - Australia, Woolloongabba - Australia, Fitzroy - Australia, Melbourne - Australia, Nedlands - Australia, Perth - Australia, Wien - Austria, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, London - Canada, Toronto - Canada, Montreal - Canada, Creteil - France, La Tronche - France, Lille - France, Nice - France, Paris - France, Paris - France, Pessac - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Hannover - Germany, Muenchen - Germany, Ulm - Germany, Bologna - Italy, Milano - Italy, Torino - Italy, Pisa - Italy, Santurce - Puerto Rico, Badalona - Spain, La Coruna - Spain, Barcelona - Spain, Barcelona - Spain, Granada - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom",2012-02,2009-03-26,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01082861,TANGO,TERMINATED,2010-09,Human Papillomavirus Infection,"Cervarix, Engerix-B",No locations listed,2011-04,2010-03-09,2010-03-19,INTERVENTIONAL,PHASE4,National Institute for Public Health and the Environment (RIVM),OTHER_GOV,hepatitis
NCT00114361,Unknown,COMPLETED,2005-03,Hepatitis B,"Ribavirin, Peginterferon alpha 2a",Rotterdam - Netherlands,2008-05,2005-06-15,2010-06-22,INTERVENTIONAL,PHASE3,Foundation for Liver Research,OTHER,hepatitis
NCT01368497,Unknown,COMPLETED,2012-09,Hepatitis B,Entecavir and peginterferon,"San Francisco - United States, Baltimore - United States, Minneapolis - United States, Saint Louis - United States, Dallas - United States, Seattle - United States, Toronto - Canada",2016-12-23,2011-06-08,2022-05-26,INTERVENTIONAL,PHASE3,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT06761261,LIVERPED,RECRUITING,2023-10-16,Hepatitis,No interventions listed,"Bologna - Italy, Bologna - Italy",2028-12-31,2025-01-07,2025-01-07,OBSERVATIONAL,Not Available,IRCCS Azienda Ospedaliero-Universitaria di Bologna,OTHER,hepatitis
NCT02762383,Unknown,TERMINATED,2005-03,HIV/HCV Coinfection,Peginterferon Alfa-2,"Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Liege - Belgium",2009-06,2016-05-04,2016-09-07,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01137383,Unknown,COMPLETED,2007-12,Hepatitis C,Pegaferon (pegylated interferon alpha 2a) + ribavirin,"Tehran - Iran, Islamic Republic of, Tehran - Iran, Islamic Republic of",2009-12,2010-06-04,2010-06-30,INTERVENTIONAL,PHASE3,Tehran University of Medical Sciences,OTHER,hepatitis
NCT01384383,Unknown,TERMINATED,2011-08,Chronic Hepatitis C,"GS-5885, GS-9451, RBV, PEG","Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Jose - United States, Stanford - United States, Englewood - United States, Indianapolis - United States, Brockton - United States, Las Vegas - United States, Great Neck - United States, New York - United States, Yonkers - United States, Asheville - United States, Chapel Hill - United States, Durham - United States, Portland - United States, Arlington - United States, Houston - United States, Salt Lake City - United States, Fairfax - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Camperdown - Australia, Concord - Australia, Darlinghurst - Australia, Kingswood - Australia, Kogarah - Australia, Sydney - Australia, Westmead - Australia, Herston - Australia, Woolloongabba - Australia, Woolloongabba - Australia, Bedford Park - Australia, Fitzroy - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Parkville - Australia, Fremantle - Australia, Nedlands - Australia, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Toronto - Canada, Aukland - New Zealand, Hamilton - New Zealand",2013-06,2011-06-29,2014-02-03,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01890083,Unknown,TERMINATED,2013-06,"Hepatitis C, Major Depressive Disorder","Exercise, Health Education",Dallas - United States,2015-10,2013-07-01,2016-12-29,INTERVENTIONAL,PHASE3,University of Texas Southwestern Medical Center,OTHER,hepatitis
NCT03591783,Unknown,UNKNOWN,2018-08,Hepatitis c,No interventions listed,No locations listed,2019-11,2018-07-19,2018-07-19,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT01502397,Unknown,COMPLETED,2011-12,Exposure to Hepatitis B Virus,No interventions listed,Hong Kong - Hong Kong,2015-12,2011-12-30,2019-10-01,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT06470997,Pro-CHILI,RECRUITING,2024-07-17,Immune-mediated Hepatitis,"Blood sample collection, Liver biopsy",Montpellier - France,2025-12-01,2024-06-24,2024-12-11,OBSERVATIONAL,Not Available,"University Hospital, Montpellier",OTHER,hepatitis
NCT00606528,Unknown,COMPLETED,2008-02,Chronic Hepatitis C Virus Infection,No intervention,Toronto - Canada,2013-07,2008-02-04,2013-07-25,OBSERVATIONAL,Not Available,"University Health Network, Toronto",OTHER,hepatitis
NCT01193361,HEPCAT,COMPLETED,2010-10,Hepatitis C Virus,"BMS-791325, BMS-791325, Placebo, Peg-interferon alfa-2a, Ribavirin","Anaheim - United States, Maywood - United States, Baltimore - United States, Baltimore - United States, Springfield - United States, Charlotte - United States, Tulsa - United States, Arlington - United States, San Antonio - United States, Fairfax - United States",2011-06,2010-09-01,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01925183,HIVCOBOC-RGT,COMPLETED,2013-08,"Hepatitis C, Chronic, HIV","Pegylated interferon alpha-2a, Ribavirin, Boceprevir",Vienna - Austria,2015-06,2013-08-19,2017-03-16,INTERVENTIONAL,PHASE4,Markus Peck-Radosavljevic,OTHER,hepatitis
NCT01349283,Unknown,COMPLETED,2011-05,Hepatitis B,"HepavaxGene (thiomersal free), Engerix B",Nanjing - China,2012-11,2011-05-06,2014-03-04,INTERVENTIONAL,PHASE3,Crucell Holland BV,INDUSTRY,hepatitis
NCT06659588,EVAH,NOT_YET_RECRUITING,2025-01,"Humoral Primary Immunodeficiencies (PIDs), Secondary Form of Humoral Immunodeficiencies, Combined Immunodeficiency (CID), Severe Combined Immunodeficiency (SCID)","Plasma, urine and stool collection","Paris - France, Paris - France, Paris - France",2027-01,2024-10-26,2024-10-26,OBSERVATIONAL,Not Available,Assistance Publique - Hôpitaux de Paris,OTHER,hepatitis
NCT02250807,Unknown,COMPLETED,2015-01,"Chronic Hepatitis C, Genotype 4 Chronic Hepatitis C","Simeprevir, Sofosbuvir","Badalona - Spain, Barcelona - Spain, Madrid - Spain, Santander N/A - Spain, Sevilla N/A - Spain, Sevilla - Spain, Valencia - Spain",2015-12,2014-09-26,2016-11-17,INTERVENTIONAL,PHASE3,Janssen R&D Ireland,INDUSTRY,hepatitis
NCT06750588,PhoenixAH,NOT_YET_RECRUITING,2025-03-01,Alcohol-Associated Hepatitis,"bacteriophage preparation, Bacteriophage preparation, bacteriophage preparation, bacteriophage preparation",Coronado - United States,2025-12,2024-12-27,2024-12-27,INTERVENTIONAL,PHASE1,Nterica Bio inc,INDUSTRY,hepatitis
NCT01005407,Unknown,COMPLETED,2010-02,Healthy,"HEPLISAV and/or Placebo, Engerix-B","Huntsville - United States, San Diego - United States, Santa Ana - United States, Denver - United States, Melbourne - United States, Pinellas Park - United States, Atlanta - United States, Chicago - United States, Peoria - United States, South Bend - United States, Rockville - United States, Brooklyn Center - United States, Edina - United States, Kansas City - United States, Saint Louis - United States, Rochester - United States, Cincinnati - United States, Erie - United States, Grove City - United States, Jefferson Hills - United States, Pittsburgh - United States, Upper Saint Clair - United States, Anderson - United States, Greer - United States, Nashville - United States, Dallas - United States, Katy - United States, San Antonio - United States, Norfolk - United States, Mount Pearl - Canada, Toronto - Canada, Montreal - Canada",2011-01,2009-11-01,2019-03-20,INTERVENTIONAL,PHASE3,Dynavax Technologies Corporation,INDUSTRY,hepatitis
NCT03468907,Unknown,COMPLETED,2015-06-01,"Hepatitis B, Chronic","Telbivudine 600mg, Tenofovir disoproxil fumarate 300mg",No locations listed,2017-12-31,2018-03-19,2018-08-29,INTERVENTIONAL,PHASE4,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01542788,POSITRON,COMPLETED,2012-03,Chronic Hepatitis C,"SOF, RBV, Placebo to match SOF, Placebo to match RBV","Birmingham - United States, Coronado - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Englewood - United States, Washington - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, New Port Richey - United States, Orlando - United States, Orlando - United States, Wellington - United States, Atlanta - United States, Marietta - United States, Indianapolis - United States, Bowling Green - United States, Baton Rouge - United States, Lutherville - United States, Boston - United States, Boston - United States, Springfield - United States, Novi - United States, St. Paul - United States, Kansas City - United States, Berlin - United States, Hillsborough - United States, Binghamton - United States, New York - United States, New York - United States, Durham - United States, Winston-Salem - United States, Philadelphia - United States, Providence - United States, Germantown - United States, Nashville - United States, Dallas - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Falls Church - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Westmead, - Australia, Herston - Australia, Melbourne - Australia, Melbourne - Australia, Calgary - Canada, Vancouver - Canada, Vancouver - Canada, Toronto - Canada, Montreal - Canada, Auckland - New Zealand, Christchurch - New Zealand, San Juan - Puerto Rico, San Juan - Puerto Rico",2012-11,2012-03-02,2014-05-19,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT00992888,Heliac,COMPLETED,2009-08,Alcoholic Hepatitis,Prometheus Liver Dialysis system (Fresenius Medical Care),Aarhus - Denmark,2011-09,2009-10-09,2011-09-15,INTERVENTIONAL,NA,University of Aarhus,OTHER,hepatitis
NCT03439488,Unknown,COMPLETED,2018-03-26,Chronic Hepatitis B,"JNJ-440, Placebo","Seoul - Korea, Republic of, Seoul - Korea, Republic of, Chisnau - Moldova, Republic of, Auckland - New Zealand, Bangkok - Thailand, Khon Kaen - Thailand, Kapitanavka - Ukraine",2019-10-10,2018-02-20,2025-02-03,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT01872988,Unknown,TERMINATED,2012-09,"Chronic Hepatitis B, Hepatocellular Carcinoma","Tenofovir, Placebo","Chia-Yi - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan",2018-02,2013-06-07,2014-09-04,INTERVENTIONAL,PHASE3,Taichung Veterans General Hospital,OTHER,hepatitis
NCT02044588,Unknown,UNKNOWN,2000-01,"HBsAg(+) Donor Kidney Allograft, HBsAg(-) Donor Kidney Allograft",HBsAg positive kidney allograft donor,Bangkok - Thailand,2014-12,2014-01-24,2014-01-24,OBSERVATIONAL,Not Available,Chulalongkorn University,OTHER,hepatitis
NCT03509688,Unknown,COMPLETED,2014-11,Hepatitis,"entecavir+resveratrol, Entecavir, entecavir+thymosin α1",No locations listed,2017-12,2018-04-26,2018-04-26,INTERVENTIONAL,NA,The First Hospital of Jilin University,OTHER,hepatitis
NCT05597488,Unknown,RECRUITING,2022-11-01,Cirrhosis Portal,EUS guided portal pressure gradient measurement,Hong Kong - China,2024-10-31,2022-10-28,2023-08-31,INTERVENTIONAL,NA,Chinese University of Hong Kong,OTHER,hepatitis
NCT01940471,Unknown,COMPLETED,2013-09-11,HBeAg-positive Chronic Hepatitis B,"TAF, TDF, TAF Placebo, TDF Placebo","Los Angeles - United States, Palo Alto - United States, Pasadena - United States, San Diego - United States, San Jose - United States, Miami - United States, Catonsville - United States, Boston - United States, Detroit - United States, Flushing - United States, Flushing - United States, Philadelphia - United States, Philadelphia - United States, Arlington - United States, Houston - United States, Camperdown - Australia, Concord - Australia, Westmead - Australia, Adelaide - Australia, Clayton - Australia, Fitzroy - Australia, Footscray - Australia, Heidelberg - Australia, Melbourne - Australia, Parkville - Australia, Perth - Australia, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Sofia - Bulgaria, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Clichy - France, Paris - France, Strasbourg - France, Villejuif - France, Hong Kong - Hong Kong, Lai Chi Kok - Hong Kong, Sha Tin - Hong Kong, Tai Po - Hong Kong, Tuen Mun - Hong Kong, Mumbai - India, Nagpur - India, Nagpur - India, Jaipur - India, Chandigarh - India, Chennai - India, Coimbatore - India, Hyderabad - India, Hyderabad - India, Jaipur - India, Kolkata - India, Kolkata - India, Mumbai - India, New Delhi - India, New Delhi - India, New Delhi - India, Parel - India, Surat - India, Bologna - Italy, Bologna - Italy, Foggia - Italy, Messina - Italy, Milano - Italy, Padova - Italy, Padova - Italy, Pisa - Italy, Fukuoka - Japan, Fukuoka - Japan, Fukuoka - Japan, Kagawa - Japan, Kobe - Japan, Kofu - Japan, Kurume - Japan, Kyoto - Japan, Musashino - Japan, Nishinomiya - Japan, Okayama - Japan, Omura - Japan, Osaka - Japan, Osaka - Japan, Sapporo - Japan, Tokyo - Japan, Busan - Korea, Republic of, Busan - Korea, Republic of, Cheonan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Daejeon - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-Do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ulsan - Korea, Republic of, Wŏnju - Korea, Republic of, Yangsan - Korea, Republic of, Auckland - New Zealand, Hamilton - New Zealand, Bialystok - Poland, Chorzow - Poland, Lodz - Poland, Warszawa - Poland, Wroclaw - Poland, Bucharest - Romania, Bucuresti - Romania, Constanţa - Romania, Iasi - Romania, Timişoara - Romania, Lipetsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Novosibirsk - Russian Federation, Novosibirsk - Russian Federation, Saint-Petersburg - Russian Federation, Saint-Petersburg - Russian Federation, Samara - Russian Federation, Yekaterinburg - Russian Federation, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Barcelona - Spain, Sevilla - Spain, Chiayi - Taiwan, Hualien - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Ankara - Turkey, Bursa - Turkey, Diyarbakir - Turkey, Istanbul - Turkey, Izmir - Turkey, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2015-11-16,2013-09-12,2023-10-10,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT06272071,Unknown,NOT_YET_RECRUITING,2024-03,Liver Failure,No interventions listed,No locations listed,2026-11,2024-02-22,2024-03-04,OBSERVATIONAL,Not Available,Zhejiang University,OTHER,hepatitis
NCT03200171,Unknown,COMPLETED,2018-02-10,"Carcinoma, Hepatocellular, Hepatitis C",No interventions listed,"Cairo - Egypt, Cairo - Egypt, Cairo - Egypt",2021-06-19,2017-06-27,2021-07-21,OBSERVATIONAL,Not Available,Al-Azhar University,OTHER,hepatitis
NCT00197171,Unknown,COMPLETED,2003-09,"Hepatitis B, Hepatitis A",Combined Hepatitis A and B vaccine,"Paramatta - Australia, Melbourne - Australia",2003-12,2005-09-20,2016-09-07,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02764671,Unknown,UNKNOWN,2015-05,"Hepatitis, Hepatitis B, Liver Diseases, Digestive System Diseases",10μg/0.5ml recombinant hepatitis B vaccine,"Maoming - China, Yunfu - China",2020-09,2016-05-06,2016-05-06,INTERVENTIONAL,PHASE4,"Shenzhen Kangtai Biological Products Co., LTD",INDUSTRY,hepatitis
NCT06191471,Unknown,COMPLETED,2023-11-01,Acute Acalculous Cholecystitis,Laparoscopic cholecystectomy for hepatitis A induced acute acalculous cholecystitis,Beirut - Lebanon,2023-12-10,2024-01-05,2024-01-05,OBSERVATIONAL,Not Available,University of Balamand,OTHER,hepatitis
NCT03330171,MV/VV/Hep-AV,UNKNOWN,2017-04-10,"Measles, Varicella, Hepatitis A","Measles vaccine, Hepatitis-A vaccine, Varicella vaccine",Soweto - South Africa,2019-02-26,2017-11-06,2020-03-17,INTERVENTIONAL,PHASE4,"University of Witwatersrand, South Africa",OTHER,hepatitis
NCT03577171,Unknown,COMPLETED,2018-06-19,Chronic Hepatitis B,"ABI-H0731, SOC ETV, Placebo Oral Tablet","Coronado - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, Baltimore - United States, New York - United States, Philadelphia - United States, Vancouver - Canada, Toronto - Canada, Hong Kong - Hong Kong, Hamilton - New Zealand, London - United Kingdom",2019-06-21,2018-07-05,2021-01-28,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT04470271,Unknown,UNKNOWN,2020-09-01,Viral Hepatitis C,Patients with hepatitis C lost follow up,Pilar - Argentina,2020-12-31,2020-07-14,2020-07-14,OBSERVATIONAL,Not Available,"Austral University, Argentina",OTHER,hepatitis
NCT00039871,Unknown,COMPLETED,2002-05,"Hepatitis, Hepatitis C, Chronic, Fibrosis, Liver Cirrhosis","PegIntron (peginterferon alfa-2b; SCH 54031), REBETOL (ribavirin; SCH 18908)",No locations listed,2007-09,2002-06-14,2017-04-04,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00739128,Unknown,TERMINATED,2009-02,Celiac Disease,"hepatitis B vaccine (EngerixB), hepatitis B vaccine (EngerixB)",Jerusalem - Israel,2011-03,2008-08-21,2011-04-15,INTERVENTIONAL,NA,Shaare Zedek Medical Center,OTHER,hepatitis
NCT02262728,Unknown,COMPLETED,2014-09-30,"Hepatitis C, Chronic","Simeprevir, Daclatasvir, Sofosbuvir",San Antonio - United States,2015-08-13,2014-10-13,2025-02-04,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT02618928,OPALE,COMPLETED,2015-12-15,Chronic Hepatitis C,No interventions listed,"Marseille CEDEX 08 - France, Marseille CEDEX 08 - France, Marseille CEDEX 08 - France, Orleans CEDEX 2 - France, Besancon - France, Limoges CEDEX 1 - France, Toulouse - France, Toulouse - France, Montpellier CEDEX 5 - France, Clichy - France, Marseille CEDEX 05 - France, Marseille CEDEX 05 - France, Amiens CEDEX 1 - France, Aix En Provence - France, Aix En Provence - France, Angers - France, Argenteuil - France, Avignon - France, Avignon - France, Besancon - France, Bourgoin Jallieu - France, Caen - France, Chambery - France, Clamart - France, Clamart - France, Creteil - France, Creteil - France, Grasse - France, Grenoble - France, Hyeres - France, Le Mans - France, Le Port - France, Libourne - France, Longjumeau - France, Lyon - France, Lyon - France, Marseille - France, Montelimar - France, Nanterre - France, Nice - France, Nimes - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Perpignan - France, Poitiers - France, Reims - France, Rennes - France, Rouen - France, Saint Laurent Du Var - France, Saint Mande - France, Strasbourg - France, Suresnes - France, Toulon - France, Toulouse - France, Toulouse - France, Tourcoing - France, Tours - France, Villejuif - France, Villejuif - France, Villejuif - France",2018-03-29,2015-12-02,2019-06-17,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01402583,MEN_EPID,COMPLETED,2011-07,Chronic Hepatitis C,PEG IFN/Ribavirin,Modena - Italy,2011-08,2011-07-26,2011-10-21,OBSERVATIONAL,Not Available,Prof. Facchinetti Fabio,OTHER,hepatitis
NCT00372983,Unknown,COMPLETED,2006-08,Hepatitis C,NOV-205,No locations listed,Unknown Date,2006-09-07,2007-12-21,INTERVENTIONAL,PHASE1,"Cellectar Biosciences, Inc.",INDUSTRY,hepatitis
NCT02744547,Unknown,COMPLETED,2015-12,Beta Thalassemia Major,Spirulina,Tanta - Egypt,2017-12,2016-04-20,2019-04-10,INTERVENTIONAL,NA,Tanta University,OTHER,hepatitis
NCT03365947,Unknown,COMPLETED,2018-03-27,Hepatitis B,"ARO-HBV, Sterile Normal Saline (0.9% NaCl), JNJ-56136379","Camperdown - Australia, Clayton - Australia, Melbourne - Australia, Nedlands - Australia, Hong Kong - Hong Kong, Grafton - New Zealand, Papatoetoe - New Zealand",2020-04-23,2017-12-08,2024-06-04,INTERVENTIONAL,PHASE2,Arrowhead Pharmaceuticals,INDUSTRY,hepatitis
NCT01718145,Unknown,COMPLETED,2012-11,Hepatitis C Virus Infection,"Daclatasvir, Asunaprevir, Ribavirin, pegIFNα-2b, Telaprevir","Nagoya-shi - Japan, Toyoake Shi - Japan, Chiba-shi - Japan, Fukuoka-shi - Japan, Kurume - Japan, Ogaki-shi - Japan, Takasaki City - Japan, Hiroshima-shi - Japan, Obihiro-shi - Japan, Sapporo-shi - Japan, Sapporo-shi - Japan, Takamatsu-shi - Japan, Kagoshima-shi - Japan, Kawasaki-shi - Japan, Yokohama-shi - Japan, Kumamoto-shi - Japan, Kyoto-shi - Japan, Sendai-shi - Japan, Matsumoto - Japan, Nagasaki-shi - Japan, Omura - Japan, Kashihara - Japan, Yufu - Japan, Okayama-shi - Japan, Osaka-sayama-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Suita - Japan, Iruma-gun - Japan, Izunokuni - Japan, Shimotsuke-shi - Japan, Bunkyo-ku - Japan, Bunkyo-ku - Japan, Minato-ku - Japan, Musashino-shi - Japan, Shinagawa-ku - Japan, Yamagata-shi - Japan, Chuo-shi - Japan, Fukui - Japan, Fukuoka - Japan, Fukuoka - Japan, Gifu - Japan, Kumamoto - Japan, Nagoya-shi - Japan, Nishinomiya-shi - Japan, Osaka - Japan, Saitama - Japan",2013-12,2012-10-31,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02826447,IMMHoTHep,UNKNOWN,2017-02-21,Exposure to Hepatitis C Virus,No interventions listed,Cairo - Egypt,2018-04,2016-07-11,2017-04-10,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT05532345,Unknown,COMPLETED,2022-07-01,"Drug-induced Liver Injury, Autoimmune Hepatitis",No interventions listed,Beijing - China,2023-05-31,2022-09-08,2023-07-21,OBSERVATIONAL,Not Available,Beijing Friendship Hospital,OTHER,hepatitis
NCT02883647,Unknown,RECRUITING,2014-01-01,Chronic Hepatitis b,Entecavir or Tenofovir,Guangzhou - China,2024-12-31,2016-08-30,2024-11-29,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04781647,Unknown,TERMINATED,2021-02-18,Chronic Hepatitis B,"ABI-H0731, ETV, Peg-IFNα","Beijing - China, Beijing - China, Guangzhou - China, Guangzhou - China, Changsha - China, Chang chun - China, Shanghai - China, Shanghai - China, Hangzhou - China",2022-12-02,2021-03-04,2023-10-06,INTERVENTIONAL,PHASE2,Assembly Biosciences,INDUSTRY,hepatitis
NCT03057847,Unknown,COMPLETED,2018-01-30,"Hepatitis C, Chronic, Opioid-use Disorder",Sofosbuvir/Velpatasvir,Pittsburgh - United States,2022-02-24,2017-02-20,2023-05-06,INTERVENTIONAL,PHASE4,"Elizabeth Krans, MD",OTHER,hepatitis
NCT00879047,Unknown,COMPLETED,2009-04,"HIV Infections, Hepatitis C","Alcohol, Alcohol placebo",San Francisco - United States,2013-04,2009-04-09,2014-05-06,INTERVENTIONAL,PHASE1,"University of California, San Francisco",OTHER,hepatitis
NCT00854087,Unknown,COMPLETED,2010-08,Chronic Hepatitis C Infection,"Fuzheng Huayu, Placebo","Coronado - United States, Palo Alto - United States, Pasadena - United States, Sacramento - United States, San Clemente - United States, Port Orange - United States, Houston - United States, Salt Lake City - United States",2013-04,2009-03-02,2021-05-19,INTERVENTIONAL,PHASE2,Tarek Hassanein,INDIV,hepatitis
NCT02582333,Unknown,COMPLETED,2015-10-01,"Virological Breakthrough, Prognosis",Observation for clinical and virological changes,"Changhua - Taiwan, Taichung - Taiwan, Taichung - Taiwan, Taichung - Taiwan",2020-10-01,2015-10-21,2021-03-16,OBSERVATIONAL,Not Available,Taichung Veterans General Hospital,OTHER,hepatitis
NCT00117533,Unknown,UNKNOWN,2005-09,"Chronic Hepatitis B, Chronic Hepatitis D",pegylated IFN alfa-2b plus ribavirin,"Taipei - Taiwan, Taipei - Taiwan",Unknown Date,2005-07-07,2006-05-25,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
NCT05310487,Unknown,COMPLETED,2022-09-30,Chronic Hepatitis B,"162, Placebo",Melbourne - Australia,2023-10-03,2022-04-05,2023-11-27,INTERVENTIONAL,PHASE1,"Yangshengtang Co., Ltd",INDUSTRY,hepatitis
NCT02545387,Unknown,WITHDRAWN,2015-01,Chronic Hepatitis C,No interventions listed,Graz - Austria,2018-12,2015-09-10,2018-12-19,OBSERVATIONAL,Not Available,Medical University of Graz,OTHER,hepatitis
NCT02480387,Unknown,COMPLETED,2015-05,Treatment of Hepatitis C,Ledipasvir/Sofosbuvir FDC,Los Angeles - United States,2015-11,2015-06-24,2016-07-20,INTERVENTIONAL,PHASE2,"Peter J. Ruane, M.D., Inc.",OTHER,hepatitis
NCT00035633,Unknown,COMPLETED,2001-12,Chronic Hepatitis B,Entecavir,"Birmingham - United States, Tucson - United States, La Jolla - United States, Los Angeles - United States, Orange - United States, Palo Alto - United States, San Francisco - United States, Torrance - United States, Farmington - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Honolulu - United States, Chicago - United States, Iowa City - United States, Boston - United States, Worcester - United States, Ann Arbor - United States, Royal Oak - United States, St Paul - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Rochester - United States, Charlotte - United States, Cleveland - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Nashville - United States, Dallas - United States, Fairfax - United States, Richmond - United States, Seattle - United States",2005-02,2002-05-06,2011-04-14,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT02766933,Unknown,COMPLETED,2016-05,"Hepatitis B, Hepatitis B, Chronic",No interventions listed,Bamenda - Cameroon,2024-12-31,2016-05-10,2025-01-20,OBSERVATIONAL,Not Available,Mayo Clinic,OTHER,hepatitis
NCT00962533,EFFORT,COMPLETED,2009-08,"Hepatitis B, Chronic","telbivudine, telbivudine","BeiJing - China, Beijing - China, Beijing - China, BeiJing - China, Beijing - China, Beijing - China, ChongQing - China, Guangzhou - China, GuangZhou - China, GuangZhou - China, Wuhan - China, ChangSha - China, NanJing - China, ChangChun - China, ShenYang - China, JINan - China, ShangHai - China, ShangHai - China, ShangHai - China, ShangHai - China, XiAn - China, ChengDu - China, HangZhou - China, Hangzhou - China",2012-04,2009-08-20,2013-01-31,INTERVENTIONAL,PHASE4,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT02038387,Unknown,UNKNOWN,2012-07,"Chronic Hepatitis C Virus, Non Alcoholic Fatty Liver Disease",normocaloric low cholesterol diet,Rome - Italy,2013-12,2014-01-16,2014-01-16,INTERVENTIONAL,NA,University of Roma La Sapienza,OTHER,hepatitis
NCT01195987,Unknown,UNKNOWN,2010-06,Hepatitis C Patients,No interventions listed,Kansas City - United States,2011-08,2010-09-08,2010-09-08,OBSERVATIONAL,Not Available,"The Center for Rheumatic Disease, Allergy, & Immunology",OTHER,hepatitis
NCT01708733,Unknown,COMPLETED,2012-08,Liver Function,KSY,Taipei - Taiwan,2014-01,2012-10-17,2014-05-29,INTERVENTIONAL,PHASE3,Taipei City Hospital,OTHER_GOV,hepatitis
NCT00919633,COPE-HCV,COMPLETED,2009-06,Hepatitis C,"interferon alfa-2b, peginterferon alfa-2b, ribavirin, USP, external drug infusion pump",Durham - United States,2012-07,2009-06-12,2019-10-09,INTERVENTIONAL,PHASE2,Medtronic Corporate Technologies and New Ventures,INDUSTRY,hepatitis
NCT03826433,Unknown,RECRUITING,2018-10-01,Hepatitis B,Peripheral iv,Changsha - China,2025-06-30,2019-02-01,2024-07-22,INTERVENTIONAL,PHASE1,"Sclnow Biotechnology Co., Ltd.",INDUSTRY,hepatitis
NCT06092333,Unknown,RECRUITING,2025-01-31,Chronic Hepatitis B,VIR-2218 and peginterferon alfa-2a,Bethesda - United States,2028-02-29,2023-10-23,2025-03-10,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT03279133,Unknown,WITHDRAWN,2017-09-01,Hematopoietic Stem Cell Transplantation,Ledipasvir 90mg/Sofosubvir 400mg,"Duarte - United States, Los Angeles - United States",2018-02-16,2017-09-12,2018-08-31,INTERVENTIONAL,PHASE4,Kaiser Permanente,OTHER,hepatitis
NCT02638233,Unknown,UNKNOWN,2015-09,Chronic Hepatitis C,Sofosbuvir 400mg / Ledipasvir 90 mg (FDC),Vienna - Austria,2016-09,2015-12-23,2015-12-23,INTERVENTIONAL,PHASE4,Wilhelminenspital Vienna,OTHER,hepatitis
NCT01833533,PEARL-IV,COMPLETED,2013-03,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin",No locations listed,2013-12,2013-04-17,2021-07-12,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02057887,Unknown,UNKNOWN,2013-07,Chronic Hepatitis C Virus Genotype I,"HM10660A, Pegasys",Estado de Mexico - Mexico,2014-08,2014-02-07,2014-02-07,INTERVENTIONAL,PHASE2,Hanmi Pharmaceutical Company Limited,INDUSTRY,hepatitis
NCT03426787,Project HELP,COMPLETED,2017-09-26,"Hepatitis C, Chronic Kidney Diseases, Patient Education",Decision Aid,Saint Louis - United States,2018-10-15,2018-02-08,2019-09-11,INTERVENTIONAL,NA,Washington University School of Medicine,OTHER,hepatitis
NCT05127187,TRODUMCRA,COMPLETED,2022-02-08,"HIV Infections, Hepatitis C, Hepatitis B",Rapid diagnosis test against HIV and hepatitis C and B,Nîmes - France,2022-12-07,2021-11-19,2025-02-13,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de Nīmes,OTHER,hepatitis
NCT03318887,Unknown,COMPLETED,2014-02-01,Hepatitis C,Sofosbuvir/daclatasvir with or without ribavirin,Lyon - France,2014-09-30,2017-10-24,2017-10-24,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT04033887,Unknown,COMPLETED,2018-09-21,Hepatitis C,13 Rapid Diagnostic Tests and reference tests,"Antwerp - Belgium, Tbilisi - Georgia, Lagos - Nigeria",2019-03-15,2019-07-26,2019-07-29,OBSERVATIONAL,Not Available,"Foundation for Innovative New Diagnostics, Switzerland",OTHER,hepatitis
NCT01263587,HBRN,COMPLETED,2010-12,Hepatitis B,No interventions listed,"Los Angeles - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Honolulu - United States, Bethesda - United States, Boston - United States, Boston - United States, Ann Arbor - United States, Minneapolis - United States, Rochester - United States, Saint Louis - United States, Saint Louis - United States, Chapel Hill - United States, Durham - United States, Dallas - United States, Dallas - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2021-06-09,2010-12-20,2022-05-31,OBSERVATIONAL,Not Available,University of Pittsburgh,OTHER,hepatitis
NCT01001754,EMERGE,UNKNOWN,2010-05,"Hepatitis C, Chronic","PEG-rIL-29, Peginterferon alfa-2a, Ribavirin","Beverly Hills - United States, Coronado - United States, La Jolla - United States, Palm Springs - United States, San Francisco - United States, Aurora - United States, Englewood - United States, Gainesville - United States, Miami - United States, Atlanta - United States, Lutherville - United States, Detroit - United States, Rochester - United States, St. Louis - United States, Newark - United States, Albuquerque - United States, Manhasset - United States, New York - United States, Charlotte - United States, Durham - United States, Statesville - United States, Philadelphia - United States, Arlington - United States, Houston - United States, San Antonio - United States, Salt Lake City - United States, Fairfax - United States, Newport News - United States, Seattle - United States, Herston - Australia, Adelaide - Australia, Camperdown - Australia, Clayton - Australia, Fitzroy - Australia, Fremantle - Australia, Greenslopes - Australia, Herston - Australia, Kogarah - Australia, Melbourne - Australia, Penrith - Australia, Perth - Australia, Westmead - Australia, Graz - Austria, Innsbruck - Austria, Linz - Austria, Wien - Austria, Vancouver - Canada, London - Canada, Toronto - Canada, Paris - France, Pessac - France, Bochum - Germany, Dusseldorf - Germany, Essen - Germany, Frankfurt/Main - Germany, Freiburg - Germany, Goettingen - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Koln - Germany, Mainz - Germany, Munchen - Germany, Tubingen - Germany, Milano - Italy, Bialystok - Poland, Krakow - Poland, Lancut - Poland, Raciborz - Poland, Wroclaw - Poland, Santurce - Puerto Rico, Bucharest - Romania, Iasi - Romania, Timisoara - Romania, Barcelona - Spain, Madrid - Spain, Majadahonda - Spain, Sevilla - Spain, Valencia - Spain",2010-11,2009-10-27,2011-12-05,INTERVENTIONAL,PHASE2,ZymoGenetics,INDUSTRY,hepatitis
NCT01221454,Unknown,UNKNOWN,2010-10,Liver Failure,"Allogenic bone marrow stem cells transplantation, Conserved therapy",Guangzhou - China,2011-11,2010-10-15,2010-10-18,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT00800787,Nabi-HB-SC,WITHDRAWN,2010-04,"Hepatitis B, Chronic",Nabi-HB,No locations listed,2010-08,2008-12-02,2016-01-18,INTERVENTIONAL,PHASE3,Biotest Pharmaceuticals Corporation,INDUSTRY,hepatitis
NCT05014087,DIGIT-AlcHep,RECRUITING,2021-10-08,"Acute Alcoholic Hepatitis, Chemical and Drug Induced Liver Injury, Alcohol-Induced Disorders, Steatohepatitis Caused by Ingestible Alcohol",Intravenous digoxin,New Haven - United States,2024-10,2021-08-20,2024-08-12,INTERVENTIONAL,PHASE2,Yale University,OTHER,hepatitis
NCT01804387,TeSLA,UNKNOWN,2011-05,Chronic Hepatitis B,"telbivudine plus adefovir, lamivudine plus adefovir","Ansan - Korea, Republic of",2013-12,2013-03-05,2013-03-05,INTERVENTIONAL,PHASE4,Korea University,OTHER,hepatitis
NCT01242787,LB80380,UNKNOWN,2010-08,Chronic Hepatitis B,"LB80380, Entecavir 0.5 mg","Hong Kong - China, Seoul - Korea, Republic of",2012-09,2010-11-17,2012-04-16,INTERVENTIONAL,PHASE2,LG Life Sciences,INDUSTRY,hepatitis
NCT00718887,Unknown,COMPLETED,2008-07,"Hepatitis B, Chronic","Entecavir, Adefovir/Entecavir","Beijing - China, Guiyang - China, Nanjing - China, Nanchang - China, Changchun - China, Shenyang - China, Shanghai - China, Shanghai - China",2009-12,2008-07-21,2013-02-11,INTERVENTIONAL,PHASE4,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00367887,Unknown,COMPLETED,2006-10,Hepatitis C,"Peg-Intron, REBETOL, HCV 796, Peg-Intron, REBETOL, HCV 796, Peg-Intron, REBETOL","Anaheim - United States, La Jolla - United States, La Jolla - United States, Los Angeles - United States, Pasadena - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, Washington - United States, Gainesville - United States, Miami - United States, Atlanta - United States, Louisville - United States, Boston - United States, Worcester - United States, Detroit - United States, Plymouth - United States, St. Paul - United States, St. Louis - United States, Albuquerque - United States, Bronx - United States, Bronx - United States, New York - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Philadelphia - United States, Houston - United States, Annandale - United States, Fairfax - United States, Richmond - United States, Santurce - Puerto Rico",2008-07,2006-08-23,2013-02-11,INTERVENTIONAL,PHASE2,Wyeth is now a wholly owned subsidiary of Pfizer,INDUSTRY,hepatitis
NCT05977283,Unknown,RECRUITING,2023-05-11,"Hepatitis B, Hepatitis B, Chronic",No interventions listed,Guangzhou - China,2027-06,2023-08-04,2024-02-20,OBSERVATIONAL,Not Available,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT00142298,Unknown,COMPLETED,2005-03,Chronic Hepatitis B,Telbivudine (LdT),"Phoenix - United States, Los Angeles - United States, Los Angeles - United States, Pasadena - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, Sarasota - United States, Atlanta - United States, Honolulu - United States, Chicago - United States, Boston - United States, Ann Arbor - United States, Saint Louis - United States, New York - United States, Chapel Hill - United States, Philadelphia - United States, Houston - United States, Richmond - United States, Heidelberg - Australia, Toronto - Canada, Beijing - China, Praha - Czechia, Paris - France, Hannover - Germany, Hong Kong - Hong Kong, New Delhi - India, Nazareth - Israel, Torino - Italy, Seoul - Korea, Republic of, Hamilton - New Zealand, Krakow - Poland, Santurce - Puerto Rico, Singapore - Singapore, Valencia - Spain, Tainan - Taiwan, Bangkok - Thailand, Istanbul - Turkey, London - United Kingdom",2009-11,2005-09-02,2020-08-21,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT04680598,Unknown,RECRUITING,2020-12-25,Hepatocellular Carcinoma,"ICI, Antiviral Prophylaxis","Guangzhou - China, Guangzhou - China, Kaiping - China, Zhongshan - China",2023-12-31,2020-12-23,2023-08-02,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT05051098,Unknown,RECRUITING,2021-05-06,Hepatitis B Virus Infection,No intervention,Hannover - Germany,2025-12,2021-09-21,2025-03-13,OBSERVATIONAL,Not Available,Hannover Medical School,OTHER,hepatitis
NCT01014845,Unknown,COMPLETED,2007-08,Hepatitis E,"hepatitis E vaccine, Hepatitis B vaccine",Dongtai - China,2017-10,2009-11-17,2020-07-13,INTERVENTIONAL,PHASE3,Xiamen University,OTHER,hepatitis
NCT02768545,EZE-2,UNKNOWN,2013-06,Hepatitis C,Ezetimibe,Santiago - Chile,2016-05,2016-05-11,2016-05-11,INTERVENTIONAL,PHASE4,Pontificia Universidad Catolica de Chile,OTHER,hepatitis
NCT04015245,Unknown,COMPLETED,2018-04-12,Hepatocellular Carcinoma,Stronger Neo-Minophagen C,Tainan - Taiwan,2019-05-09,2019-07-10,2019-07-10,INTERVENTIONAL,PHASE4,Chimei Medical Center,OTHER,hepatitis
NCT00540345,Unknown,COMPLETED,2006-10,Chronic Hepatitis C,"pegylated interferon alpha 2a and plus ribavirin, Pegylated interferon alfa-2a and ribavirin, pegylated interferon alpha 2a and ribavirin, pegylated interferon alpha 2a and ribavirin",Kaohsiung - Taiwan,2013-12,2007-10-08,2014-12-30,INTERVENTIONAL,PHASE4,Kaohsiung Medical University Chung-Ho Memorial Hospital,OTHER,hepatitis
NCT03883698,Unknown,COMPLETED,2019-03-15,"Kidney Failure, Chronic, Hepatitis C","Sofosbuvir, Daclatasvir 60 mg",Lucknow - India,2020-08-01,2019-03-21,2021-04-06,INTERVENTIONAL,PHASE3,Sanjay Gandhi Postgraduate Institute of Medical Sciences,OTHER_GOV,hepatitis
NCT02395198,ECHO,UNKNOWN,2014-08,Hepatitis C,No interventions listed,"Crailsheim - Germany, Herrenberg - Germany, Hirrlingen - Germany, St. Blasien - Germany, Aichach - Germany, Augsburg - Germany, Fürstenfeldbruck - Germany, Warngau - Germany, Bad Nauheim - Germany, Ehringshausen - Germany, Frankfurt - Germany, Parchim - Germany, Achim - Germany, Goslar - Germany, Bonn - Germany, Hamm - Germany, Herne - Germany, Köln - Germany, Münster - Germany, Koblenz - Germany, Trier - Germany, Chemnitz - Germany, Norderstedt - Germany, Wenningstedt - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Bremen - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany, Hamburg - Germany",2017-04,2015-03-23,2017-05-31,OBSERVATIONAL,Not Available,Prof. Dr. med. Jens Reimer,OTHER,hepatitis
NCT02737345,Unknown,COMPLETED,2015-11-01,Cirrhosis,Rotem,Salt Lake City - United States,2017-04-01,2016-04-13,2017-11-08,OBSERVATIONAL,Not Available,Scott Allen,OTHER,hepatitis
NCT01833845,Unknown,TERMINATED,2013-04,Hepatitis C,"Ribavirin, Hydroxychloroquine","Marseille - France, Paris - France",2014-04,2013-04-17,2014-08-28,INTERVENTIONAL,PHASE2,"BioLineRx, Ltd.",INDUSTRY,hepatitis
NCT06051045,SEE-D,RECRUITING,2023-09-27,Chronic Hepatitis D,Bulevirtide,Stockholm - Sweden,2033-03,2023-09-22,2023-09-29,OBSERVATIONAL,Not Available,Karolinska University Hospital,OTHER,hepatitis
NCT06209398,Unknown,ACTIVE_NOT_RECRUITING,2018-05-24,"Hand, Foot and Mouth Disease","Enterovirus Type 71 Vaccine, inactivated ( Human Diploid Cell ), Recombinant Hepatitis B Vaccine, Group A meningococcal polysaccharide vaccine",Nanjing - China,2024-12-31,2024-01-17,2024-01-17,INTERVENTIONAL,PHASE4,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT05961098,Unknown,ACTIVE_NOT_RECRUITING,2023-10-11,Chronic Hepatitis B,RBD1016,"Hong Kong - China, Hong Kong - China, Stockholm - Sweden, Uppsala - Sweden",2025-04-21,2023-07-27,2024-12-05,INTERVENTIONAL,PHASE2,Suzhou Ribo Life Science Co. Ltd.,INDUSTRY,hepatitis
NCT02257645,Unknown,UNKNOWN,2015-03,"Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus Influenza Type B",No interventions listed,No locations listed,2016-05,2014-10-06,2014-10-07,OBSERVATIONAL,Not Available,LG Life Sciences,INDUSTRY,hepatitis
NCT01980745,Unknown,COMPLETED,2002-02,"Hepatitis, Autoimmune","Chloroquine diphosphate 250mg, Placebo",Sao Paulo - Brazil,2013-11,2013-11-11,2016-10-26,INTERVENTIONAL,PHASE4,University of Sao Paulo General Hospital,OTHER,hepatitis
NCT04431245,Unknown,ACTIVE_NOT_RECRUITING,2021-06-01,Chronic Hepatitis b,Entecavir,Hong Kong - Hong Kong,2023-12-31,2020-06-16,2023-05-10,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT01431898,Unknown,COMPLETED,2011-09,Hepatitis C,"GS-9669 tablets, Placebo to Match GS-9669 tablet","Los Angeles - United States, Deland - United States, Orlando - United States, Las Vegas - United States, Willingboro - United States, Philadelphia - United States, San Antonio - United States, Salt Lake City - United States, Salt Lake City - United States, Tacoma - United States, San Juan - Puerto Rico",2011-12,2011-09-12,2012-07-25,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT00097045,Unknown,COMPLETED,2004-11,Hepatitis C,"omega interferon, Ribavirin","Moscow - Russian Federation, Smolensk - Russian Federation, St. Petersburg - Russian Federation",Unknown Date,2004-11-18,2007-08-23,INTERVENTIONAL,PHASE2,Intarcia Therapeutics,INDUSTRY,hepatitis
NCT01095445,EXACT-R(3),TERMINATED,2010-02,Chronic Hepatitis C,Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol),"Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Kingston - Canada, London - Canada, Mississauga - Canada, Mississauga - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada",2011-06,2010-03-30,2011-09-29,INTERVENTIONAL,PHASE3,"University Health Network, Toronto",OTHER,hepatitis
NCT01221298,Unknown,COMPLETED,2010-10,"Hepatitis C, HCV, Chronic Hepatitis C Infection, Hepatitis C Genotype 1","ABT-450, ABT-072, Ribavirin, Ritonavir","Los Angeles - United States, Chicago - United States, San Antonio - United States, Seattle - United States",2011-05,2010-10-15,2015-01-08,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT01903798,Unknown,COMPLETED,2014-12,Alcoholic Hepatitis,"Mycophenolate mofetil, Prednisolone, Rilonacept","Long Beach - United States, Los Angeles - United States, Torrance - United States",2016-04,2013-07-19,2019-01-14,INTERVENTIONAL,PHASE2,Southern California Institute for Research and Education,OTHER,hepatitis
NCT02392598,HBHS,UNKNOWN,2015-08,"Hepatitis B, Chronic, Hepatic Steatosis",No interventions listed,"Zhangzhou - China, Ji'nan - China, Chengdu - China, Tianjin - China, Urumqi - China, Hangzhou - China, Shanghai - China",2020-12,2015-03-19,2015-08-05,OBSERVATIONAL,Not Available,"Fatty Liver and Alcoholic Liver Disease Study Group, China",OTHER,hepatitis
NCT04220645,Opportuni-C,COMPLETED,2019-10-01,"Hepatitis C, Substance Use Disorders","Opportunstic treatment, Standard of care",Lørenskog - Norway,2021-12-31,2020-01-07,2022-12-08,INTERVENTIONAL,NA,"University Hospital, Akershus",OTHER,hepatitis
NCT01074645,ACLF,COMPLETED,2007-11,"Acute on Chronic Liver Failure, Hepatitis B",Tenofovir disoproxil fumarate (TDF),New Delhi - India,2009-06,2010-02-24,2010-02-24,INTERVENTIONAL,PHASE4,Govind Ballabh Pant Hospital,OTHER_GOV,hepatitis
NCT04211805,Unknown,UNKNOWN,2020-01-27,"Hepatitis B, Chronic, Pregnancy Related","Tenofovir Alafenamide 25 MG for arm (A), Tenofovir Disoproxil Fumarate 300mg for arm (B)","Shapingba - China, Fuzhou - China, Shenzhen - China, Haikou - China, Qinhuangdao - China, Harbin - China, Changsha - China, Ganzhou - China, Shenyang - China, Jinshan - China, Yuyao - China",2021-09-30,2019-12-26,2020-12-29,OBSERVATIONAL,Not Available,New Discovery LLC,INDUSTRY,hepatitis
NCT02194998,C_ASCENT,TERMINATED,2015-09-16,"HIV Infections, Hepatitis C","Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin (RBV)","Birmingham - United States, Los Angeles - United States, Aurora - United States, Washington - United States, Chicago - United States, Baltimore - United States, Newark - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Pittsburgh - United States, Providence - United States, Dallas - United States, Houston - United States, Seattle - United States, San Juan - Puerto Rico",2018-05-17,2014-07-21,2021-11-04,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT01664845,Unknown,UNKNOWN,2012-08,"Chronic Hepatitis c, Insulin Resistance","metformin, pegylated-IFN, ribavirin",Kaohsiung - Taiwan,2014-08,2012-08-14,2012-08-14,INTERVENTIONAL,PHASE3,Kaohsiung Veterans General Hospital.,OTHER,hepatitis
NCT03208998,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,Peginterferon Alfa-2a,Beijing - China,2017-12,2017-07-06,2017-07-12,INTERVENTIONAL,PHASE4,Beijing Ditan Hospital,OTHER,hepatitis
NCT01649245,HAPIC,UNKNOWN,2012-08,Chronic Hepatitis C,Reiferon retard,Shebin El-Kom - Egypt,2014-08,2012-07-25,2013-01-15,INTERVENTIONAL,PHASE4,MinaPharm Pharmaceuticals,INDUSTRY,hepatitis
NCT02615145,LIFE-C,COMPLETED,2015-12-03,Chronic Hepatitis C,No interventions listed,No locations listed,2018-03-26,2015-11-26,2019-10-07,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT03209011,Unknown,UNKNOWN,2016-01,Chronic Hepatitis B Infection,Peginterferon Alfa-2a,Beijing - China,2017-12,2017-07-06,2017-07-12,INTERVENTIONAL,PHASE4,Yao Xie,OTHER,hepatitis
NCT04072211,Unknown,COMPLETED,2019-11-25,"Hepatitis B Virus, Health Care Associated Infection",Engerix-B,Kalulushi - Zambia,2020-08-30,2019-08-28,2022-07-20,INTERVENTIONAL,PHASE4,Centre for Infectious Disease Research in Zambia,OTHER,hepatitis
NCT03823911,CHROME,COMPLETED,2018-11-18,"Cardiovascular Diseases, Hepatitis C, Hiv","Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac MRI","Washington - United States, Baltimore - United States",2022-12-31,2019-01-31,2023-05-22,INTERVENTIONAL,PHASE4,"University of Maryland, Baltimore",OTHER,hepatitis
NCT02716428,Unknown,COMPLETED,2016-05,"Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1","Faldaprevir, TD-6450, Ribavirin","Coronado - United States, Bradenton - United States, Germantown - United States, Auckland - New Zealand, Dunedin - New Zealand, Waikato - New Zealand",2017-09,2016-03-23,2017-10-17,INTERVENTIONAL,PHASE2,"Trek Therapeutics, PBC",INDUSTRY,hepatitis
NCT04056728,Unknown,UNKNOWN,2019-09-23,"Hepatitis B, Diphtheria, Haemophilus Influenzae Type B Infection, Tetanus, Pertussis",Eupenta Inj.,No locations listed,2020-10-12,2019-08-14,2019-08-14,INTERVENTIONAL,PHASE4,LG Chem,INDUSTRY,hepatitis
NCT03722628,Unknown,UNKNOWN,2018-12-15,Hepatocellular Carcinoma,MMP1 genotypes polymorphism,No locations listed,2020-12-15,2018-10-29,2018-10-29,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT04405011,Unknown,UNKNOWN,2018-08-01,HBV/HCV Co-infection,"24-week Entecavir, 12-week Entecavir","Taipei City - Taiwan, Taipei - Taiwan",2020-12-28,2020-05-28,2020-07-02,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT04914611,REACH-B,RECRUITING,2022-02-17,Hepatitis B,No intervention,"Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Darwin - Australia, Darwin - Australia, Birtinya - Australia, Cairns - Australia, Cairns - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Albany - Australia, Broome - Australia, Kalgoorlie - Australia",2026-07-01,2021-06-04,2024-12-12,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT02646111,Unknown,UNKNOWN,2016-01,Hepatitis C,"12 weeks without Ribavirin, 12 weeks with Ribavirin, 24 weeks with Ribavirin",No locations listed,2018-01,2016-01-05,2016-01-05,INTERVENTIONAL,PHASE3,Tel-Aviv Sourasky Medical Center,OTHER_GOV,hepatitis
NCT02421211,Unknown,COMPLETED,2015-05-19,"Hepatitis C, Chronic","Simeprevir (SMV), Ledipasvir (LDV), Sofosbuvir (SOF)","Antwerpen - Belgium, Brussel - Belgium, Gent - Belgium, Leuven - Belgium",2015-11-10,2015-04-20,2019-03-28,INTERVENTIONAL,PHASE2,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT02444611,ELVIS,COMPLETED,2015-03,Innate Immune Response,"BCG Vaccine, Hepatitis B Vaccine",Heidelberg - Australia,2016-06,2015-05-14,2017-08-31,INTERVENTIONAL,NA,Murdoch Childrens Research Institute,OTHER,hepatitis
NCT00709228,Unknown,COMPLETED,2006-05,Hepatitis C,"PegIntron, Rebetol",No locations listed,2008-11,2008-07-03,2015-01-26,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT06295328,HepBTer,RECRUITING,2022-04-13,Chronic Hepatitis B,"Terbinafine, Placebo, Tenofovir",Amsterdam - Netherlands,2025-04-01,2024-03-06,2025-02-07,INTERVENTIONAL,PHASE2,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),OTHER,hepatitis
NCT00028093,Unknown,COMPLETED,2001-12,Chronic Hepatitis C,"Peginterferon alfa-2a with Ribavirin, Peginterferon alfa-2a",Bethesda - United States,2010-06,2001-12-12,2013-11-08,INTERVENTIONAL,PHASE4,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT06746311,Unknown,COMPLETED,2022-11-22,Chronic Hepatitis B,"HT-101, HT-101, Placebo","Beijing - China, Beijing - China, Guangzhou - China, Xuzhou - China, Changchun - China, Yanji - China, Shanghai - China",2024-05-13,2024-12-24,2024-12-24,INTERVENTIONAL,PHASE1,"Suzhou HepaThera Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT02647593,Unknown,COMPLETED,2012-10-02,Choledocholithiasis,No interventions listed,No locations listed,2013-10-01,2016-01-06,2021-02-03,OBSERVATIONAL,Not Available,Gangnam Severance Hospital,OTHER,hepatitis
NCT02945228,Unknown,COMPLETED,2016-10-26,Chronic Hepatitis C Virus,No interventions listed,"Nagakute - Japan, Matsuyama - Japan, Fukuoka-shi - Japan, Kurume-shi - Japan, Fujioka - Japan, Takasaki-shi - Japan, Fukuyama-shi - Japan, Fukuyama-shi - Japan, Nishinomiya-shi - Japan, Kagoshima-shi - Japan, Kawasaki - Japan, Yokohama - Japan, Kumamoto-shi - Japan, Kumamoto-shi - Japan, Okayama-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Takatsuki -shi - Japan, Kawagoe-shi - Japan, Koshigaya - Japan, Hamamatsu - Japan, Komae-shi - Japan, Shinjuku-ku - Japan, Chuo-shi - Japan, Amagasaki, Hyogo - Japan, Aomori-shi - Japan, Arida - Japan, Asahikawa-shi - Japan, Asahikawa - Japan, Chiba - Japan, Chiba - Japan, Chiba - Japan, Chichibu - Japan, Fuji - Japan, Fukui - Japan, Fukui - Japan, Fukui - Japan, Fukuoka - Japan, Fukuyama - Japan, Gifu - Japan, Habikino-osaka - Japan, Hachinohe - Japan, Hamamatsu - Japan, Higashihiroshima - Japan, Higashiibaraki-gun - Japan, Higashiomi, Shiga - Japan, Higashiosaka - Japan, Higashiosaka - Japan, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Hiroshima - Japan, Hyogo - Japan, Iizuka - Japan, Ikeda - Japan, Inashiki - Japan, Inzai - Japan, Iruma-gun - Japan, Itoigawa - Japan, Iwade - Japan, Kaizuka - Japan, Kamisu - Japan, Kanagawa - Japan, Kanagawa - Japan, Kanagawa - Japan, Kanonji - Japan, Kasama - Japan, Kashiwa-shi - Japan, Kashiwazaki - Japan, Kasugai - Japan, Kawagoe - Japan, Kawagoe - Japan, Kawaguchi - Japan, Kawasaki-shi, Kanagawa - Japan, Kawasaki - Japan, Kishiwada, Osaka - Japan, Kitakyusyu - Japan, Kitamoto - Japan, Kobe - Japan, Kobe - Japan, Konan-shi - Japan, Koriyama - Japan, Koriyama - Japan, Koshigaya, Saitam - Japan, Kurashiki - Japan, Kure, Hiroshima - Japan, Kurihara - Japan, Kuroishi-aomori - Japan, Kurume - Japan, Kurume - Japan, Kushiro - Japan, Kyoto - Japan, Kyoto - Japan, Matsumoto - Japan, Minokamo - Japan, Mito - Japan, Miyagi - Japan, Miyakonojo - Japan, Miyazaki-shi - Japan, Miyazaki - Japan, Moriguchi-shi - Japan, Nagareyama - Japan, Nagoya-aichi - Japan, Nagoya-shi - Japan, Nagoya - Japan, Nagoya - Japan, Nara - Japan, Nayoro - Japan, Nishinomiya - Japan, Noshiro - Japan, Odawara - Japan, Oita - Japan, Okayama - Japan, Omuta - Japan, Onomichi - Japan, ONO - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Osaka - Japan, Otsu - Japan, Saga - Japan, Saitama - Japan, Saitama - Japan, Saitama - Japan, Saitama - Japan, Sakai - Japan, Sapporo - Japan, Sendai - Japan, Shiogama-miyagi - Japan, Suita-osaka - Japan, Suita - Japan, Takamatsu - Japan, Takaraduka - Japan, Takatsuki - Japan, Tatebayashi - Japan, Toda-shi, Saitama - Japan, Togane, Chiba - Japan, Tokorozawa - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Tokyo - Japan, Toon - Japan, Toyoma - Japan, Toyonaka - Japan, Tsu, Mie - Japan, Utsunomiya - Japan, Uwajima - Japan, Wakayama-shi - Japan, Wakayama - Japan, Yachiyo - Japan, Yamagata - Japan, Yamaguchi - Japan, Yatomi-shi - Japan, Yatsushiro-shi - Japan, Yokkaichi - Japan, Yokohama-shi - Japan, Yufu-shi - Japan, Yugawara - Japan, Yuki - Japan",2019-07-26,2016-10-26,2020-06-12,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01105611,Unknown,UNKNOWN,2010-08,"HIV Infections, Hepatitis C","Raltegravir, Atazanavir/Ritonavir","Dublin - Ireland, Dublin - Ireland",2012-12,2010-04-16,2011-07-21,INTERVENTIONAL,PHASE4,"St. James's Hospital, Ireland",OTHER,hepatitis
NCT06603311,BUL-STOP,NOT_YET_RECRUITING,2024-09-30,"Compensated Liver Disease (Disorder), Hepatitis D, Chronic",Stop Treatment with Bulevertide in patients with compensated liver disease and chronic HDV infection,Hannover - Germany,2026-09-30,2024-09-19,2024-09-19,INTERVENTIONAL,NA,Hannover Medical School,OTHER,hepatitis
NCT02594293,Unknown,COMPLETED,2015-10,Chronic Hepatitis B,PegIFN alfa-2a,"Wuhan - China, Changzhou - China, Hangzhou - China, Nanjing - China, Nantong - China, Suzhou - China, Suzhou - China, Taicang - China, Wuxi - China, Xuzhou - China, Jinan - China, Wenzhou - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China",2022-09,2015-11-03,2022-10-31,INTERVENTIONAL,PHASE4,Huashan Hospital,OTHER,hepatitis
NCT03981211,TOPIC,RECRUITING,2021-02-12,"Hepatitis C, Liver Inflammation, Liver Cirrhoses","Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet, Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet","Randwick - Australia, Sydney - Australia, Sydney - Australia, Westmead - Australia, Adelaide - Australia, Melbourne - Australia, Melbourne - Australia",2025-02-12,2019-06-10,2024-03-06,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT00069511,Unknown,UNKNOWN,2003-07,Hepatitis C,UT-231B,"Gainesville - United States, New Orleans - United States, Boston - United States, Chapel Hill - United States, Memphis - United States, Richmond - United States",Unknown Date,2003-09-30,2005-06-24,INTERVENTIONAL,PHASE2,United Therapeutics,INDUSTRY,hepatitis
NCT02339207,Unknown,COMPLETED,2014-12-31,Chronic Hepatitis C,"AL-335 matching placebo, AL-335","Rennes - France, Tbilisi - Georgia, Chisinau - Moldova, Republic of",2016-05-31,2015-01-15,2019-10-16,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT03917407,DUR-928/AH,COMPLETED,2021-06-01,Alcoholic Hepatitis,"DUR-928 (Moderate AH), DUR-928 (Severe AH)",Louisville - United States,2023-09-24,2019-04-17,2023-10-18,INTERVENTIONAL,PHASE2,Craig James McClain,OTHER,hepatitis
NCT04507607,Unknown,UNKNOWN,2020-08-01,"Chronic Hepatitis B, Mother-to-child Block, Antiviral Treatment",Tenofovir Alafenamide 25 MG,Guangzhou - China,2020-12-30,2020-08-11,2020-12-22,INTERVENTIONAL,PHASE1,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT03482388,Unknown,COMPLETED,2018-05-09,"Hepatitis, Hepatitis B, Hepatitis C","Crowdsourced materials, Control",Guangzhou - China,2018-05-15,2018-03-29,2018-06-20,INTERVENTIONAL,NA,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT02207088,Unknown,COMPLETED,2014-09-23,"Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis, Severe Renal Impairment, End-stage Renal Disease","ombitasvir/paritaprevir/ritonavir, dasabuvir, Ribavirin",No locations listed,2016-12-06,2014-08-01,2017-11-09,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00023309,Unknown,COMPLETED,2001-08,"HBV (Hepatitis B Virus), Hepatitis B, Hepatitis","Lamivudine and adefovir, Adefovir alone",Bethesda - United States,2010-04,2001-09-03,2016-09-23,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00300807,Unknown,UNKNOWN,2005-10,Hepatitis C,XTL 6865,"Indianapolis - United States, New York - United States, Chapel Hill - United States, Fairfax - United States, Jerusalem - Israel",Unknown Date,2006-03-09,2007-03-07,INTERVENTIONAL,PHASE1,XTL Biopharmaceuticals,INDUSTRY,hepatitis
NCT02556307,Unknown,COMPLETED,2009-03,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Celje - Slovenia, Ljubljana - Slovenia, Maribor - Slovenia, Novo Mesto - Slovenia",2014-07,2015-09-22,2016-02-15,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00087607,Unknown,COMPLETED,2004-01,"Hepatitis C, Chronic","Ribavirin, Peginterferon alfa-2b (PEG-Intron), Ribavirin, Peginterferon alfa-2a [Pegasys]","Birmingham - United States, Little Rock - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Mateo - United States, San Rafael - United States, Farmington - United States, Hartford - United States, Bradenton - United States, Miami - United States, Wellington - United States, Kansas City - United States, New Orleans - United States, Baltimore - United States, Boston - United States, Burlington - United States, Detroit - United States, Kansas City - United States, St Louis - United States, Omaha - United States, Las Vegas - United States, East Orange - United States, Egg Harbour Township - United States, Vineland - United States, Bronx - United States, New York - United States, New York - United States, Poughkeepsie - United States, Fayetteville - United States, Statesville - United States, Portland - United States, Columbia - United States, Austin - United States, Dallas - United States, Fairfax - United States, Norfolk - United States, Roanoke - United States, Tacoma - United States, Racine - United States",2006-03,2004-07-14,2016-07-01,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00029107,Unknown,COMPLETED,2001-12,"Hepatitis C, Vasculitis",Rituximab,Bethesda - United States,2011-05,2002-01-07,2012-04-16,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00888407,Unknown,COMPLETED,2006-09,Liver Cancer,"HBV Screening - Small group educational session, Nutrition - Small group educational session",Sacramento - United States,2011-08,2009-04-27,2017-05-30,INTERVENTIONAL,NA,"University of California, Davis",OTHER,hepatitis
NCT02038088,HBV,COMPLETED,2014-01,HBV Infection,No interventions listed,ChongQing - China,2014-08,2014-01-16,2015-01-28,OBSERVATIONAL,Not Available,Lu KZ,OTHER,hepatitis
NCT00640588,EBEREST,COMPLETED,2008-03,"Hepatitis B, Chronic","Telbivudine, oral adefovir",Barcelona - Spain,2009-12,2008-03-21,2017-03-28,INTERVENTIONAL,PHASE3,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01849588,Unknown,TERMINATED,2013-05,Hepatocellular Cancer,Sorafenib,"Boston - United States, Boston - United States, Boston - United States",2016-12,2013-05-08,2017-04-19,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT00007709,Unknown,COMPLETED,1998-01,"Hepatitis C, HIV Infections, Mental Disorders",No interventions listed,Durham - United States,Unknown Date,2001-01-01,2011-02-03,OBSERVATIONAL,Not Available,US Department of Veterans Affairs,FED,hepatitis
NCT04873609,ERASE-C,COMPLETED,2019-05-01,"Hepatitis C, Liver Diseases",Patient portal message,Palo Alto - United States,2020-04-30,2021-05-05,2021-09-22,INTERVENTIONAL,NA,Stanford University,OTHER,hepatitis
NCT00922207,Unknown,COMPLETED,2010-05-07,"Hepatitis B, Chronic","Adefovir, Entecavir, Placebo, peginterferon alfa-2a [Pegasys]","Changhua - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Keelung City - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2014-09-29,2009-06-17,2017-04-10,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01147107,Unknown,COMPLETED,2014-02,"Hepatitis C, Chronic, HIV Infection","Raltegravir, Efavirenz","Hai Phong - Vietnam, Ho Chi Minh City - Vietnam",2016-06-01,2010-06-22,2021-08-13,INTERVENTIONAL,PHASE4,University of Hawaii,OTHER,hepatitis
NCT05146609,Unknown,RECRUITING,2022-02-01,Hepatitis C,"Screening HCV. HR-HOSPITAL, Screening HCV. HR-DDP, Screening HCV. GP-HOSPITAL, Screening HCV. GP-PCC",La Laguna - Spain,2024-06,2021-12-07,2023-12-05,INTERVENTIONAL,NA,University of La Laguna,OTHER,hepatitis
NCT05005507,PENGUIN-2,TERMINATED,2021-11-03,"Hepatitis B, Chronic","JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil, TAF, ETV","Hillsborough - United States, Vancouver - Canada, Vancouver - Canada, Takamatsu - Japan, Gdansk - Poland, Mysłowice - Poland, Wroclaw - Poland, Barcelona - Spain, Madrid - Spain, Santander - Spain, Vigo - Spain, Tainan - Taiwan",2021-12-29,2021-08-13,2024-03-06,INTERVENTIONAL,PHASE2,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT02070107,Unknown,WITHDRAWN,2014-04,Hepatitis C,On Plan,Louisville - United States,2016-03,2014-02-24,2017-08-07,INTERVENTIONAL,NA,University of Louisville,OTHER,hepatitis
NCT04952207,C-DIAMOND,UNKNOWN,2019-03-06,"Hepatitis C, Chronic",Direct-acting antiviral agents,"Changzhou - China, Nanjing - China, Nanjing - China, Nanjing - China, Suzhou - China, Wuxi - China, Shanghai - China, Shanghai - China, Shanghai - China, Jiaxing - China, Ningbo - China",2021-07-31,2021-07-07,2021-07-07,OBSERVATIONAL,Not Available,Qing XIe,OTHER,hepatitis
NCT00005907,Unknown,COMPLETED,2000-06,"Active Immunity, Healthy, Stem Cell Transplantation",No interventions listed,Bethesda - United States,Unknown Date,2000-06-12,2008-03-04,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT02152709,Unknown,COMPLETED,2008-11,Hepatitis B,"3 dose of 10µg/0.5ml hepatitis B vaccine, 3 dose of 5µg/0.5ml hepatitis B vaccine",Nanjing - China,2010-03,2014-06-02,2014-06-02,INTERVENTIONAL,PHASE3,Jiangsu Province Centers for Disease Control and Prevention,NETWORK,hepatitis
NCT05016609,Unknown,RECRUITING,2022-03-09,Hepatitis C,"OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid), Sofosbuvir/Velpatasvir (Gilead)","Clayton South - Australia, Collingwood - Australia, Corio - Australia, Fitzroy - Australia, Highgate - Australia, Success - Australia",2024-04,2021-08-23,2023-11-13,INTERVENTIONAL,PHASE4,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT06761209,HAI-NEG,RECRUITING,2022-07-01,Auto-immune Hepatitis,blood sampling,"Pointe-à-Pitre - France, Paris - France",2026-12,2025-01-07,2025-01-07,OBSERVATIONAL,Not Available,Centre Hospitalier Universitaire de la Guadeloupe,OTHER,hepatitis
NCT00651209,Unknown,COMPLETED,2008-02,"Hepatitis B, Chronic",Tenofovir,"Buenos Aires - Argentina, Sao Paulo - Brazil, Frankfurt - Germany, Bangkok - Thailand",2011-12,2008-04-02,2014-03-07,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT01590407,Unknown,COMPLETED,2011-12-31,"Hepatitis C, Chronic","ALS-002200, Placebo","Rennes - France, Paris - France, Chisinau - Moldova, Republic of, Bucharest - Romania",2013-02-28,2012-05-03,2017-10-31,INTERVENTIONAL,PHASE1,Alios Biopharma Inc.,INDUSTRY,hepatitis
NCT00135798,LADR,COMPLETED,2005-09,Hepatitis C,LADR Treatment,"Los Angeles - United States, San Francisco - United States, Denver - United States, Chicago - United States, New York - United States, Philadelphia - United States, Charlottesville - United States, Richmond - United States",2009-12,2005-08-26,2013-04-23,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT02172898,Unknown,COMPLETED,2013-06,Alcoholic Hepatitis,No interventions listed,"Rochester - United States, Richmond - United States",2018-06-29,2014-06-24,2020-02-11,OBSERVATIONAL,Not Available,Indiana University,OTHER,hepatitis
NCT04891445,HEPASAME21,COMPLETED,2021-06-01,"Hepatitis C, Severe Mental Disorder","Nursing monitoring program, As usual",Málaga - Spain,2023-12-31,2021-05-18,2024-10-22,INTERVENTIONAL,NA,Hospital Regional de Malaga,OTHER,hepatitis
NCT02006745,CHAT,COMPLETED,2014-01,HIV,"Ribavirin, Telaprevir",London - United Kingdom,2016-02,2013-12-10,2017-04-12,INTERVENTIONAL,PHASE3,St Stephens Aids Trust,OTHER,hepatitis
NCT01690845,MARS in HH,UNKNOWN,2012-06,"Hypoxic Hepatitis, Ischemic Hepatitis, Shock Liver, Hypoxic Liver Injury, Acute Liver Failure",MARS,"Vienna - Austria, Hamburg - Germany",2017-06,2012-09-24,2016-09-22,INTERVENTIONAL,PHASE2,Medical University of Vienna,OTHER,hepatitis
NCT00503347,Unknown,COMPLETED,2007-07,"Hepatitis C Virus, Hiv Infections",bavituximab,"Los Angeles - United States, Newport Beach - United States, Atlanta - United States, Baltimore - United States, Newark - United States, Dallas - United States",2011-03,2007-07-18,2011-06-09,INTERVENTIONAL,PHASE1,Peregrine Pharmaceuticals,INDUSTRY,hepatitis
NCT00035945,Unknown,COMPLETED,2001-10-01,"Hepatitis C, Chronic",ISIS 14803,Carlsbad - United States,2004-05-01,2002-05-08,2022-12-05,INTERVENTIONAL,PHASE2,"Ionis Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT02366247,PEG-Tα1,UNKNOWN,2013-08,"Hepatitis B, Chronic","PEG-Tα1, Placebo to match PEG-Tα1, Adefovir","Beijing - China, Beijing - China, Chongqing - China, Chongqing - China, Lanzhou - China, Shenzhen - China, Haikou - China, Shijiazhuang - China, Shijiazhuang - China, Wuhan - China, Wuhan - China, Changsha - China, Changsha - China, Hengyang - China, Nanjing - China, Nanjing - China, Nanjing - China, Xuzhou - China, Changchun - China, Yanbian - China, Shenyang - China, Jinan - China, Jinan - China, Shanghai - China, Xi'an - China, Xi'an - China, Xi'an - China, Xi'an - China, Chengdu - China, Tianjin - China, Hangzhou - China, Taizhou - China",2015-12,2015-02-19,2015-02-19,INTERVENTIONAL,PHASE3,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01327547,Unknown,COMPLETED,2011-05-18,HIV Coinfection,"Maraviroc, Placebo","Bakersfield - United States, Los Angeles - United States, Oakland - United States, Sacramento - United States, Sacramento - United States, San Francisco - United States, San Francisco - United States, Miami - United States, Tampa - United States, Wilton Manors - United States, Augusta - United States, Iowa City - United States, Detroit - United States, Newark - United States, New York - United States, New York - United States, New York - United States, Valhalla - United States, Charlotte - United States, Clackamas - United States, Portland - United States, Dallas - United States, Dallas - United States, San Antonio - United States, Brno - Czechia, Lyon cedex 4 - France, Paris CEDEX 14 - France, Paris - France, Berlin - Germany, Bonn - Germany, Hamburg - Germany, Hamburg - Germany, Koeln - Germany, Muenchen - Germany, Budapest - Hungary, Wroclaw - Poland, Bydgoszcz - Poland, Warszawa - Poland, Ponce - Puerto Rico, San Juan - Puerto Rico, San Juan - Puerto Rico, Barcelona - Spain, Cordoba - Spain, Madrid - Spain, Sevilla - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom",2013-04-23,2011-04-01,2017-12-06,INTERVENTIONAL,PHASE4,ViiV Healthcare,INDUSTRY,hepatitis
NCT04159545,Unknown,COMPLETED,2019-12-15,"Hepatitis C, Drug Use",Qualitative and quantitative interviews,Dundee - United Kingdom,2022-06-01,2019-11-12,2023-07-18,OBSERVATIONAL,Not Available,University of Dundee,OTHER,hepatitis
NCT00662545,Unknown,COMPLETED,2008-04,"HIV Infections, Hepatitis B","Entecavir with continued standard of care antiretroviral therapy, continued standard of care with tenofovir in addition to emtricitabine or lamivudine",San Francisco - United States,2010-02,2008-04-21,2013-05-27,INTERVENTIONAL,PHASE4,"University of California, San Francisco",OTHER,hepatitis
NCT01220947,Unknown,COMPLETED,2010-11,"Hepatitis C, Chronic","Copegus, Danoprevir, Danoprevir, Danoprevir, Pegasys, Ritonavir","La Jolla - United States, Sacramento - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Orlando - United States, Orlando - United States, South Miami - United States, Decatur - United States, Honolulu - United States, Chicago - United States, Lutherville - United States, Detroit - United States, Bronx - United States, Manhasset - United States, New York - United States, Chapel Hill - United States, Fayetteville - United States, Medford - United States, Providence - United States, Nashville - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Newport News - United States, Wien - Austria, Salvador - Brazil, Porto Alegre - Brazil, Ribeirao Preto - Brazil, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Ottawa - Canada, Toronto - Canada, Clichy - France, Creteil - France, Marseille - France, Paris - France, Rennes - France, Toulouse - France, Vandoeuvre-les-nancy - France, Berlin - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Hamburg - Germany, Leipzig - Germany, Wuerzburg - Germany, Napoli - Italy, Bologna - Italy, Milano - Italy, Pavia - Italy, Novara - Italy, Bari - Italy, Guadalajara - Mexico, Monterrey - Mexico, Santurce - Puerto Rico, Badalona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Sevilla - Spain, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2012-12,2010-10-14,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02640547,Unknown,COMPLETED,2015-11-26,Chronic Hepatitis C,No interventions listed,No locations listed,2017-03-29,2015-12-29,2018-10-17,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00389298,Unknown,COMPLETED,2006-10,"Hepatitis C, Chronic",VCH-759 (BCH-27759),"Calgary - Canada, Vancouver - Canada, Ottawa - Canada, Montreal - Canada",Unknown Date,2006-10-18,2009-09-24,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01434498,Unknown,COMPLETED,2011-09,Chronic Genotype 1a or 1b HCV Infection,"GS-5885 tablet, GS-9451 tablet, tegobuvir capsule, ribavirin tablet, placebo matching ribavirin tablet, placebo matching tegobuvir capsule","Beverly Hills - United States, Coronado - United States, La Jolla - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Miami - United States, Orlando - United States, Marietta - United States, Indianapolis - United States, Kansas City - United States, Lutherville - United States, Boston - United States, Boston - United States, Springfield - United States, Novi - United States, Newark - United States, New York - United States, Asheville - United States, Chapel Hill - United States, Philadelphia - United States, Philadelphia - United States, Providence - United States, Germantown - United States, Arlington - United States, Galveston - United States, Houston - United States, San Antonio - United States, Falls Church - United States, Newport News - United States, Norfolk - United States, Seattle - United States, Calgary - Canada, Edmonton - Canada, Edmonton - Canada, Vancouver - Canada, Vancouver - Canada, Vancouver - Canada, Winnipeg - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, San Juan - Puerto Rico",2013-01,2011-09-15,2013-12-20,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00055445,Unknown,COMPLETED,2003-11,"Hepatitis C, Chronic",IdB 1016,Seattle - United States,Unknown Date,2003-03-04,2006-08-18,INTERVENTIONAL,PHASE2,National Center for Complementary and Integrative Health (NCCIH),NIH,hepatitis
NCT06460545,Unknown,NOT_YET_RECRUITING,2024-06-15,"Polio, Hepatitis A","sIPV (booster dose at 18 months of age), HepA-L, HepA-I","Chongqing - China, Chongqing - China, Chongqing - China",2026-08-15,2024-06-14,2024-06-14,INTERVENTIONAL,PHASE4,"Institute of Medical Biology, Chinese Academy of Medical Sciences",OTHER,hepatitis
NCT00467545,Unknown,COMPLETED,2007-04,Chronic Hepatitis B,telbivudine,"Daegu - Korea, Republic of, Gyeonggi-Do - Korea, Republic of, In Cheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2009-09,2007-04-30,2017-06-23,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT00115245,Unknown,COMPLETED,2004-11,Chronic Hepatitis B,"Telbivudine (LdT), Adefovir Dipivoxil","Los Angeles - United States, Pasadena - United States, San Francisco - United States, Miami - United States, Clayton - Australia, Wooloongabba - Australia, Calgary - Canada, Toronto - Canada, Winnipeg - Canada, Hong Kong - China, Paris - France, Seoul - Korea, Republic of, Singapore - Singapore, Taipei - Taiwan, Bangkok - Thailand",2006-08,2005-06-22,2015-05-12,INTERVENTIONAL,PHASE3,Novartis,INDUSTRY,hepatitis
NCT05345847,Unknown,NOT_YET_RECRUITING,2024-12-30,Hepatitis Immune,"Active Surveillance, Early initiation",No locations listed,2027-02-01,2022-04-26,2024-03-01,INTERVENTIONAL,NA,AHS Cancer Control Alberta,OTHER,hepatitis
NCT01850745,Unknown,COMPLETED,2003-01,"Hepatitis C, Chronic",Multidisciplinary support program,Barcelona - Spain,2009-01,2013-05-09,2021-09-20,OBSERVATIONAL,Not Available,Parc de Salut Mar,OTHER,hepatitis
NCT03020745,Unknown,COMPLETED,2017-02-14,Hepatitis B,"GSK3389404, Placebo","Guangzhou - China, Beijing - China, Beijing - China, Beijing - China, Shanghai - China, Pokfulam - Hong Kong, Aichi - Japan, Hiroshima - Japan, Hokkaidou - Japan, Kanagawa - Japan, Tokyo - Japan, Tokyo - Japan, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Cebu - Philippines, Makati City - Philippines, Singapore - Singapore, Singapore - Singapore",2019-01-28,2017-01-13,2020-10-01,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT06023745,Unknown,RECRUITING,2023-07-20,"Hepatitis B, Chronic",genotyping,Sohag - Egypt,2023-09-01,2023-09-05,2023-09-05,OBSERVATIONAL,Not Available,Sohag University,OTHER,hepatitis
NCT00048945,Unknown,COMPLETED,2002-01,Chronic Hepatitis B,PEGASYS,"Scottsdale - United States, Downey - United States, Los Angeles - United States, Pasadena - United States, San Francisco - United States, Atlanta - United States, Honolulu - United States, Boston - United States, Ann Arbor - United States, Minneapolis - United States, Lincoln - United States, Chapel Hill - United States, Cedar Creek - United States, Salt Lake City - United States, Seattle - United States, Concord - Australia, Herston - Australia, Campinas - Brazil, Porto Alegre - Brazil, Salvador - Brazil, Sao Paulo - Brazil, Calgary - Canada, Toronto - Canada, Toronto - Canada, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chengdu - China, Chongqing - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Hong Kong - China, Shanghai - China, Shanghai - China, Shanghai - China, Clichy - France, Lyon - France, Berlin - Germany, Bochum - Germany, Duesseldorf - Germany, Hannover - Germany, Koeln - Germany, Muenchen - Germany, Haifa - Israel, Petach Tikva - Israel, Tel Aviv - Israel, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Otahuhu - New Zealand, Bialystok - Poland, Bydgoszcz - Poland, Warszawa - Poland, Santurce - Puerto Rico, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore, Basel - Switzerland, Kaohsiung - Taiwan, Kwei Shan - Taiwan, Tainan - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Bangkok - Thailand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand, Songkla - Thailand, Nottingham - United Kingdom",2004-10,2002-11-14,2017-02-17,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01265693,HLIPT2010,COMPLETED,2011-01-09,"Hearing Loss, Sudden Deafness",No interventions listed,"Haifa - Israel, Haifa - Israel",2015-03,2010-12-23,2018-07-24,OBSERVATIONAL,Not Available,Carmel Medical Center,OTHER,hepatitis
NCT02517528,Unknown,COMPLETED,2015-07-20,Chronic Hepatitis C Virus (HCV),"ABT-450/r/ABT-267, ABT-333, ribavirin",No locations listed,2016-09-29,2015-08-07,2018-10-09,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02772328,HCV-TTP,COMPLETED,2016-12-19,"Hepatitis C, HIV, Risk Reduction Behavior",Peer Mentor,Baltimore - United States,2021-05-30,2016-05-13,2022-01-20,INTERVENTIONAL,NA,Johns Hopkins Bloomberg School of Public Health,OTHER,hepatitis
NCT04376528,Unknown,UNKNOWN,2021-06-16,"Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression","Cyclosporin A, Mycophenolate Mofetil",Chengdu - China,2021-12-30,2020-05-06,2021-06-22,INTERVENTIONAL,PHASE4,West China Hospital,OTHER,hepatitis
NCT00727311,Unknown,COMPLETED,2005-08,"Hepatitis C, Chronic, Hepatitis C","PegIntron (peginterferon alfa-2b; SCH 54031) injector, Rebetol (ribavirin; SCH 18908)",No locations listed,2009-06,2008-08-01,2015-10-09,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00623428,Unknown,COMPLETED,2008-06,"Hepatitis C, Chronic","peginterferon alfa-2a, Ribavirin","Birmingham - United States, La Jolla - United States, Lancaster - United States, Long Beach - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, Sacramento - United States, San Diego - United States, Torrance - United States, Aurora - United States, Jacksonville - United States, Orlando - United States, Atlanta - United States, Marietta - United States, Honolulu - United States, Baton Rouge - United States, Opelousas - United States, Boston - United States, Tupelo - United States, St Louis - United States, St Louis - United States, Egg Harbour Township - United States, Hackensack - United States, Albuquerque - United States, New York - United States, Syracuse - United States, Asheville - United States, Chapel Hill - United States, Winston-salem - United States, Oklahoma City - United States, Portland - United States, Kingsport - United States, Fort Sam Houston - United States, Salt Lake City - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Darlinghurst - Australia, Fremantle - Australia, Melbourne - Australia, Nedlands - Australia, Sydney - Australia, Graz - Austria, Innsbruck - Austria, Linz - Austria, Oberndorf - Austria, Wien - Austria, Wien - Austria, Antwerpen - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Gent - Belgium, Kortrijk - Belgium, Liege - Belgium, Brasilia - Brazil, Campinas - Brazil, Campinas - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Ribeirao Preto - Brazil, Rio de Janeiro - Brazil, Santo Andre - Brazil, Sao Luis - Brazil, Sao Paulo - Brazil, Sorocaba - Brazil, Vitoria - Brazil, Edmonton - Canada, Vancouver - Canada, Hamilton - Canada, Mississauga - Canada, Berlin - Germany, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Düsseldorf - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Giessen - Germany, Hamburg - Germany, Heidelberg - Germany, Jena - Germany, Kiel - Germany, Köln - Germany, Mainz - Germany, München - Germany, Offenburg - Germany, Tübingen - Germany, ULM - Germany, Guadalajara - Mexico, Guadalajara - Mexico, Mexicali - Mexico, Mexico City - Mexico, Mexico Df - Mexico, Puebla - Mexico, Santurce - Puerto Rico, Lausanne - Switzerland, Lugano - Switzerland, St. Gallen - Switzerland, Zürich - Switzerland",2012-05,2008-02-26,2013-07-22,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT06505928,L47-HD-MN,RECRUITING,2024-12-11,Hepatitis D,hepalatide,"Ulaanbaatar - Mongolia, Ulaanbaatar - Mongolia",2025-12-11,2024-07-17,2025-02-24,INTERVENTIONAL,PHASE2,"Shanghai HEP Pharmaceutical Co., Ltd.",INDUSTRY,hepatitis
NCT01474811,Unknown,COMPLETED,2011-11,Hepatitis C,No interventions listed,"Phoenix - United States, Little Rock - United States, La Jolla - United States, San Diego - United States, San Francisco - United States, San Francisco - United States, Denver - United States, New Haven - United States, Washington - United States, Washington - United States, Gainesville - United States, Miami - United States, Orlando - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Lutherville - United States, Boston - United States, Boston - United States, Worcester - United States, Ann Arbor - United States, Detroit - United States, Minneapolis - United States, Minneapolis - United States, Rochester - United States, Oxford - United States, Saint Louis - United States, Omaha - United States, Lebanon - United States, Santa Fe - United States, Beacon - United States, Manhasset - United States, New York - United States, New York - United States, Valatie - United States, Asheville - United States, Chapel Hill - United States, Durham - United States, Rocky Mount - United States, Wilmington - United States, Cincinnati - United States, Philadelphia - United States, Philadelphia - United States, Austin - United States, Austin - United States, Dallas - United States, Houston - United States, Annandale - United States, Richmond - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada, Aachen - Germany, Frankfurt - Germany, Hanover - Germany, San Juan - Puerto Rico",2022-09-09,2011-11-18,2024-02-28,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT04289428,Unknown,WITHDRAWN,2022-01,Hepatitis B,"Xpert® HBV DNA fingerstick point of care assay, Point of Care ALT, Xpert® HBV DNA point of care assay from dried blood spot",Darlinghurst - Australia,2022-07,2020-02-28,2021-12-03,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT04423393,Unknown,COMPLETED,2020-05-26,Chronic Hepatitis B,"VIR-3434, Placebo","Essen - Germany, Frankfurt - Germany, Hannover - Germany, Leipzig - Germany, Mainz - Germany, Mannheim - Germany, Ulm - Germany, Hong Kong - Hong Kong, Busan - Korea, Republic of, Busan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Havelock North - New Zealand, Newtown - New Zealand, Tauranga - New Zealand, Bucharest - Romania, Singapore - Singapore, Singapore - Singapore, Birmingham - United Kingdom, London - United Kingdom, Manchester - United Kingdom",2022-10-24,2020-06-09,2024-10-08,INTERVENTIONAL,PHASE1,"Vir Biotechnology, Inc.",INDUSTRY,hepatitis
NCT01795911,D-LITE,COMPLETED,2013-03,Hepatitis C,"Pegylated Interferon Lambda, Ribasphere, Daclatasvir",San Antonio - United States,2014-04,2013-02-21,2015-10-09,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03961828,Unknown,COMPLETED,2017-10-01,"Beta-Thalassemia, Hepatitis C",Ledipasvir 90 MG / Sofosbuvir 400 MG [Harvoni],Tanta - Egypt,2018-12-31,2019-05-23,2019-05-23,INTERVENTIONAL,PHASE4,Tanta University,OTHER,hepatitis
NCT04650828,Unknown,UNKNOWN,2020-12-01,Chronic Hepatitis B,"TDF, Tenofovir Disoproxil Fumarate 300 MG",Guangzhou - China,2022-11-30,2020-12-03,2021-01-12,OBSERVATIONAL,Not Available,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT04214028,Unknown,COMPLETED,2019-12-26,Hepatitis C Virus (HCV),No interventions listed,"Kariya-shi - Japan, Nagoya shi - Japan, Nagoya-shi - Japan, Nagoya-shi - Japan, Hirosaki-shi - Japan, Misawa-shi - Japan, Chiba-shi - Japan, Narita-shi - Japan, Matsuyama-shi - Japan, Shikoku Chuo - Japan, Fukuoka-shi - Japan, Kitakyushu-shi - Japan, Kurume-shi - Japan, Koriyama-shi - Japan, Shirakawa-shi - Japan, Gifu-shi - Japan, Maebashi-shi - Japan, Maebashi - Japan, Takasaki City - Japan, Mihara-shi - Japan, Amagasaki-shi - Japan, Amagasaki-shi - Japan, Kanzaki-gun - Japan, Kobe City - Japan, Tsukuba-shi - Japan, Fujisawa-shi - Japan, Sagamihara-shi - Japan, Yokohama-shi - Japan, Kumamoto-shi - Japan, Kyoto City - Japan, Kyoto-shi - Japan, Iga-shi - Japan, Ise-shi - Japan, Tsu-shi - Japan, Sendai-shi - Japan, Matsumoto-shi - Japan, Ikoma-shi - Japan, Nakatsu-shi - Japan, Kasaoka-shi - Japan, Nakagami-gun - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Iruma-gun - Japan, Saitama-shi - Japan, Maibara-shi - Japan, Hamamatsu-shi - Japan, Fuchu-shi - Japan, Setagaya-ku - Japan, Yonago-shi - Japan, Yonezawa-shi - Japan, Ube-shi - Japan, Oita - Japan, Yamagata - Japan",2024-08-01,2019-12-30,2024-10-29,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT00538811,Unknown,COMPLETED,Unknown Date,"Hepatitis C, Genotype 3, Non-responders, Relapsers","interferon alpha-2b, ribavirin, interferon-gamma,, interferon alpha-2b, ribavirin, amantadine","Karachi - Pakistan, Karachi - Pakistan",Unknown Date,2007-10-03,2010-10-27,INTERVENTIONAL,PHASE3,Aga Khan University,OTHER,hepatitis
NCT02265328,COBS,COMPLETED,2014-09,Severe Alcoholic Hepatitis in 'Extremis'- Defined by mDF>54,"Bovine colostrum, Enteral Nutrition, prednisolone",Ludhiana - India,2015-05,2014-10-15,2015-09-15,INTERVENTIONAL,PHASE2,Dayanand Medical College and Hospital,OTHER,hepatitis
NCT04646928,Unknown,UNKNOWN,2017-03-17,Chronic Hepatitis B,No interventions listed,"Bucheon - Korea, Republic of, Cheonan - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Gyeonggi-do - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Suwon - Korea, Republic of, Suwon - Korea, Republic of, Sŏngnam - Korea, Republic of",2022-05-28,2020-11-30,2020-11-30,OBSERVATIONAL,Not Available,CHA University,OTHER,hepatitis
NCT06550128,Unknown,ACTIVE_NOT_RECRUITING,2024-07-05,"Hepatitis B, Chronic","AHB-137 injection, Placebo","Fuzhou - China, Zhenjiang - China, Beijing - China, Chongqing - China, Guangzhou - China, Jilin - China",2025-04-01,2024-08-12,2024-11-05,INTERVENTIONAL,PHASE2,"Ausper Biopharma Co., Ltd.",INDUSTRY,hepatitis
NCT02344498,Unknown,ACTIVE_NOT_RECRUITING,2015-01,Hepatitis B,Tenofovir disoproxil,Addis Abeba - Ethiopia,2026-12,2015-01-26,2024-11-15,OBSERVATIONAL,Not Available,Oslo University Hospital,OTHER,hepatitis
NCT01724398,Unknown,UNKNOWN,2012-11,Liver Failure,"Conventional plus UC-MSC treatment, Conventional plus PE treatment, Conventional plus UC-MSC and PE therapy, Conventional treatment",Guangzhou - China,2015-03,2012-11-09,2013-02-28,INTERVENTIONAL,PHASE2,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT06179498,Unknown,RECRUITING,2024-03-25,Hepatitis C,Partner Navigation Intervention,San Francisco - United States,2027-03-01,2023-12-22,2025-03-13,INTERVENTIONAL,NA,"University of California, San Francisco",OTHER,hepatitis
NCT02399345,Unknown,COMPLETED,2015-03,Chronic Hepatitis C Virus (HCV Infection Genotype 1),"ombitasvir/paritaprevir/ritonavir, dasabuvir, sofosbuvir (SOF), ribavirin (RBV)",No locations listed,2015-11,2015-03-26,2016-12-12,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT05953545,Unknown,WITHDRAWN,2024-05-22,Chronic Hepatitis Delta,Peginterferon Lambda,Bethesda - United States,2024-05-22,2023-07-20,2024-05-23,INTERVENTIONAL,PHASE2,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT04039698,Unknown,UNKNOWN,2019-08-23,Chronic Hepatitis C,"Telemedicine, Velpatasvir/Sofosbuvir",Porto Alegre - Brazil,2020-12-16,2019-07-31,2021-08-25,INTERVENTIONAL,NA,Hospital de Clinicas de Porto Alegre,OTHER,hepatitis
NCT04059198,Unknown,TERMINATED,2019-10-10,"Hepatitis B, HBV, Hepatitis B, Chronic","Inarigivir soproxil, Tenofovir alafenamide fumarate (TAF)","Hong Kong - Hong Kong, Sha Tin - Hong Kong",2020-04-02,2019-08-16,2020-07-21,INTERVENTIONAL,PHASE2,"F-star Therapeutics, Inc.",INDUSTRY,hepatitis
NCT03801798,Unknown,UNKNOWN,2019-02-11,Hepatitis B,"GC1102, GC1102 Placebo","Seoul - Korea, Republic of",2021-12,2019-01-14,2019-12-13,INTERVENTIONAL,PHASE2,Green Cross Corporation,INDUSTRY,hepatitis
NCT06078098,AIH Database,RECRUITING,2023-03-29,"Autoimmune Hepatitis, Liver Disorder",Clinical Information,Monza - Italy,2034-03-29,2023-10-11,2023-10-11,OBSERVATIONAL,Not Available,University of Milano Bicocca,OTHER,hepatitis
NCT02461745,Unknown,COMPLETED,2015-06,"Hepatitis C, Chronic","ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r, dasabuvir","Irvine - United States, Los Angeles - United States, San Diego - United States, San Marcos - United States",2017-05,2015-06-03,2021-01-22,INTERVENTIONAL,PHASE4,Kaiser Permanente,OTHER,hepatitis
NCT03845205,Unknown,RECRUITING,2020-11-20,"Alcohol Use Disorder, Alcoholic Hepatitis",Integrated AUD Treatment,Baltimore - United States,2025-06,2019-02-19,2024-09-19,INTERVENTIONAL,NA,Johns Hopkins University,OTHER,hepatitis
NCT04156945,ICECREAM,ACTIVE_NOT_RECRUITING,2021-09-14,Hepatitis C Virus Infection,"Behavioural intervention, HCV RNA home-based test","Paris - France, Paris - France, Paris - France, Paris - France, Paris - France, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Amsterdam - Netherlands, Den Haag - Netherlands, Rotterdam - Netherlands, Utrecht - Netherlands",2026-02,2019-11-08,2024-08-02,INTERVENTIONAL,NA,Public Health Service of Amsterdam,OTHER_GOV,hepatitis
NCT00516945,Unknown,COMPLETED,2004-09,"Hepatitis B, Neoplasms",Lamivudine,Hong Kong - China,Unknown Date,2007-08-16,2013-09-05,INTERVENTIONAL,NA,"Hospital Authority, Hong Kong",OTHER_GOV,hepatitis
NCT06431945,EDVIP,RECRUITING,2023-12-15,Hepatitis C Virus Infection,"Hepatitis C antibody (anti-HCV) test, Hepatitis C RNA test and genotype test","Brno - Czechia, Brno - Czechia, Havířov - Czechia, Hradec Králové - Czechia, Hradec Králové - Czechia, Jihlava - Czechia, Karlovy Vary - Czechia, Olomouc - Czechia, Opava - Czechia, Pardubice - Czechia, Prague - Czechia, Praha - Czechia, Praha - Czechia, Prostějov - Czechia, Tábor - Czechia, Zlín - Czechia, Ústí Nad Labem - Czechia, České Budějovice - Czechia",2025-05-31,2024-05-29,2024-05-29,OBSERVATIONAL,Not Available,Institute of Health Information and Statistics of the Czech Republic,OTHER_GOV,hepatitis
NCT05242445,Unknown,COMPLETED,2022-04-19,"Hepatitis B, Chronic","Cetrelimab, Placebo","Edegem - Belgium, Mechelen - Belgium, Clichy - France, Créteil - France, Grenoble CEDEX 9 - France, Paris Cedex 12 - France, Essen - Germany, Hannover - Germany, Gdansk - Poland, Myslowice - Poland, Santander - Spain, Sevilla - Spain, Valencia - Spain",2023-05-09,2022-02-16,2023-07-24,INTERVENTIONAL,PHASE1,"Janssen Research & Development, LLC",INDUSTRY,hepatitis
NCT03345498,Unknown,COMPLETED,2017-01-01,"Hepatitis B, Liver Cirrhosis",Entecavir,Lucknow - India,2018-06-30,2017-11-17,2019-09-24,OBSERVATIONAL,Not Available,Sanjay Gandhi Postgraduate Institute of Medical Sciences,OTHER_GOV,hepatitis
NCT01492998,GGST,TERMINATED,2010-01,Chronic Hepatitis C,"guggulsterone, a natural FXR antagonist.",Lyon - France,2010-03,2011-12-15,2011-12-15,INTERVENTIONAL,NA,Hospices Civils de Lyon,OTHER,hepatitis
NCT04196998,Unknown,UNKNOWN,2019-01-01,"Hepatitis B, Compensated Cirrhosis","Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir alafenamide",Guangzhou - China,2023-12,2019-12-12,2019-12-12,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT01192698,Unknown,COMPLETED,2009-10,"Hepatitis C, Cirrhosis",IV interferon,No locations listed,2013-02,2010-09-01,2022-04-21,INTERVENTIONAL,NA,Wake Forest University Health Sciences,OTHER,hepatitis
NCT03685045,ETHOS II,RECRUITING,2018-05-28,Hepatitis C,Campaign days,"Brookvale - Australia, Campbelltown - Australia, Cessnock - Australia, Coffs Harbour - Australia, Darlinghurst - Australia, Grafton - Australia, Katoomba - Australia, Kempsey - Australia, Kingswood - Australia, Lismore - Australia, Lithgow - Australia, Liverpool - Australia, Mount Druitt - Australia, Newcastle - Australia, Nowra - Australia, Parramatta - Australia, Port Macquarie - Australia, Saint Leonards - Australia, Tamworth - Australia, Taree - Australia, Tweed Heads - Australia, Wollongong - Australia, Brisbane - Australia, Cairns - Australia, Elizabeth - Australia, Stepney - Australia, Fremantle - Australia, Joondalup - Australia, Perth - Australia",2025-01-30,2018-09-26,2024-03-06,INTERVENTIONAL,NA,Kirby Institute,OTHER_GOV,hepatitis
NCT02689245,Unknown,COMPLETED,2016-02-26,Acute on Chronic Liver Failure,"Tenofovir, Fecal Microbiota Transplantation (FMT)",New Delhi - India,2018-03-13,2016-02-23,2018-11-23,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT01581398,Unknown,COMPLETED,2012-04,Chronic Hepatitis C,"Ypeginterferon alfa-2b, Pegasys, Ypeginterferon alfa-2b, Pegasys","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changsha - China, Changsha - China, Chengdu - China, Chongqing - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guilin - China, Guiyang - China, Hangzhou - China, Harbin - China, Hefei - China, Jinan - China, Lanzhou - China, Nanchang - China, Nanjing - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shijiazhuang - China, Taiyuan - China, Tianjin - China, Wuhan - China, Wuhan - China, Wulumuqi - China, Xiamen - China, Xian - China, Xian - China, Zhengzhou - China, Zhengzhou - China",2014-04,2012-04-20,2014-10-07,INTERVENTIONAL,PHASE3,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT04294498,Unknown,ACTIVE_NOT_RECRUITING,2020-11-02,Advanced Hepatocellular Carcinoma,Durvalumab,Taipei City - Taiwan,2024-10-01,2020-03-04,2024-08-22,INTERVENTIONAL,PHASE2,National Taiwan University Hospital,OTHER,hepatitis
NCT06373198,Unknown,NOT_YET_RECRUITING,2024-05-01,"Hepatitis C Chronic, Hepatitis C",standard of care,No locations listed,2024-07-01,2024-04-18,2024-04-18,OBSERVATIONAL,Not Available,Hospital El Cruce,OTHER,hepatitis
NCT05828745,Unknown,RECRUITING,2024-04-22,Chronic Hepatitis b,"CB06-036, Placebo",Changchun - China,2024-12-27,2023-04-25,2024-08-22,INTERVENTIONAL,PHASE2,"Shanghai Zhimeng Biopharma, Inc.",INDUSTRY,hepatitis
NCT00956098,Unknown,COMPLETED,2006-02,"Liver Fibrosis, Liver Cirrhosis","oltipraz, placebo","Sosa-Dong, Wonmi-Gu - Korea, Republic of, Banpo-Dong, Seocho-Gu - Korea, Republic of",Unknown Date,2009-08-11,2009-08-11,INTERVENTIONAL,PHASE2,HK inno.N Corporation,INDUSTRY,hepatitis
NCT03222583,VOYAGE-1,COMPLETED,2017-10-04,Hepatitis C Virus (HCV),"Placebo, Glecaprevir/Pibrentasvir","Beijing - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Changsha - China, Nanjing - China, Nanjing - China, Changchun - China, Shenyang - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Chengdu - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Chongqing - China, Dalian - China, Fuzhou - China, Haikou, Hainan - China, Jinan, Shandong - China, Nanjing - China, Shenyang - China, Tianjin - China, Urumqi - China, Wuhan - China, Wuhan - China, Xi'an - China, Xi'an - China, Zhengzhou, Henan - China, Busan - Korea, Republic of, Seongnam - Korea, Republic of, Busan - Korea, Republic of, Yangsan-si, - Korea, Republic of, Jung-gu - Korea, Republic of, Seodaemun-gu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Singapore - Singapore, Singapore - Singapore, Singapore - Singapore",2018-10-18,2017-07-19,2019-12-23,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT00781105,Chinese PAC,COMPLETED,2008-08-01,Chronic Hepatitis B,Telbivudine,Beijing - China,2010-09-16,2008-10-28,2017-02-23,INTERVENTIONAL,PHASE4,Novartis Pharmaceuticals,INDUSTRY,hepatitis
NCT03231605,Unknown,UNKNOWN,2017-07-26,Hepatitis A,Hepatitis A Vaccine,Yuncheng - China,2017-08-31,2017-07-27,2017-08-01,INTERVENTIONAL,PHASE4,China National Biotec Group Company Limited,INDUSTRY,hepatitis
NCT02404805,Unknown,COMPLETED,2016-02,"HIV, Hepatitis C","dolutegravir, simeprevir",Aurora - United States,2016-10,2015-04-01,2021-03-17,INTERVENTIONAL,NA,"University of Colorado, Denver",OTHER,hepatitis
NCT03490097,Unknown,COMPLETED,2017-12-01,"Chronic Hepatitis c, Metabolic Syndrome","Simvastatin 10mg, sofosbuvir plus daclatasvir",Cairo - Egypt,2018-05-23,2018-04-06,2018-09-20,INTERVENTIONAL,PHASE3,Ain Shams University,OTHER,hepatitis
NCT02907905,Unknown,COMPLETED,2016-03-01,Social Insecurity,capillary sampling,Montpellier - France,2019-11-01,2016-09-20,2022-08-11,INTERVENTIONAL,NA,"University Hospital, Montpellier",OTHER,hepatitis
NCT00440297,Unknown,COMPLETED,2006-12,Hepatitis B Virus Infection,"Comparator: modified process hepatitis B vaccine, Comparator: ENGERIX-B™",No locations listed,2008-05,2007-02-27,2017-04-13,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00842205,Unknown,UNKNOWN,2007-01,"Chronic HCV Infection, Nonalcoholic Steatohepatitis","pegylated interferon, Ribavarin",Prague - Czech Republic,2009-06,2009-02-12,2009-02-12,INTERVENTIONAL,NA,"Charles University, Czech Republic",OTHER,hepatitis
NCT03817697,ANOVAC B,COMPLETED,2019-04-10,"Adult Patients Drug Users, Substituted / Weaned or Not",Questionnaire,Lyon - France,2019-09-04,2019-01-25,2019-09-17,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT03692897,Unknown,RECRUITING,2018-10-11,"Hepatitis B, Hepatitis, Liver Diseases",All approved therapies for the treatment of Chronic Hepatitis B (CHB),"Phoenix - United States, Los Angeles - United States, Pasadena - United States, Redwood City - United States, Sacramento - United States, San Jose - United States, New Haven - United States, Washington - United States, Gainesville - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Baltimore - United States, Ann Arbor - United States, Plymouth - United States, New Brunswick - United States, Flushing - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, Chapel Hill - United States, Dallas - United States, Norfolk - United States, Richmond - United States, Richmond - United States, Seattle - United States, Seattle - United States, Toronto - Canada",2026-01,2018-10-02,2025-01-27,OBSERVATIONAL,Not Available,"Target PharmaSolutions, Inc.",INDUSTRY,hepatitis
NCT01226797,Unknown,TERMINATED,2011-01-17,"Hepatitis C, Chronic","Placebo, PF-04136309","Hong KOng - Hong Kong, Prince Of Wales Hospital, Shatin, New Territories, - Hong Kong, Bangalore - India, Mumbai - India, New Delhi - India, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Singapore - Singapore, Kaohsiung - Taiwan, Taipei - Taiwan",2012-02-09,2010-10-22,2023-07-27,INTERVENTIONAL,PHASE2,Pfizer,INDUSTRY,hepatitis
NCT04282005,MeSH,UNKNOWN,2020-02-13,"Non-alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steato-Hepatitis (NASH)","Metabolic/Bariatric surgery, Lifestyle and Diet",London - United Kingdom,2021-03-30,2020-02-24,2020-03-05,INTERVENTIONAL,NA,King's College London,OTHER,hepatitis
NCT06221605,Unknown,NOT_YET_RECRUITING,2024-03,Chronic Hepatitis B,Probiotic,No locations listed,2024-11,2024-01-24,2024-01-24,INTERVENTIONAL,NA,"Wecare Probiotics Co., Ltd.",INDUSTRY,hepatitis
NCT00411697,Unknown,COMPLETED,2006-12,Hepatitis B,Engerix™-B Kinder,"Bad Saulgau - Germany, Bietigheim/Bissingen - Germany, Boennigheim - Germany, Ehingen - Germany, Ettenheim - Germany, Herbolzheim - Germany, Kehl - Germany, Kirchzarten - Germany, Oberstenfeld - Germany, Offenburg - Germany, Pforzheim - Germany, Stuttgart - Germany, Tettnang - Germany, Tuttlingen - Germany, Aschaffenburg - Germany, Cham - Germany, Muenchen - Germany, Muenchen - Germany, Noerdlingen - Germany, Olching - Germany, Tegernsee - Germany, Dudenhofen - Germany, Frankenthal - Germany, Gau-Odernheim - Germany, Gerolstein - Germany, Schoeneberg - Kuebelberg - Germany, Trier - Germany, Trier - Germany, Leipzig - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany, Berlin - Germany",2007-05,2006-12-14,2016-10-28,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT04515797,QUICK-CURE,TERMINATED,2021-05-01,"Kidney Failure, Hepatitis C, Kidney Disease, Chronic",Glecaprevir and Pibrentasvir,Boston - United States,2023-08-31,2020-08-17,2024-12-03,INTERVENTIONAL,PHASE4,Massachusetts General Hospital,OTHER,hepatitis
NCT06606197,Unknown,COMPLETED,2022-09-09,Hepatitis C,Having sex with other men,Vilafranca del Penedès - Spain,2022-09-11,2024-09-20,2025-02-12,OBSERVATIONAL,Not Available,Consorci Sanitari de l'Alt Penedès i Garraf,OTHER,hepatitis
NCT00362505,Unknown,TERMINATED,2004-06,Hepatitis B,Clevudine,"Daesa-dong, Jung-gu - Korea, Republic of, Jung-gu, - Korea, Republic of, Jung-gu - Korea, Republic of, Seoul - Korea, Republic of, Hak-1-dong, Dong-gu - Korea, Republic of, Bupyoung-dong, Bupyoung-gu - Korea, Republic of, Sinhung-dong, Jung-gu - Korea, Republic of, Iksan-City - Korea, Republic of, Jeonju-city - Korea, Republic of, Seoul - Korea, Republic of, Ilsan-gu - Korea, Republic of, Puch'un - Korea, Republic of, Seongnam-gu - Korea, Republic of, Incheon - Korea, Republic of, Ami-dong, Seo-gu - Korea, Republic of, Amnam-dong, Seo-gu - Korea, Republic of, Gaegeum-dong - Korea, Republic of, Anam-dong, Sungbuk-ku - Korea, Republic of, Banpo-dong, Seocho-gu - Korea, Republic of, Daelim-dong, Yongdeungpo-gu - Korea, Republic of, Dogok-dong, Kangnam-gu - Korea, Republic of, Gongneung-dong, Nowon-gu - Korea, Republic of, Hannam-dong, Yongsan-gu - Korea, Republic of, Ilwon-dong, Songpa-gu - Korea, Republic of, Jeo-dong - Korea, Republic of, Mok-dong, Yangcheon-gu - Korea, Republic of, Pungnap-dong, Kangnam-gu - Korea, Republic of, Pyoung-dong, Chongro-gu, - Korea, Republic of, Shinchon- dong, Seodaemun-gu - Korea, Republic of, Ji-dong,, Paldal-gu - Korea, Republic of, Daemyoung-dong, Nam-gu - Korea, Republic of, Seoul - Korea, Republic of",Unknown Date,2006-08-10,2017-02-01,INTERVENTIONAL,PHASE3,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT01939197,TURQUOISE-I,COMPLETED,2013-08-30,"Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis and Non-cirrhotics","ABT-450/r/ABT-267, ABT-333, ribavirin",No locations listed,2016-07-21,2013-09-11,2021-07-12,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02118597,Unknown,TERMINATED,2014-05,"Hepatitis C, Chronic","Boceprevir, Simeprevir, Pegylated Interferon (Peginterferon) Alfa-2a, Ribavirin","Budapest - Hungary, Budapest - Hungary, Békéscsaba - Hungary, Debrecen - Hungary, Eger - Hungary, Kaposvár - Hungary, Szombathely - Hungary",2015-05,2014-04-21,2016-12-12,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05128305,Unknown,UNKNOWN,2021-12-01,"Hepatic Encephalopathy, Cirrhosis, Liver, Portosystemic Shunt",traditional Chinese medicine1 and traditional Chinese medicine 2,Jinan - China,2022-06-30,2021-11-19,2021-11-19,INTERVENTIONAL,PHASE3,Qianfoshan Hospital,OTHER,hepatitis
NCT02496897,Unknown,COMPLETED,2015-07,Hepatitis B,"FP-02.2 Vaccine, Placebo, IC31® Adjuvant","Busan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Yangsan - Korea, Republic of, Birmingham - United Kingdom, Bristol - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Manchester - United Kingdom, North Yorkshire - United Kingdom, Nottingham - United Kingdom",2017-10-13,2015-07-14,2019-01-09,INTERVENTIONAL,PHASE1,"Altimmune, Inc.",INDUSTRY,hepatitis
NCT02190305,Unknown,WITHDRAWN,2014-05,"HIV Infections, Hepatitis B Infections, Hepatitis C Infections",Multiplo HBc/HIV/HCV and Reveal HBsAg,"Los Angeles - United States, Miami - United States, Minneapolis - United States, New York - United States",2015-08,2014-07-15,2023-04-21,INTERVENTIONAL,NA,MedMira Laboratories Inc.,INDUSTRY,hepatitis
NCT00725205,Unknown,COMPLETED,2006-03,"Hepatitis C, Chronic, Hepatitis C","PegIntron (Peginterferon alfa-2b), Rebetol (Ribavirin)",No locations listed,2010-10,2008-07-30,2015-10-08,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01467505,Unknown,TERMINATED,2012-02,Hepatitis C,"Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a, Immunosuppressant Regimen","Birmingham - United States, Phoenix - United States, Los Angeles - United States, Denver - United States, Bradenton - United States, Miami - United States, Evanston - United States, Indianapolis - United States, Burlington - United States, Ann Arbor - United States, Detroit - United States, St Louis - United States, Omaha - United States, New York - United States, Rochester - United States, Charlotte - United States, Cleveland - United States, Philadelphia - United States, Dallas - United States, Houston - United States, Calgary - Canada, Vancouver - Canada",2014-04,2011-11-08,2015-06-18,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01855997,Unknown,COMPLETED,2013-08-20,"Hepatitis B, Chronic",Peg-IFN alfa-2a,"Wien - Austria, Sofia - Bulgaria, Varna - Bulgaria, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changsha - China, Chengdu - China, Chongqing - China, Fu Zhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Harbin - China, Jinan - China, Nanjing - China, Nanning - China, Shanghai - China, Shanghai - China, Shen Zhen - China, Shi Jiazhuang - China, Urumqi - China, Wuhan - China, Xi'an - China, Yinchuan - China, Zhengzhou - China, Clichy - France, Creteil - France, Rennes - France, Saint Laurent Du Var - France, Berlin - Germany, Berlin - Germany, Berlin - Germany, Hamburg - Germany, Hannover - Germany, Athens - Greece, Larissa - Greece, Thessaloniki - Greece, Caserta - Italy, Napoli - Italy, Bologna - Italy, Parma - Italy, Milano - Italy, Milano - Italy, Bari - Italy, Castellana Grotte - Italy, Cagliari - Italy, Palermo - Italy, Pisa - Italy, Padova - Italy, Busan - Korea, Republic of, Chooncheon - Korea, Republic of, Seoul - Korea, Republic of, Auckland - New Zealand, Bydgoszcz - Poland, Chorzow - Poland, Krakow - Poland, Lancut - Poland, Warszawa - Poland, Warszawa - Poland, Zielona Góra - Poland, Łodz - Poland, Lisboa - Portugal, Porto - Portugal, Porto - Portugal, Bucharest - Romania, Bucharest - Romania, Craiova - Romania, Changhua - Taiwan, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Keelung City - Taiwan, Taichung - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan, Bangkok - Thailand, Chiang Mai - Thailand, Songkhla - Thailand, London - United Kingdom, Manchester - United Kingdom",2014-11-28,2013-05-17,2017-04-05,OBSERVATIONAL,Not Available,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01463683,Unknown,COMPLETED,2011-11-29,Hepatitis B,"2XP HEPTAVAX™-II SC, 1XP HEPTAVAX™-II SC, 2XP HEPTAVAX™-II IM",No locations listed,2012-11-06,2011-11-02,2018-07-18,INTERVENTIONAL,PHASE3,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04160897,Unknown,UNKNOWN,2019-10-22,"Hepatitis B, Chronic, Hepatocellular Carcinoma, Compensated Cirrhosis","Entecavir, Tenofovir Disoproxil",Shanghai - China,2020-10-31,2019-11-13,2019-11-13,OBSERVATIONAL,Not Available,Qing XIe,OTHER,hepatitis
NCT01121705,genotype-3,COMPLETED,2007-01,Chronic Hepatitis,Peg Interferon alpha2b + Ribavirin,"Canossa - Italy, Casarano - Italy, Castellana Grotte - Italy, Catania - Italy, Rome - Italy, Rome - Italy, Sassari - Italy, Venosa - Italy",2009-06,2010-05-12,2011-08-10,INTERVENTIONAL,PHASE3,Casa Sollievo della Sofferenza IRCCS,OTHER,hepatitis
NCT01140997,PEGIFN,COMPLETED,2010-07,Chronic Hepatitis C,"Ypeginterferon alfa-2b, Peginterferon alfa-2a","Beijing - China, Beijing - China, Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changsha - China, Changsha - China, Chengdu - China, Chongqing - China, Chongqing - China, Fuzhou - China, Guangzhou - China, Guangzhou - China, Guilin - China, Harbin - China, Hefei - China, Jinan - China, Lanzhou - China, Nanchang - China, Nanjing - China, Nanjing - China, Nanjing - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shanghai - China, Shenzhen - China, Shijiazhuang - China, Taiyuan - China, Tianjin - China, Wenzhou - China, Wuhan - China, Xian - China, Zhengzhou - China, Zhengzhou - China",2011-01,2010-06-10,2013-02-04,INTERVENTIONAL,PHASE2,"Xiamen Amoytop Biotech Co., Ltd.",INDUSTRY,hepatitis
NCT00116805,Unknown,COMPLETED,2005-06,Chronic Hepatitis B,"TDF, ADV, TDF placebo, ADV placebo, FTC/TDF","Orange - United States, Pasadena - United States, San Diego - United States, San Jose - United States, Miami - United States, Atlanta - United States, Atlanta - United States, Honolulu - United States, Baltimore - United States, Ann Arbor - United States, Detroit - United States, St. Louis - United States, Flushing - United States, New York - United States, New York - United States, New York - United States, Fairfax - United States, Falls Church - United States, Richmond - United States, Seattle - United States, Camperdown - Australia, Concord - Australia, Westmead - Australia, Woolloongabba - Australia, Clayton - Australia, Footscray - Australia, Parkville - Australia, Prahran - Australia, Fitzroy - Australia, Perth - Australia, Sofia - Bulgaria, Sofia - Bulgaria, Varna - Bulgaria, Calgary - Canada, Vancouver - Canada, Winnepeg - Canada, Toronto - Canada, Toronto - Canada, Brno - Czech Republic, Hradec Kralove - Czech Republic, Prague - Czech Republic, Praha 6- Stresovice - Czech Republic, Clichy - France, Grenoble - France, Lille - France, Lyon - France, Nancy - France, Paris - France, Strasbourg - France, Berlin - Germany, Duesseldorf - Germany, Dusseldorf - Germany, Essen - Germany, Hamburg - Germany, Hannover - Germany, Herne - Germany, Homburg/Saar - Germany, Kiel - Germany, Mainz - Germany, Munchen - Germany, Tubingen - Germany, Athens - Greece, Thessaloniki - Greece, Thessaloniki - Greece, Bologna - Italy, Rotterdam - Netherlands, Auckland - New Zealand, Hamilton - New Zealand, Wellington - New Zealand, Whakatane - New Zealand, Bialystok - Poland, Bydgoszcz - Poland, Chorzow - Poland, Kielce - Poland, Krakow - Poland, Warszawa - Poland, Wroclaw - Poland, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Valencia - Spain, Ankara - Turkey, Bursa - Turkey, Istanbul - Turkey, Izmir - Turkey, Birmingham - United Kingdom, London - United Kingdom",2007-05,2005-07-01,2017-03-09,INTERVENTIONAL,PHASE3,Gilead Sciences,INDUSTRY,hepatitis
NCT01571583,REPLACE,COMPLETED,2012-02,Chronic Hepatitis C Virus (HCV) Infection,"Telaprevir, Pegylated interferon alfa-2a, Ribavirin","Linz - Austria, Wien - Austria, Brussels - Belgium, Gent - Belgium, Leuven - Belgium, Liege - Belgium, Clichy - France, Marseille - France, Montpellier - France, Rennes Cedex N/A - France, Villejuif Cedex - France, Essen - Germany, Frankfurt A. M. - Germany, Hannover - Germany, Leipzig - Germany, Münster - Germany, Barcelona - Spain, Madrid - Spain, Valencia - Spain, Birmingham - United Kingdom, London - United Kingdom",2014-04,2012-04-05,2016-06-30,INTERVENTIONAL,PHASE3,Janssen-Cilag International NV,INDUSTRY,hepatitis
NCT00892697,Unknown,COMPLETED,2009-05,Hepatitis C,"Telaprevir, Peginterferon alfa-2a, Ribavirin",No locations listed,2012-12,2009-05-04,2015-03-20,INTERVENTIONAL,PHASE2,Weill Medical College of Cornell University,OTHER,hepatitis
NCT04459897,LGH,UNKNOWN,2019-01-01,Patient Diagnosed or Treated for Granulomatous Hepatitis Followed in the Internal Medicine (and or) Hepato-gastroenterology Departments,Evaluation of epithelioid and gigantocellular granulomas within the hepatic parenchyma by histopathology approach.,"Lyon - France, Lyon - France, Pierre Bénite - France",2023-01-01,2020-07-07,2020-07-07,OBSERVATIONAL,Not Available,Hospices Civils de Lyon,OTHER,hepatitis
NCT02417597,Unknown,COMPLETED,2015-04,Hepatitis E,Recombinant Hepatitis E Vaccine (Escherichia Coli),Quzhou - China,2016-05,2015-04-15,2016-05-18,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT03405597,Unknown,UNKNOWN,2017-03-30,"Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine","Commercial Hepatitis B vaccine, Standard Treatment",Bangkoknoi - Thailand,2018-02-28,2018-01-23,2018-01-23,INTERVENTIONAL,PHASE3,Mahidol University,OTHER,hepatitis
NCT00978497,Unknown,COMPLETED,2009-09,HCV Infection,"placebo, ANA598, ANA598, Peginterferon, Ribavirin","Anaheim - United States, Los Angeles - United States, San Clemente - United States, San Diego - United States, San Francisco - United States, Gainesville - United States, Miami - United States, Sarasota - United States, Lutherville - United States, Boston - United States, Detroit - United States, New York - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Philadelphia - United States, Houston - United States, San Antonio - United States, Fairfax - United States, Falls Church - United States, Santurce - Puerto Rico",2010-04,2009-09-17,2017-03-31,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02216045,HCV,COMPLETED,2014-06,Chronic Hepatitis C,"Peginterferon, Ribavirin, camel milk, Peginterferon, Ribavirin","Mashhad - Iran, Islamic Republic of, Mashhad - Iran, Islamic Republic of",2015-02,2014-08-13,2016-07-29,INTERVENTIONAL,PHASE2,Mashhad University of Medical Sciences,OTHER,hepatitis
NCT01033045,Unknown,COMPLETED,2009-09,Hepatitis C,No interventions listed,"Antequera - Spain, Cádiz - Spain, Cádiz - Spain, Granada - Spain, Huelva - Spain, Jaen - Spain, Jerez de la Frontera - Spain, Málaga - Spain, Málaga - Spain, Sevilla - Spain, Huesca - Spain, Zaragoza - Spain, Zaragoza - Spain, Oviedo - Spain, Madrid - Spain, Alcalá de Henares - Spain, Alcorcón - Spain, Getafe - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Móstoles - Spain, Parla - Spain, San Sebastian de los Reyes - Spain, Alcoy - Spain, Alicante - Spain, Alicante - Spain, Castellón - Spain, Elche - Spain, Orihuela - Spain, Valencia - Spain, Valencia - Spain, Xàtiva - Spain, Gran Canaria - Spain, Lanzarote - Spain, Tenerife - Spain, Tenerife - Spain, Tenerife - Spain, Santander - Spain, Albacete - Spain, Ciudad Real - Spain, Cuenca - Spain, Manzanares - Spain, Toledo - Spain, Toledo - Spain, Tomelloso - Spain, Valdepeñas - Spain, León - Spain, Ponferrada - Spain, Salamanca - Spain, Valladolid - Spain, Valladolid - Spain, Badalona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, El Vendrell - Spain, Figueres - Spain, Girona - Spain, Girona - Spain, Igualada - Spain, Manresa - Spain, Martorell - Spain, Reus - Spain, Sabadell - Spain, Santa Coloma de Gramanet - Spain, Tarragona - Spain, Tortosa - Spain, Vic - Spain, Viladecans - Spain, Badajoz - Spain, Coria - Spain, Cáceres - Spain, Mérida - Spain, A Coruña - Spain, A Coruña - Spain, Ferrol - Spain, Ourense - Spain, Pontevedra - Spain, Santiago de Compostela - Spain, Vigo - Spain, Vigo - Spain, Vigo - Spain, Vigo - Spain, Mallorca - Spain, Mallorca - Spain, Manacor - Spain, Cartagena - Spain, El Palmar - Spain, Lorca - Spain, Pamplona - Spain, Bilbao - Spain, Bilbao - Spain, Bilbao - Spain, San Sebastián - Spain, Barcelona - Spain, Madrid - Spain, Múrcia - Spain, Múrcia - Spain, Sevilla - Spain",2013-07,2009-12-16,2016-02-12,OBSERVATIONAL,Not Available,Fundacion IMIM,OTHER,hepatitis
NCT00723645,FAST-4,COMPLETED,2008-04,"Hepatitis C, Chronic",No interventions listed,No locations listed,2010-04,2008-07-29,2015-11-30,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05415345,Unknown,UNKNOWN,2021-10-25,"Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection","Cecolin, Hecolin",Hanzhou - China,2022-11-30,2022-06-13,2022-06-13,INTERVENTIONAL,PHASE4,"Xiamen Innovax Biotech Co., Ltd",INDUSTRY,hepatitis
NCT02166047,Unknown,COMPLETED,2014-06-30,Chronic Hepatitis B,"Vesatolimod, Placebo","Los Angeles - United States, San Diego - United States, San Francisco - United States, San Jose - United States, Honolulu - United States, Boston - United States, Boston - United States, Detroit - United States, Flushing - United States, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Toronto - Canada, San Giovanni Rotondo - Italy, Milan - Italy, Parma - Italy, Pisa - Italy, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Rotterdam - Netherlands, Auckland - New Zealand",2016-05-11,2014-06-18,2020-10-14,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT01639547,Unknown,TERMINATED,2012-07,Chronic Hepatitis C,Peginterferon alfa-2a plus Ribavirin,"Changhua City - Taiwan, Changhua County - Taiwan, Keelung City - Taiwan, Taichung City - Taiwan, Taichung City - Taiwan, Taipei County - Taiwan, Taoyuan County - Taiwan",2014-07,2012-07-12,2015-07-29,INTERVENTIONAL,NA,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT06184347,PreMAO,NOT_YET_RECRUITING,2024-02,"HBV Infection, Chronic Hepatitis B, Cirrhosis, HCC",Rapid tests for HBsAg,No locations listed,2025-03,2023-12-28,2024-01-09,OBSERVATIONAL,Not Available,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT00797745,NEXT-1,COMPLETED,2008-11,"Hepatitis C, Chronic","peginterferon alfa 2b, ribavirin, SCH 900518, ritonavir",No locations listed,2009-07,2008-11-25,2015-01-22,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00192647,Unknown,COMPLETED,2004-08,"Hepatitis C, Chronic","PEG-IFN alfa-2a, Ribavirin","Buenos Aires - Argentina, Buenos Aires - Argentina, La Plata - Argentina, Rosario - Argentina, Adelaide - Australia, Adelaide - Australia, Bankstown - Australia, Box Hill - Australia, Brisbane - Australia, Cottontree - Australia, Darlinghurst - Australia, Douglas - Australia, Fitzroy - Australia, Fremantle - Australia, Geelong - Australia, Greenslopes - Australia, Kingswood - Australia, Lismore - Australia, Liverpool - Australia, Liverpool - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Melbourne - Australia, Miranda - Australia, Nedlands - Australia, New Lambton Heights - Australia, Parkville - Australia, Perth - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Victoria - Australia, Woden - Australia, Wollongong - Australia, Woolloongabba - Australia, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Mississauga - Canada, Montreal - Canada, Guadalajara - Mexico, Guadalajara - Mexico, Monterrey - Mexico, Auckland - New Zealand, Hamilton - New Zealand, Riccarton, Christchurch - New Zealand, Bangkok - Thailand, Bangkok - Thailand, Chiang Mai - Thailand",2009-03,2005-09-19,2016-08-04,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05403047,TOPCHIB,NOT_YET_RECRUITING,2022-07,Hepatitis B Virus - Chronic Active,"Fumarate, Tenofovir Disoproxil",No locations listed,2025-07,2022-06-03,2022-06-03,INTERVENTIONAL,PHASE4,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT01911845,Unknown,COMPLETED,2013-04,"Chronic Hepatitis C Infection, Chronic Hepatitis C","ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV)",No locations listed,2013-12,2013-07-30,2018-05-30,INTERVENTIONAL,PHASE2,AbbVie,INDUSTRY,hepatitis
NCT06872047,Unknown,NOT_YET_RECRUITING,2025-04-01,Non-invasive Hepatocellular Carcinoma,No interventions listed,No locations listed,2026-04-01,2025-03-12,2025-03-12,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT02167945,TOPAZ-II,COMPLETED,2014-06-12,Chronic Hepatitis C Virus (HCV) Infection Genotype 1,"ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV)","Phoenix - United States, Bakersfield - United States, Los Angeles - United States, San Francisco - United States, Aurora - United States, Washington - United States, Bradenton - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Wellington - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, New Orleans - United States, Shreveport - United States, Baltimore - United States, Catonsville - United States, Boston - United States, Detroit - United States, Plymouth - United States, Saint Louis - United States, Egg Harbor Township - United States, Newark - United States, Albuquerque - United States, Santa Fe - United States, New Hyde Park - United States, New York - United States, New York - United States, New York - United States, Poughkeepsie - United States, Rochester - United States, Charlotte - United States, Statesville - United States, Cincinnati - United States, Tulsa - United States, Providence - United States, Germantown - United States, Baytown - United States, Houston - United States, Houston - United States, Pflugerville - United States, San Antonio - United States, Murray - United States, Seattle - United States, Seattle - United States, Madison - United States",2021-05-13,2014-06-19,2022-07-19,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02782247,Unknown,COMPLETED,2016-05,"Hepatitis B, Hepatitis C","Transient elastography, Indocyanine Green excretion",London - United Kingdom,2022-10,2016-05-25,2023-03-08,OBSERVATIONAL,Not Available,Queen Mary University of London,OTHER,hepatitis
NCT00871845,Unknown,TERMINATED,2008-09,"Obesity, Insulin Resistance, Metabolic Syndrome, Hepatitis C",Dietary and Lifestyle modification educational sessions,Pittsburgh - United States,2011-08,2009-03-30,2018-11-05,INTERVENTIONAL,NA,Hossam Kandil,OTHER,hepatitis
NCT00226447,Unknown,COMPLETED,2002-12,Chronic Hepatitis B,"Pegylated Interferon, Lamivudine",Hong Kong SAR - China,2006-07,2005-09-27,2008-10-24,INTERVENTIONAL,PHASE2,Chinese University of Hong Kong,OTHER,hepatitis
NCT00832247,CELTHEP-02,UNKNOWN,2009-01,Liver Cirrhosis Due to Virus C Chronic Hepatitis,Autologous bone marrow mononuclear cells infusion,Rio de Janeiro - Brazil,2010-04,2009-01-30,2009-01-30,INTERVENTIONAL,PHASE1,Universidade Federal do Rio de Janeiro,OTHER,hepatitis
NCT01829347,Unknown,TERMINATED,2014-04,Severe Acute Alcoholic Hepatitis,"ELAD, Standard of Care treatment","Little Rock - United States, San Diego - United States, Washington - United States, Miami - United States, Weston - United States, Atlanta - United States, Atlanta - United States, Bethesda - United States, Boston - United States, Minneapolis - United States, Omaha - United States, Newark - United States, Bronx - United States, Manhasset - United States, Charlotte - United States, Cleveland - United States, Philadelphia - United States, Philadelphia - United States, San Antonio - United States, Seattle - United States, Milwaukee - United States, Berlin - Germany, Hannover - Germany, Santiago de Compostela - Spain, Majadahonda - Spain, Baracaldo - Spain, Barcelona - Spain, Cordoba - Spain, Madrid - Spain, Madrid - Spain, Santander - Spain, Sevilla - Spain, Valencia - Spain, London - United Kingdom, London - United Kingdom, Hampstead - United Kingdom, Dundee - United Kingdom, Doncaster - United Kingdom, Brighton - United Kingdom",2015-10,2013-04-11,2019-02-19,INTERVENTIONAL,PHASE3,"Vital Therapies, Inc.",INDUSTRY,hepatitis
NCT03294798,Unknown,COMPLETED,2017-06-13,Hepatitis B Virus,"Human Serum Albumin/interferon alpha2b fusion protein, Pegasys",Beijing - China,2019-03-15,2017-09-27,2021-04-01,INTERVENTIONAL,PHASE2,Tianjin SinoBiotech Ltd.,INDUSTRY,hepatitis
NCT03143998,Unknown,WITHDRAWN,2018-02-12,Hepatitis C,MK-5172A,No locations listed,2019-01-12,2017-05-08,2017-11-09,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT05616598,Unknown,COMPLETED,2022-03-01,"Male Infertility, HCV",Sofosbuvir +daclatasvir+ simeprevir+Ribavirin,"Al Qalyūbīyah - Egypt, Banhā - Egypt",2022-11-25,2022-11-15,2023-02-08,INTERVENTIONAL,PHASE3,Benha University,OTHER,hepatitis
NCT02995005,Unknown,COMPLETED,2018-05-24,Hepatitis B,Tenofovir Disoproxil Fumarate,Mae Sot - Thailand,2023-01-31,2016-12-16,2023-02-06,INTERVENTIONAL,PHASE2,Johns Hopkins Bloomberg School of Public Health,OTHER,hepatitis
NCT00209898,PEGPRI,TERMINATED,2003-08,Chronic Hepatitis C,Fast initiation procedure,Bergen - Norway,2009-01,2005-09-21,2015-03-20,INTERVENTIONAL,PHASE4,Haukeland University Hospital,OTHER,hepatitis
NCT02806505,Unknown,COMPLETED,2004-06,"Hepatitis C, Chronic",Peginterferon alfa-2a,"Graz - Austria, Wien - Austria, Brasilia - Brazil, Porto Alegre - Brazil, Sao Jose Rio Preto - Brazil, Sao Luis - Brazil, Sao Paulo - Brazil, Creteil - France, Le Kremlin-bicetre - France, Marseille - France, Paris - France, Strasbourg - France, Toulouse - France, Athens - Greece, Nikea - Greece, Medan - Indonesia, Cagliari - Italy, Istanbul - Turkey, Istanbul - Turkey, Istanbul - Turkey, Izmir - Turkey, Abu Dhabi - United Arab Emirates",2007-08,2016-06-20,2016-10-31,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01138098,Unknown,COMPLETED,2010-06-07,Hepatitis B,Engerix™-B,"Banska Bystrica - Slovakia, Dolny Kubin - Slovakia, Dubnica Nad Vahom - Slovakia, Martin - Slovakia, Nitra - Slovakia, Nova Dubnica - Slovakia, Nove Zamky - Slovakia, Puchov - Slovakia, Roznava - Slovakia, Trebisov - Slovakia, Zlate Moravce - Slovakia",2010-11-26,2010-06-07,2018-08-20,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT03813498,Unknown,UNKNOWN,2019-01,Hepatitis C,"HCV articles, general health articles",No locations listed,2019-11,2019-01-23,2019-01-23,INTERVENTIONAL,NA,China Liver Health,OTHER,hepatitis
NCT05152498,Unknown,UNKNOWN,2021-01-01,Hepatocellular Carcinoma,Fu Zheng Jie Du Hua Yu therapy,Beijing - China,2023-12-31,2021-12-09,2021-12-09,INTERVENTIONAL,PHASE1,Beijing Ditan Hospital,OTHER,hepatitis
NCT01182298,LATHCV,TERMINATED,2010-07,"Hepatitis C, HIV",No interventions listed,Bethesda - United States,2013-03,2010-08-16,2019-09-24,OBSERVATIONAL,Not Available,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT02391805,Unknown,COMPLETED,2015-05-17,"Hepatitis B, Chronic","Entecavir, Placebo, RO6864018, Tenofovir","Hong Kong - Hong Kong, N.t. - Hong Kong, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Ampang - Malaysia, Batu Caves - Malaysia, Kuala Lumpur - Malaysia, Grafton - New Zealand, Hamilton - New Zealand, Singapore - Singapore, Kaohsiung - Taiwan, Taipei City - Taiwan, Taipei - Taiwan",2017-10-16,2015-03-18,2018-06-06,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT00698087,Unknown,COMPLETED,1995-01,Hepatitis B,"MPL-Adjuvanted recombinant hepatitis B vaccine, Engerix™-B",Vienna - Austria,1996-02,2008-06-16,2008-06-16,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00354653,Unknown,COMPLETED,2002-02-09,CHRONIC HEPATITIS B,LAMIVUDINE,"Tehran - Iran, Islamic Republic of",2007-01-23,2006-07-20,2020-03-03,INTERVENTIONAL,PHASE4,ViiV Healthcare,INDUSTRY,hepatitis
NCT03491553,Unknown,COMPLETED,2018-04-06,Chronic Hepatitis B,"Selgantolimod, Placebo, Hepatitis B virus (HBV) OAV Therapy","Baltimore - United States, Auckland - New Zealand",2019-03-22,2018-04-09,2021-08-19,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT03886077,SHERPA,RECRUITING,2019-03-20,"Coronary Artery Disease, Morality",glecaprevir/pibrentasivir,Norfolk - United States,2024-12-20,2019-03-22,2024-04-19,OBSERVATIONAL,Not Available,Sentara Norfolk General Hospital,OTHER,hepatitis
NCT00686777,Unknown,COMPLETED,2008-01,"Hepatitis C, Chronic","Pegylated Interferon alfa-2b, Ribavirin",No locations listed,2010-12,2008-05-30,2017-04-07,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02186977,POC_VAX-ID,COMPLETED,2016-03,Hepatitis B,"VAX-ID, 1.0 cc HBVAXPRO 10mcgr/ml (Sanofi Pasteur MSD), 0.1cc HBVAXPRO 40mcgr/ml (Sanofi Pasteur MSD)",Wilrijk - Belgium,2016-12,2014-07-10,2017-03-28,INTERVENTIONAL,PHASE1,Novosanis NV,INDUSTRY,hepatitis
NCT02950077,Unknown,COMPLETED,2017-04-14,Autoimmune Hepatitis,mindfulness based stress reduction,New Haven - United States,2018-04-14,2016-10-31,2020-07-02,INTERVENTIONAL,NA,Yale University,OTHER,hepatitis
NCT04437277,DeViCHO,COMPLETED,2019-11-22,Hepatitis C,"Hepatitis C, serology",Marseille - France,2021-11-30,2020-06-18,2022-01-11,INTERVENTIONAL,NA,"Hospital St. Joseph, Marseille, France",OTHER,hepatitis
NCT00230477,Unknown,COMPLETED,2003-04,Hepatitis B,"Hepsera, Hepsera and lamivudine",Seattle - United States,Unknown Date,2005-09-30,2007-11-15,INTERVENTIONAL,PHASE4,University of Washington,OTHER,hepatitis
NCT00127777,Unknown,UNKNOWN,2002-07,"Hepatitis C, Chronic",Amantadine sulphate (in addition to standard treatment),No locations listed,Unknown Date,2005-08-08,2005-08-25,INTERVENTIONAL,PHASE4,"University Hospital, Saarland",OTHER,hepatitis
NCT03654677,Unknown,COMPLETED,2017-09-19,Hepatitis A Vaccine,"inactivated hepatitis A vaccine, Havrix Inj","Seoul - Korea, Republic of, Incheon - Korea, Republic of, Uijeongbu - Korea, Republic of, Bucheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bucheon - Korea, Republic of, Ilsan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2018-10-12,2018-08-31,2020-03-23,INTERVENTIONAL,PHASE3,"Boryung Pharmaceutical Co., Ltd",INDUSTRY,hepatitis
NCT02652377,Unknown,COMPLETED,2016-01-10,Hepatitis C,"EDP-494, Placebo",Auckland - New Zealand,2016-12-27,2016-01-11,2017-01-23,INTERVENTIONAL,PHASE1,"Enanta Pharmaceuticals, Inc",INDUSTRY,hepatitis
NCT00394277,Unknown,COMPLETED,2007-02,"Hepatitis C, Chronic","peginterferon alfa-2a, Ribavirin, peginterferon alfa-2a, Ribavirin","Birmingham - United States, Huntsville - United States, Anchorage - United States, Phoenix - United States, Fresno - United States, La Jolla - United States, Lancaster - United States, Los Angeles - United States, Los Angeles - United States, Sacramento - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Luis Obispo - United States, San Marcos - United States, Ventura - United States, Aurora - United States, Englewood - United States, Washington - United States, Washington - United States, Jacksonville - United States, Jacksonville - United States, Miami - United States, North Miami Beach - United States, Sarasota - United States, Atlanta - United States, Austell - United States, Marietta - United States, Honolulu - United States, Chicago - United States, Chicago - United States, Winfield - United States, Indianapolis - United States, Des Moines - United States, Iowa City - United States, Iowa City - United States, Louisville - United States, Baton Rouge - United States, New Orleans - United States, Boston - United States, Worcester - United States, Detroit - United States, Ypsilanti - United States, Plymouth - United States, Kansas City - United States, St Louis - United States, St Louis - United States, Lebanon - United States, Egg Harbour Township - United States, Vineland - United States, Bronx - United States, Manhasset - United States, New York - United States, New York - United States, Rochester - United States, Williamsville - United States, Yonkers - United States, Asheville - United States, Chapel Hill - United States, Fayetteville - United States, Cincinnati - United States, Cleveland - United States, Cleveland - United States, Tulsa - United States, Medford - United States, Lancaster - United States, Philadelphia - United States, Philadelphia - United States, Pittsburgh - United States, Cranston - United States, Providence - United States, Columbia - United States, Germantown - United States, West Nashville - United States, Dallas - United States, Dallas - United States, Dallas - United States, Fort Sam Houston - United States, Houston - United States, Salt Lake City - United States, Annandale - United States, Charlottesville - United States, Chesapeake - United States, Fairfax - United States, Richmond - United States, Seattle - United States, Tacoma - United States, Vancouver - United States, Casper - United States, Cheyenne - United States, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Caixa - Brazil, Campinas - Brazil, Juiz de Fora - Brazil, Porto Alegre - Brazil, Porto Alegre - Brazil, Salvador - Brazil, Sao Jose Do Rio Preto - Brazil, Sao Paulo - Brazil, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Halifax - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Kolding - Denmark, Odense - Denmark, Clermont-ferrand - France, Clichy - France, Lille - France, Lyon - France, Rouen - France, Strasbourg - France, Berlin - Germany, Bonn - Germany, Düsseldorf - Germany, Frankfurt Am Main - Germany, Freiburg - Germany, Giessen - Germany, Hamburg - Germany, Hannover - Germany, Heidelberg - Germany, Kiel - Germany, Köln - Germany, Tübingen - Germany, Bekescsaba - Hungary, Budapest - Hungary, Budapest - Hungary, Debrecen - Hungary, Gyor - Hungary, Gyula - Hungary, Pecs - Hungary, Szombathely - Hungary, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Bydgoszcz - Poland, Chorzow - Poland, Kielce - Poland, Lodz - Poland, Warszawa - Poland, Wroclaw - Poland, Ponce - Puerto Rico, San Juan - Puerto Rico, Santurce - Puerto Rico, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Cluj-napoca - Romania, Constanta - Romania, Iasi - Romania, Timisoara - Romania, Jaloslave - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Samara - Russian Federation, Smolensk - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Stockholm - Sweden, Uppsala - Sweden, London - United Kingdom, London - United Kingdom, London - United Kingdom, Newcastle Upon Tyne - United Kingdom, Plymouth - United Kingdom, Southampton - United Kingdom",2009-04,2006-10-31,2010-08-03,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01951677,Unknown,COMPLETED,2013-07,Exposure to Hepatitis B Virus,"HBsAg, PreS HBsAg, Advax-1(TM), Advax-2(TM), Advax-3(TM), Alum",Adelaide - Australia,2017-10,2013-09-27,2019-05-07,INTERVENTIONAL,PHASE1,Vaxine Pty Ltd,INDUSTRY,hepatitis
NCT00782353,Unknown,COMPLETED,2008-10,Chronic Hepatitis C,"ANA598 200 mg bid or placebo, ANA598 400 mg bid or placebo, ANA598 800 mg bid or placebo","St. Louis - United States, New York - United States, San Antonio - United States, Santurce - Puerto Rico",2009-03,2008-10-31,2012-11-14,INTERVENTIONAL,PHASE1,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT03979053,Unknown,COMPLETED,2019-06-26,Autoimmune Hepatitis,Multiparametric MRI Scan,London - United Kingdom,2019-10-31,2019-06-07,2020-01-14,OBSERVATIONAL,Not Available,Perspectum,INDUSTRY,hepatitis
NCT02591277,Unknown,COMPLETED,2015-11-30,Hepatitis C,Harvoni,"Ageo-shi - Japan, Akita-shi - Japan, Amagasaki-shi - Japan, Aomori-shi - Japan, Arao-shi - Japan, Asahi-shi - Japan, Asahikawa-shi - Japan, Asakura-shi - Japan, Bunkyo-ku - Japan, Chiba-shi - Japan, Chichibu-shi - Japan, Chuo-shi - Japan, Fujioka-shi - Japan, Fukui-shi - Japan, Fukuoka-shi - Japan, Gifu-shi - Japan, Hakodate-shi - Japan, Hamamatsu-shi - Japan, Handa-shi - Japan, Hashima-shi - Japan, Hatsukaichi-shi - Japan, Higashiibaraki-gun - Japan, Hirosaki-shi - Japan, Hiroshima-shi - Japan, Hitachi-shi - Japan, Hukui-shi - Japan, Ichikawa-shi - Japan, Iizuka-shi - Japan, Ikeda-shi - Japan, Inashiki-gun - Japan, Inzai-shi - Japan, Iruma-gun - Japan, Ise-shi - Japan, Iwaki-shi - Japan, Izumo-shi - Japan, Izunokuni-shi - Japan, Kagoshima-shi - Japan, Kamogawa-shi - Japan, Kanazawa-shi - Japan, Karatsu-shi - Japan, Kashihara-shi - Japan, Kashiwa-shi - Japan, Kasukabe-shi - Japan, Kawagoe-shi - Japan, Kawaguchi-shi - Japan, Kawasaki-shi - Japan, Kirishima-shi - Japan, Kitakyushu-shi - Japan, Kitamoto-shi - Japan, Kobe-shi - Japan, Kodaira-shi - Japan, Kofu-shi - Japan, Komae-shi - Japan, Komaki-shi - Japan, Koriyama-shi - Japan, Koshigaya-shi - Japan, Koto-ku - Japan, Kuga-gun - Japan, Kuki-shi - Japan, Kumamoto-shi - Japan, Kurashiki-shi - Japan, Kure-shi - Japan, Kurume-shi - Japan, Kyoto-shi - Japan, Maebashi-shi - Japan, Matsumoto-shi - Japan, Matsuyama-shi - Japan, Minato-ku - Japan, Miyazaki-shi - Japan, Moriguchi-shi - Japan, Morioka-shi - Japan, Nagakute-shi - Japan, Nagasaki-shi - Japan, Nagoya-shi - Japan, Nakagami-gun - Japan, Nerima-ku - Japan, Niigata-shi - Japan, Nishinomiya-shi - Japan, Noshiro-shi - Japan, Obihiro-shi - Japan, Ogi-shi - Japan, Oita-shi - Japan, Okayama-shi - Japan, Omihachiman-shi - Japan, Osaka-shi - Japan, Osakasayama-shi - Japan, Ota-ku - Japan, Otsu-shi - Japan, Oume-shi - Japan, Saga-shi - Japan, Saitama-shi - Japan, Sakai-shi - Japan, Sano-shi - Japan, Sapporo-shi - Japan, Sasebo-Shi - Japan, Sendai-shi - Japan, Shimonoseki-shi - Japan, Shimotsuga-gun - Japan, Shimotsuke-shi - Japan, Shinagawa-ku - Japan, Shinjuku-ku - Japan, Shirakawa-shi - Japan, Shizuoka-shi - Japan, Shunan-shi - Japan, Sumida-ku - Japan, Tagawa-shi - Japan, Takamatsu-shi - Japan, Takasaki-shi - Japan, Toda-shi - Japan, Tokorozawa-shi - Japan, Tokushima-shi - Japan, Tonami-shi - Japan, Toyama-shi - Japan, Toyoake-shi - Japan, Ureshino-shi - Japan, Utsunomiya-shi - Japan, Wakayama-shi - Japan, Yachiyo-shi - Japan, Yamagata-shi - Japan, Yanagawa-shi - Japan, Yatsushiro-shi - Japan, Yokkaichi-shi - Japan, Yokohama-shi - Japan, Yonago-shi - Japan, Yoshida-gun - Japan",2017-11-01,2015-10-29,2019-02-06,OBSERVATIONAL,Not Available,Gilead Sciences,INDUSTRY,hepatitis
NCT01126853,Unknown,WITHDRAWN,2010-04,Hepatitis B,Twinrix,Toronto - Canada,2011-06,2010-05-20,2020-06-01,INTERVENTIONAL,PHASE4,"Mount Sinai Hospital, Canada",OTHER,hepatitis
NCT00023153,Unknown,COMPLETED,2001-08,"HIV Infections, Chronic Hepatitis B",Adefovir Dipivoxil,Bethesda - United States,Unknown Date,2001-08-27,2008-03-04,INTERVENTIONAL,PHASE3,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT05467553,Unknown,NOT_YET_RECRUITING,2023-02-24,Hepatitis D,"Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide","Taipei - Taiwan, Taipei - Taiwan",2025-02-28,2022-07-20,2022-12-29,INTERVENTIONAL,PHASE2,National Taiwan University Hospital,OTHER,hepatitis
NCT02219477,TURQUOISE-CPB,COMPLETED,2014-11-24,"Chronic Hepatitis C, Decompensated Cirrhosis, Hepatitis C Virus","ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin",No locations listed,2016-06-13,2014-08-19,2017-07-11,INTERVENTIONAL,PHASE3,AbbVie,INDUSTRY,hepatitis
NCT02101177,eNTC,WITHDRAWN,2014-04,Chronic Hepatitis C,No interventions listed,"Cairo - Egypt, Cairo - Egypt",2015-06,2014-04-02,2014-07-23,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT00841477,Unknown,COMPLETED,2004-01,"Hepatitis B Infection, Hepatitis C Infection, HIV Infection","hepatitis B vaccine 3 dose schedule (0,1,2 month), HBV Vaccination Self-Efficacy Intervention",Houston - United States,2007-06,2009-02-11,2017-01-11,INTERVENTIONAL,PHASE3,National Institute on Drug Abuse (NIDA),NIH,hepatitis
NCT02482077,Unknown,COMPLETED,2015-01,Chronic Hepatitis C Infection,"SOF+RBV, SOF+DCV, LDV/SOF","Beijing - China, Hong Kong - China",2017-12-31,2015-06-25,2018-03-19,INTERVENTIONAL,PHASE4,Humanity and Health Research Centre,OTHER,hepatitis
NCT00880477,Unknown,COMPLETED,2001-01,Hepatitis B,"DTPa-HBV-IPV/Hib vaccine, DTPa-IPV/Hib vaccine, EngerixTM-B",No locations listed,2002-11,2009-04-13,2016-09-07,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT04518553,Unknown,UNKNOWN,2021-03-23,Chronic Hepatitis b,"active comarator using antiviral drug of nucleoside analogues, HA+purification",No locations listed,2023-09-01,2020-08-19,2021-03-17,INTERVENTIONAL,NA,Shanghai Pudong Hospital,OTHER,hepatitis
NCT00219453,Unknown,COMPLETED,2004-10,"Virus Diseases, Hepatitis B",Jet Injector with Protector Cap (HSI-500),No locations listed,Unknown Date,2005-09-22,2007-04-19,INTERVENTIONAL,PHASE1,PATH,OTHER,hepatitis
NCT06131177,Unknown,NOT_YET_RECRUITING,2025-01-01,Alcoholic Hepatitis,Nutritional supplement,No locations listed,2025-12-31,2023-11-14,2024-05-29,INTERVENTIONAL,NA,"Western University, Canada",OTHER,hepatitis
NCT03410953,Unknown,COMPLETED,2018-04-13,"Hepatitis B, Hepatitis, Hepatitis, Viral, Human, Hepatitis B Immunization","Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).","Majadahonda - Spain, León - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Palencia - Spain, Salamanca - Spain, Valladolid - Spain, Zamora - Spain",2019-10-31,2018-01-25,2021-07-08,INTERVENTIONAL,PHASE4,Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León,OTHER,hepatitis
NCT01684787,CONTRA,COMPLETED,2006-09,Chronic Hepatitis C,"Peginterferon alfa-2a + ribavirin in normal ALT, Peginterferon alfa-2a + ribavirin in elevated ALT","Vitoria - Spain, Hospitalet - Spain, Hospitalet - Spain, Mataró - Spain, Terrassa - Spain, San Sebastián - Spain, Vigo - Spain, Baracaldo - Spain, Barcelona - Spain, Barcelona - Spain, Barcelona - Spain, Huesca - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Madrid - Spain, Tarragona - Spain, Zaragoza - Spain",2011-05,2012-09-13,2012-09-13,INTERVENTIONAL,PHASE4,Miguel Santin,OTHER,hepatitis
NCT06457477,Unknown,RECRUITING,2024-06-15,Chronic Hepatitis B,"Sintilimab, NAs, Peg-IFNα-2b",Beijing - China,2025-12-15,2024-06-13,2024-06-20,INTERVENTIONAL,NA,Beijing 302 Hospital,OTHER,hepatitis
NCT06381453,BELief,RECRUITING,2024-12-11,Autoimmune Hepatitis,Belimumab Auto-Injector [Benlysta],Toronto - Canada,2028-04-30,2024-04-24,2025-02-14,INTERVENTIONAL,PHASE2,"University Health Network, Toronto",OTHER,hepatitis
NCT03293953,FULLFIBRO01,UNKNOWN,2017-05-01,Liver Fibrosis,No interventions listed,Genova - Italy,2018-11-01,2017-09-26,2017-09-26,OBSERVATIONAL,Not Available,Ente Ospedaliero Ospedali Galliera,OTHER,hepatitis
NCT03434353,Unknown,TERMINATED,2018-02-28,Chronic Hepatitis B,"Inarigivir Soproxil, TAF","Hong Kong - Hong Kong, Hong Kong - Hong Kong, Hong Kong - Hong Kong, Ansan - Korea, Republic of, Daegu - Korea, Republic of, Daegu - Korea, Republic of, Ilsan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of",2020-01-20,2018-02-15,2022-04-04,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00561353,Unknown,COMPLETED,2008-01,"Hepatitis C, Chronic","TMC435, Placebo, Peginterferon (PegIFNα-2a), Ribavirin","Brugge - Belgium, Brussels - Belgium, Bruxelles - Belgium, Edegem - Belgium, Gent - Belgium, Clichy - France, Lyon - France, Marseille - France, Paris Cedex 10 - France, Paris - France, Pessac - France, Vandoeuvre Les Nancy - France, Berlin - Germany, Düsseldorf - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Kiel - Germany, Munchen - Germany, Amsterdam Zuidoost - Netherlands, Bialystok - Poland, Kielce - Poland, Lodz - Poland, Warszawa - Poland, London - United Kingdom, Plymouth - United Kingdom",2008-12,2007-11-20,2014-05-20,INTERVENTIONAL,PHASE2,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT02901951,Unknown,COMPLETED,2016-10-11,Hepatitis B Vaccine,Engerix-B,"Ghent - Belgium, Wilrijk - Belgium, Québec City - Canada, Sherbrooke - Canada",2017-05-01,2016-09-15,2020-01-02,INTERVENTIONAL,PHASE4,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00051077,Unknown,WITHDRAWN,Unknown Date,"HIV Infections, Hepatitis B, Hepatitis C","Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin, Liver Biopsy",No locations listed,Unknown Date,2003-01-06,2021-11-01,INTERVENTIONAL,PHASE2,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT00724451,Unknown,COMPLETED,2008-07,"Hepatitis C, Hepatitis C, Chronic","Peginterferon alfa-2b, Ribavirin, Peginterferon alfa-2a",No locations listed,2011-10,2008-07-29,2015-09-25,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00255177,Unknown,COMPLETED,2005-11,Hepatitis C Virus Infection,"VGX-410 (Mifepristone), Placebo","Farmington - United States, Orlando - United States, Saint Louis - United States, Philadelphia - United States",2007-09,2005-11-17,2009-11-03,INTERVENTIONAL,PHASE2,"VGX Pharmaceuticals, LLC",INDUSTRY,hepatitis
NCT02138253,POLT-HCV-SVR,COMPLETED,2014-05,"Liver Fibrosis, Hepatic Fibrosis, Liver Cirrhosis, Hepatic Cirrhosis","IDN-6556, Placebo","Coronado - United States, La Jolla - United States, Loma Linda - United States, Los Angeles - United States, Washington - United States, Washington - United States, Gainesville - United States, Miami - United States, Atlanta - United States, Chicago - United States, Chicago - United States, Indianapolis - United States, Kansas City - United States, Louisville - United States, New Orleans - United States, New Orleans - United States, Baltimore - United States, Boston - United States, Detroit - United States, Saint Louis - United States, Newark - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Philadelphia - United States, Philadelphia - United States, Fort Worth - United States, Houston - United States, Houston - United States, Houston - United States, Salt Lake City - United States, Newport News - United States, Richmond - United States, Richmond - United States, Seattle - United States",2018-02-15,2014-05-14,2019-12-11,INTERVENTIONAL,PHASE2,Conatus Pharmaceuticals Inc.,INDUSTRY,hepatitis
NCT00665353,Unknown,COMPLETED,2009-03,HIV-1 and Hepatitis C Co-Infection,"pioglitazone, peginterferon, ribavirin","San Francisco - United States, Chicago - United States, Newark - United States, New York - United States, New York - United States, Rochester - United States, Cleveland - United States, Richmond - United States",2011-05,2008-04-23,2018-10-12,INTERVENTIONAL,PHASE2,Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections,NETWORK,hepatitis
NCT03123653,Unknown,UNKNOWN,2017-03-17,Hepatitis B,Peg IFN 2b,New Delhi - India,2019-09-17,2017-04-21,2020-02-05,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT04540653,Unknown,UNKNOWN,2017-07-29,"Vaccine Response Impaired, Hepatitis B, Aging","Standard vaccination schedule, Reinforced vaccination schedule",Goiânia - Brazil,2020-07-03,2020-09-07,2020-09-09,INTERVENTIONAL,PHASE4,Universidade Federal de Goias,OTHER,hepatitis
NCT04071353,Unknown,UNKNOWN,2019-08-01,Chronic Hepatitis C,"Interferon, ribavirin, DAAs",Beijing - China,2020-08-01,2019-08-28,2019-08-28,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT05951751,TRI-MOM,RECRUITING,2024-03-18,"Hiv, Syphilis, HBV",TRI-MOM intervention,"Bobo-Dioulasso - Burkina Faso, Fajara - Gambia",2025-05,2023-07-19,2024-06-20,INTERVENTIONAL,NA,Institut de Recherche pour le Developpement,OTHER_GOV,hepatitis
NCT01405677,Unknown,COMPLETED,2004-06,Hepatitis A,"Epaxal 0.25 mL, Epaxal 0.5 mL, Havrix Junior 0.5 mL","Antwerp - Belgium, Antwerp - Belgium",2012-04,2011-07-29,2014-07-29,INTERVENTIONAL,PHASE2,Crucell Holland BV,INDUSTRY,hepatitis
NCT00727077,Unknown,TERMINATED,2006-06,"Hepatitis C, Chronic, Hepatitis C","IntronA (interferon alfa-2b; SCH 30500), Rebetol (ribavirin; SCH 18908)",No locations listed,2007-06,2008-08-01,2015-04-08,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00593151,PLUS,COMPLETED,2008-01,Hepatitis C,"Locteron (controlled-release interferon alpha 2b), pegylated IFNa2b","Detroit - United States, Dallas - United States, San Antonio - United States, Annandale - United States, Richmond - United States",2008-12,2008-01-14,2012-02-03,INTERVENTIONAL,PHASE2,"Biolex Therapeutics, Inc.",INDUSTRY,hepatitis
NCT06564051,Unknown,ENROLLING_BY_INVITATION,2017-11-14,"Chronic Viral Hepatitis C, Monoclonal B-Cell Lymphocytosis",Non-Interventional Study,Rochester - United States,2027-11-30,2024-08-21,2025-02-18,OBSERVATIONAL,Not Available,Mayo Clinic,OTHER,hepatitis
NCT06544551,Unknown,COMPLETED,2021-12-28,Chronic Hepatitis B Virus Infection,"Peginterferon Alfacon-2, Peginterferon Alfacon-2 placebo","Beijing - China, Beijing - China, Beijing - China, Changchun - China, Changsha - China, Changsha - China, Chengdu - China, Chizhou - China, Chongqing - China, Chongqing - China, Fuzhou - China, Fuzhou - China, Guangzhou - China, Harbin - China, Heze - China, Jinan - China, Langfang - China, Nanchang - China, Nanjing - China, Pingxiang - China, Qingdao - China, Qingyuan - China, Shenyang - China, Shijiazhuang - China, Shijiazhuang - China, Tianjin - China, Tianjin - China, Wuhan - China, Wuhan - China, Xi'an - China, Xingxiang - China, Yanbian - China, Zhengzhou - China, Zhengzhou - China",2023-11-30,2024-08-09,2024-08-09,INTERVENTIONAL,PHASE3,"Beijing Kawin Technology Share-Holding Co., Ltd.",INDUSTRY,hepatitis
NCT01296451,Unknown,COMPLETED,2010-12,Hepatitis C Infection,"MVA-NSmut, AdCh3NSmut, AdCh3NSmut1","Oxford - United Kingdom, Headington, Oxford - United Kingdom, High Wycombe - United Kingdom",2016-01,2011-02-15,2016-04-26,INTERVENTIONAL,PHASE1,ReiThera Srl,INDUSTRY,hepatitis
NCT01159951,Unknown,COMPLETED,2009-01,Hepatitis,Epidemiologic Surveillance System of the Ministry of Health of Panama,Clayton - Panama,2011-08,2010-07-12,2017-06-07,OBSERVATIONAL,Not Available,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02102451,CEASE,UNKNOWN,2014-07,"Hepatitis C, HIV, HIV-HCV Coinfection",No interventions listed,"Burwood - Australia, Katoomba - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Sydney - Australia, Brisbane - Australia, Adelaide - Australia, Carlton - Australia, Melbourne - Australia, North Fitzroy - Australia, Prahran - Australia, St Kilda - Australia",2022-12,2014-04-03,2021-09-08,OBSERVATIONAL,Not Available,Kirby Institute,OTHER_GOV,hepatitis
NCT05382351,Unknown,UNKNOWN,2022-05-10,Chronic Hepatitis B Virus Infection,"Entecavir, Entecavir combined with Tenofovir Amibufenamide",Guangzhou - China,2024-04-30,2022-05-19,2022-05-19,INTERVENTIONAL,PHASE2,Sun Yat-sen University,OTHER,hepatitis
NCT01470651,Unknown,TERMINATED,2011-10,Hepatitis C,"Armodafinil, Sugar Pill","New York City - United States, New York City - United States",2014-06,2011-11-11,2017-02-10,INTERVENTIONAL,PHASE4,"Research Foundation for Mental Hygiene, Inc.",OTHER,hepatitis
NCT01468051,Unknown,COMPLETED,2008-10,Renal Failure,"four doses of Euvax B vaccine, 20 μg (1 ml) three doses of Euvax B vaccine",No locations listed,2008-10,2011-11-09,2011-11-09,INTERVENTIONAL,NA,Tehran University of Medical Sciences,OTHER,hepatitis
NCT00304551,Unknown,COMPLETED,2006-06,"Liver Cirrhosis, Chronic Hepatitis C","peginterferon alfa-2a 180μg, peginterferon alfa-2a 90μg, ribavirin","Chugoku - Japan, Hokkaido - Japan, Kanto - Japan, Kinki - Japan, Kyusyu - Japan, Shikoku - Japan, Tohoku - Japan, Tokai - Japan",2009-12,2006-03-20,2010-06-03,INTERVENTIONAL,PHASE3,Chugai Pharmaceutical,INDUSTRY,hepatitis
NCT01380951,Unknown,UNKNOWN,2011-05,"Liver Cirrhosis, Chronic Hepatitis B",telbivudine,Suzhou - China,2012-12,2011-06-27,2011-06-27,INTERVENTIONAL,PHASE4,The Fifth People's Hospital of Suzhou,OTHER,hepatitis
NCT01170351,Unknown,COMPLETED,2005-12,Autoimmune Hepatitis,Cyclosporine-A,"Tehran - Iran, Islamic Republic of",2013-12,2010-07-27,2019-07-19,INTERVENTIONAL,PHASE3,Tehran University of Medical Sciences,OTHER,hepatitis
NCT00313287,Unknown,TERMINATED,2003-06,Hepatitis B,clevudine,"Bupyoung-dong - Korea, Republic of, Pyoung-dong - Korea, Republic of, Jung-gu - Korea, Republic of, Jung-gu - Korea, Republic of, Hak-1-dong - Korea, Republic of, Seoul - Korea, Republic of, Iksan-City - Korea, Republic of, Jeonju-city - Korea, Republic of, Daesa-dong - Korea, Republic of, Sinhung-dong - Korea, Republic of, Dogok-dong - Korea, Republic of, Pungnap-dong - Korea, Republic of, Ilsan-gu, - Korea, Republic of, Pucheon - Korea, Republic of, Seongnam-gu - Korea, Republic of, Dae myoung-dong - Korea, Republic of, Gongneung-dong - Korea, Republic of, Hagye 1-dong - Korea, Republic of, Ji-dong, - Korea, Republic of, Gaegeum-dong - Korea, Republic of, Ami-dong - Korea, Republic of, Amnam-dong - Korea, Republic of, Banpo-dong - Korea, Republic of, Shinchon- dong - Korea, Republic of, Jeo-dong - Korea, Republic of, Ilwon-dong - Korea, Republic of, Anam-dong - Korea, Republic of, Mok-dong - Korea, Republic of, Daelim-dong - Korea, Republic of, Hannam-dong - Korea, Republic of, Seoul - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of",Unknown Date,2006-04-12,2017-02-01,INTERVENTIONAL,PHASE3,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT03712553,Unknown,COMPLETED,2019-03-15,Hepatitis C,"Opt-Out, Letter, Behavioral Economic Messaging, Usual Care Messaging",Philadelphia - United States,2020-10-15,2018-10-19,2020-12-01,INTERVENTIONAL,NA,University of Pennsylvania,OTHER,hepatitis
NCT04202653,Neptune,UNKNOWN,2020-01-01,Chronic Hepatitis b,"ETV, TQ-A3334, TQ-B2450",No locations listed,2020-12-31,2019-12-17,2019-12-19,INTERVENTIONAL,PHASE2,Tongji Hospital,OTHER,hepatitis
NCT01341951,G-CSF,UNKNOWN,2010-06,"Liver Failure, Acute",Granulocyte colony stimulating factor,Chandigarh - India,2011-06,2011-04-26,2011-04-26,INTERVENTIONAL,NA,"Post Graduate Institute of Medical Education and Research, Chandigarh",OTHER,hepatitis
NCT04538651,Unknown,UNKNOWN,2020-08-31,"Hepatitis B, Chronic",No interventions listed,Guangzhou - China,2021-08-31,2020-09-04,2020-09-04,OBSERVATIONAL,Not Available,Sun Yat-sen University,OTHER,hepatitis
NCT00697853,Unknown,COMPLETED,1998-11,Hepatitis B,"Engerix™-B, HBV-MPL vaccine 208129",Brussels - Belgium,1999-07,2008-06-16,2008-06-16,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02161653,Unknown,COMPLETED,2010-04,Severe Alcoholic Hepatitis,"Prednisone plus Metadoxine, Pentoxifylline plus Metadoxine",Mexico City - Mexico,2014-09,2014-06-12,2014-11-11,INTERVENTIONAL,PHASE4,Hospital General de Mexico,OTHER_GOV,hepatitis
NCT02355951,Unknown,COMPLETED,2014-12,Chronic Hepatitis B,blood draw,"Montréal - Canada, Grenoble - France, Lyon - France, Nancy - France, Paris - France, Strasbourg - France, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Mainz - Germany, München - Germany",2016-02,2015-02-04,2016-02-02,INTERVENTIONAL,NA,Transgene,INDUSTRY,hepatitis
NCT00469651,MSP3TN,UNKNOWN,2007-10,Malaria,"MSP 3 Long Synthetic Peptide, MSP3 vaccine, Hepatitis B vaccine, MSP3 candidate vaccine, Hepatitis B control vaccine",Korogwe - Tanzania,Unknown Date,2007-05-04,2007-12-14,INTERVENTIONAL,PHASE1,African Malaria Network Trust,NETWORK,hepatitis
NCT01771653,Unknown,COMPLETED,2011-09,Hepatitis C Infection,No interventions listed,Springfield - United States,2015-07,2013-01-18,2016-01-18,OBSERVATIONAL,Not Available,Southern Illinois University,OTHER,hepatitis
NCT01633554,Unknown,UNKNOWN,2011-01,Sequela of Chronic Liver Disease,No interventions listed,Altındağ - Turkey,2012-07,2012-07-04,2012-07-04,OBSERVATIONAL,Not Available,Turkiye Yuksek Ihtisas Education and Research Hospital,OTHER_GOV,hepatitis
NCT01573351,Hallmark QUAD,COMPLETED,2012-05,Hepatitis C Virus,"Asunaprevir, Daclatasvir, Peg-interferon Alfa-2a, Ribavirin","Montgomery - United States, La Jolla - United States, Los Angeles - United States, Aurora - United States, Englewood - United States, Jacksonville - United States, Miami - United States, Chicago - United States, Manhasset - United States, Chapel Hill - United States, Cincinnati - United States, Tulsa - United States, Portland - United States, Philadelphia - United States, Philadelphia - United States, Germantown - United States, Houston - United States, San Antonio - United States, Richmond - United States, Madison - United States, Ciudad De Buenos Aires - Argentina, Mar Del Plata - Argentina, Prov. Buenos Aires - Argentina, Edmonton - Canada, Vancouver - Canada, Victoria - Canada, Toronto - Canada, Montreal - Canada, Aalborg - Denmark, Hvidovre - Denmark, Odense - Denmark, Creteil - France, Montpellier Cedex 5 - France, Nice Cedex 03 - France, Paris Cedex 12 - France, Paris Cedex 14 - France, Pessac - France, Berlin - Germany, Duesseldorf - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Heidelberg - Germany, Tuebingen - Germany, Brescia - Italy, Cisanello (pisa) - Italy, Milano - Italy, Palermo - Italy, Bucheon-si - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Busan - Korea, Republic of, Daegu - Korea, Republic of, Gyeongsangnam-do - Korea, Republic of, Incheon - Korea, Republic of, Incheon - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Mexico - Mexico, Mexico City - Mexico, Amsterdam - Netherlands, Rotterdam - Netherlands, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Stavropol - Russian Federation, Tyumen - Russian Federation, Alcorcon - Spain, Barcelona - Spain, Madrid - Spain, Sevilla - Spain, Gvteborg - Sweden, Stockholm - Sweden, Bern - Switzerland, Lausanne - Switzerland, Chia-Yi - Taiwan, Kaohsiung - Taiwan, Taichung - Taiwan, Taipei - Taiwan",2013-09,2012-04-09,2015-10-09,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT05791851,HBR2,COMPLETED,2019-10-23,"HIV Infections, Hepatitis B, Vaccine Response Impaired",No interventions listed,"Baltimore - United States, Baltimore - United States",2022-06-14,2023-03-30,2023-03-30,OBSERVATIONAL,Not Available,"University of Maryland, Baltimore",OTHER,hepatitis
NCT04220151,Unknown,UNKNOWN,2020-03-01,Hepatocellular Carcinoma,DNA methylation,No locations listed,2020-12-01,2020-01-07,2020-01-14,OBSERVATIONAL,Not Available,Assiut University,OTHER,hepatitis
NCT00725751,Unknown,COMPLETED,2007-09,"Hepatitis C, Chronic","Pegylated interferon alfa-2b (PegIFN-2b), Ribavirin",No locations listed,2011-03,2008-07-30,2015-10-02,OBSERVATIONAL,Not Available,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01891851,Unknown,COMPLETED,2007-10,Healthy,"TMC435350 200 mg, Ritonavir 100 mg",Aalst - Belgium,2008-01,2013-07-03,2013-10-14,INTERVENTIONAL,PHASE1,"Tibotec Pharmaceuticals, Ireland",INDUSTRY,hepatitis
NCT06114251,Unknown,COMPLETED,2015-01-01,Liver Transplant; Complications,Diagnosis of postoperative recurrence of liver cancer,No locations listed,2020-12-31,2023-11-02,2023-11-02,OBSERVATIONAL,Not Available,Zhejiang University,OTHER,hepatitis
NCT01259453,HVS,COMPLETED,2003-05,Hepatitis B,Vaccination to prevent hepatitis B virus infection,"Hartford - United States, Chicago - United States, Cleveland - United States",2006-08,2010-12-14,2010-12-14,INTERVENTIONAL,PHASE4,Yale University,OTHER,hepatitis
NCT00834353,Unknown,COMPLETED,2005-09,Pulmonary Tuberculosis,ATT,New Delhi - India,2008-03,2009-02-03,2009-02-03,OBSERVATIONAL,Not Available,Maulana Azad Medical College,OTHER,hepatitis
NCT01083251,Unknown,UNKNOWN,2010-03,Hepatitis B Virus,"Peginterferon + Vitamin D, Peginterferon, Sebivo, entecavir+ vitamin d","Safed, Israel - Israel, Safed - Israel",2012-02,2010-03-09,2011-01-19,INTERVENTIONAL,NA,Ziv Hospital,OTHER_GOV,hepatitis
NCT03478254,AVADI-1,COMPLETED,2017-12-01,Type 1 Diabetes Mellitus,"Influenza vaccination, Pneumococcal vaccination, Hepatitis B Virus (HBV) vaccination",Ciudad Real - Spain,2018-12-01,2018-03-27,2021-01-11,OBSERVATIONAL,Not Available,Jesús Moreno Fernández,OTHER,hepatitis
NCT00821587,Unknown,COMPLETED,2004-06,Hepatitis C,"Cyclosporine, Tacrolimus",No locations listed,2008-05,2009-01-13,2023-06-01,INTERVENTIONAL,PHASE4,University of Florida,OTHER,hepatitis
NCT00291954,Unknown,COMPLETED,2006-03,Hepatitis B,"HB-AS02V, HBVAXPRO vaccine","Aalst - Belgium, ATH - Belgium, Baudour - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Bruxelles - Belgium, Charleroi - Belgium, Edegem - Belgium, Gent - Belgium, La Louvière - Belgium, Leuven - Belgium, Montigny le tilleul - Belgium, Tournai - Belgium, Hradec Kralove - Czech Republic, Jihlava - Czech Republic, Olomouc - Czech Republic, Ostrava - Poruba - Czech Republic, Pardubice - Czech Republic, Sokolov - Czech Republic, Debrecen - Hungary, Eger - Hungary, Esztergom - Hungary, Győr - Hungary, Hatvan - Hungary, Zalaegerszeg - Hungary",2007-10,2006-02-15,2008-08-28,INTERVENTIONAL,PHASE3,Henogen,INDUSTRY,hepatitis
NCT06483451,Unknown,NOT_YET_RECRUITING,2025-01,HCV,No interventions listed,No locations listed,2025-12,2024-07-03,2024-11-29,OBSERVATIONAL,Not Available,State University of New York at Buffalo,OTHER,hepatitis
NCT04499651,LINKHCV,TERMINATED,2020-07-31,"HIV (Human Immunodeficiency Virus), Hepatitis C",Navigation,Los Angeles - United States,2021-02-22,2020-08-05,2021-02-26,INTERVENTIONAL,NA,"University of California, Los Angeles",OTHER,hepatitis
NCT00120354,Unknown,COMPLETED,2005-07-11,"Hepatitis B, Chronic","Blood Testing, Percutaneous Liver Biopsy, Lamivudine Therapy",Bethesda - United States,Unknown Date,2005-07-15,2017-07-02,INTERVENTIONAL,PHASE4,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT04029454,NEOVAC2BK,COMPLETED,2020-10-19,Hepatitis B,birth dose vaccination against hepatitis B strategy,"Bobo-Dioulasso - Burkina Faso, Bobo-Dioulasso - Burkina Faso",2023-08-31,2019-07-23,2023-12-19,INTERVENTIONAL,NA,Institut Pasteur,INDUSTRY,hepatitis
NCT01610115,Unknown,UNKNOWN,2012-01,"Hepatitis B, Pregnancy",No interventions listed,Taoyuan - Taiwan,2013-12,2012-06-01,2012-06-01,OBSERVATIONAL,Not Available,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT01884415,Unknown,COMPLETED,2012-09-07,"Hepatitis B, Cirrhosis, Awaiting Organ Transplant","HBV vaccine, HBV vaccine",Seville - Spain,2017-12,2013-06-24,2018-05-14,INTERVENTIONAL,PHASE3,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,OTHER,hepatitis
NCT03093415,Unknown,COMPLETED,2017-05-30,"Hepatitis C, Substance Use Disorders, Substance Abuse, Intravenous",elbasvir-grazoprevir (50 mg/100 mg),"Portland - United States, Portland - United States",2019-06-06,2017-03-28,2020-11-12,INTERVENTIONAL,PHASE4,Oregon Health and Science University,OTHER,hepatitis
NCT02798315,Unknown,COMPLETED,2016-05-25,Chronic Hepatitis C,No interventions listed,No locations listed,2017-06-12,2016-06-14,2018-12-31,OBSERVATIONAL,Not Available,AbbVie,INDUSTRY,hepatitis
NCT01448915,Unknown,COMPLETED,2021-03-31,"HIV Infection, Hepatitis C",No interventions listed,Baltimore - United States,2021-03-31,2011-10-07,2022-02-21,OBSERVATIONAL,Not Available,Johns Hopkins University,OTHER,hepatitis
NCT00551915,Unknown,COMPLETED,2001-05,Bacterial Infections; Virus Diseases,"AR51 (12, 10), PR51 (3, 10), PR51 (6, 10), PENTACEL™, RECOMBIVAX HB™",No locations listed,2003-01,2007-10-31,2015-10-30,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT00863785,HAA-NAC,COMPLETED,2004-04,Alcoholic Hepatitis,Corticoids plus N Acetyl Cysteine,"Abbeville - France, Beauvais - France, Besancon - France, Caen - France, Cambrai - France, Compiegne - France, Lens - France, Paris - France, Paris - France, Reims - France, Rouen - France, Saint-quentin - France, Valenciennes - France",2009-08,2009-03-18,2009-10-20,INTERVENTIONAL,PHASE3,"Centre Hospitalier Universitaire, Amiens",OTHER,hepatitis
NCT01231685,Unknown,COMPLETED,2011-12,"HIV, Hepatitis C, Liver Fibrosis","Raltegravir, Ritonavir-boosted protease inhibitor","Vancouver - Canada, Toronto - Canada, Montreal - Canada",2016-03,2010-11-01,2016-09-21,INTERVENTIONAL,PHASE2,McGill University Health Centre/Research Institute of the McGill University Health Centre,OTHER,hepatitis
NCT04493385,Unknown,UNKNOWN,2019-09-16,"Transplant; Failure, Heart, Hepatitis C",No interventions listed,Dallas - United States,2023-12,2020-07-30,2023-01-26,OBSERVATIONAL,Not Available,Baylor Research Institute,OTHER,hepatitis
NCT05686785,HEPSCAN,RECRUITING,2023-06-01,Chronic Viral Hepatitis,Transient elastography,Helsingborg - Sweden,2026-02-01,2023-01-17,2023-10-04,OBSERVATIONAL,Not Available,Lund University,OTHER,hepatitis
NCT01715415,Unknown,COMPLETED,2012-11,Chronic Hepatitis C Infection,"ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267, Placebo for ABT-333, Placebo for ribavirin",No locations listed,2013-11,2012-10-29,2021-08-02,INTERVENTIONAL,PHASE3,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT06789315,Unknown,NOT_YET_RECRUITING,2025-01-20,Alcoholic Hepatitis,"Mycophenolate Mofetil, Prednisone",New Delhi - India,2026-01-31,2025-01-23,2025-01-23,INTERVENTIONAL,NA,"Institute of Liver and Biliary Sciences, India",OTHER,hepatitis
NCT05671315,Unknown,RECRUITING,2019-07-03,"Chronic Hepatitis B, Intermediate to High Risk of HCC","Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide analogue","Chengdu - China, Hefei - China, Qingdao - China, Shanghai - China, Shanghai - China, Shanghai - China, Suzhou - China, Xiamen - China, Xinxiang - China",2023-08,2023-01-04,2023-05-25,INTERVENTIONAL,NA,Qing XIe,OTHER,hepatitis
NCT02617615,Unknown,UNKNOWN,2017-12-01,Chronic Hepatitis C,"MB-110, Placebo",Taipei - Taiwan,2018-06,2015-12-01,2017-04-05,INTERVENTIONAL,PHASE1,Microbio Co Ltd,INDUSTRY,hepatitis
NCT00873652,Unknown,COMPLETED,2009-02,Healthy,"Engerix B®, a recombinant hepatitis B vaccine",Oxford - United Kingdom,2011-01,2009-04-01,2017-12-08,OBSERVATIONAL,Not Available,University of Oxford,OTHER,hepatitis
NCT02161952,Unknown,COMPLETED,2005-05,"Fibrosis, Hepatitis C Chronic","Pirfenidone, Matched equivalent placebo",No locations listed,2006-08,2014-06-12,2014-07-09,INTERVENTIONAL,PHASE2,University of Guadalajara,OTHER,hepatitis
NCT02447705,Unknown,COMPLETED,2013-06,"Disorder Related to Transplantation, Virus Diseases, Injury Due to Exposure to External Cause",telbivudine,No locations listed,2016-12-31,2015-05-19,2017-02-07,INTERVENTIONAL,PHASE3,Chang Gung Memorial Hospital,OTHER,hepatitis
NCT04659005,Unknown,COMPLETED,2021-02-01,"Hepatitis B, Hepatocellular Carcinoma","Nurse-led decision counseling, Usual care","Zhengzhou - China, Hong Kong - China",2022-01-20,2020-12-09,2022-04-06,INTERVENTIONAL,NA,Chinese University of Hong Kong,OTHER,hepatitis
NCT00005305,Unknown,COMPLETED,1987-09,"Blood Disease, Hepatitis, Viral, Human, Liver Diseases, Hemophilia A",No interventions - observational study,No locations listed,1991-09,2000-05-26,2016-06-14,OBSERVATIONAL,Not Available,"University of North Carolina, Chapel Hill",OTHER,hepatitis
NCT01779505,Unknown,COMPLETED,2013-01,Healthy Volunteers,GS-4774,Phoenix - United States,2013-08,2013-01-30,2014-01-08,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT00493805,Unknown,TERMINATED,2007-04,"Hepatitis C, Chronic, Insulin Resistance","Combination of pegylated interferon alfa-2b and ribavirin, Combination of pegylated interferon alfa-2b and ribavirin",No locations listed,2009-10,2007-06-28,2017-04-07,INTERVENTIONAL,PHASE4,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT02683005,HIP,COMPLETED,2016-09,"Hepatitis C, Pregnancy",ledipasvir/sofosbuvir,Pittsburgh - United States,2020-02-03,2016-02-17,2020-03-04,INTERVENTIONAL,PHASE1,Catherine Chappell,OTHER,hepatitis
NCT03920605,HBV,UNKNOWN,2019-02-01,"Hepatitis B, Liver Fibrosis","Tenofovir Disoproxil Fumarate, Peginterferon Alfa-2a, Peginterferon Alfa-2b",Guangzhou - China,2021-10-30,2019-04-19,2019-05-22,INTERVENTIONAL,NA,"Third Affiliated Hospital, Sun Yat-Sen University",OTHER,hepatitis
NCT00704405,Unknown,COMPLETED,2009-03-27,"Hepatitis C, Chronic","Vaniprevir, Pegylated Interferon (Peg-IFN), Ribavirin (RBV), Placebo (PBO)",No locations listed,2012-03-26,2008-06-24,2018-10-09,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01594905,Unknown,UNKNOWN,2012-08,Chronic Hepatitis B,Entecavir + Tenofovir (MDR group),No locations listed,2014-04,2012-05-09,2014-01-31,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT02744105,Unknown,COMPLETED,2015-12,Beta Thalassemia Major,Spirulina,Tanta - Egypt,2017-12,2016-04-20,2018-09-11,INTERVENTIONAL,NA,Tanta University,OTHER,hepatitis
NCT03050905,Unknown,COMPLETED,2017-06-22,HCV Coinfection,"VEKIRAX, EXVIERA",Afula - Israel,2017-11-16,2017-02-13,2019-08-09,INTERVENTIONAL,PHASE4,"HaEmek Medical Center, Israel",OTHER,hepatitis
NCT00535847,Unknown,COMPLETED,2007-10,Hepatitis C,"Telaprevir, Ribavirin, Pegylated interferon alfa 2a","Birmingham - United States, Los Angeles - United States, San Diego - United States, San Francisco - United States, Denver - United States, Englewood - United States, Gainesville - United States, Jacksonville - United States, Jacksonville - United States, Miami - United States, Sarasota - United States, Atlanta - United States, Chicago - United States, Indianapolis - United States, Baton Rouge - United States, Portland - United States, Baltimore - United States, Boston - United States, Worcester - United States, Detroit - United States, St Louis - United States, Omaha - United States, Albuquerque - United States, Manhasset - United States, New York - United States, Durham - United States, Cincinnati - United States, Cleveland - United States, Hershey - United States, Pittsburgh - United States, Columbia - United States, Germantown - United States, Dallas - United States, Houston - United States, San Antonio - United States, Annandale - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Vienna - Austria, Calgary - Canada, Edmonton - Canada, Vancouver - Canada, Winnipeg - Canada, Toronto - Canada, Creteil - France, Lyon - France, Nice - France, Paris - France, Pessac - France, Vandoeuvre - France, Berlin - Germany, Bonn - Germany, Cologne - Germany, Dusseldorf - Germany, Frankfurt - Germany, Hannover - Germany, Amsterdam - Netherlands, Leiden - Netherlands, Rotterdam - Netherlands, Santurce - Puerto Rico, London - United Kingdom",2010-02,2007-09-26,2014-08-05,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT00401947,Unknown,TERMINATED,2006-11-30,HCV Infection,ACH-0137171,"Phoenix - United States, La Jolla - United States, San Francisco - United States, Boston - United States, New York - United States, Dallas - United States, San Antonio - United States, Berlin - Germany, Utrecht - Netherlands",Unknown Date,2006-11-22,2022-09-15,INTERVENTIONAL,PHASE2,"Alexion Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT01948193,Unknown,COMPLETED,2014-02,"Diphtheria, Tetanus, Whooping Cough, Hepatitis B, Poliomyelitis, Invasive Hib Infections",Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine,"Ludhiana - India, Pune - India",2014-12,2013-09-23,2015-10-20,INTERVENTIONAL,PHASE3,"Sanofi Pasteur, a Sanofi Company",INDUSTRY,hepatitis
NCT00473993,HepCOP,COMPLETED,2007-07,"Hepatitis C, Chronic, Substance Abuse Treatment Centers, Opioid-Related Disorders",No interventions listed,No locations listed,Unknown Date,2007-05-16,2009-02-16,OBSERVATIONAL,Not Available,"Seidenberg, Arztpraxis A., M.D.",INDIV,hepatitis
NCT05785793,CAMERA,RECRUITING,2023-02-01,Autoimmune Hepatitis,No interventions listed,Shanghai - China,2028-02-01,2023-03-27,2023-03-28,OBSERVATIONAL,Not Available,Shanghai Jiao Tong University School of Medicine,OTHER,hepatitis
NCT06047093,RES-HBV,RECRUITING,2024-03-08,Chronic Hepatitis b,"Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique, Creation of a serum biobank, FNA feasibility and acceptability questionnaire",Lyon - France,2028-03-08,2023-09-21,2024-11-26,INTERVENTIONAL,NA,Hospices Civils de Lyon,OTHER,hepatitis
NCT00160251,Unknown,COMPLETED,2005-09,Chronic Hepatitis C,"Boceprevir (BOC), PegIntron (PEG), Ribavirin (RBV)",No locations listed,2007-07,2005-09-12,2015-10-14,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01842451,Unknown,COMPLETED,2013-06,"Chronic Hepatitis C, CHC, HCV, Hepatitis C","VX-135, Daclatasvir","Auckland - New Zealand, Christchurch - New Zealand",2014-05,2013-04-29,2015-12-29,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT01533051,Unknown,UNKNOWN,2012-02,Chronic Hepatitis B,No interventions listed,"Seoul - Korea, Republic of",2015-03,2012-02-15,2012-05-08,OBSERVATIONAL,Not Available,Yonsei University,OTHER,hepatitis
NCT03160651,Unknown,UNKNOWN,2018-02-09,Alcoholic Hepatitis,Methylprednisolone or placebo,Brussels - Belgium,2022-06,2017-05-19,2021-02-26,INTERVENTIONAL,NA,Erasme University Hospital,OTHER,hepatitis
NCT00244751,Unknown,COMPLETED,2005-11-02,"Cirrhosis, Liver","GI262570 0.5 mg, GI262570 1.0 mg, Placebo","Birmingham - United States, Tucson - United States, North Little Rock - United States, Bakersfield - United States, La Jolla - United States, Los Angeles - United States, Los Angeles - United States, Newport Beach - United States, Pasadena - United States, Sacramento - United States, San Clemente - United States, San Francisco - United States, Santa Clara - United States, Englewood - United States, Washington - United States, Fort Lauderdale - United States, Miami - United States, Orlando - United States, Sarasota - United States, Atlanta - United States, Atlanta - United States, Atlanta - United States, Marietta - United States, Honolulu - United States, Indianapolis - United States, Iowa City - United States, Louisville - United States, Lutherville-Timonium - United States, Boston - United States, Boston - United States, Boston - United States, Worcester - United States, Ann Arbor - United States, Detroit - United States, Saint Louis - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, New York - United States, New York - United States, Syracuse - United States, The Bronx - United States, Chapel Hill - United States, Durham - United States, Cincinnati - United States, Cincinnati - United States, Cleveland - United States, Tulsa - United States, Hershey - United States, Lancaster - United States, Dallas - United States, Houston - United States, San Antonio - United States, Charlottesville - United States, Fairfax - United States, Richmond - United States, Richmond - United States, Herston - Australia, Camperdown - Australia, Clayton - Australia, Fitzroy, Melbourne - Australia, Heidelberg - Australia, Melbourne - Australia, Calgary - Canada, Vancouver - Canada, Victoria - Canada, Winnipeg - Canada, Halifax - Canada, London - Canada, Ottawa - Canada, Toronto - Canada, Toronto - Canada, Toronto - Canada, Montreal - Canada, Brno - Bohunice - Czechia, Hradec Kralove - Czechia, Praha 4 - Czechia, Praha 6 - Czechia, Freiburg - Germany, Heidelberg - Germany, Tuebingen - Germany, Erlangen - Germany, Frankfurt - Germany, Hannover - Germany, Bonn - Germany, Duesseldorf - Germany, Muenster - Germany, Homburg - Germany, Halle - Germany, Leipzig - Germany, Berlin - Germany, Hamburg - Germany, Haifa - Israel, Jerusalem - Israel, Nazareth - Israel, Petach-Tikva - Israel, Rehovot - Israel, Tel-Aviv - Israel, Daegu - Korea, Republic of, Pusan - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Bandar Tun Razak, Cheras - Malaysia, Kepong - Malaysia, Auckland - New Zealand, San Juan - Puerto Rico, Bucharest - Romania, Bucharest - Romania, Cluj-Napoca, Cluj - Romania, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Saint-Petersburg - Russian Federation, Singapore - Singapore, Kaohsiung - Taiwan, Kaohsiung - Taiwan, Taipei - Taiwan, Taoyuan - Taiwan",2008-03-13,2005-10-27,2017-12-11,INTERVENTIONAL,PHASE2,GlaxoSmithKline,INDUSTRY,hepatitis
NCT02114151,Unknown,COMPLETED,2014-04,Hepatitis C Virus Infection,"Simeprevir, Sofosbuvir","Dothan - United States, Bakersfield - United States, Chula Vista - United States, Los Angeles - United States, San Diego - United States, Englewood - United States, Bradenton - United States, Lauderdale Lakes - United States, Maitland - United States, Miami - United States, Orlando - United States, Wellington - United States, Atlanta - United States, Columbus - United States, Marietta - United States, Jackson - United States, Kansas City - United States, Hillsborough - United States, Vineland - United States, New York - United States, Asheville - United States, Winston Salem - United States, East Greenwich - United States, Providence - United States, Greer - United States, Germantown - United States, Knoxville - United States, Nashville - United States, Arlington - United States, Austin - United States, San Antonio - United States, Norfolk - United States, Vancouver - Canada, Montreal - Canada",2015-01,2014-04-15,2016-04-04,INTERVENTIONAL,PHASE3,Janssen Infectious Diseases BVBA,INDUSTRY,hepatitis
NCT01289951,LIVERAL,COMPLETED,2010-12,"Human Immunodeficiency Virus, Hepatitis C","Raltegravir 400 mg/12hours, Raltegravir 400 mg/12hours",Madrid - Spain,2011-06,2011-02-04,2013-02-01,INTERVENTIONAL,PHASE1,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,OTHER,hepatitis
NCT01475851,Unknown,COMPLETED,2011-12,"Hepatitis B, Chronic",GSK548470 300 mg tablet,"Aichi - Japan, Aichi - Japan, Chiba - Japan, Fukuoka - Japan, Hiroshima - Japan, Hokkaido - Japan, Kagoshima - Japan, Kanagawa - Japan, Miyagi - Japan, Tokyo - Japan, Tokyo - Japan",2013-06,2011-11-21,2015-06-22,INTERVENTIONAL,PHASE3,GlaxoSmithKline,INDUSTRY,hepatitis
NCT00559247,Unknown,COMPLETED,2008-01,Chronic Hepatitis C,BMS-650032 or Placebo,"Cypress - United States, Orlando - United States, Baltimore - United States, Rochester - United States, San Antonio - United States",2008-07,2007-11-16,2010-09-13,INTERVENTIONAL,PHASE2,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT03382847,Unknown,COMPLETED,2018-01-05,Heart Failure,"Transplant with HCV positive donor, followed by surveillance and treatment of viremia",New York - United States,2020-05-06,2017-12-26,2021-02-03,INTERVENTIONAL,PHASE4,NYU Langone Health,OTHER,hepatitis
NCT02114177,Unknown,COMPLETED,2014-04,Hepatitis C Virus Infection,"Simeprevir, Simeprevir, Sofosbuvir, Sofosbuvir","Dothan - United States, Bakersfield - United States, Chula Vista - United States, Los Angeles - United States, San Diego - United States, Englewood - United States, Bradenton - United States, Jacksonville - United States, Lauderdale Lakes - United States, Maitland - United States, Miami - United States, Orlando - United States, Wellington - United States, Zephyrhills - United States, Atlanta - United States, Columbus - United States, Marietta - United States, Indianapolis - United States, Jackson - United States, Kansas City - United States, Hillsborough - United States, Vineland - United States, Manhasset - United States, New York - United States, Ny - United States, Asheville - United States, Winston Salem - United States, Pittsburgh - United States, East Greenwich - United States, Providence - United States, Greer - United States, Germantown - United States, Knoxville - United States, Nashville - United States, Arlington - United States, Austin - United States, San Antonio - United States, Falls Church - United States, Norfolk - United States, Vancouver - Canada, Montreal - Canada",2015-01,2014-04-15,2016-04-12,INTERVENTIONAL,PHASE3,Janssen Infectious Diseases BVBA,INDUSTRY,hepatitis
NCT02917577,Unknown,COMPLETED,2016-11-22,Autoimmune Rheumatologic Disease,"Avaxim Pediatric®, Avaxim ® (adult)",Calgary - Canada,2023-06,2016-09-28,2024-10-03,INTERVENTIONAL,NA,University of Calgary,OTHER,hepatitis
NCT02822547,Unknown,UNKNOWN,2015-03,Chronic Hepatitis B,Peginterferon alfa-2a,"Seoul - Korea, Republic of",2016-09,2016-07-04,2016-07-04,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT03670251,MOVIDA-Hep,COMPLETED,2019-05-09,"Hepatitis C, Dried Blood Spot",Blood sampling,"Hanoi - Vietnam, Hanoi - Vietnam",2019-07-11,2018-09-13,2022-04-01,INTERVENTIONAL,NA,Institut Pasteur,INDUSTRY,hepatitis
NCT04044651,Unknown,WITHDRAWN,2019-10-30,Hepatocellular Carcinoma,"Lenvatinib, Nivolumab","Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China",2021-03-30,2019-08-05,2020-01-09,INTERVENTIONAL,PHASE3,Shi Ming,OTHER,hepatitis
NCT03932851,Unknown,UNKNOWN,2018-08-01,Pregnancy,IVF-ET,Beijing - China,2019-05-01,2019-05-01,2019-05-01,OBSERVATIONAL,Not Available,Beijing Ditan Hospital,OTHER,hepatitis
NCT00487747,Unknown,COMPLETED,2006-08,"Hepatitis B, Chronic",peginterferon alfa-2a [Pegasys],"Chelyabinsk - Russian Federation, Ekaterinburg - Russian Federation, Ekaterinburg - Russian Federation, Irkutsk - Russian Federation, Kazan - Russian Federation, Krasnoyarsk - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Nizhny Novgorod - Russian Federation, Novokuznetsk - Russian Federation, Novosibirsk - Russian Federation, Rostov-na-donu - Russian Federation, Samara - Russian Federation, St Petersburg - Russian Federation, Stavropol - Russian Federation, Tomsk - Russian Federation, Tumen - Russian Federation, UFA - Russian Federation, Volgograd - Russian Federation, Yakutsk - Russian Federation",2009-10,2007-06-19,2017-04-06,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT04204447,Unknown,COMPLETED,2019-11-27,Hepatitis C,"Hepatitis C Educational Brochure, Hepatitis C Educational Video","Buffalo - United States, Orchard Park - United States",2020-10-31,2019-12-19,2024-09-19,INTERVENTIONAL,NA,State University of New York at Buffalo,OTHER,hepatitis
NCT03771677,IFNA2/ISGs,RECRUITING,2018-12-01,Hepatitis B,"Nucleotide Analog, Interferon Alfa-2A",Guangzhou - China,2023-12-30,2018-12-11,2023-05-08,INTERVENTIONAL,NA,Sun Yat-sen University,OTHER,hepatitis
NCT04112147,Unknown,UNKNOWN,2018-08-10,Chronic Hepatitis B,"Antroquinonol capsule 100mg, Antroquinonol capsule 200mg, Placebo oral capsule",Taichung - Taiwan,2020-06-30,2019-10-02,2019-10-02,INTERVENTIONAL,PHASE2,Cheng-Chung Wei,OTHER,hepatitis
NCT01928147,Unknown,COMPLETED,2013-08,"Hepatitis C, Chronic","PPI-383, Placebo","Phoenix - Mauritius, London - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom, Nottingham - United Kingdom",2015-07,2013-08-23,2015-11-26,INTERVENTIONAL,PHASE1,"Presidio Pharmaceuticals, Inc.",INDUSTRY,hepatitis
NCT05738447,Unknown,UNKNOWN,2023-02-15,"Liver Cancer, Hepatocellular Carcinoma",HBV mRNA vaccine,Chengdu - China,2024-01-01,2023-02-22,2023-02-22,INTERVENTIONAL,PHASE1,West China Hospital,OTHER,hepatitis
NCT01311947,Unknown,COMPLETED,2011-03,"Hepatitis B, Chronic",Peginterferon alfa-2a,Taichung - Taiwan,2012-03,2011-03-10,2013-07-30,OBSERVATIONAL,Not Available,China Medical University Hospital,OTHER,hepatitis
NCT02523547,Unknown,UNKNOWN,2015-01,Chronic Hepatitis B,"Cavir, Baraclude","Seoul - Korea, Republic of",2017-02,2015-08-14,2015-08-14,INTERVENTIONAL,PHASE4,Hanmi Pharmaceutical Company Limited,INDUSTRY,hepatitis
NCT01821547,Unknown,COMPLETED,2013-03,Hepatitis B,Hepatitis B vaccine,Oxford - United Kingdom,2014-04,2013-04-01,2021-01-14,INTERVENTIONAL,PHASE4,University of Oxford,OTHER,hepatitis
NCT04136405,REVERSO,UNKNOWN,2020-07-14,"Hepatitis C Virus Infection, Past or Present, Chronic Hepatitis c",No interventions listed,Gaoua - Burkina Faso,2020-08-04,2019-10-23,2021-04-19,OBSERVATIONAL,Not Available,"ANRS, Emerging Infectious Diseases",OTHER_GOV,hepatitis
NCT03708705,Unknown,UNKNOWN,2018-11-20,Hepatocellular Carcinoma,Risk model of tumor relapse,No locations listed,2020-05-01,2018-10-17,2018-10-19,OBSERVATIONAL,Not Available,Zhejiang University,OTHER,hepatitis
NCT00528528,Unknown,COMPLETED,2007-10,Chronic Hepatitis C,"Telaprevir, Peg-IFN-alfa-2a, Peg-IFN-alfa-2b, Ribavirin (RBV) tablet, Ribavirin (RBV) capsule","Wien - Austria, Brussels - Belgium, Bruxelles - Belgium, Gent - Belgium, Leuven - Belgium, Liège - Belgium, Angers Cedex 9 - France, Clichy - France, Grenoble - France, Lille Cedex - France, Nice - France, Paris Cedex 12 - France, Paris - France, Vandoeuvre Les Nancy - France, Düsseldorf - Germany, Frankfurt N/A - Germany, Freiburg - Germany, Hamburg - Germany, Hannover - Germany, Koln - Germany, Tübingen - Germany, Leiden - Netherlands, Nijmegen - Netherlands, Barcelona - Spain, Madrid - Spain, Valencia - Spain",2009-07,2007-09-12,2014-06-25,INTERVENTIONAL,PHASE2,Tibotec BVBA,INDUSTRY,hepatitis
NCT05497388,Unknown,ACTIVE_NOT_RECRUITING,2023-02-23,HIV Infections,Serious Game,Taipei - Taiwan,2024-07-31,2022-08-11,2024-10-18,INTERVENTIONAL,NA,National Taiwan University Hospital,OTHER,hepatitis
NCT00441493,Unknown,COMPLETED,2006-09,Hepatitis C,fluvastatin,Oklahoma City - United States,2007-03,2007-03-01,2012-07-27,INTERVENTIONAL,NA,"Bader, Ted, M.D.",INDIV,hepatitis
NCT06115993,Unknown,ACTIVE_NOT_RECRUITING,2023-08-03,"Hepatitis B, Chronic","AHB-137 injection, Placebo","Chongqing - China, Guangzhou - China, Jilin - China",2024-12,2023-11-03,2024-11-05,INTERVENTIONAL,PHASE2,"Ausper Biopharma Co., Ltd.",INDUSTRY,hepatitis
NCT01590654,Unknown,COMPLETED,2012-04,Hepatitis B,"Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts GS-9620","Phoenix - United States, Indianapolis - United States, New Orleans - United States, Boston - United States, Detroit - United States, Kansas City - United States, New York - United States, Houston - United States, Salt Lake City - United States, Kingswood - Australia, Herston - Australia, Clayton - Australia, Melbourne - Australia, Nedlands - Australia, Calgary - Canada, Edmonton - Canada, Laval - Canada, Seoul - Korea, Republic of, Seoul - Korea, Republic of, Grafton - New Zealand",2013-11,2012-05-03,2013-12-20,INTERVENTIONAL,PHASE1,Gilead Sciences,INDUSTRY,hepatitis
NCT01970254,Unknown,COMPLETED,2013-06-24,"Cancer, Hepatitis B, HBV, Hepatitis B Infection, Malignant Neoplasm","Hepatitis B Screening, Survey Administration",Houston - United States,2022-07-19,2013-10-28,2022-08-15,OBSERVATIONAL,Not Available,M.D. Anderson Cancer Center,OTHER,hepatitis
NCT02056054,Unknown,TERMINATED,2013-09-09,De Novo Autoimmune Hepatitis,"Pediatric transplant subject with d-AIH, Pediatric transplant subject with acute rejection, Pediatric transplant subject with chronic rejection, Adult non-transplant patients with auto-immune hepatitis, Adult non-transplant subjects with chronic hepatitis C virus, Pediatric control subjects, Adult transplanted subjects with de novo autoimmune hepatitis",No locations listed,2019-11-25,2014-02-05,2021-12-10,OBSERVATIONAL,Not Available,Yale University,OTHER,hepatitis
NCT01853254,Unknown,COMPLETED,2003-09,"Hepatitis C, Chronic","Peginterferon alfa-2a, Ribavirin","Birmingham - United States, La Jolla - United States, Long Beach - United States, San Diego - United States, San Diego - United States, San Francisco - United States, Aurora - United States, Gainesville - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Orlando - United States, Orlando - United States, Sarasota - United States, Wellington - United States, Atlanta - United States, Atlanta - United States, Marietta - United States, Honolulu - United States, Boise - United States, Indianapolis - United States, Iowa City - United States, Kansas City - United States, Baltimore - United States, Framingham - United States, Worcester - United States, Plymouth - United States, Newark - United States, Vineland - United States, Binghamton - United States, Manhasset - United States, New York - United States, New York - United States, Poughkeepsie - United States, Durham - United States, Statesville - United States, Cleveland - United States, Portland - United States, Lancaster - United States, Philadelphia - United States, Providence - United States, Germantown - United States, Dallas - United States, Houston - United States, San Antonio - United States, Charlottesville - United States, Bellevue - United States, Seattle - United States, Tacoma - United States, Adelaide - Australia, Herston - Australia, Ribeirao Preto - Brazil, Salvador - Brazil, Sao Paulo - Brazil, Sao Paulo - Brazil, Vandoeuvre-les-nancy - France, Thessaloniki - Greece, Bergamo - Italy, Napoli - Italy, Warszawa - Poland, Ponce - Puerto Rico, San Juan - Puerto Rico, San Juan - Puerto Rico, Santurce - Puerto Rico, Barcelona - Spain, Taoyuan - Taiwan, Plymouth - United Kingdom",2011-09,2013-05-14,2013-09-04,INTERVENTIONAL,PHASE3,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT02738554,Unknown,COMPLETED,2016-01,Chronic Hepatitis B,Treatment cessation,Hong Kong - Hong Kong,2020-01,2016-04-14,2020-02-10,INTERVENTIONAL,NA,The University of Hong Kong,OTHER,hepatitis
NCT01905254,Unknown,COMPLETED,2007-08,Liver Cirrhosis,"Transient elastography (TE), Liver biopsy",Hamburg - Germany,2010-08,2013-07-23,2015-05-06,INTERVENTIONAL,NA,Universitätsklinikum Hamburg-Eppendorf,OTHER,hepatitis
NCT02105454,Unknown,COMPLETED,2014-05-23,Hepatitis C Virus,"Grazoprevir (GZR), Elbasvir (EBR), Ribavirin (RBV)",No locations listed,2015-05-04,2014-04-07,2018-09-24,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT01903954,Unknown,COMPLETED,2011-01,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], placebo, ribavirin [Copegus], setrobuvir",No locations listed,2013-05,2013-07-19,2016-11-02,INTERVENTIONAL,PHASE2,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01264354,Unknown,COMPLETED,2010-03,Chronic Hepatitis B,"Clevudine 30mg, Clevudine 20mg+Adefovir dipivoxil 10mg, Clevudine 20mg","Seoul - Korea, Republic of",2012-08,2010-12-21,2014-12-18,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT00230854,Unknown,COMPLETED,2005-08,"Chronic Hepatitis C, Hepatitis, Viral, Human",EMZ702,"London - Canada, Ottawa - Canada",Unknown Date,2005-10-03,2019-10-18,INTERVENTIONAL,PHASE1,"OPKO Health, Inc.",INDUSTRY,hepatitis
NCT02123654,Unknown,COMPLETED,2014-04,Hepatitis C Virus Infection,"Daclatasvir, Asunaprevir, DCV 3DAA, Placebo for DCV 3DAA, Placebo for Daclatasvir, Placebo for Asunaprevir","Nagoya-shi - Japan, Nagoya-shi - Japan, Fukuoka-shi - Japan, Kurume-shi - Japan, Gifu-shi - Japan, Ogaki-shi - Japan, Takasaki - Japan, Hiroshima-Shi - Japan, Sapporo-shi - Japan, Sapporo-shi - Japan, Kobe-shi - Japan, Kanazawa-shi - Japan, Takamatsu-shi - Japan, Kagoshima-shi - Japan, Kawasaki-shi - Japan, Yokohama - Japan, Kyoto-shi - Japan, Kashihara - Japan, Okayama-shi - Japan, Osaka-shi - Japan, Osaka-shi - Japan, Suita-shi - Japan, Suita - Japan, Iruma-gun - Japan, Bunkyo-ku - Japan, Minato-ku - Japan, Musashino-shi - Japan, Shinjuku-Ku - Japan, Yamagata-shi - Japan, Chuo-shi - Japan, Fukui - Japan, Kumamoto - Japan, Miyazaki - Japan, Nishinomiya-shi - Japan, Saga - Japan",2015-01,2014-04-25,2015-09-18,INTERVENTIONAL,PHASE3,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT01518933,LEG-SIL-LTX-02,TERMINATED,2011-08,Hepatitis C Virus Recurrence,"Silibinin (Legalon-SIL), Saline",Bari - Italy,2012-04,2012-01-26,2015-03-05,INTERVENTIONAL,PHASE2,Rottapharm,INDUSTRY,hepatitis
NCT01210287,IHBVRL,UNKNOWN,2010-10,Lymphoma,nucleoside analog reverse transcriptase inhibitor,"Shanghai - China, Shanghai - China",2014-08,2010-09-28,2014-01-08,INTERVENTIONAL,PHASE3,Fudan University,OTHER,hepatitis
NCT01974687,Unknown,COMPLETED,2013-10-31,Chronic Hepatitis C,"Uprifosbuvir, Placebo, Itraconazole",No locations listed,2015-09-02,2013-11-01,2018-09-13,INTERVENTIONAL,PHASE2,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT03071133,Unknown,COMPLETED,2018-01-01,Hepatitis C,No interventions listed,Tokyo - Japan,2019-01-08,2017-03-06,2022-02-23,OBSERVATIONAL,Not Available,Bristol-Myers Squibb,INDUSTRY,hepatitis
NCT00896233,Unknown,COMPLETED,2009-08,"Liver Fibrosis, Hepatitis C Virus",MRE,No locations listed,2010-01,2009-05-11,2015-08-25,INTERVENTIONAL,PHASE1,Merck Sharp & Dohme LLC,INDUSTRY,hepatitis
NCT04129554,Unknown,COMPLETED,2019-11-06,"Hepatitis B, Chronic","JNJ-73763989, JNJ-56136379, Placebo for JNJ-73763989, Placebo for JNJ-56136379, Entecavir (ETV) monohydrate, Tenofovir disoproxil fumarate (TDF), Tenofovir alafenamide (TAF)","Bruxelles - Belgium, Edegem - Belgium, Edegem - Belgium, Gent - Belgium, Leuven - Belgium, Clichy - France, Lyon - France, Marseille - France, Paris - France, Rennes - France, Vandoeuvre les Nancy - France, Villejuif - France, Essen - Germany, Frankfurt - Germany, Freiburg - Germany, Hamburg - Germany, Hamburg - Germany, Hannover - Germany, Leipzig - Germany, Mainz - Germany, Messina - Italy, Milano - Italy, Modena - Italy, Pisa - Italy, Rome - Italy, Bydgoszcz - Poland, Gdansk - Poland, Myslowice - Poland, Wroclaw - Poland, Barcelona - Spain, Barcelona - Spain, Madrid - Spain, Madrid - Spain, Santander - Spain, Valencia - Spain, Birmingham - United Kingdom, Crumpsall - United Kingdom, Glasgow - United Kingdom, London - United Kingdom, London - United Kingdom, London - United Kingdom",2021-07-08,2019-10-17,2025-02-04,INTERVENTIONAL,PHASE2,Janssen Sciences Ireland UC,INDUSTRY,hepatitis
NCT01948687,RT-ELASTO,UNKNOWN,2013-08,"Cirrhosis, Chronic Liver Disease",No interventions listed,"Craiova - Romania, Timisoara - Romania",2014-03,2013-09-24,2013-09-24,OBSERVATIONAL,Not Available,University of Medicine and Pharmacy Craiova,OTHER,hepatitis
NCT04464733,Unknown,COMPLETED,2020-07-20,Chronic Hepatitis b,"HRS9950, Placebo",Beijing - China,2023-05-30,2020-07-09,2024-11-05,INTERVENTIONAL,PHASE1,"Jiangsu HengRui Medicine Co., Ltd.",INDUSTRY,hepatitis
NCT01112033,Unknown,COMPLETED,2010-06,"Hepatitis C, Chronic",No interventions listed,Prague - Czech Republic,2013-03,2010-04-28,2015-08-07,OBSERVATIONAL,Not Available,"Charles University, Czech Republic",OTHER,hepatitis
NCT01609933,Unknown,COMPLETED,2012-12-18,Chronic Hepatitis C,"ABT-450/r, ABT-267, pegylated interferon alpha-2a (pegIFN), Ribavirin (RBV)",No locations listed,2017-05-03,2012-06-01,2018-06-19,INTERVENTIONAL,PHASE2,"AbbVie (prior sponsor, Abbott)",INDUSTRY,hepatitis
NCT03977987,Unknown,COMPLETED,2011-01-01,Hepatitis B,nucleos(t)ide analogue,Suzhou - China,2018-12-30,2019-06-06,2019-06-12,OBSERVATIONAL,Not Available,Huashan Hospital,OTHER,hepatitis
NCT01595633,Unknown,UNKNOWN,2012-03,Chronic Hepatitis B,Switching from adefovir (10mg/day) to tenofovir (300mg/day),"Seoul - Korea, Republic of",2014-02,2012-05-10,2012-05-10,INTERVENTIONAL,PHASE4,Yonsei University,OTHER,hepatitis
NCT01264133,Unknown,TERMINATED,2009-09,Chronic Hepatitis B,"Clevudine, Adefovir","Seoul - Korea, Republic of",2013-06,2010-12-21,2014-12-18,INTERVENTIONAL,PHASE4,Bukwang Pharmaceutical,INDUSTRY,hepatitis
NCT02581033,STOP,UNKNOWN,2014-05,Chronic Hepatitis B.,Nucleoside Analogue therapy,Melbourne - Australia,2018-05,2015-10-20,2016-10-14,INTERVENTIONAL,NA,St Vincent's Hospital Melbourne,OTHER,hepatitis
NCT04294433,Unknown,UNKNOWN,2018-06-11,Hepatitis B,"Infanrix-hexa, Twinrix-Junior","Quebec - Canada, Quebec - Canada",2020-12-30,2020-03-04,2020-03-04,INTERVENTIONAL,PHASE3,Laval University,OTHER,hepatitis
NCT00863187,Unknown,UNKNOWN,2009-02,Lymphoma,rituximab,No locations listed,2010-02,2009-03-17,2009-03-17,INTERVENTIONAL,NA,Rambam Health Care Campus,OTHER,hepatitis
NCT01433133,Unknown,TERMINATED,2012-10,Hepatitis C,implantation,No locations listed,2013-10,2011-09-13,2016-09-13,INTERVENTIONAL,PHASE2,Medgenics Medical Israel Ltd.,INDUSTRY,hepatitis
NCT02443233,Unknown,COMPLETED,2014-01,Hepatitis B Infection,No interventions listed,Hong Kong - China,2016-12,2015-05-13,2017-06-12,OBSERVATIONAL,Not Available,The University of Hong Kong,OTHER,hepatitis
NCT00418054,Unknown,COMPLETED,2005-12,Chronic Hepatitis C,"Nitazoxanide plus peginterferon alfa-2b, Peginterferon alfa-2b","Alexandria - Egypt, Tanta - Egypt",Unknown Date,2007-01-04,2007-01-04,INTERVENTIONAL,PHASE2,Romark Laboratories L.C.,INDUSTRY,hepatitis
NCT02732054,Unknown,COMPLETED,2015-03,Hepatitis B,"Recombinant Hepatitis B vaccine [(CIGB) La Habana, Cuba]",Muang - Thailand,2016-02,2016-04-08,2017-04-19,INTERVENTIONAL,PHASE4,Chiang Mai University,OTHER,hepatitis
NCT00641654,RelapC,TERMINATED,2007-01,Chronic Hepatitis C,"Pegylated interferon alfa-2a and ribavirin, Pegylated interferon alfa-2a and ribavirin, Pegylated interferon alfa-2a and ribavirin",Goteborg - Sweden,2009-12,2008-03-24,2012-08-30,INTERVENTIONAL,PHASE4,Göteborg University,OTHER,hepatitis
NCT02828254,Unknown,COMPLETED,2014-12-18,Hepatitis C Virus-infected Cirrhosis,PRI-724,Tokyo - Japan,2017-03-27,2016-07-11,2022-07-07,OBSERVATIONAL,Not Available,Komagome Hospital,OTHER,hepatitis
NCT02759354,Unknown,COMPLETED,2016-04-26,"Hepatitis B, Pertussis",Blood Sample,No locations listed,2016-07-29,2016-05-03,2020-06-09,INTERVENTIONAL,PHASE3,MCM Vaccines B.V.,INDUSTRY,hepatitis
NCT00001854,Unknown,COMPLETED,1999-02-12,Chronic Hepatitis C,Ribavirin,Bethesda - United States,2007-10-10,1999-11-04,2017-07-02,INTERVENTIONAL,PHASE4,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT01581554,Unknown,COMPLETED,2011-05-18,"Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative",No interventions listed,Bethesda - United States,Unknown Date,2012-04-20,2025-02-27,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT00983853,Unknown,COMPLETED,2009-10,"Hepatitis C, HIV Infections","telaprevir or matching placebo, telaprevir or matching placebo, peginterferon alfa-2a, ribavirin (fixed dose), ribavirin (weight-based dose)","Beverly Hills - United States, San Diego - United States, San Francisco - United States, Miami - United States, Orlando - United States, Chicago - United States, Baltimore - United States, Boston - United States, New York - United States, Cincinnati - United States, Dallas - United States, Paris - France, Bonn-Venusberg - Germany, Hamburg - Germany, Barcelona - Spain, Madrid - Spain",2012-03,2009-09-24,2013-10-10,INTERVENTIONAL,PHASE2,Vertex Pharmaceuticals Incorporated,INDUSTRY,hepatitis
NCT02190253,Unknown,COMPLETED,2014-07-12,Hepatitis E,No interventions listed,"Washington - United States, Philadelphia - United States, Madison - United States",2019-02-05,2014-07-15,2024-09-19,OBSERVATIONAL,Not Available,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,hepatitis
NCT04061551,Unknown,UNKNOWN,2016-12,"Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic",EC clinic support - whole of practice interventions delivery through nurse-led model,Melbourne - Australia,2021-12-31,2019-08-20,2021-08-24,INTERVENTIONAL,NA,Macfarlane Burnet Institute for Medical Research and Public Health Ltd,OTHER,hepatitis
NCT00107653,Unknown,COMPLETED,2004-10,"Hepatitis C, Chronic","Ribavirin, Peginterferon alfa-2a, Ribavirin, Peginterferon alfa-2a","Scottsdale - United States, Tucson - United States, Anaheim - United States, Fountain Valley - United States, Fresno - United States, Lancaster - United States, Los Angeles - United States, Los Angeles - United States, Los Angeles - United States, Palo Alto - United States, Redlands - United States, Sacramento - United States, San Bernardino - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Diego - United States, San Francisco - United States, San Luis Obispo - United States, Ventura - United States, Pueblo - United States, Boca Raton - United States, Bradenton - United States, Miami - United States, North Miami Beach - United States, Plantation - United States, Austell - United States, Chicago - United States, Chicago - United States, Gurnee - United States, Indianapolis - United States, Baton Rouge - United States, New Orleans - United States, Baltimore - United States, Framingham - United States, Worcester - United States, St Louis - United States, Vineland - United States, Bayside - United States, New York - United States, Rochester - United States, Chapel Hill - United States, Fayetteville - United States, Philadelphia - United States, Philadelphia - United States, Nashville - United States, Dallas - United States, Fort Sam Houston - United States, Fort Worth - United States, Galveston - United States, Houston - United States, Houston - United States, San Antonio - United States, San Antonio - United States, Salt Lake City - United States, Fairfax - United States, Seattle - United States, Tacoma - United States, Ponce - Puerto Rico, Santurce - Puerto Rico",2007-09,2005-04-07,2016-06-21,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT05172453,Unknown,RECRUITING,2015-07-01,"Hepatitis B, Chronic, Mother to Child Transmission",comprehensive management algorithm for preventing mother-to-child transmission of HBV,"Guangzhou - China, Beijing - China, Beijing - China, Chang chun - China, Foshan - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Guangzhou - China, Hangzhou - China, Jiujiang - China, Nanjing - China, Shanghai - China, Shenzhen - China, Shenzhen - China",2025-06-30,2021-12-29,2021-12-29,OBSERVATIONAL,Not Available,"Nanfang Hospital, Southern Medical University",OTHER,hepatitis
NCT00403533,Unknown,COMPLETED,2006-02,Hepatitis C,20 mg of atorvastatin daily,Boston - United States,Unknown Date,2006-11-23,2006-11-23,INTERVENTIONAL,PHASE2,Massachusetts General Hospital,OTHER,hepatitis
NCT00239733,Unknown,TERMINATED,2005-03,"Thrombocytopenia, Hepatitis C, HIV Infections",Anti-D,New York - United States,2010-02,2005-10-17,2017-05-16,INTERVENTIONAL,PHASE4,National Institute of Allergy and Infectious Diseases (NIAID),NIH,hepatitis
NCT03852433,Unknown,COMPLETED,2019-05-31,Chronic Hepatitis Delta,"Bulevirtide, Peginterferon Alfa-2a (PEG-IFN alfa)","Clichy - France, Grenoble - France, Lione - France, Marseille - France, Paris - France, Paris - France, Chisinau - Moldova, Republic of, Chisinau - Moldova, Republic of, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Bucharest - Romania, Chelyabinsk - Russian Federation, Krasnodar - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Moscow - Russian Federation, Samara - Russian Federation",2022-04-05,2019-02-25,2024-10-08,INTERVENTIONAL,PHASE2,Gilead Sciences,INDUSTRY,hepatitis
NCT00087633,Unknown,COMPLETED,2004-10,"Hepatitis C, Chronic","peginterferon alfa-2a [Pegasys], Copegus","Birmingham - United States, Phoenix - United States, Los Angeles - United States, San Francisco - United States, San Francisco - United States, Aurora - United States, Gainesville - United States, Jacksonville - United States, Miami - United States, Chicago - United States, Indianapolis - United States, Baltimore - United States, Burlington - United States, Minneapolis - United States, Rochester - United States, Saint Louis - United States, Omaha - United States, Newark - United States, New York - United States, New York - United States, Cincinnati - United States, Philadelphia - United States, Philadelphia - United States, Nashville - United States, Dallas - United States, San Antonio - United States, Seattle - United States, Madison - United States",2008-10,2004-07-14,2018-03-29,INTERVENTIONAL,PHASE4,Hoffmann-La Roche,INDUSTRY,hepatitis
NCT01472354,LEAP-C,COMPLETED,2010-10,Hepatitis c,Leap-c group intervention,Worcester - United States,2012-11,2011-11-16,2013-05-30,INTERVENTIONAL,NA,"University of Massachusetts, Worcester",OTHER,hepatitis
NCT03313154,Unknown,COMPLETED,2015-11,"Psychiatric Disorders, Cognitive Impairment, Chronic Hepatitis c",Neuropsychiatric screening,Monserrato - Italy,2018-07,2017-10-18,2019-01-09,OBSERVATIONAL,Not Available,Azienda Ospedaliero Universitaria di Cagliari,OTHER,hepatitis
NCT01732354,Unknown,COMPLETED,2012-09,Hepatitis B,No interventions listed,Tainan - Taiwan,2013-11-20,2012-11-22,2018-04-19,OBSERVATIONAL,Not Available,Tainan Municipal Hospital,OTHER,hepatitis
NCT01395654,Unknown,UNKNOWN,2011-07,"Hepatitis, Tuberculosis, Pulmonary","isoniazid, rifampin, pyrazinamide","Tainan - Taiwan, Taipei - Taiwan",2013-12,2011-07-15,2012-12-27,INTERVENTIONAL,PHASE4,National Taiwan University Hospital,OTHER,hepatitis
